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Message from Donna E. Shalala 
Secretary of Health and Human Services 
The United States leads the world in understanding the importance of overall health and well- 
being to the strength of a Nation and its people. What we are coming to realize is that mental health 
is absolutely essential to achieving prosperity. According to the landmark “Global Burden of 
Disease” study, commissioned by the World Health Organization and the World Bank, 4 of the 10 
leading causes of disability for persons age 5 and older are mental disorders. Among developed 
nations, including the United States, major depression is the leading cause of disability. Also near 
the top of these rankings are manic-depressive illness, schizophrenia, and obsessive-compulsive 
disorder. Mental disorders also are tragic contributors to mortality, with suicide perennially 
representing one of the leading preventable causes of death in the United States atid.worldwide. 
The U.S. Congress declared the 1990s the Decade of the Brain. In this decade we have learned 
much through research-in basic neuroscience, behavioral science, and genetics-about the complex 
workings of the brain. Research can help us gain a further understanding of the fundamental 
mechanisms underlying thought, emotion, and behavior- and an understanding of what goes wrong 
in the brain in mental illness. It can also lead to better treatments and improved services for our 
diverse population. 
Now, with the publication of this first Surgeon General’s Report on Mental Health, we are 
poised to take what we know and to advance the state of mental health in the Nation. We can with 
great confidence encourage individuals to seek treatment when they find themselves experiencing 
the signs and symptoms of mental distress. Research has given us effective treatments and service 
delivery strategies for many mental disorders. An array of safe and potent medications and 
psychosocial interventions, typically used in combination, allow us to effectively treat most mental 
disorders. 
This seminal report provides us with an opportunity to dispel the myths and stigma surrounding 
mental illness. For too long the fear of mental illness has been profoundly destructive to people’s 
lives. In fact mental illnesses are just as real as other illnesses, and they are like other illnesses in 
most ways. Yet fear and stigma persist, resulting in lost opportunities for individuals to seek 
treatment and improve or recover. 
In this Administration, a persistent, courageous advocate of affordable, quality mental health 
services for all Americans is Mrs. Tipper Gore, wife of the Vice President. We salute her for her 
historic leadership and for her enthusiastic support of the initiative by the Surgeon General, Dr. 
David Satcher, to issue this groundbreaking Report on Mental Health. 
The 1999 White House Conference on Mental Health called for a national antistigma campaign. 
The Surgeon General issued a Call to Action on Suicide Prevention in 1999 as well. This Surgeon 
General’s Report on Mental Health takes the next step in advancing the important notion that mental 
health is fundamental health. 
Foreword 
Since the turn of this century, thanks in large measure to research-based public health 
innovations, the lifespan of the average American has nearly doubled. Today, our Nation’s physical 
health-as a whole-has never been better. Moreover, illnesses of the body, once shrouded in 
fear-such as cancer, epilepsy, and HIV/AIDS to name just a few -increasingly are seen as treatable, 
survivable, even curable ailments. Yet, despite unprecedented knowledge gained in just the past three 
decades about the brain and human behavior, mental health is often an afterthought and illnesses of 
the mind remain shrouded in fear and misunderstanding. 
This Report of the Surgeon General on Mental Health is the product, of an invigorating 
collaboration between two Federal agencies. The Substance Abuse and Men&Health Services 
Administration (SAMHSA), which provides national leadership and funding to the states and many 
professional and citizen organizations that are striving to improve the availability, accessibility, and 
quality of mental health services, was assigned lead responsibility for coordinating the development 
of the report. The National Institutes of Health (NM), which supports and conducts research on 
mental illness and mental health through its National Institute of Mental Health (NIMH), was pleased 
to be a partner in this effort. The agencies we respectively head were able to rely on the enthusiastic 
participation of hundreds of people who played a role in researching, writing, reviewing, and 
disseminating this report. We wish to express our appreciation and that of a mental health 
constituency, millions of Americans strong, to Surgeon General David Satcher, M.D., Ph.D., for 
inviting us to participate in this landmark report. 
The year 1999 witnessed the first White House Conference on Mental Health and the first 
Secretarial Initiative on Mental Health prepared under the aegis of the Department of Health and 
Human Services. These activities set an optimistic tone for progress that will be realized in the years 
ahead. Looking ahead, we take special pride in the remarkable record of accomplishment, in the 
spheres of both science and services, to which our agencies have contributed over past decades. With 
the impetus that the Surgeon General’s report provides, we intend to expand that record of 
accomplishment. This report recognizes the inextricably intertwined relationship between our mental 
health and our physical health and well-being. The report emphasizes that mental health and mental 
illnesses are important concerns at all ages. Accordingly, we will continue to attend to needs that 
occur across the lifespan, from the youngest child to the oldest among us. 
The report lays down a challenge to the Nation- to our communities, our health and social 
service agencies, our policymakers, employers, and citizens-to take action. SAMHSA and NIH look 
forward to continuing our collaboration to generate needed knowledge about the brain and behavior 
and to translate that knowledge to the service systems, providers, and citizens. 
Nelba Chavez, Ph.D. Steven E. Hyman, M.D. 
Administrator Director 
Substance Abuse and Mental Health National Institute of Mental Health 
Services Administration for The National Institutes of Health 
Bernard S. Arons, M.D. 
Director 
Center for Mental Health Services 
Preface 
from the Surgeon C&era/ 
U.S. Public Health Service 
The past century has witnessed extraordinary progress in our improvement of the public health 
through medical science and ambitious, often innovative, approaches to health care services. Previous 
Surgeons General reports have saluted our gains while continuing to set ever higher benchmarks for 
the public health. Through much of this era of great challenge and greater achievement, however, 
concerns regarding mental illness and mental health too often were relegated to the rear of our 
national consciousness. Tragic and devastating disorders such as schizophrenia, depression and 
bipolar disorder, Alzheimer’s disease, the mental and behavioral disorders suffered by children, and 
a range of other mental disorders affect nearly one in five Americans in any year, yet continue too 
frequently to be spoken of in whispers and shame. Fortunately, leaders in the mental health 
field-fiercely dedicated advocates, scientists, government officials, and consumers-have been 
insistent that mental health flow in the mainstream of health. I agree and issue this report in that spirit. 
This report makes evident that the neuroscience of mental health-a term that encompasses 
studies extending from molecular events to psychological, behavioral, and societal phenomena-has 
emerged as one of the most exciting arenas of scientific activity and human inquiry. We recognize 
that the brain is the integrator of thought, emotion, behavior, and health. Indeed, one of the foremost 
contributions of contemporary mental health research is the extent to which it has mended the 
destructive split between “mental’ and “physical” health. 
We know more today about how to treat mental illness effectively and appropriately than we 
know with certainty about how to prevent mental illness and promote mental health. Common sense 
and respect for our fellow humans tells us that a focus on the positive aspects of mental health 
demands our immediate attention. 
Even more than other areas of health and medicine, the mental health field is plagued by 
disparities in the availability of and access to its services. These disparities are viewed readily through 
the lenses of racial and cultural diversity, age, and gender. A key disparity often hinges on a person’s 
financial status; formidable financial barriers block off needed mental health care from too many 
people regardless of whether one has health insurance with inadequate mental health benefits, or is 
one of the 44 million Americans who lack any insurance. We have allowed stigma and a now 
unwarranted sense of hopelessness about the opportunities for recovery from mental illness to erect 
these barriers. It is time to take them down. 
Promoting mental health for all Americans will require scientific know-how but, even more 
importantly, a societal resolve that we will make the needed investment. The investment does not call 
for massive budgets; rather, it calls for the willingness of each of us to educate ourselves and others 
about mental health and mental illness, and thus to confront the attitudes, fear, and misunderstanding 
that remain as barriers before us. It is my intent that this report will usher in a healthy era of mind and 
body for the Nation. 
David Satcher, M.D., Ph.D. 
Surgeon General 
Acknowledgments 
Acknowledgments 
This report was prepared by the Department of 
Health and Human Services under the direction of 
the Substance Abuse and Mental Health Services 
Administration, Center for Mental Health Services, 
in partnership with the National Institute of Mental 
Health, National Institutes of Health. 
Nelba Chavez, Ph.D., Administrator, Substance 
Abuse and Mental Health Services Administration, 
Rockville, Maryland. 
Harold E. Varmus, M.D., Director, National 
Institutes of Health, Bethesda, Maryland. 
Bernard Arons, M.D., Director, Center for Mental 
Health Services, Substance Abuse and Mental Health 
Services Administration, Rockville, Maryland. 
Steven Hyman, M.D., Director, National Institute of 
Mental Health, National Institutes of Health, 
Bethesda, Maryland. 
RADM Thomas Bornemann, Ed.D., Deputy Director, 
Center for Mental Health Services, Substance Abuse 
and Mental Health Services Administration, 
Rockville, Maryland. 
Richard Nakamura, Ph.D., Deputy Director, National 
Institute of Mental Health, National Institutes of 
Health, Bethesda, Maryland. 
RADM Kenneth Moritsugu, M.D., M.P.H., Deputy 
Surgeon General, Office of the Surgeon General, 
Office of the Secretary, Rockville, Maryland. 
RADM Susan Blumenthal, M.D., M.P.A., Assistant 
Surgeon General and Senior Science Advisor, Office 
of the Surgeon General, Office of the Secretary, 
Rockville, Maryland. 
Nicole Lurie, M.D., M.S.P.H., Principal Deputy 
Assistant Secretary for Health, Office of Public 
Health and Science, Office of the Secretary, 
Washington, D.C. 
RADM Arthur Lawrence, Ph.D., Deputy Assistant 
Secretary for Health, Office of Public Health and 
Science, Office of the Secretary, Washington, D.C. 
VirginiaTrotterBetts,M.S.N., J.D.,R.N.,F.A.A.N., 
Senior Advisor on Nursing and Policy, Office of 
Public Health and Science, .Office of the Secretary, 
Washington, D.C. 
Editors 
Howard H. Goldman, M.D., Ph.D., Senior Scientific 
Editor, Professor of Psychiatry, University of Mary- 
land School of Medicine, Baltimore, Maryland. 
CAPT Patricia Rye, J.D., M.S.W., Managing Editor, 
Office of the Director, Center for Mental Health 
Services, Substance Abuse and Mental Health 
Services Administration, Rockville, Maryland. 
Paul Sirovatka, M.S., Coordinating Editor, Science 
Writer, Office of Science Policy and Program 
Planning, National Institute of Mental Health, 
National Institutes of Health, Bethesda, Maryland. 
Section Editors 
Jeffrey A. Buck, Ph.D., Director, Office of Managed 
Care, Center for Mental Health Services, Substance 
Abuse and Mental Health Services Administration, 
Rockville, Maryland. 
CAPT Peter Jensen, M.D., Associate Director for 
Child and Adolescent Research, National Institute of 
Mental Health, National Institutes of Health, 
Bethesda, Maryland. . 
vii 
Mental Health: A Report of the Surgeon General 
Judith Katz-Leavy, M.Ed., Senior Policy Analyst, 
Office of Policy, Planning and Administration, Center 
for Mental Health Services, Substance Abuse and 
Mental Health Services Administration, Rockville, 
Maryland. 
Planning Board 
Mary Lou Andersen, Deputy Director, Bureau of 
Primary Health Care, Health Resources and Services 
Administration, Bethesda, Maryland. 
Barry Lebowitz, Ph.D., Chief, Adult and Geriatric 
Treatment and Preventive Intervention Research 
Branch. Division of Services and Intervention Research, 
National Institute of Mental Health, National Institutes 
of Health, Bethesda, Maryland. 
Andrea Baruchin, Ph.D., Chief, Science Policy Branch, 
Office of Science Policy and Communication, National 
Institute on Drug Abuse, National Institutes of Health, 
Bethesda, Maryland. 
Ronald W. Manderscheid, Ph.D., Chief, Survey and 
Analysis Branch, Center for Mental Health Services, 
Substance Abuse and Mental Health Services 
Administration, Rockville, Maryland. 
Michael Benjamin, M.P.H., Executive Director, 
National Council on Family Relations, Minneapolis, 
Minnesota. 
Robert Bernstein, Ph.D., Executive Director, Bazelon 
Center, Washington, D.C. 
RADM Darrel Regier, M.D., M.P.H., Associate 
Director, Epidemiology and Health Policy Research, 
National Institute of Mental Health, National Institutes 
of Health, Bethesda, Maryland. 
Gene Cohen, M.D., Ph.D., Director, George 
Washington University Center on Aging, Health and 
Humanities; Director, Washington D.C. Center on 
Aging, Washington, D.C. 
Matthew V. Rudorfer, M.D., Associate Director for 
Treatment Research, Division of Services and 
Intervention Research, National Institute of Mental 
Health, National Institutes of Health, Bethesda, 
Maryland. 
Judith Cook, Ph.D., Director, National Research and 
Training Center on Psychiatric Disability; Professor, 
Department of Psychiatry, University of Illinois at 
Chicago, Chicago, Illinois. 
Senior Science Writer 
Margaret Coopey, R.N., Senior Health Policy Analyst, 
Director, Center for Practice and Technology 
Assessment, Agency for Health Care Policy and 
Research, Rockville, Maryland. 
Miriam Davis, Ph.D., Medical Writer and Consultant, 
Silver Spring, Maryland. Gail Daniels, Board President, The Federation of 
Families for Children’s Mental Health, Washington, 
D.C. 
Science Writers 
Birgit An der Lan, Ph.D., Science Writer, Bethesda, 
Maryland. 
Anne H. Rosenfeld, Special Assistant to the Director, 
Division of Mental Disorders, Behavioral Research and 
AIDS, National Institute of Mental Health, National 
Institutes of Health, Bethesda, Maryland. 
. . . 
Vlll 
Paolo Del Vecchio, M.S.W., Senior Policy Analyst, 
Office of Policy, Planning, and Administration, Center 
for Mental Health Services, Substance Abuse and 
Mental Health Services Administration, Rockville, 
Maryland. 
Michael Eckardt, Ph.D., Senior Science Advisor, Office 
of Scientific Affairs, National Institute on Alcohol 
Abuse and Alcoholism National Institutes of Health, 
Rockville, Maryland. 
Acknowledgments 
Mary Jane England, M.D., President, Washington Elliott Heiman, M.D., Chief of Staff of Psychiatry, St. 
Business Group on Health, Washington, D.C. Mary’s Hospital, Tucson, Arizona. 
Michael English, J.D., Director, Divisionof Knowledge 
Development and Systems Change, Center for Mental 
Health Services, Substance Abuse and Mental Health 
Sewices Administration, Rockville, Maryland. 
Michael M. Faenza, M.S.S.W., President and Chief 
Executive Officer, National Mental Health Association, 
Alexandria, Virginia. 
Michael Fishman, M.D., Assistant Director, Division of 
Child. Adolescent and Family Health, Bureau of 
Maternal and Child Health, Health Resources and 
Services Administration, Rockville, Maryland. 
Laurie Flynn, Executive Director, National Alliance for 
the Mentally Ill, Arlington, Virginia. 
Larry Fricks, Director, Office of Consumer Relations, 
Georgia Division of Mental Health, Atlanta, Georgia. 
Robert Friedman, Ph.D., Director, Research and 
Training Center for Children’s Mental Health, Florida 
Mental Health Institute, University of South Florida, 
Tampa. Florida. 
Laurie Garduque, Ph.D., Senior Program Officer, 
Program and Community Development, MacArthur 
Foundation, Chicago, Illinois. 
John J. Gates, Ph.D., Director of Programs, 
Collaborative Center for Child Well-being, Decatur, 
Georgia. 
Rosa M. Gil, D.S.W., Special Advisor to the Mayor for 
Health Policy, New York City Mayor’s Office of Health 
Services, New York, New York. 
Barbara Gill, M.B.A., Executive Director, Dana 
Alliance for Brain Initiatives, New York, New York. 
Kevin Hennessy, M.P.P., Ph.D., Health Policy Analyst, 
Office of the Assistant Secretary for Planning and 
Evaluation, Office of the Secretary, Washington, D.C. 
Pablo Hemandez, M.D., Administrator, Wyoming State 
Commission for Mental Health, Division of Behavioral 
Health, Evanston, Wyoming. 
Thomas Horvath, M.D., Chief of Staff, Houston 
Veterans Affairs Medical Cent&, .Houston, Texas. 
J. Rock Johnson, J.D., Consultant, Lincoln, Nebraska. 
Miriam Kelty, Ph.D., Associate Director for Extramural 
Affairs, National Institute on Aging, National Institutes 
of Health, Bethesda, Maryland. 
Lloyd Kolbe, Ph.D., Director, Division of Adolescent 
and School Health, National Center for Chronic Disease 
Prevention and Health Promotion, Centers for Disease 
Control and Prevention, Atlanta, Georgia. 
Jeffrey Lieberman, M.D., Vice Chairman of Research, 
University of North Carolina, Department of Psychiatry, 
Chapel Hill, North Carolina. 
Spero Manson, Ph.D., Director, Division of American 
Indian and Alaska Native Programs, University of 
Colorado Health Science Center, Department of 
Psychiatry, Denver, Colorado. 
RADM C. Beth Mazzella, R.N., Ph.D., Chief Nurse 
Officer, Office of the Administrator, Health Resources 
and Services Administration, Rockville, Maryland. 
Bruce McEwen, Ph.D., Professor and Head of the Lab 
for Neuroendocrinology, Rockefeller University, New 
York, New York. 
Mary Harper, R.N., Ph.D., Gerontologist, Tuscaloosa, 
Alabama. 
ix 
Mental Health: A Report of the Surgeon General 
Herbert Pardes, M.D., Vice President for Health 
Sciences and Dean of the Faculty of Medicine, 
Columbia University Health Sciences Center, New 
York, New York. 
Ruth Ralph, Ph.D., Research Associate, Edmund S. 
Muskie School of Public Service, University of 
Southern Maine, Portland, Maine. 
The Honorable Robert Ray, Former Governor, State of 
Iowa, Des Moines, Iowa. 
Corinne Rieder, Ed.D., Executive Director, John A. 
Hartford Foundation, New York, New York. 
Mona Rowe, M.C.P., Deputy Director, Office of 
Science Policy, Analysis, and Communication, National 
Institute of Child Health and Human Development, 
National Institutes of Health, Bethesda, Maryland. 
Steve Schreiber, M.D., Associate Professor of 
Neurology, Cell and Neurobiology, University of 
Southern California School of Medicine, Department of 
Neurology, Los Angeles, California. 
Steven A. Schroeder, M.D., President, Robert Wood 
Johnson Foundation, Princeton, New Jersey. 
Brent Stanfield, Ph.D., Director, Office of Science 
Policy and Program Planning, National Institute of 
Mental Health, National Institutes of Health, Bethesda, 
Maryland. 
Stanley Sue, Ph.D., Professor of Psychology and 
Psychiatry, Director, Asian American Studies Program, 
Department of Psychology, University of California at 
Davis, Davis, California. 
Jeanette Takamura, Ph.D., Assistant Secretary for 
Aging, Administration on Aging, Washington, D.C. 
Roy C. Wilson, M.D., Director, Missouri Department of 
Mental Health, Jefferson City, Missouri. 
Participants in Developing the Report 
Norman Abeles, Ph.D., Department of Psychology, 
Michigan State University, East Lansing, Michigan. 
Catherine Acuff, Ph.D., Senior Health Policy Analyst, 
Office of the Director, Center for Mental Health 
Services, Substance Abuse and Mental Health Services 
Administration, Rockville, Maryland. 
Laurie Ahem, Director, National Empowerment Center, 
Inc., Lawrence, Massachusetts. 
Marguerite Alegria, Ph.D., University of Puerto Rico, 
Medical Sciences Campus, School of Public Health, 
San Juan. Puerto Rico. 
Rene Andersen, M.Ed., Human Resource Association 
of the Northeast, Holyoke, Massachusetts. 
Thomas E. Arthur, M.H.A., Coordinator of Consumer 
Affairs, Maryland Health Partners, Columbia, 
Maryland. 
Rosina Becerra, Ph.D., Professor, Department of Social 
Welfare, Center for Child and Family Policy, University 
of California at Los Angeles, Los Angeles, California. 
Comelia Beck, R.N., F.A.A.N., Ph.D., College of 
Nursing, University of Arkansas for Medical Services, 
Little Rock, Arkansas. 
Peter G. Beeson, Ph.D., Administrator, Strategic 
Management Services, Nebraska Health and Human 
Services Finance and Support Agency, Lincoln, 
Nebraska. 
Leonard Bickman, Ph.D., Professor of Psychology, 
Center for Mental Health Policy, Institute for Public 
Policy Studies, Vanderbilt University, Nashville, 
Tennessee. 
Robert Boorstin, Senior Advisor to the Secretary of 
the Treasury, Department of the Treasury, 
Washington, D.C. 
X 
Acknowledgments 
David Brown, Consultant, Survey and Analysis 
Branch, Division of State and Community Systems 
Development, Center for Mental Health Services, 
Substance Abuse and Mental Health Services 
Administration, Rockville, Maryland. 
Barbara J. Bums, Ph.D., Professor of Medical 
Psychology, Department of Psychiatry and Behavioral 
Sciences, Duke University Medical Center, Durham, 
North Carolina. 
Jean Campbell, Ph.D., Research Assistant Professor, 
Missouri Institute of Mental Health, School of 
Medicine, University of Missouri-Columbia, St. 
Louis, Missouri. 
JosefinaCarbonell, President, Little Havana Activities 
and Nutrition Centers of Dade County, Inc., Miami, 
Florida. 
Elaine Carmen, M.D., Medical Director, Brockton 
Multi Service Center, Brockton, Massachusetts. 
H. Westley Clark, M.D., J.D., M.P.H., Director, 
Center for Substance Abuse Treatment, Substance 
Abuse and Mental Health Services Administration, 
Rockville, Maryland. 
Donald J. Cohen, M.D., Professor of Child and 
Adolescent Psychiatry, Yale University School of 
Medicine, New Haven, Connecticut. 
Judith Cohen, Ph.D., Director, Association for 
Women’s AIDS Risk Education, Corte Madera, 
California. 
King Davis, Ph.D., William and Camille Cosby 
Scholar, Howard University, Washington, D.C. 
Laura A. DeRiggi, L.S.W ., M.S.W., Clinical Director, 
Community Behavioral Health, Philadelphia, 
Pennsylvania. 
Lisa Dixon, M.D., Associate Professor, Center for 
Mental Health Services Research; Director of 
Education, Department of Psychiatry, University of 
Maryland School of Medicine, Baltimore, Maryland. 
Susan Dubuque, President, Market Strategies, Inc., 
Richmond, Virginia. 
Mina K. Dulcan, M.D., Head, Department of Child 
and Adolescent Psychiatry, Children’s Memorial 
Hospital, Chicago, Illinois. 
Nellie Fox Edwards, American Association of Retired 
Persons, Beaverton, Oregon. 
Lisa T. Eyler-Zorrilla, Ph.D., Post-Doctoral Fellow, 
Geriatric Psychiatry Clinical Research Center, 
Department of Psychiatry, University of 
California-San Diego, La Jolla, California. 
Theodora Fine, M.A., Special Assistant to the 
Director, Office of the Director, Center for Mental 
Health Services, Substance Abuse and Mental Health 
Services Administration, Rockville, Maryland. 
Dan Fisher, M.D., Ph.D., Executive Director, National 
Empowerment Center, Inc., Lawrence, Massachusetts. 
Richard G. Frank, Ph.D., Professor of Health 
Economics, Department of Health Care Policy, 
Harvard University, Boston, Massachusetts. 
Barbara Friesen, Ph.D., Director, Research and 
Training Center, Family Support and Children’s 
Mental Health, Portland State University, Portland, 
Oregon. 
Darrell Gaskin, Ph.D., Research Assistant Professor, 
Institute for Health Care Research and Policy, 
Georgetown University Medical Center, Washington, 
D.C. 
Mary Jo Gibson, Ph.D., Associate Director of Public 
Policy Institute, AARP, Washington, D.C. 
Xi 
Mental Health: A Report of the Surgeon General 
Sherry Glied. Ph.D., Associate Professor and Head, 
Division of Health Policy and Management, Joseph L. 
Mailman School of Public Health, Columbia 
University, New York, New York. 
Margo Goldman, M.D., Policy Director, National 
Coalition for Patients’ Rights, Lexington, .. 
Massachusetts. 
Junius Gonzales, M.D., Deputy Chairman, Psychiatry 
Department, Georgetown University, Washington, 
D.C. 
Jack Gorman, M.D., Professor of Psychiatry, 
Columbia University; Deputy Director, New York 
State Psychiatric Institute, New York, New York. 
Barbara Guthrie, Ph.D., R.N., University of Michigan 
School of Nursing, Ann Arbor, Michigan. 
Jennifer Gutstein, Research Assistant, Department of 
Child Psychiatry, Columbia University, New York, 
New York. 
Laura Lee Hall, Ph.D., Deputy Director of Policy and 
Research, National Alliance for the Mentally Ill, 
Arlington, Virginia. 
Richard K. Harding, M.D., Medical Director, 
Psychiatric Services, Richland Springs Hospital, 
Columbia, South Carolina. 
Herbert W. Harris, M.D., Ph.D., Chief, Geriatric 
Pharmacology Programs, Adult and Geriatric 
Treatment and Preventive Intervention Research 
Branch, Division of Services and Intervention 
Research, National Institute of Mental Health, 
National Institutes of Health, Bethesda, Maryland. 
Seth Hassett, M.S.W., Public Health Advisor, 
Emergency Services and Disaster Relief Branch, 
Division of Program Development, Special 
Populations and Projects, Center for Mental Health 
Services, Substance Abuse and Mental Health 
Services Administration, Rockville, Maryland. 
Mario Hemandez, Ph.D., Director, Division of 
Training, Research, Evaluation and. Demonstrations, 
Department of Child and Family Studies, Florida 
Mental Health Institute, Tampa, Florida. 
Kimberly Hoagwood, Ph.D., Associate Director, Child 
and Adolescent Research, Natitinal Institute of Mental 
Health, National Institutes of Health, Bethesda, 
Maryland. 
Ron Honberg, Director of Legal Affairs, National 
Alliance for the Mentally Ill, Arlington, Virginia. 
Teh-wei Hu, Ph.D., Professor’of Health Economics, 
School of Public Health, University of 
California-Berkeley, Berkeley, California. 
Edwin C. Hustead, Senior Consultant, Hay Group, 
Inc., Washington, D.C. 
Dilip V. Jeste, M.D., Director, Geriatric Psychiatry 
Clinical Research Center, University of California at 
San Diego, Veterans Affairs Medical Center 
Psychiatry Service, San Diego, California. 
Ira Katz, M.D., Ph.D., Professor of Psychiatry, 
Director, Section on Geriatric Psychiatry, University 
of Pennsylvania, Philadelphia, Pennsylvania. 
Kelly J. Kelleher, M.D., Staunton Professor of 
Pediatrics, Psychiatry and Health Services, Schools of 
Medicine and Public Health, Departments of 
Pediatrics and Psychiatry, University of Pittsburgh, 
Pittsburgh, Pennsylvania. 
Chris Koyanagi, Director of Legislative Policy, 
Bazelon Center for Mental Health Law, Washington, 
D.C. 
Celinda Lake, M.P.S., President and Founder, Lake 
Snell Perry and Associates, Inc., Washington, D.C. 
Christopher Langston, Ph.D., Program Officer, John 
A. Hartford Foundation, New York, New York. 
xii 
Acknowledgments 
John B. Lavigne, Ph.D., Chief Psychologist, 
Department of Child and Adolescent Psychiatry, 
Children’s Memorial Hospital, Chicago, Illinois. 
Anthony Lehman, M.D., Director, Center for Mental 
Health Services Research, University of Maryland 
School of Medicine, Baltimore, Maryland. 
Keh-Ming Lin, M.D., M.P.H., Director of Research 
Center on the Psychobiology of Ethnicity, Professor 
of Psychiatry, University of California at Los Angeles 
School of Medicine, Harbor-University of California 
at Los Angeles Medical Center, Torrance, California. 
Steven Lopez, Ph.D., Clinical Psychologist, 
Department of Psychology, University of California at 
Los Angeles, Los Angeles, California. 
Ira Lourie, M.D., Partner, Human Service 
Collaborative, Rockville, Maryland. 
Francis Lu, M.D., Director of Cultural Competence 
and Diversity Program, Department of Psychiatry, San 
Francisco General Hospital, San Francisco, California. 
Alicia Lucksted, Ph.D., Senior Research Associate, 
Department of Psychiatry, University of Maryland, 
Baltimore, Maryland. 
Bryce Miller, Consultant, National Alliance for the 
Mentally Ill, Topeka, Kansas. 
Jeanne Miranda, Ph.D., Associate Professor, 
Psychiatry Department, Georgetown University, 
Washington, D.C. 
Joseph P. Morrissey, Ph.D., Deputy Director, Senior 
Fellow, Sheps Center for Health Services Research, 
University of North Carolina at Chapel Hill, Chapel 
Hill, North Carolina. 
Patricia J. Mrazek, Ph.D., President, Scientific 
Director, Prevention Technologies, LLC, Bethesda, 
Maryland. 
Denise Nagel, M.D., Executive Director, National 
Coalition for Patients’ Rights, Lexington, 
Massachusetts. 
William Narrow, M.D., M.P.H., Senior Advisor for 
Epidemiology, Office of the Associate Director for 
Epidemiology and Health Policy Research, National 
Institute of Mental Health, National Institutes of 
Health, Bethesda, Maryland. 
Cassandra F. Newkirk, M.D., Forensic Psychiatrist 
and Consultant, Caldwell, New Jersey. 
Silvia W. Orlate, M.D., Clinical Professor of 
Psychology, New York Medical College-Vahalla, 
New York, New York. 
Trina Osher, M.S.W., Coordinator of Policy and 
Research, Federation of Families for Children’s 
Mental Health, Alexandria, Virginia. 
John Petrila, J.D., L.L.M., Chairman and Professor, 
Department of Mental Health Law and Policy, 
University of South Florida, Florida Mental Health 
Institute, Tampa, Florida. 
RADM Retired William Prescott, M.D., Psychiatrist, 
Brook Lane Health Service, Hagerstown, Maryland. 
Juan Ramos, Ph.D., Associate Director for Prevention, 
National Institute of Mental Health, National 
Institutes of Health, Bethesda, Maryland. 
Burton Reifler, M.D., Professor and Chairman, 
Department of Psychiatry, Wake Forest University 
School of Medicine, Winston-Salem, North Carolina. 
Donald J. Richardson, Ph.D., The Carter Center 
National Advisory Council; Co-founder and Vice 
President, National Alliance for Research on 
Schizophrenia and Depression, Los Angeles, 
California. 
Jean Risman, Consumer Researcher, North Berwick, 
Maine. 
. . . 
x111 
Mental Health: A Report of the Surgeon General 
Ariela C. Rod-iguez, Ph.D., L.C.S.W., A.C.S.W., 
Director, Hlislth dnd Social Services, Little Havana 
Activities and Nutrition Centers of Dade County, Inc., 
Miami, Florida. 
Gloria Rodriguez, Ph.D., President and Chief 
Executive Officer, Avance Corporation, San Antonio, 
Texas. 
Abram Rosenblatt, Ph.D., Research Director, 
University of California at San Francisco Child 
Services Research Group, San Francisco, California 
Agnes E. Rupp, Ph.D., Senior Economist and Chief, 
Financing and Managed Care Research Program, 
Services Research and Clinical Epidemiology Branch, 
Division of Services and Intervention Research, 
National Institute of Mental Health, National 
Institutes of Health, Bethesda, Maryland. 
A. John Rush, M.D., Professor of Psychiatry, 
University of Texas Southwest Medical Center, 
Department of Psychiatry, Dallas, Texas. 
David Shaffer, M.D., Professor of Psychiatry and 
Pediatrics, Director, Division of Child and Adolescent 
Psychiatry, Columbia University, New York, New 
York. 
David Shore, M.D., Associate Director for Clinical 
Research, Office of the Director, National Institute of 
Mental Health, National Institutes of Health, 
Bethesda, Maryland. 
Lonnie Snowden, Ph.D., Professor, School of Social 
Welfare, University of California-Berkeley; Director, 
Center for Mental Health Services Research, 
Berkeley, California. 
George Snicker, Ph.D., Distinguished Research 
Professor of Psychology, Demer Institute, Adelphi 
University, Garden City, New York. 
Michael E. Thase, M.D., Professor of Psychiatry, 
University of Pittsburgh School of Medicine, 
Pittsburgh, Pennsylvania. 
Jurgen Unutzer, M.D., M.P.H., M.A., Assistant 
Professor in Residence, Department of Psychiatry, 
University of California at Los Angeles 
Neuropsychiatric Institute, Center for Health Services 
Research, Los Angeles, California. 
Laura Van Tosh, Consultant, Silver Spring, Maryland. 
Joan Ellen Zweben, Ph.D., Clinical Professor, 
Department of Psychiatry, School of Medicine, 
University of California-San Francisco, Berkeley, 
California. 
Other Participants 
Joan G. Abell, Chief, Information Resources and 
Inquiries Branch, National Institute of Mental Health, 
National Institutes of Health, Bethesda, Maryland. 
Curtis Austin, Director, Office of External Liaison, 
Center for Mental Health Services, Substance Abuse 
and Mental Health Services Administration, 
Rockville, Maryland. 
Elaine Baldwin, M.Ed., Chief, Public Affairs and 
Science Reports Branch, Office of Scientific 
Information, National Institute of Mental Health, 
National Institutes of Health, Bethesda, Maryland. 
Leslie Bassett, Program Assistant, Office of the 
Director, Center for Mental Health Services, 
Substance Abuse and Mental Health Services 
Administration, Rockville, Maryland. 
Bonni Bennett, Desktopping Specialist, R.O.W. 
Sciences, Inc., Rockville, Maryland. 
Margaret Blasinsky, M.A., Vice President, R.O.W. 
Sciences, Inc., Rockville, Maryland. 
Anne B. Carr (formerly Program Assistant, Office of 
the Director, Center for Mental Health Services, 
Substance Abuse and Mental Health Services 
Administration), Silver Spring, Maryland. 
xiv 
Lemuel B. Clark, M.D., Chief, Community Mental 
Health Centers Construction Monitoring Branch, 
Division of Program Development, Special 
Populations and Projects, Center for Mental Health 
Services, Substance Abuse and Mental Health 
Services Administration, Rockville, Maryland. 
Olavo Da Rocha, Graphic Designer, R.O.W. Sciences, 
Inc.. Rockville, Maryland. 
Daria Donaldson, Editor, R.O.W. Sciences, Inc., 
Rockville, Maryland. 
Betsy Furin, Program Assistant, Community Mental 
Health Centers Construction Monitoring Branch, 
Division of Program Development, Special 
Populations and Projects, Center for Mental’Health 
Services, Substance Abuse and Mental Health 
Services Administration, Rockville, Maryland. 
David Fry, Consultant Writer, Cabin John, Maryland. 
Charlotte Gordon, Public Affairs Specialist, Office of 
the Director, Center for Mental Health Services, 
Substance Abuse and Mental Health Services 
Administration, Rockville, Maryland. 
Beatriz GrarnIey, Public Health Analyst, Primary Care 
Services Branch, Division of Community Based 
Programs, HIV/AIDS Bureau, Health Resources and 
Services Administration, Rockville, Maryland. 
CAPT G. Bryan Jones, Ph.D., Emergency Coordin- 
ator, Public Health Service Region Three- 
Philadelphia, Office of Emergency Preparedness, 
Office of Public Health and Science, Office of the 
Secretary, Philadelphia, Pennsylvania. 
Walter Leginski, Ph.D., Branch Chief, Homeless 
Programs Branch, Division of Knowledge 
Development and Systems Change, Center for Mental 
Health Services, Substance Abuse and Mental Health 
Services Administration, Rockville, Maryland. 
Ken Lostoski, Senior Graphic Designer, R.O.W. 
Sciences, Inc., Rockville, Maryland. 
Acknowledgments 
Michael Malden, Public Affairs Specialist, 
Knowledge Exchange Network, Office of External 
Liaison, Center for Mental Health Services, Substance 
Abuse and Mental Health Services Administration, 
Rockville, Maryland. 
Anne Matthews-Younes, Ed.D., Chief, Special 
Programs Development Branch, Division of Program 
Development, Special Populations and Projects, 
Center for Mental Health Services, Substance Abuse 
and Mental Health Services Administration, 
Rockville, Maryland. 
Kevin McGowan, Contract, Specialist, General 
Acquisitions Branch, Division of Acquisition 
Management, Administrative Operations Service, 
Program Support Center, Rockville, Maryland. 
Niyati Pandya, M.S., M.Phil., M.L.S., Reference 
Librarian, R.O.W. Sciences, Inc., Rockville, 
Maryland. 
Theodora Radcliffe, Technical Writer/Editor, R.O. W. 
Sciences, Inc., Rockville, Maryland. 
Sanjeev Rana, M.S., Research Assistant, R.O.W. 
Sciences, Inc., Rockville, Maryland. 
Lisa Robbins, Wordprocessing & Desktopping 
Coordinator, R.O.W. Sciences, Inc., Rockville, 
Maryland. 
Doreen Major Ryan, M.A., Writer/Editor, R.O.W. 
Sciences, Inc., Rockville, Maryland. 
Sally Sieracki, M.A., Editor, R.O.W. Sciences, Inc., 
Rockville, Maryland, 
Damon Thompson, Director of Communications, 
Office of Public Health and Science, Office of the 
Assistant Secretary, Washington, D.C. 
Robin Toliver, Senior Conference Planner, BL 
Seamon and Associates, Inc., Lanham, Maryland. 
Joanna Tyler, Ph.D., Project Director, R.O.W. 
Sciences, Inc., Rockville, Maryland. 
xv 
Mental Health: A Report of the Surgeon General 
Mark Weber, Associate Administrator, Office of 
Communications, Substance Abuse and Mental 
Health Services Administration, Rockville, Maryland. 
Clarissa Wittenberg, Director, Office of Scientific 
Information, National Institute of Mental Health, 
National Institutes of Health, Bethesda, Maryland. 
Baldwin Wong, Program Analyst, Office of Science 
Policy, Analysis, and Communication. National 
Institute of Child Health and Human Development, 
National Institutes of Health, Bethesda, Maryland. 
Special Thanks To 
Organizafions 
The Carter Center, Atlanta, Georgia. 
The John D. and Catherine T, MacArthur Foundation, 
Chicago, Illinois. 
Individuals 
Virginia Shankle Bales, M.P.H., Deputy Director for 
Program Management, Centers for Disease Control 
and Prevention, Atlanta, Georgia. 
Byron Breedlove, M.A., Senior Writer/Editor, 
Technical Information and Editorial Services Branch, 
National Center for Chronic Disease Prevention and 
Health Promotion, Centers for Disease Control and 
Prevention, Atlanta, Georgia. 
Thomas Bryant, M.D., J.D., Chairman, Non-Profit 
Management Associates, Inc., Washington, DC. 
Rosalynn Carter, Vice Chair, The Carter Center, 
Atlanta, Georgia. 
RADM J. Jarrett Clinton, M.D., Regional Health 
Administrator, Office of the Secretary, Atlanta, 
Georgia. 
Michael P. Eriksen, Sc.D., Director, Office on 
Smoking and Health, National Center for Chronic 
Disease Prevention and Health Promotion, Centers for 
Disease Control and Prevention, Atlanta, Georgia. 
Christine S. Fralish, M.L.I.S., Chief, Technical 
Information and Editorial Services Branch, National 
Center for Chronic Disease Prevention and Health 
Promotion, Centers for Disease Control and 
Prevention, Atlanta, Georgia. 
Adele Franks, M.D., Prudential Center for Health 
Services Research (formerly Assistant Director for 
Science, National Center. for Chronic Disease 
Prevention and Health Promotio&Centers for Disease 
Control and Prevention), Atlanta, Georgia. 
RADM Retired Peter Frommer, M.D., Deputy 
Director Emeritus, National Heart, Lung, and Blood 
Institute, National Institutes of Health, Bethesda, 
Maryland. 
Gayle Lloyd, M.A., Managing Editor, Surgeon 
General Reports, Office on Smoking and Health, 
National Center for Chronic Disease Prevention and 
Health Promotion, Centers for Disease Control and 
Prevention, Atlanta, Georgia. 
Sandra P. Perlmutter, Executive Director, President’s 
Council on Physical Fitness and Sports, Washington, 
D.C. 
NOTICE 
The editor, the contributors, and the 
publisher are grateful to the American 
Psychiatric Association for permission to 
quote directly from Diagnostic and Statistical 
Manual of Mental Disorders (DSM-IV), 4th 
ed. in this work. Descriptive matter is 
enclosed in quotation marks in the text 
exactly as it appears in DSM-IV. Tabular 
matter is modified slightly as to form only in 
accordance with the publisher’s editorial 
usage. 
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CHAPTER 1 
INTRODUCTION AND THEMES 
T his first Surgeon General’s Report on Mental Health is issued at the culmination of a half-century 
[hat has witnessed remarkable advances in the 
understanding of mental disorders and the brain and in 
(,llr appreciation of the centrality of mental health to 
c,\.rrall health and well-being. The report was prepared 
;\g;iinst a backdrop of growing awareness in the United 
States and throughout the world of the immense burden 
,,f disability associated with mental illnesses. In the 
[ Tllitcd States. mental disorders collectively account for 
1110rc than 15 percent of the overall burden of disease 
t’r~rn trll causes and slightly more than the burden 
;lssociated with all forms of cancer (Murray & Lopez, 
1~16). These data underscore the importance and 
r~rgcncy of treating and preventing mental disorders and 
01‘ promoting mental health in our society. 
The report in its entirety provides an up-to-date 
rcvicw of scientific advances in the study of mental 
hcalrh and of mental illnesses that affect at least one in 
I’ivc Americans. Several important conclusions may be 
drawn from the extensive scientific literature 
\ummarized in the report. One is that a variety of 
treatments of well-documented efficacy exist for the 
~Irray of clearly defined mental and behavioral 
disorders that occur across the life span. Every person 
\hould be encouraged to seekhelp when questions arise 
about mental health, just as each person is encouraged 
to seek help when questions arise about health. 
Research highlighted in the report demonstrates that 
mental health is a facet of health that evolves 
throughout the lifetime. Just as each person can do 
much to promote and maintain overall health regardless 
Of age, each also can do much to promote and 
‘trengthen mental health at every stage of life. 
Much remains to be learned about the causes, 
treatment. and prevention of mental and behavioral 
disorders. Obstacles that may limit the availability or 
accessibility of mental health services for some 
Americans are being dismantled, but disparities persist. 
Still, thanks to research tid Be experiences of millions 
of individuals who have a mental disorder, their family 
members, and other advocates, the Nation has the 
power today to tear down the most formidable obstacle 
to future progress in the arena of mental illness and 
health. That obstacle is stigma. Stigmatization of 
mental illness is an excuse for inaction and 
discrimination that is inexcusably outmoded in 1999. 
As evident in the chapters that follow, we have 
acquired an immense amount of knowledge that permits 
us, as a Nation, to respond to the needs of persons with 
mental illness in a manner that is both effective and 
respectful. 
Overarching Themes 
Mental Health and Mental Illness: A Public 
Health Approach 
The Nation’s contemporary mental health enterprise, 
like the broader field of health, is rooted in a 
population-based public health model. The public 
health model is characterized by concern for the health 
of a population in its entirety and by awareness of the 
linkage between health and the physical and psycho- 
social environment. Public health focuses not only on 
traditional areas of diagnosis, treatment, and etiology, 
but also on epidemiologic surveillance of the health of 
the population at large, health promotion, disease pre- 
vention, and access to and evaluation of services (Last 
& Wallace, 1992). 
Just as the mainstream of public health takes a 
broad view of health and illness, this Surgeon 
General’s Report on Mental Health takes a wide-angle 
lens to both mental health and mental illness. In years 
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past, the mental health field often focused principally 
on mental illness in order to serve individuals who 
were most severely affected. Only as the field has 
matured has it begun to respond to intensifying interest 
and concerns about disease prevention and health pro- 
motion. Because of the more recent consideration of 
these topic areas, the body of accumulated knowledge 
regarding them is not as expansive as that for mental 
illness. 
Mental Disorders are Disabling 
The burden of mental illness on health and productivity 
in the United States and throughout the world has long 
been profoundly underestimated. Data developed by the 
massive Global Burden of Disease study,’ conducted by 
the World Health Organization, the World Bank, and 
Harvard University, reveal that mental illness, 
including suicide,’ ranks second in the burden of 
disease in established market economies, such as the 
United States (Table l-l). 
Mental illness emerged from the Global Burden of 
Disease study as a surprisingly significant contributor 
to the burden of disease. The measure of calculating 
disease burden in this study, called Disability Adjusted 
Life Years (DALYs), allows comparison of the burden 
Table l-l. Disease burden by selected illness 
categories in established market 
economies, 1990 
Percent of 
Total DALY& 
All cardiovascular conditions 16.6 
All mental illness** 15.4 
All malignant diseases (cancer) 15.0 
All respiratory conditions 4.8 
All alcohol use 4.7 
All infectious and parasitic diseases 2.8 
All drug use 1.5 
*Disability-adjusted life year (DALY) is a measure that 
expresses years of life lost to premature death and years 
lived with a disability of specified severity and duration 
(Murray & Lopez, 1996). 
**Disease burden associated with “mental illness” includes 
suicide. 
* Murray & Lopez, 1996. 
* The Surgeon General issued a Call to Action on Suicide in 1999, 
reflecting the public health magnitude of this consequence of mental 
illness. The Call to Action is summarized in Figure 4-l. 
of disease across many different disease conditions. 
DALYs account for lost years of healthy life regardless 
of whether the years were lost to premature death or 
disability. The disability component of this measure is 
weighted for severity of the disability. For example, 
,major depression is equivalent in burden to blindness 
or paraplegia, whereas active psychosis seen in 
schizophrenia is equal in disability burden to 
quadriplegia. 
By this measure, major depression alone ranked 
second only to ischemic heart disease in magnitude of 
disease burden (see Table l-2). Schizophrenia, bipolar 
disorder, obsessive-compuliive disorder, panic 
disorder, and post-traumatic stress disorder also 
contributed significantly to the burden represented by 
mental illness. 
Table l-2. Leading sources of disease burden in 
established market economies, 1990 
Total 
DALYs Percent ’ 
(millions) of Total 
All causes 98.7 
1 lschemic heart disease 8.9 9.0 
2 Unipolar major depression 6.7 6.8 
3 Cardiovascular disease 5.0 5.0 
4 Alcohol use 4.7 4.7 * 
5 Road traffic accidents 4.3 4.4 
Source: Murray & Lopez, 1996. 
Mental Health and Mental Illness: Points on 
a Continuum 
As will be evident in the pages that follow, “mental 
health” and “mental illness” are not polar opposites but 
may be thought of as points on a continuum. Mental 
health is a state of successful performance of mental 
function, resulting in productive activities, fulfilling 
relationships with other people, and the ability to adapt 
to change and to cope with adversity. Mental health is 
indispensable to personal well-being, family and 
interpersonal relationships, and contribution to 
community or society. It is easy to overlook the value 
of mental health until problems surface. Yet from early 
childhood until death, mental health is the springboard 
of thinking and communication skills, learning, 
emotional growth, resilience, and self-esteem. These 
4 
Introduction and Themes 
.LTc’ thr ingredients of each individual’s successful 
;(,,,tihution to community and society. Americans are 
inundated with messages about success-in school, in 
,1 profession. in parenting, in relationships-without 
L,ppr~~i~tin~ that successful performance rem On a 
~~,und;ltion of mental health. 
Jlany ingredients of mental health may be 
,dcntifiable. but mental health is not easy to define. In 
(hc \vords of a distinguished leader in the field of 
,ncntal health prevention, “. . . built into any definition 
01‘ \\,rllness . . . are overt and covert expressions of 
\ ;,llles. Because values differ across cultures as well as 
an,ong subgroups (and indeed individuals) within a 
~uI[l~rc. the ideal of a uniformly acceptable definition 
,,f the constructs is illusory” (Cowen, 1994). h other 
\vords. what it means to be mentally healthy is subject 
10 ~nnny different interpretations that are rooted in 
~~;tluc *judgments that may VW across cultures. The 
~hallcnge of defining mental health has stalled the 
tlcvclopment of programs to foster mental health 
( Scckcr. I998), although strides have been made with 
~~~llncss programs for older people (Chapter 5). 
Mc~tclf illness is the term that refers collectively to 
AI diagnosable mental disorders. Mental disorders are 
I~caltl~ conditions that are characterized by alterations 
itI thinking, mood, or behavior (or some.combination 
~l~crct~t’) associated with distress and/or impaired 
lunclioning. Alzheimer’s disease exemplifies a mental 
&\ordcr largely marked by alterations in thinking 
(c+xially forgetting). Depression exemplifies a 
~l~nt:il disorder largely marked by alterations in mood. 
Xltcn[ion-deficit/hyperactivity disorder exemplifies a 
~nt:~l disorder largely marked by alterations in 
IWhavior (overactivity) and/or thinking (inability to 
concentrate). Alterations in thinking, mood, or behavior 
contribute to a host of problems-patient distress, 
iVaired functioning, or heightened risk of death, pain, 
clihahilitYV or loss of freedom (American Psychiatric 
~-\~~ociation. 1994). 
This report uses the term “mental health problems” 
t’0r hiens and symptoms of insufficient intensity or 
duration to meet the criteria for any mental disorder. 
.\lnlost everyone has experienced mental health 
problems in which the distress one feels matches some 
of the signs and symptoms of mental disorders. Mental 
health problems may warrant active efforts in health 
promotion, prevention, and treatment. Bereavement 
symptoms in older adults offer a case in point. 
Bereavement symptoms of less than 2 months’ duration 
do not qualify as a mental disorder, according to 
professional manuals for diagnosis (American 
Psychiatric Association, 1994). Nevertheless, 
bereavement symptoms can be debilitating if they are 
left unattended. They place older people at risk for 
depression, which, in turn, is linked to death from 
suicide, heart attack, or other causes (Zisook & 
Shuchter, 1991,1993; Frasufe-Smithet al., 1993,1995; 
Conwell, 1996). Much can be done-through formal 
treatment or through support group participation-to 
ameliorate the symptoms and to avert the consequences 
of bereavement. In this case, early intervention is 
needed to address a mental health problem before it 
becomes a potentially life-threatening disorder. 
Mind and Body are Inseparable 
Considering health and illness as points along a 
continuum helps one appreciate that neither state exists 
in pure isolation from the other. In another but related 
context, everyday language tends to encourage a 
misperception that “mental health” or “mental illness” 
is unrelated to “physical health” or “physical illness.” 
In fact, the two are inseparable. 
Seventeenth-century philosopher Rene Descartes 
conceptualized the distinction between the mind and 
the body. He viewed the “mind” as completely 
separable from the “body” (or “matter” in general). The 
mind (and spirit) was seen as the concern of organized 
religion, whereas the body was seen as the concern of 
physicians (Eisendrath & Feder, in press). This 
partitioning ushered in a separation between so-called 
“mental” and “physical” health, despite advances in the 
20th century that proved the interrelationships between 
mental and physical health (Cohen & Herbert, 1996; 
Baum & Posluszny, 1999). 
Although “mind” is a broad term that has had many 
different meanings over the centuries, today it refers to 
the totality of mental functions related to thinking, 
mood, and purposive behavior. The mind is generally 
5 
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seen as deriving from activities within the brain but 
displaying emergent properties, such as consciousness 
(Fischbach, 1992; Gazzaniga et al., 1998). 
One reason the public continues to this day to 
emphasize the difference between mental and physical 
health is embedded in language. Common parlance 
continues to use the term “physical” to distinguish 
some forms of health and illness from “mental” health 
and illness. People continue to see mental and physical 
as separate functions when, in fact, mental functions 
(e.g., memory) are physical as well (American 
Psychiatric Association, 1994). Mental functions are 
carried out by the brain. Likewise, mental disorders are 
reflected in physical changes in the brain (Kandel, 
1998). Physical changes in the brain often trigger 
physical changes in other parts of the body too. The 
racing heart, dry mouth, and sweaty palms that 
accompany a terrifying nightmare are orchestrated by 
the brain. A nightmare is a mental state associated with 
alterations of brain chemistry that, in turn, provoke 
unmistakable changes elsewhere in the body. 
Instead of dividing physical from mental health, the 
more appropriate and neutral distinction is between 
“mental” and “somatic” health. Somatic is a medical 
term that derives from the Greek word soma for the 
body. Mental health refers to the ’ successful 
performance of mental functions in terms of thought, 
mood, and behavior. Mental disorders are those health 
conditions in which alterations in mental functions are 
paramount. Somatic conditions are those in which 
alterations in nonmental functions predominate. While 
the brain carries out all mental functions, it also carries 
out some somatic functions, such as movement, touch, 
and balance. That is why not all brain diseases are 
mental disorders. For example, a stroke causes a lesion 
in the brain that may produce disturbances of 
movement, such as paralysis of limbs. When such 
symptoms predominate in a patient, the stroke .is 
considered a somatic condition. But when a stroke 
mainly produces alterations of thought, mood, or 
behavior, it is considered a mental condition (e.g., 
dementia). The point is that a brain disease can be seen 
as a mental disorder or a somatic disorder depending on 
the functions it perturbs. 
The Roots of Stigma 
Stigmatization of people with mental disorders has 
persisted throughout history. It is manifested by bias, 
distrust, stereotyping, fear, embarrassment, anger, 
and/or avoidance. Stigma leads others to avoid living, 
,socializing or working with, renting to, or employing 
people with mental disorders, especially severe 
disorders such as schizophrenia (Penn & Martin, 1998; 
Corrigan & Penn, 1999). It reduces patients’ access to 
resources and opportunities (e.g., housing, jobs) and 
leads to low self-esteem, isolation, and hopelessness. It 
deters the public from seeking, and wanting to pay for, 
care. In its most overt and egregious form, stigma 
results in outright discrimination and abuse. More 
tragically, it deprives people of their dignity and 
interferes with their full participation in society. 
Explanations for stigma stem, in part, from the 
misguided split between mind and body first proposed 
by Descartes. Another source of stigma lies in the 19th- 
century separation of the mental health treatment 
system in the United States from the mainstream of 
health. These historical influences exert an often 
immediate influence on perceptions and behaviors in 
the modem world. 
Separation of Treatment Systems 
In colonial times in the United States, people with 
mental illness were described as “lunaticks” and were 
largely cared for by families. There was no concerted 
effort to treat mental illness until urbanization in the 
early 19th century created a societal problem that 
previously had been relegated to families scattered 
among small rural communities. Social policy assumed 
the form of isolated asylums where persons with mental 
illness were administered the reigning treatments of the 
era. By the late 19th century, mental illness was 
thought to grow “out of a violation of those physical, 
mental and moral laws which, properly understood and 
obeyed, result not only in the highest development of 
the race, but the highest type of civilization” (cited in 
Grob, 1983). Throughout the history of 
institutionalization in asylums (later renamed mental 
hospitals), reformers strove to improve treatment and 
curtail abuse. Several waves of reform culminated in 
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[he deinstitutionalization movement that began in the 
I 950s with the goal of shifting patients and care to the 
community. 
public Affifudes About Mental /ihess: 1950s to 
1990s 
Sationally representative surveys have tracked public 
attitudes about mental illness since the 1950s (StU, 
195:. 1955; Gurin et al., 1960; Veroff et al., 1981). To 
pcrlnit comparisons over time, several surveys of the 
1 970s and the 1990s phrased questions exactly as they 
had been asked in the 1950s (Swindle et al., 1997). 
ln the 195Os, the public viewed mental illness as a 
,tigInatized condition and displayed an unscientific 
understanding of mental illness. Survey respdndents 
typically were nbt able to identify individuals as 
“mentally ill” when presented with vignettes of 
individuals who would have been said to be mentally ill 
according to the professional standards of the day. The 
public was not particularly skilled at distinguishing 
mental illness from ordinary unhappiness and worry 
and tended to see only extreme forms of be- 
havior-namely psychosis-as mental illness. Mental 
illness carried great social stigma, especially linked 
with fear of unpredictable and violent behavior (Star, 
1952, 1955; Gurin et al., 1960; Veroff et al., 1981). 
By 1996, a modem survey revealed that Americans 
had achieved greater scientific understanding of mental 
illness. But the increases in knowledge did not defuse 
social stigma (Phelan et al., 1997). The public learned 
to define mental illness and to distinguish it from 
ordinary worry and unhappiness. It expanded its 
definition of mental illness to encompass anxiety, 
depression, and other mental disorders. The public 
attributed mental illness to a mix of biological 
abnormalities and vulnerabilities to social and 
phychological stress (Link et al., in press). Yet, in 
comparison with the 195Os, the public’s perception of 
mental illness more frequently incorporated violent 
behavior (Phelan et al., 1997). This was primarily true 
among those who defined mental illness to include 
psychosis (a view held by about one-third of the entire 
sample). Thirty-one percent of this group mentioned 
violence in its descriptions of mental illness, in 
comparison with 13 percent in the 1950s. In other 
words, the perception of people with psychosis as being 
dangerous is stronger today than in the past (Phelan et 
al., 1997). 
The 1996 survey also probed how perceptions of 
those with mental illness varied by diagnosis. The 
public was more likely to consider an individual with 
schizophrenia as having mental illness than an 
individual with depression. All of them were 
distinguished reasonably well from a worried and 
unhappy individual who did not meet professional 
criteria for a mental disor&r. The desire for social 
distance was consistent with this hierarchy (Link et al., 
in press). 
Why is stigma so strong despite better public 
understanding of mental illness? The answer appears 
to be fear of violence: people with mental illness, 
especially those with psychosis, are perceived to be 
more violent than in the past (Phelan et al., 1997). 
This finding begs yet another question: Are people 
with mental disorders truly more violent? Research 
supports some public concerns, but the overall 
likelihood of violence is low. The greatest risk of 
violence is from those who have dual diagnoses, i.e., 
individuals who have a mental disorder as well as a 
substance abuse disorder (Swanson, 1994; Eronen et 
al., 1998; Steadman et al., 1998). There is a small 
elevation in risk of violence from individuals with 
severe mental disorders (e.g., psychosis), especially if 
they are noncompliant with their medication (Eronen et 
al., 1998; Swartz et al., 1998). Yet the risk of violence 
is much less for a stranger than for a family member or 
person who is known to the person with mental illness 
(Eronen et al., 1998). Infact, there is very little risk of 
violence or harm to a stranger from casual contact 
with an individual who has a mental disorder. Because 
the average person is ill-equipped to judge whether 
someone who is behaving erratically has any of these 
disorders, alone or in combination, the natural tendency 
is to be wary. Yet, to put this all in perspective, the 
overall contribution of mental disorders to the total 
level of violence in society is exceptionally small 
(Swanson, 1994). 
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Because most people should have little reason to 
fear violence from those with mental illness, even in its 
most severe forms, why is fear of violence so 
entrenched? Most speculations focus on media 
coverage anddeinstitutionalization (Phelan et al., 1997; 
Heginbotham, 1998). One series of surveys found that 
selective media reporting reinforced the public’s 
stereotypes linking violence and mental illness and 
encouraged people to distance themselves from those 
with mental disorders (Angermeyer & Matschinger, 
1996). And yet, deinstitutionalization made this 
distancing impossible over the 40 years as the 
population of state and county mental hospitals- was 
reduced from a high of about 560,000 in 1955 to well 
below 100,000 by the 1990s (Bachrach, 1996). Some 
advocates of deinstitutionalization expected stigma to 
be reduced with community care and commonplace 
exposure. Stigma might have been greater today had 
not public education resulted in a more scientific 
understanding of mental illness. 
Stigma and Seeking Help for Mental Disorders 
Nearly two-thirds of all people with diagnosable mental 
disorders do not seek treatment (Regier et al., 1993; 
Kessler et al., 1996). Stigma surrounding.the receipt of 
mental health treatment is among the many barriers that 
discourage people from seeking treatment (Sussman et 
al., 1987; Cooper-Patrick et al., 1997). Concern about 
stigma appears to be heightened in rural areas in 
relation to larger towns or cities (Hoyt et al., 1997). 
Stigma also disproportionately affects certain age 
groups, as explained in the chapters on children and 
older people. 
Stigma and Paying for Mental Disorder Treatment 
Another manifestation of stigma is reflected in the 
public’s reluctance to pay for mental health services. 
Public willingness to pay for mental health treatment, 
particularly through insurance premiums or taxes, has 
been assessed largely through public opinion polls. 
Members of the public report a greater willingness to 
pay for insurance coverage for’individuals with severe 
mental disorders, such as schizophrenia and depression, 
rather than for less severe conditions such as worry and 
unhappiness (Hanson, 1998). While the public 
generally appears to support paying for treatment, its 
support diminishes upon the realization that higher 
taxes or premiums would be necessary (Hanson, 1998). 
In the lexicon of survey research, the willingness to pay 
for mental illness treatment services is considered to be 
“soft.” The public generally ranks insurance coverage 
for mental disorders below that for somatic disorders 
(Hanson, 1998). 
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The surveys cited above concerning evolving 
public attitudes about mental illness also monitored 
how people would cope with, and seek treatment for, 
mental illness if they became symptomatic. (The term 
“nervous breakdown” was used in lieu of the term 
“mental illness” in the 1996 survey to allow for 
comparisons with the surveys in the 1950s and 1970s.) 
The 1996 survey found that people were likelier than in 
the past to approach mental illness by coping with, 
rather than by avoiding, the problem. They also were 
more likely now to want informal social supports (e.g., 
self-help groups). Those who now sought form-d 
support increasingly preferred counselors, 
psychologists, and social workers (Swindle et al., 
1997). 
Reducing Stigma 
There is likely no simple or single panacea to eliminate 
the stigma associated with mental illness. Stigma was 
expected to abate with increased knowledge of mental 
illness, but just the opposite occurred: stigma in some 
ways intensified over the past 40 years even though 
understanding improved. Knowledge of mental illness 
appears by itself insufficient to dispel stigma (Phelan et 
al., 1997). Broader knowledge may be warranted, 
especially to redress public fears (Penn & Martin, 
1998). Research is beginning to demonstrate that 
negative perceptions about severe mental illness can be 
lowered by furnishing empirically based information on 
the association between violence and severe mental 
illness (Penn & Martin, 1998). Overall approaches to 
stigma reduction involve programs of advocacy, public 
education, and contact with persons with mental illness 
through schools and other societal institutions 
(Conigan & Penn, 1999). 
Another way to eliminate stigma is to find causes 
3nd effective treatments for mental disorders (Jones, 
,998). History suggests this to be true. Neurosyphilis 
and petlagra are illustrative of mental disorders for 
\vhich stigma has receded. In the early part of this 
srntury. about 20 percent of those admitted to mental 
ho5Pitats had “general paresis,” later identified as 
tcniary syphilis (Grob, 1994). This advanced stage of 
,yPhitis occurs when the bacterium invades the brain 
rind causes neurological deterioration (including 
P\ychosis). paralysis, and death. The discoveries of an 
infectious etiology and of penicillin led to the virtual 
elimination of neurosyphilis. Similarly, when pellagra 
\v;ts traced to a nutrient deficiency, and nutritional 
,upplementation with niacin was introduced, the 
cnndition was eventually eradicated in the developed 
\vorld. Pellagra’s victims with delirium had been placed 
in mental hospitals early in the 20th century before its 
etiology was clarified. Although no one has 
documented directly the reduction of public stigma 
reward these conditions over the early and later parts of 
this century, disease eradication through widespread 
acceptance of treatment (and its cost) offers indirect 
Proof. 
Ironically, these examples also illustrate a more 
unsettling consequence: that the mental health field was 
:ttlvcrsely affected when causes and treatments were 
identified. As advances were achieved, each condition 
\~;Is transferred from the mental health field to another 
medical specialty (Grob, 1991). For instance, dominion 
over syphilis was moved to dermatology, internal 
medicine, and neurology upon advances in etiology and 
treatment. Dominion over hormone-related mental 
disorders was moved to endocrinology under similar 
circumstances. The consequence of this transformation, 
according to historian Gerald Grob, is that the mental 
health field became over the years the repository for 
mental disorders whose etiology was unknown. This 
left the mental health field “vulnerable to accusations 
by their medical brethren that psychiatry was not part 
of medicine, and that psychiatric practice rested on 
\uPerstition and myth” (Grob, 1991). 
These historical examples signify that stigma 
dissipates for individual disorders once advances 
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render them less disabling, infectious, or disfiguring. 
Yet the stigma surrounding other mental disorders not 
only persists but may be inadvertently reinforced by 
leaving to mental health care only those behavioral 
conditions without known causes or cures. To point this 
out is not intended to imply that advances in mental 
health should be halted; rather, advances should be 
nurtured and heralded. The purpose here is to explain 
some of the historical origins of the chasm between the 
health and mental health fields. 
Stigma must be overcome. Research that will 
continue to yield increasingly effective treatments for 
mental disorders promises ti, be an effective antidote. 
When people understand that mental disorders are not 
the result of moral failings or limited will power, but 
are legitimate illnesses that are responsive to specific 
treatments, much of the negative stereotyping may 
dissipate. Still, fresh approaches to disseminate 
research information and, thus, to counter stigma need 
to be developed and evaluated. Social science research 
has much to contribute to the development and 
evaluation of anti-stigma programs (Corrigan & Penn, 
1999). As stigma abates, a transformation in public 
attitudes should occur. People should become eager to 
seek care. They should become more willing to absorb 
its cost. And, most importantly, they should become far 
more receptive to the messages that are the subtext of 
this report: mental health and mental illness are part of 
the mainstream of health, and they are a concern for all 
people. 
The Science Base of the Report 
Reliance on Scientific Evidence 
The statements and conclusions throughout this report 
are documented by reference to studies published in the 
scientific literature. For the most part, this report cites 
studies of empirical-rather than theoretical-research, 
peer-reviewed journal articles including reviews that 
integrate findings fromnumerous studies, and books by 
recognized experts. When a study has been accepted for 
publication but the publication has not yet appeared, 
owing to the delay between acceptance and final 
publication, the study is referred to as “in press.” The 
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report refers, on occasion, to unpublished research by 
means of reference to a presentation at a professional 
meeting or to a “personal communication” from the 
researcher, a practice that also is used sparingly in 
professional journals. These personal references are to 
acknowledged experts whose research is in progress. 
Research Methods 
Quality research rests on accepted methods of testing 
hypotheses. Two of the more common research 
methods used in the mental health field are 
experimental research and correlational research. 
Experimental research is the preferred method for 
assessing causation but may be too difficult or too 
expensive to conduct. Experimental research strives to 
discover cause andeffect relationships, such as whether 
a new drug is effective for treating a mental disorder. In 
an experimental study, the investigator deliberately 
introduces an intervention to. determine its conse- 
quences (i.e., the drug’s efficacy). The investigator sets 
up an experiment comparing the effects of giving the 
new drug to one group of people, the experimental 
group, while giving a placebo (an inert pill) to another 
group, the so-called control group. The incorporation of 
a control group rules out the possibility that something 
other than the experimental treatment (i.e., the new 
drug) produces the results. The difference in outcome 
between the experimental and control group-which, 
in this case, may be the reduction or elimination of the 
symptoms of the disorder-then can be causally 
attributed to the drug. Similarly, in an experimental 
study of a psychological treatment, the experimental 
group is given a new type of psychotherapy, while the 
control or comparison group receives either no 
psychotherapy or a different form of psychotherapy. 
With both pharmacological and psychological studies, 
the best way to assign study participants, called 
subjects, either to the treatment or the control (or 
comparison) group is by assigning them randomly to 
different treatment groups. Randomization reduces bias 
in the results. An experimental study in humans with 
randomization is called a randomized controlled trial. 
Correlational research is employed when 
experimental research is logistically, ethically, or 
financially impossible. Instead of deliberately 
introducing an intervention, researchers observe 
relationships to uncover whether two factors are 
associated, or correlated. Studying the relationship 
between stress and depression is illustrative. It would 
be unthinkable to introduce seriously stressful events to 
see if they cause depression. A correlational study in 
this case would compare a group of people already 
experiencing high levels of stress with another group 
experiencing low levels of stress to determine whether 
the high-stress group is more likely to develop 
depression. If this happens, then the results would 
indicate that high levels of stress are associated with 
depression. The limitation of this type of study is that 
it only can be used to establish associations, not cause 
and effect relationships. (The positive relationship 
between stress and depression is discussed most 
thoroughly in Chapter 4.) 
Controlled studies-that is, studies with control or 
comparison groups-are considered superior to 
uncontrolled studies. But not every question in mental 
health can be studied with a control or comparison 
group. Findings from an uncontrolled study may be 
better than no information at all. An uncontrolled study 
also may be beneficial in generating hypotheses or in 
testing the feasibility of an intervention. The results 
presumably would lead to a controlled study. In short, 
uncontrolled studies offer a good starting point but are 
never conclusive by themselves. 
levels of Evidence 
In science, no single study by itself, however well 
designed, is generally considered sufficient to establish 
causation. The findings need to be replicated by other 
investigators to, gain widespread acceptance by the 
scientific community. 
The strength of the evidence amassed for any 
scientific fact or conclusion is referred to as “the level 
of evidence.” The level of evidence, for example, to 
justify the entry of a new drug into the marketplace has 
to be substantial enough to meet with approval by the 
U.S. Food and Drug Administration (FDA). According 
to U.S. drug law, a new drug’s safety and efficacy must 
be established through controlled clinical trials 
10 
Introduction and Themes 
;,,uducted by the drug’s manufacturer or sponsor 
, l~D.4. 1998). The FDA’s decision to approve a drug 
rcpr,=sents the culmination of a lengthy, research- 
,utcusive process of drug development, which often 
consumes years of animal testing followed by human 
clinical trials (DiMasi & Lasagna, 1995). The FDA 
requires three phases of clinical trials3 before a new 
drug can be approved for marketing (FDA, 1998). 
With psychotherapy, the level of evidence similarly 
,llust be high. Although there are no formal Federal 
laLvs governing which psychotherapies can be 
iutroduced into practice, professional groups and 
cspees in the field strive to assess the level of evidence 
ill 3 giveu area through task forces, review articles, and 
otbcr methods for evaluating the body of published 
\tudies on a topic. This Surgeon General’s report is 
replete with references to such evaluations. One of the 
most prominent series of evaluations was set in motion 
hy a group within the American Psychological 
:\ssociation (APA), one of the main professional 
organizations of psychologists. Beginning in the mid- 
I WOs. the APA’s Division of Clinical Psychology 
convened task forces with the objective of establishing 
which psychotherapies were of proven efficacy. To 
guide their evaluation, the first task force created a set 
ol‘critcria that also was used or adapted by subsequent 
Iask forces. The first task force actually developed two 
~1s of criteria: the first, and more rigorous, set of 
ukria was for Well-Established Treatments, while the 
()[kr set was for Probably Eficacious Treatments 
t Chumbless et al., 1996). For a psychotherapy to be 
~11 established, at least two experiments with group 
designs or similar types of studies must have been 
published to demonstrate efficacy. Chapters 3 through 
5 of this report describe the findings of the task forces 
in relation to psychotherapies for children, adults, and 
older adults. Some types of psychotherapies that do not 
meet the criteria might be effective but may not have 
been studied sufficiently. 
’ The first phase is to establish safety (Phase I), while the latter two 
phases establish efficacy through small and then large-scale 
randomized controlled clinical trials (Phases II and III) (FDA, 
1998). 
Another way of evaluating a collection of studies 
is through a formal statistical technique called a meta- 
analysis. A meta-analysis is a way of combining results 
from multiple studies. Its goal is to determine the size 
and consistency of the “effect” of a particular treatment 
or other intervention observed across the studies. The 
statistical technique makes. the results of different 
studies comparable so that an overall “effect size” for 
the treatment can be identified. A meta-analysis 
determines if there is consistent evidence of a 
statistically significant effect of a specified treatment 
and estimates the size of the effect, according to widely 
accepted standards for a small, medium, or large effect. 
Overview of the Report’s Chapters 
The preceding sections have addressed overarching 
themes in the body of the report. This section provides 
a brief overview of the entire report, including a 
description of its general orientation and a summary of 
key conclusions drawn from each chapter. 
Chapter 2 begins with an overview of research 
under way today that is focused on the brain and 
behavior in mental health and mental illness. It explains 
how newer approaches to neuroscience are mending the 
mind-body split, which for so long has been a 
stumbling block to understanding the relationship of 
the brain to behavior, thought, and emotion. Modem 
integrative neuroscience offers a means of linking 
research on broad “systems-level” aspects of brain 
function with the remarkably detailed tools and 
findings of molecular genetics. There follows an 
overview of mental illness that highlights topics 
including symptoms, diagnosis, epidemiology (i.e., 
research having to do with the distribution and 
determinants of mental disorders in population groups), 
and cost, all of which are discussed in the context of 
specific disorders throughout the report. The section on 
etiology reviews research that is seeking to define, with 
ever greater precision, the causes of mental illnesses. 
As will be seen, etiology research must examine 
fundamental biological and behavioral processes, as 
well as a necessarily broad array of life events. No less 
than research on normal healthy development, 
etiological research underscores the inextricability of 
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nature and nurture, or biological and psychosocial 
influences, in mental illness. The section on 
development of temperament reveals how mental health 
research has attempted over much of the past century to 
understand how biological, psychological, and 
sociocultural factors meld in health as well as illness. 
The chapter then reviews research approaches to the 
prevention and treatment of mental disorders and 
provides an overview of mental health services and 
their delivery. Final sections cover the growing 
influence on the mental health field of cultural 
diversity, the importance of consumerism, and new 
optimism about recovery from mental illness. 
Chapters 3,4, and 5 capture the breadth, depth, and 
vibrancy of the mental health field. The chapters probe 
mental health and, mental illness in children and 
adolescents, in adulthood (i.e., in persons up to ages 55 
to 65), and in older adults, respectively. This life span 
approach reflects awareness that-mental health, and the 
brain and behavioral disorders that impinge upon it, are 
dynamic, ever-changing phenomena that, at any given 
moment, reflect the sum total of every person’s genetic 
inheritance and life experiences. The brain is 
extraordinarily “plastic,” or malleable. It interacts with 
and responds-both in its function and in its very 
structure-to multiple influences continuously, across 
every stage of life. Variability in expression of mental 
health and mental illness over the life span can be very 
subtle or very pronounced. As an example, the 
symptoms of separation anxiety are normal in early 
childhood but are signs of distress in later childhood 
and beyond. It is all too common for people to 
appreciate the impact of developmental processes in 
children yet not to extend that conceptual 
understanding to older people. In fact, older people 
continue to develop and change. Different stages of life 
are associated with distinct forms of mental and 
behavioral disorders and with distinctive capacities for 
mental health. 
With rare exceptions, few persons are destined to 
a life marked by unremitting, acute mental illness. The 
most severe, persistent forms of mental illness tend to 
be amenable to treatment, even when recurrent and 
episodic. As conditions wax and wane, opportunities 
exist for interventions. The goal of an intervention at 
any given time may vary. The focus may be. on 
recovery, prevention of recurrence, or the acquisition of 
knowledge or skills that permit more effective 
management of an illness. Chapters 3 through 5 cover 
a uniform list of topics most relevant to each age 
cluster. Topics include mental health; prevention, 
diagnosis, and treatment of mental illness; service 
delivery; and other services and supports. 
It would be impractical for a report of this type to 
attempt to address every domain of mental health and 
mental illness; therefore, this report casts a spotlight on 
selected topics in each of Chapters 3 through 5. The 
various disorders featured in Depth in a given chapter 
were selected on the basis of their prevalence and the 
clinical, societal, and economic burden associated with 
each. To the extent that data permit, the report takes 
note of how gender and culture, in addition to age, 
influence the diagnosis, course, and treatment of mental 
illness. The chapters also note the changing role of 
consumers and families, with attention to informal 
support services (i.e., unpaid services) with which 
patients are so comfortable (Phelan et al., 1997) and 
upon which they depend for information. Patients and 
families welcome a proliferating array of support 
services-such as self-help programs, family self-help, 
crisis services, and advocacy-that help them cope 
with the isolation, family disruption, and possible loss 
of employment and housing that may accompany 
mental disorders. Support services can help dissipate 
stigma and guide patients into formal care as well. 
Although the chapters that address stages of 
development afford a sense of the breadth of issues 
pertinent to mental health and illness, the report is not 
exhaustive. The neglect of any given disorder, 
population, or topic should not be construed as 
signifying a lack of importance. 
Chapter 6 discusses the organization and financing 
of mental health services. The first section provides an 
overview of the current system of mental health 
services, describing where people get care and how 
they use services. The chapter then presents 
information on the costs of care and trends in spending. 
Only within recent decades have the dynamics of 
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,I,4ur3nce financing become a significant issue in the 
I,,ental health field; these are discussed, as is the advent 
,,t managed care. The chapter addresses both positive 
.,,,d adverse effects of managed care on access and 
qudlity and describes efforts to guard against untoward 
Lon\cquences of aggressive cost-containment policies. 
The final section documents some of the inequities 
bettVeen general health care and mental health care and 
&,cribes efforts to correct them through legislative 
regulation and financing changes. 
The confidentiality of all health care information 
has emerged as a core issue in recent years, as concerns 
regarding the accessibility of health care information 
& its uses have risen. As Chapter 7 illustrates, privacy 
c(Juccrns are particularly keenly felt in the ‘mental 
tlcdth field, beginning with the importance of an 
;l\surance of confidentiality in individual decisions to 
\cck mental health treatment. The chapter reviews the 
kyal I’rumework governing confidentiality and potential 
prohlcms with that framework, and policy issues that 
must be addressed by those concerned with the 
~oul‘idcntiality of mental health and substance abuse 
iril~ormation. 
Chapter 8 concludes, on the basis of the extensive 
literature that the Surgeon General’s reportreviews and 
4umm;lrizes, that the efficacy of mentul health 
treatment is well-documented. Moreover, there exists 
:I range of treatments from which people may choose a 
t’;lrticular approach to suit their needs and preferences. 
1i:~d on this finding, the report’s principal 
recommendation to the American people is to seek help 
if YOU have a mental health problem or think you 
IlaVe SYWtoms of mental illness. The chapter explores 
TPofiunities to overcome barriers to implementing the 
recommendation and to have seeking help lead to 
dfective treatment. 
Chapter Conclusions 
Chapter 2: The Fundamentals of Mental 
Health and Mental Illness 
The past 25 years have been marked by several 
discrete, defining trends in the mental health field. 
These have included: 
1. The extraordinary pace and productivity of 
scientific research on the brain and behavior; 
2. The introduction of a range of effective treatments 
for most mental disorders; 
3. A dramatic transformation of our society’s 
approaches to the organization and financing of 
mental health care; and 
4. The emergence of powerful consumer and family 
movements. 
Scientific Research. The brain has emerged as the 
central focus for studies of mental health and mental 
illness. New scientific disciplines, technologies, and 
insights have begun to weav’e a seamless picture of the 
way in which the brain mediates the influence of 
biological, psychological, and social factors on human 
thought, behavior, and emotion in health and in illness. 
Molecular and cellular biology and molecular genetics, 
which are complemented by sophisticated cognitive and 
behavioral sciences, are preeminent research 
disciplines in the contemporary neuroscience of mental 
health. These disciplines are affording unprecedented 
opportunities for “bottom-up” studies of the brain. This 
term refers to research that is examining the workings 
of the brain at the most fundamental levels. Studies 
focus, for example, on the complex neurochemical 
activity that occurs within individual nerve cells, or 
neurons, to process information; on the properties and 
roles of proteins that are expressed, or produced, by a 
person’s genes; and on the interaction of genes with 
diverse environmental influences. All of these activities 
now are understood, with increasing clarity, to underlie 
learning, memory, the experience of emotion, and, 
when these processes go awry, the occurrence of 
mental illness or a mental health problem. 
Equally important to the mental health field is “top- 
down” research; here, as the term suggests, the aim is 
to understand the broader behavioral context of the 
brain’s cellular and molecular activity and to learn how 
individual neurons work together in well-delineated 
neural circuits to perform mental functions. 
ESfective Treatments. As information accumulates 
about the basic workings of the brain, it is the task of 
translational research to transfer new knowledge into 
clinically relevant questions and targets of research 
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opportunity-to discover, for example, what specific 
properties of a neural circuit might make it receptive to 
safer, more effective medications. To elaborate on this 
example, theories derived from knowledge about basic 
brain mechanisms are being wedded more closely to 
brain imaging tools such as functional Magnetic 
Resonance Imaging (MRI) that can observe actual brain 
activity. Such a collaboration would permit investi- 
gators to monitor the specific protein molecules 
intended as the “targets” of a new medication to treat a 
mental illness or, indeed, to determine how to optimize 
the effect on the brain of the learning achieved through 
psychotherapy. 
In its entirety, the new “integrative neuroscience” 
of mental health offers a way to circumvent the 
antiquated split between the mind and the body that 
historically has hampered mental health research. It 
also makes it possible to examine scientifically many of 
the important psychological and behavioral theories 
regarding normal development and mental illness that 
have been developed in years past. The unswerving 
goal of mental health research is to develop and refine 
clinical treatments as well as preventive interventions 
that are based on an understanding of specific 
mechanisms that can contribute to or lead to illness but 
also can protect and enhance mental health. 
Mental health clinical research encompasses 
studies that involve human participants, conducted, for 
example, to test the efficacy of a new treatment. A 
noteworthy feature of contemporary clinical research is 
the new emphasis being placed on studying the 
effectiveness of interventions in actual practice 
settings. Information obtained from such studies 
increasingly provides the foundation for services 
research concerned with the cost, cost-effectiveness, 
and “deliverability” of interventions and the 
design-including economic considerations-of ser- 
vice delivery systems. 
Organization and Financing of Mental Health 
Care. Another of the defining trends has been the 
transformation of the mental illness treatment and 
mental health services landscapes, including increased 
reliance on primary health care and other human 
service providers. Today, the U.S. mental health system 
is multifaceted and complex, comprising the public and 
private sectors, general health and specialty mental 
health providers, and social services, housing, criminal 
justice, and educational agencies. These agencies do 
not always function in a coordinated manner. Its 
configuration reflects necessary responses to a broad 
array of factors including reform movements, financial 
incentives based on who pays for what kind of services, 
and advances in care and treatment technology. 
Although the hybrid system that exists today serves 
diverse functions well for many people, individuals 
with the most complex need? and the fewest financial 
resources often find the system fragmented and 
difficult to use. A challenge for the Nation in the near- 
term future is to speed the transfer of new evidence- 
based treatments and prevention interventions into 
diverse service delivery settings and systems, while 
ensuring greater coordination among these settings and 
systems. 
Consumer and Family Movements. The emergence 
of vital consumer and family movements promises to 
shape the direction and complexion of mental health 
programs for many years to come. Although divergent 
in their historical origins and philosophy, organizations 
representing consumers and family members have 
promoted important, often overlapping goals and have 
invigorated the fields of research as well as treatment 
and service delivery design. Among the principal goals 
shared by much of the consumer movement are to 
overcome stigma and prevent discrimination in policies 
affecting persons with mental illness: to encourage self- 
help and a focus on recovery from mental illness; and 
to draw attention to the special needs associated with a 
particular disorder or disability, as well as by age or 
gender or by the racial and cultural identity of those 
who have mental illness. 
Chapter 2 of the report was written to provide 
background information that would help persons from 
outside the mental health field better understand topics 
addressed in subsequent chapters of the report. 
Although the chapter is meant to serve as a mental 
health primer, its depth of discussion supports a range 
of conclusions: 
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, . The multifaceted complexity Of the brain iS fully 
consistent with the fact that it SUPPOSES all behavior 
and mental life. Proceeding from an 
,chowledgment that all psychological experiences 
are recorded ultimately in the brain and that all 
ps~chologicaI phenomena reflect biological 
processes, the modem neuroscience of mental 
health offers an enriched understanding of the 
inseparability of human experience, brain, and 
mind. 
2. .Mental functions, which are disturbed in mental 
disorders, are mediated by the brain. In the process 
of transforming human experience into physical 
events, the brain undergoes changes in its cellular 
structure and function. 
3. Few lesions or physiologic abnormalities define the 
mental disorders, and for the most part their causes 
remain unknown. Mental disorders, instead, are 
defined by signs, symptoms, and functional 
impairments. 
J. Diagnoses of mental disorders made using specific 
criteria are as reliable as those for general medical 
disorders. 
5. About one in five Americans experiences a mental 
disorder in the course of a year. Approximately 15 
percent of all adults who have a mental disorder in 
one year also experience a co-occurring substance 
(alcohol or other drug) use disorder, which 
complicates treatment. 
6. A range of treatments of well-documented efficacy 
exists for most mental disorders. Two broad types 
of intervention include psychosocial treat- 
ments -for example, psychotherapy or 
counseling-and psychopharmacologic treatments; 
these often are most effective when combined. 
7. In the mental health field, progress in developing 
Preventive interventions has been slow because, for 
most major mental disorders, there is insufficient 
understanding about etiology (or causes of illness) 
andor there is an inability to alter the known 
etiology of a particular disorder. Still, some 
successful strategies have emerged in the absence 
of a full understanding of etiology. 
8. About 10 percent of the U.S. adult population use 
mental health services in the health sector in any 
year, with another 5 percent seeking such services 
from social service agencies, schools, or religious 
or self-help groups. Yet critical gaps exist between 
those who need service and those who receive 
service. 
9. Gaps also exist between optimally effective 
treatment and what many individuals receive in 
actual practice settings. 
10. Mental illness and less severe mental health 
problems must be understood in a social and 
cultural context, and mental health services must 
be designed and delivered in a manner that is 
sensitive to the perspectives and needs of racial and 
ethnic minorities. 
11. The consumer movement has increased the 
involvement of individuals with mental disorders 
and their families in mutual support services, 
consumer-run services, and advocacy. They are 
powerful agents for changes in service programs 
and policy. 
12. The notion of recovery reflects renewed optimism 
about the outcomes of mental illness, including that 
achieved through an individual’s own self-care 
efforts, and the opportunities open to persons with 
mental illness to participate to the full extent of 
their interests in the community of their choice. 
Mental Health and Mental illness Across the 
Lifespan 
The Surgeon General’s report takes a lifespan ap- 
proach to its consideration of mental health and mental 
illness. Three chapters that address, respectively, the 
periods of childhood and adolescence, adulthood, and 
later adult life beginning somewhere between ages 55 
and 65, capture the contributions of research to the 
breadth, depth, and vibrancy that characterize all facets 
of the contemporary mental health field. 
The disorders featured in depth in Chapters 3, 4, 
and 5 were selected on the basis of the frequency with 
which they occur in our society, and the clinical, 
societal, and economic burden associated with each. To 
the extent that data permit, the report takes note of how 
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gender and culture, in addition to age, influence the 
diagnosis, course, and treatment of mental illness. The 
chapters also note the changing role of consumers and 
families, with attention to informal support services 
(i.e., unpaid services), with which many consumers are 
comfortable and upon which they depend for 
information. Persons with mental illness and, often, 
their families welcome a proliferating array of support 
services-such as self-help programs, family self-help, 
crisis services, and advocacy-that help them cope 
with the isolation, family disruption, and possible loss 
of employment and housing that may accompany 
mental disorders. Support services can help to dissipate 
stigma and to guide patients into formal care as well. 
Mental health and mental illness are dynamic, ever- 
changing phenomena. At any given moment, a person’s 
mental status reflects the sum total of that individual’s 
genetic inheritance and life experiences. The brain 
interacts with and responds-both in its function and in 
its very structure- to multiple influences continuously, 
across every stage of life. At different stages, 
variability in expression of mental health and mental 
illness can be very subtle or very pronounced. As an 
example, the symptoms of separation anxiety are 
normal in early childhood but are signs of distress in 
later childhood and beyond. It is all too common for 
people to appreciate the impact of developmental 
processes in children, yet not to extend that conceptual 
understanding to older people. In fact, people continue 
to develop and change throughout life. Different stages 
of life are associated with vulnerability to distinct 
forms of mental and behavioral disorders but also with 
distinctive capacities for mental health. 
Even more than is true for adults, children must be 
seen in the context of their social environments-that 
is, family and peer group, as well as that of their larger 
physical and cultural surroundings, Childhood mental 
health is expressed in this context, as children proceed 
along the arc of development. A great deal of 
contemporary research focuses on developmental 
processes, with the aim of understanding and predicting 
the forces that will keep children and adolescents 
mentally healthy and maintain them on course to 
become mentally healthy adults. Research also focuses 
on identifying what factors place some at risk for 
mental illness and, yet again, what protects some 
children but not others despite exposure to the same 
risk factors. In addition to studies of normal 
development and of risk factors, much research focuses 
on mental disorders in childhood and adolescence and 
what can be done to prevent or treat these conditions 
and on the design and operation of service settings best 
suited to the needs experienced by children. 
For about one in five Americans, adulthood-a 
time for achieving productive vocations and for 
sustaining close relationships at home and in the 
community-is interrupted by mental illness. 
Understanding why and how mental disorders occur in 
adulthood, often with no apparent portents of illness in 
earlier years, draws heavily on the full panoply of 
research conducted under the aegis of the mental health 
field. In years past, the onset, or occurrence, of mental 
illness in the adult years, was attributed principally to 
observable phenomena-for example, the burden of 
stresses associated with career or family, or the 
inheritance of a disease viewed to run in a particular 
family. Such explanations now may appear naive at 
best. Contemporary studies of the brain and behavior 
are racing to fill in the picture by elucidating specific 
neurobiological and genetic mechanisms that are the 
platform upon which a person’s life experiences can 
either strengthen mental health or lead to mental 
illness. It now is recognized that factors that influence 
brain development prenatally may set the stage for a 
vulnerability to illness that may lie dormant throughout 
childhood and adolescence. Similarly, no single gene 
has been found to be responsible for any specific 
mental disorder; rather, variations in multiple genes 
contribute to a disruption in healthy brain function that, 
under certain environmental conditions, results in a 
mental illness. Moreover, it is now recognized that 
socioeconomic factors affect individuals’ vulnerability 
to mental illness and mental health problems. Certain 
demographic and economic groups are more likely than 
others to experience mental health problems and some 
mental disorders. Vulnerability alone may not be 
sufficient to cause a mental disorder; rather, the causes 
of most mental disorders lie in some combination of 
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,,enetic and environmental factors, which may be 
biological or psychosocial. 
The fact that many, if not most, peOpk have 
esperienced mental health problems that mimic or even 
match some of the symptoms of a diagnosable mental 
disorder tends, ironically, t0 PrOrIlpt many people t0 
underestimate the painful, disabling nature of severe 
mental illness. In fact, schizophrenia, mood disorders 
,uch as major depression and bipolar illness, and 
anxiety often are devastating conditions. Yet relatively 
fe\v mental illnesses have an unremitting course mark- 
ed by the most acute manifestations of illness; rather, 
for reasons that are not yet understood, the symptoms 
;tssociated with mental illness tend to wax and wane. 
These patterns pose special challenges to the 
implementation of treatment plans and the design of 
service systems that are optimally responsive to an 
individual’s needs during every phase of illness. As this 
report concludes, enormous strides are being made in 
diagnosis, treatment, and service delivery, placing the 
productive and creative possibilities of adulthood 
within the reach of persons who are encumbered by 
mental disorders. 
Late adulthood is when changes in health status 
may become more noticeable and the ability to 
compensate for decrements may become limited. As the 
brain ages, a person’s capacity for certain mental tasks 
tends to diminish, even as changes in other mental 
activities prove to be positive and rewarding. Well into 
late life, the ability to solve novel problems can be 
enhanced through training in cognitive skills and 
problem-solving strategies. 
The promise of research on mental health 
Promotion notwithstanding, a substantial minority of 
older people are disabled, often severely, by mental 
disorders including Alzheimer’s disease, major 
depression, substance abuse, anxiety, and other 
conditions. In the United States today, the highest rate 
of suicide-an all-too-common consequence of 
unrecognized or inappropriately treated depression-is 
found in older males. This fact underscores the urgency 
of ensuring that health care provider training properly 
emphasizes skills required to differentiate accurately 
me causes of cognitive, emotional, and behavioral 
symptoms that may, in some instances, rise to the level 
of mental disorders, and in other instances be 
expressions of unmet general medical needs. 
As the life expectancy of Americans continues to 
extend, the sheer number-although not necessarily the 
proportion--of persons experiencing mental disorders 
of late life will expand, confronting our society with 
unprecedented challenges in organizing, financing, and 
delivering effective mental health services for this 
population. An essential part of the needed societal 
response will include recognizing and devising 
innovative ways of support@g the increasingly more 
prominent role that families are assuming in caring for 
older, mentally impaired and mentally ill family 
members. 
Chapter 3: Children and Mental Health 
1. Childhood is characterized by periods of transition 
and reorganization, making it critical to assess the 
mental health of children and adolescents in the 
context of familial, social, and cultural 
expectations about age-appropriate thoughts, 
emotions, and behavior. 
2. The range of what is considered “normal” is wide; 
still, children and adolescents can and do develop 
mental disorders that are more severe than the “ups 
and downs” in the usual course of development. 
3. Approximately one in five children and adolescents 
experiences the signs and symptoms of a DSM-IV 
disorder during the course of a year, but only about 
5 percent of all children experience what 
professionals term “extreme functional impair- 
ment.” 
4. Mental disorders and mental health problems 
appear in families of all social classes and of all 
backgrounds. No one is immune. Yet there are 
children who are at greatest risk by virtue of a 
broad array of factors. These include physical 
problems; intellectual disabilities (retardation); low 
birth weight; family history of mental and addictive 
disorders; multigenerational poverty; and caregiver 
separation or abuse and neglect. 
5. Preventive interventions have been shown to be 
effective in reducing the impact of risk factors for 
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mental disorders and improving social and 
emotional development by providing, for example, 
educational programs for young children, parent- 
education programs, and nurse home visits. 
6. A range of efficacious psychosocial and 
pharmacologic treatments exists for many mental 
disorders in children, including attention- 
deficit/hyperactive disorder, depression, and the 
disruptive disorders. 
7. Research is under way to demonstrate the 
effectiveness of most treatments for children in 
actual practice settings (as opposed to evidence of 
“efficacy” in controlled research settings), and 
significant barriers exist to receipt of treatment. 
8. Primary care and the schools are major settings for 
the potential recognition of mental disorders in 
children and adolescents, yet trained staff are 
limited, as are options for referral to specialty care. 
9. The multiple problems associated with “serious 
emotional disturbance” in children and adolescents 
are best addressed with a “systems” approach in 
which multiple service sectors work in an 
organized, collaborative way. Research on the 
effectiveness of systems of care shows positive 
results for system outcomes and functional 
outcomes for children; however, the relationship 
between changes at the system level and clinical 
outcomes is still unclear. 
10. Families have become essential partners in the 
delivery of mental health services for children and 
adolescents. 
11. Cultural differences exacerbate the general 
problems of access to appropriate mental health 
services. Culturally appropriate services have been 
designed but are not widely available. 
Chapter 4: Adults and Mental Health 
1. As individuals move into adulthood, develop- 
mental goals focus on productivity and intimacy 
including pursuit of education, work, leisure, 
creativity, and personal relationships. Good mental 
health enables individuals to cope with adversity 
while pursuing these goals. 
2. Untreated, mental disorders can lead to lost 
productivity, unsuccessful relationships, and 
significant distress and dysfunction. Mental illness 
in adults can have a significant and continuing 
effect on children in their care. 
3. Stressful life events or the manifestation of mental 
illness can disrupt the balance adults seek in life 
and result in distress and dysfunction. Severe or 
life-threatening trauma experienced either in 
childhood or adulthood can further provoke 
emotional and behavioral reactions that jeopardize 
mental health. 
4. Research has improve3 our understanding of 
mental disorders in the adult stage of the life cycle. 
Anxiety, depression, and schizophrenia, 
particularly, present special problems in this age 
group. Anxiety and depression contribute to the 
high rates of suicide in this population. 
Schizophrenia is the most persistently disabling 
condition, especially for young adults, in spite of 
recovery of function by some individuals in mid to 
late life. 
5. Research has contributed to our ability to 
recognize, diagnose, and treat each of these 
conditions effectively in terms of symptomcontrol 
and behavior management. Medication and other 
therapies can be independent, combined, or 
sequenced depending on the individual’s diagnosis 
and personal preference. 
6. A new recovery perspective is supported by 
evidence on rehabilitation and treatment as well as 
by the personal experiences of consumers. 
7. Certain common events of midlife (e.g., divorce or 
other stressful life events) create mental health 
problems (not necessarily disorders) that may be 
addressed through a range of interventions. 
8. Care and treatment in the real world of practice do 
not conform to what research determines is best. 
For many reasons, at times care is inadequate, but 
there are models for improving treatment. 
9. Substance abuse is a major co-occurring problem 
for adults with mental disorders. Evidence supports 
combined treatment, although there are substantial 
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gaps between what research recommends and what 
typically is available in communities. 
,o, Sensitivity to culture, race, gender, disability, 
poverty. and the need for consumer involvement 
are important considerations for care and treatment. 
,I. Bat-tiers of access exist in the organization and 
financing of services for adults. There are specific 
problems with Medicare, Medicaid, income 
supp~m, housing, and managed care. 
Chapter 5: Older Adults and Mental Health 
1. Important life tasks remain for individuals as they 
age. Older individuals continue to learn and 
contribute to the society, in spite of physiologic 
changes due. to aging and increasing health 
problems. 
1 -. Continued intellectual, social, and physical activity 
throughout the life cycle. are important for the 
maintenance of mental health in late life. 
!. Stressful life events, such as declining health 
and/or the loss of mates, family members, or 
friends often increase with age. However, 
persistent bereavement or serious depression is not 
“normal” and should be treated. 
4. Normal aging is not characterized by mental or 
cognitive disorders. Mental or substance use 
disorders that present alone or co-occur should be 
recognized and treated as illnesses. 
5. Disability due to mental illness in individuals over 
65 years old will become a major public health 
problem in the near future because of demographic 
changes. In particular, dementia, depression, and 
schizophrenia, among other conditions, will all 
Present special problems in this age group: 
a. Dementia produces significant dependency and 
is a leading contributor to the need for costly 
long-term care in the last years of life; 
b. Depression contributes to the high rates of 
suicide among males in this population; and 
c. Schizophrenia continues to be disabling in 
spite of recovery of function by some 
individuals in mid to late life. 
6. There are effective interventions for most mental 
disorders experienced by older persons (for 
7. 
8. 
9. 
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example, depression and anxiety), and many 
mental health problems, such as bereavement. 
Older individuals can benefit from the advances in 
psychotherapy, medication, and other treatment 
interventions for mental disorders enjoyed by 
younger adults, when these interventions are 
modified for age and health status. 
Treating older adults with mental disorders accrues 
other benefits to overall health by improving the 
interest and ability of individuals to care for 
themselves and follow their primary care 
provider’s directions anaadvice, particularly about 
taking medications. 
Primary care practitioners are a critical link in 
identifying and addressing mental disorders in 
older adults. Opportunities are missed to improve 
mental health and general medical outcomes when 
mental illness is underrecognized and undertreated 
in primary care settings. 
10. Barriers to access exist in the organization and 
financing of services for aging citizens. There are 
specific problems with Medicare, Medicaid, 
nursing homes, and managed care. 
Chapter 6: Organization and Financing of 
Mental Health Services 
In the United States in the late 20th century, research- 
based capabilities to identify, treat, and, in some 
instances, prevent mental disorders is outpacing the 
capacities of the service system the Nation has in place 
to deliver mental health care to all who would benefit 
from it. Approximately 10 percent of children and 
adults receive mental health services from mental 
health specialists or general medical providers in a 
given year. Approximately one in six adults, and one in 
five children, obtain mental health services either from 
health care providers, the clergy, social service 
agencies, or schools in a given year. 
Chapter 6 discusses the organization and financing 
of mental health services. The chapter provides an 
overview of the current system of mental health 
services, describing where people get care and how 
they use services. The chapter then presents 
information on the costs of care and trends in spending. 
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Only within recent decades, in the face of concerns 
about discriminatory policies in mental health 
financing, have the dynamics of insurance financing 
become a significant issue in the mental health field. In 
particular, policies that have emphasized cost 
containment have ushered in managed care. Intensive 
research currently is addressing both positive and 
adverse effects of managed care on access and quality, 
generating information that will guard against untoward 
consequences of aggressive cost-containment policies. 
Inequities in insurance coverage for mental health and 
general medical care-the product of decades of stigma 
and discrimination-have prompted efforts to correct 
them through legislation designed to produce financing 
changes and create parity. Parity calls for equality 
between mental health and other health coverage. 
1. Epidemiologic surveys indicate that one in five 
Americans has a mental disorder in any one year. 
2. Fifteen percent of the adult population use some 
form of mental health service during the year. Eight 
percent have a mental disorder; 7 percent have a 
mental health problem. 
3. Twenty-one percent of children ages 9 to 17 
receive mental health services in a year. 
4. The U.S. mental health service system is complex 
and connects many sectors (public-private, 
specialty-general health, health-social welfare, 
housing, criminal justice, and education). As a 
result, care may become organizationally 
fragmented, creating barriers to access. The system 
is also financed from many funding streams, 
adding to the complexity, given sometimes 
competing incentives between funding sources. 
5. In 1996, the direct treatment of mental disorders, 
substance abuse, and Alzheimer’s disease cost the 
Nation $99 billion; direct costs for mental 
disorders alone totaled $69 billion. In 1990, 
indirect costs for mental disorders alone totaled 
$79 billion. 
6. Historically, financial barriers to mental health 
services have been attributable to a variety of 
economic forces and concerns (e.g., market failure, 
adverse selection, moral hazard, and public 
provision). This has accounted for differential 
resource allocation rules for financing mental 
health services. 
a. “Parity” legislation has been a partial solution 
to this set of problems. 
b. Implementing parity has resulted in negligible 
cost increases where the care has been 
managed. 
7. In recent years, managed care has begun to 
introduce dramatic changes into the organization 
and financing of health and mental health services. 
8. Trends indicate that in some segments of the 
private sector per capita mental health expenditures 
have declined much faster than they have for other 
conditions. 
9. There is little direct evidence of problems with 
quality in well-implemented managed care 
programs. The risk for more impaired populations 
and children remains a serious concern. 
10. An array of quality monitoring and quality 
improvement mechanisms has been developed, 
although incentives for their full implementation 
has yet to emerge. In addition, competition on the 
basis of quality is only beginning in the managed 
care industry. 
11. There is increasing concern about consumer 
satisfaction and consumers’ rights. A Consumers 
Bill of Rights has been developed and implemented 
in Federal Employee Health Benefit Plans, with 
broader legislation currently pending in the 
Congress. 
Chapter 7: Confidentiality of Mental Health 
Information: Ethical, legal, and Policy Issues 
In an era in which the confidentiality of all health care 
information, its accessibility, and its uses are of 
concern to all Americans, privacy issues are 
particularly keenly felt in the mental health field. An 
assurance of confidentiality is understandably critical 
in individual decisions to seek mental health treatment. 
Although an extensive legal framework governs 
confidentiality of consumer-provider interactions, 
potential problems exist and loom ever larger. 
1. people’s willingness to seek help is contingent on 
their confidence that personal revelations of mental 
distress will not be disclosed without their consent. 
2. The U.S. Supreme Court recently has upheld the 
right to the privacy of these records and the 
therapist-client relationship. 
3. Although confidentiality issues are common to 
health care in general, there are special concerns 
for mental health care and mental health care 
records because of the extremely personal nature of 
the material shared in treatment. 
4. State and Federal laws protect the confidentiality 
of health care information but are often incomplete 
because of numerous exceptions which often vary 
from state to state. Several states have imple- 
mented or proposed models for protecting privacy 
that may serve as a guide to others. 
5. States, consumers, and family advocates take 
differing positions on disclosure of mental health 
information without consent to family caregivers. 
In states that allow such disclosure, information 
provided is usually limited to diagnosis, prognosis, 
and information regarding treatment, specifically 
medication. 
0. When conducting mental health research, it is in 
the interest of both the researcher and the 
individual participant to address informed consent 
and to obtain certificates of confidentiality before 
proceeding. Federal regulations require informed 
consent for research being conducted with Federal 
funds. 
7. New approaches to managing care and information 
technology threaten to further erode the 
confidentiality and trust deemed so essential 
between the direct provider of mental health 
services and the individual receiving those 
services. It is important to monitor advances so that 
confidentiality of records is enhanced, instead of 
impinged upon, by technology. 
8. Until the stigma associated with mental illnesses is 
addressed, confidentiality of mental health 
information will continue to be a critical point of 
concern for payers, providers, and consumers. 
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Chapter 8: A Vision for the Future- 
Actions for Mental Health in the New 
Millennium 
The extensive literature that the Surgeon General’s 
report reviews and summarizes leads to the conclusion 
that a range of treatments of documented efficacy 
exists for most mental disorders. Moreover, a person 
may choose a particular approach to suit his or her 
needs and preferences. Based on this finding, the 
report’s principal recommendation to the American 
people is to seek help if you have a mental health 
problem or think you have symptoms of a mental 
disorder. As noted earlier, stigma interferes with the 
willingness of many people--even those who have a 
serious mental illness-to seek help. And, as 
documented in this report, those who do seek help will 
all too frequently learn that there are substantial gaps in 
the availability of state-of-the-art mental health services 
and barriers to their accessibility. Accordingly, the final 
chapter of the report goes on to explore opportunities to 
overcome barriers to implementing the 
recommendation and to have seeking help lead to 
effective treatment. 
The final chapter identifies the following courses 
of action. 
1. Continue to Build the Science Base: Today, 
integrative neuroscience and molecular genetics 
present some of the most exciting basic research 
opportunities in medical science. A plethora of new 
pharmacologic agents and psychotherapies for 
mental disorders afford new treatment 
opportunities but also challenge the scientific 
community to develop new approaches to clinical 
and health services interventions research. Because 
the vitality and feasibility of clinical research 
hinges on the willing participation of clinical 
research volunteers, it is important for society to 
ensure that concerns about protections for 
vulnerable research subjects are addressed. 
Responding to the calls of managed mental and 
behavioral health care systems for evidence-based 
interventions will have a much needed and 
discernible impact on practice. Special effort is 
required to address pronounced gaps in the mental 
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health knowledge base. Key among these are the 
urgent need for evidence which supports strategies 
for mental health promotion and illness prevention. 
Additionally, research that explores approaches for 
reducing risk factors and strengthening protective 
factors for the prevention of mental illness should 
be encouraged. As noted throughout the report, 
high-quality research and the effective services it 
promotes are a potent weapon against stigma. 
2. Overcome Stigma: Powerful and pervasive, stigma 
prevents people from acknowledging their own 
mental health problems, much less disclosing them 
to others. For our Nation to reduce the burden of 
mental illness, to improve access to care, and to 
achieve urgently needed knowledge about the 
brain, mind, and behavior, stigma must no longer 
be tolerated. Research on brain and behavior that 
continues to generate ever more effective 
treatments for mental illnesses is a potent antidote 
to stigma. The issuance of this Surgeon General’s 
Report on Mental Health seeks to help reduce 
stigma by dispelling myths about mental illness, by 
providing accurate knowledge to ensure more 
informed consumers, and by encouraging help 
seeking by individuals experiencing mental health 
problems. 
3. ImprovePublicAwarenessofEffective Treatment: 
Americans are often unaware of the choices they 
have for effective mental health treatments. In fact, 
there exists a constellation of several treatments of 
documented efficacy for most mental disorders. 
Treatments fall mainly under several broad catego- 
ries-counseling, psychotherapy, medication ther- 
apy, rehabilitation-yet within each category are 
many more choices. All human services 
professionals, notjust health professionals, have an 
obligation to be better informed about mental health 
treatmentresources in theircommunities and should 
encourage individuals to seek help from any source 
in which they have confidence. 
4. Ensure the Supply of Mental Health Services and 
Providers: The fundamentalcomponents ofeffective 
service delivery, which include integrated 
community-based services, continuity of providers 
and treatments, family support services (including 
psychoeducation),andculturallysensitiveservices, 
are broadly agreed upon, yet certain of these and 
other mental health services are inconsistently short 
supply, both regionally and, in some instances, 
nationally. Because the service systemasawhole, as 
opposed to treatment services considered in 
isolation, dictates the outcome of recovery-oriented 
mental health care, it is imperative to expand the 
supply of effective, evidence-based services 
throughout the Nation. Key personnel shortages 
include mental healt’h, professionals serving 
children/adolescents and older people with serious 
mental disorders and specialists with expertise in 
cognitive-behavioral therapy and interpersonal 
therapy, two forms of psychotherapy that research 
has shown to be effective for several severe mental 
disorders. For adults and children with less severe 
conditions, primary health care, the schools, and 
otherhumanservicesmustbepreparedtoassessand, 
at times, to treat individuals who come seeking help. 
5. Ensure Delivery of State-of-the-Art Treatments: A 
wide variety of effective, community-based services, 
carefully refined through years of research, exist for 
even the most severe mental illnesses yet are not 
being translatedinto community settings. Numerous 
explanationsforthegapbetweenwhatisknownfrom 
research and what is practiced beg for innovative 
strategies to bridge it. 
6. Tailor Treatment to Age, Gender, Race, and 
Culture: Mental illness, no less than mental health, 
is influencedby age, gender,race, and culture as well 
as additional facets of diversity that can be found 
within all of these population groups-for example, 
physical disability or a person’s sexual orientation 
choices. To be effective, the diagnosis and treatment 
of mental illness must be tailored to all 
characteristics that shape a person’s image and 
identity. The consequences of not understanding 
these influences can be profoundly deleterious. 
“Culturally competent” services incorporate 
understanding of racial and ethnic groups, their 
histories,traditions, beliefs,andvaluesystems. With 
appropriate training and a fundamental respect for 
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clients, any mental health professional can provide 
culturallycompetentservicesthatreflectsensitivity 
toindividualdifferencesand,atthesametime,assign 
validity to an individual’s group identity. 
Nonetheless, the preference of many members of 
ethnic and racial minority groups to be treated by 
lnental health professionals of similar background 
underscores the need to redress the current 
insufficient supply of mental health professionals 
\++o are members of racial and ethnic minority 
k’roups. 
7. La&tate Entry Into Treatment: Public and private 
agencies have an obligation to facilitate entry into 
Imental health care and treatment through’ the 
multiple “portals of entry” that exist: primary health 
care, schools, and the child welfare system. To 
enhance adherence to treatment, agencies should 
offer services that are responsive to the needs and 
preferencesofserviceusersandtheirfamilies.Atthe 
same time, some agencies receive inappropriate 
referrals. For example, an alarming number of 
children and adults with mental illness are in the 
criminaljusticesysteminappropriately.Importantly, 
assuringthesmallnumberofindividualswithsevere 
mental disorders who pose a threat of danger to 
themselves or others ready access to adequate and 
appropriate services promises to reduce significantly 
the rreed for coercion in the form of involuntary 
commitment to a hospital andfor certain outpatient 
treatment requirements that have been legislated in 
most states and territories. Coercion should not be a 
substitute for effective care that is sought 
voluntarily; consensus on this point testifies to the 
need for research designed to enhance adherence to 
treatment. 
8. Reduce Financial Barriers to Treatment: Concerns 
about the cost of care-concerns made worse by the 
disparity in insurance coverage for mental disorders 
in contrast to other illnesses-are among the 
foremost reasons why people do not seek needed 
mental health care. While both access to and use of 
mental health services increase when benefits for 
those services are enhanced, preliminary data show 
that the effectiveness-and, thus, the value-of 
Introduction and Themes 
mental health care also has increased in recent years, 
while expenditures for services, under managed care. 
have fallen. Equality between mental health 
coverage and other health coverage-a concept 
known as parity-is an affordable and effective 
objective. 
Scope of Coverage of the Report 
This report is comprehensive but not exhaustive in its 
coverage of mental healthandmental illness. It considers 
mental health facets of some conditions which are not 
always associated with thementaldisorders and does not 
consider all conditions which can be found in 
classifications of mental disorders such as DSM-IV. The 
report includes, for example, a discussion of autism in 
Chapter 3 and provides an extensive section on 
Alzheimer’s disease in Chapter 5. Although DSM-IV 
lists specific mental disorder criteria for both of these 
conditions, they often are viewed as being outside the 
scope of the mental health field. In both cases, mental 
health professionals are involved in the diagnosis and 
treatment of these conditions, often characterized by 
cognitive and behavioral impairments. The 
developmentaldisabilitiesandmentalretardationarenot 
discussed except in passing in this report. These 
conditions were considered to be beyond its scope with a 
care system all their own and very special needs. The 
same is generally true for the addictive disorders, such as 
alcohol andotherdruguse disorders. The latter, however, 
co-occur with such frequency with the other mental 
disorders, which are the focus of this report, that the co- 
occurrenceisdiscussedthroughout.Thereportcoversthe 
epidemiology of addictive disorders and their co- 
occurrence with other mental disorders as well as the 
treatment of co-occurring conditions. Brief sections on 
substance abuse in adolescence and late life also are 
included in the report. 
Preparation of the Report 
In September 1997, the Office of the Surgeon General, 
with the approval of the Secretary of the Department of 
Health and Human Services, authorized the Substance 
Abuse and Mental Health Services Administration 
(SAMHSA) to serve as lead operating division for 
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preparing the first Surgeon General’s Report on Mental 
Health. SAMHSA’s Center for Mental Health Services 
worked in partnership with the National Institute of 
Mental Health of the National Institutes of Health to 
develop this report under the guidance of Surgeon 
General David Satcher. These Federal partners 
established a Planning Board comprising individuals 
representing a broad range of expertise in mental 
health, including academicians, mental health 
professionals, researchers in neuroscience and service 
delivery, and self-identified consumers of mental health 
services and family members of consumers of mental 
health services. Also included on the Planning,Board 
were individuals representing Federal operating 
divisions, offices, centers, and institutes and private 
nonprofit foundations with interests in mental health. 
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CHAPTER 2 
THE FUNDAMENTALS OF MENTAL HEALTH 
AND MENTAL ILLNESS 
A vast body of research on mental health and, to an even greater extent, on mental illness constitutes 
me foundation of this Surgeon General’s report. TO 
understand and better appreciate the content of the 
chapters that follow, readers outside the mental health 
field may desire some background information. Thus, 
this chapter furnishes a “primer” on topics that the 
report addresses. 
The chapter begins with an overview of research 
under way today that is focused on the neuroscience of 
rncntal health. Modem integrative neuroscience offers 
;I mcans of linking research on broad “systems level” 
;tspects of brain function with the remarkably detailed 
tools and findings of molecular biology. The report 
begins with a discussion of the brain because it is 
central to what makes us human and provides an 
understanding of mental health and mental illness. All 
of human behavior is mediated by the brain. Consider, 
for example, a memory that most people have from 
childhood-that of learning to ride a bicycle with the 
help of a parent or friend. The fear of falling, the 
anxiety of lack of control, the reassurances of a loved 
one. and the final liberating experience of mastery and 
a newly extended universe create an unforgettable 
combination. For some, the memories are not good 
ones: falling and being chased by dogs have left marks 
of anxiety and fear that may last a lifetime. Science is 
revealing how the skill learning, emotional overtones, 
and memories of such experiences are put together 
physically in the brain. The brain and mind are two 
sides of the same coin. Mind is not possible without the 
remarkable physical complexity that is built into the 
brain, but, in addition, the physical complexity of the 
brain is useless without the sculpting that environment, 
experience, and thought itself provides. Thus the brain 
is now known to be physically shaped by contributions 
from our genes and our experience, working together. 
This strengthens the view that mental disorders are both 
caused and can be treated by biological and experiential 
processes, working together. This understanding has 
emerged from the breathtaking progress in modem 
neuroscience that has begun to integrate knowledge 
from biological and behavioral sciences. 
An overview of mental illness follows the section 
on modem integrative brain science. The section 
highlights topics including symptoms, diagnosis, 
epidemiology (i.e., research having to do with the 
distribution and determinants of mental disorders in 
population groups, including various racial and ethnic 
minority groups), and cost, all of which are discussed 
in greater and more pointed detail in the chapters that 
follow. Etiology is the study of the origins and causes 
of disease, and that section reviews research that is 
seeking to define, with ever greater precision, the 
causes of mental disorders. As will be seen, etiology 
research examines fundamental biological, behavioral, 
and so&cultural processes, as well as a necessarily 
broad array of life events. The section on development 
of temperament reveals how mental health science has 
attempted over much of the past century to understand 
how biological, psychological, and sociocultural factors 
meld in health as well as in illness. The chapter then 
reviews research approaches to the prevention and 
treatment of mental disorders and provides an overview 
of mental health services and their delivery. Final 
sections cover the growing influence on the mental 
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health field of the need for attention to cultural 
diversity, the importance of the consumer movement, 
and new optimism about recovery from mental 
illness-that is, the possibility of recovering one’s life. 
The Neuroscience of Mental Health’ 
Complexity of the Brain I: Structural 
As befits the organ of the mind, the human brain is the 
most complex structure ever investigated by our 
science. The brain contains approximately 100 billion 
nerve cells, or neurons, and many more supporting 
cells, or glia. In and of themselves, the number of cells 
Figure 2-1. Structural variety of neurons 
F’URKINJE CELL 
in this 3-pound organ reveal little of its complexity. Yet 
most organs in the body are composed of only a 
handful of cell types; the brain, in contrast, has literally 
thousands of different kinds of neurons, each distinct in 
terms of its chemistry, shape, and connections 
(Figure 2-l depicts the structural variety of neurons). 
To illustrate, one careful, recent investigation of a kind 
of interneuron that is a small local circuit neuron in the 
retina, called the amacrine cell, found no less than 23 
identifiable types. 
But this is only the beginning of the brain’s 
complexity. 
Source: Fischbach, 1992, p. 53. (Permission granted: Patricia J. Wynne.) 
’ Special thanks to Steven E. Hyman, M.D., Director, National Institute of Mental Health, and Gerald D. Fischbach, M.D., Director, 
National Institute of Neurological Diseases and Stroke. for their contributions to this section. 
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The workings of the brain depend on the ability of 
nclr\‘e cells to communicate with each other. 
communication occurs at small, specialized structures 
C.lled synapses. The synapse typically has two parts. 
one is a specialized presynaptic structure on a terminal 
portion of the sending neuron that contains packets of 
rignalling chemicals, or neurotransmitters. The second 
is a postsynaptic structure on the dendrites of the 
fscriving neuron that has receptors for the 
nrnrotransmitter molecules. 
The typical neuron has a cell body, which contains 
[he genetic material, and much of the cell’s energy- 
producing machinery. Emanating from the cell body are 
dendrites. branches that are the most important 
receptive surface of the cell for communication. The 
dendrites of neurons can assume a great many shapes 
and sizes, all relevant to the way in which incoming 
messages are processed. The. output of neurons is 
curried along what is usually a single branch called the 
axon. It is down this part of the neuron that signals are 
trunsmitted out to the next neuron. At its end, the axon 
may branch into many terminals. (Figure 2-2.) 
The usual form of communication involves 
clcctrical signals that travel within neurons, giving rise 
IO chemical signals that diffuse, or cross, synapses, 
\vhich in turn give rise to new electrical signals in the 
postsynaptic neuron. Each neuron, on average, makes 
more than 1,000 synaptic connections with other 
neurons. One type of cell-a Purkinje cell-may make 
hctween 100,000 and 200,000 connections with other 
ncnrons. In aggregate, there may be between 100 
trillion and a quadrillion synapses in the brain. These 
synapses are far from random. Within each region of 
the brain, there is an exquisite architecture consisting 
of layers and other anatomic substructures in which 
WaPtic connections are formed. Ultimately, the 
Pattern of synaptic connections gives rise to what are 
called circuits in the brain. At the integrative level, 
large- and small-scale circuits are the substrates of 
behavior and of mental life. One of the most awe- 
insPifing mysteries of brain science is how neuronal 
activity within circuits gives rise to behavior and, even, 
consciousness. 
The complexity of the brain is such that a single 
neuron may be part of more than one circuit. The 
organization of circuits in the brain reveals that the 
brain is a massively parallel, distributed information 
processor. For example, the circuits involved in vision 
receive information from the retina. After initial 
processing, these circuits analyze information into 
different streams, so that there is one stream of 
information describing what the visual object is, and 
another stream is concerned with where the object is in 
space. The information stream having to do with the 
identity of the object is actually broken down into 
several more refined parallel streams. One, for 
example, analyzes shape while another analyzes color. 
Ultimately, the visual world is resynthesized with 
information about the tactile world, and the auditory 
world, with information from memory, and with 
emotional coloration. The massively parallel design is 
a great pattern recoguizer and very tolerant of failure in 
individual elements. This is why a brain of neurons is 
still a better and longer-lasting information processor 
than a computer. 
The specific connectivity of circuits is, to some 
degree, stereotyped, or set in expected patterns within 
the brain, leading to the notion that certain places in the 
brain are specialized for certain functions (Figure 2-3). 
Thus, the cerebral cortex, the mantle of neurons with its 
enormous surface area increased by outpouchings, 
called gyri, and indentations, called sulci, can be 
functionally subdivided. The back portion of the 
cerebral cortex (i.e., the occipital lobe), for example, is 
involved in the initial stages of visual processing. Just 
behind the central sulcus is the part of the cerebral 
cortex involved in the processing of tactile information 
(i.e., parietal lobe). Just in front of the central sulcus is 
a part of the cerebral cortex involved in motor behavior 
(frontal lobe). In the front of the brain is a region called 
the prefrontal cortex, which is involved with some of 
the highest integrated functions of the human being, 
including the ability to plan and to integrate cognitive 
and emotional streams of information. 
Beneath the cortex are enormous numbers of axons 
sheathed in the insulating substance, myelin. This sub- 
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Figure 2-2. How neurons communicate 
Source: Fischbach, 1992, p. 52. (Permission granted: Tomo Narashima.) 
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Figure 2-3. The brain: Organ of the mind 
PlTULT..Y blAND 
PWIETAL 
SOUrCe: Fischbach, 1992, p. 51. (Permission granted: Carol Donner.) 
cortical “white matter,” so named because of its the brain processes information. The white matter is 
appearance on freshly cut brain sections, surrounds akin to wiring that conveys information from one 
deep aggregations of neurons, or “gray matter,” which, region to another. Gray matter regions include the basal 
Iike the cortex, appears gray because of the presence of ganglia, the part of the brain that is involved in the 
neuronal cell bodies. It is within this gray matter that initiation of motion and thus profoundly affected in 
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Parkinson’s disease, but that is also involved in the 
integration of motivational states and, thus, a substrate 
of addictive disorders. Other important gray matter 
structures in the brain include the amygdala and the 
hippocampus. The amygdala is involved in the 
assignment of emotional meaning to events and objects, 
and it appears to play a special role in aversive, or 
negative, emotions such as fear. The hippocampus 
includes, among its many functions, responsibility for 
initially encoding and consolidating explicit or episodic 
memories of persons, places, and things. 
In summary, the organization of the brain at the 
cellular level involves many thousands of distinct kinds 
of neurons. At a higher integrative level, these neurons 
form circuits for information processing determined by 
their patterns of synaptic connections. The organization 
of these parallel distributed circuits results in the 
specialization of different geographic regions of the 
brain for different functions. It is important to state at 
this point, however, that, especially in younger 
individuals, damage to a particular brain region may 
yield adaptations that permit circuits spared the damage 
and, therefore, other regions of the brain, to pick up 
some of the functions that would otherwise have been 
lost. 
Complexity of the Brain II: Neurochemical 
Superimposed on this breathtaking structural 
complexity is the chemical complexity of the brain. As 
described above, electrical signals within neurons are 
converted at synapses into chemical signals which then 
elicit electrical signals on the other side of the synapse. 
These chemical signals are molecules called 
neurotransmitters. There are two major kinds of 
molecules that serve the function of neurotransmitters: 
small molecules, some quite well known, with names 
such as dopamine, serotonin, or norepinephrine, and 
larger molecules, which are essentially protein chains, 
called peptides. These include the endogenous opiates, 
Substance P, and corticotropin releasing factor (CRF), 
among others. All told, there appear to be more than 
100 different neurotransrnitters in the brain (Table 2-1 
contains a selected list). 
A neurotransmitter can elicit a biological effect in 
the postsynaptic neuron by binding to a protein called 
a neurotransmitter receptor. Its job is to pass the 
information contained in the neurotransmitter message 
from the synapse to the inside of the receiving cell. It 
appears that almost every known neurotransmitter has 
Table 2-1. Selected neurotransmitters important In 
psychopharmacology 
Excitatory amino acid 
Glutamate 
Inhibitory amino acids 
Gamma aminobutyric acid 
Glycine 
Monoamines and related neurotransmitters 
Norepinephrine 
Dopamine 
Serotonin 
Histamine 
Acetylcholine (quarternary amine) 
Purine 
Adenosine 
Neuropeptides 
Opioids 
Enkephalins 
Beta-endorphin 
Dynorphin 
Tachykinin 
Substance P 
Hypothalamic-re/easing factors 
Corticotropin-releasing hormone 
more than one different kind of receptor that can confer 
rather different signals on the receiving neuron. 
Dopamine has 5 known neurotransmitter receptors; 
serotonin has at least 14. 
Although there are many kinds of receptors with 
many different signaling functions, we can divide most 
neurotransmitter receptors into two general classes. 
One class of neurotransmitter receptor is called a 
ligand-gated channel, where “ligand” simply means a 
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,,,olecule (i.e.. a neurotransmitter) that binds to a 
receptor. When neurotransmitters interact with this 
kind of receptor, a pore within the receptor molecule 
itself is opened and positive or negative charges enter 
[he cell. The entry of positive charge may activate 
;,dditional ion channels that allow more positive charge 
to enter. At a certain threshold, this causes a cell to fire 
an action potential- an electrical event that leads 
ultimately to the release of neurotransmitter. By 
definition. therefore, receptors that admit positive 
charge are excitatory neurotransmitter receptors. The 
classic excitatory neurotransmitter receptors in the 
brain utilize the excitatory amino acids glutamate and, 
to a lesser degree, aspartate as neurotransmitters. 
Conversely, inhibitory neurotransmitters act by 
permitting negative charges into the cell, taking the cell 
thrther away from firing. The classic inhibitory 
ncurotransmitters in the brain are the amino acids 
~;unma ammo butyric acid, or GABA, and, to a lesser 
degree. glycine. 
Most of the other neurotransmitters in the brain, 
huch as dopamine, serotonin, and norepinephrine, and 
;III of the many neuropeptides constitute the second 
major class. These are neither precisely excitatory nor 
inhibitory but rather act to produce complex 
biochemical changes in the receiving cell. Their 
receptors do not contain intrinsic ion pores but rather 
intcmct with signaling proteins, called “G proteins” 
found inside the cell membrane. These receptors thus 
;ire called G protein-linked receptors. The details are 
less important than understanding the general scheme. 
Stimulation of G protein-linked receptors alters the way 
in which receiving neurons can process subsequent 
r*ignals from glutamate or GAB A. To use a metaphor of 
a musical instrument, if glutamate, the excitatory 
neurotransmitter, is puffing wind into a flute or 
clarinet. it is the modulatory neurotransmitters such as 
doPamine or serotonin that might be seen as playing the 
keys and. thus, altering the melody via G protein-linked 
receptors. 
The architecture of these systems drives home this 
Point. The precise brain circuits that carry specific 
information about the world and that are involved in 
precise point-to-point communication within the brain 
use excitatory or inhibitory neurotransmission. 
Examples of such circuits, which are massively 
parallel, can be found in the visual and auditory cortex. 
Overlying this pattern of precise, rapid (timing in the 
range of milliseconds) neurotransmission are the 
modulatory systems in the brain that use 
norepinephrine, serotonin, and dopamine. In each case, 
the neurotransmitter in question is made by a very 
small number of nerve cells clustered in a limited 
number of areas in the brain, Of the hundred billion 
neurons in the brain, only about 500,000, for example, 
make dopamine-that is, for every 200,000 cells in the 
brain, only one makes dopamine. Even fewer make 
norepinephrine. The cell bodies of the dopamine 
neurons are clustered in a few brain regions, most 
importantly, regions deep in the brain, in the midbrain, 
called the substuntia n&u, and the ventral tegmentul 
urea. Norepinephrine neurons are made in the nucleus 
locus coeruleus even farther down in the brain stem in 
a structure called the pow. Serotonin is made by a 
somewhat larger number of nuclei but, still, not by 
many cells. Nuclei called the ruphe nuclei spread along 
the brain stem. While each of these neurotransmitters 
is made by a small number of neurons with clustered 
cell bodies, each sends its axons branching throughout 
the brain, so that in each case a very small number of 
neurons, which largely appear to fire in unison when 
excited, influence almost the entire brain. This is not 
the picture of systems that are communicating precise 
bits of information about the world but rather are 
intrinsic modulatory systems that act via other G 
protein-linked receptors to alter the overall 
responsiveness of the brain. These neurotransmitters 
are responsible for brain states such as degree of 
arousal, ability to pay attention, and for putting 
emotional color or significance on top of cold cognitive 
information provided by precise glutaminergic circuits. 
It is no wonder that these modulatory neurotransmitters 
and their receptors are critical targets of medications 
used to treat mental disorders-for example, the 
antidepressant and antipsychotic drugs-and also are 
the targets of drugs of abuse. 
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Complexity of the Brain III: Plasticity 
The preceding paragraphs have illustrated the chemical 
and anatomic structure of the brain and, in so doing, 
provided some picture of its complexity as well as 
some picture of its function. The crowning complexity 
of the brain, however, is that it is not static. The brain 
is always changing. People learn so much and have so 
many distinct types of memory: conscious, episodic 
memory of the sort that is encoded initially in the 
hippocampus; memory of motor programs or 
procedures that are encoded in the striatum; emotional 
memories that can initiate physiologic and behaviorally 
adaptive repertoires encoded, for example, in the 
amygdala; and many other kinds. Every time a person 
learns something new, whether it is conscious or 
unconscious, that experience alters the structure of the 
brain. Thus, neurotransmission in itself not only 
contains current information but alters subsequent 
neurotransmission if it occurs with the right intensity 
and the right pattern. Experience that is salient enough 
to cause memory creates new synaptic connections, 
prunes away old ones, and strengthens or weakens 
existing ones. Similarly, experiences as diverse as 
stress, substance abuse, or disease can kill neurons, and 
current data suggest that new neurons .continue to 
develop even in adult brains, where they help to 
incorporate new memories. The end result is that 
information is now routed over an altered circuit. Many 
of these changes are long-lived, even permanent. It is in 
this way that a person can look back 10 or 20 or 50 
years and remember family, a home or school room, or 
friends. The general theme is that to really understand 
the kind of memory-indeed, any brain function-one 
must think at least at two levels: one, the level of 
molecular and cellular alterations that are responsible 
for remodeling synapses, and, two, the level of 
information content and behavior which circuits and 
synapses serve. 
To summarize this section, scientists are truly 
beginning to learn about the structure and function of 
the brain. Its awe-inspiring complexity is fully 
consistent with the fact that it supports all behavior and 
mental life. Implied in the foregoing, is the fact that 
brains are built not only by genes-and again, it is the 
lion’s share of the 80,000 or so human genes that are 
involved in building a structure so complex as the 
brain. Genes are not by themselves the whole story. 
Brains are built and changed through life through the 
interaction of genes with environment, including 
experience. It is true that a set of genes might create 
repetitive multiples of one type of unit, yet the brain 
appears far more complex than that. It stands to reason 
that if 50,000 or 60,000 genes are involved in building 
a brain that may have 100 trillion or a quadrillion 
synapses, additional information is needed, and that 
information comes from the environment. It is this 
fundamental realization that is beginning to permit an 
understanding of how treatment of mental disorders 
works-whether in the form of a somatic intervention 
such as a medication, or a psychological “talk” 
therapy-by actually changing the brain. 
Imaging the Brain 
There are many exciting developments in brain science. 
Of great relevance to the study of mental function and 
mental illness is the ability to image the activity of the 
living human brain with technologies developed in 
recent decades, such as positron emission tomography 
scanning or functional magnetic resonance imaging. 
Such approaches can exploit surrogates of neuronal 
firing such as blood flow and blood oxygenation to 
provide maps of activity. As science learns more about 
brain circuitry and learns more from cognitive and 
affective neuroscience about how to activate and 
examine the function of particular brain circuits, 
differences between health and illness in the function 
of particular circuits certainly will become evident. We 
will be able to see the action of psychotropic drugs and, 
perhaps most exciting, we will be able to see the impact 
of that special kind of learning called psychotherapy, 
which works after all because it works on the brain. 
Different brain chemicals, brain receptors, and 
brain structures will come up in the discussion of 
particular illnesses throughout this document. This 
section is meant to provide a panoramic, not a detailed, 
introduction and also to provide certain overarching 
lessons. When something is referred to as biological or 
brain-based, that is not shorthand for saying it is 
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,,enetic and, thus, predetermined; similarly, references 
2 
to ..psychological” or even “social” phenomena do not 
Csc]ude biological processes. The brain is the great 
integrator, bringing together genes and environment. 
The study of the brain requires reducing problems 
initially to bite-sized bits that will allow investigators 
to learn something, but ultimately, the agenda of 
,,euroscience is not reductionist; the goal is to 
cnderstand behavior, not to put blinders on and try to 
csplain it away. As the foregoing discussion illustrates, 
rhe brain also is complex. Thus, having a disease that 
affccts one or even many critical circuits does not 
overthrow, except in extreme cases, such as advanced 
.\lzheimer’s disease, all aspects of a person. Typically, 
people retain their personality and, in most cases, their 
;lbility to take responsibility for themselves. 
In retrospect, early biological models of the mind 
\ccm impoverished and deterministic-for example, 
~nodels that held that “levels” of a neurotransmitter 
huch as serotonin in the brain were the principal 
intluence on whether one was depressed or aggressive. 
Neuroscience is far beyond that now, working to 
integrate information coming “bottom-up” from genes 
:rnd molecules and cells, with information flowing 
“top-down” from interactions with the environment and 
experience to the internal workings of the mind and its 
ncuronal circuits. Ultimately, however, the goal is not 
only human self-understanding. In knowing eventually 
precisely what goes wrong in what circuits and what 
hynapses and with what chemical signals, the hope is to 
develop treatments with greater effectiveness and with 
l&ver side effects. Indeed, as the following chapters 
indicate, the hope is for cures and ultimately for 
prevention. There is every reason to hope that as our 
science progresses, we will achieve those goals. 
Ckmdew of Mental Illness 
hlental illness is a term rooted in history that refers 
collectively to all of the diagnosable mental disorders. 
Mental disorders are characterized by abnormalities in 
cognition, emotion or mood, or the highest integrative 
aspects of behavior, such as social interactions or 
Planning of future activities. These mental functions 
are all mediated by the brain. It is, in fact, a core tenet 
of modem science that behavior and our subjective 
mental lives reflect the overall workings of the brain. 
Thus, symptoms related to behavior or our mental lives 
clearly reflect variations or abnormalities in brain 
function. On the more difficult side of the ledger are 
.the terms disorder, disease, or illness. There can be no 
doubt that an individual with schizophrenia is seriously 
ill, but for other mental disorders such as depression or 
attention-deficit/hyperactivity disorder, the signs and 
symptoms exist on a continuum and there is no bright 
line separating health from illness, distress from 
disease. Moreover, the mapifestations of mental 
disorders vary with age, gender, race, and culture. The 
thresholds of mental illness or disorder have, indeed, 
been set by convention, but the fact is that this gray 
zone is no different from any other area of medicine. 
Ten years ago a serum cholesterol of 200 was 
considered normal. Today, this same number alarms 
some physicians and may lead to treatment. Perhaps 
every adult in the United States has some 
atherosclerosis, but at what point does this move along 
a continuum from normal into the realm of illness? 
Ultimately, the dividing line has to do with severity of 
symptoms, duration, and functional impairment. 
Despite the existence of a gray zone between health 
and illness, science can study the mechanisms by which 
illness occurs. Indeed, understanding mood regulation 
and its abnormalities, for example, proceeds 
independently from any set of diagnostic clinical 
criteria. Family studies, molecular genetics strategies, 
epidemiology, and the tools of clinical investigation 
tailored to specific populations are being used to 
investigate the mechanisms of mental illness. Specific 
manifestations of mental illness will be covered in 
succeeding pages. 
This overview of mental illness focuses on those 
features of the disease process that are most common 
and characteristic of these disorders. The chapters that 
follow will present specific details about major 
categories of mental disorders that occur across the life 
span. The purpose here is to provide a framework upon 
which subsequent discussions of specific disorders can 
rest. The section leads with a descriptive overview of 
the cardinal manifestations, signs, and symptoms of 
The Fundamentals of Mental Health and Mental Illness 
39 
Mental Health: A Report of the Surgeon General 
mental disorders. It then describes how mental 
disorders are diagnosed and classified and provides an 
overview of the epidemiology and societal burden of 
mental disorders. 
Manifestations of Mental Illness 
Persons suffering from any of the severe mental 
disorders present with a variety of symptoms that may 
include inappropriate anxiety, disturbances of thought 
and perception, dysregulation of mood, and cognitive 
dysfunction. Many of these symptoms may be 
relatively specific to a particular diagnosis or cultural 
influence. For example, disturbances of thought and 
perception (psychosis) are most commonly associated 
with schizophrenia. Similarly, severe disturbances in 
expression of affect and regulation of mood are most 
commonly seen in depression and bipolar disorder. 
However, it is not uncommon to see psychotic 
symptoms in patients diagnosed with mood disorders or 
to see mood-related symptoms in patients diagnosed 
with schizophrenia. Symptoms associated with mood, 
anxiety, thought process, or cognition may occur in any 
patient at some point during his or her illness. 
Anxiety 
Anxiety is one of the most readily accessible and easily 
understood of the major symptoms of mental disorders. 
Each of us encounters anxiety in many forms 
throughout the course of our routine activities. It may 
often take the concrete formof intense fear experienced 
in response to an immediately threatening experience 
such as narrowly avoiding a traffic accident. 
Experiences like this are typically accompanied by 
strong emotional responses of fear and dread as well as 
physical signs of anxiety such as rapid heart beat and 
perspiration. Some of the more common signs and 
symptoms of anxiety are listed in Table 2-2. Anxiety is 
aroused most intensely by immediate threats to one’s 
safety, but it also occurs commonly in response to 
dangers that are relatively remote or abstract. Intense 
anxiety may also result from situations that one can 
only vaguely imagine or anticipate, 
Anxiety has evolved as a vitally important 
physiological response to dangerous situations that pre- 
Table 2-2. Common signs of acute anxiety 
. Feelings of fear or dread \ 
. Trembling, restlessness, and muscle tension 
. Rapid heart rate 
. Lightheadedness or dizziness 
. Perspiration 
. Cold hands/feet 
. Shortness of breath 
pares one to evade or confront a threat in the 
environment. The appropriatti regulation of anxiety is 
critical to the survival of virtually every higher 
organism in every environment. However, the 
mechanisms that regulate anxiety may break down in a 
wide variety of circumstances, leading to excessive or 
inappropriate expression of anxiety. Specific examples 
include phobias, panic attacks, and generalized anxiety. 
In phobias, high-level anxiety is aroused by specific 
situations or objects that may range from concrete 
entities such as snakes, to complex circumstances such 
as social interactions or public speaking. Panic attacks 
are brief and very intense episodes of anxiety that often 
occur without a precipitating event or stimulus. 
Generalized anxiety represents a more diffuse and 
nonspecific kind of anxiety that is most often 
experienced as excessive worrying, restlessness, and 
tension occurring with a chronic and sustained pattern. 
In each case, an anxiety disorder may be said to exist if 
the anxiety experienced is disproportionate to the 
circumstance, is difficult for the individual to control, 
or interferes with normal functioning. 
In addition to these common manifestations of 
anxiety, obsessive-compulsive disorder and post- 
traumatic stress disorder are generally believed to be 
related to the anxiety disorders. The specific clinical 
features of these disorders will be described more fully 
in the following chapters; however, their relationship to 
anxiety warrants mention in the present context. In the 
case of obsessive-compulsive disorder, individuals 
experience a high level of anxiety that drives their 
obsessional thinking or compulsive behaviors. When 
such an individual fails to carry out a repetitive 
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khdvior such as hand washing or checking, there is an 
,,ps+nce of severe anxiety. Thus while the outward 
,,,~nifestations of obsessive-compulsive disorder may 
rCem fO be related to other anxiety disorders, there 
.1ppet;lrs to be a strong component of abnormal 
rC,,uiation of anxiety underlying this disorder. Post- 
truumatic stress disorder is produced by an intense and 
,,,.cnvhejmjngly fearful event that is often life- 
tureatening in nature. The characteristic symptoms that 
rc,ult from such a traumatic event include the persistent 
reesperience of the event in dreams and memories, 
persistent avoidance of stimuli associated with the 
cvcnt. and increased arousal. 
Psychosis 
l)ihturbances of perception and thought process fall 
into a broad category of symptoms referred to as 
Il‘;ychosis. The threshold for. determining whether 
ttlmyht is impaired varies somewhat with the cultural 
context. Like anxiety, psychotic symptoms may occur 
III ;I wide variety of mental disorders. They are most 
characteristically associated with schizophrenia, but 
Ilsychotic symptoms can also occur in severe mood 
disorders. 
One of the most common groups of symptoms that 
rcsu I t from disordered processing and interpretation of 
\cnsory information are the hallucinations. 
Ilallucinations are said to occur when an individual 
cxpcriences a sensory impression that has no basis in 
rcillity. This impression could involve any of the 
~nsory modalities. Thus hallucinations may be 
auditory, olfactory, gustatory, kinesthetic, tactile, or 
visual. For example, auditory hallucinations frequently 
involve the impression that one is hearing a voice. In 
each case, the sensory impression is falsely experienced 
as real. 
A more complex group of symptoms resulting from 
disordered interpretation of information consists of 
delusions. A delusion is a false belief that an individual 
holds despite evidence to the contrary. A common 
example is paranoia, in which a person has delusional 
beliefs that others are trying to harm him or her. 
Attempts to persuade the person that these beliefs are 
unfounded typically fail and may even result in the 
further entrenchment of the beliefs. 
Hallucinations and delusions are among the most 
commonly observed psychotic symptoms. A list of 
other symptoms seen in psychotic illnesses such as 
schizophrenia appears in Table 2-3. Symptoms of 
schizophrenia are divided into two broad classes: 
positive symptoms and negative symptoms. Positive 
symptoms generally involve the experience of 
something in consciousness that should not 
normally be present. For example, hallucinations 
and delusions represent perceptions or beliefs that 
should not normally be expirienced. In addition to 
hallucinations and delusions, patients with 
psychotic disorders such as schizophrenia fre- 
quently have marked disturbances in the logical 
process of their thoughts. Specifically, psychotic 
thought processes are characteristically loose, 
disorganized, illogical, or bizarre. These 
disturbances in thought process frequently produce 
observable patterns of behavior that are also 
disorganized and bizarre. The severe disturbances 
of thought content and process that comprise the 
positive symptoms often are the most recognizable 
and striking features of psychotic disorders such as 
schizophrenia or manic depressive illness. 
Table 2-3. Common manifestations of 
schizophrenia 
Positive Symptoms 
. Hallucinatidns 
. Delusions 
. Disorganized thoughts and behaviors 
. Loose or illogical thoughts 
. Agitation 
Negative Symptoms 
. Flat or blunted affect 
. Concrete thoughts 
. Anhedonia (inability to experience pleasure) 
. Poor motivation, spontaneity, and initiative 
However, in addition to positive symptoms, 
patients with schizophrenia and other psychoses 
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have been noted to exhibit major deficits in 
motivation and spontaneity that are referred to as 
negative symptoms. While positive symptoms 
represent the presence of something not normally 
experienced, negative symptoms reflect the absence 
of thoughts and behaviors that would otherwise be 
expected. Concreteness of thought represents 
impairment in the ability to think abstractly. 
Blunting of affect refers to a general reduction in 
the ability to express emotion. Motivational failure 
and inability to initiate activities represent a major 
source of long-term disability in schizophrenia. 
Anhedonia reflects a deficit in the ability to 
experience pleasure and to react appropriately. to 
pleasurable situati,ons. Positive symptoms such as 
hallucinations are responsible for much of the acute 
distress associated with schizophrenia, but negative 
symptoms appear to be responsible for much of the 
chronic and long-term disability associated with the 
disorder. 
The psychotic symptoms represent 
manifestations of disturbances in the flow, 
processing, and interpretation of information in the 
central nervous system. They seem to share an 
underlying commonality of mechanism, insofar as 
they tend to respond as a group to specific 
pharmacological interventions. However, much 
remains to be learned about the brain mechanisms 
that lead to psychosis. 
Disturbances of Mood 
Most of us have an immediate and intuitive 
understanding of the notion of mood. We readily 
comprehend what it means to feel sad or happy. 
These concepts are nonetheless very difficult to 
formulate in a scientifically precise and 
quantifiable way; the challenge is greater given the 
cultural differences that are associated with the 
expression of mood. In turn, disorders that impact 
on the regulation of mood are relatively difficult to 
define and to approach in a quantitative manner. 
Nevertheless, dysregulation of mood and the 
expression of mood, or affect, represent a major 
category among mental disorders. 
Disturbances of mood characteristically 
manifest themselves as a sustained feeling of 
sadness or sustained elevation of mood. As with 
anxiety and psychosis, disturbances of mood may 
occur in a variety of patterns associated with 
.different mental disorders. The disorder most 
closely associated with persistent sadness is major 
depression, while that associated with sustained 
elevation or fluctuation of mood is bipolar disorder. 
The most common signs of these mood disorders 
are listed in Table 2-4. Along with the prevailing 
feelings of sadness or elation, disorders of mood 
are associated with a host of related symptoms that 
include disturbances in appetite, sleep patterns, 
energy level, concentration, and memory. 
Table 2-4. Common signs of mood disorders 
Symptoms Commonly Associated With 
Depression 
. Psychomotor retardation i 
Irritability I 
I* Suicidal ideation I 
Symptoms Commonly Associated With Mania 
~I’) ‘,p-*.v**;‘r$.~i ” 
1 ~Yf$ersis 
:sx: (” 
Grandiosity (inappropriately high self-esteem) / 
Decreased sleep 
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lt is not known why diverse functions such as 
,leep and appetite should be altered in disorders of 
nlood. However, depression and mania are typically 
,ssociated with characteristic changes in these 
basic functions. Mood appears to represent a 
,.umplex group of behaviors and responses that 
undergo precise and tightly controlled regulation. 
Higher organisms that must adapt to changing 
suvironments depend on optimal control of basic 
functions such as sleep, appetite, sex, and physical 
;ictivity. This regulation must adapt to diurnal and 
seasonal changes in the environment. In addition, 
more complex behaviors such as exploration, 
aggression, and social interaction must also 
undergo a similar, perhaps closely linked, 
regulation. In humans, these complex behaviors and 
their regulation are believed to be associated with 
the expression of mood. A depressed mood appears 
to reflect a kind of global damping of these 
t’unctions, while a manic state may result from an 
excessive activation of these same functions. The 
mechanisms underlying the diverse changes 
associated with the mood disorders are largely 
unknown, but their appearance as clusters in 
specific disorders along with their collective 
response to specific therapeutics suggests a 
common mechanistic basis. 
Disturbances of Cognition 
Cognitive function refers to the general ability to 
organize, process, and recall information. Cognitive 
tasks may be subdivided into a large number of 
more specific functions depending on the nature of 
the information remembered and the circumstances 
of its recall. In addition, there are many functions 
commonly associated with cognition such as the 
ability to execute complex sequences of tasks. 
Disturbances of cognitive function may occur in a 
variety of disorders. Progressive deterioration of 
cognitive function is referred to as dementia. 
Dementia may be caused by a number of specific 
conditions including Alzheimer’s disease (to be 
discussed in subsequent chapters). Impairment of 
cognitive function may also occur in other mental 
disorders such as depression. It is not uncommon to 
find profound disturbances of cognition in patients 
suffering from severe mood disturbances. More 
recently, cognitive deficits have been reported in 
schizophrenia and now have become a major new 
topic of research. Lastly, cognitive impairment 
.frequently occurs in a host of chemical, metabolic, 
and infectious diseases that exert an impact on the 
brain. 
The manifestations of cognitive impairment can 
vary across an extremely wide range, depending on 
severity. Short-term memory is one of the earliest 
functions to be affected and, as severity increases, 
retrieval of more remote memories becomes more 
difficult. Attention, concentration, and higher 
intellectual functions can be impaired as the 
underlying disease process progresses. Language 
difficulties range from mild word-finding problems 
to complete inability to comprehend or use 
language. Functional impairments associated with 
cognitive deficits can markedly interfere with the 
ability to perform activities of daily living such as 
dressing and bathing. 
Other Symptoms 
Anxiety, psychosis, mood disturbances, and 
cognitive impairments are among the most common 
and disabling manifestations of mental disorders. It 
is important, however, to appreciate that mental 
disorders leave no aspect of human experience 
untouched. It is beyond the scope of the present 
chapter to detail the full spectrum of presentations 
of mental disorders. Other common manifestations 
include, for example, somatic or other physical 
symptoms and impairment of impulse control. 
Many of these issues will be touched upon in 
subsequent chapters with reference to specific 
disorders. 
Diagnosis of Mental Illness 
The foregoing discussion has suggested that the 
manifestations of mental disorders fall into a 
number of distinct categories such as anxiety, 
psychosis, mood disturbance, and cognitive 
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deficits. These categories are broad, heterogeneous, 
and somewhat overlapping. Moreover, any 
particular patient may manifest symptoms from 
more than one of these categories. This is not 
unexpected, given the highly complex interactions 
that take place among the neurobiological and 
behavioral substrates that produce these symptoms. 
Despite these confounding difficulties, a systematic 
approach to the classification and diagnosis of 
mental illness has been developed. Diagnosis is 
essential in all areas of health for shaping treatment 
and supportive care, establishing a prognosis, and 
preventing related disability. Diagnosis also serves 
as shorthand to enhance communication, research, 
surveillance, and reimbursement. 
The diagnosis of mental disorders is often 
believed to be more difficult than diagnosis of 
somatic, or general medical, disorders, since there 
is no definitive lesion,- laboratory test, or 
abnormality in brain tissue that can identify the 
illness. The diagnosis of mental disorders must rest 
with the patients’ reports of the intensity and 
duration of symptoms, signs from their mental 
status examination, and clinician observation of 
their behavior including functional impairment. 
These clues are grouped together by the clinician 
into recognizable patterns known as syndromes. 
When the syndrome meets all the criteria for a 
diagnosis, it constitutes a mental disorder. Most 
mental health conditions are referred to as 
disorders, rather than as diseases, because 
diagnosis rests on clinical criteria. The term 
“disease” generally is reserved for conditions with 
known pathology (detectable physical change). The 
term “disorder,” on the other hand, is reserved for 
clusters of symptoms and signs associated with 
distress and disability (i.e., impairment of 
functioning), yet whose pathology and etiology are 
unknown. 
The standard manual used for diagnosis of 
mental disorders in the United States is the 
Diagnostic and Statistical Manual of Mental 
Disorders. Most recently revised in 1994, this 
manual now is in its fourth edition (American 
Psychiatric Association, 1994, hereinafter cited in 
this report as DSM-IV). The first edition was 
published in 1952 by the American Psychiatric 
Association; subsequent revisions, which were 
made on the basis of field trials, analysis of data 
sets, and systematic reviews of the research 
literature, have sought to gain greater objectivity, 
diagnostic precision, and reliability. DSM-IV 
organizes mental disorders into 16 major diagnostic 
classes listed in Table 2-5. For each disorder within 
a diagnostic class, DSPUI;IV enumerates specific 
criteria for making the diagnosis. DSM-IV also.lists 
diagnostic “subtypes” for some disorders. A 
subtype is a subgroup within a diagnosis that 
confers greater specificity. DSM-IV is descriptive 
in its listing of symptoms and does not take a 
position about underlying causation. 
Table 2-5. Major Diagnostic Classes of Mental 
Disorders (DSM-IV1 
Disorders usually first diagnosed in infancy, 
childhood, or adolescence 
Delerium, dementia, and amnestic and other 
cognitive disorders 
Mental disorders due to a general medical condition 
Substance-related disorders 
Schizophrenia and other psychotic disorders 
Mood disorders 
Anxiety disorders 
Somatoform disorders 
Factitious disorders 
Dissociative disorders 
Sexual and gender identity disorders 
Eating disorders 
Sleep disorders 
Impulse-control disorders 
Adjustment disorders 
Personality disorders 
44 
DSM-IV and its predecessors* represent a 
“nioue approach to diagnosis by a professional 
field. No other sphere of health care has created 
,“ch an extensive compendium of all of its 
Jisorders with explicit diagnostic criteria. The 
if’orld Health Organization’s international 
CILIxSification ofDiseases (10th edition, 1992) is a 
valuable compendium of all diseases. Its mental 
health categories are expanded upon in DSM-IV. 
The ~,rternationaf C~assijication ofDiseases (ICD) 
is the official classification for mortality and 
morbidity statistics for all signatories to theU.N. 
Charter establishing the World Health 
Organization. ICD-9CM (9th edition, Clinical 
Xlodification, 1991) is still the official 
classification for the Health Care Financing 
Administration. 
Knowledge about diagnosis continues to 
evolve. Evolution in the diagnosis of mental 
disorders generally reflects greater understanding 
of disorders as well as the influence of social 
norms. Years ago, for instance, addiction to 
tobacco was not viewed as a disorder, but today it 
l’alls under the category of “Substance-Related 
Disorders.” Although DSM-IV strives to cover all 
populations, it is not without limitations. The 
difficulties encountered in diagnosing mental 
disorders in children, older persons, and racial and 
ethnic minority groups are discussed later in this 
chapter and throughout this report. Diagnosis rests 
on clinician judgment about whether clients’ 
symptom patterns and impairments of functioning 
meet diagnostic criteria. Cultural differences in 
emotional expression and social behavior can be 
misinterpreted as “impaired” if clinicians are not 
sensitive to the cultural context and meaning of 
exhibited symptoms, a topic discussed later in this 
chapter in Overview of Cultural Diversity and 
Mental Health Services. 
’ DSM-1 (American Psychiatric Association, 1952), DSM-II 
(Amerkan Psychiatric Association, 1968), DSM-III (American 
Psychiatric Association, 1979). and DSM-III-R (American 
Psychiatric Association, 1987). 
Epidemiology of Mental Illness 
Few families in the United States are untouched by 
mental illness. Determining just how many people 
have mental illness is one of the many purposes of 
the field of epidemiology. Epidemiology is the 
study of patterns of disease in the population. 
,Among the key terms of this discipline, 
encountered throughout this report, are incidence, 
which refers to new cases of a condition which 
occur during a specified period of time, and 
prevalence, which refers to cases (i.e., new and 
existing) of a condition observed at a point in time 
or during a period of time.*According to current 
epidemiological estimates, at least one in five 
people has a diagnosable mental disorder during the 
course of a year (i.e., l-year prevalence). 
Epidemiological estimates have shifted over 
time because of changes in the definitions and 
diagnosis of mental health and mental illness. In 
the early 1950s the rates of mental illness 
estimated by epidemiologists were far higher than 
those of today. One study, for example, found 81.5 
percent of the population of Manhattan, New York, 
to have had signs and symptoms of mental distress 
(Srole, 1962). This led the authors of the study to 
conclude that mental illness was widespread. 
However, other studies began to find lower rates 
when they used more restrictive definitions that 
reflected more contemporary views about mental 
illness. Instead of classifying anyone with signs and 
symptoms as being mentally ill, this more recent 
line of epidemiological research only identified 
people as mentally ill if they had a cluster of signs 
and symptoms that, when taken together, impaired 
people’s ability to function (Pasamanick, 1959; 
Weissman et al., 1978). By 1978, the President’s 
Commission on Mental Health (1978) concluded 
conservatively that the annual prevalence of 
specific mental disorders in the United States was 
about 15 percent. This figure comports with recent 
estimates of the extent of mental illness in the 
population. Even as this figure has become more 
sharply delineated, the older and larger estimates 
underscore the magnitude of mental distress in the 
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population, which this report refers to as “mental 
health problems.” 
Adults 
The current prevalence estimate is that about 20 
percent of the U.S. population are affected by 
mental disorders during a given year. This estimate 
comes from two epidemiologic surveys: the 
Epidemiologic Catchment Area (ECA) study of the 
early 1980s and the National Comorbidity Survey 
(NCS) of the early 1990s. Those surveys defined 
mental illness according to the prevailing editions 
of the Diagnostic and Statistical Manual of Mental 
Disorders (i.e., DSM-III and DSM-III-R). The 
surveys estimate that during a 1 -year period, .22 to 
23 percent of the U.S. adult population-or 44 
million people -have diagnosable mental disorders, 
according to reliable, established criteria. In 
general, 19 percent of the adult U.S. population 
have a mental disorder alone (in 1 year); 3 percent 
have both mental and addictive disorders; and 6 
percent have addictive disorders alone.3 
Consequently, about 28 to 30 percent of the 
population have either a mental or addictive 
disorder (Regier et al., 1993b; Kessler et al., 1994). 
Table 2-6 summarizes the results synthesized from 
these two large national surveys. 
Individuals with co-occurring disorders (about 
3 percent of the population in 1 year) are more 
likely to experience a chronic course and to utilize 
services than are those with either type of disorder 
alone. Clinicians, program developers, and policy- 
makers need to be aware of these high rates of 
comorbidity-about 15 percent of those with a 
mental disorder in 1 year (Regier et al., 1993a; 
Kessler et al., 1996). 
Based on data on functional impairment, it is 
estimated that 9 percent of all U.S. adults have the 
mental disorders listed in Table 2-6 and experience 
some significant functional impairment (National 
’ Although addictive disorders are included as mental disorders in 
the DSM classification system, the ECA and NCS distinguish 
between addictive disorders and (all other) mental disorders. 
Epidemiologic data in this report follow that convention. 
Advisory Mental Health Council [NAMHC], 1993). 
Most (7 percent of adults) have disorders that 
persist for at least 1 year (Regier et al., 1993b; 
Regier et al., in press). A subpopulation of 5.4 
percent of adults is considered to have a “serious” 
mental illness (SMI) (Kessler et al., 1996). Serious 
.mental illness is a term defined by Federal 
regulations that generally applies to mental 
disorders that interfere with some area of social 
functioning. About half of those with SMI (or 2.6 
percent of all adults) were identified as being even 
more seriously affected, that is, by having “severe 
and persistent” mental illness (SPMI) (NAMHC, 
1993; Kessler et al., 1996). This category includes 
schizophrenia, bipolar disorder, other severe forms 
of depression, panic disorder, and obsessive- 
compulsive disorder. These disorders and the 
problems faced by these special populations with 
SMI and SPMI are described further in subsequent 
chapters. Among those most severely disabled are 
the approximately 0.5 percent of the population 
who receive disability benefits for mental health- 
related reasons from the Social Security 
Administration (NAMHC, 1993). 
Children and Adolescents 
The annual prevalence of mental disorders in 
children and adolescents is not as well documented 
as that for adults. About 20 percent of children are 
estimated to have mental disorders with at least 
mild functional impairment (see Table 2-7). Federal 
regulations also define a sub-population of children 
and adolescents with more severe functional 
limitations, known as “serious emotional 
disturbance” (SED).4 Children and adolescents with 
SED number approximately 5 to 9 percent of 
children ages 9 to 17 (Friedman et al., 1996b). 
4 The term “serious emotional disturbance” is used in a variety of 
Federal statutes in reference to children under the age of 18 with a 
diagnosable mental health problem that severely disrupts their 
ability to function socially. academically, and emotionally. The term 
does not signify any particular diagnosis; rather, it is a legal term 
that triggers a host of mandated services to meet the needs of these 
children. 
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Table 2-6. Best estimate l-year prevalence rates based on ECA and NCS, ages 18-54 
4ny Anxiety Disorder 13.1 18.7 
16.4 
Simple Phobia 8.3 8.6 6.3 
Social Phobia 2.0 7.4 2.0 
Agoraphobia 
GAD 
(::E)* 3.7 4.9 
3.4 3.4 
Panic Disorder 1.6 1.6 
OCD (kg 2.4 
PTSD 3.6 3.6 .- ._ . . _‘ . .;hx.b& 
any Mood Disorder 
MD Episode 
Unipolar MD 
Dysthymia 
Bipolar I 
Bipolar II 
.I. .- ~ .“,?>.4YFp .id‘i’d. 
Schizophrenia 
Nonaffective Psychosis 
Somatization 
ASP 
Anorexia Nervosa 
Severe Cognitive 
Impairment 
7.1 11.1 7.1 
6.5 10.1 6.5 
5.3 8.9 5.3 
1.6 2.5 1.6 
1.1 1.3 1.1 
0.6 0.2 0.6 
.I.*= .&.?: 
1.3 1.3 
0.2 0.2 
0.2 - 0.2 
2.1 - 2.1 
0.1 0.1 
1.2 - 1.2 
Anv Disorder 19.5 23.4 21 .o 
‘Numbers in parentheses indicate the prevalence of the disorder without any comorbidity. These rates were calculated using the NCS data for 
GAD and PTSD, and the ECA data for OCD. The rates were not used in calculating the any anxiety disorder and any disorder totals for the ECA 
and NCS columns. The unduplicated GAD and PTSD rates were added to the best estimate total for any anxiety disorder (3.3%) and any disorder 
(1.5%). 
“In developing best-estimate 1 -year prevalence rates from the two studies, a conservative procedure was followed that had previously been used 
in an independent scientific analysis comparing these two data sets (Andrews, 1995). For any mood disorder and any anxiety disorder, the lower 
estimate of the two surveys was selected, which for these data was the ECA. The best estimate rates for the individual mood and anxiety disorders 
were then chosen from the ECA only, in order to maintain the relationships between the individual disorders. For other disorders that were not 
covered in both surveys, the available estimate was used. 
Key to abbreviations: ECA, Epidemiologic Catchment Area; NCS, National Comorbidity Study; GAD, generalized anxiety disorder; OCD, 
obsessive-compulsive disorder; PTSD, post-traumatic stress disorder; MD, major depression; ASP, antisocial personality disorder. 
Source: D. Regier, W. Narrow, & D. Rae, personal communication, 1999 
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Table 2-7. Children and adolescents ages 9 to 17 
with mental or addictive disorders,* 
combined MECA sample 
Prevalence (%) 
Anxiety disorders 13.0 
Mood disorders 6.2 
Disruptive disorders 10.3 
Substance use disorders 2.0 
Any disorder 20.9 
*Disorders include diagnosis-specific impairment and 
Child Global Assessment Scale ~70 (mild global 
impairment). 
Source: Shaffer et al., 1996 
Not all mental disorders identified in childhood 
and adolescence persist into adulthood, even 
though the prevalence of mental disorders in 
children and adolescents is about the same as that 
for adults (i.e., about 20 percent of each age 
population). While some disorders do continue into 
adulthood, a substantial fraction of children and 
adolescents recover or .“grow out of’ a disorder, 
whereas, a substantial fraction of adults develops 
mental disorders in adulthood. In short, the nature 
and distribution of mental disorders in young 
people are somewhat different from those of adults. 
Older Adults 
The annual prevalence of mental disorders among 
older adults (ages 55 years and older) is also not as 
well documented as that for younger adults. 
Estimates generated from the ECA survey indicate 
that 19.8 percent of the older adult population have 
a diagnosable mental disorder during a l-year 
period (Table 2-8). Almost 4 percent of older adults 
have SMI, and just under 1 percent has SPMI 
(Kessler et al., 1996); these figures do not include 
individuals with severe cognitive impairments such 
as Alzheimer’s disease. 
Future Directions for Epidemiology 
The epidemiology of mental disorders is somewhat 
handicapped by the difficulty of identifying a 
“case” of a mental disorder. “Case” is an 
Table 2-9. Best estlmate prevalence rates based 
I I 
L 
on Epldemiolo@c Catchment Area, 
age 55+ 
Prevalence (%) 
9ny Anxiety Disorder 11.4 
Simple Phobia 7.3 
Social Phobia 1 .o 
Agoraphobia 4.1 
Panic Disorder 0.5 
Obsessive-Compulsive Disorder 1.5 
?m 
Any Mood Disorder 4.4 
Major Depressive Episode 3.8 
Unipolar Major Depression 3.7 
Dysthymia 1.6 
Bipolar I 0.2 
Bipolar II 0.1 
Schizophrenia 
Somatization 
Antisocial Personality Disorder 0.0 
Anorexia Nervosa 
Severe Cognitive Impairment 
Source: D. Regier, W. Narrow, & D. Rae, personal com- 
munication, 1999 
epidemiological term for someone who meets the 
criteria for a disease or disorder. It is not always 
easy to establish a threshold for a mental disorder, 
particularly in light of how common symptoms of 
mental distress are and the lack of objective, 
physical symptoms. It is sometimes difficult to 
determine when a set of symptoms rises to the level 
of a mental disorder, a problem that affects other 
areas of health (e.g., criteria for certain pain 
syndromes). In many cases, symptoms are not of 
sufficient intensity or duration to meet the criteria 
for a disorder and the threshold may vary from 
culture to culture. 
Diagnosis of mental disorders is made on the 
basis of a multidimensional assessment that takes 
into account observable signs and symptoms of 
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illness, the course and duration of illness, response 
[o treatment. and degree of functional impairment. 
one Problem has been that there is no clearly 
,,,easurable threshold for functional impairments. 
Efforts are currently under way in the epidemiology 
,,f mental disorders to create a threshold, or agreed- 
uPon minimum level of functional limitation, that 
,hould be required to establish a “case” (i.e., a 
clinically significant condition). Epidemiology 
reflecting the state of psychiatric nosology during 
the Past two decades has focused primarily on 
sbrmptom clusters and has not uniformly 
abplied-or, at times, even measured-the level of 
Jysfunction. Ongoing reanalyses of existing 
cpidemiological data are expected to yield better 
understanding of the rates of mental disorder and 
dysfunction in the population. 
Another limitation of contemporary mental 
health knowledge is the lack of standard measures 
of “need for treatment,” particularly those which 
arc culturally appropriate. Such measures are at the 
heart of the public health approach to mental 
health. Current epidemiological estimates therefore 
cannot definitively identify those who are in need 
of treatment. Other estimates presented, in Chapter 
6 indicate that some individuals with. mental 
disorders are in treatment and others are not; some 
are seen in primary care settings and others in 
specialty care. In the absence of valid measures of 
riced.. rates of disorder estimated in epidemiological 
surveys serve as an imperfect proxy for the need for 
care and treatment (Regier et al., in press). 
Subsequent sections of this report reveal the 
Population basis of our understanding of mental 
health. Where appropriate, the report discusses 
mental health and illness across the entire 
Population. At other times, the focus is on care in 
specialized mental health settings, primary health 
care, schools, the criminal justice system, and even 
the streets. A mainstream public health and 
Population-based perspective demands such a broad 
view of mental health and mental illness. 
Costs of Mental Illness 
The costs of mental illness are .exceedingly high. 
Although the question of cost is discussed more 
fully in Chapter 6, a few of the central findings are 
presented here. The direct costs of mental health 
services in the United States in 1996 totaled $69.0 
billion. This figure represents 7.3 percent of total 
health spending. An additional $17.7 billion was 
spent on Alzheimer’s disease and $12.6 billion on 
substance abuse treatment. Direct costs correspond 
to spending for treatment and rehabilitation 
nationwide. 
When economists calcblate the costs of an 
illness, they also strive to identify indirect costs. 
Indirect costs can be defined in different ways, but 
here they refer to lost productivity at the 
workplace, school, and home due to premature 
death or disability. The indirect costs of mental 
illness were estimated in 1990 at $78.6 billion 
(Rice & Miller, 1996). More than 80 percent of 
these costs stemmed from disability rather than 
death because mortality from mental disorders is 
relatively low. 
Overview of Etiology 
The precise causes (etiology) of most mental 
disorders are not known. But the key word in this 
statement is precise. The precise causes of most 
mental disorders-or, indeed, of mental health- 
may not be known, but the broad forces that shape 
them are known: these are biological, psycho- 
logical, and social/cultural factors. 
What is most important to reiterate is that the 
causes of health and disease are generally viewed 
as a product of the interplay or interaction between 
biological, psychological, and sociocultural factors. 
This is true for all health and illness, including 
mental health and mental illness. For instance, 
diabetes and schizophrenia alike are viewed as the 
result of interactions between biological, 
psychological, and sociocultural influences. With 
these disorders, a biological predisposition is 
necessary but not sufficient to explain their 
occurrence (Barondes, 1993). For other disorders, 
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a psychological or sociocultural cause may be 
necessary, but again not sufficient. 
As described in the section on modern 
neuroscience, the brain and behavior are 
inextricably linked by the plasticity of the nervous 
system. The brain is the organ of mental function; 
psychological phenomena have their origin in that 
complex organ. Psychological and sociocultural 
phenomena are represented in the brain through 
memories and learning, which involve structural 
changes in the neurons and neuronal circuits. Yet 
neuroscience does not intend to reduce all 
phenomena to neurotransmission or to reinterpret 
them in a new language of synapses, receptors, and 
circuits. Psychological and sociocultural events.and 
phenomena continue to have meaning for mental 
health and mental illness. 
Much of the research that is presented in the 
remainder of this report draws on theories and 
investigations that predate the more modern view 
of integrative neuroscience. It is still meaningful, 
however, to speak of the interaction of biological 
and psychological and sociocultural factors in 
health and illness. That is where the overview of 
etiology begins-with the biopsychosocial model 
of disease, followed by an explanation of important 
terms used in the study of etiology. Then, against 
the backdrop of the introductory section on brain 
and behavior, the following sections address 
biological and psychosocial influences on mental 
health and mental illness, a separation that reflects 
the distinctive research perspectives of past 
decades. The overview of etiology draws to a close 
with a discussion of the convergence of biological 
and psychosocial approaches in the study of mental 
health and mental illness. 
Biopsychosocial Model of Disease 
The modern view that many factors interact to 
produce disease may be attributed to the seminal 
work of George L. Engel, who in 1977 put forward 
the Biopsychosocial Model of Disease (Engel, 
1977). Engel’s model is a framework, rather than a 
set of detailed hypotheses, for understanding health 
and disease. To many scientists, the model lacks 
sufficient specificity to make predictions about the 
given cause or causes of any one disorder. 
Scientists want to find out what specifically is the 
contribution of different factors (e.g., genes, 
parenting, culture, stressful events) and how they 
operate. But the purpose of. the biopsychosocial 
model is to take a broad view, to assert that simply 
looking at biological factors alone-which had 
been the prevailing view of disease at the time 
Engel was writing-is not sufficient to explain 
health and illness. 
According to Engel’s ‘model, biopsychosocial 
factors are involved in the causes, manifestation, 
course, and outcome of health and disease, 
including mental disorders. The model certainly fits 
with common experience. Few people with a 
condition such as heart disease or diabetes, for 
instance, would dispute the role of stress in 
aggravating their condition. Research bears this out 
and reveals many other relationships between stress 
and disease (Cohen & Herbert, 1996; Baum & 
Posluszny, 1999). 
One single factor in isolation-biological, 
psychological, or social-may weigh heavily or 
hardly at all, depending on the behavioral trait or 
mental disorder. That is, the relative importance or 
role of any one factor in causation often varies. For 
example, a personality trait like extroversion is 
linked strongly. to genetic factors, according to 
identical twin studies (Plomin et al., 1994). 
Similarly, schizophrenia is linked strongly to 
genetic factors, also according to twin studies (see 
Chapter 4). But this does not mean that genetic 
factors completely preordain or fix the nature of the 
disorder and that psychological and social factors 
are unimportant. These social factors modify 
expression and outcome of disorders. Likewise, 
some mental disorders, such as post-traumatic 
stress disorder (PTSD), are clearly caused by 
exposure to an extremely stressful event, such as 
rape, combat, natural disaster, or concentration 
camp (Yehuda, 1999). Yet not everyone develops 
PTSD after such exposure. On average, about 9 
50 
i,crccnt do (Breslau et al., 1998), but estimates are 
higher for particular types of trauma. For women 
,, ho are victims of crime, one study found the 
ptcvalence of PTSD in a representative sample of 
I\ omen to be 26 percent (Resnick et al., 1993). The 
likelihood of developing PTSD is related to 
p,-rtrauma vulnerability (in the form of genetic, 
biological. and personality factors), magnitude of 
the stressful event, preparedness for the event, and 
rl,r quality of care after the event (Shalev, 1996). 
The relative roles of biological, psychological, 
or social factors also may vary across individuals 
and across stages of the life span. In some people, 
for example, depression arises primarily as a result 
of exposure to stressful life events, whereas in 
others the foremost cause of depression is genetic 
predisposition. 
Understanding Correlation, Causation, 
and Consequences 
(\ny discussion of the etiology of mental health and 
tncntal illness needs to distinguish three key terms: 
correlation, causation, and consequences. These 
terms are often confused. All too frequently a 
biological change in the brain (a lesion) is 
purported to be the “cause” of a mental’disorder, 
based on finding an association between the lesion 
and a mental disorder. The fact is that any simple 
association-or correlation-cannot and does not, 
by itself, mean causation. The lesion could be a 
correlate, a cause of, or an effect of the mental 
disorder. 
When researchers begin to tease apart etiology, 
they usually start by noticing correlations. A 
correlation is an association or linkage of two (or 
more) events. A correlation simply means that the 
events are linked in some way. Finding a 
correlation between stressful life events and 
depression would prompt more research on 
causation. Does stress cause depression? Does 
depression cause stress? Or are they both caused by 
an unidentified factor? These would be the 
questions guiding research. But, with correlational 
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research, several steps are needed before causation 
can be established. 
If a correlational study shows that a stressful 
event is associated with an increased probability 
for depression and that the stress usually precedes 
depression’s onset, then stress is called a “risk 
factor” for depression.5 Risk factors are biological, 
psychological, or sociocultural variables that 
increase the probability for developing a disorder 
and antedate its onset (Garmezy, 1983; Werner & 
Smith, 1992; Institute of Medicine [IOM], 1994a). 
For each mental disorder, there are likely to be 
multiple risk factors, which are woven together in 
a complex chain of causation (IOM, 1994a). Some 
risk factors may carry more weight than others, and 
the interaction of risk factors may be additive or 
synergistic. 
Establishing causation of mental health and 
mental illness is extremely difficult, as explained in 
Chapter 1. Studies in the form of randomized, 
controlled experiments provide the strongest 
evidence of causation. The problem is that 
experimental research in humans may be 
logistically, ethically, or financially impossible. 
Correlational research in humans has thus provided 
much of what is known about the etiology of mental 
disorders. Yet correlational research is not as 
strong as experimental research in permitting 
inferences about causality. The establishment of a 
cause and effect relationship requires multiple 
studies and requires judgment about the weight of 
all the evidence. Multiple correlational studies can 
be used to support causality, when, for example, 
evaluating the effectiveness of clinical treatments 
(Chambless et al., 1996). But, when studying 
etiology, correlational studies are, if possible, best 
combined with evidence of biological plausibility 
s Chapter 4 contains a fuller discussion of the relationship between 
stress and depression. In common parlance, stress refers either to the 
stressful event or to the individual’s response to the event. However, 
mental health professionals distinguish the two by referring to the 
external events as the “stressor” (or stressful life event) and to the 
individual’s response as the “stress response.” 
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(IOM, 1994b).6 This means that correiational 
findings should fit with biological, chemical, and 
physical findings about mechanisms of action 
relating to cause and effect. 
Biological plausibility is often established in 
animal models of disease. That is why researchers 
seek animal models in which to study causation. In 
mental health research, there are some animal 
models-such as for anxiety and hyperactivity-but 
a major problem is the difficulty of finding animal 
models that simulate what is often uniquely human 
functioning. The search for animal models, 
however, is imperative. 
Consequences are defined as the later outcomes 
of a disorder. For example, the most serious 
consequence of depression in older people is 
increased mortality from either suicide or medical 
illness (Frasure-Smith et al., 1993, 1995; Conwell, 
1996; Penninx et al., 1998). The basis for this 
relationship is not fully known. The relationship 
between depression and suicide in adolescents is 
presented in Chapter 3. 
Putting this all together, the biopsychosocial 
model holds that biological, psychological, or 
social factors may be causes, correlates, and/or 
consequences in relation to menial health and 
mental illness. A stressful life event, such as 
receiving the news of a diagnosis of cancer, offers 
a graphic example of a psychological event that 
causes immediate bi,ological changes and later has 
psychological, biological, and social consequences. 
When a patient receives news of the cancer 
diagnosis, the brain’s sensory cortex simultan- 
eously registers the information (a correlate) and 
sets in motion biological changes that cause the 
heart to pound faster. The patient may experience 
an almost immediate fear of death that may later 
escalate to anxiety or depression. This certainly has 
been established for breast cancer patients 
(Farragher, 1998). Anxiety and depression are, in 
’ Other types of information used to establish cause and effect 
relationships are the strength and consistency of the association, 
time sequence information, dose-response relationships, and 
disappearance of the effect when the cause is removed. 
this case, consequences of the cancer diagnosis,’ 
although the exact mechanisms are not understood. 
Being anxious or depressed may prompt further 
changes in behavior, such as social withdrawal. So 
there may be social consequences to the diagnosis 
as well. This example is designed to lay out some 
of the complexity of the biopsychosocial model 
applied to mental health and mental illness. 
Biological Influences on Mental Health 
and Mental Illness 
There are far-reaching biological and physical 
influences on mental health and mental illness. The 
major categories are genes, infections, physical 
trauma, nutrition, hormones, and toxins (e.g., lead). 
Examples have been noted throughout Chapter 1 
and earlier in this chapter. This section focuses on 
the first two categories-genes and infections-for 
these are among the most exciting and intensive 
areas of research relating to biological influences 
on mental health and mental illness. 
The Genetics of Behavior and Mental illness 
That genes influence behavior, normal and 
abnormal, has long been established (Plomin et al., 
1997). Genes influence behavior across the animal 
spectrum, from the lowly fruitfly all the way to 
humans. Sorting out which genes are involved and 
determining how they influence behavior present 
the greatest challenge. Research suggests that many 
mental disorders arise in part from defects not in 
single genes, but in multiple genes. However, none 
of the genes has yet been pinpointed for common 
mental disorders (National Institute of Mental 
Health [NIMH], 1998). 
The human genome contains approximately 
80,000 genes that occupy approximately 5 percent 
of the DNA sequences of the human genome. By 
the spring of 2000, the human genome project will 
have provided an initial rough draft version of the 
entire sequence of the human genome, and in the 
’ Anxiety and depression may in some cases be caused by hormonal 
changes related to the tumor itself. 
52 
The Fundamentals of Mental Health and Mental Illness 
ensuing years, gaps in the sequence will be closed, 
errors will be corrected, and the precise boundaries 
\,f genes will be identified. 
ln parallel, clinical medicine is studying the 
;tgcregation of human disease in families. This se 
c’ffort includes the study of mental illness, most 
notably schizophrenia, bipolar disorder (manic 
depressive illness), early onset depression, autism, 
mention-deficit/hyperactivity disorder, anorexia 
uervosa. panic disorder, and a number of other 
mental disorders (NIMH, 1998). From studying 
how these disorders run in families, and from initial 
molecular analyses of the genomes of these 
families, we have learned that heredity-that ‘is, 
genes-plays a role in the transmission of 
vulnerability of all the aforementioned disorders 
from generation to generation. 
But we have also learned that the transmission 
of risk is not simple. Certain human diseases such 
;LS Huntington’s disease and cystic fibrosis result 
from the transmission of a mutation-that is, a 
rlclcteriously altered gene sequence-at one 
location in the human genome. In these diseases, a. 
single mutation has everything to say about whether 
one will get the illness. The transmission of a trait 
due to a single gene in the human genome is called 
hlendelian transmission, after the Austrian monk, 
(lrcgor Mendel, who was the first to develop 
principles of modern genetics and who studied 
traits due to single genes. When a single gene 
determines the presence or absence of a disease or 
other trait, genes are rather easy to discover on the 
hasis of modern methods. Indeed, for almost all 
hlrndelian disorders across medicine that affect 
more than a few people, the genes already have 
heen identified. 
ln contrast to Mendelian disorders, to our 
knowledge, all mental illnesses and all normal 
variants of behavior are genetically complex. What 
this means is that no single gene or even a 
combination of genes dictates whether someone 
\vill have an illness or a particular behavioral trait. 
Rather. mental illness appears to result from the 
interaction of multiple genes that confer risk, and 
this risk is converted into illness by the interaction 
of genes with environmental factors. The 
implications for science are, first, that no gene is 
equivalent to fate for mental illness. This gives us 
hope that modifiable environmental risk factors can 
eventually be identified and become targets for 
prevention efforts. In addition, we recognize that 
genes, while significant in their aggregate 
contribution to risk, may each contribute only a 
small increment, and, therefore, will be difficult to 
discover. As a result, however, of the Human 
Genome Project, we will know the sequence of 
each human gene and the common variants for each 
gene throughout the human race. With this 
information, combined with modern technologies, 
we will in the coming years identify genes that 
confer risk of specific mental illnesses. 
This information will be of the highest 
importance for several reasons. First, genes are the 
blueprints of cells. The products of genes, proteins, 
work together in pathways or in building cellular 
structures, so that finding variants within genes 
will suggest pathways that can be targets of 
opportunity for the development of new therapeutic 
interventions. Genes will also be important clues to 
what goes wrong in the brain when a disease 
occurs. For example, once we know that a certain 
gene is involved in risk of a particular mental 
illness such as schizophrenia or autism, we can ask 
at what time during the development of the brain 
that particular gene is active and in which cells and 
circuits the gene is expressed. This will give us 
clues to critical times for intervention in a disease 
process and information about what it is that goes 
wrong. Finally, genes will provide tools for those 
scientists who are searching for environmental risk 
factors. Information from genetics will tell us at 
what age environmental cofactors in risk must be 
active, and genes will help us identify 
homogeneous populations for studies of treatment 
and of prevention. 
Heritability refers to how much genetics con- 
tributes to the variation of a disease or trait in a 
population at a given point in time (Plomin et al., 
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1997). Once a disorder is established as running in 
families, the next step is to determine its 
heritability (see below), then its mode of 
transmission, and, lastly, its location through 
genetic mapping (Lombroso et al., 1994). 
One powerful method for estimating heritability 
is through twin studies.* Twin studies often 
compare the frequency with which identical versus 
fraternal twins display a disorder. Since identical 
twins are from the same fertilized egg, they share 
the exact genetic inheritance. Fraternal twins are 
from separate eggs and thereby share only 50 
percent of their genetic inheritance. If a disorder is 
heritable, identical twins should have a higher .rate 
of concordance-the expression of the trait by both 
members of a twin pair-than fraternal twins. Such 
studies, however, do not furnish information about 
which or how many genes are involved. They just 
can be used to estimate heritability. For example, 
the heritability of bipolar disorder, according to the 
most rigorous twin study, is about 59 percent, 
although other estimates vary (NIMH, 1998). The 
heritability of schizophrenia is estimated, on the 
basis of twin studies, at a somewhat higher level 
(NIMH, 1998). 
Even with a high level of heritability, however, 
it is essential to point out that environmental 
factors (e.g., psychosocial environment, nutrition, 
health care access) can play a significant role in the 
severity and course of a disorder. 
Another point is that environmental factors may 
even protect against the disorder developing in the 
first place. Even with the relatively high heritabili- 
ty of schizophrenia, the median concordance rate 
among identical twins is 46 percent’ (NIMH, 1998), 
meaning that in over half of the cases, the second 
* Establishing that a disorder runs in families could suggest 
environmental and/or genetic influences because families share 
genes and environment. Comparing identical versus fraternal twins 
assumes that their shared environments are about equal, thereby 
providing insight about genetic influences. Such comparisons are 
further enhanced by studies of twins (identical vs. fraternal) 
separated at birth and adopted by different families. 
9 The median concordance rate for identical twins is only 14 percent 
(NIMH, 1998). 
twin does not manifest schizophrenia even though 
he or she has the same genes as the affected twin. 
This implies that environmental factors exert a 
significant role in the onset of schizophrenia. 
Infectious Influences 
It has been known since the early part of the 20th 
century that infectious agents can penetrate into the 
brain where they can cause mental disorders. A 
highly common mental disorder of unknown 
etiology at the turn of the century, termed “general 
paresis,” turned out to be a late manifestation of 
syphilis. The sexually transmitted infectious 
agent-Treponema pallidurn-first caused 
symptoms in reproductive organs and then, 
sometimes years later, migrated to the brain where 
it led to neurosyphilis. Neurosyphilis was manifest 
by neurological deterioration (including psychosis), 
paralysis, and later death. With the wide 
availability of penicillin after World War II, 
neurosyphilis was virtually eliminated (Barondes, 
1993). 
Neurosyphilis may be thought of as a disease of 
the past (at least in the developed world), but 
dementia associated with infection by the human 
immunodeficiency virus (HIV) is certainly not. 
HIV-associated dementia continues to encumber 
HIV-infected individuals worldwide. HIV infection 
penetrates into the brain, producing a range of 
progressive cognitive and behavioral impairments. 
Early symptoms include impaired memory and 
concentration, psychomotor slowing, and apathy. 
Later symptoms, usually appearing years after 
infection, include global impairments marked by 
mutism, incontinence, and paraplegia (Navia et al., 
1986). The prevalence of HIV-associated dementia 
varies, with estimates ranging from 15 percent to 
44 percent of patients with HIV infection (Grant et 
al., 1987; McArthur et al., 1993). The high end of 
this estimate includes patients with subtle 
neuropsychological abnormalities. What is 
remarkable about HIV-associated dementia is that 
it appears to be caused not by direct infection of 
neurons, but by infection of immune cells known as 
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lnacrophages that enter the brain from the blood. 
The macrophages indirectly cause dysfunction and 
death in nearby neurons by releasing soluble toxins 
, Epstein & Gendelman, 1993). 
Besides HIV-associated dementia and 
neurosyphilis, other mental disorders are caused by 
infectious agents. They include herpes simplex 
encephalitis, measles encephalomyelitis, rabies 
encephalitis, chronic meningitis, and subacute 
,clerosing panencephalitis (Kaplan & Sadock, 
1998). More recently, research has uncovered an 
infectious etiology to one form of obsessive- 
compulsive disorder, as explained below. 
PANDAS 
ln the late 198Os, it was discovered that some 
children with obsessive-compulsive disorder (OCD) 
experienced a sudden onset of symptoms soon after 
;I streptococcal pharyngitis (Garvey et al., 1998). 
The symptoms were classic for OCD-concerns 
about contamination, spitting compulsions, and 
extremely excessive hoarding-but the abrupt onset 
was unusual. Further study of these children led to 
the identification of a new classification of OCD 
called PANDAS. This acronym stands for pediatric 
:tutoimmune neuropsychiatric disorders associated 
with streptococcal infection. PANDAS are distinct 
from classic cases of OCD because of their 
episodic clinical course marked by sudden 
symptom exacerbation linked to streptococcal 
infection, among other unique features. The 
exacerbation of symptoms is correlated with a rise 
in levels of antibodies that the child produces to 
fight the strep infection. Consequently, researchers 
proposed that PANDAS are caused by antibodies 
against the strep infection that also manage to 
attack the basal ganglia region of the child’s brain 
(Garvey et al., 1998). In other words, the strep 
infection triggers the child’s immune system to 
develop antibodies, which, in turn, may attack the 
child’s brain, leading to obsessive and compulsive 
behaviors. Under this proposal, the strep infection 
does not directly induce the condition; rather, it 
may do so indirectly by triggering antibody 
formation. How the antibodies are so damaging to 
a discrete region of the child’s brain and how this 
attack ignites OCD-like symptoms are two of the 
fundamental questions guiding research. 
Psychosocial Influences on Mental 
Health and Mental Illness 
This chapter thus far has highlighted some of the 
psychosocial influences on mental health and 
mental illness. Stressful life eyents, affect (mood 
and level of arousal), personality, and gender are 
prominent psychological influences. Social 
influences include parents, socioeconomic status, 
racial, cultural, and religious background, and 
interpersonal relationships. These psychosocial 
influences, taken individually or together, are 
integrated into many chapters of this report in 
discussions of epidemiology, etiology, risk factors, 
barriers to treatment, and facilitators to recovery. 
Since these psychosocial influences are familiar 
to the general reader, detailed description of each 
is beyond the scope of this section (with the 
exception of cultural influences, which are 
discussed in the Overview of Cultural Diversity and 
Mental Health Services section). Instead, this 
section summarizes the sweeping theories of 
individual behavior and personality that inspired a 
vast body of psychosocial research: psychodynamic 
theories, behaviorism, and social learning theories. 
The therapeutic strategies that arose from these 
theories, and modifications necessary to make them 
relevant to the changing demography of the U.S. 
population, are discussed in a later section, 
Overview of Treatment. 
Psychodynamic Theories 
Psychodynamic theories of personality assert that 
behavior is the product of underlying conflicts over 
which people often have scant awareness. Sigmund 
Freud (1856-1939) was the towering proponent of 
psychoanalytic theory, the first of the 20th-century 
psychodynamic theories. Many of Freud’s 
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followers pioneered their own psychodynamic 
theories, but this section covers only 
psychoanalytic theory. A brief discussion of 
Freud’s work contributes to an historical 
perspective of mental health theory and treatment 
approaches. 
Freud’s theory of psychoanalysis holds two 
major assumptions: (1) that much of mental life is 
unconscious (i.e., outside awareness), and (2) that 
past experiences, especially in early childhood, 
shape how a person feels and behaves throughout 
life (Brenner, 1978). 
Freud’s structural model of personality divides 
the personality into three parts-the id, the ego, 
and the superego. The id is the unconscious part 
that is the cauldron of raw drives, such as for sex or 
aggression. The ego, which -has conscious and 
unconscious elements, is the rational and 
reasonable part of personality. Its role is to 
maintain contact with the outside world in order to 
help keep the individual in touch with society. As 
such, the ego mediates between the conflicting 
tendencies of the id and the superego. The latter is 
a person’s conscience that develops early in life 
and is learned from parents, teachers, ahd others. 
Like the ego, the superego has conscious and 
unconscious elements (Brenner, 1978). 
When all three parts of the personality are in 
dynamic equilibrium, the individual is thought to 
be mentally healthy. However, according to 
psychoanalytic theory, if the ego is unable to 
mediate between the id and the superego, an 
imbalance would occur in the form of 
psychological distress and symptoms of mental 
disorders. Psychoanalytic theory views symptoms 
as important only in terms of expression of 
underlying conflicts between the parts of 
personality. The theory holds that the conflicts 
must be understood by the individual with the aid 
of the psychoanalyst who would help the person 
unearth the secrets of the unconscious. This was the 
basis for psychoanalysis as a form of treatment, as 
explained later in this chapter. 
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Behaviorism and Social learning Theory 
Behaviorism (also called learning theory) posits 
that personality is the sum of an individual’s 
observable responses to the outside world 
(Feldman, 1997). As charted by J. B. Watson and 
h. F. Skinner in the early part of the 20th century, 
behaviorism stands at loggerheads with 
psychodynamic theories, which strive to understand 
underlying conflicts. Behaviorism rejects the 
existence of underlying conflicts and an 
unconscious. Rather, it focuses on observable, 
overt behaviors that are’ learned from the 
environment (Kazdin, 1996, 1997). Its application 
to treatment of mental problems, which is discussed 
later, is known as behavior modification. 
Learning is seen as behavior change molded by 
experience. Learning is accomplished largely 
through either classical or operant conditioning. 
Classical conditioning is grounded in the research 
of Ivan Pavlov, a Russian physiologist. It explains 
why some people react to formerly neutral stimuli 
in their environment, stimuli that previously would 
not have elicited a reaction. Pavlov’s dogs, for 
example, learned to salivate merely at the sound of 
the bell, without any food in sight. Originally, the 
sound of the bell would not have elicited salvation. 
But by repeatedly pairing the sight of the food 
(which elicits salvation on its own) with the sound 
of the bell, Pavlov taught the dogs to salivate just 
to the sound of the bell by itself. 
Operant conditioning, a process described and 
coined by B. F. Skinner, is a form of learning in 
which a voluntary response is strengthened or 
attenuated, depending on its association with 
positive or negative consequences (Feldman, 1997). 
The strengthening of responses occurs by positive 
reinforcement, such as food, pleasurable activities, 
and attention from others. The attenuation or 
discontinuation of responses occurs by negative 
reinforcement in the form of removal of a 
pleasurable stimulus. Thus, human behavior is 
shaped in a trial and error way through positive and 
negative reinforcement, without any reference to 
inner conflicts or perceptions. What goes on inside 
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the individual is irrelevant, for humans are equated 
\vith “black boxes.” Mental disorders represented 
,,,llladaptive behaviors that were learned. They 
Could be unlearned through behavior modification 
,hehavior therapy) (Kazdin, 1996; 1997). 
The movement beyond behaviorism was 
<Pearheaded by Albert Bandura (1969, 1977), the 
originator of social learning theory (also known as 
\ocial cognitive theory). Social learning theory has 
its roots in behaviorism, but it departs in a 
,ignificant way. While acknowledging classical and 
operant conditioning, social learning theory places 
l’ar greater emphasis on a different type of learning, 
particularly observational learning. Observational 
learning occurs through selectively observing the 
behavior of another person, a model. When the 
behavior of the model is rewarded, children are 
more likely to imitate the behavior. For example, a 
child who observes another child receiving candy 
for a particular behavior is more likely to carry out 
similar behaviors. Social learning theory asserts 
that people’s cognitions-their views, perceptions, 
and expectations toward their environment-affect 
what they learn. Rather than being passively 
conditioned by the environment, as behaviorism 
proposed, humans take a more active role in 
deciding what to learn as a result of cognitive 
processing. Social learning theory gave rise to 
cognitive-behavioral therapy, a mode of treatment 
described later in this chapter and throughout this 
report. 
The Integrative Science of Mental Illness 
and Health 
Progress in understanding depression and schizo- 
phrenia offers exciting examples of how findings 
from different disciplines of the mental health field 
have many common threads (Andreasen, 1997). 
Despite the differences in terminology and 
methodology, the results from different disciplines 
have converged to paint a vivid picture of the 
nature of the fundamental defects and the regions 
of the brain that underlie these defects. Even in the 
case of depression and schizophrenia, there is much 
to be uncovered about etiology, yet the mental 
health field is seen as poised “to use the power of 
multiple disciplines.” The disciplines are urged to 
link together the study of the mind and the brain in 
the search for understanding mental health and 
mental illness (Andreasen, 1997). 
This linkage already has been cemented 
between cognitive psychology, behavioral 
neurology, computer science, and neuroscience. 
These disciplines have knit together the field of 
“cognitive neuroscience’* (Kysslyn & Shin, 1992). 
This new and joint discipline has carved out its 
own professional society, journals (Waldrop, 
1993), and textbooks (Gazzaniga et al., 1998). 
There is movement toward integration of other 
disciplines within the field. To promote linkages 
between psychiatry and the neurosciences, neuro- 
scientist Eric R. Kandel has furnished a novel 
approach. His essay, “A New Intellectual Frame- 
work for Psychiatry,” supplies a set of biological 
principles to forge a rapprochement-conceptual as 
well as practical-between the two disciplines 
(Kandel, 1998). Integrated approaches are seen as 
vital to tackle the monumental complexity of 
mental function. 
Overview of Development, 
Temperament, and Risk Factors 
How we come to be the way we are is through the 
process of development. Generally defined as the 
lifelong process of growth, maturation, and change, 
development is the product of the elaborate 
interplay of biological, psychological, and social 
influences. By studying development, researchers 
hope to uncover the origins of both mental health 
and mental illness. 
This section elaborates and extends concepts 
introduced above regarding the fundamental 
workings of the brain at different developmental 
stages. It then proceeds to explain several seminal 
theories of development pioneered by Jean Piaget, 
Erik Erikson, and John Bowlby. Their theories 
cover cognitive development, personality 
development, and social development, respectively, 
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although there is some overlap. Their major works, 
published in the 1950s and 196Os, were pivotal for 
the psychological and social sciences, galvanizing 
a huge body of theoretical and empirical research. 
However, with the advancements of science and the 
diversity of the population, these models may not 
apply to all groups without some adaptation for 
cultural context. The section concludes with a 
reminder that the brain is the “great synthesizer” of 
the many biological, psychological, and sociocul- 
tural phenomena that make us who we are. 
Physical Development 
Physical development of the nervous system 
provides the architecture for mental function 
(cognition, mood, and intentional behavior). As can 
be inferred from the discussion of brain complexity 
in the introductory section, nervous system 
development is arguably one of the most monu- 
mentally complicated developmental achievements. 
One hundred billion neurons must form elaborate 
and precise arrays of interconnections. Neurons 
begin the developmental process as 
undifferentiated cells, cells so seemingly 
anonymous that they are almost indistinguishable 
from other cells in an embryo. On the basis of 
genetic and epigenetic” influences, the cells must 
first specialize, or differentiate, into neurons, 
migrate to their final position, and then send their 
growing axons (the branch of a neuron that 
transmits impulses) to project over long distances 
in order to form synapses with distant target cells 
(Kandel et al., 1995). 
Most neurobiologists are astounded at the level 
of precision that neurons achieve in their 
interconnections. The process of nervous system 
development has been studied at increasingly 
complex levels-molecular, cellular, tissue, and 
behavioral levels. Yet, while researchers have 
charted many of the behavioral milestones of 
development because they are so amenable to 
lo Epigenetic influences are those that arise from outside the genes 
and lead to emergent, as opposed to predetermined, properties. 
observation and analysis, far less is known about 
molecular, cellular, and tissue interactions that 
underlie them. 
Four overarching findings or organizing 
principles have been gleaned from decades of 
neuroscience research. The first finding is that the 
formation of connections between neurons and their 
target cells depends on axons growing along 
anatomical pathways that are studded with 
signaling molecules, much like landing lights 
illuminate the runway for a descending plane. The 
second finding is that. an axon’s reaching the 
vicinity of, and locating, its correct target cell 
depends on diffusable chemical signals being 
transmitted from the target cell. The third finding 
is that if an axon does not reach its correct target, 
it is likely to die. This phenomenon, known as cell 
death, or apoptosis, is so common that it affects up 
to half of all developing neurons. The brain 
overproduces the number of cells it needs, from 
which it pares down to only the correct connections 
(Kandel et al., 1995). Finally, neuron activity is 
essential to strengthening the connections that are 
formed. In other words, stimulation from the 
environment-which is translated into neuron 
activity-is vital for the forging of normal neural 
development (Shatz, 1993; Kandel, 1995). This is 
a fundamental principle that is revisited later in this 
section. This principle helps to explain why, for 
example, babies who are deprived of a stimulating 
environment during their first year sometimes 
suffer irreparable developmental effects. 
Behavior at birth consists of a repertoire of 
simple reflexes, that is, inborn neurological 
reactions that are involuntary in nature. Two 
examples are the sucking reflex and the rooting 
reflex,” both of which are designed to ensure food 
intake. Over time, the infant displays an expanded 
repertoire of fine and gross -motor skills (e.g., 
crawling, walking) that begin to unfold in the first 
few months and year of life. These include the 
IL Newborns turn their head towards things-typically the 
breast-that touch their cheek. 
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,.herished ability to smile, which helps to solidify 
;1 social bond with parents and caregivers. What 
begins as a child’s biological survival need for 
food-evidenced by such behaviors as rooting and 
I;uckin, o-can turn into a social, interpersonal 
rsperience with the caregiver, as in the smile of an 
infant at the sight of a nurturing parent. These 
burgeoning motor capabilities are the forerunners 
of more complex behavioral and mental functions, 
but the actual relationships between early and later 
abilities, and their molecular and cellular basis, are 
understood only in the most rudimentary terms. 
Theories of Psychological Development 
Theories of human development are grounded in 
the developmental perspective. The developmental 
perspective takes into account the biological, 
social, and psychological -environment; their 
interaction; and their combined effect upon the 
individual throughout the life span. 
Developmentalist L. Breger (1974) proposes that 
the developmental perspective incorporates three 
key precepts: 
l Behavioral maturation proceeds from the 
simple to the complex; 
l Future behaviors, whether temporally near or 
distant, are a product of their antecedents (prior 
responses to the developmental environment); 
and 
l The human response to a particular event or 
experience often depends on the developmental 
stage at which the experience occurs. 
Each of these precepts is thought to apply to 
nemobiological development, as well as behav- 
ioral/psychosocial development, Moreover, each 
has implications for whether an individual 
experiences either healthful or unhealthful 
development that may lead to a mental disorder. 
The three precepts are at the heart of each of 
the three major mainstream theories of 
developmental psychology that have guided 
research and increased our understanding of both 
normal and abnormal human development across 
the life span. The following paragraphs offer brief 
sketches of the developmental theories of Jean 
Piaget, Erik Erikson, and John Bowlby; again, these 
sketches are provided to afford the reader an 
historical perspective of research on psychological 
development. 
Piaget: Cognitive Developmental Theory 
Jean Piaget formulated one of the most influential 
theories of cognitive development (Inhelder & 
Piaget, 1958). Its focus was on cognitive 
(intellectual) development, that is, the processes by 
which children come to kno,w and understand the 
world. Other aspects of human growth, both 
physical and emotional, are beyond the scope of his 
theory. Piaget posited that each step of cognitive 
development proceeds from the previous step in a 
fixed pattern, beginning at birth and ending in the 
teen years. 
Piaget had a seminal influence on the discipline 
of cognitive psychology. Although empirical 
research has called into question some of the 
specifics of his theories, the broad outlines remain 
widely accepted. 
Erik frikson: Psychoanalytic Developmental 
Theory 
The psychoanalytic theory of development is best 
exemplified in the work of Erik Erikson, a 
psychoanalyst who expanded upon Freud’s original 
theories of psychosexual development. One of 
Erikson’s pioneering contributions was that 
development unfolded throughout the life span, a 
view that has become widely embraced. 
Freud postulated that development proceeded 
through a series of stages in which children seek 
pleasure or gratification from a particular body part 
(i.e., the oral, anal, and phallic stage). In contrast, 
Erikson’s theories of child development focus on 
the interrelationship between a developing child’s 
internal psychosexual development and his or her 
more external emotional development, emphasizing 
the interpersonal relationships that arise between 
the child and parents (Erikson, 1950). 
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Erikson conceived of the life course, from birth 
to old age, as a series of eight epigenetic stages 
that, as other developmental theories, proceed in a 
stepwise fashion, the next dependent upon how 
well the previous has been mastered: trust versus 
mistrust; autonomy versus shame and doubt; 
initiative versus guilt; industry versus inferiority; 
identity versus role diffusion; intimacy versus 
isolation; generativity versus stagnation; ego 
integrity versus despair. 
Erikson portrayed each stage as a crisis or 
conflict that needed resolution, either at the time or 
at a subsequent stage. Each successive stage 
presents its own challenges but, at the same time, 
offers the opportunity for correction of unresolved 
challenges of previous stages. At each stage the 
tension was between the psychosocial and 
psychosexual-the outward-looking versus inward- 
looking perspectives. Psychopathology, in the form 
of a mental disorder, would arise if a stage was 
ultimately not mastered successfully. 
Over the years, Erikson’s theory has had great 
heuristic value to guide theorists and practitioners 
in organizing their approach to mental health and 
mental illness. However, his theory does not readily 
lend itself to empirical scrutiny. His theory also has 
been criticized as reflecting the concerns of male 
European culture (where Erikson was born and 
trained before moving to the United States) rather 
than those of women and other cultures. The need 
for cultural sensitivity and competence is discussed 
later in this chapter. 
John Bow/by: Attachment Theory of 
Development 
Fifty years ago, a new conceptualization of the 
psychoanalytic approach to development came into 
the lexicon of human development theory. John 
Bowlby’s reinterpretation of Freudian development 
is grounded in both Darwinian evolutionary theory 
and animal ethology. The previous work of Konrad 
Lorenz and others, who explored the relationship 
between other animals and their caregivers, 
determined that the bonds of infant care and the 
attachment of young to their caregivers are seminal 
in the drive for survival. Similarly, Bowlby 
theorized that for humans, attachment to a 
caregiver had a biological basis in the need for 
survival (Bowlby, 195 1). Moreover, he suggested 
that this attachment drive exists alongside the drive 
for nutrition and the sex drive, yet distinct and 
separate from them. Attachment is seen as the 
anchor that enables the developing child to explore 
the world. 
With the comfort and security of a stable and 
routine attachment to the mother-or other primary 
caregiver-a child is abk to organize other 
elements of development in a coherent way. In 
contrast, instability in the caregiving relation- 
ship-whether physical distance, erratic patterns of 
parental behavior, or even physical or emotional 
abuse-may interfere with the sense of trust and 
security, potentially giving rise to anxiety and 
psychological problems later in childhood or even 
decades later in life. 
Nature and Nurture: The Ultimate 
Synthesis 
For over a century, an intense debate among 
developmentalists and other scientists has pitted 
nature (genetic inheritance) against nurture 
(environment) as the engine of human development 
and behavior. Francis Galton, a 19th-century 
geneticist and cousin of Charles Darwin, declared 
that “there is no escape from the conclusion that 
nature prevails enormously over nurture” (cited in 
Plomin, 1996). As the debate raged, either nature or 
nurture gained ascendancy. During the 1940s and 
195Os, for example, behaviorism held sway over 
American psychology with its argument that 
nurture was preeminent. 
The pendulum now is coming to rest with the 
recognition that behavior is the product of both 
nature and nurture (Plomin, 1996). Each 
contributes to the development of mental health and 
mental illness. Nature and nurture are not 
necessarily independent forces but can interact with 
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,,,,r’ another: nature can influence nurture, and 
,,urture can influence nature (Plomin, 1996). 
Studies comparing identical and fraternal twins 
I,a,s shed light on the contributions of nature and 
Ilurwre. These studies show that for many 
b,l,avioral traits, as well as mental disorders, there 
,, :, noticeable heritable component (see earlier 
,li>sussion of heritability). Yet even with the most 
l,ighlY heritable traits or conditions, identical twins 
,( lro share the same genetic endowment display 
,n;trked differences. Identical twins, for example, 
;,rc concordant for schizophrenia in 46 percent of 
ll;iirs (NIMH, 1998), meaning that more than 50 
llcrcent of pairs are not concordant. Something yet 
utlkt~own about the environment protects against 
the development of schizophrenia in genetically 
itlcntical individuals (Plomin, 1996). 
How do nature and nurture interact? This 
ilucstion cannot be directly answered by twin 
\tudies. Animal models have proven to be fertile 
IFround for study of the mechanisms-at the ? 
niolecular and cellular level-by which nature and 
nurture interact. As reviewed earlier, research in 
different animal models has established that the 
environment can alter the structure andfunction of 
the central nervous system (Baily & Kandel, 1993). 
This holds true not only during early development, 
but also into adulthood. Nurture influences nature, 
right down to detectable changes in the brain. 
During development of the nervous system, 
each neuron forms myriad intricate synaptic 
connections with other neurons, the outcome of the 
interaction of genes and the environment described 
above. In this case, the environment is a very 
general term-it denotes the local extracellular 
environment surrounding the growing neuron, as 
well as what we traditionally think of as the 
environment (sensory environment, psychosocial 
environment, diet, etc.). When a neuron forms a 
synapse with its target cell, the pattern of activity, 
usually furnished by external environmental 
stimulation, strengthens or weakens the developing 
synapse. Only strengthened synaptic connections 
survive early development to form enduring 
connections, while weakened synaptic connections 
are eliminated (Shatz, 1993; Kandel et al., 1995). 
For example, kittens deprived of visual experience 
early in life sustain permanent disruption to 
synapses in parts of their visual cortex (Hubel & 
Wiesel, 1970). 
Later in the course of development, established 
patterns of connections still can be altered by the 
environment-through learning. Studies in a 
variety of animal models have found that certain 
forms of learning lead to changes in the structure 
and function of neurons. With long-term . 
memory-the long-term storage of learned 
information-these changes take the form of an 
enhanced number of synaptic connections and 
increased gene expression (Kandel et al., 1995). 
Increased gene expression appears to be for 
synthesis of new proteins needed for the structural 
changes occurring at the synapse (Bailey & Kandel, 
1993). 
Researchers continue to probe for changes in 
the brain associated with mental disorders. They 
have found, for instance, that repeated stress from 
the environment affects the hippocampus, an area 
of the brain located deep within the cerebral 
hemispheres. Research in animals has shown that 
repeated stress triggers atrophy of dendrites of 
certain types of neurons in a segment of the 
hippocampus (Sapolsky, 1996; McEwen, 1998). 
Similarly, imaging studies in humans suggest that 
stress-related disorders (e.g., post-traumatic stress 
disorder) induce possibly irreversible atrophy of 
the hippocampus (McEwen & Magarinos, 1997). 
Anxiety disorders also alter neuroendocrine 
systems (Sullivan et al., 1998). These are some of 
the tantalizing ways in which nurture influences 
nature. 
The mental health field is far from a complete 
understanding of the biological, psychological, and 
sociocultural bases of development, but develop- 
pment clearly involves interplay among these 
influences. Understanding the process of develop- 
ment requires knowledge, ranging from the most 
fundamental level-that of gene expression and 
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interactions between molecules and cells-all the 
way up to the highest levels of cognition, memory, 
emotion, and language. The challenge requires 
integration of concepts from many different 
disciplines. A fuller understanding of development 
is not only important in its own right, but it is 
expected to pave the way for our ultimate 
understanding of mental health and mental illness 
and how different factors shape their expression at 
different stages of the life span. 
Overview of Prevention 
The field of public health has long recognized the 
imperative of prevention to contain a major health 
problem (IOM, 1,988). The principles of pre- 
vention were first applied to infectious diseases in 
the form of mass vaccination, water safety, and 
other forms of public hygiene. As successes 
amassed, prevention came to be applied to other 
areas of health, including chronic diseases (IOM, 
1994a). A landmark report published by the 
Institute of Medicine in 1994 extended the concept 
of prevention to mental disorders (IOM, 1994a). 
Reducing Risks for Mental Disorders evaluated the 
body of research on the prevention of mental 
disorders, offered new definitions of prevention, 
and provided recommendations on Federal policies 
and programs, among other goals. 
Preventing an illness from occurring is 
inherently better than having to treat the illness 
after its onset. In many areas of health, increased 
understanding of etiology and the role of risk and 
protective factors in the onset of health problems 
has propelled prevention. In the mental health field, 
however, progress has been slow because of two 
fundamental and interrelated problems: for most 
major mental disorders, there is insufficient 
understanding about etiology and/or there is an 
inability to alter the known etiology of a particular 
disorder. While these have stymied the develop- 
ment of prevention interventions, some successful 
strategies have emerged in the absence of a full 
understanding of etiology. 
Rigorous scientific trials have documented 
successful prevention programs in such areas as 
dysthymia and major depressive disorder (Munoz et 
al., 1987; Clarke et al., 1993, conduct problems 
(Berrento-Clement et al., 1984), and risky 
behaviors leading to HIV infection (Kalichman et 
al., in press) and low birthweight babies (Olds et 
al., 1986). Much progress also has been made to 
prevent the occurrence of lead poisoning, which, if 
unchecked, can lead to serious and persistent 
cognitive deficits in children (Centers for Disease 
Control and Prevention, 1991; Pirkle et al., 1994). 
Lastly, historical milestones’ in prevention of 
mental illness led to the successful eradication of 
neurosyphilis, pellagra, and measles encephalo- 
myelitis (measles invasion of the brain) in the 
developed world. 
Definitions of Prevention 
The term “prevention” has different meanings to 
different people. It also has different meanings to 
different fields of health. The classic definitions 
used in public health distinguish between primary 
prevention, secondary prevention, and tertiary 
prevention (Commission on Chronic Illness, 1957). 
Primary prevention is the prevention of a disease 
before it occurs; secondary prevention is the 
prevention of recurrences or exacerbations of a 
disease that already has been diagnosed; and 
tertiary prevention is the reduction in the amount of 
disability caused by a disease to achieve the highest 
level of function. 
The Institute of Medicine report on prevention 
identified problems in applying these definitions to 
the mental health field (IOM, 1994a). The problems 
stemmed mostly from the difficulty of diagnosing 
mental disorders and from shifts in the definitions 
of mental disorders over time (see Diagnosis of 
Mental Illness). Consequently, the Institute of 
Medicine redefined prevention for the mental 
health field in terms of three core activities: 
prevention, treatment, and maintenance (IOM, 
1994a). Prevention, according to the IOM report, is 
similar to the classic concept of primary prevention 
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t’rc,lll public health: it refers to interventions to 
,\ard off the initial onset of a mental disorder. 
Ire,tment refers to the identification of individuals 
,t irh mental disorders and the standard treatment 
tar those disorders, which includes interventions to 
reduce the likelihood of future co-occurring 
disorders. And maintenance refers to interventions 
,llat are oriented to reduce relapse and recurrence 
;,,,d to provide rehabilitation. (Maintenance 
incorporates what the public health field 
tmditionally defines as some forms of secondary 
aIld all forms of tertiary prevention.) 
The Institute of Medicine’s new definitions .of 
prevention have been very important in 
conceptualizing th’e nature of prevention activities 
for mental disorders; however, the terms have not 
yet been universally adopted by mental health 
rusearchers. As a result, this report strives to use 
the terms employed by the researchers themselves. 
To avoid confusion, the report furnishes the 
rclcvant definition along with study descriptions. 
When the term “prevention” is used in this 
report withour a qualifying term, it refers to the 
prevention of the initial onset of a mental disorder 
or emotional or behavioral problem,. including 
prevention of comorbidity. First onset corresponds 
to the initial point in time when an individual’s 
mental health problems meet the full criteria for a 
diagnosis of a mental disorder. 
Risk Factors and Protective Factors 
The concepts of risk and protective factors, risk 
reduction, and enhancement of protective factors 
(also sometimes referred to as fostering resilience) 
are central to most empirically based prevention 
Programs. Risk factors are those characteristics, 
variables, or hazards that, if present for a given 
individual, make it more likely that this individual, 
rather than someone selected at random from the 
general population, will develop a disorder 
(Garmezy, 1983; Werner & Smith, 1992; TOM, 
1994a). TO qualify as a risk factor the variable must 
antedate the onset of the disorder. Yet risk factors 
are not static. They can change in relation to a 
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developmental phase or a new stressor in one’s life, 
and they can reside within the individual, family, 
community, or institutions. Some risks such as 
gender and family history are fixed; that is, they are 
not malleable to change. Other risk factors such as 
lack of social support, inability to read, and 
exposure to bullying can be altered by strategic and 
potent interventions (Coie & Krehbiel, 1984; 
Silverman, 1988; Olweus, 1991; Kellam & Rebok, 
1992). Current research is focusing on the interplay 
between biological risk factors and psychosocial 
risk factors and how they can be modified. As 
explained earlier, even with’ a highly heritable 
condition such as schizophrenia, concordance 
studies show that in over half of identical twins, the 
second twin does not have schizophrenia. This 
suggests the possibility of modifying the 
environment to eventually prevent the biological 
risk factor (i.e., the unidentified genes that 
contribute to schizophrenia) from being expressed. 
Prevention not only focuses on the risks 
associated with a particular illness or problem but 
also on protective factors. Protective factors 
improve a person’s response to some environmental 
hazard resulting in an adaptive outcome (Rutter, 
1979). Such factors, which can reside with the 
individual or within the family or community, do 
not necessarily foster normal development in the 
absence of risk factors, but they may make an 
appreciable difference on the influence exerted by 
risk factors (IOM, 1994a). There is much to be 
learned in the mental health field about the role of 
protective factors across the life span and within 
families as well as individuals. The potential for 
altering these factors in intervention studies is 
enormous. The construct of “resilience” is related 
to the concept of protective factors, but it focuses 
more on the ability of a single individual to 
withstand chronic stress or recover from traumatic 
life events. There are many different perceptions of 
what constitutes resilience or “competence,” 
another related term. Despite the increasing 
popularity of these ideas, “virtually no intervention 
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studies have been conducted that test the outcomes 
of resilience variables” (Grover, 1998). 
Preventive researchers use risk status to 
identify populations for intervention, and then they 
target risk factors that are thought to be causal and 
malleable and target protective factors that are to 
be enhanced. If the interventions are successful, the 
amount of risk decreases, protective factors 
increase, and the likelihood of onset of the 
potential problem also decreases. The risks for 
onset of a disorder are likely to be somewhat 
different from the risks involved in relapse of a 
previously diagnosed condition. This is an 
important distinction because at-risk terminology is 
used throughout the mental health intervention 
spectrum. The optimal treatment protocol for an 
individual with a serious mental condition aims to 
reduce the length of time the disorder exists, halt a 
progression of severity, and halt the recurrence of 
the original disorder, or if not possible, to increase 
the length of time between episodes (IOM, 1994a). 
To do this requires an assessment of the 
individual’s specific risks for recurrence. 
Many mental health problems, especially in 
childhood, share some of the same risk factors for 
initial onset, so targeting those factors can result in 
positive outcomes in multiple areas. Risk factors 
that are common to many disorders include 
individual factors such as neurophysiological 
deficits, difficult temperament, chronic physical 
illness, and below-average intelligence; family 
factors such as severe marital discord, social 
disadvantage, overcrowding or large family size, 
paternal criminality, maternal mental disorder, and 
admission into foster care; and community factors 
such as living in an area with a high rate of 
disorganization and inadequate schools (IOM, 
1994a). Also, some individual risk factors can lead 
to a state of vulnerability in which other risk 
factors may have more effect. For example, low 
birthweight is a general risk factor for multiple 
physical and mental outcomes; however, when it is 
combined with a high-risk social environment, it 
more consistently has poorer outcomes (McGauhey 
et al., 1991). The accumulation of risk factors 
usually increases the likelihood of onset of 
disorder, but the presence of protective factors can 
attenuate this to varying degrees. 
The concept of accumulation of risks in 
pathways that accentuate other risks has led 
prevention researchers to the concept of “breaking 
the chain at its weakest links” (Robins, 1970; IOM, 
1994a). In other words, some of the risks, even 
though they contribute significantly to onset, may 
be less malleable than others to intervention. The 
preventive strategy is to change the risks that are 
most easily and quickly amen$ble to intervention. 
For example, it may be easier to prevent a child 
from being disruptive and isolated from peers by 
altering his or her classroom environment and 
increasing academic achievement than it is to 
change the home environment where there is severe 
marital discord and substance abuse. 
Because mental health is so intrinsically 
related to all other aspects of health, it is 
imperative when providing preventive interventions 
to consider the interactions of risk and protective 
factors, etiological links across domains, and 
multiple outcomes. For example, chronic illness, 
unemployment, substance abuse, and being the 
victim of violence can be risk factors or mediating 
variables for the onset of mental health problems 
(Kaplan et al., 1987). Yet some of the same factors 
also can be related to the consequences of mental 
health problems (e.g., depression may lead to 
substance abuse, which in turn may lead to lung or 
liver cancer). 
Overview of Treatment 
Introduction to Range of Treatments 
Mental disorders are treatable, contrary to what 
many think.12 An armamentarium of efficacious 
treatments is available to ameliorate symptoms. In 
I2 About 40 percent of those surveyed thought that they “didn’t think 
anyone could help” as a reason for not seeking mental health 
treatment (Sussman et al., 1987). 
64 
The Fundamentals of Mental Health and Mental Illness 
t‘a,.t. for most mental disorders, there is generally 
not just one but a range of treatments of proven 
CificXv. Most treatments fall under two general 
i2tegories. psychosocial and pharmacologicaLi 
\loreover. the combination of the two-known as 
,nultimodal therapy-can sometimes be even more 
<ffective than each individually (see Chapter 3). 
The evidence for treatment being more effective 
Ihan placebo is overwhelming, as documented in 
[he main chapters of this report (Chapters 3 through 
5). The degree of effectiveness tends to vary, 
depending on the disorder and the target population 
cc’.g.. older adults with depression). What is 
t,ptimnl for one disorder and/or age group may not 
he optimal for another. Further, treatments 
generally need td be tailored t’o the client and to 
client preferences. 
The inescapable point is that studies 
demonstrate conclusively that treatment is more 
effective than placebo. Placebo (an inactive formof 
treatment) in both pharmacological and psycho- 
therapy studies has a powerful effect in its own 
right. as this section later explains. Placebo is more 
cffcctive than no treatment. Therefore, to capitalize 
on the placebo response, people are encouraged to 
\cck treatment, even if the treatment is not as 
optimal as that described in this report. 
If tmmnent is so effective, then why are so few 
prqle receiving it ? Studies reveal that less than 
one-third of adults with a diagnosable mental 
disorder, and even a smaller proportion of children, 
receive any mental health services in a given year. 
This section of the chapter strives to explain why 
by examining the types of barriers that prevent 
People from seeking help. But the chapter first 
covers some general points about psychological and 
Pharmacological therapies. It also discusses why 
therapies that work so well in research settings do 
not work as well in practice. 
mer treatments are electroconvulsive therapy (Chapters 4 and 5) and 
wne types of surgery. 
Psychotherapy 
Psychotherapy is a learning process in which 
mental health professionals seek to help individuals 
who have mental disorders and mental health 
problems. It is a process that is accomplished 
largely by the exchange of verbal communication, 
.hence it often is referred .to as “talk therapy.” 
Many of the theories undergirding each orientation 
to psychotherapy were summarized earlier in this 
chapter. 
Participants in psychotherapy can vary in age 
from the very young to the very old, and problems 
can vary from mental health problems to disabling 
and catastrophic mental disorders. Although people 
often are seen individually, psychotherapy also can 
be done with couples, families, and groups. In each 
case, participants present their problems and then 
work with the psychotherapist to develop a more 
effective means of understanding and handling 
their problems. This report focuses on individual 
psychotherapy and also mentions couples therapy 
and various forms of family interventions, 
particularly psycho-educational approaches. 
Although not discussed in the report, group 
psychotherapy is effective for selected individuals 
with some mood disorders, anxiety disorders, 
schizophrenia, personality disorders, and for mental 
health problems seen in somatic illness (Yalom, 
1995; Kanas, in press). 
Estimates of the number of orientations to 
psychotherapy vary from a very small number to 
well over 400. The larger estimate generally refers 
to all the variations of the three major orientations, 
that is, psychodynamic, behavioral, and humanistic. 
Each orientation falls under the more general 
conceptual category of either action or reflection. 
Psychodynamic orientations are the oldest. 
They place a premium on self-understanding, with 
the implicit (or sometimes explicit) assumption that 
increased self-understanding will produce salutary 
changes in the participant. Behavioral orientations 
are geared toward action, with a clear attempt to 
mobilize the resources of the patient in the 
direction of change, whether or not there is any 
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understanding of the etiology of the problem. 
Humanistic orientations aim toward increased self- 
understanding, often in the direction of personal 
growth, but use treatment techniques that often are 
much more active than are likely to be employed by 
the psychodynamic clinician. 
While the following paragraphs focus on 
psychodynamic, behavioral, and humanistic 
orientations, they also discuss interpersonal therapy 
and cognitive-behavioral therapy as outgrowths of 
psychodynamic and behavioral therapy, respect- 
ively. Psychodynamic, interpersonal, and cognitive- 
behavioral therapy are most commonly the focus of 
treatment research reported throughout this report. 
Psychodynamic Therapy 
The first major approach to psychotherapy was 
developed by Sigmund Freud and is called 
psychoanalysis (Horowitz, 1988). Since its origin 
more than a century ago, psychoanalysis has 
undergone many changes. Today, Freudian (or 
classical) psychoanalysis is still practiced, but 
other variations have been developed-ego 
psychology, object relations theory, interpersonal 
psychology, and self-psychology, each of which 
can be grouped under the general term 
“psychodynamic” (Horowitz, 1988). The 
psychodynamic therapies, even though they differ 
somewhat in theory and approach, all have some 
concepts in common. With each, the role of the past 
in shaping the present is emphasized, so it is 
important, in understanding behavior, to understand 
its origins and bow people come to act and feel as 
they do. A second critical concept common to all 
psychodynamic approaches is the belief in the 
unconscious, so that there is much that influences 
our behavior of which we are not aware. This 
makes the process of understanding more difficult, 
as we often act for reasons that we cannot state, and 
these reasons often are linked to previous 
experiences. Thus, an important part of 
psychodynamic psychotherapy is to make the 
unconscious conscious or to help the patient 
understand the origin of actions that are troubling 
so that they can be corrected. 
For some psychodynamic approaches, such as 
the classical Freudian approach, the focus is on the 
individual and the experiences the person had in the 
early years that give shape to current behavior, 
.even beyond the awareness of the patient. For 
other, more contemporary approaches, such as 
interpersonal therapy, the focus is on the 
relationship between the person and others. First 
developed as a time-limited treatment for midlife 
depression, interpersonal therapy focuses on grief, 
role disputes, role transitions, and interpersonal 
deficits (Klerman et al., 1984). The goal of 
interpersonal therapy is to improve current 
interpersonal skills. The therapist takes an active 
role in teaching patients to evaluate their 
interactions with others and to become aware of 
self-isolation and interpersonal difficulties. The 
therapist also offers advice and helps the patient to 
make decisions. 
Behavior Therapy 
A second major approach to psychotherapy is 
known as behavior modification or behavior 
therapy (Kazdin, 1996,1997). It focuses on current 
behavior rather than on early patterns of the 
patient. In its earlier form, behavior therapy dealt 
exclusively with what people did rather than what 
they thought or felt. The general principles of 
learning were applied to the learning of maladap- 
tive as well as adaptive behaviors. Thus, if a person 
could be conditioned to act in a functional way, 
there was no reason why the same principles of 
conditioning could not be employed to help the 
person unlearn dysfunctional behavior and learn to 
replace it with more functional behavior. The role 
of the environment was very important for behavior 
therapists, because it provided the positive and 
negative reinforcements that sustained or 
eliminated various behaviors. Therefore, ways of 
shaping that environment to make it more 
responsive to the needs of the individual were 
important in behavior therapy. 
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More recently, there has been a significant 
,ddition to the interests and activities of behavior 
therapists. Although behavior continued to be 
itnportant in relation t0 reinforcements, Cog- 
nitions- what the person thought about, perceived, 
or interpreted what was transpiring-were also 
seen as important. This combined emphasis led to 
a therapeutic variant known as cognitive- 
b~j~a\~ioral therapy, an approach that incorporates 
cognition with behavior in understanding and 
altering the problems that patients present (Kazdin, 
1996). 
Cognitive-behavioral therapy draws on 
behaviorism as well as cognitive psychology,. a 
field devoted to the scientific study of mental 
processes, such as perceiving, remembering, 
reasoning, decisionmaking, and problem solving. 
The use of cognition in cognitive-behavioral 
therapy varies from attending to the role of the 
environment in providing a model for behavior, to 
the close study of irrational beliefs, to the 
importance of individual thought processes in 
constructing a vision of the surrounding world. In 
each case, it is critical to study what the individual 
in therapy thinks and does and less important to 
understand the past events that led to that,pattern of 
thinking and doing. Cognitive-behavioral therapy 
strives to alter faulty cognitions and replace them 
with thoughts and self-statements that promote 
adaptive behavior (Beck et al., 1979). For instance, 
cognitive-behavioral therapy tries to replace self- 
defeatist expectations (“I can’t do anything right”) 
with positive expectations (“I can do this right”). 
Cognitive-behavioral therapy has gained such 
ascendancy as a means of integrating cognitive and 
behavioral views of human functioning that the 
field is more frequently referred to as cognitive- 
behavioral therapy rather than behavior therapy 
(Kazdin, 1996). 
Humanis tic Therapy 
The third wave of psychotherapy is referred to 
variously as humanistic (Rogers, 1961), existential 
(Yalom, 1980), experiential, or Gestalt therapy. It 
owes its origins as a treatment to the client- 
centered therapy that was originated by Carl 
Rogers, and the theory can be traced to 
philosophical roots beginning with the 19th century 
philosopher, Soren Kierkegaard. The central focus 
of humanistic therapy is the immediate experience 
of the client. The emphasis is on the present and the 
potential for future development rather than on the 
past, and on immediate feelings rather than on 
thoughts or behaviors. It is rooted in the everyday 
subjective experience of the person seeking 
assistance and is much less concerned with mental 
illness than it is with human growth. 
One critical aspect of humanistic treatment is 
the relationship that is forged between the 
therapist, who in some ways serves as a guide in an 
exploration of self-discovery, and the client, who is 
seeking greater knowledge of the self and an 
expansion of inherent human potential. The focus 
on the self and the search for self-awareness is akin 
to psychodynamic psychotherapy, while the 
emphasis on the present is more similar to behavior 
therapy. 
Although it is possible to describe distinctive 
orientations to psychotherapy, as has been done 
above, most psychotherapists describe themselves 
as eclectic in their practice, rather than as adherents 
to any single approach to treatment. As a result, 
there is a growing development referred to as 
“psychotherapy integration” (Wolfe & Goldfried, 
1988). It strives to capture what is best about each 
of the individual approaches. Psychotherapy 
integration includes various attempts to look 
beyond the confines of any single orientation but 
rather to see what can be learned from other 
perspectives. It is characterized by an openness to 
various ways of integrating diverse theories and 
techniques. Psychotherapy also should be modified 
to be culturally sensitive to the needs of racial and 
ethnic minorities (Acosta et al., 1982; Sue et al., 
1994; Lopez, in press). 
The scientific evidence on efficacy presented in 
this report, however, is focused primarily on 
specific, standardized forms of psychotherapy. 
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Pharmacological Therapies 
The past decade has seen an outpouring of new 
drugs introduced for the treatment of mental 
disorders (Nemeroff, 1998). New medications for 
the treatment of depression and schizophrenia are 
among the achievements stoked by research 
advances in both neuroscience and molecular 
biology. Through the process known as rational 
drug design, researchers have become increasingly 
sophisticated at designing drugs by manipulating 
their chemical structures. Their goal is to create 
more effective therapeutic agents, with fewer side 
effects, exquisitely targeted to correct the 
biochemical alterations that accompany mental 
disorders. 
The process was not always so rational. Many 
of the older pharmacotherapies (drug treatments) 
that had been introduced -by 1960 had been 
discovered largely by accident. Researchers 
studying drugs for completely different purposes 
serendipitously found them to be useful for treating 
mental disorders (Barondes, 1993). Thanks to their 
willingness to follow up on unexpected leads, drugs 
such as chlorpromazine (for psychosis), lithium 
(for bipolar disorder), and imipramine (for 
depression) became available. The ‘advent of 
chlorpromazine in 1952 and other neuroleptic drugs 
was so revolutionary that it was one of the major 
historical forces behind the deinstitutionalization 
movement that is discussed later in this chapter. 
The past generation of pharmacotherapies, once 
shown to be safe and effective, was introduced to 
the market generally before their mechanism of 
action was understood. Years of research after their 
introduction revealed how many of them work 
therapeutically. Knowledge about their actions has 
had two cardinal consequences: it helped probe the 
etiology of mental disorders, and it ushered in the 
next generation of pharmacotherapies that are more 
selective in their mechanism of action. 
Mechanisms of Action 
The mechanism of action refers to how a 
pharmacotherapy interacts with its target in the 
body to produce therapeutic effects. Pharma- 
cotherapies that act in similar ways are grouped 
together into broad categories (e.g., stimulants, 
antidepressants). Within each category are several 
chemical classes. The individual pharmacotherapies 
within a chemical class share similar chemical 
structures. Table 2-9 presents several common 
categories and classes, along with their indication, 
that is, their clinical use. 
Many pharmacotherapies for mental disorders 
have as their initial action the alteration-either 
increase or decrease-in the amount of a 
neurotransmitter. Neurotransmitter levels can be 
altered by pharmacotherapies in myriad ways: 
pharmacotherapies can mimic the action of the 
neurotransmitter in cell-to-cell signaling; they can 
block the action of the neurotransmitter; or they 
can alter its synthesis, breakdown (degradation), 
release, or reuptake, among other possibilities 
(Cooper et al., 1996). 
Neurotransmitters generally are concentrated in 
separate brain regions and circuits. Within the cells 
that form a circuit, each neurotransmitter has its 
own biochemical pathway for synthesis, 
degradation, and reuptake, as well as its own 
specialized molecules known as receptors. At the 
time of neurotransmission, when a traveling signal 
reaches the tip (terminal) of the presynaptic cell, 
the neurotransmitter is released from the cell into 
the synaptic cleft. It migrates across the synaptic 
cleft in less than a millisecond and then binds to 
receptors situated on the membrane of the 
postsynaptic cell. The neurotransmitter’s binding to 
the receptor alters the shape of the receptor in such 
a way that the neurotransmitter can either excite the 
postsynaptic cell, and thereby transmit the signal to 
this next cell, or inhibit the receptor, and thereby 
block signal transmission. The neurotransmitter’s 
action is terminated either by enzymes that degrade 
it right there, in the synaptic cleft, or by transporter 
proteins that return unused neurotransmitter back to 
the presynaptic neuron for reuse, a “recycling” 
process known as reuptake. The widely prescribed 
class of antidepressants referred to as the selective 
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fable 2-g. Selected types of pharmacotherapies 
-- 
Categov and Class 
AntipsychotiCS (neuroleptics) 
Typical antipsychotics* 
Atypical antipsychotics*’ 
Example(s) of Clinical Use 
Schizophrenia, psychosis 
Antidepressants 
Selective serotonin 
reuptake inhibitors 
Tricyclic and heterocyclic 
antidepressants’** 
Monoamine oxidase inhibitors 
Depression, anxiety 
Stimulants 
Antimanic 
Lithium 
Anticonvulsants 
Thyroid supplementation 
Attention-deficit/hyperactivity disorder 
Mania 
Antianxiety (anxioiytics) 
Benzodiazepines 
Antidepressants 
p-Adrenergic-blocking drugs 
Anxiety 
Cholinesterase inhibitors ~~ Alzheimer’s disease 
* Also known as first-generation antipsychotics, they include these chemical classes: phenothiazines (e.g., chlorpromazine), 
butyrophenones (e.g., haloperidol), and thioxanthenes (Dixon et al., 1995). 
*’ Also known as second-generation antipsychotics, they include these chemical classes: dibenzoxazepine (e.g., clozapine), 
thienobenzodiazepine (e.g., olanzapine), and benzisoxazole (e.g., risperidone). 
*** Include imipramine and amitriptyline. 
Source: Perry et al., 1997 
\erotonin reuptake inhibitors primarily block the 
Lrction of the transporter protein for serotonin, thus 
leaving more serotonin to remain at the synapse 
(Schloss & Williams, 1998). Depression is thought 
to be reflected in decreased serotonin transmission, 
so one rationale for this class of antidepressants is 
to boost the level of serotonin (see Chapter 4). 
Although the effects of reuptake inhibitors on 
neurotransmitter concentrations in the synapse 
occur with the first dose, therapeutic benefit 
typically lags behind by days or weeks. This 
observation has spurred considerable recent 
research on chronic and “downstream” actions of 
psychotropics, particularly antidepressants. For 
example, in animal models the repeated 
administration of nearly all antidepressants is 
associated with a reduction in the number of 
postsynaptic p receptors, so-called down-regulation 
that parallels the time course of clinical effect in 
patients (Schatzberg & Nemeroff, 1998). Some of 
the secondary effects of reuptake inhibitors may be 
mediated by the activation of intraneuronal “second 
messenger” proteins which result from the 
stimulation of postsynaptic receptors (Schatzberg 
& Nemeroff, 1998). 
Receptors for each transmitter come in 
numerous varieties. Not only are there several types 
of receptor for each neurotransmitter, but there may 
be many subtypes. For serotonin, for example, there 
are seven types of receptors, designated 5-HT,-5- 
HT,, and seven receptor subtypes, totaling 14 
separate receptors (Schatzberg & Nemeroff, 1998). 
The pace at which receptors are identified has 
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become so dizzying that these figures are likely to 
be obsolete by the time this paragraph is read. 
A pharmacotherapy typically interacts with a 
receptor in either one of two ways-as an agonist 
or as an antagonist.14 When a pharmacotherapy acts 
as an agonist, it mimics the action of the natural 
neurotransmitter. When a pharmacotherapy acts as 
an antagonist, it inhibits, or blocks, the neuro- 
transmitter’s action, often by binding to the 
receptor and preventing the natural transmitter from 
binding there. An antagonist disrupts the action of 
the neurotransmitter. 
The diversity of receptors presents vast 
opportunities for drug development. Through 
rational drug design, pharmacotherapies have 
become increasingly selective in their actions. 
Generally speaking, the more selective the 
pharmacotherapy’s action, the more targeted it is to 
one receptor rather than another, the narrower its 
spectrum of action, and the fewer the side effects. 
Conversely, the broader the pharmacotherapy’s 
action, the less targeted to a receptor type or 
subtype, the broader the effects, and the broader the 
side effects (Minneman, 1994). However, the 
interaction among neurotransmitter systems in the 
brain renders some of the apparent distinctions 
among medications more apparent than real. Thus, 
despite differential initial actions on neuro- 
transmitters, both serotonin and norepinephrine 
reuptake blockers have similar biochemical effects 
after chronic dosing (Potter et al., 1985). 
Complementary and Aiterna tive Treatment 
Recent interest in the health benefits of a plethora 
of natural products has engendered claims related 
to putative effects on mental health. These have 
ranged from reports of enhanced memory in people 
taking the herb, ginseng, to the use of the St. John’s 
wort flowers as an antidepressant (see Chapter 4). 
There are major challenges to evaluating the 
role of complementary and alternative treatments in 
” There are certainly exceptions to this general rule. Some 
pharmacotherapies work as partial agonists and partial antagonists 
simultaneously. 
maintaining mental health or treating mental 
disorders. In many cases, preparations are not 
standardized and consist of a variabIe mixture of 
substances, any of which may be the active 
ingredient(s). Purity, bioavailability, amount and 
timing of doses, and other factors that are 
standardized for traditional pharmaceutical agents 
prior to testing cannot be taken for granted with 
natural products. Current regulations in the United 
States classify most complementary and alternative 
treatments as “food supplements,” which are not 
subject to premarketing approval of the Food and 
Drug Administration. . 
At present, no conclusions about the role, if 
any, of complementary and alternative treatments 
in mental health or illness can be accepted with 
certainty, as very few claims or studies meet 
acceptable scientific standards. With funding from 
government and private industry, controlled clinical 
trials are under way, including the use of St. John’s 
wort (Hypericum perforutum) as a treatment for 
depression, and omega-3 fatty acids (fish oils) as a 
mood stabilizer in bipolar depression. In addition, 
it is important for clinicians and investigators to 
account for any herbs or natural products being 
taken by their patients or research subjects that 
might interact with traditional treatments. 
Issues in Treatment 
The foregoing section has furnished an overview of 
the types and nature of mental health treatment. 
The resounding message, which is echoed 
throughout this report, is that a range of efficacious 
treatments is available. The following material 
deals with four issues surrounding treatment-the 
placebo response, benefits and risks, the gap be- 
tween how well treatments work in clinical trials 
versus in the real world, and the constellation of 
barriers that hinder people from seeking mental 
health treatment. 
Placebo Response 
Recognized since antiquity, the placebo effect 
refers to the powerful role of patients’ attitudes and 
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perceptions that help them improve and recover 
from health problems. Hippocrates established the 
therapeutic principle of physicians laying their 
hands in a reassuring manner to draw on the inner 
resources of the patient to fight disease. 
Technically speaking, the placebo effect refers to 
treatment responses in the placebo group, responses 
that cannot be explained on the basis of active 
treatment (Friedman et al., 1996a). A placebo is an 
inactive treatment, either in the form of an inert pill 
for studying a new drug treatment or an inactive 
procedure for studying a psychological therapy. 
The effects of active treatment are often compared 
with a control group that receives a pharm- 
acological or psychological placebo, 
It is not unusual for a placebo effect to be found 
in up to 50 percent of patients in any study of a 
medical treatment (Schatzberg& Nemeroff, 1998). 
For example, about 30 percent of patients typically 
respond to a placebo in a clinical trial of a new 
antidepressant (see Chapter 4). The rate is even 
higher for an antianxiety agent (an anxiolytic) 
(Schweizer & Rickels, 1997). The placebo effect is 
of such import that a placebo group or other control 
group’* is mandated by the Food and Drug 
Administration in clinical trials of a new 
pharmacotherapy to establish its efficacy prior to 
marketing (Friedman et al., 1996a). If the 
pharmacotherapy is not statistically superior to the 
control, efficacy cannot be established. It is 
somewhat more difficult to fashion an analog of an 
inert pill in the testing of new and experimental 
psychological therapies. Psychological studies can 
employ a “psychological” placebo in the form of a 
treatment known to be ineffectual. Or they can 
employ a comparison group, which receives an 
alternative psychological therapy. Some treatment 
studies employ both a “psychological” placebo, as 
well as a comparison group.‘6 
I5 when it is unethical to deprive patients of treatment, such as the 
case with AIDS, conventional treatment is given as the control. 
” The criteria developed by a division of the American 
Psychological Association for establishing treatment efficacy call 
for the experimental treatment to be statistically superior to “pill or 
The basis of the placebo response is not fully 
known, but there are thought to be many possible 
reasons. These reasons, which relate to attributes of 
the disorder or the disease, the patient, and the 
treatment setting, include spontaneous remission, 
personality variables (e.g., social acquiescence), 
patient expectations, attitudes of and compassion 
by clinicians, and receiving treatment in a 
specialized setting (Schweizer & Rickels, 1997). In 
studies of postoperative pain, the placebo response 
is mediated by patients’ production of endogenous 
pain-killing substances known as endorphins 
(Levine et al., 1978). 
Benefits and Risks 
Throughout this report, currently accepted 
treatments for mental disorders will be described. 
Except where otherwise indicated, the efficacy of 
these interventions has been documented in 
multiple controlled, clinical trials published in the 
peer-reviewed literature. In some cases, these have 
been supplemented by expert consensus reports or 
practice guidelines. 
Most studies of efficacy of specific treatments 
for mental disorders have been highly structured 
clinical trials, performed on individuals with a 
single disorder, in good physical health. While 
necessary and important, these trials do not always 
generalize easily to the wider population, which 
includes many individuals whose mental disorder is 
accompanied by another mental or somatic disorder 
and/or alcohol or substance abuse, and who may be 
taking other medications. Moreover, children, 
adolescents, and the elderly are excluded from 
many clinical trials,” as are those in certain 
settings, such as nursing homes. Newer, more 
generalizable studies are being undertaken to 
psychological placebo or to another treatment” (Chambless et al., 
1998). 
I7 In March 1998, the NIH issued a policy guideline stating that 
NM-funded investigators will be expected to include children in 
clinical trials, which normally would involve adults only, when 
there is sound scientific rationale and in the absence of a strong 
justification to the contrary. 
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address these shortcomings of the scientific 
literature (Lebowitz & Rudorfer, 1998). 
Pending the results of these newer studies, it is 
important, for clinical decisionmakers to review the 
current best evidence for the efficacy of treatments. 
People with mental disorders and their health 
providers should consider all possible options and 
carefully weigh the pros and cons of each, as well 
as the possibility of no treatment at all, before 
deciding upon a course of action. Such an informed 
consent process entails the calculation of a 
“benefit-to-risk ratio” for each available treatment 
option. Most medications or somatic treatments 
have side effects, for example, but a likelihood of 
significant clinical benefit often overrides side- 
effects in support of a treatment recommendation. 
Gap Between Efficacy and Effectiveness 
Mental health professionals have long observed 
that treatments work better in the clinical research 
trial setting as opposed to typical clinical practice 
settings. The diminished level of treatment 
effectiveness in real-world settings is so 
perceptible that it even has a name, the “efficacy- 
effectiveness gap.” Efficacy is the term for what 
works in the clinical trial setting, and effectiveness 
is the term for what works in typical clinical 
practice settings. The efficacy-effectiveness gap 
applies to both pharmacological therapies and to 
psychotherapies (Munoz et al., 1994; Seligman, 
1995). The gap is not unique to mental health, for 
it is found with somatic disorders too. 
The magnitude of the gap can be surprisingly 
high. With schizophrenia medications, one review 
article found that, in clinical trials, the use of 
traditional antipsychotic medications for 
schizophrenia was associated with an average 
annual relapse rate of about 23 percent, whereas the 
same medications used in clinical practice carried 
a relapse rate of about 50 percent (Dixon et al., 
1995). The magnitude of the gap found in this study 
may not apply to other medications and other 
‘disorders, much less to psychological therapies. 
Studies of real-world effectiveness are scarce. Yet 
some degree of gap is widely recognized. The 
question is, why? 
Efficacy studies test whether treatment works 
under ideal circumstances. They typically exclude 
patients with other mental or somatic disorders. In 
the past, they typically have examined relatively 
homogeneous populations, usually white males. 
Furthermore, efficacy studies are carried out by 
highly trained specialists following strict protocols 
that require frequent patient monitoring. Finally, 
participation in efficacy studies is often free of 
charge to patients. 
It is not surprising that the reasons commonly 
cited to explain the discrepancy between efficacy 
and effectiveness focus on the practicalities and 
constraints imposed by the real world. In real-world 
settings, patients often are more heterogeneous and 
ethnically diverse, are beset by comorbidity (more 
than one mental or somatic disorder),i8 are often 
less compliant, and are seen more often in general 
medical rather than specialty settings; providers are 
less inclined to adequately monitor and standardize 
treatment; and cost pressures exist on both patients 
and providers, depending on the nature of the 
financing of care (Dixon et al., 1995; Wells & 
Sturm, 1996). This constellation of real-world 
constraints appears to explain the gap. 
Barriers to Seeking Help 
Most people with mental disorders do not seek 
treatment, according to figures presented in the 
next section of this chapter and in Chapter 6. This 
general statement applies to adults and older adults 
and to parents and guardians who make treatment 
decisions for children with mental disorders. There 
is a multiplicity of reasons why people fail to seek 
treatment for mental disorders but few detailed 
studies. The barriers to treatment fall under several 
umbrella categories: demographic factors, patient 
attitudes toward a service system that often 
I* Having a second disorder increases the possibility of drug 
interactions, which may translate into reduced dosing. Comorbidity 
is discussed throughout this report. 
neglects the special needs of racial and ethnic 
minorities, financial, and organizational. 
Several demographic factors predispose people 
against seeking treatment. African Americans, 
Hispanics (Sussman et al., 1987; Gallo et al., 
1995), and poor women (Miranda & Green, 1999) 
are less inclined than non-Hispanic 
whites-particularly females-to seek treatment. 
Common patient attitudes that deter people from 
seeking treatment are not having the time, fear of 
being hospitalized, thinking that they could handle 
it alone, thinking that no one could help, and 
stigma (being too embarrassed to discuss the 
problem) (Sussman et al., 1987). Above all, the 
cost of treatment is the most prevalent deterrent to 
seeking care, according to a large study of 
community residents (Sussman et al., 1987). Cost 
is a major determinant of seeking treatment even 
among people with health insurance because of 
inferior coverage of mental health as compared 
with health care in general. Finally, the 
organizational barriers include fragmentation of 
services and lack of availability of services 
(Horwitz, 1987). Members of racial and ethnic 
minority groups often perceive that services offered 
by the existing system do not or will not meet their 
needs, for example, by taking into account their 
cultural or linguistic practices. These particular 
barriers are discussed in greater depth with respect 
to minority groups (later in this chapter) and with 
respect to different ages (Chapters 3 to 5). 
Demographic, attitudinal, financial, and 
organizational barriers operate at various points 
and to various degrees. Seeking treatment is 
conceived of as a complex process that begins with 
an individual or parent recognizing that thinking, 
mood, or behaviors are unusual and severe enough 
to require treatment; interpreting symptoms as a 
“medical” or mental health problem; deciding 
whether or not to seek help and from whom; 
receiving care; and, lastly, evaluating whether 
continuation of treatment is warranted (Sussman et 
al., 1987). 
Overview of Mental Health Services 
Over the past three centuries, the complex 
patchwork of mental health services in the United 
States has become so fragmented that it is referred 
to as the defacto menraE health system (Regier et 
al., 1993b). Its shape has been determined by many 
heterogeneous factors rather than by a single 
guiding set of organizing principles. The de facto 
system has been characterized as having distinct 
sectors, financing, duration of care, and settings 
(see Figure 2-4). 
The four sectors of the system are the specialty 
mental health sector, the geberal medical/primary 
care sector, the human services sector, and the 
voluntary support network sector. Specialty mental 
health services include services provided by 
specialized mental health professionals (e.g.. 
psychologists, psychiatric nurses, psychiatrists, and 
psychiatric social workers) and the specialized 
offices, facilities, and agencies in which they work. 
Specialty services were designed expressly for the 
provision of mental health services. The general 
medical/primary care sector consists of health care 
professionals (e.g., family physicians, nurse 
practitioners, internists, pediatricians, etc.) and 
the settings (i.e., offices, clinics, and hospitals) in 
which they work. These settings were designed for 
the full range of health care services, including, but 
not specialized for, the delivery of mental health 
services. The human services sector consists of 
social welfare, criminal justice, educational, 
religious, and charitable services. The voluntary 
support network refers to self-help groups and 
organizations. These are groups devoted to 
education, communication, and support, all of 
which extend beyond formal treatment. 
Financing of the de facto system refers to the 
payer of services. The system is often described as 
being divided into a public (i.e., government) and 
a private sector. The term “public sector” refers 
both to services directly operated by government 
agencies (e.g., state and county mental hospitals) 
and to services financed with government resources 
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Figure 2-4. The mental health service system 
ical/Primafy Care 
ces . -( 
pport Network J i .- ’ 
(e.g., Medicaid, a Federal-State program for 
financing health care services for people who are 
poor and disabled, and Medicare, a Federal health 
insurance program primarily for older Americans 
and people who retired early due to disability). 
Publicly financed services may be provided by 
private organizations. The term “private sector” 
refers both to services directly operated by private 
agencies and to services financed with private 
resources (e.g., employer-provided insurance). 
The duration of care is divided between 
services for the treatment of acute conditions and 
those devoted to the long-term care of chronic (i.e., 
severe and persistent) conditions, such as 
schizophrenia, bipolar disorder, and Alzheimer’s 
disease. The former, provided in psychiatric 
hospitals, psychiatric units in general hospitals, and 
in beds “scattered” in general hospital wards, 
includes brief treatment-oriented services. Long- 
term care includes residential care as well as some 
treatment services. Residential care is often 
referred to as “custodial,” when supervised living 
predominates over active treatment. 
The settings for care and treatment include 
institutional, community-based, and home-based. 
The former refers to facilities, particularly public 
mental hospitals and nursing homes, which usually 
are seen by patients and families as large, 
regimented, and impersonal. They often are 
removed from the community by distance and 
frequency of contact with friends and family. In 
contrast, community-based services are close to 
where patients or clients live. Services are typically 
provided by community agencies and organizations. 
Home-based services include informal supports 
provided in an individual’s residence. 
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Chapter 6 examines the impact of recent 
changes in financing and organizing services on 
access and quality of care. Many of these issues 
also are addressed in Chapters 3 to 5, where they 
are discussed in the context of care and treatment at 
each stage of the life cycle. The following material 
provides general information on current patterns of 
use and focuses on the historical origins of mental 
health services. 
Overall Patterns of Use 
According to recent national surveys (Regier et al, 
1993b; Kessler et al., 1996), a total of about 15 
percent of the U.S. adult population use mental 
health services in any given year. Eleven percent 
receive their services from either the general 
medical care sector or the specialty mental health 
sector, in roughly equal proportions. In addition, 
about 5 percent receive care from the human 
services sector, and about 3 percent receive care 
from the voluntary support network. (The overlap 
across these latter two sectors accounts for these 
figures totaling more than 15 percent.) 
Slightly more than half of the 15 percent of the 
adult population that use mental health services 
have a diagnosable mental or addictive disorder (8 
percent), while the remaining portion has a mental 
health problem (7 percent). Bearing in mind that 28 
percent of the population have a diagnosable 
mental or substance abuse disorder, only about 
one-third with a diagnosable mental disorder 
receives treatment in 1 year (Figure 2-5). In short, 
this transjates to the majority of those with 
a diagnosable mental disorder not receiving 
treatment. 
Similarly, about 21 percent of the child and 
adolescent population use mental health services 
annually. Nine percent ieceive care from the health 
care sector, almost exclusively from the specialty 
mental health sector. Seventeen percent of the child 
and adolescent population receive care from the 
human services sector, mostly in the school system, 
yet there is much overlap with the health sector 
(again accounting for the sum being more than 21 
percent). The distribution of those who do and do 
not currently meet diagnostic criteria for. a mental 
disorder is similar to that for adults (Figure 2-6). 
History of Mental Health Services 
The history of mental health services in the United 
States has been chronicled by historian Gerald N. 
Grob in a series of landmark books from which this 
account is drawn (Grob, 1983, 1991, 1994). The 
origins of the mental health services system 
coincide with the colonial settlement of the United 
States. Individuals with mental illness were cared 
for at home until urbanization induced state 
governments‘to confront a problem that had been 
relegated largely to families. The states’ response 
was to build institutions, known first as asylums 
and later as mental hospitals. When the 
Pennsylvania Hospital opened in Philadelphia in 
the mid- 18th century, it had provisions for 
individuals with mental illness housed in its 
basement: Also in the mid-18th century, colonial 
Virginia was the first state to build an asylum for 
mentally ill citizens, which it constructed in its 
capital at Williamsburg. If not cared for at home or 
in asylums, those with mental illness were likely to 
be found in jails, almshouses, work houses, and 
other institutions. By the time of the Revolutionary 
War, the beginnings were in place for each of the 
four sectors of the de facto mental health system. 
The origins of treatment for mental illness in 
the general medical/primary care sector can be 
traced to the Pennsylvania Hospital. The origins of 
specialty mental health care can be traced to the 
Williamsburg asylum. Home care, the most 
common response to mental illness, probably 
became a part of the voluntary support network, 
whereas the human services sector was by far the 
most common organized or institutional response, 
by placing individuals in almshouses (homes for 
the poor) and work houses. The first form of treat- 
ment-known as “moral treatment”-was not given 
until the very end of the 18th century, after the 
Revolutionary War. 
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Figure 2-5a. Annual prevalence of mental/addictive disorders and services for adults 
Percent of Population (28%) With 
Mental/Addictive Disorders 
(in one year) 
Percent of Population (15%) Receiving 
Mental Health Services* 
Diagnosis and 
No Treatment 
(20%) 
Treatment and No Diagnosis, 
Other Mental Health Problem 
Inferred 57%) 
Diagnosis and Treatment (6%) 
Figure 2-5b. Annual prevalence of mentaUaddictive disorders and services for adults 
Percent of Population (28%) With Percent of Population (15%) Receiving 
Mental/Addictive Disorders Mental Health Services* 
(in one year) 
Diagnosis and 
No Treatment 
(20%) 
1 (in one year) 
Percent of Population Receiving 
Specialty Care (6%) 
Percent of Population Receiving 
General Medical Care (5%) 
r 
Percent of Population Receiving 
Other Human Services and . Voluntary Support (4%) 
-- 
-- 
’ Due to rounding, it appears that 9 percent of the population has a diagnosis and receives treatment. The actual 
figure is closer to 6 percent, as stated in the text. It also appears that 6 percent of the population receives 
services but has no diagnosis, due to rounding. The actual total is 7 percent, as stated in the text. 
** For those who use more than one sector of the service system, preferential assignment is to the most 
specialized level of mental health treatment in the system. 
Sources: Regier et al., 1993; Kessler et al., 1996 
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Percent of Population (21%) With Percent of Population (21%) Receiving 
MentaVAddictive Disorders Mental Health Services 
(in one year) (In one yefar) 
Figure 2-6a. Annual prevalence of mentapaddictive disorders and servfces for children 
Diagnosis and 
No Treatment 
(11%) 
Treatment and No Diagnosis, 
Other Mental Health Problem 
Inferred (11%) 
Diagnosis and Treatment (10%) 
Figure 26b. Annual prevalence of mentaVaddictive disorders and services for children 
Percent of Populatlon (21%) With 
MentaUAddictlve Dlsorders 
(In one year) 
Percent of Populatlon (21%) Receiving 
Mental Health Services 
k 
(in one year) 
Diagnosis and 
No Treatment 
(11%) 
--. 
‘9 
_------_------- ---- 
Percent o! Population Receivir 
Specialty Care (8%) 
-_---_--_--- 
rcent of Population Receiving 
General Medical Care (1%) ----e--e---- 
--_ 
- L - 
Percent of Population 
Receiving School 
Services (11%) 
’ ~~~~~o~~o~~aiio~~~~ - 
Other Human Services and 
Voluntaw Suooort (1%) -----------‘-AL-L-i --- 
l * For those who use more than one sector of the service system, preferential assignment is to the most 
specialized level of mental health treatment in the system. 
Source: Shaffer et al., 1996 
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An era of “moral treatment” was introduced 
from Europe at the turn of the 19th century, 
representing the first of four reform movements in 
mental health services in the United States 
(Morrissey & Goldman, 1984; Goldman & 
Morrissey, 1985) (Table 2-10). 
The first reformers, including Dorothea Dix and 
Horace Mann, imported the idea that mental illness 
could be treated by removing the individual to an 
asylum to receive a mix of somatic and psychosoci- 
al treatments in a controlled environment 
characterized by “moral” sensibilities, The term 
“moral” had a connotation different from that of 
today. It meant the return of the individual to 
reason by the application of psychologically 
oriented therapy” (Grob, 1994). The “moral treat- 
ment” period was characterized by the building of 
private and public asylums. Almost every state had 
an asylum dedicated to the early treatment of 
mental illness to restore mental health and to keep 
patients from becoming chronically ill. Moral 
treatment accomplished the former objective, but it 
could not prevent chronicity. 
Shortly after the Civil War, the failures of the 
promise of early treatment were recognized and 
asylums were built for untreatable, chronic 
patients. The quality of care deteriorated in public 
institutions, where overcrowding and underfunding 
ran rampant. A new reform movement, devoted to 
“mental hygiene,” began late in the 19th century. It 
combined the newly emerging concepts of public 
health (which at the time was referred to as 
“hygiene”), scientific medicine, and social 
progressivism. Although the states built the public 
asylums, local government was expected to pay for 
each episode of care. To avoid the expense, many 
communities continued to use local almshouses and 
jails. Asylums could not maintain their budgets, 
care deteriorated, and newspaper exposes revealed 
inhuman conditions both in asylums and local 
I9 According to a student of the originator of moral treatment, 
Philippe Pinel, “moral treatment is the application of the faculty of 
intelligence and of the emotions in the treatment of mental 
alienation” (Grob, 1994). 
welfare institutions. State Care Acts were passed 
between 1894 and World War I. These acts 
centralized financial responsibility for the care of 
individuals with mental illness in every state 
government. Local government took the 
opportunity to send everyone with a mental illness, 
including dependent older citizens, to the state 
asylums. Dementia was redefined as a mental 
illness, although only some of the older residents 
were demented. For the past century the states have 
carried this responsibility at very low cost, in spite 
of the magnitude of the task. 
The reformers of the “mentaihygiene” period, 
who formed the National Committee on Mental 
Hygiene (now the National Mental Health 
Association [NMHA]), called for an expansion of 
the new science, particularly of neuropathology, in 
asylums, which were renamed mental hospitals. 
They also called for “psychopathic hospitals and 
clinics” to bring the new science to patients in 
smaller institutions associated with medical 
schools. They opened several psychiatric units in 
general hospitals to move mental health care into 
the mainstream of health care. The mental 
hygienists believed in the principles of early 
treatment and expected to prevent chronic mental 
illness. To support this effort, they advocated for 
outpatient treatment to identify early cases of 
mental disorder and to follow discharged 
inpatients. 
Treatments were not effective. Early treatment 
was no more successful in preventing patients from 
becoming chronically ill in the early 20th century 
than it was in the early years of the previous 
century. At best, the hospitals provided humane 
custodial care; at worst, they neglected or abused 
the patients. Length of stay did begin to decline for 
newly admitted inpatients, but older, long-stay 
patients filled public asylums. The financial 
problems and overcrowding deepened during the 
Depression and during World War II. 
Enthusiasm for early interventions, developed 
by military mental health services during World 
War II, brought a new sense of optimism about 
78 
The Fundamentals of Mental Health and Mental Illness 
Table 2-10. Historical reform movements in mental health treatment in the United States 
ommunity Mental Health 1955-l 970 Community mental health center Deinstitutionalization, 
social integration x -_. ,< (. . . . .” ‘,. m__*_ /A”_. *;*s , %^ * ,* ,“F,F7F *. , “. “i,. a. x ” --.e 1 ea_-I _.a?;.4a1_ .” 5-r xrr E..,,.r,.*-.a*~ 
Community Support 1975-present Community support Mental illness as a social welfare 
Sources: Morrissey & Goldman, 1984; Goldman & Morrissey, 1985 
treatment by the middle of the 20th century. Again, 
early treatment of mental disorders was 
championed and a new concept was born, 
“community mental health.“- The NMHA figured 
prominently in this reform, along with the Group 
for the Advancement of Psychiatry. Borrowing 
some ideas from the mental hygienists and 
capitalizing on the advent of new drugs for treating 
psychosis and depression, community mental health 
reformers argued that they could bring mental 
health services to the public in their communities. 
They suggested that long-term instituti’onal care in 
mental hospitals had been neglectful, ineffective, 
even harmful. The joint policies of “community 
care” and “deinstitutionalization” led to dramatic 
declines in the length of hospital stay and the 
discharge of many patients from custodial care in 
hospitals. 
Concomitantly, these policies led to the 
expansion of outpatient services in the community, 
particularly in federally funded community mental 
health centers. Federal legislation beginning in the 
mid-1960s fueled this expansion through grants to 
centers and then through the inclusion of some 
(albeit limited) mental health benefits in Medicare 
and Medicaid. The latter was particularly 
important, because it stimulated the transfer of 
many long-term inpatients from public mental 
hospitals to nursing homes, encouraged the opening 
of psychiatric units in general hospitals, and 
ultimately paid for many rehabilitation services for 
individuals with severe and persistent mental 
disorders. 
The dual policies of community care and 
deinstitutionalization, however, were implemented 
without evidence of effectiveness of treatments and 
without a social welfare system attuned to the 
needs of hundreds of thousands of individuals with 
disabling mental illness. Housing, support services, 
community treatment approaches, vocational 
opportunities, and income supports for those unable 
to work were not universally available in the 
community. Neither was there a truly welcoming 
spirit of community support for “returning” mental 
patients. Many discharged mental patients found 
themselves in welfare and criminal justice 
institutions, as had their predecessors in earlier 
eras; some became homeless or lived in regimented 
residential (e.g., board and care) settings in the 
community. 
The special needs of individuals with severe 
and persistent mental illness were not being met 
(General Accounting Office, 1977; Turner & 
TenHoor, 1978). Early treatment did not prevent 
disability, although new approaches to treatment 
would eventually reduce morbidity and improve 
quality of life. A fourth reform era (197%present), 
called the “community support” movement, grew 
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directly out of the “community mental health 
movement.” This new reform movement called for 
an end to viewing and responding to chronic mental 
disorder only as the object of neglect, by favoring 
acute treatment and prevention. Reformers 
advocated for developing “community support 
systems,” with an expanded vision of care and 
treatment as encompassing the social welfare needs 
of individuals with disabling mental illness. The 
emphasis favored the view that individuals could 
once again become citizens of their community, if 
given support and access to mainstream resources 
such as housing and vocational opportunities 
(Goldman, 1998). At first, mental health treatments 
were deemphasized in favor of social supports, but 
newer medications, such as SSRIs and novel anti- 
psychotic drugs, and more effective psychosocial 
interventions, such as assertive- community 
treatment for schizophrenia (Chapter 4), facilitated 
the objectives of community support and recovery 
in the community. 
The voluntary support network expanded with 
an emphasis on “recovery,” a concept introduced 
by service users, or consumers, who began to take 
an active role in their own care and support and in 
making policy. From their inception in the late 
197Os, family organizations, such as the National 
Alliance for the Mentally Ill and the Federation of 
Families, advocated for services for individuals 
who are most impaired. As discussed later in this 
chapter, consumers, who also call themselves 
“survivors,” have formed their own networks for 
support and advocacy and work with other 
advocacy groups such as the National Mental 
Health Association and the Bazelon Center for 
Mental Health Law. 
The de facto mental health system is complex 
because it has metamorphosed over time under the 
influence of a wide array of factors, including 
reform movements and their ideologies, financial 
incentives based on who would pay for what kind 
of services, and advances in care and treatment 
technology. Each factor has been important in its 
own way. The hybrid system that emerged serves 
many diverse functions. Unfortunately for those 
individuals with the most complex needs, and who 
often have the fewest financial resources, the 
system is fragmented and difficult to use to meet 
those needs effectively. Efforts at integrating the 
service system and tailoring it to those with the 
greatest needs are discussed, by age group, in 
subsequent chapters of the report. Many problems 
remain, including the lack of health insurance by 16 
percent of the U.S. population, underinsurance for 
mental disorders even among those who have health 
insurance, access barriers to members of many 
racial and ethnic groups, discrimiiation, and the 
stigma about mental illness, which is one of the 
factors that impedes help-seeking behavior. 
Overview of Cultural Diversity and 
Mental Health Services 
The U.S. mental health system is not well equipped 
to meet the needs of racial and ethnic minority 
populations. Racial and ethnic minority groups are 
generally considered to be underserved by the 
mental health services system (Neighbors et al., 
1992; Takeuchi & Uehara, 1996; Center for Mental 
Health Services [CMHS], 1998). A constellation of 
barriers deters ethnic and racial minority group 
members from seeking treatment, and if individual 
members of groups succeed in accessing services, 
their treatment may be inappropriate to meet their 
needs. 
Awareness of the problem dates back to the 
1960s and 197Os, with the rise of the civil rights 
and community mental health movements (Rogler 
et al., 1987) and with successive waves of 
immigration from Central America, the Caribbean, 
and Asia (Takeuchi & Uehara, 1996). These 
historical forces spurred greater recognition of the 
problems that minority groups confront in relation 
to mental health services. 
Research documents that many members of 
minority groups fear, or feel ill at case with, the 
mental health system (Lin et al., 1982; Sussman et 
al., 1987; Scheffler & Miller, 1991). These groups 
experience it as the product of white, European 
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culture, shaped by research primarily on white, 
European POpUlatiOUS. They may find only 
clinicians who represent a white middle-class 
orientation, with its cultural values and beliefs, as 
well as its biases, misconceptions, and stereotypes 
of other cultures. 
Research and clinical practice have propelled 
advocates and mental health professionals to press 
for “linguistically and culturally competent 
services” to improve utilization and effectiveness 
of treatment for different cultures. Culturally 
competent services incorporate respect for and 
understanding of, ethnic and racial groups, as well 
as their histories, traditions, beliefs, and value 
systems (CMHS, 1998). Without culturally 
competent services, the failure to serve racial and 
ethnic minority groups adequately is expected to 
worsen, given the huge demographic growth in 
these populations predicted over the next decades 
(Takeuchi & Uehara, 1996; CMHS, 1998; 
Snowden, 1999). 
This section of the chapter amplifies these 
major conclusions. It explains the confluence of 
clinical, cultural, organizational, and financial 
reasons for minority groups being underserved by 
the mental health system. The first task, however, 
is to explain which ethnic and racial groups 
constitute underserved populations, to describe 
their changin g demographics, and to define the 
term “culture” and its consequences for the mental 
health system. 
Introduction to Cultural Diversity and 
Demographics 
The Federal government officially designates four 
major racial or ethnic minority groups in the United 
States: African American (black), Asian/Pacific 
Islander, Hispanic American (Latino),20 and Native 
American/American Indian/Alaska Native/Native 
Hawaiian (referred to subsequently as “American 
Indians”) (CMHS, 1998). There are many other 
I0 The term “Latino(a)” refers to all persons of Mexican, Puerto 
Rican, Cuban, or other Central and South American or Spanish 
origin (CMHS. 1998). 
racial or ethnic minorities and considerable 
diversity within each of thg four groupings listed 
above. The representation of the four officially 
designated groups in the U.S. population in 1999 is 
as follows: African Americans constitute the 
largest group, at 12.8 percent of the U.S. 
,population; followed by Hispanics (11.4 percent), 
Asian/Pacific Islanders (4.0 percent), and American 
Indians (0.9 percent) (U.S. Census Bureau, 1999). 
Hispanic Americans are among the fastest-growing 
groups. Because their population growth outpaces 
that of African Americans, they are projected to be 
the predominant minority group (24.5 percent of 
the U.S. population) by tGe. year 2050 (CMHS, 
1998). 
Racial and ethnic populations differ from one 
another and from the larger society with respect to 
culture. The term “culture” is used loosely to 
denote a common heritage and set of beliefs, 
norms, and values. The cultures with which 
members of minority racial and ethnic groups 
identify often are markedly different from 
industrial societies of the West. The phrase 
“cultural identity” specifies a reference group-an 
identifiable social entity with whom a person 
identifies and to whom he or she looks for 
standards of behavior (Cooper & Denner, 1998). Of 
course, within any given group, an individual’s 
cultural identity may also involve language, 
country of origin, acculturation,2’ gender, age, 
class, religious/spiritual beliefs, sexual 
orientation”, and physical disabilities (Lu et al., 
1995). Many people have multiple ethnic or 
cultural identities. 
The historical experiences of ethnic and 
minority groups in the United States are reflected 
?’ Acculturation refers to the “social distance” separating members 
of an ethnic or racial group from the wider society in areas of beliefs 
and values and primary group relations (work, social clubs, family, 
friends) (Gordon, 1964). Greater acculturation thus reflects greater 
adoption of mainstream beliefs and practices and entry into primary 
group relations. 
z Research is emerging on the importance of tailoring services to 
the special needs of gay, lesbian, and bisexual mental health service 
users (Cabaj & Stein, 1996). 
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in differences in economic, social, and political 
status. The most measurable difference relates to 
income. Many racial and ethnic minority groups 
have limited financial resources. In 1994, families 
from these groups were at least three times as likely 
as white families to have incomes placing them 
below the Federally established poverty line. The 
disparity is even greater when considering extreme 
poverty-family incomes at a level less than half of 
the poverty threshold-and is also large when 
considering children and older persons (O’Hare, 
1996). Although some Asian Americans are 
somewhat better off financially than other minority 
groups, they still are more than one and a half times 
more likely than whites to live in poverty. Poverty 
disproportionately affects minority women and 
their children (Miranda & Green, 1999). The 
effects of poverty are compounded by differences 
in total value of accumulated assets, or total wealth 
(O’Hare et al., 1991). 
Lower socioeconomic status-in terms of 
income, education, and occupation-has been 
strongly linked to mental illness. It has been known 
for decades that people in the lowest 
socioeconomic strata are about two and a half times 
more likely than those in the highest strata to have 
a mental disorder (Holzer et al., 1986; Regier et al., 
1993b). The reasons for the association between 
lower socioeconomic status and mental illness are 
not well understood. It may be that a combination 
of greater stress in the lives of the poor and greater 
vulnerability to a variety of stressors leads to some 
mental disorders, such as depression. Poor women, 
for example, experience more frequent, threatening, 
and uncontrollable life events than do members of 
the population at large (Belle, 1990). It also may be 
that the impairments associated with mental 
disorders lead to lower socioeconomic status 
(McLeod & Kessler, 1990; Dohrenwend, 1992; 
Regier et al., 1993b). 
Cultural identity imparts distinct patterns of 
beliefs and practices that have implications for the 
willingness to seek, and the ability to respond to, 
mental health services. These include coping styles 
and ties to family and community, discussed below. 
Coping Styles 
Cultural differences can be reflected in differences 
in preferred styles of coping with day-to-day 
problems. Consistent with a cultural emphasis on 
restraint, certain Asian American groups, for 
example, encourage a tendency not to dwell on 
morbid or upsetting thoughts, believing that 
avoidance of troubling internal events is warranted 
more than recognition and outward expression 
(Leong & Lau, 1998). They. have little willingness 
to behave in a fashion that might disrupt social 
harmony (Uba, 1994). Their emphasis on willpower 
is similar to the tendency documented among 
African Americans to minimize the significance of 
stress and, relatedly, to try to prevail in the face of 
adversity through increased striving (Broman, 
1996). 
Culturally rooted traditions of religious beliefs 
and practices carry important consequences for 
willingness to seek mental health services. In many 
traditional societies, mental health problems can be 
viewed as spiritual concerns and as occasions to 
renew one’s commitment to a religious or spiritual 
system of belief and to engage in prescribed 
religious or spiritual forms of practice. African 
Americans (Broman, 1996) and a number of ethnic 
groups (Lu et al., 1995), when faced with personal 
difficulties, have been shown to seek guidance from 
religious figures.23 
Many people of all racial and ethnic 
backgrounds believe that religion and spirituality 
favorably impact upon their lives and that well- 
being, good health, and religious commitment or 
faith are integrally intertwined (Taylor, 1986; 
Priest, 1991; Bacote, 1994; Pargament, 1997). 
Religion and spirituality are deemed important 
because they can provide comfort, joy, pleasure, 
and meaning to life as well as be means to deal 
u Of the 15 percent of the U.S. population that use mental health 
services in a given year, about 2.8 percent receive care only from 
members of the clergy (Larson et al., 1988). 
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with death, suffering, pain, injustice, tragedy, and 
stressful experiences in the life of an individual or 
family (Pargament, 1997). In the family/com- 
munity-centered perception of mental illness held 
by Asians and Hispanics, religious organizations 
are viewed as an enhancement or substitute when 
the family is unable to cope or assist with the 
problem (Acosta et al., 1982; Comas-Diaz, 1989; 
Cook & Timberlake, 1989; Meadows, 1997). 
Culture also imprints mental health by 
influencing whether and how individuals 
experience the discomfort associated with mental 
illness. When conveyed by tradition and sanctioned 
by cultural norms, characteristic modes of 
expressing suffering are sometimes called “idioms 
of distress” (Lu et al., 1995). Idioms of distress 
often reflect values and themes found in the 
societies in which they originate. 
One of the most common idioms of distress is 
somatization, the expression of mental distress in 
terms of physical suffering. Somatization occurs 
widely and is believed to be especially prevalent 
among persons from a number of ethnic minority 
backgrounds (Lu et al., 1995). Epidemiological 
studies have confirmed that there are relatively 
high rates of somatization among African 
Americans (Zhang & Snowden, in press). Indeed, 
somatization resembles an African American folk 
disorder identified in ethnographic research and is 
linked to seeking treatment (Snowden, 1998). 
A number of idioms of distress are well 
recognized as culture-bound syndromes and have 
been included in an appendix to DSM-IV. Among 
culture-bound syndromes found among some Latin0 
psychiatric patients is ataque de nervios, a 
syndrome of “uncontrollable shouting, crying, 
trembling, and aggression typically triggered by a 
stressful event involving family. . . ” (Lu et al., 
1995, p. 489). A Japanese culture-bound syndrome 
has appeared in that country’s clinical modification 
of ICD-10 (WHO Znternafional Classification of 
Diseases, 10th edition, 1993). Taijin kyofusho is an 
intense fear that one’s body or bodily functions 
give offense to others. Culture-bound syndromes 
sometimes reflect comprehensive systems of belief, 
typically emphasizing a need for a balance between 
opposing forces (e.g., yin/yang, “hot-cold” theory) 
or the power of supernatural forces (Cheung & 
Snowden, 1990). Belief in indigenous disorders and 
adherence to culturally rooted coping practices are 
more common among older adults and among 
persons who are less acculturated. It is not well 
known how applicable DSM-IV diagnostic criteria 
are to culturally specific symptom expression and 
culture-bound syndromes. 
Family and Community as Resources 
Ties to family and community, especially strong in 
African, Latino, Asian, and Native American 
communities, are forged by cultural tradition and 
by the current and historical need to assist arriving 
immigrants, to provide a sanctuary against 
discrimination practiced by the larger society, and 
to provide a sense of belonging and affirming a 
centrally held cultural or ethnic identity. 
Among Mexican-Americans (de1 Pinal & 
Singer, 1997) and Asian Americans (Lee, 1998) 
relatively high rates of marriage and low rates of 
divorce, along with a greater tendency to live in 
extended family households, indicate an orientation 
toward family. Family solidarity has been invoked 
to explain relatively low rates among minority 
groups of placing older people in nursing homes 
(Short et al., 1994). 
The relative economic success of Chinese, 
Japanese, and Korean Americans has been 
attributed to family and communal bonds of 
association (Fukuyama, 1995). Community 
organizations and networks established in the 
United States include rotating credit associations 
based on lineage, surname, or region of origin. 
These organizations and networks facilitate the 
startup of small businesses. 
There is evidence of an African American 
tradition of voluntary organizations and clubs often 
having political, economic, and social functions 
and affiliation with religious organizations 
(Milburn & Bowman, 1991). African Americans 
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and other racial and ethnic minority groups have 
drawn upon an extended family tradition in which 
material and emotional resources are brought to 
bear from a number of linked households. 
According to this literature, there is “(a) a high 
degree of geographical propinquity; (b) a strong 
sense of family and familial obligation; (c) fluidity 
of household boundaries, with greater willingness 
to absorb relatives, both real and fictive, adult and 
minor, if need arises; (d) frequent interaction with 
relatives; (e) frequent extended family get- 
togethers for special occasions and holidays; and 
(f) a system of mutual aid” (Hatchett & Jackson, 
1993, p. 92). 
Families play an important role in providing 
support to individuals with mental health problems. 
A strong sense of family loyalty means that, despite 
feelings of stigma and shame, families are an early 
and important source of assistance in efforts to 
cope, and that minority families may expect to 
continue to be involved in the treatment of a 
mentally ill member (Uba, 1994). Among Mexican 
American families, researchers have found lower 
levels of expressed emotion and lower levels of 
relapse (Karno et al., 1987). Other investigators 
have demonstrated an association between family 
warmth and a reduced likelihood of relapse (Lopez 
et al., in press). 
Epidemiology and Utilization of Services 
One of the best ways to identify whether a minority 
group has problems accessing mental health 
services is to examine their utilization of services 
in relation to their need for services. As noted 
previously, a limitation of contemporary mental 
health knowledge is the lack of standard measures 
of “need for treatment” and culturally appropriate 
assessment tools. Minority group members’ needs, 
as measured indirectly by their prevalence of 
mental illness in relation to the U.S. population, 
should be proportional to their utilization, as 
measured by their representation in the treatment 
population. These comparisons turn out to be 
exceedingly complicated by inadequate under- 
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standing of the prevalence of mental disorders 
among minority groups in the United States.24 
Nationwide studies conducted many years ago 
overlooked institutional populations, which are 
disproportionately represented by minority groups. 
Treatment utilization information on minority 
groups in relation to whites is more plentiful, yet, 
a clear understanding of health seeking behavior in 
various cultures is lacking. 
The following paragraphs reveal that disparities 
abound in treatment utilization: some minority 
groups are underrepresented in ,the outpatient 
treatment population while, at the same time, 
overrepresented in the inpatient population. 
Possible explanations for the differences in utili- 
zation are discussed in a later section. 
African Americans 
The prevalence of mental disorders is estimated to 
be higher among African Americans than among 
whites (Regier et al., 1993a). This difference does 
not appear to be due to intrinsic differences 
between the races; rather, it appears to be due to 
socioeconomic differences. When socioeconomic 
factors are taken into account, the prevalence 
difference disappears. That is, the socioeconomic 
status-adjusted rates of mental disorder among 
African Americans turn out to be the same as those 
of whites. In other words, it is the lower 
socioeconomic status of African Americans that 
places them at higher risk for mental disorders 
(Regier et al., 1993a). 
African Americans are underrepresented in 
some outpatient treatment populations, but over- 
represented in public inpatient psychiatric care in 
relation to whites (Snowden & Cheung, 1990; 
24 In spring 2000, survey field work begins on an NJMH-funded 
study of the prevalence of mental disorders, mental health 
symptoms, and related functional impairments in African 
Americans, Caribbean blacks, and non-Hispanic whites. The study 
will examine the effects of psychosocial factors and race-associated 
stress on mental health, and how coping resources and strategies 
influence that impact. The study will provide a database on mental 
health, mental disorders, and ethnicity and race. James Jackson, 
Ph.D., University of Michigan, is principal investigator. 
Snowden, in press-b). Their underrepresentation in 
outpatient treatment varies according to setting, 
type of provider, and source of payment. The racial 
gap between African Americans and whites in 
utilization is smallest, if not nonexistent, in com- 
munity-based programs and in treatment financed 
by public sources, especially Medicaid (Snowden, 
1998) and among older people (Padgett et al., 
1995). The underrepresentation is largest in 
privately financed care, especially individual 
outpatient practice, paid for either by fee-for- 
service arrangements or managed care. As a result, 
underrepresentation in the outpatient setting occurs 
more among working and middle-class African 
Americans, who ‘are privately insured, than among 
the poor. This suggests that socioeconomic 
standing alone cannot explain the problem of 
underutilization (Snowden, i998). 
African Americans are, as noted above, 
overrepresented in inpatient psychiatric care 
(Snowden, in press-b). Their rate of utilization of 
psychiatric inpatient care is about double that of 
whites (Snowden & Cheung, 1990). This difference 
is even higher than would be expected on the basis 
of prevalence estimates. Overrepresentation is 
found in hospitals of all types except private 
psychiatric hospitals.25 While difficult to explain 
definitively, the problem of overrepresentation in 
psychiatric hospitals appears more rooted in 
poverty, attitudes about seeking help, and a lack of 
community support than in clinician bias in 
diagnosis and overt racism, which also have been 
implicated (Snowden, in press-b). This line of 
reasoning posits that poverty, disinclination to seek 
help, and lack of health and mental health services 
deemed appropriate, and responsive, as well as 
community support, are major contributors to 
delays by African Americans in seeking treatment 
until symptoms become so severe that they warrant 
inpatient care. 
” African Americans are overrepresented among persons 
undergoing involuntary civil commitment (Snowden, in press-b). 
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Finally, African Americans are more likely than 
whites to use the emergency room for mental health 
problems (Snowden, in press-a). Their overreliance 
on emergency care for mental health problems is an 
extension of their overreliance on emergency care 
for other health problems. The practice of using the 
emergency room for routine care is generally 
attributed to a lack of health care providers in the 
community willing to offer routine treatment to 
people without insurance (Snowden, in press-a). 
Asian Americans/Pacific &landers 
The prevalence of mental .illness among Asian 
Americans is difficult to determine for 
methodological reasons (i.e., population sampling). 
Although some studies suggest higher rates of 
mental illness, there is wide variance across 
different groups of Asian Americans (Takeuchi & 
Uehara, 1996). It is not well known how applicable 
DSM-IV diagnostic criteria are to culturally 
specific symptom expression and culture-bound 
syndromes. With respect to treatment-seeking 
behavior, Asian Americans are distinguished by 
extremely low levels at which specialty treatment 
is sought for mental health problems (Leong & Lau, 
1998). Asian Americans have proven less likely 
than whites, African Americans, and Hispanic 
Americans to seek care. One national sample 
revealed that Asian Americans were only a quarter 
as likely as whites, and half as likely as African 
Americans and Hispanic Americans, to have sought 
outpatient treatment (Snowden, in press-a). Asian 
Americans/Pacific Islanders are less likely than 
whites to be psychiatric inpatients (Snowden & 
Cheung, 1990). The reasons for the underutilization 
of services include the stigma and loss of face over 
mental health problems, limited English 
proficiency among some Asian immigrants, 
different cultural explanations for the problems, 
and the inability to find culturally competent ser- 
vices. These phenomena are more pronounced for 
recent immigrants (Sue et al., 1994). 
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Hispanic Americans 
Several epidemiological studies revealed few 
differences between Hispanic Americans and 
whites in lifetime rates of mental illness (Robins & 
Regier, 1991; Vega & Kolody, 1998). A recent 
study of Mexican Americans in Fresno County, 
California, found that Mexican Americans born in 
the United States had rates of mental disorders 
similar to those of other US. citizens, whereas 
immigrants born in Mexico had lower rates (Vega 
et al., 1998a). A large study conducted in Puerto 
Rico reported similar rates of mental disorders 
among residents of that island, compared with those 
of citizens of the mainland United States (Canino et 
al., 1987). 
Although rates of mental illness may be similar 
to whites in general, the prevalence of particular 
mental health problems, the manifestation of 
symptoms, and help-seeking behaviors within 
Hispanic subgroups need attention and further 
research. For instance, the prevalence of depressive 
symptomatology is higher in Hispanic women 
(46%) than men (almost 20%); yet, the known risk 
factors do not totally explain the gender difference 
(Vega et al., 1998a; Zunzunegui et al., 1998). 
Several studies indicate that Puerto Rican and 
Mexican American women with depressive 
symptomatology are underrepresented in mental 
health services and overrepresented in general 
medical services (Hough et al., 1987; Sue et al., 
1991, 1994; Duran, 1995; Jimenez et al., 1997). 
Native Americans 
American Indians/Alaska Natives have, like Asian 
Americans and Pacific Islanders, been studied in 
few epidemiological surveys of mental health and 
mental disorders. The indications are that 
depression is a significant problem in many 
American Indian/Alaska Native communities 
(Nelson et al., 1992). One study of a Northwest 
Indian village found rates of DSM-III-R affective 
disorder that were notably higher than rates 
reported from national epidemiological studies 
(Kinzie et al., 1992). Alcohol abuse and 
dependence appear also to be especially 
problematic, occurring at perhaps twice the rate of 
occurrence found in any other population group. 
Relatedly, suicide occurs at alarmingly high levels. 
(Indian Health Service, 1997). Among Native 
American veterans, post-traumatic stress disorder 
has been identified as especially prevalent in 
relation to whites (Manson, 1998). In terms of 
patterns of utilization, Native Americans are 
overrepresented in psychiatric inpatient care in 
relation to whites, with the exception of private 
psychiatric hospitals (Snowden & Cheung, 1990; , 
Snowden, in press-b). 
Barriers to the Receipt of Treatment 
The underrepresentation in outpatient treatment of 
racial and ethnic minority groups appears to be the 
result of cultural differences as well as financial, 
organizational, and diagnostic factors. The service 
system has not been designed to respond to the 
cultural and linguistic needs presented by many 
racial and ethnic minorities. What is unresolved are 
the relative contribution and significance of each 
factor for distinct minority groups. 
Help-Seeking Behavior 
Among adults, the evidence is considerable that 
persons from minority backgrounds are less likely 
than are whites lo seek outpatient treatment in the 
specialty mental health sector (Sussman et al., 
1987; Gallo et al., 1995; Leong & Lau, 1998; 
Snowden, 1998; Vega et al., 1998a, 1998b; Zhang 
et al., 1998). This is not the case for emergency 
department care, from which African Americans 
are more likely than whites to seek care for mental 
health problems, as noted above. Language, like 
economic and accessibility differences, can play an 
important role in why people from other cultures do 
not seek treatment (Hunt, 1984; Comas-Diaz, 1989; 
Cook & Timberlake, 1989; Taylor, 1989). 
Mistrust 
The reasons why racial and ethnic minority groups 
are less apt to seek help appear to be best studied 
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among African Americans. By comparison with 
whites, African Americans are more likely to give 
the following reasons for not seeking professional 
help in the face of depression: lack of time, fear of 
hospitalization, and fear of treatment (Sussman et 
al., 1987). Mistrust among African Americans may 
stem from their experiences of segregation, racism, 
and discrimination (Primm et al., 1996; Priest, 
199 1). African Americans have experienced racist 
slights in their contacts with the mental health 
system, called “microinsults” by Pierce (1992). 
Some of these concerns are justified on the basis of 
research, cited below, revealing clinician bias in 
overdiagnosis of schizophrenia and underdiagnosis 
of depression among’ African Americans. 
Lack of trust is likely to operate among other 
minority groups, according to research about their 
attitudes toward government-operated institutions 
rather than toward mental health treatment per se. 
This is particularly pronounced for immigrant 
families with relatives who may be undocumented, 
and hence they are less likely to trust authorities 
for fear of being reported and having the family 
member deported. People from El Salvador and 
Argentina who have experienced imprisonment or 
watched the government murder family members 
and engage in other atrocities may have an 
especially strong mistrust of any governmental 
authority (Garcia & Rodriguez, 1989). Within the 
Asian community, previous refugee experiences of 
groups such as Vietnamese, Indochinese, and 
Cambodian immigrants parallel those experienced 
by Salvadoran and Argentine immigrants. They, 
too, experienced imprisonment, death of family 
members or friends, physical abuse, and assault, as 
well as new stresses upon arriving in the United 
States (Cook & Timberlake, 1989; Mollica, 1989). 
American Indians’ past experience in this 
country also imparted lack of trust of government. 
T.hose living on Indian reservations are particularly 
fearful of sharing any information with white 
clinicians employed by the government. As with 
African Americans, the historical relationship of 
forced control, segregation, racism, and 
discrimination has affected their ability to trust a 
white majority population (Herring, 1994; 
Thompson, 1997). 
Stigma 
The stigma of mental illness is another factor 
preventing African Americans from seeking 
treatment, but not at a rate significantly different 
from that of whites. Both African American and 
white groups report that embarrassment hinders 
them from seeking treatment (Sussman et al., 
1987). In general, African Americans tend to deny 
the threat of mental illness ind strive to overcome 
mental health problems through self-reliance and 
determination (Snowden, 1998). Stigma, denial, 
and self-reliance are likely explanations why other 
minority groups do not seek treatment, but their 
contribution has not been evaluated empirically, 
owing in part to the difficulty of conducting this 
type of research. One of the few studies of Asian 
Americans identified the barriers of stigma, 
suspiciousness, and a lack of awareness about the 
availability of services (Uba, 1994). Cultural 
factors tend to encourage the use of family, 
traditional healers, and informal sources of care 
rather than treatment-seeking behavior, as noted 
earlier. 
Cost 
Cost is yet another factor discouraging utilization 
of mental health services (Chapter 6). Minority 
persons are less likely than whites to have private 
health insurance, but this factor alone may have 
little bearing on access. Public sources of insurance 
and publicly supported treatment programs fill 
some of the gap. Even among working class and 
middle-class African Americans who have private 
health insurance, there is underrepresentation of 
African Americans in outpatient treatment 
(Snowden, 1998). Yet studies focusing only on 
poor women, most of whom were members of 
minority groups, have found cost and lack of 
insurance to be barriers to treatment (Miranda & 
Green, 1999). The discrepancies in findings suggest 
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that much research remains to be performed on the 
relative importance of cost, cultural, and 
organizational barriers, and poverty and income 
limitations across the spectrum of racial and ethnic 
and minority groups. 
CIinician Bias 
Advocates and experts alike have asserted that bias 
in clinician judgment is one of the reasons for 
overutilization of inpatient treatment by African 
Americans. Bias in clinician judgment is thought to 
be reflected in overdiagnosis or misdiagnosis of 
mental disorders. Since diagnosis is heavily reliant 
on behavioral signs and patients’ reporting of the 
symptoms, rather than on laboratory tests, clinician 
judgment plays an enormous role in the diagnosis 
of mental disorders. The strongest evidence of 
clinician bias is apparent for African Americans 
with schizophrenia and depression. Several studies 
found that African Americans were more likely 
than were whites to be diagnosed with 
schizophrenia, yet less likely to be diagnosed with 
depression (Snowden & Cheung, 1990; Hu et al., 
1991; Lawson et al., 1994). 
In addition to problems of overdiagnosis or 
misdiagnosis, there may well be a problem of 
underdiagnosis among minority groups, such as 
Asian Americans, who are seen as “problem-free” 
(Takeuchi & Uehara, 1996). The presence and 
extent of this type of clinician bias are not known 
and need to be investigated. 
Improving Treatment for Minority 
Groups 
The previous paragraphs have documented 
underutilization of treatment, less help-seeking 
behavior, inappropriate diagnosis, and other 
problems that have beset racial and ethnic minority 
groups with respect to mental health treatment. 
This kind of evidence has fueled the widespread 
perception of mental health treatment as being 
uninviting, inappropriate, or not as effective for 
minority groups as for whites. The Schizophrenia 
Patient Outcome Research Team demonstrated that 
African Americans were less likely. than others to 
have received treatment that conformed to 
recommended practices (Lehman & Steinwachs, 
1998). Inferior treatment outcomes are widely 
assumed but are difficult to prove, especially 
because of sampling, questionnaire, and other 
design issues, as well as problems in studying 
patients who drop out of treatment after one session 
or who otherwise terminate prematurely. In a 
classic study, 50 percent of Asian Americans versus 
30 percent of whites dropped out of treatment early 
(Sue & McKinney, 1975). However, the disparity in 
dropout rates may have abated more recently 
(O’Sullivan et al., 1989; Snowden et al., 1989). 
One of the few studies of clinical outcomes, a pre- 
versus post-treatment study, found that African 
Americans fared more poorly than did other 
minority groups treated as outpatients in the Los 
Angeles area (Sue et al., 1991). Earlier studies from 
the 1970s and 1980s had given inconsistent results 
(Sue et al., 1991). 
Ethnopsychopharmacojogy 
There is mounting awareness that ethnic and 
cultural influences can alter an individual’s 
responses to medications (pharmacotherapies). The 
relatively new field of ethnopsychopharmacology 
investigates cultural variations and differences that 
influence the effectiveness of pharmacotherapies 
used in the mental health field. These differences 
are both genetic and psychosocial in nature. They 
range from genetic variations in drug metabolism to 
cultural practices that affect diet, medication 
adherence, placebo effect, and simultaneous use of 
traditional and alternative healing methods (Lin et 
al., 1997). Just a few examples are provided to 
illustrate ethnic and racial differences. 
Pharmacotherapies given by mouth usually 
enter the circulation after absorption from the 
stomach. From the circulation they are distributed 
throughout the body (including the brain for 
psychoactive drugs) and then metabolized, usually 
in the liver, before they are cleared and eliminated 
from the body (Brody, 1994). The rate of 
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metabolism affects the amount of the drug in the 
circulation. A slow rate of metabolism leaves more 
drug in the circulation. Too much drug in the 
circulation typically leads to heightened side 
effects. A fast rate of metabolism, on the other 
hand, leaves less drug in the circulation. Too little 
drug in the circulation reduces its effectiveness. 
There is wide racial and ethnic variation in drug 
metabolism. This is due to genetic variations in 
drug-metabolizing enzymes (which are responsible 
for breaking down drugs in the liver). These genetic 
variations alter the activity of several drug- 
metabolizing enzymes. Each drug-metabolizing 
enzyme normally breaks down not just one type of 
pharmacoiherapy, but usually several types. Since 
most of the ethnic variation comes in the form of 
inactivation or reduction in activity in the enzymes, 
the result is higher amounts -of medication in the 
blood, triggering untoward side effects. 
For example, 33 percent of African Americans 
and 37 percent of Asians are slow metabolizers of 
several antipsychotic medications and 
antidepressants (such as tricyclic antidepressants 
and selective serotonin reuptake inhibitors) (Lin et 
al., 1997). This awareness should lead to more 
cautious prescribing practices, which usually entail 
starting patients at lower doses in the beginning of 
treatment. Unfortunately, just the opposite typically 
had been the case with African American patients 
and antipsychotic drugs. Clinicians in psychiatric 
emergency services prescribed more oral doses and 
more injections of antipsychotic medications to 
African American patients (Segel et al., 1996). The 
combination of slow metabolism and overmedica- 
tion of antipsychotic drugs in African Americans 
can yield very uncomfortable extrapyramidal side 
effects (Lin et al., 1997). These are the kinds of 
experiences that likely contribute to the mistrust of 
mental health services reported among African 
Americans (Sussman et al., 1987). 
*’ Dystonia (brief or prolonged contraction of muscles), akathisia 
(an urge to move about constantly), or parkinsonism (tremor and 
rigidity) (Perry et al., 1997). 
Psychosocial factors also can play an important 
role in ethnic variation. Comphance with dosing 
may be hindered by communication difficulties; 
side effects can be misinterpreted or carry different 
connotations; some groups may be more responsive 
to placebo treatment; and reliance on psychoactive 
traditional and alternative healing methods (such as 
medicinal plants and herbs) may result in 
interactions with prescribed pharmacotherapies. 
The result could be greater side effects and 
enhanced or reduced effectiveness of the 
pharmacotherapy, depending on the agents involved 
and their concentrations (Lin.et al., 1997). Greater 
awareness of ethnopsychopharmacology is 
expected to improve treatment effectiveness for 
racial and ethnic minorities. More research is 
needed on this topic across racial and ethnic 
groups. 
Minority-Oriented Services 
Through employment of minority practitioners and 
the creation of specialized minority-oriented 
programs, community-based, publicly supported 
mental health programs have achieved greater 
minority representation than are found in other 
mental health settings (Snowden, 1999). Mental 
health care providers who are themselves from 
ethnic minority backgrounds are especially likely to 
treat ethnic minority clients and have been found to 
enjoy good success in retaining them in treatment 
(Sue et al., 1991). 
The character of the mental health program in 
which treatment is provided has proven particularly 
important in encouraging minority mental health 
service use. Research has shown that programs that 
specialize in serving identified minority 
communities have been successful in encouraging 
minorities to enter and remain in treatment (Yeh et 
al., 1994; Snowden et al., 1995; Takeuchi et al., 
1995; Snowden & Hu, 1996). Modeled on programs 
successfully targeting groups of recent immigrants 
and refugees, minority-oriented programs appear to 
succeed by maintaining active, committed 
relationships with community institutions and 
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leaders and making aggressive outreach efforts; by 
maintaining a familiar and welcoming atmosphere; 
and by identifying and encouraging styles of 
practice best suited to the problems particular to 
racial and ethnic minority group members. A 
challenge for such programs is to meet specialized 
sociocultural needs for clients from various 
backgrounds. The track record of minority-oriented 
programs at improving treatment outcomes is not 
yet clear for adults but appears to be positive for 
children and adolescents (Yeh et al., 1994). 
There is a specialized system of care for Native 
Americans that provides mental health treatment. 
The Indian Health Service (IHS) includes a Mental 
Health Programs Branch; it offers mental health 
treatment intended to be culturally appropriate. 
Urban Indian Health Programs also provide for 
mental health treatment. The IHS Alcohol- 
ism/Substance Abuse Program Branch sponsors 
services on reservations and in urban communities 
through contracts with service providers. Most 
mental health programs in the IHS focus on 
screening and treatment in primary care settings. 
Due to budgetary restraints, IHS is able to provide 
only limited medical, including mental health, 
coverage of Native American peoples (Manson, 
1998). 
Many tribes have moved toward self- 
determination and, as a result, toward assuming 
direct control of local programs. When surveyed, 
these tribal health programs reported providing 
mental health care in a substantial number of 
instances, although questions remain about the 
nature and scope of services. Finally, the 
Department of Veterans Affairs and many state and 
local authorities provide specialized mental health 
programming targeting persons of Native American 
heritage (Manson, 1998). Little is known about the 
levels and types of care provided under any of these 
arrangements. 
Cultural Competence 
Advocates and policymakers have called for all 
mental health practitioners to be culturally 
competent: to recognize and to respond to cultural 
concerns of ethnic and racial groups, including 
their histories, traditions, beliefs, and value 
systems (CMHS, 1998). 
Cultural competence is one approach to helping 
mental health service systems and professionals 
create better services and ensure their adequate 
utilization by diverse populations (Cross et al., 
1989). It is defined as a set of belfaviors, attitudes, 
and policies that come together in a system or 
agency or among professionals that enables that 
system, agency, or professionals to work 
effectively in cross-cultural situations (Cross et al., 
1989). This is especially important because most 
mental health providers are not racial and ethnic 
minority group members (Hernandez et al., 1998). 
Using the term “competence” places the 
responsibility on the mental health services 
organization and all of its employees, challenging 
them all to become part of a process of providing 
culturally appropriate services. This approach 
emphasizes understanding the importance of 
culture and building service systems that recognize, 
incorporate, practice, and value cultural diversity. 
There is no single prescribed method for 
accomplishing cultural competence. It begins with 
respect, and not taking an ethnocentric perspective 
about behavior, values, or beliefs. Three possible 
methods are to render mainstream treatments more 
inviting and accessible to minority groups through 
enhanced communication and greater awareness; to 
select a traditional therapeutic approach according 
to the perceived needs of the minority group; or to 
adapt available therapeutic approaches to the needs 
of the minority group (Rogler et al., 1987). One 
effort to promote cultural competence has been 
directed toward mental health services systems 
and programs. The Center for Mental Health 
Services has developed, with national input, a 
preliminary set of performance indicators for 
“cultural competence” by which service and 
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funding organizations might be judged. Cultural 
competence in this context includes consultation 
with cross-cultural experts and training of staff, a 
capacity to provide services in languages other than 
English, and the monitoring of caseloads to ensure 
proportional racial and ethnic representation. The 
ultimate test of any performance indicator will be 
documented by improvements in care and treatment 
of ethnic and racial minorities. 
Another response has been to develop 
guidelines that more directly convey variations 
believed necessary in the course of clinical 
practice. An appendix to DSM-IV presents 
clinicians with an Outline for Cultural Formulation. 
The guidelines are intended as a supplement to 
standard diagnosis, for use in multicultural environ- 
ments and for the provision of a “systematic review 
of the individual’s cultural background, the role of 
the cultural context in the expression and 
evaluation of symptoms and dysfunction, and the 
effect that cultural differences may have on the 
relationship between the individual and the 
clinician” (DSM-IV). 
The Outline for Cultural Formulation covers 
several areas. It calls for an assessment of cultural 
identity, including degree of involvement with 
alternative cultural reference groups; cultural 
explanations of illness; cultural factors related to 
stresses, supports, and level of functioning and 
disability (e.g., religion, kin networks); differences 
in culture or social status between patient and 
clinician and possible barriers (e.g., communi- 
cation, trust); and overall cultural assessment. 
Others have focused attention on the process by 
which mental health practitioners must engage, 
assess, and treat patients and on understanding how 
cultural differences might affect that process 
(Lopez et al., in press). Viewed from this 
perspective, the task is to maintain two points of 
view-that of the cultural group and that of 
evidence-based mental health practice-and 
strategically integrate them with the aim of valuing 
and utilizing culture, context, and practice in a way 
that promotes mental health. 
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This capacity has a dual advantage. The 
practitioner comes to understand the problem as it 
is experienced and understood by the patient and, 
in so doing, gains otherwise inaccessible 
information on personal and social reality for the 
‘patient, as well as a sense of trust and credibility. 
At the same time the practitioner is able to plan for 
and implement an appropriate intervention. It is 
through a facility and a willingness to switch from 
a professional orientation to that of the client and 
his or her cultural group that the clinician is best 
able to implement guidelines for cultural 
competence such as those specified in DSM-IV 
(Mezzich et al., 1996). 
In the end, to be culturally competent is to 
deliver treatment that is equally effective to all 
sociocultural groups. The treatments provided must 
not only be efficacious (based on clinical research), 
but also effective in community delivery. The 
delivery of effective treatments is complicated 
because most research on efficacy has been 
conducted on predominantly white populations. 
This suggests the importance of both efficacy and 
effectiveness studies on racial and ethnic 
minorities. 
At present, there is scant knowledge about 
treatment effectiveness according to race, culture, 
or ethnicity (Snowden & Hu, 1996). Rarely has 
research evaluating standard forms of treatment 
examined differential effectiveness. In fact, the 
American Psychological Association’s Division of 
Clinical Psychology Task Force, which tried to 
identify the efficacy of different psychotherapeutic 
treatments, could not find a single rigorous study of 
treatment efficacy published on ethnic minority 
clients (Chambless et al., 1996). Nor have studies 
been carried out on the efficacy of proposed 
cultural adaptations of treatment in comparison 
with standard alternatives. Only as more knowledge 
is gained will it become possible to mount a full- 
fledged and appropriate response to racial and 
ethnic differences in the provision of mental health 
care. 
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Rural Mental Health Services 
The differences between rural and urban communi- 
ties present another source of diversity in mental 
health services. People in rural America encounter 
numerous barriers to the receipt of effective 
services. Some barriers are geographic, created by 
the problem of delivering services in less densely 
populated rural areas and even more sparsely 
populated frontier areas. Some barriers are 
“cultural,” insofar as rural America reflects a range 
of cultures and life styles that are distinct from 
urban life. Urban culture and its approach to 
delivering mental health services dominate mental 
health services (Beeson et al., 1998). 
Rural America is shrinking in size and political 
influence (Danbom, 1995; Dyer, 1997). As a 
consequence, rural mental health services do not 
figure prominently in mental health policy (Ahr & 
Holcomb, 1985; Kimmel, 1992). Furthermore, rural 
economies are in decline, and the population is 
decreasing in most areas (yet expanding rapidly in 
a few boom areas) (Hannan, 1998). Rural America 
is no longer a stable or homogeneous environment. 
The farm crisis of the 1980s unleashed a period of 
economic hardship and rapid social change, 
adversely affecting the mental health of the 
population (Ortega et al., 1994; Hoyt et al., 1995). 
Policies and programs designed for urban 
mental health services often are not appropriate for 
rural mental health services (Beeson et al., 1998). 
Beeson and his colleagues (1998) list a host of 
important differences that should be considered in 
designing rural mental health services. In an era of 
specialized services, rural mental health relies 
heavily on primary medical care and social 
services. Stigma is particularly intense in rural 
communities, where anonymity is difficult to 
maintain (Hoyt et al., 1997). In an era of expanding 
private mental health services, rural mental health 
services have been predominantly publicly funded. 
Consumer and family involvement in advocacy, 
characteristic of urban and suburban areas, is rare 
in rural America. The supply of services and 
providers is limited, so choice is constrained. 
Mental health services in rural areas cannot achieve 
certain economies of scale, and some state-of-the 
art services (e.g., assertive community treatment) 
are inefficient to deliver unless there is a critical 
mass of patients. Informal supports and indigenous 
healers assume more importance in rural mental 
health care. 
Rural mental health concerns are being raised 
nationally (Rauch, 1997; Ciarlo, 1998; Beeson et 
al., 1998). Model programs offer new designs for 
services (Mohatt & Kirwan, 1995), particularly 
through the integration of mental health and 
primary care (Bird et al., 1995, 1998; Size, 1998). 
Newer technology, such as advanced tele- 
communications in the form of “telemental health,” 
may improve rural .access to expertise from 
professionals located in urban areas (Britain, 1996; 
La Mendola, 1997; Smith & Allison, .1998). 
Internet access, videoconferencing, and various 
computer applications offer an opportunity to 
enhance the quality of care in rural mental health 
services. 
Overview of Consumer and Family 
Movements 
Since the late 197Os, mental health services 
continue to be transformed by the growing 
influence of consumer and family organizations 
(Lefley, 1996). Through strong advocacy, consumer 
and family organizations have gained a voice in 
legislation and policy for mental health service 
delivery. Organizations representing consumers and 
family members, though divergent in their 
historical origins and philosophy, have developed 
some important, overlapping goals: overcoming 
stigma and preventing discrimination, promoting 
self-help groups, and promoting recovery from 
mental illness (Frese, 1998). 
This section covers the history, goals, and 
impact of consumer and family organizations, 
whereas the next section covers the process of 
recovery from mental illness. With literally 
hundreds of grassroots consumer organizations 
across the United States, no single organization 
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speaks for all consumers or all families. In fact, 
even the term “consumer” is not uniformly 
accepted. Despite the heterogeneity, these 
organizations typically offer some combination of 
advocacy and self-help groups (Lefley, 1996). 
Many users of mental health services refer 
to themselves as “consumers.” The lexicon is 
complicated by objections to the term “consumer.” 
To some, being a consumer erroneously signifies 
that service users have the power to choose services 
most suitable to their needs. Those who object 
contend that consumers have neither choices, 
leverage, nor power to select services. Instead, 
some consumers refer to themselves as “surviv&s” 
or “ex-patients” to denote that they have survived 
what they experienced as oppression by the mental 
health system (Chamberlin & Rogers, 1990). This 
distinction can best be understood in its historical 
context. 
Origins and Goals of Consumer Groups 
The consumer movement arose as a protest in the 
1970s by former patients of mental hospitals. Their 
antecedents trace back to the 19th century, when a 
handful of individuals recovered enough to write 
exposCs expressing their outrage at the’ indignities 
and abuses inside mental hospitals. The most 
persuasive former patient was Clifford Beers, 
whose classic book, A Mind That Found Itself 
(1908), galvanized the mental hygiene reform 
movement (Grab, 1994). Beers was among the 
founders of the National Committee on Mental 
Hygiene, an advocacy group that later was renamed 
the National Mental Health Association. This group 
focuses on linking citizens and mental health 
professionals in broad-based prevention of mental 
illness. 
With the advent of deinstitutionalization in the 
195Os, increasing numbers of former patients of 
mental hospitals began to forge informal ties in the 
community. By the 196Os, the civil rights move- 
ment inspired former patients to become better 
organized into what was then coined the mental 
patients’ liberation movement (Chamberlin, 1995). 
Groups of patients saw themselves as having been 
rejected by society and robbed of power and 
control over their lives. To surmount what they saw 
as persecution, they began to advocate for self- 
determination and basic rights (Chamberlin, 1990; 
.-Frese & Davis, 1997). The ,posture of these early 
groups was decidedly militant against psychiatry, 
against laws favoring involuntary commitment, and 
often against interventions such as electroconvul- 
sive therapy and antipsychotic medications (Lefley, 
1996; Frese, 1998). Groups called Alliance for the 
Liberation of Mental Patients, the Insane Liberation 
Front, and Project Release met in homes and 
churches, drawing their membership from those 
with firsthand experiences with the mental health 
system. Largely unfunded, they sustained their 
membership by providing peer support, education 
about services in the community, and advocacy to 
help members access services and to press for 
reforms (Furlong-Norman, 1988). 
The book On Our Own (1978) by former patient 
Judi Chamberlin was a benchmark in the history of 
the consumer movement. Consumers and others 
were able to read in the mainstream press what it 
was like to have experienced the mental health 
system. For many consumers, reading this book was 
the beginning of their involvement in consumer 
organizations (Van Tosh & de1 Vecchio, in press). 
Early consumer groups, although geographically 
dispersed, voluntary, and independent, were linked 
through the newsletter Madness Network News, 
which continued publication from 1972 to 1986. 
During the same era, the Conference on Human 
Rights and Against Psychiatric Oppression was 
established and met annually from 1973 through 
1985 (Chamberlin, 1990). In 1978, early consumer 
groups gained what they perceived as their first 
official acknowledgment from the highest levels of 
government. The President’s Commission on 
Mental Health stated that “. . . groups composed of 
individuals with mental or emotional problems are 
being formed all over the United States” 
(President’s Commission on Mental Health, 1978, 
pp. 14-15). To date, racial and ethnic minority 
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group members are underrepresented within the 
consumer movement proportionate to their growing 
representation in the U.S. population. There is a 
need for more outreach and involvement of 
consumers representing the special concerns of 
racial and ethnic minorities. 
The advocacy positions of consumers have 
dealt with the role of involuntary treatment, self- 
managed care, the role of consumers in research, 
the delivery of services, and access to mental health 
services. By 1985, consumer views became so 
divergent that two groups emerged: The National 
Association of Mental Patients*’ and the National 
Mental Health Consumers’ Association. The former 
opposed all forms of involuntary treatment, 
supported the prohibition of electroconvulsive 
therapy, and rejected psychotropic medications and 
hospitalization. The latter organization held more 
moderate views for improving rather than 
eschewing the mental health service system 
(Lefley, 1996; Frese, 1998). Both groups eventually 
disbanded, but the differences of opinion that they 
reflected became deeply entrenched. 
Self-Help Groups 
Self-help refers to groups led by peers to promote 
mutual support, education, and growth (Lefley, 
1996). Self-help is predicated on the belief that 
individuals who share the same health problem can 
help themselves and each other to cope with their 
condition. The self-help approach enjoys a long 
history, most notably with the formation of 
Alcoholics Anonymous in 1935 (IOM, 1990). Over 
time, the self-help approach has been brought to 
virtually every conceivable health condition. 
Since the 197Os, many mental health consumer 
groups emphasized self-help as well as advocacy 
(Chamberlin, 1995), although to different degrees. 
Self-help for recovering mental patients initially 
emphasized no involvement with mental health 
professionals. Over time the numbers and types of 
” Later renamed the Nationa 
(Chamberlin. 1995). 
ivors 
self-help groups began to flourish and more 
moderate viewpoints became represented. Self-help 
groups assume three different postures toward 
health professionals: the separatist model, the 
supportive model that allows professionals to aid in 
auxiliary roles, and partnership models in which 
professionals act as leaders alongside patients 
(Chamberlin, 1978; Emerick, 1990). The focus of 
groups varies, with some groups united on the basis 
of diagnosis, such as Schizophrenics Anonymous 
and the National Depressive and Manic-Depressive 
Association, whereas others are more broad based. 
Chamberlin’s influential book and another book 
by former patients, Reaching Across (Zinman et al., 
1987), explained to consumers how to form self- 
help groups. These books also extended the concept 
of self-help more broadly into the provision of 
consumer-run services as alternatives (as opposed 
to adjuncts) to mental health treatment (Lefley, 
1996). 
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Programs entirely run by consumers include 
drop-in centers, case management programs, 
outreach programs, businesses, employment and 
housing programs, and crisis services (Long & Van 
Tosh, 1988; National Resource Center on 
Homelessness and Mental Illness, 1989; Van Tosh 
& de1 Vecchio, in press). Drop-in centers are places 
for consumers to obtain social support and 
assistance with problems. Although research is 
limited, the efficacy of consumer-run services is 
discussed in Chapter 4. 
Consumer positions also are being incorporated 
into more conventional mental health services-as 
job coaches and case manager extenders, among 
others. The rationale for employing consumers in 
service delivery- in consumer-run or conventional 
programs-is to benefit those hired and those 
served. Consumers who are hired obtain 
employment, enhance self-esteem, gain work 
experience and skills, and sensitize other service 
providers to the needs of people with mental 
disorders. Consumers who are served may be more 
receptive to care and have role models engaged in 
their care (Mowbray et al., 1996). 
Accomplishments of Consumer 
Organizations 
Consumer organizations have had measurable 
impact on mental health services, legislation, and 
research. One of their greatest contributions has 
been the organization and proliferation of self-help 
groups and their impact on the lives of thousands of 
consumers of mental health services. In 1993, a 
collaborative survey found that 46 state mental 
health departments funded 567 self-help groups and 
agencies for persons with mental disabilities and 
their family members (National Association of 
State Mental Health Program Directors, 1993). A 
nationwide directory lists all 50 states and the 
District of.Columbia as having 235 different mental 
health consumer organizations (South Carolina 
SHARE, 1995). 
On a systems level, the consumer movement has 
substantially influenced mental health policy to 
tailor services to consumer needs. This influence is 
described by consumers and researchers as 
“empowerment.” A concept from the social 
sciences, empowerment has come to be defined by 
mental health researchers as “gaining control over 
one’s life in influencing the organizational and 
societal structures in which one lives” (Segal et al., 
1995). 
Consumers are now involved in all aspects of 
the planning, delivery, and evaluation of mental 
health services, and in the protection of individual 
rights. One prominent example is the passage of 
Public Law 102-321, which established mental 
health planning councils in every state. Planning 
councils are required to have membership from 
consumers and families. Having a planning council 
so constituted is required for the receipt of Federal 
block grant funds for mental health services. Other 
Federal legislation required the establishment of 
protection and advocacy agencies for patients’ 
rights in every state (Chamberlin & Rogers, 1990; 
Lefley, 1996). 
Another significant development has been the 
establishment of offices of consumer affairs in 
many state mental health authorities. Offices of 
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consumer affairs are generally staffed by 
consumers to support consumer empowerment and 
self-help in their particular states, A recent survey 
of state mental health authorities identified 27 
states as having paid positions for consumers in 
central offices (Geller et al., 1998). In 1995, the 
Federal Center for Mental Health Services hired its 
first consumer affairs specialist. 
The consumer movement also has had a 
substantial influence on increasing the utilization 
of consumers as employees in the traditional mental 
health system, as well as in other human service 
agencies (Specht, 1988; ‘U.S. Department of 
Education, 1990; Schlageter, 1990; Interagency 
Council on the Homeless, 1991). Consumers are 
being hired at all levels in the mental health 
system, ranging from case manager aides to 
management positions in national advocacy 
organizations, as well as state and Federal 
governmental agencies. 
Finally, consumers continue to be involved in 
research in several ways: as participants of clinical 
research; as respondents who are asked questions 
about conditions in their life; as partners in some 
aspect of the planning, designing, and conducting 
of the research project with professional 
researchers in control; and as independent 
researchers who conduct, analyze the data, and 
publish the results of the research project 
(Campbell et al., 1993). The past decade has 
witnessed the blossoming of a vibrant consumer 
research agenda and the growing belief that 
consumer involvement in research and evaluation 
holds great promise for system reform, quality 
improvement, and outcome measurement (Campbell 
et al., 1993; Campbell, 1997). In an effort to 
enhance the active role of consumers and others in 
the research process, the National Institute of 
Mental Health is developing a systematic means of 
including public participants in the initial review of 
grant applications in the areas of clinical treatment 
and services research. This innovation follows up 
on a recommendation made by the Institute of 
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Medicine and Committee for the Study of the 
Future of Public Health (1988). 
Family Advocacy 
The family movement has experienced spectacular 
growth and influence since its beginnings in the 
late 1970s (Lefley, 1996). Although several 
advocacy and professional organizations speak to 
the needs of families, the family movement is 
principally represented by three large 
organizations. They are the National Alliance for 
the Mentally Ill (NAMI), the Federation of Families 
for Children’s Mental Health (FFCMH), and the 
National Mental Health Association (NMHA). 
NAM1 serves families of adults with chronic mental 
illness, whereas the Federation serves children and 
youth with emotional, behavioral, or mental 
disorders. NMHA serves a broad base of family 
members and other supporters of children and 
adults with mental disorders and mental health 
problems. Though the target populations are 
different, these organizations are similar in their 
devotion to advocacy, family support, research, and 
public awareness. 
Fragmentation and lack of availability of 
services were motivating forces behind’ the 
establishment of the family movement. 
Deinstitutionalization, in particular, was a cogent 
impetus for the formation of NAMI. 
Deinstitutionalization of the mentally ill left 
families in the unexpected position of having to 
assume care for their adult children, a role for 
which they were ill prepared. Another motivating 
force behind the family movement was the past 
tendency by the mental health establishment to 
blame parents for the mental illness in children 
(Frese, 1998). The cause of schizophrenia, for 
example, had been attributed to the 
“schizophrenogenic mother,” who was cold and 
aloof, according to a reigning but now discredited 
view of etiology. Similarly, parents were viewed as 
partly to blame for children with serious emotional 
or behavioral disturbances (Melaville & Asayesh 
1993; Friesen & Stephens, 1998). 
NAM1 was created as a grassroots organization 
in 1979 by a small cadre of families in Madison, 
Wisconsin. Since then, its membership has 
skyrocketed to 208,000 in all 50 states (NAMI, 
1999). NAMI’s principal goal is to advocate for 
impro.ved services for persons with severe and 
persistent mental illness-for example, 
schizophrenia and bipolar disorder. Its sole 
emphasis on the most severely affected consumers 
distinguishes it from most other consumer and 
family organizations. Another NAM1 goal is to 
transform public attitudes and rtduce stigma by 
emphasizing the biological basis of ,serious mental 
disorders, as opposed to poor parenting (Frese, 
1998; NAMI, 1999). Correspondingly, NAM1 
advocates for intensification of research in the 
neurosciences. Through state and local affiliates, 
NAM1 operates a network of family groups for self- 
help and education purposes. 
NAMI’s accomplishments are formidable. The 
organization has become a powerful voice for the 
expansion of community-based services to fulfill 
the vision of the community support reform 
movement. NAM1 has successfully pressed for 
Federal legislation for family membership in state 
mental health planning boards. It is a prime force 
behind congressional legislation for parity in the 
financing of mental health services. It also has 
made substantial inroads in the training of mental 
health professionals to sensitize them to the 
predicament of the chronically mentally ill. It has 
promoted “psychoeducation,” specific information 
to family members, usually in small-group settings, 
about schizophrenia and about strategies for 
dealing with relatives with schizophrenia (Lamb, 
1994). Finally, NAM1 has successfully lobbied for 
increased Federal research funding, and it has set 
up private research foundations (Lefley, 1996). 
Similarly, advocacy by parents on behalf of 
children with serious emotional or behavioral 
disturbances has had a compelling impact. 
Advocacy for children was electrified by the 
publication of Jane Knitzer’s 1982 book, 
Unclaimed Children; shortly afterward, the 
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National Mental Health Association (NMHA) 
issued Invisible Children (NMHA, 1983), followed 
by A Guide for Advocates to All Systems Failure 
(NMHA, 1993). Knitzer chronicled the plight of 
families in trying to access care from disparate and 
uncoordinated public agencies, many of which 
blamed or ignored parents. NMHA, a pioneer in the 
mental health advocacy field, assumed a pivotal 
role in strengthening the child mental health 
movement in the 1980s and early 1990s. Over time, 
the Federation of Families for Children’s Mental 
Health has become another focal point for families, 
championing family participation and support in 
systems of care and access to services. The 
Federation’s chapters across the United States offer 
self-help, education, and networking (FFCMH, 
1999). Through the efforts of these groups and 
individuals, among the- most noteworthy 
accomplishments of the family movement has been 
the emergence of family participation in 
decisionmaking about care for children, one of the 
decisive historical shifts in service delivery in the 
past 20 years. 
Overview of Recovery 
Until recently, some severe mental disorders were 
generally considered to be marked by lifelong 
deterioration. Schizophrenia, for instance, was seen 
by the mental health profession as having a 
uniformly downhill course (Harding et al., 1992). 
At the beginning of the 20th century, the leading 
psychiatrist of the era, Emil Kraepelin, judged the 
outcome of schizophrenia to be so dismal that he 
named the disorder “dementia praecox,” or 
premature dementia. Negative conceptions of 
severe mental illness, perpetuated in textbooks for 
decades by Kraepelin’s original writings, dampened 
consumers’ and families’ expectations, leaving 
them without hope. A turnabout in attitudes came 
as a result of the consumer movement and self-help 
activities. They mobilized a shift toward a more 
positive set of consumer attitudes and self- 
perceptions. Research provided a scientific basis 
for and supported a more optimistic view of the 
possibility of recovering function (Harding et al., 
1992). Promoting recovery became a rallying point 
and common ground for the consumer and family 
movements (Frese, 1998). 
The concept of recovery is having substantial 
impact on consumers and families, mental health 
research, and service delivery. Before describing 
that impact, this section first turns to an 
introduction and definitions. 
Introduction and Definitions 
Recovery is a concept introduced in the lay 
writings of consumers beginning in the 1980s. It 
was inspired by consumers who had themselves 
recovered to the extent that they were able to write 
about their experiences of coping with symptoms, 
getting better, and gaining an identity (Deegan, 
1988; Leete, 1989). Recovery also was fueled by 
longitudinal research uncovering a more positive 
course for a significant number of patients with 
severe mental illness (Harding et al., 1992), 
although findings across several studies were 
variable (Harrow et al., 1997) (see discussion in 
Chapter 4). 
Recovery is variously called a process, an 
outlook, a vision, a guiding principle. There is 
neither a single agreed-upon definition of recovery 
nor a single way to measure it. But the overarching 
message is that hope and restoration of a 
meaningful life are possible, despite serious mental 
illness (Deegan, 1988; Anthony, 1993; Stocks, 
1995; Spaniol et al., 1997). Instead of focusing 
primarily on symptom relief, as the medical model 
dictates, recovery casts a much wider spotlight on 
restoration of self-esteem and identity and on 
attaining meaningful roles in society. 
Written testimonials by former mental patients 
have appeared for centuries. These writings, 
according to historian of medicine Roy Porter, 
“shore up that sense of personhood and identity 
which they feel is eroded by society and 
psychiatry” (Porter, 1987). What distinguishes the 
contemporary wave of writings is their critical 
mass, organizational backing, and freedom of 
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expression from outside the confines of the 
institution. Deinstitutionalization, the emergence of 
community supports and psychosocial rehabili- 
tation, and the growth of the consumer and family 
advocacy movements all paved the way for 
recovery to take hold (Anthony, 1993). 
The concept of recovery continues to be defined 
in the writings of consumers (see Figure 2-7). 
These lay writings offer a range of possible 
definitions, many of which seek to discover 
meaning, purpose, and hope from having mental 
illness (Lefley, 1996). The definitions do not, 
however, imply full recovery, in which full 
functioning is restored and no medications are 
needed. Instead .they suggest a journey or process, 
not a destination or cure (Deegan, 1997). One of 
the most prominent professional proponents of 
recovery, William A. Anthony, crystallized con- 
sumer writings on recovery with the following 
definition: 
. . . a person with mental illness can 
recover even though the illness is not 
“cured” . . . . [Recovery] is a way of living 
a satisfying, hopeful, and contributing life 
even with the limitations caused by illness. 
Recovery involves the development of new 
meaning and purpose in one’s life as one 
grows beyond the catasrrophic effects of 
mental illness (Anthony, 1993). 
It is important to point out that consumers see 
a distinction between recovery and psychosocial 
rehabilitation. The latter, which is discussed more 
extensively in Chapter 4, refers to professional 
mental health services that bring together 
approaches from the rehabilitation and the mental 
health fields (Cook et al., 1996). These services 
combine pharmacological treatment, skills training, 
and psychological and social support to clients and 
families in order to improve their lives and 
functional capacities. Recovery, by contrast, does 
not refer to any specific services. Rather, according 
to the writings of pioneering consumer Patricia 
Deegan, recovery fefers to the “lived experience” 
Figure 2-7. Definitions of recovery from 
rfnnrlrmfar writinna “-.m”w...w, I.. .-...a- 
7ecovet-y is a process, a way of life, an attitude, 
2nd a way of approaching the day’s challenges. It 
s not a perfect/y linear process. At times our 
:ouee is erratic and we falter, slide back, regroup 
2nd start again. . . . The need is to meet the 
challenge of the disability and to re-establish a 
7ew and valued sense of integrity and purpose 
within and beyond the limits of the disability; the 
sspiration is to live, work, and love in a community 
in which one makes a significant contribution 
(Deegan, 1988, p. 15). 
. 
One of the elements that makes recovery possible 
is the regaining of one’s belief in oneself 
(Chamberlin, 1997, p. 9). 
Having some hope is. crucial to recovery; none of 
us would strive if we believed it a futile effort. . .I 
believe that if we confront our illnesses with 
courage and struggle with our symptoms 
persistently, we can overcome our handicaps to 
live independent/y, learn ski//s, and contribute to 
society, the society that has traditionally 
abandoned us (Leete, 1989, p. 32). 
A recovery paradigm is each person’s unique 
experience of their road to recovery. . . .My 
recovery paradigm included my re-connection 
which included the following four key ingredients: 
connection, safety, hope, and acknowledgment of 
my spiritual se/f (Long, 1994, p. 4). 
To return renewed with an enriched perspective 01 
the human condition is the major benefit of 
recovery. To return at peace, with yourse/( your 
experience, your world, and your God, is the majo 
joy of recovery (Granger, 1994, p. 10). 
of gaining a new and valued sense of self and of 
purpose (Deegan, 1988). 
Impact of the Recovery Concept 
The impact of the recovery concept is felt most by 
consumers and families. Consumers and families 
are energized by the message of hope and self- 
determination. Having more active roles in 
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treatment, research, social and vocational 
functioning, and personal growth strikes a 
responsive cord. Consumers’ harboring more 
optimistic attitudes and expectations may improve 
the course of their illness, based on related research 
from the field of psychosocial and vocational 
rehabilitation (see Chapter 4). Yet direct empirical 
support for the salutary, long-term effect of 
positive expectations, on both consumers and 
families, is still in its infancy (Lefley, 1997). 
The recovery concept likewise is having a 
bearing on mental health research and services. 
Researchers are beginning to study consumer 
attitudes and behavior to attempt to identify .the 
elements contributing to recovery. Though still at 
an early stage, research is being driven by 
consumer perspectives on recovery. Consumers 
assert that the recovery process is governed by 
internal factors (their psychological perceptions 
and expectations), external factors (social 
supports), and the ability to self-manage care, all of 
which interact to give them mastery over their 
lives. The first systematic efforts to define 
consumer perceptions of recovery was conducted 
by consumers. The Well-Being Project, sponsored 
by the California Department of Mental Health, 
was a landmark effort in which mental health 
consumers conducted a multifaceted study to define 
and explore factors promoting or deterring the well- 
being of persons diagnosed with serious mental 
illness (Campbell & Schraiber, 1989). Using 
quantitative survey research, focus groups, and oral 
histories, Campbell (1993) arrived at a definition of 
recovery that incorporates “good health, good food, 
and a decent place to live, all supported by an 
adequate income that is earned through meaningful 
work. We need adequate resources and a satisfying 
social life to meet our desires for comfort and 
intimacy. Well-being is enriched by creativity, a 
satisfying spiritual and sexual life, and a sense of 
happiness” (p. 28). 
Through semistructured interviews with 
consumers about recovery, a subsequent study 
identified the most common factors associated with 
their success in dealing with a mental illness. They 
included medication, community support/case 
management, self-will/self-monitoring, vocational 
activity (including school), and spirituality 
(Sullivan, 1994). Other researchers, also using 
semistructured interviews, suggested that the 
rediscovery and reconstruction of a sense of self 
were important to recovery (Davidson & Strauss, 
1992). 
These early forays by researchers set the stage 
for consumer-driven research efforts to identify 
some of the aspects of recovery. A group of 
consumers with consultant’researchers developed 
the Empowerment Scale (Rogers et al., 1997). After 
testing a 28-item scale on members of six self-help 
programs in six states, factor analysis revealed the 
underlying dimensions of empowerment to be 
(1) self-efficacy-self-esteem; (2) power-powerless- 
ness ; (3) community activism; (4) righteous anger; 
and (5) optimism-control over the future. Other 
instruments, found to have consistency and 
construct validity, are the Personal Empowerment 
Scale, the Organizational Empowerment Scale, and 
the Extra-Organizational Empowerment Scale 
(Segal et al., 1995). 
Mental health services continue to be refined 
and shaped by the consumer and recovery 
emphasis. The most tangible changes in services 
come from assertive community treatment and 
psychosocial and vocational rehabilitation, which 
emphasize an array of approaches to maximize 
functioning and promote recovery. Consumer 
interest in self-help and recovery has stimulated the 
proliferation of interventions for what has been 
called “illness management” or “self-managed 
care” for relapse prevention of psychotic 
symptoms. Illness management training programs 
now teach individuals to identify early warning 
signs of relapse and to develop strategies for their 
prevention. All of these transformations in service 
delivery and research affirming their benefits are 
discussed at length in Chapter 4. 
Champions of recovery assert that its greatest 
impact will be on mental health providers and the 
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future design of the service system. They envision 
services being structured to be recovery-oriented to 
ensure that recovery takes place. They envision 
mental health professionals believing in and 
supporting consumers in their quest to recover. In 
a groundbreaking article, William A. Anthony 
described recovery as a guiding vision that “pulls 
the field of services into the future. A vision is not 
reflective of what we are currently achieving, but 
of what we hope for and dream of achieving. 
Visionary thinking does not raise unrealistic 
expectations. A vision begets not false promises but 
a passion for what we are doing.” 
Conclusioris 
The past 25 years have been marked by several 
discrete, defining trends in the mental health field. 
These have included: 
1. The extraordinary pace and productivity of 
scientific research on the brain and behavior; 
2. The introduction of a range of effective 
treatments for most mental disorders; 
3. A dramatic transformation of our society’s 
approaches to the organization and financing of 
mental health care; and 
4. The emergence of powerful consumer and 
family movements. 
Scientific Research. The brain has emerged as 
the central focus for studies of mental health and 
mental illness. New scientific disciplines, 
technologies, and insights have begun to weave a 
seamless picture of the way in which the brain 
mediates the influence of biological, psychological, 
and social factors on human thought, behavior, and 
emotion in health and in illness. Molecular and 
cellular biology and molecular genetics, which are 
complemented by sophisticated cognitive and 
behavioral science, are preeminent research 
disciplines in the contemporary neuroscience of 
mental health. These disciplines are affording 
unprecedented opportunities for “bottom-up” 
studies of the brain. This term refers to research 
that is examining the workings of the brain at the 
,most fundamental levels. Studies focus, for 
example, on the complex neurochemical activity 
that occurs within individual nerve cells, or 
neurons, to process information; on the properties 
and roles of proteins that are expressed, or 
produced, by a person’s genes; and on the 
interaction of genes with diverse environmental 
influences. All of these activities now are 
understood, with increasing clarity, to underlie 
learning, memory, the experience of emotion, and, 
when these processes go awry, the occurrence of 
mental illness or a mental health problem. 
Equally important to the mental health field is 
“top-down” research; here, as the?erm suggests, the 
aim is to understand the broader behavioral context 
of the brain’s cellular and molecular activity and to 
learn how individual neurons work together in 
well-delineated neural circuits to perform mental 
functions. 
Effective Treatments. As information accumu- 
lates about the basic workings of the brain, it is the 
task of translational research to transfer new 
knowledge into clinically relevant questions and 
targets of research opportunity-to discover, for 
example, what specific properties of a neural 
circuit might make it receptive to safer, more 
effective medications. To elaborate on this 
example, theories derived from knowledge about 
basic brain mechanisms are being wedded more 
closely to brain imaging tools such as functional 
Magnetic Resonance Imaging (MRI) that can 
observe actual brain activity, Such a collaboration 
would permit investigators to monitor the specific 
protein molecules intended as the “targets” of a 
new medication to treat a mental illness or, indeed, 
to determine how to optimize the effect on the brain 
of the learning achieved through psychotherapy. 
In its entirety, the new “integrative neuro- 
science” of mental health offers a way to 
circumvent the antiquated split between the mind 
and the body that historically has hampered mental 
health research. It also makes it possible to 
examine scientifically many of the important 
psychological and behavioral theories regarding 
normal development and mental illness that have 
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been developed in years past. The unswerving goal 
of mental health research is to develop and refine 
clinical treatments as well as preventive inter- 
ventions that are based on an understanding of 
specific mechanisms that can contribute to or lead 
to illness but also can protect and enhance mental 
health. 
Mental health clinical research encompasses 
studies that involve human participants, conducted, 
for example, to test the efficacy of a new treatment. 
A noteworthy feature of contemporary clinical 
research is the new emphasis being placed on 
studying the effectiveness of interventions in actual 
practice settings. Information obtained from such 
studies increasingly provides the foundation for 
services research concerned with the cost, cost- 
effectiveness, and “deliverability” of interventions 
and the design-including economic consider- 
ations -of service delivery systems. 
Organization and Financing of Mental Health 
Care. Another of the defining trends has been the 
transformation of the mental illness treatment and 
mental health services landscapes, including 
increased reliance on primary health care and other 
human service providers. Today, the U.S. mental 
health system is multifaceted and complex, 
comprising the public and private sectors, general 
health and specialty mental health providers, and 
social services, housing, criminal justice, and 
educational agencies. These agencies do not always 
function in a coordinated manner. Its configuration 
reflects necessary responses to a broad array of 
factors including reform movements, financial 
incentives based on who pays for what kind of 
services, and advances in care and treatment 
technology. Although the hybrid system that exists 
today serves diverse functions well for many 
people, individuals with the most complex needs 
and the fewest financial resources often find the 
system fragmented and difficult to use. A challenge 
for the Nation in the near-term future is to speed 
the transfer of new evidence-based treatments and 
prevention interventions into diverse service 
delivery settings and systems, while ensuring 
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greater coordination among these settings and 
systems. 
Consumer and Family Movements. The emerg- 
ence of vital consumer and family movements 
promises to shape the direction and complexion of 
mental health programs for many years to come. 
.Although divergent in their historical origins and 
philosophy, organizations representing consumers 
and family members have promoted important, 
often overlapping goals and have invigorated the 
fields of research as well as treatment and service 
delivery design. Among the principal goals shared 
by much of the consumer movement are to 
overcome stigma and prevent discrimination in 
policies affecting persons with mental illness; to 
encourage self-help and a focus on recovery from 
mental illness; and to draw attention to the special 
needs associated with a particular disorder or 
disability, as well as by age or gender or by the 
racial and cultural identity of those who have 
mental illness. 
Chapter 2 of the report was written to provide 
background information that would help persons 
from outside the mental health field better 
understand topics addressed in subsequent chapters 
of the report. Although the chapter is meant to 
serve as a mental health primer, its depth of 
discussion supports a range of conclusions: 
1. The multifaceted complexity of the brain is 
fully consistent with the fact that it supports all 
behavior and mental life. Proceeding from an 
acknowledgment that all psychological 
experiences are recorded ultimately in the brain 
and that all psychological phenomena reflect 
biological processes, the modern neuroscience 
of mental health offers an enriched 
understanding of the inseparability of human 
experience, brain, and mind. 
2. Mental functions, which are disturbed in mental 
disorders, are mediated by the brain. In the 
process of transforming human experience into 
physical events, the brain undergoes changes in 
its cellular structure and function. 
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3. Few lesions or physiologic abnormalities define 
the mental disorders, and for the most part their 
causes remain unknown. Mental disorders, 
instead, are defined by signs, symptoms, and 
functional impairments. 
4. Diagnoses of mental disorders made using 
specific criteria are as reliable as those for 
general medical disorders. 
5. About one in five Americans experiences a 
mental disorder in the course of a year. 
Approximately 15 percent of all adults who 
have a mental disorder in one year also 
experience a co-occurring substance (alcohol or 
other drug) use disorder, which complicates 
treatment. 
6. A range of treatments of well-documented 
efficacy exists for most mental disorders. Two 
broad types of intervention include psycho- 
social treatments-for example, psycho- 
therapy or counseling-and psychopharma- 
cologic treatments; these often are most 
effective when combined. 
7. In the mental health field, progress in 
developing preventive interventions has been 
slow because, for most major mental disorders, 
there is insufficient understanding about 
etiology (or causes of illness) and/or there is an 
inability to alter the known etiology of a 
particular disorder. Still, some successful 
strategies have emerged in the absence of a full 
understanding of etiology. 
8. About 10 percent of the U.S. adult population 
uses mental health services in the health sector 
in any year, with another 5 percent seeking 
such services from social service agencies, 
schools, religious, or self-help groups. Yet 
critical gaps exist between those who need 
9. 
10. 
service and those who receive service. 
Gaps also exist between optimally effective 
treatment and what many individuals receive in 
actual practice settings. 
Mental illness and less severe mental health 
problems must be understood in a social and 
cultural context, and mental health services 
must be designed and delivered in a manner 
that is sensitive to the perspectives and needs 
of racial and ethnic minorities. 
11. The consumer movement has increased the 
involvement of individuals with mental 
disorders and their families in mutual support 
services, consumer-run services, and advocacy. 
They are powerful agents for changes in service 
programs and policy. 
12. The notion of recovery reflects renewed 
optimism about the outcomes of mental illness, 
including that achieved through an individual’s 
own self-care efforts, and the opportunities 
open to persons with mental illness to 
participate to the full extent of their interests in 
the community of their choice. 
Mental Health and Mental Illness Across 
the lifespan 
The Surgeon General’s report takes a lifespan 
approach to its consideration of mental health and 
mental illness. Three chapters that address, 
respectively, the periods of childhood and 
adolescence, adulthood, and later adult life 
beginning somewhere between ages 55 and 65, 
capture the contributions of research to the breadth, 
depth, and vibrancy that characterize all facets of 
the contemporary mental health field. 
The disorders featured in depth in Chapters 3, 
4, and 5 were selected on the basis of the frequency 
with which they occur in our society, and the 
clinical, societal, and economic burden associated 
with each. To the extent that data permit, the report 
takes note of how gender and culture, in addition to 
age, influence the diagnosis, course, and treatment 
of mental illness. The chapters also note the 
changing role of consumers and families, with 
attention to informal support services (i.e., unpaid 
services), with which many consumers are 
comfortable and upon which they depend for 
information. Persons with mental illness and, often, 
their families welcome a proliferating array of 
support services-such as self-help programs, 
family self-help, crisis services, and advocacy- 
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that help them cope with the isolation, family 
disruption, and possible loss of employment and 
housing that may accompany mental disorders. 
Support services can help to dissipate stigma and to 
guide patients into formal care as well. 
Mental health and mental illness are dynamic, 
ever-changing phenomena. At any given moment, 
a person’s mental status reflects the sum total of 
that individual’s genetic inheritance and life 
experiences. The brain interacts with and re- 
sponds-both in its function and in its very 
structure-to multiple influences continuously, 
across every stage of life. At different stages, 
variability in expression of mental health and 
mental illness can be very subtle or very pro- 
nounced. As an example, the symptoms of 
separation anxiety are normal in early childhood 
but are signs of distress in later childhood and 
beyond. It is all too common for people to 
appreciate the impact of developmental processes 
in children, yet not to extend that conceptual 
understanding to older people. In fact, people 
continue to develop and change throughout life. 
Different stages of life are associated with 
vulnerability to distinct forms of mental and 
behavioral disorders but also with, distinctive 
capacities for mental health. 
Even more than is true for adults, children must 
be seen in the context of their social 
environments-that is, family and peer group, as 
well as that of their larger physical and cultural 
surroundings. Childhood mental health is expressed 
in this context, as children proceed along the arc of 
development. A great deal of contemporary 
research focuses on developmental processes, with 
the aim of understanding and predicting the forces 
that will keep children and adolescents mentally 
healthy and maintain them on course to become 
mentally healthy adults. Research also focuses on 
identifying what factors place some at risk for 
mental illness and, yet again, what protects some 
children but not others despite exposure to the 
same risk factors. In addition to studies of normal 
development and of risk factors, much research 
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focuses on mental disorders in childhood and 
adolescence and what can be done to prevent or 
treat these conditions and on the design and 
operation of service settings best suited to the 
needs experienced by children. 
For about one in five Americans, adulthood-a 
..time for achieving productive vocations and for 
sustaining close relationships at home and in the 
community-is interrupted by mental illness. 
Understanding why and how mental disorders occur 
in adulthood, often with no apparent portents of 
illness in earlier years, draws heavily on the full 
panoply of research conducted under the aegis of 
the mental health field. In years past, the onset, or 
occurrence, of mental illness in the adult years, was 
attributed principally to observable phenomena- 
for example, the burden of stresses associated with 
career or family, or the inheritance of a disease 
viewed to run in a particular family. Such 
explanations now may appear naive at best. 
Contemporary studies of the brain and behavior 
are racing to fill in the picture by elucidating 
specific neurobiological and genetic mechanisms 
that are the platform upon which a person’s life 
experiences can either strengthen mental health or 
lead to mental illness. It now is recognized that 
factors that influence brain development prenatally 
may set the stage for a vulnerability to illness that 
may lie dormant throughout childhood and 
adolescence. Similarly, no single gene has been 
found to be responsible for any specific mental 
disorder; rather, variations in multiple genes 
contribute to a disruption in healthy brain function 
that, under certain environmental conditions, 
results in a mental illness. Moreover, it is now 
recognized that socioeconomic factors affect 
individuals’ vulnerability to mental illness and 
mental health problems. Certain demographic and 
economic groups are more likely than others to 
experience mental health problems and some 
mental disorders. Vulnerability alone may not be 
sufficient to cause a mental disorder; rather, the 
causes of most mental disorders lie in some 
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combination of genetic and environmental factors, 
which may be biological or psychosocial. 
The fact that many, if not most, people have 
experienced mental health problems that mimic or 
even match some of the symptoms of a diagnosable 
mental disorder tends, ironically, to prompt many 
people to underestimate the painful, disabling 
nature of severe mental illness. In fact, 
schizophrenia, mood disorders such as major 
depression and bipolar illness, and anxiety often 
are devastating conditions. Yet relatively few 
mental illnesses have an unremitting course marked 
by the most acute manifestations of illness; rather, 
for reasons that are not yet understood, the 
symptoms assqciated with mental illness tend to 
wax and wane. These patterns pose special 
challenges to the implementation of treatment plans 
and the design of service systems that are optimally 
responsive to an individual’s needs during every 
phase of illness. As this report concludes, 
enormous strides are being made in diagnosis, 
treatment, and service delivery, placing the 
productive and creative possibilities of adulthood 
within the reach of persons who are encumbered by 
mental disorders. 
Late adulthood is when changes in health status 
may become more noticeable and the ability to 
compensate for decrements may become limited. As 
the brain ages, a person’s capacity for certain 
mental tasks tends to diminish, even as changes in 
other mental activities prove to be positive and 
rewarding. Well into late life, the ability to solve 
novel problems can be enhanced through training in 
cognitive skills and problem-solving strategies. 
The promise of research on mental health 
promotion notwithstanding, a substantial minority 
of older people are disabled, often severely, by 
mental disorders including Alzheimer’s disease, 
major depression, substance abuse, anxiety, and 
other conditions. In the United States today, the 
highest rate of suicide-an all-too-common 
consequence of unrecognized or inappropriately 
treated depression- is found in older males. This 
fact underscores the urgency of ensuring that health 
care provider training properly emphasizes skills 
required to differentiate accurately the causes of 
cognitive, emotional, and behavioral symptoms that 
may, in some instances, rise to the level of mental 
disorders, and in other instances be expressions of 
unmet general medical needs. 
As the life expectancy of Americans continues 
to extend, the sheer number-although not neces- 
sarily the proportion-of persons experiencing 
mental disorders of late life will expand, confront- 
ing our society with unprecedented challenges in 
organizing, financing, and delivering effective 
mental health services for this population. An 
essential part of the needed societal response will 
include recognizing and devising innovative ways 
of supporting the increasingly more prominent role 
that families are assuming in caring for older, 
mentally impaired and mentally ill family members. 
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CHAPTER 3 
CHILDREN AND MENTAL HEALTH 
S panning roughly 20 years, childhood and adolescence are marked by dramatic changes in 
physical, cognitive, and social-emotional skills and 
capacities. Mental health in childhood and adolescence 
is defined by the achievement of expected 
developmental cognitive, social, and emotional 
milestones and by secure attachments, satisfying social 
relationships, and effective coping skills. Mentally 
healthy children and adolescents enjoy a positive 
quality of life; function well at home, in school, and in 
their communities; and are free of disabling symptoms 
of psychopathology (Hoagwood et al., 1996). 
The basic principles for understanding health and 
illness discussed in the previous chapter apply to 
children and adolescents, but it is important to 
underscore the often heard admonition that “children 
are not little adults.” Even more than is true for adults, 
children must be seen in the context of their social 
environments, that is, family, peer group, and their 
larger physical and cultural surroundings, Childhood 
mental health is expressed in this context, as children 
proceed through development. 
Development, characterized by periods of transition 
and reorganization, is the focus of much research on 
children and adolescents. Studies focus on normal and 
abnormal development, trying to understand and 
predict the forces that will keep children and 
adolescents mentally healthy and maintain them on 
course to become mentally healthy adults. These 
studies ask what places some at risk for mental illness 
and what protects some but not others, despite exposure 
to the same risk factors. 
In addition to studies of normal development and of 
risk factors, much additional research focuses on 
mental illness in childhood and adolescence and what 
can be done to prevent or treat it. The science is 
challenging because of the ongoing process of 
development. The normally developing child hardly 
stays the same long enough to make stable 
measurements. Adult criteria for illness can be difficult 
to apply to children and ado&cents, when the signs 
and symptoms of mental disorders are often also the 
characteristics of normal development. For example, a 
temper tantrum could be an expected behavior in a 
young child but not in an adult. At some point, 
however, it becomes clearer that certain symptoms and 
behaviors cause great distress and may lead to 
dysfunction of children, their family, and others in their 
social environment. At these points, it is helpful to 
consider serious deviations from expected cognitive, 
social, and emotional development as “mental 
disorders.‘* Specific treatments and services are 
available for children and adolescents with such mental 
disorders, but one cannot forget that these disorders 
emerge in the context of an ongoing developmental 
process and shifting relationships within the family and 
community. These developmental factors must be 
carefully addressed, if one is to maximize the healthy 
development of children with mental disorders, 
promote remediation of associated impairments, and 
enhance their adult outcomes. 
The developmental perspective helps us understand 
how estimated prevalence rates for mental disorders in 
children and adolescents vary as a function of the 
degree of impairment that the child experiences in 
association with specific symptom patterns. For 
example, the MECA Study (Methodology for 
Epidemiology of Mental Disorders in Children and 
Adolescents) estimated that almost 21 percent of U.S. 
children ages 9 to 17 had a diagnosable mental or 
addictive disorder associated with at least minimum 
impairment (see Table 3-l). When diagnostic criteria 
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Table 3-1. Children and adolescents age g-17 with 
mental or addictive disorders, combined 
MECA sample, 6-month (current) prevalence* 
w 
Anxiety Disorders 13.0 
Mood Disorders 6.2 
Disruptive Disorders 10.3 
Substance Use Disorders 2.0 
Any Disorder 20.9 
l Disorders include diagnosis-specific impairment and Child 
Global Assessment Scale 170 (mild global impairment) 
Source: Shaffer et al., 1996a 
required the presence of significant functional impair- 
ment, estimates dropped to 11 percent. This estimate 
translates into a total of 4 million youth who suffer 
from a major mental illness that results in significant 
impairments at home, at school, and with peers. 
Finally, when extreme functional impairment is the 
criterion, the estimates dropped to 5 percent. 
Given the process of development, it is not 
surprising that these disorders in some youth are known 
to wax and wane, such that some afflicted children 
improve as development unfolds, perhaps as a result of 
healthy influences impinging on them. Similarly, other 
youth, formerly only “at risk,” may develop full-blown 
forms of disorder, as severe and devastating in their 
impact on the youth and his or her family as are the 
analogous conditions that affect adults. Characterizing 
such disorders as relatively unchangeable under- 
estimates the potential beneficial influences that can 
redirect a child whose development has gone awry. 
Likewise, characterizing children with mental disorders 
as “only” the victims of negative environmental 
influences that might be fixed if societal factors were 
just changed runs the risk of underestimating the 
severity of these conditions and the need for focused, 
intensive clinical interventions for suffering children 
and adolescents. Thus, the science of mental health in 
childhood and adolescence is a complex mix of the 
study of development and the study of discrete 
conditions or disorders. Both perspectives are useful. 
Each alone has its limitations, but together they 
constitute a more fully informed approach that spans 
mental health and illness and allows one to design 
developmentally informed strategies for prevention and 
treatment. 
Normal Development 
Development is the lifelong process of growth, matur- 
ation, and change that unfolds at the fastest pace during 
childhood and adolescence. An appreciation of normal 
development is crucial to understanding mental health 
in children and adolescents and the risks they face in 
maintaining mental health. Distortions in the process of 
development may lead to mental disorders. This section 
deals with the normal development of understanding 
(cognitive development) in young children and the 
development of social relationships and temperament. 
Theories of Development 
Historically, the changes that take place in a child’s 
psyche between birth and adulthood were largely 
ignored. Child development first became a subject of 
serious inquiry at the beginning of this century but was 
mostly viewed from the perspective of mental disorders 
and from the cultural mainstream of Europe and white 
America. Some of the “grand theories” of child 
development, such as that propounded by Sigmund 
Freud, grew out of this focus, and they unquestionably 
drew attention to the importance of child development 
in laying the foundation for adult mental health. Even 
those theories that resulted from the observation of 
healthy children, such as Piaget’s theory of cognitive 
development, paid little attention to the relationship 
between the development of the “inner self’ and the 
environment into which the individual was placed. In 
contrast, the interaction of an individual with the 
environment was central to the school of thought 
known as behaviorism. 
Theories of normal development, introduced in 
Chapter 2, are presented briefly below, because they 
form the basis of many current approaches to 
understanding and treating mental illness and mental 
health problems in children and adults. These theories 
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have not achieved the broader objective of explaining 
how children grow into healthy adults. More study and 
perhaps new theories will be needed to improve our 
ability to guide healthy child-rearing with scientific 
evidence. 
Development Viewed as a Series of Stages 
Freud and the psychoanalyst Erik Erikson proposed a 
series of stages of development reflecting the 
attainment of biological objectives. The stages are 
expressed in terms of functioning as an individual and 
with others-within the family and the broader social 
environment (particularly in E&son’s theories). (see 
Chapter 2). Although criticized as unscientific and 
relevant primarily to the era and culture in which they 
were conceived, these theories introduced the 
importance of thinking developmentally, that is, of 
considering the ever-changing physical and 
psychological capacities and tasks faced by people as 
they age. They emphasized the concept of “maturation” 
and moving through the stages of life, adapting to 
changing physical capacities and new psychological 
and social challenges. And they described mental 
health problems associated with failure to achieve 
milestones and objectives in their developmental 
schemes. 
These theories have guided generations of 
psychodynamic therapists and child development 
experts. They are important to understand as the 
underpinnings of many therapeutic approaches, such as 
interpersonal therapy, some of which have been 
evaluated and found to be efficacious for some 
conditions. By and large, however, these theories have 
rarely been tested empirically. 
Intellectual Development 
The Swiss psychologist Jean Piaget also developed a 
stage-constructed theory of children’s intellectual 
development. Piaget’s theory, based on several 
decades’ observations of children (Inhelder & Piaget, 
1958), was about how children gradually acquire the 
ability to understand the world around them through 
active engagement with it. He was the first to recognize 
that infants take an active role in getting to know their 
world and that children have a different understanding 
of the world than do adults. The principal limitations of 
Piaget’s theories are that they are descriptive rather 
than explanatory. Furthermore, he neglected variability 
in development and temperament and did not consider 
the crucial interplay between a child’s intellectual 
development and his or her social experiences (Bide11 
& Fischer, 1992). 
Behavioral Development 
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Other approaches to understanding development are 
less focused on the stages ofdevelopment. Behavioral 
psychology focused on observation and measurement, 
explaining development in terms of responses to 
stimuli, such as rewards. Not only did the theories of 
the early pioneers (e.g., Pavlov, Watson, and Skinner) 
generate a number of valuable treatments, but their 
focus on precise description set the stage for current 
programs of research based on direct observation. 
Social learning theory (Bandura, 1977) emphasized role 
models and their impact on children and adolescents as 
they develop. Several important clinical tools came out 
of behaviorism (e.g., reinforcement and behavior 
modification) and social learning theory (cognitive- 
behavioral therapy). Both treatment approaches are 
used effectively with children and adolescents. 
Social and Language Development 
Parent-Child Relationships 
It is common knowledge that infants and, for the most 
part, their principal caretakers typically develop a close 
bond during the first year of life, and that in the second 
year of life children become distressed when they are 
forcibly separated from their mothers. However, the 
clinical importance of these bonds was not fully 
appreciated until John Bowlby introduced the concept 
of atfuchment in a report on the effects of maternal 
deprivation (Bowlby, 1951). Bowlby (1969) postulated 
that the pattern of an infant’s early attachment to 
parents would form the basis for all later social 
relationships. On the basis of his experience with 
disturbed children, he hypothesized that, when the 
mother was unavailable or only partially available 
Children and Mental Health 
Mental Health: A Report of the Surgeon General 
during the first months of the child’s life, the 
attachment process would be interrupted, leaving 
enduring emotional scars and predisposing a child to 
behavioral problems. 
A mother’s bond with her child often starts when 
she feels fetal movements during pregnancy. 
Immediately after birth, most, but by no means all, 
mothers experience a surge of affection that is followed 
by a feeling that the baby belongs to them. This 
experience may not occur at all or be delayed under 
conditions of addiction or postnatal depression (Robson 
& Kumar, 1980; Kumar, 1997). Yet, like all enduring 
relationships, it seems that the relationship between 
mother and child develops gradually and strengthens 
over time. Some infants who experience severe neglect 
in early life may develop -mentally and emotionally 
without lasting consequences, for example, if they are 
adopted and their adoptive parents -provide sensitive, 
stable, and enriching care, or if depressed or substance- 
abusing mothers recover fully (Koluchova, 1972; 
Dennis, 1973; Downey & Coyne, 1990). Unfortunately, 
however, early neglect is all too often the precursor of 
later neglect. When the child remains subject to 
deprivation, inadequate or insensitive care, lack of 
affection, low levels of stimulation, and poor education 
over long periods of time, later adjustment is likely to 
be severely compromised (Dennis, 1973; Curtiss, 
1977). 
In general, it appears that the particular caregiver 
with whom infants interact (i.e., biological mother or 
another) is less important for the development of good 
social relationships than the fact that infants interact 
over a period of time with someone who is familiar and 
sensitive (Lamb, 1975; Bowlby, 1988). One of the 
problems in the later development of children who 
experience early institutionalization or significant 
neglect is that there may have been no opportunities for 
the caretakers and the infants to establish strong and 
mutual attachments in a reciprocating relationship. 
Origins of language 
Recent research has established that successful use of 
language and communication is a cornerstone of 
childhood mental health. Not only are strong language 
capabilities critical to the development of such skills as 
listening and speaking, but they also are fundamental to 
the acquisition of proficient reading and writing 
abilities. In turn, children with a variety of speech and 
language impediments are at increasing risk as their 
language abilities fall behind those of their peers. 
Caretaker and baby start to communicate with each 
other vocally as well as visually during the first months 
of life. Many, but not all, developmental psychologists 
believe that this early pattern of mother-infant 
reciprocity and interchange is the basis on which 
subsequent language and communication develop. 
Various theorists have attemp&d to explain the 
relations between language and cognitive development 
(Vygotsky, 1962; Chomsky, 1965,1975,1986; Bruner, 
197 1; Luria, 197 l), but no single theory has achieved 
preeminence. While a number of theories address 
language development from different perspectives, all 
theories suggest that language development depends on 
both biological and socio-environmental factors. It is 
clear that language competence is a critical aspect of 
children’ s mental health. 
Relationships With Other Children 
To be healthy, children must form relationships not 
only with their parents, but also with siblings and with 
peers. Peer relationships change over time. In the 
toddler period, children’s social skills are very limited; 
they spend most of their time playing side by side 
rather than with each other in a give-and-take fashion. 
As children grow, their abilities to form close 
relationships become highly dependent on their social 
skills. These include an ability to interpret and 
understand other children’s nonverbal cues, such as 
body language and pitch of voice. Children whose 
social skills develop optimally respond to what other 
children say, use eye contact, often mention the other 
child’s name, and may use touch to get attention. If 
they want to do something that other children oppose, 
they can articulate the reasons why their plan is a good 
one. They can suppress their own wishes and desires to 
reach a compromise with other children and may be 
willing to change -at least in the presence of another 
child-a stated belief or wish. When they are with a 
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group of children they do not know, they are quiet but 
observant until they have a feeling for the structure and 
dynamics of the group (Coie & Kuperschmidt, 1983; 
Dodge, 1983; Putallaz, 1983; Dodge & Feldman, 1990; 
Kagan et al., 1998). 
In contrast, children who lack such skills tend to be 
rejected by other children. Commonly, they are 
withdrawn, do not listen well, and offer few if any 
reasons for their wishes; they rarely praise others and 
find it difficult to join in cooperative activities (Dodge, 
1983). They often exhibit features of oppositional 
defiant or conduct disorder, such as regular fighting, 
dominating and pushing others around, or being 
spiteful (Dodge et al., 1990). Social skills improve with 
opportunities to mix with others (Bridgeman, 1981). In 
recent years, knowledge of the importance of children’s 
acquisition of social skills has led to the development 
and integration of social skills training components into 
a number of successful therapeutic interventions. 
Temperament 
During the past two decades, as psychologists began to 
view the child less as a passive recipient of 
environmental input but rather as an active player in the 
process, the importance of temperament has become 
better appreciated (Plomin, 1986). Temperament is 
defined as the repertoire of traits with which each child 
is born; this repertoire determines how people react to 
the world around them. Such variations in character- 
istics were first described systematically by Anna 
Freud from her observations of children orphaned by 
the ravages of World War II. She noticed that some 
children were affectionate, some wanted to be close but 
were too shy to approach adults, and some were 
difficult because they were easily angered and 
frustrated (A. Freud, 1965). 
The first major longitudinal observations on 
temperament were begun in the 1950s by Thomas and 
Chess (1977). They distinguished 10 aspects of 
temperament, but there appear to be many different 
ways to describe temperamental differences (Goldsmith 
et al., 1987). Although there is some continuity in 
temperamental qualities throughout the life span (Chess 
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& Thomas, 1984; Mitchell, 1993), temperament is 
often modified during development, particularly by the 
interaction with the caregiver. For example, a timid 
child can become bolder with the help of parental 
encouragement (Kagan, 1984, 1989). Some traits of 
temperament, such as attention span, goal orientation, 
lack of distractibility, and curiosity, can affect 
cognitive functioning because the more pronounced 
these traits are, the better a child will learn (Campos et 
al., 1983). Of note, it is not always clear whether 
extremes of temperament should be considered within 
the spectrum of mental disorder (for example, shyness 
or anxiety) or whether certain forms of temperament 
might predispose a child to the development of certain 
mental disorders. 
Developmental Psychopathology 
Current Developmental Theory Applied to Child 
Mental Health and lllness 
A number of central concepts and guiding assumptions 
underpin our current understanding of children’s 
mental health and illness. These have been variously 
defined by different investigators (Sroufe & Rutter, 
1984; Cicchetti & Cohen, 1995; Jensen, 1998), but by 
and large these tenets are based on the premise that 
psychopathology in childhood arises from the complex, 
multilayered interactions of specific characteristics of 
the child (including biological, psychological, and 
genetic factors), his or her environment (including 
parent, sibling, and family relations, peer and 
neighborhood factors, school and community factors, 
and the larger social-cultural context), and the specific 
manner in which these factors interact with and shape 
each other over the course of development. Thus, an 
understanding of a child’s particular history and past 
experiences (including biologic events affecting brain 
development) is essential to unravel the why’s and 
wherefore’s of a child’s particular behaviors, both 
normal and abnormal. 
While this principle assumes developmental 
continuities, to the extent that early experiences are 
“brought forward” into the current behavior, it is also 
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important to consider developmental discontinuities, 
where qualitative shifts in the child’s biological, 
psychological, and social capacities may occur. These 
may not be easily discerned or predicted ahead of time 
and may reflect the emergence of new capacities (or 
incapacities) as the child’s psychological self, brain, 
and social environment undergo significant 
reorganization. 
A second precept underlying an adequate 
understanding of children’s mental health and illness 
concerns the innate tendencies of the child to adapt to 
his or her environment. This principle of adaptation 
incorporates and acknowledges children’s “self- 
righting” and “self-organizing” tendencies; namely, that 
a child within a given context naturally adapts (as much 
as possible) to a particular ecological niche, or when 
necessary, modifies that niche to get needs met. When 
environments themselves are highly disordered or 
pathological, children’s adaptations to such settings 
may also be pathologic, especially when compared with 
children’s behaviors within more healthy settings. This 
principle underscores the likelihood that some (but not 
all) “pathologic” behavioral syndromes might be best 
characterized as adaptive responses when the child or 
adolescent encounters difficult or adverse 
circumstances. Notably, this ability to adapt 
behaviorally is reflected at multiple levels, including 
the level of brain and nervous system structures 
(sometimes called neuroplasticity). 
A third consideration that guides both research- 
based and clinical approaches to understanding child 
mental health and illness concerns the importance of 
age and timing factors. For example, a behavior that 
may be quite normal at one age (e.g., young children’s 
distress when separated from their primary caretaking 
figure) can be an important symptom or indicator of 
mental illness at another age. Similarly, stressors or risk 
factors may have no, little, or profound impact, 
depending on the age at which they occur and whether 
they occur alone or with other accumulated risk factors. 
A fourth premise underpinning an adequate 
understanding of children’s mental health and illness 
concerns the importance of the child’s context. Perhaps 
the most important context for developing children is 
their caretaking environment. Research with both 
humans and animals has demonstrated that gross 
disruptions in this critical parameter have immediate 
and long-term effects, not just on the young organism’s 
later social-emotional development but also on physical 
health, long-term morbidity and mortality, later 
parenting practices, and even behavioral outcomes of 
its offspring. Moreover, context may play a role in the 
definition of what actually constitutes psychopathology 
or health. The same behavior in one setting or culture 
might be acceptable and even “normative,” whereas it 
may be seen as pathological in another. 
Yet another principle central to understanding child 
mental health and illness is that normal and abnormal 
developmental processes are often separated only by 
differences of degree. Thus, supposed differences 
between normal and abnormal behavior may be better 
understood by taking into account the differences in the 
amount or degree of the particular behavior, or the 
degree of exposure to a particular risk factor. 
Frequently, no sharp distinctions can be made. 
The virtue of these developmental considerations 
when applied to children is that (a) they enable a 
broader, more informed search for factors related to the 
onset of, maintenance of, and recovery from abnormal 
forms of child behavior; (b) they help move beyond 
static diagnostic terms that tend to reduce the behaviors 
of a complex, developing, adapting, and feeling child to 
an oversimplified diagnostic term; (c) they offer a new 
perspective on potential targets for intervention, 
whether child-focused or directed toward 
environmental or contextual factors; and (d) they 
highlight the possibility of important timing 
considerations: windows of opportunity during a 
child’s development when preventive or treatment 
interventions may be especially effective. 
In the sections that follow, these considerations 
will help the reader understand the important 
differences from chapters focusing principally on 
adults, as well as the unique opportunities for 
intervention that occur because of these differences. 
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Overview of Risk Factors and 
Prevention 
Current approaches to understanding the etiology of 
mental disorders in childhood are driven by empirical 
advances in neuroscience and behavioral research 
rather than by theories. Epidemiological research on the 
factors that make children vulnerable to mental illness 
is important for several reasons: delineating the range 
of risk factors for particular mental disorders helps to 
understand their etiology; the populations most at risk 
can be identified; understanding the relative strength of 
different risk factors allows for the design of 
appropriate prevention programs for children in 
different contexts; and resources can be better allocated 
to intervene so as to maximize their effectiveness. 
Risk Factors 
There is now good evidence that both biological factors 
and adverse psychosocial experiences during childhood 
influence-but not necessarily “cause’‘-the mental 
disorders of childhood. Adverse experiences may occur 
at home, at school, or in the community. A stressor or 
risk factor may have no, little, or a profound impact, 
depending on individual differences among children 
and the age at which the child is exposed to it, as well 
as whether it occurs alone or in association with other 
risk factors. Although children are influenced by their 
psychosocial environment, most are inherently resilient 
and can deal with some degree of adversity. However, 
some children, possibly those with an inherent 
biological vulnerability (e.g., genes that convey 
susceptibility to an illness), are more likely to be 
harmed by an adverse environment, and there are some 
environmental adversities, especially those that are 
long-standing or repeated, that seem likely to induce a 
mental disorder in all but the hardiest of children. A 
recent analysis of risk factors by Kraemer and 
colleagues (1997) has provided a useful framework for 
differentiating among categories of risk and may help 
point this work in a more productive direction. 
Risk factors for developing a mental disorder or 
experiencing problems in social-emotional 
development include prenatal damage fromexposure to 
alcohol, illegal drugs, and tobacco; low birth weight; 
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difficult temperament or an inherited predisposition to 
a mental disorder; external risk factors such as poverty, 
deprivation, abuse and neglect; unsatisfactory relation- 
ships; parental mental health disorder; or exposure to 
traumatic events. 
Biologica/ Influences on Mental Disorders 
It seems likely that the roots of most mental disorders 
lie in some combination of genetic and environmental 
factors-the latter may be biological or psychosocial 
(Rutter et al., 1999). However, increasing consensus 
has emerged that biologic factors exert especially 
pronounced influences on s&era1 disorders in par- 
ticular, including pervasive developmental disorder 
(Piven & O’Leary, 1997), autism (Piven & O’Leary, 
1997), and early-onset schizophrenia (McClellan & 
Werry, in press). It is also likely that biological factors 
play a large part in the etiology of social phobia (Pine, 
1997), obsessive-compulsive disorder (Leonard et al., 
1997), and other disorders such as Tourette’s disorder 
(Leckman et al., 1997). 
Two important points about biological factors 
should be borne in mind. The first is that biological 
influences are not necessarily synonymous with those 
of genetics or inheritance. Biological abnormalities of 
the central nervous system that influence behavior, 
thinking, or feeling can be caused by injury, infection, 
poor nutrition, or exposure to toxins, such as lead in the 
environment. These abnormalities are not inherited. 
Mental disorders that are most likely to have genetic 
components include autism, bipolar disorder, 
schizophrenia, and attention-deficit/hyperactivity 
disorder (ADHD) (National Institute of Mental Health 
[NIMH], 1998). Second, it is erroneous to assume that 
biological and environmental factors are independent of 
each other, when in fact they interact. For example, 
traumatic experiences may induce biological changes 
that persist. Conversely, children with a biologically 
based behavior may modify their environment. For 
example, low-birth-weight infants who have sustained 
brain damage, and thereby become excessively 
irritable, may change the behavior of caretakers in a 
way that adversely affects the caretaker’s ability to 
provide good care. Thus, it is now well documented 
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that a number of biologic risk factors exert important 
effects on brain structure and function and increase the 
likelihood of subsequently developing mental dis- 
orders. These well-established factors include intra- 
uterine exposure to alcohol or cigarette smoke (Nichols 
& Chen, 1981), perinatal trauma (Whitaker et al., 
1997), environmental exposure to lead (Needleman et 
al., 1990), malnutrition of pregnancy, traumatic brain 
injury, nonspecific forms of mental retardation, and 
specific chromosomal syndromes. 
Psychosocial Risk Factors 
A landmark study on risks from the environment 
(Rutter & Quinton, 1977) showed that several factors 
can endanger a child’s mental health. Dysfunctional 
aspects of family life such as severe parental discord, 
a parent’s psychopathology or criminality, 
overcrowding, or large family size can predispose to 
conduct disorders and antisocial personality disorders, 
especially if the child does not have a loving 
relationship with at least one of the parents (Rutter, 
1979). Economic hardship can indirectly increase a 
child’ s risk of developing a behavioral disorder because 
it may cause behavioral problems in the parents or 
increase the risk of child abuse (Dutton, 1986; Link et 
al., 1986; Wilson, 1987; Schorr, 1988). Exposure to 
acts of violence also is identified as a possible cause of 
stress-related mental health problems (Jenkins & Bell, 
1997). Studies point to poor caregiving practices as 
being a risk factor for children of depressed parents 
(Zahn-Waxler et al., 1990). 
The quality of the relationship between infants or 
children and their primary caregiver, as manifested by 
the security of attachment, has long been felt to be of 
paramount importance to mental health across the life 
span. In this regard, the relationship between maternal 
problems and those factors in children that predispose 
them to form insecure attachments, particularly young 
infants’ and toddlers’ security of attachment and 
temperament style and their impact on the development 
of mood and conduct disorders, is of great interest to 
researchers. Many investigators have taken the view 
that the nature and the outcome of the attachment 
process are related to later depression, especially when 
the child is raised in an abusive environment (Toth & 
Cicchetti, 1996), and to later conduct disorder 
(Sampson & Laub, 1993). The relationship of 
attachment to mental disorders has been the subject of 
several important review articles (Rutter, 1995; van 
Llzendoom et al., 1995). 
There is controversy as to whether the key 
determinant of “insecure” responses to strange 
situations stems from maternal behavior or from an 
inborn predisposition to respond to an unfamiliar 
stranger with avoidant behaviors, such as is found in 
socially phobic children (Belsky & Rovine, 1987; 
Kagan et al., 1988; Thompson et’al., 1988; Kagan, 
1994, 1995). Kagan demonstrated that infants who 
were more prone to being active, agitated, and tearful 
at 4 months of age were less spontaneous and sociable 
and more likely to show anxiety symptoms at age 4 
(Snidman et al., 1995; Kagan et al., 1998). These 
findings are of considerable significance, because long- 
term study of such highly reactive, behaviorally 
inhibited infants and toddlers has shown that they are 
excessively shy and avoidant in early childiiood and 
that this behavior persists and predisposes to later 
anxiety (Biederman et al., 1993). There is also some 
controversy as to whether “difficult” temperament in an 
infant is an early manifestation of a behavior problem, 
particularly in children who go on to demonstrate such 
problems as conduct disorder (Olds et al., 1999). One 
analysis of the attachment literature suggests that 
abnormal or insecure forms of attachment are largely 
the product of maternal problems, such as depression 
and substance abuse, rather than of individual 
differences in the child (van llzendoom et al., 1992). 
The relationship between a child’s temperament 
and parenting style is complex (Thomas et al., 1968); 
it may be either protective if it is good or a risk factor 
if it is poor. Thus, a difficult child’s chances of 
developing mental health problems are much reduced 
if he or she grows up in a family in which there are 
clear rules and consistent enforcement (Maziade et al., 
1985), while a child exposed to inconsistent discipline 
is at greater risk for later behavior problems (Werner & 
smith, 1992). 
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Famjjy and Genetic Risk Factors 
As noted above in the relationships between 
temperament and attachment, in some instances the 
relative contributions of biologic influences and 
environmental influences are difficult to tease apart, a 
problem that particularly affects studies investigating 
the impact of family and genetic influences on risk for 
childhood mental disorder. For example, research has 
shown that between 20 and 50 percent of depressed 
children and adolescents .have a family history of 
depression (Puig-Antich et al., 1989; Todd et al., 1993; 
Williamson et al., 1995; Kovacs, 1997b). The exact 
reasons for this increased risk have not been fully 
clarified, but experts tend to agree that both factors 
interact to result in this increased risk (Weissman et al., 
1997). Family research has found that children of 
depressed parents are more than three times as likely as 
children of nondepressed parents to experience a 
depressive disorder (see Birmaher et al., 1996a and 
1996b for review). Parental depression also increases 
the risk of anxiety disorders, conduct disorder, and 
alcohol dependence (Downey & Coyne, 1990; 
Weissman et al., 1997; Wickramaratne & Weissman, 
1998). The risk is greater if both parents have had a 
depressive illness, if the parents were depressed when 
they were young, or if a parent had several episodes of 
depression (Merikangas et al., 1988; Downey &Coyne, 
1990; McCracken, 1992a, 1992b; Mufson et al., 1992; 
Warner et al., 1995; Wickramaratne & Weissman, 
1998). 
Effects of Parental Depression 
Depressed parents may be withdrawn and lack energy 
and consequently pay little attention to, or provide 
inadequate supervision of, their children. Alternatively, 
such parents may be excessively irritable and 
overcritical, thereby upsetting children, demoralizing 
them, and distancing them (Cohn et al., 1986; Field et 
al., 1990). At a more subtle level, parents’ distress- 
being pessimistic, tearful, or threatening suicide-is 
sometimes seen or heard by the child, thereby inducing 
anxiety. Depressed parents may not model effective 
coping strategies for stress; instead of “moving on,” 
some provide an example of “giving up” (Garber & 
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Hilsman, 1992). Depression is also often associated 
with marital discord, which may have its own adverse 
effect on children and adolescents. Conversely, the 
behavior of the depressed child or teenager may 
contribute to family stress as much as being a product 
of it. The poor academic performance, withdrawal from 
normal peer activities, and lack of energy or motivation 
of a depressed teenager may lead to intrusive or 
reprimanding reactions from parents that may further 
reduce the youngster’s self-esteem and optimism. 
The consequences of maternal depression vary with 
the state of development of the child, and some of the 
effects are quite subtle (Cicchetti & Toth, 1998). For 
example, in infancy, a withdrawn or unresponsive 
depressed mother may increase an infant’s distress, and 
an intrusive or hostile depressed mother may lead the 
infant to avoid looking at and communicating with her 
(Cohn et al., 1986). Other studies have shown that if 
infants smiles are met with a somber or gloomy face, 
they respond by showing a similarly somber expression 
and then by averting their eyes (Murray et al., 1993). 
During the toddler stage of development, research 
shows that the playful interactions of a toddler with a 
depressed mother are often briefer and more likely to 
be interrupted (by either the mother or the child) than 
those with a nondepressed parent (Jameson et al., 
1997). Research has shown that some depressed 
mothers are less able to provide structure or to modify 
the behavior of excited toddlers, increasing the risk of 
out-of-control behavior, the development of a later 
conduct disorder, or later aggressive dealings with 
peers (Zahn-Waxler et al., 1990; Hay et al., 1992). A 
depressed mother’s inability to control a young child’s 
behavior may result in the child failing to learn 
appropriate skills for settling disputes without reliance 
on aggression. 
Stressful life Events 
The relationship between stressful life events and risk 
for child mental disorders is well established (e.g., 
Garmezy, 1983; Hammen, 1988; Jensen et al., 1991; 
Garber & Hilsman, 1992), although this relationship in 
children and adolescents is complicated, perhaps 
reflecting the impact of individual differences and 
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developmental changes. For example, there is a 
relationship between stressful life events, such as 
parental death or divorce, and the onset of major 
depression in young children, especially if they occur 
in early childhood and lead to a permanent and negative 
change in the child’s circumstances. Yet findings are 
mixed as to whether the same relationship is true for 
depression in midchildhood or in adolescence 
(Birmaher et al., 1996a and 1996b; Garrison et al., 
1997). 
Childhood Malffeafrnent 
Child abuse is a very widespread problem; it is 
estimated that over 3 million children are maltreated 
every year in the United States (National Committee to 
Prevent Child Abuse, 1995). Physical abuse is 
associated with insecure attachment (Main & Solomon, 
1990), psychiatric disorders such as post-traumatic 
stress disorder, conduct disorder, ADHD (Famularo et 
al., 1992), depression (Kaufman, 1991), and impaired 
social functioning with peers (Salzinger et al., 1993). 
Psychological maltreatment is believed to occur more 
frequently than physical maltreatment (Cicchetti & 
Carlson, 1989); it is associated with depression, 
conduct disorder, and delinquency (Kazdin et al., 1985) 
and can impair social and cognitive functioning in 
children (Smetana & Kelly, 1989). 
Peer and Sibling Influences 
The influence of maladaptive peers can be very 
damaging to a child and greatly increases the likelihood 
of adverse outcomes such as delinquency, particularly 
if the child comes from a family beset by many 
stressors (Friday & Hage, 1976; Loeber & Farrington, 
1998). One way to reduce antisocial behavior in 
adolescents is to encourage such youths to interact with 
better adapted youths under the supervision of a mental 
health worker (Feldman et al., 1983). Sibling rivalry is 
a common component of family life and, especially in 
the presence of other risk factors, may contribute to 
family stresses (Patterson & Dishion, 1988). Although 
almost universal, in the presence of other risk factors it 
may be the origin of aggressive behavior that 
eventually extends beyond the family (Patterson & 
Dishion, 1988). In stressed or large families, parents 
have many demands placed on their time and find it 
difficult to oversee, or place limits on, their young 
children’s behavior. When parental attention is in short 
supply, young siblings squabbling with each other 
attract available attention. In such situations, parents 
rarely comment on good or neutral behavior but do pay 
attention, even if in a highly critical and negative way, 
when their children start to fight; as a result, the act of 
fighting may be inadvertently rewarded. Thus, any 
attention, whether it be praise or physical punishment, 
increases the likelihood that the ‘behavior is repeated. 
Correlations and Interactions Among Risk 
Factors 
Recent evidence suggests that social/environmental risk 
factors may combine with physical risk factors of the 
child, such as neurological damage caused by birth 
complications or low birth-weight, fearlessness and 
stimulation-seeking behavior, learning impairments, 
autonomic underarousal, and insensitivity to physical 
pain and punishment (Raine et al., 1996, 1997, 1998). 
However, testing models of the impact of risk factor 
interactions for the development of mental disorders is 
difficult, because some of the risk factors are difficult 
to measure. Thus, the trend these days is to move away 
from the consideration of individual risk factors toward 
identifying measurable risk factors and their com- 
binations and incorporating all of them into a single 
model that can be tested (Patterson, 1996). 
The next section describes a series of preventive 
interventions directed against the environmental risk 
factors described above. 
Prevention 
Childhood is an important time to prevent mental 
disorders and to promote healthy development, because 
many adult mental disorders have related antecedent 
problems in childhood. Thus, it is logical to try to 
intervene early in children’s lives before problems are 
established and become more refractory. The field of 
prevention has now developed to the point that 
reduction of risk, prevention of onset, and early 
intervention are realistic possibilities. Scientific 
132 
methodologies in prevention are increasingly 
sophisticated, and the results from high-quality 
research trials are as credible as those in other areas of 
biomedical and psychosocial science. There is a 
growing recognition that prevention does work; for 
example, improving parenting skills through training 
can substantially reduce antisocial behavior in children 
(Patterson et al., 1993). 
The wider human services and law enforcement 
communities, not just the mental health community, 
have made prevention a priority. Policymakers and 
service providers in health, education, social services, 
and juvenile justice have become invested in 
intervening early in children’s lives: they have come to 
appreciate that mental health is inexorably linked with 
general health, child care, and success in the classroom 
and inversely related to involvement in the juvenile 
justice system. It is also perceived that investment in 
prevention may be cost-effective. Although much 
research still needs to be done, communities and 
managed health care organizations eager to develop, 
maintain, and measure empirically supported 
preventive interventions are encouraged to use a risk 
and evidence-based framework developed by the 
National Mental Health Association (Mrazek, 1998). 
Some forms of primary prevention are so familiar 
that they are no longer thought of as mental health 
prevention activities, when, in fact, they are. For 
example, vaccination against measles prevents its 
neurobehavioral complications; safe sex practices and 
maternal screening prevent newborn infections such as 
syphilis and HIV, which also have neurobehavioral 
manifestations. Efforts to control alcohol use during 
pregnancy help prevent fetal alcohol syndrome 
(Stratton et al., 1996). All these conditions may 
produce mental disorders in children. 
This section describes several exemplary 
interventions that focus on enhancing mental health and 
primary prevention of behavior problems and mental 
health disorders. Prevention of a disorder or its 
recurrence or exacerbation is discussed together with 
that disorder in other sections of this chapter. 
Prevention strategies usually target high-risk infants, 
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young children, adolescents, and/or their caregivers, 
addressing the risk factors described above. 
Project Head Start 
Project Head Start, though generally conceived of as an 
,early childhood intervention program, is probably this 
country’s best known prevention program. In 1965, 
when it was designed and first implemented in 2,500 
communities, Head Start’s target population was 
economically disadvantaged preschool children. Its 
goal was to improve the social competence of these 
children through an 8-weekcomprehensive intervention 
that included a center-based component and a home 
visit by community aides, focusing on social, health, 
and education services (Karoly et al., 1998). A number 
of psychologists, most notably Jerome Bruner (197 l), 
argued that children can be trained to think in a more 
logical way and that the development of logic is not 
entirely predetermined. Bruner’s views were very 
influential in launching early intervention programs 
such as Head Start. There is now ample evidence that, 
by providing an appropriately stimulating environment, 
significant advances in knowledge and reasoning 
ability can be achieved, 
The program has served over 15 million children 
and has cost $31 billion since its inception (General 
Accounting Office, 1997). It has changed in many ways 
in the intervening years, and there now is considerable 
program variation across localities (Zigler & Styfco, 
1993). Early evaluations of Head Start showed 
promising results in terms of higher IQ scores, but over 
the years many of the findings have met with criticism 
and skepticism. The reason is that there has been no 
national randomized controlled trial to evaluate the 
program as originally designed (Karoly et al., 1998). 
Repeated evaluations of Head Start programs that 
did not employ such a rigorous design (Berrento- 
Clement et al., 1984;.Seitz et al., 1985; Lee et al., 1990; 
Yoshikawa, 1995) have shown that, although focused 
early education can improve test scores, the advantage 
is short-lived. The test scores of children of comparable 
ability who do not receive early childhood education 
quickly catch up with those who have been in Head 
Start programs (Lee et al., 1990). Yet there appear to be 
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more enduring academic outcomes. A review of 36 
studies of Head Start and other early childhood 
programs found them to lower enrollment in special 
education and to enhance rates of high school 
graduation and promotion to the next grade level 
(Barnett, 1995). Head Start and other forms of early 
education offer arguably even more important benefits, 
which do not become apparent until children are older. 
The advantages are mainly social, rather than cognitive, 
and include better peer relations, less truancy, and less 
antisocial behavior (Berrento-Clement et al., 1984; 
Provence, 1985; Seitz et al., 1985; Webster-Stratton, 
1998; Weikart, 1998). Although important from a 
societal perspective, it is not known whether these very 
significant benefits are due to direct effects on the child 
or to the parent education programs that often accom- 
pany Head Start programs (Zigler & Styfco, 1993). 
Carolina Abecedarian Project 
The Carolina Abecedarian Project is an example of an 
early educational intervention for high-risk children 
that has been tested more rigorously than Head Start in 
well-designed, randomized, and controlled trials. It 
addresses the issue of the timing of the intervention, 
that is, when an intervention should begin and *how 
long it should continue. Unlike Head Start, children 
were enrolled in this program at birth and remained in 
it for several years. 
In the Carolina Abecedarian Project, children who 
had been identified at birth as being at high risk for 
school failure on the basis of social and economic 
variables were enrolled in a child-centered prevention- 
oriented intervention program delivered in a day care 
setting from infancy to age 5 (Campbell & Ramey, 
1994’). The preschool intervention operated 8 hours a 
day for 50 weeks a year and included an infant 
curriculum to enhance development and parent 
activities. At elementary school age, a second 
intervention was provided: the children, who were then 
in kindergarten, received 15 home visits a year for 3 
years from a teacher who prepared a home program to 
’ Also see Ramey et al., 1984; Ramey & Campbell, 1984; Horacek 
et al., 1987; Martin et al., 1990. 
supplement the school’s basic curriculum. There were 
significant positive effects ‘from the two-phase 
intervention on intellectual development and academic 
achievement, and these effects were maintained 
through age 12, which was 4 -years after the 
intervention ended. 
Infant Health and Development Program 
The Infant Health and Development Program (IHDP) 
also began at birth and continued for several years and 
was also designed for low-birth-weight and premature 
infants (McCarton et al., 1997’). T&intervention was 
provided until the children reached 3 years of age. It 
included pediatric care, home visits, parent group 
meetings, and center-based schooling 5 days a week 
from 12 months of age to 3 years. At the end of the 
intervention, the group receiving it had significantly 
higher mean IQ scores than did the control group. Of 
note, although children’s behavior problems were not 
targeted by the intervention, mothers of children in the 
intervention group reported significantly fewer 
behavior problems than those in the control group. 
Elmira Prena tallEarly Infancy Project 
The Elmira Prenatal/Early Infancy Project is an 
excellent example of a preventive intervention that 
targeted an at-risk population to prevent the onset of a 
series of health, social, and mental health problems in 
children and in their mothers (Olds et al., 1998 and 
previous years3). This study warrants special attention 
because of its positive and enduring findings, 
randomized, controlled design, cost-benefit analysis, 
and unusually long-term follow up of 15 years. The 
study began by focusing on pregnant women bearing 
their first child in a small, semirural county in upstate 
New York. The children of these women were 
considered high risk because of their mother’s young 
maternal age, single-parent status, or low socio- 
economic level. There were four study groups to which 
* Also see IHDP, 1990; Ramey et al., 1992; Brooks-Gun et al., 
1994a, 1994b; Casey et al., 1994. 
3 Also see Olds et al., 1986a, 1986b, 1988, 1993, 1994a. 1994b, 
1995, and 1997. 
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random assignment was made. The first group received 
developmental screening at ages 1 and 2; the second 
group received screening and free transportation to 
health care; the third group received screening, 
transportation, and nurse home visits once every 2 
weeks during pregnancy; and the fourth group received 
all of the above plus continued home visits by a nurse 
on a diminishing schedule until the infants were 24 
months of age. The intervention focused on parent 
education, enhancement of the women’s informal 
support systems, and linkage with community services. 
Women in both groups receiving home visits from 
nurses had many positive behavioral outcomes 
compared with groups that received screening only or 
screening plus transportation. Among the women at 
highest risk for caregiver dysfunction, those who were 
visited by a nurse had fewer instances of verified child 
abuse and neglect during the first 2 years of their 
children’s lives. They were observed in their homes to 
restrict and punish their children less frequently, and 
they provided more appropriate play materials. There 
were no differences between groups in the rates of new 
cases of child abuse and neglect or in the children’s 
intellectual functioning in the period when the children 
were 25 to 48 months of age. However, nurse-visited 
children had fewer behavioral and parental coping 
problems (as noted in the physician record). Nurse- 
visited mothers were observed to be more involved 
with their children than were mothers in the 
comparison groups. 
A cost-benefit analysis estimated program costs 
(direct costs of nurse visitation, costs of services to 
which nurses linked families, and costs of 
transportation) and benefits (cost outcomes presumed 
to be affected by the program through improved 
maternal and child functioning, such as less use of Aid 
to Families With Dependent Children, Medicaid, food 
stamps, child protective services, and greater tax 
revenues generated by women’s working). Taking a 
time point of 2 years after the program ended, the net 
cost of the program for the sample as a whole was 
S 1,582 per family, but for low-income families, the cost 
Fifteen years after the birth of the index child (13 
years after termination of the intervention), women 
who were visited by nurses during pregnancy and 
infancy had significantly fewer subsequent preg- 
nancies, less use of welfare, fewer verified reports of 
abuse and neglect, fewer behavioral impairments due to 
use of alcohol and other drugs, and fewer arrests. Their 
children, now adolescents, reported fewer instances of 
running away, fewer arrests, fewer convictions and 
violations of probation, fewer lifetime sex partners, 
fewer cigarettes smoked per day, and fewer days having 
consumed alcohol in the last 6 months. The parents of 
these adolescents reported that their children had fewer 
behavioral problems related to use of alcohol and other 
drugs. 
Primary Mental Health Project 
The Primary Mental Health Project (PMHP) is a 42- 
year-old program for early detection and prevention of 
young children’s school adjustment problems. PMHP 
currently operates in approximately 2,000 schools in 
700 school districts nationally and internationally. 
Seven states in the United States are implementing the 
program systematically, based on authorizing 
legislation and state appropriations. 
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PMHP has four key elements: (1) a focus on 
primary grade children; (2) systematic use of brief 
objective screening measures for early identification of 
children in need; (3) use of carefully selected, trained, 
closely supervised nonprofessionals (called child 
associates) to establish a caring and trusting 
relationship with children; and (4) a changing role for 
the school professionals that features selection, 
training, and supervision of child associates, early 
systematic screening, and functioning as program 
coordinator, liaison, and consultant to parents, teachers 
and other school personnel. 
The PMHP model has been applied flexibly to 
diverse ethnic and sociodemographic groups in settings 
where help is most needed. Over 30 programevaluation 
studies, including several at the state level, underscore 
Children and Mental Health 
of the program was recovered with a dividend of $180 
per family. 
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the program’s efficacy (Cowen et al., 1996). Significant 
improvements were detected in children’s grades, 
achievement test scores, and adjustment ratings by 
teachers and child associates. PMHP represents a 
successful mental health intervention that does not 
require highly trained and skilled mental health 
professionals. 
Other Prevention Programs and Strategies 
These and other prevention trials demonstrate that 
positive adaptation and social-emotional well-being in 
children and youth can be enhanced, and that risk 
factors for behavioral and emotional disorders can be 
reduced, by intervening in home, school, day care, and 
other settings. Programs have focused not only on 
mental health problems but also on other problem 
behaviors (Botvin et al., 1995; St.. Lawrence et al., 
1995; Kellam & Anthony, 1998). 
Other prevention trials are showing similar 
benefits. For example, a large-scale, four-site school- 
and home-based prevention trial, known as FastTrack, 
has shown clear benefits in reducing behavior problems 
among high-risk children, as well as in reducing needs 
for and use of special education, which has substantial 
cost-effectiveness implications (Conduct Problems 
Prevention Research Group, 1999a, 1999b). Another 
trial is now under way to test the efficacy of a 
preventive intervention provided to adolescents whose 
parents are currently being treated for depression 
within a health maintenance organization (Clark et al., 
1998). Treatment of mood disorders also has potential 
effectiveness for the primary prevention of suicide, as 
explained in the later section on Depression and 
Suicide in Children and Adolescents. 
Overview of Mental Disorders in 
Children 
A consideration of developmental principles enhances 
understanding of mental illness in children and 
adolescents by reconciling the concept of mental 
disorder as a stable ‘state or condition with the ongoing 
development of the child. According to these 
principles, a mental disorder results from the inter- 
action of a child and his or her environment. Thus, 
mental illness often does not lie within the child alone. 
Within the conceptual framework and language of 
integrative neuroscience, the mental disorder is an 
“emergent property” of the transaction with the 
environment. Proper assessment of a child’s mood, 
thought, and behaviors demands a simultaneous 
consideration of nature and nurture, genes and 
environment, and biology and psychosocial influences. 
These relationships are reciprocal, The brain shapes 
behavior, and learning shapes the brain. 
Mental disorders must be considered within the 
context of the family and peers, school, home, and 
community. Taking the social-cultural environment into 
consideration is essential to understanding mental 
disorders in children and adolescents, as it is in adults. 
However, the changing nature of these environments, 
coupled with the progressively unfolding processes of 
brain de,velopment, makes the emphasis on context, as 
well as development, more complex and more central 
in child mental health (Jensen & Hoagwood, 1997). 
Thus, developmental psychopathology encourages 
consideration of the transactions between the individual 
and the social and physical environment at the same 
time that signs and symptoms of mental disorder are 
considered. Moreover, focusing on diagnostic labels 
alone provides too limited a view of mental disorders 
in children and adolescents. 
General Categories of Mental Disorders of 
Children 
Mental disorders with onset in childhood and 
adolescence are listed in Table 3-2 as they appear in 
DSM-IV. These disorders fall into a number of broad 
categories, most of which apply not just to children but 
across the entire life span: anxiety disorders; attention- 
deficit and disruptive behavior disorders; autism and 
other pervasive developmental disorders; eating 
disorders (e.g., anorexianervosa); elimination disorders 
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Table 3-2. Selected mental disorders of childhood and 
adolescence from the DSM-IV 
I 
Anxiety Disorders 
Attention-Deficit and Disruptive Behavior Disorders 
Autism and Other Pervasive Developmental 
Disorders 
Eating Disorders 
Elimination Disorders 
Learning and Communication Disorders 
Mood Disorders (e.g., Depressive Disorders) 
Schizophrenia 
Tic Disorders 
(e 0 aa.9 enuresis, encopresis); learning and communi- 
cation disorders; mood disorders (e.g., major depres- 
sive disorder, bipolar disorder); schizophrenia; and tic 
disorders (Tourette’s disorder). Several of the more 
common childhood conditions are described below. 
Disorders of anxiety and mood are characterized by 
the repeated experience of intense internal or emotional 
distress over a period of months or years. Feelings 
associated with these conditions may be those of 
unreasonable fear and anxiety, lasting depression, low 
self-esteem, or worthlessness. Syndromes of depression 
and anxiety very commonly co-occur in children. The 
disorders in this broad group include separation anxiety 
disorder, generalized anxiety disorder, post-traumatic 
stress disorder, obsessive-compulsive disorder, major 
depressive disorder, dysthymia, and bipolar disorder 
(DSM-IV). 
Children who suffer from attention-deficit disorder, 
disruptive disorder, and oppositional defiant disorder 
may be inattentive, hyperactive, aggressive, and/or 
defiant; they may repeatedly defy the societal rules of 
the child’s own cultural group or disrupt a well-ordered 
environment such as a school classroom. 
Children with autism and other pervasive 
developmental disorders often suffer from disordered 
cognition or thinking and have difficulty understanding 
and using language, understanding the feelings of 
others, or, more generally, understanding the world 
around them. Such disorders are often associated with 
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severe learning difficulties and impaired intelligence. 
The disorders in this category include the pervasive 
developmental disorders, autism, Asperger’s disorder, 
and Rett’s disorder (DSM-IV). 
It is not uncommon for a child to have more than 
one disorder or to have disorders from more than one of 
these groups. Thus, children with pervasive 
developmental disorders often suffer from ADHD. 
Children with a conduct disorder are often depressed, 
and the various anxiety disorders may co-occur with 
mood disorders. Learning disorders are common in all 
these conditions, as are alcohol and other substance use 
disorders (DSM-IV). 
Assessment and Diagnosis 
As with adults, assessment of the mental function of 
children has several important goals: to learn the 
unique functional characteristics of each individual 
(sometimes called formulation) and to diagnose signs 
and symptoms that suggest the presence of a mental 
disorder. Case formulation helps the clinician 
understand the child in the context of family and 
community. Diagnosis helps identify children who may 
have a mental disorder with an expected pattern of 
distress and limitation, course, and recovery. Both 
processes are useful in planning for treatment and 
supportive care. Both are helpful in developing a 
treatment plan. 
Even with the aid of widely used diagnostic 
classification systems such as DSM-IV (see Chapter 2), 
diagnosis and diagnostic classification present a greater 
challenge with children than with adults for several 
reasons. Children are often unable to verbalize thoughts 
and feelings. Clinicians by necessity become more 
reliant on parents, teachers, and other professionals, 
who may be unable to assess these mental processes in 
children. Children’s normal development also presents 
an ever-changing backdrop that complicates clinical 
presentation. As previously noted, some behaviors may 
be quite normal at one age but suggest mental illness at 
another age. Finally, the criteria for diagnosing most 
mental disorders in children are derived from those for 
adults, even though relatively little research attention 
has been paid to the validity of these criteria in 
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children. Expression, manifestation, and course of a 
disorder in children might be very different from those 
in adults. The boundaries between normal and 
abnormal are less distinct and those between one 
diagnosis and another are fluid. 
Thus, the field of childhood mental health 
historically downplayed diagnosis. This trend began to 
change in the 198Os, in part as a result of developing 
practice guidelines and tougher reimbursement 
standards (Lonigan et al., 1998) and more appropriate 
diagnostic categories and criteria (DSM III, III-R, and 
IV): The body of accumulated research on treatment 
and services referred to throughout this chapter reflects 
the past emphasis on the efficacy of treatments, 
sometimes with and sometimes independently of 
diagnosis. 
Most disorders are diagnosed by. their manifesta- 
tions, that is, by symptoms and signs, as well as 
functional impairment (see Chapter 2). A diagnosis is 
made when the combination and intensity of symptoms 
and signs meet the criteria for a disorder listed in DSM- 
IV. However, diagnosis of childhood mental disorders, 
as noted earlier, is rarely an easy task. Many of the 
symptoms, such as outbursts of aggression, difficulty in 
paying attention, fearfulness or shyness, difficulties in 
understanding language, food fads, or distress of a child 
when habitual behaviors are interfered with, are normal 
in young children and may occur sporadically 
throughout childhood. Well-trained clinicians 
overcome this problem by determining whether a given 
symptom is occurring with an unexpected frequency, 
lasting for an unexpected length of time, or is occurring 
at an unexpected point in development. Clinicians with 
less experience may either overdiagnose normal 
behavior as a disorder or miss a diagnosis by failing to 
recognize abnormal behavior. Inaccurate diagnoses are 
more likely in children with mild forms of a disorder. 
Evaluation Process 
When conducted by a mental health professional, the 
evaluation process usually consists of gathering 
information from several sources: the child, parents, 
teachers, pediatricians, and hospital .records. The 
mental health professional also makes observations of 
the child’s or teenager’s behavior and patterns of 
speech. Very often, additional testing is requested to 
assess the child’s or youth’s intelligence and learning 
abilities. Information about symptoms can be obtained 
more reliably by direct questioning (Gittelman-Klein, 
1978; Gittelman, 1985). 
A full evaluation may take several hours. By that 
time, the professional should have a good 
understanding of how the child is functioning at home, 
at school, and in society and some u6derstanding of the 
family’s characteristics. With this information, the 
child or adolescent psychiatrist, clinical psychologist, 
or social worker can suggest further investigations and, 
if needed, initiate treatment of the child and provide 
counseling to parents and teachers on how to best assist 
the child or teenager to overcome problems. 
There is a dearth of child psychiatrists, appro- 
priately trained clinical child psychologists, or social 
workers (Thomas & Holzer, 1999). Furthermore, many 
barriers remain that prevent children, teenagers, and 
their parents from seeking help from the small number 
of specially trained professionals who are available. 
This places a burden on pediatricians, family 
physicians, and other gatekeepers (such as school 
counselors and primary child care workers) to identify 
children for referral and treatment decisions. These 
gatekeepers are unlikely to have the time and 
specialized training to do an evaluation requiring 
several hours. Their responsibility often is to “triage” 
cases, that is, refer children who need further 
evaluation to specialists. Many, however, are involved 
in treating children and adolescents. They may be 
greatly aided by various diagnostic aids such as brief 
questionnaires that can be completed in the waiting 
room of the pediatrician, the school counseling office, 
or some other community setting. Ideally, these 
screening questionnaires would be accompanied by a 
clear guide on interpreting results and identifying what 
kind of score or behavior would normally indicate a 
need for referral to a professional. 
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Some of the questionnaires that specifically address 
mood disorders are shown in Figure 3-l. Other ques- 
tionnaires, such as the Adolescent Antisocial Self- 
Report Behavior Checklist (Kulik et al., 1968), the 
Eyberg Child Behavior Inventory (Eyberg & Robinson, 
1983), and the Family Interaction Coding Pattern 
(Patterson, 1982), assess antisocial behavior. Adults 
and teachers can use instruments such as the Child 
Behavior Checklist (Achenbach & Edelbrock, 1983) to 
assess a relatively full range of behavioral and 
emotional symptoms and disorders from the perspective 
of adult informants. The Minnesota Multiphasic 
Personality Inventory-2 (MMPI-2; Hathaway & 
McKinley, 1989) and the Millon Adolescent Personal- 
Treatment Strategies 
Children and adolescents receive most of the traditional 
treatments described in Chapter 2, particularly psycho- 
social treatments, such as psychotherapies, and various 
medications. Specific psychosocial and pharma- 
cological treatment approaches are described in 
subsequent sections on specific mental disorders. Much 
of the research, however, has been conducted on adults. 
with results extrapolated to children. Some of the 
treatments, such as interactive or play therapy with 
young children, are unique to clinical work with this 
group, while others, such as individual psychotherapy 
with adolescents, are sim& to clinical work with 
adults. Many of the treatment interventions have been 
Figure 3-1. Questionnaires used to assess childhood mood disorders 
Title 
The Children’s Depression inventory 
WI) 
Beck Depression Inventory 
WI) 
Reynolds Adolescent Depression Scale 
(RADS) 
Children’s Depression Scale 
(CDS) 
Center for Epidemiological Studies of Depression 
(CES-D) 
Kandel Depression Scale 
WDS) 
Zung Self-Rating Depression Scale 
(SDS) 
Diagnostic interview Schedule for Children 
(DISC) 
Source 
Kovacs, 1985 
Beck, Ward, Mendelson, Mock, & Erbaugh, 1961 
Reynolds, 1986 
Tisher & Lang, 1983 
Radloff, 1977 
Kandel 81 Davies, 1982 
Zung, 1965 
Shaffer & Fisher, 1998 
ity Inventory (MAPI) (Millon et al., 1982) 
questionnaires may be used with adolescents to assess 
normal and abnormal personality function. 
The advent of highly structured, computer-driven 
assessment tools, such as the NIMH Diagnostic 
Interview Schedule for Children, which comes in a 
spoken version that can be given through headphones 
to children and/or their parents (Shaffer et al., 1996a), 
promises to greatly improve the ability of professionals 
outside of the mental health field to obtain robust 
diagnostic information, which can guide them in 
decisions about further referral or treatment. 
“packaged” together in particular arrangements for 
delivery in specific clinical settings. 
More attention is being paid to the value of 
multimodal therapies, that is, the combination of 
pharmacological and psychosocial therapies. While 
research is limited, multimodal studies have shown 
benefits for treatment of ADHD (see later section), 
anxiety (Keamey & Silverman, 1998), and depression. 
Tempering the value of psychotherapy as well as 
pharmacotherapy, which is discussed below, is that the 
efficacy of these therapies in the research setting is 
greater than that in the real world. The problem of the 
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gap between research and clinical practice is discussed 
in greater depth elsewhere in this chapter and in 
Chapter 2. 
Psychotherapy 
The major types of psychotherapy for children are 
supportive, psychodynamic, cognitive-behavioral, inter- 
personal, and family systemic. With the exception of 
the latter, these therapies originally were developed for 
adults and then tailored for use in‘children. 
Most psychotherapies are deemed effective for 
children and adolescents because they improve more 
than with no treatment, as discussed later in this 
chapter under Treatment Interventions (Casey & 
Berman, 1985; Hazelrigg et al., 1987; Weisz et al., 
1987; Kazdin et al., 1990; Baer & Nietzel, 1991; 
Grossman &Hughes, 1992; Shadish et al., 1993; Weisz 
& Weiss, 1993; Weisz et al., 1995). But despite this 
strong body of research on children comparing 
treatment with no treatment, far less attention has been 
paid to, and guidance provided about, the efficacy of a 
given psychotherapy for a specific diagnosis (Lonigan 
et al., 1998). In other words, it is not clear which 
therapies are best for which conditions. The American 
Psychological Association sought to rectify this 
problem by convening two task forces, the second of 
which exhaustively reviewed the professional literature 
to evaluate the strength of the evidence for treating 
individual disorders in children. The second task force 
refined two sets of criteria against which to evaluate the 
evidence: the first, and more rigorous, set of criteria 
was for Well-Established Psychosocial Interventions, 
while the other was for Probably Eficacious Psycho- 
social Znterventions (Lonigan et al., 1998). The 
findings of the task force’s comprehensive evaluation 
were published, disorder by disorder, in an entire issue 
of the Journal of Clinical Child Psychology in June 
1998. While findings relating to individual disorders 
are presented in the next section of this chapter, this 
was the overarching conclusion: “. . . the majority of 
these [psychosocial] interventions do not meet criteria 
for the highest level of empirical support, the well- 
established criteria” (Lonigan et al., 1998). The 
problem, according to these authors, is that too few 
well-controlled studies have been performed for each 
disorder. To meet the criteria for a Well-Established 
Psychosocial Intervention, there must be at least two 
well-conducted group-design studies conducted by 
different teams of researchers, among other criteria.4 
Hereafter, these criteria are referred to as the American 
Psychological Association Task Force Criteria. 
Some other general points are warranted about the 
value of psychotherapies for children. Psychotherapies 
are especially important alternatives for those children 
who are unable to tolerate, or whose parents prefer 
them not to take, medications. They also are important 
for conditions for which there are no’medications with 
well-documented efficacy. They also are pivotal for 
families under stress from a child’s mental disorder. 
Therapies can serve to reduce stress in parents and 
siblings and teach parents strategies for managing 
symptoms of the mental disorder in their child (see 
later sections on Disruptive Disorders and Home-Based 
Services). 
Psychopharmacology 
Dramatic increases have occurred over the past decade 
in the use of pharmacological therapies for children and 
adolescents with mental disorders, but research has 
lagged behind the surge in their use (Jensen et al., 
1999). Our gaps in knowledge span three areas in 
particular. First, for most prescribed medications, there 
are no studies of safety and efficacy for children and 
adolescents. This is true for medications for mental 
disorders as well as for somatic disorders. Depending 
on the specific medication, evidence may be lacking for 
short-term, or most commonly, for long-term safety and 
efficacy. The problem is even more pronounced with 
newer medications, most of which have been 
introduced into the market for adults. Only in the case 
of psychostimulants for ADHD is there an adequate 
body of research on their safety and efficacy in children 
and adolescents, albeit short-term information only 
(Greenhill et al., 1998) (see later section on ADHD). 
Second, there is often limited information about 
pharmacokinetics, that is, drug concentrations in body 
4 The criteria are listed in Chapter 1. 
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fluids and tissues over time (Clein & Riddle, 1996). 
Most of what is known about pharmacokinetics comes 
from studies of adults. But pediatric pharmacokinetic 
studies are crucial to identifying the appropriate dose 
and dose frequency for children of different ages and 
body sizes. Third, the combined effectiveness of 
pharmacological and psychosocial treatments, that is, 
multimodal treatments, is seldom studied. Multimodal 
treatments have the potential to yield dose reductions 
in pharmacological treatments, thereby improving the 
side-effect profile, parental acceptance, and patient 
compliance. 
The dearth of research on children and adolescents 
has allowed for widespread “off-label” use of 
medications. This .means that, for this population, 
physicians who are prescribing a given drug do not 
have the benefit of research and drug labeling 
information developed by the sponsor and approved by 
the Food and Drug Administration (FDA). Under U.S. 
food and drug law, a drug is approved by the FDA only 
for a defined population. Yet after its approval and 
market availability, physicians are at liberty to 
prescribe it for anyone, even though the sponsor only is 
allowed to market the drug for the approved population 
(which typically is adults) (FDA, 1998). Fortunately, 
there is a large body of clinical experience with 
children and adolescents to guide prescribing practices, 
despite few controlled studies (Green, 1996). 
There are several reasons for the paucity of 
research on medications for children and adolescents. 
One is greater caution on the part of both the medical 
profession and parents to experiment with children or 
to prescribe drugs with potentially serious side effects. 
Another reason is the need for compliance with dosing 
requirements of the clinical trial protocol. When 
children are research subjects, enforcing compliance is 
generally perceived to be more difficult. Researchers 
must rely on parents to assess the degree of 
compliance. A final reason is the cost of research. Once 
drugs have reached the market for adults, pharmaceuti- 
cal companies have fewer financial incentives to 
conduct expensive and methodologically demanding 
studies with children, to whom drugs may be given 
Despite the relative lack of information concerning 
safety and efficacy of psychotropic agents in children, 
six scientific reviews have been completed recently; 
these reviews comprehensively surveyed all available 
published research concerning the safety and efficacy 
of psychotropic medication, focusing on six general 
classes of medication: the psychostimulants (Greenhill 
et al., 1998), the mood stabilizers and antimanic agents 
(Ryan et al., 1999), the selective serotonin reuptake 
inhibitors (SSRIs) (Emslie et al., 1999), antidepressants 
(Geller et al., 1998), antipsychotic agents (Campbell et 
al., 1999), and other miscellaneous agents (Riddle et 
al., 1998). 
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Review of this comprehensive body of research 
evidence indicates strong support for the safety and 
efficacy of several classes of agents for several 
conditions, specifically, SSRIs for childhood/ 
adolescent obsessive-compulsive disorder, and the 
psychostimulants for ADHD. For many other disorders 
and medications, however, information fromrigorously 
controlled trials is sparse or altogether absent (see 
Figure 3-2). Further, only in the area of ADHD is in- 
formation now emerging on longer term safety and 
efficacy, as well as on the merits of combining 
psychopharmacologic and psychotherapeutic 
treatments. 
Given the inadequacy of efficacy data for most 
nonstimulant psychotropics, studies are needed for the 
majority of agents. However, efficacy data appear to be 
most urgently needed for SSRIs, mood stabilizers, and 
novel antipsychotics, since the level of usage of these 
medications appears to be highest among the growing 
list of psychotropic medications used in youth (Fisher 
& Fisher, 1996). In contrast to adult psycho- 
pharmacology that is focusing on differential efficacy 
and speed of onset of these categories of psychotropics, 
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through off-label prescribing. The problem has been 
significant enough to have galvanized Congress into 
passing legislation, the FDA Modernization Act of 
1997, to create financial incentives for drug sponsors to 
conduct research with pediatric subjects [FDA, 1999 
Title 21 USC 505A(g)]. The FDA Modernization Act 
may help alleviate this problem, but it is too early to 
tell. 
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Figure 3-2. Grading the Level of Evidence for Efficacy of Psychotropic Drugs in Children 
Estimated 
Frequency 
Level of Supportlng Data of Use 
j Short-Term j Long-Temt j Short-Term j Long-Term I 
Category Indication t Efficacy f Efficacy f Safety j Safety j Rank 
I I I I I 
Stimulants ADHD I A I B I A I A I 1 
Selective Serotonin Major depression B j C j A j C j 
Reuptake inhibitors OCD 
Anxiety disorders 
I ; I ; I ; I ; I 2 
I I I I I 
Central Adrenergic Tourette syndrome 
Agonists ADHD 
I F I E I ; I “c I 3 
I I I I I 
Valproate and Bipolar disorders 
Carbamazepine Aggressive conduct ) c 
.c I c I A I A I 4 
I C I A I A I I 
Tricyclic Major depression 
Antidepressants ADHD 
I ; I g I ; I ; I 5 
I I I 
Benzodiazepines Anxiety disorders I C C C I C I 6 
Antipsychotics Childhood schizophrenia I I I I I 
and psychoses 
Tourette syndrome 
I ; I g I ; I ; I 7 
I I I I I I I 
Lithium Bipolar disorders 
Aggressive conduct 
1 ; 1 ; 1 ; 1 ; 1 8 
I I I I I 
Key: A = 12 randomized controlled trials (RCTs). 
B = At least 1 RCT. 
C = Clinical opinion, case reports, and uncontrolled trials. 
Source: Jensen et al., 1999 
pediatric psychopharmacology needs basic studies of 
efficacy. 
Additional information on specific medication 
treatment is presented in the succeeding sections, 
providing more detailed discussion of particular 
disorders. Indepth information is presented on two 
disorders where a great deal of research has been done, 
namely, ADHD and major depressive disorder, 
followed by briefer discussions of other childhood 
mental disorders. 
Attention-Deficit/Hyperactivity 
Disorder 
As its name implies, attention-deficit/hyperactivity 
disorder (ADHD) is characterized by two distinct sets 
of symptoms: inattention and hyperactivity-impulsivity 
. 
(see Table 3-3). Although these problems usually occur 
together, one may be present without the other to 
qualify for a diagnosis (DSM-IV). Inattention or 
attention deficit may not become apparent until a child 
enters the challenging environment of elementary 
school. Such children then have difficulty paying 
attention to details and are easily distracted by other 
events that are occurring at the same time; they find it 
difficult and unpleasant to finish their schoolwork; they 
put off anything that requires a sustained mental effort; 
they are prone to make careless mistakes, and are 
disorganized, losing their school books and assign- 
ments; they appear not to listen when spoken to and 
often fail to follow through on tasks (DSM-IV; Waslick 
8z Greenhill, 1997). 
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fable 3-3. DSM-IV criteria for Attention-Deficit/Hyperactivity Disorder 
7 
’ A. 
, 
1 
Either (1) or (2): 
(1) six (or more) of the following symptoms of inattention have persisted for at least 6 months to a degree that 
is maladaptive and inconsistent with developmental level: 
lnatten tion 
(a) often fails to give close attention to details or makes careless mistakes in schoolwork, work, or other 
activities 
(b) often has difficulty sustaining attention in tasks or play activities 
(c) often does n?t seem to listen when spoken to directly 
(d) often does not follow through on instructions and fails to finish schoolwork, chores, or duties in the 
workplace (not due to oppositional behavior or failure to understand instructions) 
(e) often has dlff iculty organizing tasks and activities 
(f) often avoids, dislikes, or is reluctant to engage in tasks that require sustained mental effort (such as 
schoolwork or homework) 
(g) ;)fte;)loses things necessary for tasks or activities (e.g., toys, school assignmen;s, pencils, books, or 
(h) is often easily distracted by extraneous stimuli 
(i) is often forgetful in daily activities 
(2) six (or more) of the following symptoms of hyperactivity-impulsivity have persisted for at least 6 months 
to a degree that is maledaptive and inconsistent with developmental level: 
Hyperactivity 
(a) often fidgets with hands or feet or squirms in seat 
(b) often leaves seat in classroom or in other situations in which remaining seated is expected 
(c) often runs about or climbs excessively in situations in which it is inappropriate (in adolescents or adults, 
may be limited to subjective feelings of restlessness) 
(d) often has difficulty playing or engaging in leisure activities quietly 
(e) is often “on the go” or often acts as if “driven by a motor” 
(f) often talks excessively ’ 
lmpulsivity 
(g) often blurts out answers before questions have been completed 
(h) often has difficulty awaiting turn 
(i) often interrupts or intrudes on others (e.g., butts into conversations or games) 
I 
B. Some hyperactive-impulsive or inattentive symptoms that cause impairment were present before age 7 years. ) 
C. Some impairment from the symptoms is present in two or more settings (e.g., at school [or work] and at home). I 
D. There must be clear evidence of clinically significant impairment in social, academic, or occupational 
functioning. 
E. The symptoms do not occur exclusively during the course of a pervasive developmental disorder, 
schizophrenia, or other psychotic disorder and are not better accounted for by another mental disorder 
(e.g., mood disorder, anxiety disorder, dissociative disorder, or a personality disorder). 
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The symptoms of hyperactivity may be apparent in 
very young preschoolers and are nearly always present 
before the age of 7 (Halperin et al., 1993; Waslick & 
Greenhill, 1997). Such symptoms include fidgeting, 
squirming around when seated, and having to get up 
frequently to walk or run around. Hyperactive children 
have difficulty playing quietly, and they may talk 
excessively. They often behave in an inappropriate and 
uninhibited way, blurting out answers in class before 
the teacher’s question has been completed, not waiting 
their turn, and interrupting often or intruding on others’ 
conversations or games (Waslick & Greenhill, 1997). 
Many of these symptoms occur from time to time 
in normal children. However, in children with ADHD 
they occur very frequently and in several settings, at 
home and at school, or when visiting with friends, and 
they interfere with the child’s functioning. Children 
suffering from ADHD may perform poorly at school; 
they may be unpopular with their peers, if other 
children perceive them as being unusual or a nuisance; 
and their behavior can present significant challenges 
for parents, leading some to be overly harsh (DSM-IV). 
Inattention tends to persist through childhood and 
adolescence into adulthood, while the symptoms of 
motor hyperactivity and impulsivity tend to diminish 
with age. Many children with ADHD develop learning 
difficulties that may not improve with treatment 
(Mannuzza et al., 1993). Hyperactive behavior is often 
associated with the development of other disruptive 
disorders, particularly conduct and oppositional-defiant 
disorder (see Disruptive Disorders). The reason for the 
relationship is not known. Some believe that the 
impulsivity and heedlessness associated with ADHD 
interfere with social learning or with close social bonds 
with parents in a way that predisposes to the 
development of behavior disorders (Barkley, 1998). 
Even though a great many children with this 
disorder ultimately adjust (Mannuzza et al., 1998), 
‘some-especially those with an associated conduct or 
oppositional-defiant disorder-are more likely to drop 
out of school and fare more poorly in their later careers 
than children without ADHD. As they grow older, 
some teens who have had severe ADHD since middle 
childhood experience periods of anxiety or depression. 
This seems to be especially common in children whose 
predominant symptom is inattention (Morgan et al., 
1996). Excellent reviews of ADHD can be found in 
DSM-IV and other sources.’ 
Prevalence 
ADHD, which is the most commonly diagnosed 
behavioral disorder of childhood, occurs in 3 to 5 
percent of school-age children -in ,a 6-month period 
(Anderson et al., 1987; Bird et al., 1988; Esser et al., 
1990; Pelham et al., 1992; Shaffer et al., 1996c; 
Wolraich et al., 1996). Pediatricians report that 
approximately 4 percent of their patients have ADHD 
(Wolraich et al., 1990), but in practice the diagnosis is 
often made in children who meet some, but not all, of 
the criteria recommended in DSM-IV (Wolraich et al., 
1990) (see also Treatment later in this section). Boys 
are four times more likely to have the illness than girls 
are (Ross & Ross, 1982). The disorder is found in all 
cultures, although prevalences differ; differences are 
thought to stem more from differences in diagnostic 
criteria than from differences in presentation 
(DSM-IV). 
Causes 
The exact etiology of ADHD is unknown, although 
neurotransmitter deficits, genetics, and perinatal 
complications have been implicated. In the early post- 
World War Ii years, a number of pediatricians, 
neurologists, and child psychiatrists noted that brain- 
damaged children were often hyperactive (Strauss & 
Lehtinen, 1947; Eisenberg, 1957; Laufer & Denhoff, 
1957). These observations led to the diagnostic concept 
of “minimal brain damage” (Wender, 197 l), which was 
thought to be characterized by hyperactivity, inat- 
tention, learning difficulties, and a wide variety of 
behavior problems. However, large epidemiological 
studies (Rutter & Quinton, 1977) of grossly brain- 
damaged children with cerebral palsy, epilepsy, and so 
5 Taylor, 1994; Cantwell, 1996; Waslick & Greenhill, 1997; 
Barkley, 1998; and MH Consensus Statement 110, 1998. 
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forth, did not find an excess of hyperactivity, and more 
recent imaging studies have found no evidence of gross 
brain damage in children with ADHD (Swanson et al., 
1998). The past view that ADHD is a form of minimal 
brain damage has therefore been abandoned by experts. 
Many brain-damaged children are, if anything, 
significantly underactive. 
In the late 1970s it was postulated that the core 
problem in hyperkinetic children was one of inattention 
(Douglas & Peters, 1979). This view led, in 1980, to 
the adoption, in the official DSM-III (American 
Psychiatric Association, 1980) nomenclature, of the 
new diagnostic label attention-deficit disorder. 
Because the symptoms of ADHD respond well to 
treatment with stimulants, and because stimulants 
increase the availability of the neurotransmitter 
dopamine, the “dopamine hypothesis” has gained a 
wide following. The dopamine hypothesis posits that 
ADHD is due to inadequate availability of dopamine in 
the central nervous system. The neurotransmitter 
dopamine plays a key role in initiating purposive 
movement, increasing motivation and alertness, 
reducing appetite, and inducing insomnia, effects that 
are often seen when a child responds well to 
methylphenidate. The dopamine hypothesis has thus 
driven much of the recent research into the causes of 
ADHD. 
The fact that ADHD runs in families suggests that 
inheritance is an important risk factor. Between 10 and 
35 percent of children with ADHD have a first-degree 
relative with past or present ADHD. Approximately 
one-half of parents who had ADHD have a child with 
the disorder (Biederman et al., 1995). Over the past 
decade, a large number of twin studies have shown that, 
when ADHD is present in one twin, it is significantly 
more likely also to be present in an identical twin than 
in a fraternal twin (Goodman & Stevenson, 1989). 
These findings have led geneticists to estimate that 
genes are important in a high proportion of children 
with ADHD. 
Research to pinpoint abnormal genes is honing in 
on two genes: a dopamine-receptor (DRD) gene on 
chromosome 11 and the dopamine-transporter gene 
(DATl) on chromosome 5 (Cook et al., 1995; Smalley 
et al., 1998). Several studies have found evidence that 
children with ADHD have genetic variations in one of 
the dopamine-receptor genes (DRD4), although the 
.largest of these studies suggests that the presence of 
such a variation is associated with only a modest 
increase in the risk of developing ADHD (Smalley et 
al., 1998). Several other studies have found evidence 
for abnormalities of the dopamine-transporter gene 
(DATl) in children with very severe forms of ADHD 
(Cook et al., 1995; Gill et.al, 1997; Waldman et al,, 
1998). 
Yet for most children with ADHD, the overall 
effects of these gene abnormalities appear small, 
suggesting that nongenetic factors also are important. 
Although none of the many imaging studies have found 
evidence of gross brain damage, some investigators 
have suggested that exposure to toxins, such as lead, or 
episodes of oxygen deprivation for the fetus, as may 
occur during some complications of pregnancy, may 
adversely affect dopamine-rich areas of the brain. 
These theories support observations that hyperactivity 
and inattention are more common in children whose 
mothers smoked during pregnancy (Nichols & Chen, 
1981), in children who have been exposed to high 
quantities of lead (Needleman et al., 1990), and in 
children who had a lack of oxygen in the neonatal 
period (Whittaker et al., 1997). 
Some investigators have noted that the parents of 
hyperactive children are often overintrusive and 
overcontrolling (Carlson et al., 1995). It has therefore 
been suggested that such parental behavior is another 
possible risk factor for ADHD. However, others have 
noted that, when children are treated with 
methylphenidate, there is a reduction in parental 
negativity and intrusiveness. This suggests that the 
observed overintrusive and overcontrolling behavior of 
the parent is a response to the child’s behavior rather 
than the cause (Barkley et al., 1985). 
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Treatment 
The American Academy of Child and Adolescent 
Psychiatry (AACAP) published “practice parameters” 
(i.e., guidelines for clinical practice) on the diagnosis 
and treatment of ADHD. The AACAP parameters 
include an extensive literature review, detailed 
descriptions of the clinical presentation of the disorder, 
and recommendations for treatment. The practice 
parameters state that “the cornerstones of treatment are 
support and education of parents, appropriate school 
placement, and pharmacology” (AACAP, 199 1). These 
practice parameters evolved out of research relating to 
two major types of treatment: pharmacological 
treatment and psychosocial treatment, particularly 
behavioral modification, as well as multimodal 
treatment, the combination of psychosocial and 
pharmacological treatments. 
Pharmacological Treatment 
Psychostimulants 
Pharmacological treatment with psychostimulants is the 
most widely studied treatment for ADHD. Stimulant 
treatment has been used for childhood behavioral 
disorders since the 1930s (Bradley, 1937). 
Psychostimulants are highly effective for 75 to 90 
percent of children with ADHD. At least four sep&ate 
psychostimulant medications consistently reduce the 
core features of ADHD in literally hundreds of 
randomized controlled trials: methylphenidate, dextro- 
amphetamine, pemoline, and a mixture of amphetamine 
salts (Spencer et al., 1995; Greenhill, 1998a, 1998b; 
Greenhill et al., 1998). 
These medications are metabolized, leave the body 
fairly quickly, and work for 1 to 4 hours. Administra- 
tion is timed to meet the child’s school schedule, to 
help the child pay attention and meet his or her 
academic demands, and to mitigate side effects. These 
medications have their greatest effects on symptoms of 
hyperactivity, impulsivity, and inattention and the 
associated features of defiance, aggression, and 
oppositionality. They also improve classroom 
performance and behavior and promote increased 
interaction with teachers, parents, and peers. Small 
effe.cts were found on learning and school achievement 
(see reviews by Barkley, 1990; Pelham, 1993; Swanson 
et a1.,1993, 1995b; Greenhill et al., 1998; Cantwell, 
1996a; Spencer et al., 1996.) However, psychostimu- 
lants do not appear to achieve long-term changes in 
outcomes such as peer relationships, social or academic 
skills, or school achievement (Pelham et al., 1998). 
Children who do not respond to one stimulant may 
respond to another (Elia et al., 199 1; Elia & Rapoport, 
1991). Children should be reevaluated without the 
medication to see if stimulant treatment is still 
indicated. Many families choose to have their child 
take a “drug holiday” on weekends and vacations to 
reduce overall exposure, but the utility of this strategy 
has not been demonstrated (AACAP, 1991). 
Dosing 
Stimulants are usually started at a low dose and 
adjusted weekly (AACAP, 1991). A recent study 
demonstrated that the practice of dosing 
methylphenidate on the basis of body weight fails to 
predict the optimal dose of medication (Rapport & 
Denney, 1997). One of the goals of the recently 
completed NIMH Multimodal Treatment Study of 
ADHD (described more fully below) was to develop 
medication strategies to guide “best dose,” dose 
changes, management of side effects, and integration 
with other treatments (Greenhill et al., 1996). 
Side Effects 
Common stimulant side effects include insomnia, 
decreased appetite, stomach aches, headaches, and 
jitteriness. Some children may develop tics, but a recent 
study suggests that they disappear with continued 
treatment (Gadow et al., 1995). Rebound activation 
(i.e., a sudden increase in attention deficit and 
hyperactivity) has been noted anecdotally after the 
child’s last dose of medication wears off (Johnston et 
al., 1988). Most of the side effects are mild, recede over 
time, and respond to dose changes. Children rarely 
experience cognitive impairment, which, if it does 
occur, can be resolved with reduction or cessation of 
the drug (Cantwell, 1996). A few cases of psychosis 
have been reported. Pemoline has been associated with 
hepatotoxicity, so monitoring of liver function is 
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necessary. Two studies have shown no long-term 
effects of stimulants on later height or weight (Klein & 
Mannuzza, 1988; Vincent et al., 1990). Nonetheless, 
regular precautionary monitoring of weight and height 
for children on stimulants is recommended. 
Other Medications 
For children with ADHD who do not respond to 
stimulants (10 to 30 percent) or cannot tolerate the side 
effects, there are other .useful medications. The 
antidepressant bupropion has been found to be superior 
to placebo, although the response is not as strong as 
that found with stimulants (Cantwell, 1998). Bupropion 
can also be used as an adjunct to augment stimulant 
treatment. Well-controlled trials have shown tricyclic 
antidepressants to be superior to placebo but less 
effective than stimulants (Elia et al., 1991; Elia & 
Rapoport, 1991). Reports of sudden death of a few 
children in the early 1990s on the tricyclic compound 
desipramine led to great caution with the use of 
tricyclics in children (Riddle et al., 1991). 
Considerable controversy surrounds the use of 
central alpha-adrenergic blocking drugs, such as 
clonidine and guanfacine, to treat ADHD. There is 
some evidence that clonidine is effective for ADHD 
when it occurs with a tic disorder (Hunt, 1987; Hunt et 
al., 1990, 1995). Caution is warranted in’view of the 
four cases of sudden death that have been reported in 
children taking methylphenidate and clonidine together 
and of a number of reports of nonfatal cardiac side 
effects in children taking clonidine alone or in 
combination (Swanson et al., 1995a). 
Neuroleptics have been found to be occasionally 
effective (Green, 1995), yet the risk of movements 
disorders, such as tardive dyskinesia, makes their use 
problematic. Lithium, fenfluramine, or benzodiazapines 
have not been found to be effective treatments for 
ADHD (Cantwell, 1996a; Green, 1995), nor have 
SSRIs, such as fluoxetine (Goldman et al., 1998). 
Furthermore, more than 20 studies have shown that 
dietary manipulation (e.g., the Feingold diet) is not 
efficacious (Mattes & Gittelman, 1981), and controlled 
studies failed to demonstrate that sugar exacerbates the 
symptoms of children with ADHD (Milich & Pelham, 
1986). 
Psychosocial Treatment 
Important options for the management of ADHD are 
psychosocial treatments, particularly in the form of 
training in behavioral techniques for parents and 
teachers. Behavioral techniques, which are described 
more fully below, typically employ “time-out,” point 
systems and contingent attention (adults reinforcing 
appropriate behavior by paying attention to it). 
Psychosocial treatments are useful for the child who 
does not respond to medication at all or for whom the 
therapeutic benefits of the midication have worn off 
and for the child who responds only partially to 
medication or cannot tolerate medication. In addition, 
some families express a strong preference not to use 
medication. Even children who are receiving 
medication may continue to have residual ADHD 
symptoms or symptoms from other disorders, such as 
oppositional defiant disorder or depression, which 
make specialized child management skills necessary 
and helpful (see next section, Multimodal Treatments). 
Furthermore, children with ADHD can present a 
challenge that puts significant stress on the family. 
Skills training for parents can help reduce this stress on 
parents and siblings. 
Behavioral Approaches 
The main psychosocial treatments for ADHD are 
behavioral training for parent and teacher, as well as 
systematic programs of contingency management (this 
behavioral technique is described in more detail in the 
Treatment section later in this chapter). Of these 
options, systematic programs of intensive contingency 
management conducted in specialized classrooms or 
summer camps with the setting controlled by highly 
trained individuals is the most effective (Abramowitz 
et al., 1992; Carlson et al., 1992; Pelham & Hoza, 
1996). The efficacy of behavioral training of teachers 
is well-established, while the evidence for parent 
training is less solid, according to the criteria, noted 
earlier, promulgated by the American Psychological 
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Association Task Force (Pelham et al., 1998). There is, 
however, indirect support for the effectiveness of 
parent training in the literature, demonstrating the 
efficacy of parent training for children with 
oppositional defiant disorder who share many 
characteristics with children who have ADHD (see 
section on Disruptive Disorders). 
A number of studies have compared parent training 
(Gittelman et al., 1980; Firestone et al., 1986; Horn et 
al., 1987, 1990, 1991; Pelham et al., 1988) or school- 
based behavioral modification (Gittelman et al., 1980; 
Pelham et al., 1988) with the use of stimulants. Most of 
the studies are of outpatient behavioral therapy 
programs in which parents meet in groups and are 
taught behavioral techniques such as time out, point 
systems, and contingent attention. Teachers are taught 
similar classroom strategies, as well as the use of a 
daily report card for parents that evaluates the child’s 
in-school behavior. The improvements in the symptoms 
of ADHD achieved with psychosocial treatments are 
not as large as those found with psychostimulants 
(Pelham et al., 1998). Behavioral interventions tend to 
improve targeted behaviors or skills but are not as 
helpful in reducing the core symptoms of inattention, 
hyperactivity, or impulsivity. Questions remain about 
the effectiveness of these treatments in other settings. 
To be fully effective, treatments for ADHD need to be 
conducted across settings (school, home, community) 
and by different people (e.g., parents, teachers, 
therapists)-a consistency and comprehensiveness that 
can be hard to achieve. 
Cognitive-Behavioral Therapy 
Cognitive-behavioral therapy (CBT), primarily training 
in problem solving and social skills, has not been 
shown to provide clinically important changes in 
behavior and academic performance of children with 
ADHD (Pelham et al., 1998). However, CBT might be 
helpful in treating symptoms of accompanying 
disorders such as oppositional defiant disorder, 
depression, or anxiety disorders (Abikoff, 1985; 
Hinshaw & Ehardt, 1991; Lochman, 1992). 
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Psychoeducation 
Although there are no studies evaluating the efficacy of 
psychoeducation as a treatment modality for ADHD, 
providing information to parents, children, and teachers 
about ADHD and treatment options is considered 
critical in the development of a comprehensive 
treatment plan (AACAP, 1991). Educational 
accommodations for children with ADHD are federally 
mandated, and mental health providers are required to 
ensure that patients and families have access to 
adequate and appropriate educational resources. 
Organizations such as Chiklren and Adults with 
Attention Deficit Disorder (CHADD) and the National 
Attention Deficit Disorder Association can be helpful 
sources of information and support for families. 
Multimodal Treatments 
Many researchers and families have long suspected that 
multimodal treatment-medication used together with 
multiple psychosocial interventions in multiple 
settings-should be more effective than medication 
alone. Multimodal treatment has thus been used in the 
absence of empirical support (Hechtman, 1993). To 
determine whether multimodal treatment is indeed 
effective, the recent NIMH Multimodal Treatment 
Study of ADHD (called the MTA Study) examined 
three experimental conditions: medication management 
alone, behavioral treatment alone, or a combination of 
medication and behavioral treatments. The study 
compared the effectiveness of these three treatment 
modes with each other and with standard care provided 
in the community (the control group). The behavioral 
treatment condition consisted of parent training, a 
school intervention, and a summer treatment program. 
The MTA Study was also designed to determine the 
relative benefits of these treatments over time (Richters 
et al., 1995). All subjects were treated for 14 months 
and then followed for an additional 22 months. 
Results of the MTA Study comparing the 1Cmonth 
outcomes of 579 children randomly assigned to one of 
the four treatment conditions were presented in the fall 
of 1998 (MTA Cooperative Group, 1998). At 14 
months, medication and the combination treatment 
were generally more effective than the behavioral 
treatment alone or the control treatment. Notably, the 
combined treatment resulted in significant improve- 
ment over the control condition in six outcome 
areas-social skills, parent child relations, internalizing 
(e.g., anxiety) symptoms, reading achievement, 
oppositional and/or aggressive symptoms, and parent 
and/or consumer satisfaction-whereas the single 
forms of treatment (medication or behavior therapy) 
were each superior to the c&trol condition in only one 
to two of these domains. The conclusions from this 
major study are that carefully managed and monitored 
stimulant medication, alone or combined with 
behavioral treatment, is effective for ADHD over a 
period of 14 months. Addition of behavioral treatment 
yields no additional benefits for core ADHD symptoms 
but appears to provide some additional benefits for 
non-ADHD-symptom outcomes. 
Treatment Controversies 
Overprescription of Stimulants 
Concerns have been raised that children, particularly 
active boys, are being overdiagnosed with ADHD and 
thus are receiving psychostimulants unnecessarily. 
However, recent reports found little evidence of 
overdiagnosis of ADHD or overprescription of 
stimulant medications (Goldman et al., 1998; Jensen et 
al., 1999). Indeed, fewer children (2 to 3 percent of 
school-aged children) are being treated for ADHD than 
suffer from it. Treatment rates are much lower for 
selected groups such as girls, minorities, and children 
receiving care though public service systems (Bussing 
et al., 1998a, 1998b). However, there have been major 
increases in the number of stimulant prescriptions since 
1989 (Hoagwood et al., 1998), and methylphenidate is 
being manufactured at 2.5 times the rate of a decade 
ago (Goldman et al., 1998). Most researchers believe 
that much of the increased use of stimulants reflects 
better diagnosis and more effective treatment of a 
prevalent disorder. Medical and public awareness of 
the problem of ADHD has grown considerably, leading 
to longer treatment, fewer interruptions in treatment, 
and increased treatment of adults. Adolescents and 
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younger girls with ADHD, who were underdiagnosed 
in the past, are being identified and treated. 
Nonetheless, some of the increase in use may 
reflect inappropriate diagnosis and treatment. In one 
study, the rate of stimulant treatment was twice the rate 
of parent-reported ADHD, based on a standardized 
psychiatric interview (Angold & Costello, 1998). While 
many children who do meet the full criteria for ADHD 
are not being treated, the majority of children and 
adolescents who are receiving stimulants did not fully 
meet the criteria. These findings may reflect a failure of 
proper, comprehensive evaluation and diagnosis rather 
than a failure of the diagnostic criteria, which are clear 
and validated by research (Angold & Costello, 1998). 
A diagnosis of ADHD requires the presence of 
impairing ADHD symptoms in multiple settings for at 
least 6 months. Although fidgeting and not paying 
attention are normal, common childhood behaviors, 
DSM-IV criteria reserve a diagnosis of ADHD for 
children in whom such frequent behavior produces 
persistent and pervasive dysfunction. An adequate 
diagnostic evaluation requires histories to be taken 
from multiple sources (parents, child, teachers), a 
medical evaluation of general and neurological health, 
a full cognitive assessment including school history, 
use of parent and teacher rating scales, and all 
necessary adjunct evaluation (such as assessment of 
speech, language). These evaluations take time and 
require multiple clinical skills. Regrettably, there is a 
dearth of appropriately trained professionals. 
Family practitioners are more likely than either 
pediatricians or psychiatrists to prescribe stimulants 
and less likely to use diagnostic services, provide 
mental health counseling, or provide followup care 
(Hoagwood et al., 1998). The American Academy of 
Pediatrics published a policy statement in 1996 on the 
use of medication for children with attentional 
disorders, concluding that use of medication should not 
be considered the complete treatment program for 
children with ADHD and should be prescribed only 
after a careful evaluation (American Academy of 
Pediatrics Committee on Children With Disabilities and 
Committee on Drugs, 1996). 
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Safety of Long-Term Stimulant Use 
Even though the MTA Study found no safety issues 
over a 14-month period (Greenhill et al., 1998), 
concerns have been raised about the longer term safety 
of stimulant treatment. Since ADHD has an early onset 
and requires an extended course of treatment, research 
is needed to examine the long-term safety of treatment 
and to investigate whether other forms of treatment 
could be combined with psychostimulants to lower 
their dose as well as to reduce other problem behaviors 
found with ADHD. Such combined treatments could be 
targeted for symptoms of disorders that often 
accompany ADHD, such as conduct disorder, substance 
abuse, and learning disabilities, and could be targeted 
to improve overall functioning (Laufer, 1971; 
Gittelman et al., 1985). 
Because stimulants are also drugs of abuse and 
because children with ADHD are at increased risk for 
a substance abuse disorder, concerns have also been 
raised about the potential for abuse of stimulants by 
children taking the medication or diversion of the drug 
to others. While stimulants clearly have abuse 
potential, the rate of lifetime nonmedical methyl- 
phenidate use has not significantly increased since 
methylphenidate was introduced as a treatment for 
ADHD, suggesting that abuse is not a major problem 
(Goldman et al., 1998). Case reports describing abuse 
by children prescribed stimulants for ADHD are rare 
(Hechtman, 1985). 
Depression and Suicide in Children 
and Adolescents 
In children and adolescents, the most frequently 
diagnosed mood disorders are major depressive 
disorder, dysthymic disorder, and bipolar disorder. 
Because mood disorders such as depression 
substantially increase the risk of suicide, suicidal 
behavior is a matter of serious concern for clinicians 
who deal with the mental health problems of children 
and adolescents. The incidence of suicide attempts 
reaches a peak during the midadolescent years, and 
mortality from suicide, which increases steadily 
through the teens, is the third leading cause of death at 
that age (CDC, 1999; Hoyert et al., 1999). Although 
suicide cannot be defined as a mental disorder, the 
various risk factors-especially the presence of mood 
disorders-that predispose young people to such 
behavior are given special emphasis in this section, as 
is a discussion of the effectiveness of various forms of 
treatment. The evidence is strong that over 90 percent 
of children and adolescents who commit suicide have 
a mental disorder, as explained later in this section. 
Major depressive disorder is a serious condition 
characterized by one or more major depressive 
episodes. In children and adolescents, an episode lasts 
on average from 7 to 9 months (Birmaher et al., 1996a, 
1996b) and has many clinical features similar to those 
in adults. Depressed children are sad, they lose interest 
in activities that used to please them, and they criticize 
themselves and feel that others criticize them. They feel 
unloved, pessimistic, or even hopeless about the future; 
they think that life is not worth living, and thoughts of 
suicide may be present. Depressed children and 
adolescents are often irritable, and their irritability may 
lead to aggressive behavior. They are indecisive, have 
problems concentrating, and may lack energy or 
motivation; they may neglect their appearance and 
hygiene; and their normal sleep patterns are disturbed 
(DSM-IV). 
Despite some similarities, childhood depression 
differs in important ways from adult depression. 
Psychotic features do not occur as often in depressed 
children and adolescents, and when they occur, 
auditory hallucinations are more common than 
delusions (Ryan et al., 1987; Birmaher et al., 1996a, 
1996b). Associated anxiety symptoms, such as fears of 
separation or reluctance to meet people, and somatic 
symptoms, such as general aches and pains, 
stomachaches, and headaches, are more common in 
depressed children and adolescents than in adults with 
depression (Kolvin et al., 1991; Birmaher et al., 1996a, 
1996b). 
Dysthymic disorder is a mood disorder like major 
depressive disorder, but it has fewer symptoms and is 
more chronic. Because of its persistent nature, the 
disorder is especially likely to interfere with normal 
adjustment. The onset of dysthymic disorder (also 
called dysthymia) is usually in childhood or 
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adolescence (Akiskal, 1983; Klein et al., 1997). The 
child or adolescent is depressed for most of the day, on 
most days, and symptoms continue for several years. 
The average duration of a dysthymic period in children 
and adolescents is about 4 years (Kovacs et al., 1997a). 
Sometimes children are depressed for so long that they 
do not recognize their mood as out of the ordinary and 
thus may not complain of feeling depressed. Seventy 
percent of children and adolescents with dysthymia 
eventually experience an episode of major depression6 
(Kovacs et al., 1994). When a combination of major 
depression and dysthymia occurs, the condition is 
referred to as double depression. 
Bipolar disorder is a mood disorder in which 
episodes of mania alternate with episodes of 
depression. Frequently, the condition begins in 
adolescence. The first manifestation of bipolar illness 
is usually a depressive episode. The first manic features 
may not occur for months or even years thereafter, or 
may occur either during the first depressive illness or 
later, after a symptom-free period (Strober et al., 1995). 
The clinical problems of mania are very different 
from those of depression. Adolescents with mama or 
hypomania feel energetic, confident, and special; they 
usually have difficulty sleeping but do not tire; and 
they talk a great deal, often speaking very rapidly or 
loudly. They may complain that their thoughts are 
racing. They may do schoolwork quickly and creatively 
but in a disorganized, chaotic fashion. When manic, 
adolescents may have exaggerated or even delusional 
ideas about their capabilities and importance, may 
become overconfident, and may be “fresh” and 
uninhibited with others; they start numerous projects 
that they do not finish and may engage in reckless or 
risky behavior, such as fast driving or unsafe sex. 
Sexual preoccupations are increased and may be 
associated with promiscuous behavior. 
Reactive depression, also known as adjustment 
disorder with depressed mood, is the most common 
form of mood problem in children and adolescents. In 
6 Major depression refers to conditions marked by a major 
depressive episode, such as major depressive disorder, bipolar 
disorder, and related conditions. The word “major” refers to the 
number of symptoms. See Chapter 4 for DSM-IV diagnostic criteria. 
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children suffering from reactive depression, depressed 
feelings are short-lived and usually occur in response to 
some adverse experience, such as a rejection, a slight, 
a letdown, or a loss. In contrast, children may feel sad 
or lethargic and appear preoccupied for periods as short 
as a few hours or as long as 2 weeks. However, mood 
improves with a change in activity or an interesting or 
pleasant event. These transient mood swings in reaction 
to minor environmental adversities are not regarded as 
a form of mental disorder. 
Conditions Associated Wjth Depression 
Roughly two-thirds of childretrand adolescents with 
major depressive disorder also have another mental 
disorder (Angold & Costello, 1993; Anderson & 
McGee, 1994). The most commonly associated 
disorders are dysthymia (see above), an anxiety 
disorder, a disruptive or antisocial disorder, or a 
substance abuse disorder. When more than one 
diagnosis is present, depression is more likely to begin 
after the onset of the accompanying disorder, except 
when that disorder is substance abuse (Biederman et 
al., 1995; Kessler&Walters, 1998). This suggests that, 
in some cases, depression may arise in response to the 
associated disorder. In other instances, such as the co- 
occurrence of conduct disorder and depression, the two 
may arise independently in response to inadequate 
maternal supervision and control, raising the possibility 
that parental behavior may be a risk factor for both 
conditions (Downey & Coyne, 1990; Rutter & 
Sandberg, 1992; Harrington, 1994). 
Prevalence 
Major Depression 
Population studies show that at any one time between 
10 and 15 percent of the child and adolescent 
population has some symptoms of depression (Smucker 
et al., 1986). The prevalence of the full-fledged 
diagnosis of major depression among all children ages 
9 to 17 has been estimated at 5 percent (Shaffer et al., 
1996c). Estimates of l-year prevalence in children 
range from 0.4 and 2.5 percent and in adolescents, 
considerably higher (in some studies, as high as 8.3 
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percent) (Anderson & McGee, 1994; Lewinsohn et al., 
1994a; Garrison et al., 1997; Kessler&Walters, 1998). 
For purposes of comparison, l-year prevalence in 
adults is about 5.3 percent (Murphy et al., 1988; 
Rorsman et al., 1990; Regier et al., 1993). 
Dysthymic Disorder 
The prevalence of dysthymic disorder in adolescents 
has been estimated at around 3’percent (Garrison et al., 
1997). Before puberty, major depressive disorder and 
dysthymic disorder are equally common in boys and 
girls (Rutter, 1986). But after age 15, depression is 
twice as common in girls and women as in boys and 
men (Weissman & Klerrnan, 1977; McGee et al., 1990; 
Linehan et al., 1993). 
Suicide 
In 1996, the age-specific mortality rate from suicide 
was 1.6 per 100,000 for lo- to 14-year-olds, 9.5 per 
100,000 for 15- to 19-year-olds (i.e., about six times 
higher than in the younger age group; in this age group, 
boys are about four times as likely to commit suicide 
than are girls, while girls are twice as likely to attempt 
suicide), compared with 13.6 per 100,000 for 20- to 24- 
year-olds (CDC, 1999). Hispanic high school Students 
are more likely than other students to attempt suicide 
(CDC, 1998). There have been some notable changes 
in these rates over the past few decades: since the early 
196Os, the reported suicide rate among 15- to 19-year- 
old males increased threefold but remained stable 
among females in that age group and among lo- to 14- 
year-olds (National Center for Health Statistics, 1998); 
the rate among white adolescent males reached a peak 
in the late 1980s (18.0 per 100,000 in 1986) and has 
since declined somewhat (16.0 per 100,000 in 1997), 
whereas among African American male adolescents, 
the rate increased substantially in the same period 
(from 7.1 per 100,000 in 1986 to 11.4 per 100,000 in 
1997 (CDC, 1998). From 1979 to 1992, the Native 
American male adolescent and young adult suicide rate 
in Indian Health Service Areas was the highest in the 
Nation, with a suicide rate of 62.0 per 100,000 
(Wallace et al., 1996). 
It has been proposed that the iise in suicidal 
behavior among teenage boys results from increased 
availability of firearms (Boyd, 1983; Boyd & Moscicki, 
1986; Brent et al., 1987; Brent et al., 1991) and 
increased substance abuse in the youth population 
(Shaffer et al., 1996c; Birckmayer & Hemenway, 
1999). However, although the rate of suicide by 
firearms increased more than suicide by other methods 
(Boyd, 1983; Boyd & Moscicki, 1986; Brent et al., 
1987), suicide rates also increased markedly in many 
other countries in Europe, in Avstralia, and in New 
Zealand, where suicide by firearms is rare. 
Course and Natural History 
Most children with depression experience a recurrence. 
Twenty to 40 percent of depressed children relapse 
within 2 years, and 70 percent will do so by adulthood 
(Garber et al., 1988; Velez et al., 1989; Harrington et 
al., 1990; Fleming et al., 1993; Kovacs et al., 1994; 
Lewinsohn et al., 1994a; Garrison et al., 1997). The 
reasons for relapse are not known, but there is some 
evidence that experiencing a depression leaves behind 
psychological “scars” that may increase vulnerability 
throughout early life (see below). 
The age of first onset of depression appears to play 
a role in its course. Children who first become 
depressed before puberty are at risk for some form of 
mental disorder in adulthood, while teenagers who first 
become depressed after puberty are most likely to 
experience another episode of depression (Harrington 
et al., 1990; McCracken, 1992a; Lewinsohn et al., 
1994a, 1994b; Rao et al., 1995). These differences in 
outcome suggest that different mechanisms may lead to 
superficially similar but inherently different clinical 
conditions. Factors that worsen the prognosis for 
depressed children and adolescents include depression 
occurring in the context of conduct disorder (Harring- 
ton et al., 1990; Asarnow et al., 1994) and living in 
conflict-ridden families (Asamow et al., 1994). 
Children and particularly adolescents who suffer from 
depression are at much greater risk of committing 
suicide than are children without depression (Shaffer et 
al., 1996b). 
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The prognosis for dysthymia (Klein et al., 1997a) 
is unfavorable, with most patients continuing to feel 
depressed and to have social difficulties even after they 
have apparently recovered. The prognosis for double 
depressives (major depressive disorder plus dysthymia) 
is worse than that for either condition alone (Kovacs et 
al., 1994). 
Twenty to 40 percent of adolescents with depres- 
sion eventually develop bipolar disorder. Factors that 
predict later bipolar disorder include young age at the 
time of the first depressive episode, psychotic features 
in the initial depression, a family history of bipolar 
illness, and symptoms of hypomania developing during 
treatment with antidepressant drugs (Garber et al., 
1988; Strober et al.‘, 1993). 
Causes 
The precise causes of depression are not known. 
Extensive research on adults with depression generally 
points to both biological and psychosocial factors 
(Kendler, 1995). However, there has been substantially 
less research on the causes of depression in children 
and adolescents. Further discussion of the risk factors 
for depression can be found in Chapter 4, as well as the 
preceding Overview of Risk Factors and Prevention 
section. 
Family and Genetic Factors 
Much of the research on children and adolescents with 
depression has been conducted with those who attend 
mental health clinics and with patients who tend to 
have the more severe and recurrent forms of 
depression, and thus they may not be representative of 
all children and adolescents with depression. With this 
limitation, research has shown that between 20 and 50 
percent of depressed children and adolescents have a 
family history of depression (Puig-Antich et al., 1989; 
Todd et al., 1993; Williamson et al., 1995; Kovacs, 
1997b). Family research has found that children of 
depressed parents are more than three times as likely as 
children with nondepressed parents to experience a 
depressive disorder (see Birmaher et al., 1996a, 1996b 
for a review). They also are more vulnerable to other 
mental and somatic disorders (Downey & Coyne, 
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1990). Conversely, estimates of the proportion of 
depressed parents who have a depressed child or 
adolescent vary from approximately one in six to just 
under a half (Hammen et al., 1990). It is not clear 
whether the relationship between parent and childhood 
depression derives from genetic factors, or whether 
depressed parents create an environment that increases 
the likelihood of a mental disorder developing in their 
children (see below). 
Gender Differences 
One reason advanced to explain the greater prevalence 
of depression in adolescent girls (see above) is that they 
are more socially oriented, more dependent on positive 
social relationships, and more vulnerable to losses of 
social relationships than are boys (Allgood-Merten et 
al., 1990). This would increase their vulnerability to the 
interpersonal stresses that are common in teenagers. 
There is also evidence that the methods girls use to 
cope with stress may entail less denial and more 
focused and repetitive thinking about the event (Nolen- 
Hoeksema & Girgus, 1994). The higher prevalence, 
therefore, could be a result of greater vulnerability, 
combined with coping mechanisms different than those 
of boys. 
Biological Factors 
Some of the core symptoms of depression, such as 
changes in appetite and sleep patterns, are related to the 
functions of the hypothalamus. The hypothalamus is, in 
turn, closely tied to the function of the pituitary gland. 
Abnormalities of pituitary function, such as increased 
rates of circulating cortisol and hypo- or hyperthyroid- 
ism, are well established features of depression in 
adults (Goodwin & Jamison, 1990). However, far less 
research has been done in this area among children and 
adolescents (see Birmaher et al., 1996a, 1996b for a 
review). It is in the .neuroendocrine area that most 
research has been done on child and adolescent 
depression (see Birmaher et al., 1996a, b). In suicidal 
adults dysregulation of the serotonergic system is 
common (Mann, 1998; Pine et al., 1995), making them 
typically impulsive, intense, and given to extreme 
reactions. However, little is known about the 
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association between abnormal serotonin metabolism 
and suicidal behavior in children and adolescents. 
Cognitive Factors 
For over two decades there has been considerable 
interest in the relationship between a particular 
“mindset” or approach to perceiving external events 
and a predisposition to depression. The mindset in 
question is known as a pessimistic “attribution bias” 
(Abramson et al., 1978; Beck, 1987; Hops et al., 1990). 
A person with this mindset is one who readily assumes 
personal blame for negative events (“All the problems 
in the family are my fault”), who expects that one 
negative experience is part of a pattern of many other 
negative events (“Everything I do is wrong”), and who 
believes that a cunently negative situation will endure 
permanently (“Nothing I do is going to make anything 
better”). Such pessimistic individuals take a 
characteristically negative view of positive events (i.e., 
that they are a result of someone else’s effort, that they 
are isolated events, and that they are unlikely to recur). 
Individuals with this mindset react more passively, 
helplessly, and ineffectively to negative events than 
those without a pessimistic mindset (Seligman, 1975). 
There is uncertainty over whether this mindset 
precedes depression (and represents a permanknt style 
of thinking as part of an individual’s personality), is a 
manifestation of depression that is only present when 
the patient is depressed, and/or is a consequence or 
“scar” of a previous, perhaps unnoticed, depressive 
episode (Lewinsohn et al., 1981). This pessimistic 
mode of thinking does not occur in children under age 
5, which could be one of the reasons why depression 
and suicide are rare in early childhood @holes et al., 
1980; Rotenberg, 1982). 
There is evidence that children and adolescents 
who previously have been depressed may learn, during 
their depression, to interpret events in this fashion. This 
may make them prone to react similarly to negative 
events experienced after recovery, which could be one 
of the reasons why previously depressed children and 
adolescents are at continuing risk for depression 
(Nolen-Hoeksema et al., 1993). 
Perceptions of hopelessness, negative views about 
one’s own competence, poor self- esteem, a sense of 
responsibility for negative events, and the immutability 
of these distorted attributions may contribute to the 
hopelessness that has been repeatedly found to be 
associated with suicidality (Ov&holser et al., 1995). 
Risk Factors for Suicide and Suicidal Behavior 
There is good evidence that over 90 percent of children 
and adolescents who commit suicide have a mental 
disorder before their death (Shaffer & Craft, 1999). The 
most common disorders that predjspose to suicide are 
some form of mood disorder, ‘with or without 
alcoholism or other substance abuse problem, and/or 
certain forms of anxiety disorder (Shaffer et al., 
1996b). Psychological postmortem studies also show 
that a significant proportion of suicide victims suffered 
from an anxiety disorder at the time of their death, but 
the number of victims has been too small to yield 
precise odds ratios for the calculation of an effect. 
Although the rate of suicide is greatly increased in 
schizophrenia, because of its rarity, it accounts for very 
few suicides in the child and adolescent age group. 
Controlled studies of completed suicide suggest 
similar risk factors for boys and girls (Shafii et al., 
1985; Brent et al., 1988; Groholt et al., 1997), but with 
marked differences in their relative importance (Shaffer 
et al., 1996c). 
Among girls, the most significant risk factor is the 
presence of major depression, which, in some studies, 
increases the risk of suicide 1Zfold. The next most 
important risk factor is a previous suicide attempt, 
which increases the risk approximately threefold. 
Among boys, a previous suicide attempt is the most 
potent predictor, increasing the rate over 30-fold. It is 
followed by depression (increasing the rate by about 
12-fold), disruptive behavior (increasing the rate by 
twofold), and substance abuse (increasing the rate by 
just under twofold) (Shaffer et al., 1996c). 
Stressful life events often precede a suicide and/or 
suicide attempt (de Wilde et al., 1992; Gould et al., 
1996). As indicated earlier, these stressful life events 
include getting into trouble at school or with a law 
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enforcement agency; a ruptured relationship with a 
boyfriend or a girlfriend; or a fight among friends.’ 
They are rarely a sufficient cause of suicide, but they 
can be precipitating factors in young people. 
Controlled studies (Gould et al., 1996; Hollis, 
1996) indicate that low levels of communication 
between parents and children may act as a significant 
risk factor. While family discord, lack of family 
warmth, and disturbed pai-entchild relationship are 
commonly associated with child and adolescent 
psychopathology (violent behavior, mood disorder, 
alcohol and substance abuse disorders) (Brent et al., 
1994; Pfeffer et al., 1994), these factors do not play a 
specific role in suicide (Gould et al., 1998). 
Evidence has accumulated that supports the 
observation that suicide can be facilitated in vulnerable 
teens by exposure to real or fictional accounts of 
suicide (Velting & Gould, 1997), including media 
coverage of suicide, such as intensive reporting of the 
suicide of a celebrity, or the fictional representation of 
a suicide in a popular movie or TV show. The risk is 
especially high in the young, and it lasts for several 
weeks (Gould & Shaffer, 1986; Phillips et al., 1989). 
The suicide of a prominent person reported on 
television or in the newspaper or exposure to some 
sympathetic fictional representation of suicide may also 
tip the balance and make the at-risk individual feel that 
suicide is a reasonable, acceptable, and in some 
instances even heroic, decision (Gould & Shaffer, 
1986). 
The phenomenon of suicide clusters is presumed to 
be related to imitation (Davidson, 1989). Suicide 
clusters nearly always involve previously disturbed 
young people who knew about each other’s death but 
rarely knew the other victims personally (Gould, 
personal communication, 1999). 
’ The relationship between sexual orientation, depression, and 
suicidal thoughts and behavior is not well understood. Several 
studies suggest a link (Faullener & Cranston, 1998; Garofolo et al., 
1998; Garofolo et al., 1999). 
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Consequences 
Both major depressive disorder and dysthymic disorder 
are inevitably associated with personal distress, and if 
they last a long time or occur repeatedly, they can lead 
to a circumscribed life with fewer friends and sources 
of support, more stress, and missed educational and job 
opportunities (Klein et al., 1997). The psychological 
scars of depression include an enduring pessimistic 
style of interpreting events, which may increase the risk 
of further depressive episodes. Impairment is greater 
for those with dysthymic disorder than for those with 
major depression (Klein et a., 1997a), presumably 
because of the longer duration of depression in 
dysthymic disorder, which is also a prime risk factor 
for suicide. In a lo- to 15year followup study of 73 
adolescents diagnosed with major depression, 7 percent 
of the adolescents had committed suicide sometime 
later. The depressed adolescents were five times more 
likely to have attempted suicide as well, compared with 
a control group of age peers without depression 
(Weissman et al., 1999). 
Treatment 
Depression 
Psychosocial Interventions 
To be deemed effective and approved by the American 
Psychological Association, treatments for mental 
disorders have to meet very strict criteria. While 
interpersonal therapy and systemic family therapy show 
promise, they have not been studied sufficiently to 
evaluate their effectiveness by these standards. 
However, in acomprehensive review article (Kaslow & 
Thompson, 1998) that evaluated interventions for 
depression in children and adolescents against the 
American Psychological Association Task Force 
criteria, two forms of cognitive-behavioral therapy 
(CBT) were found to be “probably effective 
treatments,” although none of the interventions for 
depression were deemed, as yet, to meet the 
Association’s higher standard for a well-established 
intervention. 
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In studies that focused on relieving symptoms of 
depression in preadolescents, only one form of CBT 
met the criteria for a probably e&ctive intervention. In 
the first study, the relative efficacy of two types of 
CBT-12-session group interventions based on either 
self-control therapy or behavior-solving therapy-were 
compared with a “waiting list” control group (Stark et 
al., 1987). Children responded to both CBT inter- 
ventions with fewer symptoms of depression and 
anxiety, whereas the waiting list group exhibited 
minimal change. Because improvement was greatest 
with self-control therapy, this intervention was 
compared in a later study with a traditional counseling 
condition. Self-control therapy, enhanced by doubling 
the number of sessions, entailed social skills training, 
assertiveness training, relaxation training and imagery, 
and cognitive restructuring. Monthly family meetings 
were also added to both the experimental and control 
conditions. Children receiving self-control therapy 
reported fewer symptoms at 7-month followup (Stark 
et al., 1991). 
Among the numerous studies of adolescents 
reviewed by Kaslow and Thomson (1998), one form of 
CBT-coping skills-was judged probably e$jT- 
cacious. This intervention, based on the “Coping with 
Depression” course, was developed originally in 
Oregon for adults by Lewinsohn and colleagues 
(Lewinsohn et al., 1996) and adapted by Clarke and 
colleagues (1992) for school-based programs to treat 
adolescent depression. Compared with controls on the 
waiting list, adolescents who received CBT had lower 
rates of depression, less self-reported depression, 
improvement in cognitions, and increased activity 
levels (Lewinsohn et al., 1990, 1996). To achieve well- 
estubEished status, as defined by the American Psycho- 
logical Association Task Force, the intervention has to 
be studied by another team of investigators-which has 
not as yet been done. 
Pharmacologica/ Treatment 
Prior to 1996, the medications of choice for major 
depression in children and adolescents were the 
tricyclic antidepressants, a choice based on numerous 
studies in adults. However, 13 distinct trials in children 
and adolescents failed to demonstrate the efficacy of 
tricyclic antidepressants for younger ages. Tricyclic 
antidepressants also have a higher risk of toxicity than 
selective serotonin reuptake inhibitors (SSRIs) (Walsh 
et al., 1994; Kutcher, 1998). The current consensus is 
that tricyclic medications are not the medication of 
choice for depressed children and adolescents 
(Eisenberg, 1996; Fisher & Fisher, 1996). 
Recent research indicates that young people with 
depressive disorders may respond more favorably to 
SSRIs than to tricyclic antidepressants. The first SSRI 
tested in children and adolescents was fluoxetine. In a 
study of 96 outpatients over 8 weeks, 56 percent 
receiving fluoxetine and 33 percent receiving placebo 
were “much” or “very much” improved on the Clinical 
Global Improvement Scale. Benefits were comparable 
across age groups. Complete symptom remission 
occurred for 31 percent of fluoxetine-treated patients 
compared with 23 percent of placebo-treated patients 
(Emslie et al., 1997). A recent open trial of fluoxetine 
for adolescents hospitalized for treatment of major 
depression found it to decrease depression scores more 
effectively than imipramine, a tricyclic antidepressant 
(Strober et al., 1999), with the further advantage that 
fluoxetine was well tolerated. 
The safety of a second SSRI, paroxetine, was 
demonstrated in a multicenter double-blind placebo- 
controlled trial. Paroxetine was compared with 
imipramine and placebo in 275 adolescents who met 
the DSM-IV criteria for major depression. Preliminary 
results indicate that, mostly because of side effects, 
one-third of imipramine patients withdrew from the 
study, a proportion significantly higher than that for 
paroxetine (10 percent) and placebo (7 percent) 
(Wagner et al., 1998). One of the co-investigators of 
this study noted that paroxetine’s efficacy was superior 
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to that of imipramine and placebo on the Clinical 
Global Improvement Scale (Graham Emslie, personal 
communication, October 1998). However, final 
conclusions about the benefit of this second SSRI must 
await publication of the outcomes of this multicenter 
study. 
In summary, psychosocial interventions for 
depressed children and adolescents indicate great 
promise, with several types of cognitive-behavioral 
therapy for the child or adolescent leading the way. 
With respect to pharmacotherapy, new studies attest to 
the safety and efficacy of two SSRIs. These promising 
findings are being extended in the recently begun 
NIMH-funded Treatment of Adolescents with 
Depression study. 
Bipolar Disorder 
Pharmacological Treatment 
The treatment of bipolar disorder entails treating 
symptoms of both depression and mania. For decades, 
lithium has been the well-researched mainstay 
treatment for maniain adults. Mania in bipolar disorder 
of children is also treated with lithium, although the 
relevant research on children lags behind that on adults. 
Only in recent years have researchers begun to study 
lithium in children and adolescents, with good clinical 
response. Open trials of lithium were conducted in the 
late 1980s (Varanka et al., 1988; Strober et al., 1990). 
More recently, lithium proved to be more effective than 
placebo in treating adolescents who were bipolar and 
substance dependent (Geller et al., 1998). 
Children experience the same safety problems with 
lithium as do adults: toxicity and impairment of renal 
and thyroid functioning (Geller & Luby, 1997). 
Lithium is therefore not recommended for families 
unable to keep regular appointments that would ensure 
monitoring of serum lithium levels and of adverse 
events. Patients who discontinue taking the drug have 
a high relapse rate (Strober et al., 1990). 
As yet, there are no controlled studies on a number 
of other psychotropic agents also used clinically in 
children and adolescents with bipolar disorder, 
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including valproate, carbamazepine, methylphenidate, 
and low-dose chlorpromazine (Campbell & Cueva, 
1995; Geller & Luby, 1997). 
Suicide 
Psychotherapeutic Treatments 
Suicidal children and adolescents report feelings of 
intense emotional distress involving depression, anger, 
anxiety, hopelessness, and worthlessness and an 
inability to change problematic, frustrating 
circumstances or to find a solution to their problems 
(Kienhorst et al., 1995; Ohring et al., 1996). They feel 
so distraught that they often respond impulsively to 
their despair. Psychotherapeutic techniques aim to 
decrease such intolerable feelings and thoughts and to 
re-orient the cognitive and emotional perspectives of 
the suicidal child or adolescent (Kemberg, 1994; 
Spirito, 1997). 
Cognitive-behavioral therapy (CBT) may be a 
useful intervention, considering that suicidal children 
and adolescents often experience negative cognitions 
about themselves, their environment, and their futures. 
Recent research suggests that CBT may be more 
effective than systemic behavior family therapy or 
individual nondirective supportive therapy in reducing 
depressive symptoms associated with suicidal ideation 
(Brent et al., 1997). Such treatment can focus on re- 
attribution of precipitating issues for suicidal behavior 
and enable the suicidal child or adolescent to rank 
stresses and to consider avenues of problem-solving 
(Rotheram-Borus et al., 1994; Brent et al., 1997; 
Spirito, 1997). 
Interpersonal conflicts are important stresses 
related to the risk imparted by poor social adjustment 
of potentially suicidal children and adolescents. 
Treatment of interpersonal strife may significantly 
reduce suicidal risk. Recent research into the efficacy 
of interpersonal psychotherapy of depressed 
adolescents suggests beneficial effects (Kaslow & 
Thompson, 1998); it is a treatment that may be 
modified to address the risk factor issues related to 
interpersonal loss, conflicts, and need for restitution 
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often reported by children and adolescents with suicidal 
tendencies. 
A significant class of risk factors for suicide 
involves family discord, which is characterized by poor 
communication, disagreements, and lack of cohesive 
values and goals and of common activities (de Long, 
1992; Miller et al., 1992; Wagner, 1997). Suicidal 
children and adolescents often feel that they are 
isolated within the family, exhibit problems in 
independence, and view themselves as expendable to 
the family, a perception that is a motivating force for 
self-annihilation (Sabbath, 1969; Pfeffer, 1986; Miller 
et al., 1992). Family intervention with suicidal children 
and adolescents is an important method to decrease 
such problems and to enhance effective family 
problem-solving and conflict resolution, so that blame 
is not directed toward the suicidal child or adolescent. 
Cognitive-behavioral approaches with suicidal children 
and adolescents and their families aim to reframe their 
understanding of family problems, alter the family style 
of maladaptive problem-solving techniques, and 
encourage positive family interactions (Rotheram- 
Borus et al., 1994). Time-limited home-based 
intervention to reduce suicidal ideation in children and 
adolescents and to improve family functioning has been 
reported to have limited efficacy for children and 
adolescents without major depressive disorder 
(Harrington et al., 1998). Psychoeducational approach- 
es to reduce the extent of expressed anger may be 
helpful in lowering risk for suicidal behavior in 
children and adolescents (Fristad et al., 1996). 
Psychopharmacologica/ Treatments 
There is a dearth of research on the efficacy of 
pharmacological treatments for reducing suicidal 
thoughts or preventing suicide in children and 
adolescents. Most of the research on pharmacotherapies 
has been conducted in adults. In depressed adults, 
SSRIs have been found to reduce suicidal ideation 
(Letizia et al., 1996; Wemicke et al., 1997) and to 
reduce the frequency of suicide attempts in 
.nondepressed patients who had previously made at least 
one suicide attempt (Verkes et al., 1998). In a 
controlled trial of the experimental neuroleptic drug 
flupenthixol, researchers noted a significant reduction 
in suicide-attempt behavior in adults who had made 
numerous previous attempts (Montgomery & 
Montgomery, 1982). Similar studies have yet to be 
conducted on adolescents, although trials of SSRIs in 
depressed adolescents suggest that these drugs are 
effective for treating depression and for reducing 
suicidal ideas also in this age group (Emslie et al., 
1997; Ryan & Varma, 1998). Because placebo- 
controlled, methodologically appropriate studies of 
tricyclic antidepressants have failed’tofmd a significant 
effect in depressed children and adolescents (Ryan & 
Varma, 1998), it is reasonable to regard SSRIs as a 
first-choice medication in treating depressed suicidal 
children and adolescents (also see American Academy 
of Child and Adolescent Psychiatry, 1998). In contrast 
to tricyclic antidepressants, SSRIs have low lethal 
potential when taken in overdoses (Ryan & Varma, 
1998). 
In adults with major depressive disorder, controlled 
research suggests that lithium reduces suicide risk 
(Thies-Flechtner et al., 1996), but this has not yet been 
demonstrated in children and adolescents. Clinicians 
should be cautious about prescribing medications that 
may reduce self-control, such as the benzodiazapines, 
amphetamines, and phenobarbital. These drugs also 
have a high lethal potential if taken in overdose 
(Carlsten et al., 1996). 
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Intervention After a Suicidal Death of a Relative, 
Friend, or Acquaintance 
The suicidal death of a relative or acquaintance may 
increase the risk for childhood or adolescent suicidal 
behavior and other dysphoric states (Brent et al., 1992, 
1994; Pfeffer et al., 1994, 1997; Clark & Goebel, 
1996). Major depression, post-traumatic stress disorder, 
and suicidal ideation often occur after the death of an 
adolescent friend or acquaintance and relative (Brent et 
al., 1992, 1994, 1996). 
The goal of the clinician is to decrease the 
likelihood that a child or adolescent comes to view the 
suicidal behavior of the deceased as a coping strategy 
in dealing with adversity (Brent et al., 1997). Psycho- 
educational counseling may reduce the risk for suicidal 
behavior in these circumstances. Intervention is also 
needed to decrease the child’s or teen’s personal sense 
of guilt, trauma, and social isolation. This treatment can 
be given in individual meetings, at group sessions with 
other teens, or in conjunction with parents who need 
help to support the adaptive capacities of their children 
and adolescents. School professionals sometimes offer 
programs of this kind and can be invaluable in 
identifying grieving friends who may need help. 
Community-Based Suicide Prevention 
The principal public health approaches to suicide 
prevention have been (1) crisis hotlines*; (2) restric- 
tions covering access to suicide methods; (3) media 
counseling to minimize imitative suicide; (4) indirect 
case-finding by educating potential gate-keepers, 
teachers, parents, and peers to identify the warning 
signs of an impending suicide; (5) direct case-finding 
among high school or college students or among the 
patients of primary practitioners by screening for 
conditions that place teens at risk for suicide; and (6) 
training professionals to improve recognition and 
treatment of mood disorders. As discussed below, the 
level of evidence for these strategies varies. There is 
more support for direct case-finding and improved 
recognition and treatment of mood disorders than for 
the other strategies. 
Crisis Hotlines 
Although crisis hotlines are available almost every- 
where in the United States, research has failed to show 
that they reduce the incidence of suicide (Bleach & 
Clairbom, 1974; Apsler & Hodas, 1976; Miller et al., 
1984; Shaffer et al., 1990a, 199Ob). Possible reasons 
for this are that actively suicidal individuals (males and 
individuals with an acute mental disturbance) do not 
call hotlines because they are acutely disturbed, 
preoccupied, or intent on not being deflected from their 
intended course of action (Shaffer et al., 1989). 
Hotlines are often busy, and there may be a long wait 
* Crisis hotlines are only one of the services offered through crisis 
services, a topic discussed subsequently. 
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before a call is answered, so that callers disconnect; the 
advice individuals get on calling a hotline may be 
stereotyped, inappropriate for an individual’s needs, 
and perceived as unhelpful by the caller. Gender 
preferences in seeking help result in the large majority 
of callers being females, whereas males are at greatest 
risk for suicide. While each of these deficiencies is 
potentially modifiable, there have been no systematic 
attempts to do so. 
Method Restriction 
Method preference for suicide varies by gender and by 
nationality. In the United States, the most common 
method for committing suicide is by firearms, and it has 
been suggested that reducing firearms availability will 
reduce the incidence of suicide (Moscicki, 1995). 
However, a natural experiment in Great Britain 
suggests this is unlikely. The favored suicide method, 
self-asphyxiation with coal gas, became impossible 
after the introduction of natural gas. This resulted in a 
marked but short-lived decline in the suicide rate. 
Within a decade, the suicide rate had returned to 
previous levels, and suicides were being committed by 
other means (Farberow, 1985). Although reducing 
access to firearms with gun-security laws reduces 
accidental deaths from firearms (Cummings et al., 
1997), there is no evidence to date that such laws have 
a significant impact on suicides attributable to firearms. 
Media Counseling 
Even though it appears prudent for reporters and editors 
to minimize coverage of youth suicide in general and 
attention to individual suicides (O’Carroll & Potter, 
1994), there is as yet no evidence that these guidelines, 
issued by the Centers for Disease Control and 
Prevention, are effective in reducing the suicide rate. 
Indirect Case-finding Through Education 
Controlled studies have failed to show that classes for 
high school students about suicide increase students’ 
help-seeking behavior when they are troubled or 
depressed (Spirit0 et al., 1988; Shaffer et al., 1991; 
Vieland et al., 1991). On the other hand, there is 
evidence that previously suicidal adolescents are upset 
159 
Mental Health: A Report of the Surgeon General 
by exposure to such classes (Shaffer et al., 1990a, 
1990b), even though this does not necessarily lead to a 
suicide attempt. Such educational programs seem, 
therefore, to be both an ineffective mode of case- 
finding and to carry with them an unjustified risk of 
activating suicidal thoughts. 
Direct Case-Finding 
Judging from the high response rate to surveys about 
suicidal attempts and ideation (National Center for 
Health Statistics, 1997), adolescents will provide 
accurate information about their own suicidal thoughts 
and/or behaviors if asked directly in a nonthreatening 
way. A sensible approach to suicide prevention that 
needs further study, therefore, is to screen 
systematically 15 to 19-year-olds (the age group at 
greatest risk) for (1) previous suicide attempts; 
(2) recent, serious, suicidal preoccupations; (3) depres- 
sion; or (4) complications of substance or alcohol use. 
Clearly, screening programs need to go beyond 
identifying a teen with a high-risk profile. Youth 
identified in this way should be referred for evaluation 
and, if necessary, treatment. Contingency arrangements 
may need to be made to assist uninsured adolescents 
with help if it is needed (Shaffer & Craft, 1999). 
Aggressive Treatment of Mood Disorders 
Preliminary and as yet unreplicated studies in Sweden 
(Rihmer et al., 1995) suggest that education of primary 
medical practitioners to better identify the 
characteristics of mood disorders and to treat these 
effectively produced a significant reduction in suicide 
and suicide-attempt rates. Although the optimal 
treatment of adolescent depression is not yet as well 
understood as that of adult depression, this is an option 
that may prove to be useful. 
Air force Suicide Prevention Program-A 
Community Approach 
Combining many of the approaches for adolescents 
described above, the Air Force Surgeon General 
developed and implemented a community approach to 
suicide prevention for older adolescents and young 
adults on active duty. The program involved education 
on suicide risk awareness, reducing barriers to mental 
health services, and stigma-reducing efforts.’ 
Other Mental Disorders in Children 
and Adolescents 
Anxiety Disorders 
The combined prevalence of the group of disorders 
known as anxiety disorders is higher than that of 
virtually all other mental disorders of childhood and 
adolescence (Costello et al., l,996). The l-year 
prevalence in children ages 9 to 17 is.13 percent (Table 
3-l). This section furnishes brief overviews of several 
anxiety disorders: separation anxiety disorder, 
generalized anxiety disorder, social phobia, and 
obsessive-compulsive disorder. Treatments for all but 
the latter are grouped together below. 
Separation Anxiety Disorder 
Although separation anxieties are normal among 
infants and toddlers, they are not appropriate for older 
children or adolescents and may represent symptoms of 
separation anxiety disorder. To reach the diagnostic 
threshold for this disorder, the anxiety or fear must 
cause distress or affect social, academic, or job 
functioning and must last at least 1 month (DSM-IV). 
Children with separation anxiety may cling to their 
parent and have difficulty falling asleep by themselves 
at night. When separated, they may fear that their 
parent will be involved in an accident or taken ill, or in 
some other way be “lost” to the child forever. Their 
need to stay close to their parent or home may make it 
difficult for them to attend school or camp, stay at 
friends’ houses, or be in a room by themselves. Fear of 
separation can lead to dizziness, nausea, or palpitations 
(DSM-IV). 
Separation anxiety is often associated with 
symptoms of depression, such as sadness, withdrawal, 
apathy, or difficulty in concentrating, and such children 
often fear that they or a family member might die. 
’ In 1995, prior to implementation, suicide rates were almost 16 per 
100,000; following 3 years of exposure to the program, suicide rates 
fell to below 2 per 100,000 (Air Force Surgeon General, personal 
communication, 1999) 
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Young children experience nightmares or fears at 
bedtime. 
About 4 percent of children and young adolescents 
suffer from separation anxiety disorder (DSM-IV). 
Among those who seek treatment, separation anxiety 
disorder is equally distributed between boys and girls. 
In survey samples, the disorder is more common in 
girls (DSM-IV). The disorder may be over-diagnosed in 
children and teenagers who live in dangerous 
neighborhoods and have reasonable fears of leaving 
home. 
The remission rate with separation anxiety disorder 
is high. However, there are periods where the illness is 
more severe and other times when it remits. Sometimes 
the condition lasts many years or is a precursor to panic 
disorder with agoraphobia. Older individuals with 
separation anxiety disorder may have difficulty moving 
or getting married and may,. in turn, worry about 
separation from their own children and partner. 
The cause of separation anxiety disorder is not 
known, although some risk factors have been identified. 
Affected children tend to come from families that are 
very close-knit. The disorder might develop after a 
stress such as death or illness in the family or a move. 
Trauma, especially physical or sexual assault, might 
bring on the disorder (Goenjian et al.,’ 1995). The 
disorder sometimes runs in families, but the precise 
role of genetic and environmental factors has not been 
established. The etiology of anxiety disorders is more 
thoroughly discussed in Chapter 4. 
Generalized Anxiety Disorder 
Children with generalized anxiety disorder (or 
overanxious disorder of childhood) worry excessively 
about all manner of upcoming events and occurrences. 
They worry unduly about their academic performance 
or sporting activities, about being on time, or even 
about natural disasters such as earthquakes. The worry 
persists even when the child is not being judged and 
has always performed well in the past. Because of their 
anxiety, children may be overly conforming, 
perfectionist, or unsure of themselves. They tend to 
redo tasks if there are any imperfections. They tend to 
seek approval and need constant reassurance about 
Children and Mental Health 
their performance and their anxieties (DSM-IV). The l- 
year prevalence rate for all generalized anxiety disorder 
sufferers of all ages is approximately 3 percent. The 
lifetime prevalence rate is about 5 percent (DSM-IV). 
About half of all adults seeking treatment for this 
disorder report that it began in childhood or 
adolescence, but the proportion of children with this 
disorder who retain the problem into adulthood is 
unknown. The remission rate is not thought to be as 
high as that of separation anxiety disorder. 
Social Phobia 
Children with social phobia (&so called social anxiety 
disorder) have a persistent fear of being embarrassed in 
social situations, during a performance, or if they have 
to speak in class or in public, get into conversation with 
others, or eat, drink, or write in public. Feelings of 
anxiety in these situations produce physical reactions: 
palpitations, tremors, sweating, diarrhea, blushing, 
muscle tension, etc. Sometimes a full-blown panic 
attack ensues; sometimes the reaction is much more 
mild. Adolescents and adults are able to recognize that 
their fear is unreasonable or excessive, although this 
recognition does not prevent the fear, Children, 
however, might not recognize that their reaction is 
excessive, although they may be afraid that others will 
notice their anxiety and consider them odd or babyish. 
Young children do not articulate their fears, but 
may cry, have tantrums, freeze, cling, appear extremely 
timid in strange social settings, shrink from contact 
with others, stay on the side during social events, and 
try to stay close to familiar adults. They may fall 
behind in school, avoid school completely, or avoid 
social activities among children their age. The 
avoidance of the fearful situations or worry preceding 
the feared event may last for weeks and interfere with 
the individual’s daily routine, social life, job, or school. 
They may find it impossible to speak in social 
situations or in the presence of unfamiliar people (for 
review of social phobia, see DSM-IV; Black et al., 
1997). 
Social phobia is common, the lifetime prevalence 
ranging from 3 to 13 percent, depending on how great 
the fear is and on how many different situations induce 
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the anxiety (DSM-IV; Black et al., 1997). In survey 
studies, the majority of those with the disorder were 
found to be female (DSM-IV). Often the illness is 
lifelong, although it may become less severe or 
completely remit. Life events may reassure the 
individual or exacerbate the anxiety and disorder. 
Treatment of Anxiety 
Although anxiety disorders are the most common 
disorder of youth, there is relatively little research on 
the efficacy of psychotherapy (Kendall et al., 1997). 
For childhood phobias, contingency management” was 
the only intervention deemed to be well-established, 
according to an evaluation by Ollendick and King 
(1998), which applied ,the American Psychological 
Association Task Force criteria (noted earlier). Several 
psychotherapies are probably ejkacious for treating 
phobias: systematic desensitization”; modeling, based 
on research by Bandura and colleagues, which 
capitalizes on an observational learning technique 
(Bandura, 197 1; see also Chapter 2); and several cogni- 
tive-behavioral therapy (CBT) approaches (Ollendick 
& King, 1998). 
CBT, as pioneered by Kendall and colleagues 
(Kendall et al., 1992; Kendall, 1994), is deemed by the 
American Psychological Association Task Foice as 
probably efJicacious. It has four major components: 
recognizing anxious feelings, clarifying cognitions in 
anxiety-provoking situations,12 developing a plan for 
coping, and evaluating the success of coping strategies. 
A more recent study in Australia added a parent 
component to CRT, which enhanced reduction in post- 
treatment anxiety disorder significantly compared with 
CBT alone (Barrett et al., 1996). However, none of the 
interventions identified above as well-established or 
probably eflcacious has, for the most part, been tested 
in real-world settings. 
lo Contingency management attempts to alter behavior by 
manipulating its consequences through the behavioral principles of 
shaping, positive reinforcement, and extinction. 
I’ A technique that trains people to “unlearn” fears by presentation 
of fearful stimuli along with nonfearful stimuli. 
I2 This refers to understanding how cognitions are being distorted. 
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In addition, psychodynamic treatment to address 
underlying fears and worries can be helpful, and 
behavior therapy may reduce the child’s fear of 
separation or of going to school; however, the 
experimental support for these approaches is limited. 
Preliminary research suggests that selective 
serotonin reuptake inhibitors may provide effective 
treatment of separation anxiety disorder and other 
anxiety disorders of childhood and adolescence. Two 
large-scale randomized controlled trials are currently 
being undertaken (Greenhill, 1998a, 1998b). Neither 
tricyclic antidepressants norbenzodiazepines have been 
shown to be more effective than placebo in children 
(Klein et al., 1992; Bernstein et al., 1998). 
Obsessive-Compulsive Disorder 
Obsessive-compulsive disorder (OCD), which is 
classified in DSM-IV as an anxiety disorder, is 
characterized by recurrent, time-consuming obsessive 
or compulsive behaviors that cause distress and/or 
impairment. The obsessions may be repetitive intrusive 
images, thoughts, or impulses. Often the compulsive 
behaviors, such as hand-washing or cleaning rituals, are 
an attempt to displace the obsessive thoughts 
(DSM-IV). Estimates of prevalence range from 0.2 to 
0.8 percent in children, and up to 2% of adolescents 
(Flament et al., 1998). 
There is a strong familial component to OCD, and 
there is evidence from twin studies of both genetic 
susceptibility and environmental influences. If one twin 
has OCD, the other twin is more likely to have OCD if 
the children are identical twins rather than fraternal 
twin pairs. OCD is increased among first-degree 
relatives of children with OCD, particularly among 
fathers (Lenane et al., 1990). It does not appear that the 
child is simply imitating the relative’s behavior, 
because children who develop OCD tend to have 
symptoms different from those of relatives with the 
disease (Leonard et al., 1997). Many adults with either 
childhood- or adolescent-onset of OCD show evidence 
of abnormalities in a neural network known as the 
orbitofrontal-striatal area (Rauch & Savage, 1997; 
Grachev et al., 1998). 
Recent research suggests that some children with 
oCD develop the condition after experiencing one type 
of streptococcal infection (Swedo et al., 1995). This 
condition is referred to by the acronym PANDAS, 
which stands for Pediatric Autoimmune Neuro- 
psychiatric Disorders Associated with Streptococcal 
infections. Its hallmark is a sudden and abrupt 
exacerbation of OCD symptoms after a strep infection. 
This form of OCD occurs when the immune system 
generates antibodies to the’streptococcal bacteria, and 
the antibodies cross-react with the basal ganglia13 of a 
susceptible child, provoking OCD (Garvey et al., 
1998). In other words, the cause of this form of OCD 
appears to be antibodies directed against the infection 
mistakenly attacking a region of the brain and setting 
off an inflammatory reaction. 
The selective serotonin reuptake inhibitors appear 
effective in ameliorating the symptoms of OCD in 
children, although more clinical trials have been done 
with adults than with children. Several randomized, 
controlled trials revealed SSRIs to be effective in 
treating children and adolescents with OCD @lament 
et al., 1985; DeVeaugh-Geiss et al., 1992; Riddle et al., 
1992, 1998). The appropriate duration of treatment is 
still being studied. Side effects are not inconsequential: 
dry mouth, somnolence, dizziness, fatigue, tremors, and 
constipation occur .at fairly high rates. Cognitive- 
behavioral treatments also have been used to treat OCD 
(March et al., 1997), but the evidence is not yet 
conclusive. 
Autism 
Autism, the most common of the pervasive develop- 
mental disorders (with a prevalence of 10 to 12 
children per 10,000 [Bryson & Smith, 1998]), is 
characterized by severely compromised ability to 
engage in, and by a lack of interest in, social 
interactions. It has roots in both structural brain 
abnormalities and genetic predispositions, according to 
family studies and studies of brain anatomy. The search 
for genes that predispose to autism is considered an 
I3 Basal ganglia are groups of neurons responsible for motor and 
impulse control, attention, and regulation of mood and behavior. 
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extremely high research priority for the National 
Institute of Mental Health (NIMH, 1,998). Although the 
reported association between autism and obstetrical 
hazard may be due to genetic factors (Bailey et al., 
1995), there is evidence that several different causes of 
toxic or infectious damage to the central nervous 
system during early development also may contribute 
to autism. Autism has been reported in children with 
fetal’ alcohol syndrome (Aronson et al., 1997), in 
children who were infected with rubella during 
pregnancy (Chess et al., 1978), and in children whose 
mothers took a variety of medications that are known to 
damage the fetus (Williams &Hersh, 1997). 
Cognitive deficits in social perception likely result 
from abnormalities in neural circuitry. Children with 
autism have been studied with several imaging 
techniques, but no strongly consistent findings have 
emerged, although abnormalities in the cerebellum and 
limbic system (Rapin & Katzman, 1998) and larger 
brains (Piven, 1997) have been reported. In one small 
study (Zilbovicius et al., 1995), evidence of delayed 
maturation of the frontal cortex was found. The 
evidence for genetic influences include a much greater 
concordance in identical than in fraternal twins (Cook, 
1998). 
Treatment 
Because autism is a severe, chronic developmental 
disorder, which results in significant lifelong disability, 
the goal of treatment is to promote the child’s social 
and language development and minimize behaviors that 
interfere with the child’s functioning and learning. 
Intensive, sustained special education programs and 
behavior therapy early in life can increase the ability of 
the child with autism to acquire language and ability to 
learn. Special education programs in highly structured 
environments appear to help the child acquire self-care, 
social, and job skills. Only in the past decade have 
studies shown positive outcomes for very young 
children with autism. Given the severity of the 
impairment, high intensity of service needs, and costs 
(both human and financial), there has been an ongoing 
search for effective treatment. 
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Thirty years of research demonstrated the efficacy 
of applied behavioral methods in reducing inap- 
propriate behavior and in increasing communication, 
learning, and appropriate social behavior. A well- 
designed study of a psychosocial intervention was 
carried out by Lovaas and colleagues (Lovaas, 1987; 
McEachin et al., 1993). Nineteen children with autism 
were treated intensively with behavior therapy for 2 
years and compared with two control groups. Followup 
of the experimental group in first grade, in late 
childhood, and in adolescence found that nearly half 
the experimental group but almost none of the children 
in the matched control group were able to participate in 
regular schooling. Up to this point, a number of other 
research groups have, provided at least a partial 
replication of the Lovaas model (see Rogers, 1998). . 
Several uncontrolled studies of comprehensive 
center-based programs have been conducted, focusing 
on language development and other developmental 
skills. A comprehensive model, Treatment and 
Education of Autistic and Related Communication 
Handicapped Children (TEACCH), demonstrated short- 
term gains for preschoolers with autism who received 
daily TEACCH home-teaching sessions, compared with 
a matched control group (Ozonoff & Cathcart, 1998). 
A review of other comprehensive, center-based 
programs has been conducted, focusing on elements 
considered critical to school-based programs, including 
minimum hours of service and necessary curricular 
components (Dawson & Osterling, 1997). 
The antipsychotic drug, haloperidol, has been 
shown to be superior to placebo in the treatment of 
autism (Perry et al., 1989; Locascio et al., 1991), 
although a significant number of children develop 
dyskinesias14 as a side effect (Campbell et al., 1997). 
Two of the SSRIs, clomipramine (Gordon et al., 1993) 
and fluoxetine (McDougle et al., 1996), have been 
tested, with positive results, except in young autistic 
children, in whom clomipramine was not found to be 
therapeutic, and who experienced untoward side effects 
(Sanchez et al., 1996). Of note, preliminar- studies of 
I4 Dyskinesia is an impairment of voluntary movement, such that it 
becomes fragmentary or incomplete. 
some of the newer antipsychotic drugs suggest that they 
may have fewer side effects than conventional 
antipsychotics such as haloperidol, but controlled 
studies are needed before fm conclusions can be 
drawn about any possible advantages in safety and 
efficacy over traditional agents. 
Disruptive Disorders 
Disruptive disorders, such as oppositional defiant 
disorder and conduct disorder, are characterized by 
antisocial behavior and, as such, seem to be a collection 
of behaviors rather than a coherent pattern of mental 
dysfunction. These behaviors are dso frequently found 
in children who suffer from attention-deficitiyper- 
activity disorder, another disruptive disorder, which is 
discussed separately in this chapter. Children who 
develop the more serious conduct disorders often show 
signs of these disorders at an earlier age. Although it is 
common for a very young children to snatch something 
they want from another child, this kind of behavior may 
herald a more generally aggressive behavior and be the 
first sign of an emerging oppositional defiant or 
conduct disorder if it occurs by the ages of 4 or 5 and 
later. However, not every oppositional defiant child 
develops conduct disorder, and the difficult behaviors 
associated with these conditions often remit. 
Oppositional defiant disorder (ODD) is diagnosed 
when a child displays a persistent or consistent pattern 
of defiance, disobedience, and hostility toward various 
authority figures including parents, teachers, and other 
adults. ODD is characterized by such problem 
behaviors as persistent fighting and arguing, being 
touchy or easily annoyed, and deliberately annoying or 
being spiteful or vindictive to other people. Children 
with ODD may repeatedly lose their temper, argue with 
adults, deliberately refuse to comply with requests or 
rules of adults, blame others for their own mistakes, 
and be repeatedly angry and resentful. Stubbornness 
and testing of limits are common. These behaviors 
cause significant difficulties with family and friends 
and at school or work (DSM-IV; Weiner, 1997). 
Oppositional defiant disorder is sometimes a precursor 
of conduct disorder (DSM-IV). 
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In different studies, estimates of the prevalence of 
ODD have ranged from 1 to 6 percent, depending on 
the population sample and the way the disorder was 
evaluated, but not depending on diagnostic criteria. 
Rates are lower when impairment criteria are more 
strict and when information is obtained from teachers 
and parents rather than from the children alone (Shaffer 
et al., 1996a). Before puberty, the condition is more 
common in boys, but after puberty the rates in both 
genders are equal. 
In preschool boys, high reactivity, difficulty being 
soothed, and high motor activity may indicate risk for 
the disorder. Marital discord, disrupted child care with 
a succession of different caregivers, and inconsistent, 
unsupervised child-rearing may contribute to the 
condition. 
Children or adolescents with conduct disorder 
behave aggressively by fighting, bullying, intimidating, 
physically assaulting, sexually coercing, and/or being 
cruel to people or animals. Vandalism with deliberate 
destruction of property, for example, setting fires or 
smashing windows, is common, as are theft; truancy; 
early tobacco, alcohol, and substance use and abuse; 
and precocious sexual activity. Girls with a conduct 
disorder are prone to running away from home and may 
become involved in prostitution. The behavior 
interferes with performance at school or work, so that 
individuals with this disorder rarely perform at the level 
predicted by their IQ or age. Their relationships with 
peers and adults are often poor. They have higher 
injury rates and are prone to school expulsion and 
problems with the law. Sexually transmitted diseases 
are common. If they have been removed from home, 
they may have difficulty staying in an adoptive or 
foster family or group home, and this may further 
complicate their development. Rates of depression, 
suicidal thoughts, suicide attempts, and suicide itself 
are all higher in children diagnosed with a conduct 
disorder (Shaffer et al., 1996b). 
The prevalence of conduct disorder in 9- to 17- 
year-olds in the community varies from 1 to 4 percent, 
depending on how the disorder is defined (Shaffer et 
al., 1996a). Children with an early onset of the 
disorder, i.e., onset before age 10, are predominantly 
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male. The disorder appears to be more common in 
cities than in rural areas (DSM-IV). Those with early 
onset have a worse prognosis and are at higher risk for 
adult antisocial personality disorder (DSM-IV; Rutter 
& Giller, 1984; Hendren & Mullen, 1997). Between a 
quarter and a half of highly antisocial children become 
antisocial adults. 
The etiology of conduct disorder is not fully 
known. Studies of twins and adopted children suggest 
that conduct disorder has both biological (including 
genetic) and psychosocial components (Hendren & 
Mullen, 1997). Social risk factors for conduct disorder 
include early maternal rejeztion, separation from 
parents with no adequate alternative caregiver 
available, early institutionalization, family neglect, 
abuse or violence, parents’ psychiatric illness, parental 
marital discord, large family size, crowding, and 
poverty (Loeber & Stouthamer-Loeber, 1986). These 
factors are thought to lead to a lack of attachment to the 
parents or to the family unit and eventually to lack of 
regard for the rules and rewards of society (Sampson & 
Laub, 1993). Physical risk factors for conduct disorder 
include neurological damage caused by birth 
complications or low birthweight, attention- 
deficit/hyperactivity disorder, fearlessness and stim- 
ulation-seeking behavior, learning impairments, 
autonomic underarousal, and insensitivity to physical 
pain and punishment. A child with both social 
deprivation and any of these neurological conditions is 
most susceptible to conduct disorder (Raine et al., 
1998). 
Since many of the risk factors for conduct disorder 
emerge in the first years of life, intervention must begin 
very early. Recently, screening instruments have been 
developed to enable earlier identification of risk factors 
and signs of conduct disorder in young children (Feil et 
al., 1995). Studies have shown a correlation between 
the behavior and attributes of 3-year-olds and the 
aggressive behavior of these children at ages 11 to 13 
(Raine et al., 1998). Measurements of aggressive 
behaviors have been shown to be stable over time 
(Sampson & Laub, 1993). Training parents of high-risk 
children how to deal with the children’s demands may 
help. Parents may need to be taught to reinforce 
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appropriate behaviors and not harshly punish 
transgressing ones, and encouraged to find ways to 
increase the strength of the emotional ties between 
parent and child. Working with high-risk children on 
social interaction and providing academic help to 
reduce rates of school failure can help prevent some of 
the negative educational consequences of conduct 
disorder (Johnson & Breckenridge, 1982). 
Treatment 
Several psychosocial interventions can effectively 
reduce antisocial behavior in disruptive disorders. A 
recent review of psychosocial treatments for children 
and adolescents identified 82 studies conducted 
between 1966 and 1995 involving 5,272 youth (Brestan 
& Eyberg, 1998). The criterion for inclusion was that 
the child was in treatment for conduct problem 
behavior, based on displaying a symptom of conduct 
disorder or oppositional defiant disorder, rather than on 
a DSM diagnosis of either, although children did meet 
DSM criteria for one of these conditions in about one- 
third of the studies. 
By applying criteria established by the American 
Psychological Association Task Force (see earlier) to 
the 82 studies, two treatments met criteria for well- 
established treatment and 10 for probably efJicacious 
treatment. Two well-established treatments, both di- 
rected at training parents, succeeded in reducing 
problem behaviors. The two treatments were a parent 
training program based on the manual Living With 
ChiEdren (Bemal et al., 1980) and a videotape modeling 
parent training (Spaccarelli et al., 1992). The first 
teaches parents to reward desirable behaviors and 
ignore or punish deviant behaviors, based on principles 
of operant conditioning. The second provides a series 
of videotapes covering parent-training lessons, after 
which a therapist leads a group discussion of the 
videotape lessons. The identification of 12 treatments 
as well-established or probably eficacious is very 
encouraging because of the potential to intervene 
effectively with youth at high risk of poor outcomes. A 
new and promising approach for the treatment of 
conduct disorder is multisystemic therapy, an intensive 
home- and family-focused treatment that is described 
under Home-Based Services. 
Despite strong enthusiasm for improving care for 
conduct-disordered youth, there are important groups of 
children, specifically girls and ethnic minority 
populations, who were not sufficiently represented in 
these’ studies to ensure that the identified treatments 
work for them. Other issues raised by Brestan and 
Eyberg (1998) are cost-effectiveness, the sufficiency of 
a given intervention, effectiveness over time, and the 
prevention of relapse. 
No drugs have been demonstrated to be 
consistently effective in treating *conduct disorder, 
although four drugs have been tested. Lithium and 
methylphenidate have been found (one double-blind 
placebo trial each) to reduce aggressiveness effectively 
in children with conduct disorder (Campbell et al., 
1995; Klein et al., 1997b), but in two subsequent 
studies with the same design, the positive findings for 
lithium could not be reproduced (Rifkin et al., 1989; 
Klein, 1991). In one of the latter studies, methyl- 
phenidate was superior to lithium and placebo. A third 
drug, carbamazepine, was found in a pilot study to be 
effective, but multiple side effects were also reported 
(Kafantaris et al., 1992). The fourth drug, clonidine, 
was explored in an open trial, in which 15 of 17 
patients showed a significant decrease in aggressive 
behavior, but there were also significant side effects 
that would require monitoring of cardiovascular and 
blood pressure parameters (Kemph et al., 1993). 
Substance Use Disorders in Adolescents 
Since the early 1990s there has been a “sharp 
resurgence” in the misuse of alcohol and other drugs by 
adolescents (Johnston et al., 1996). A recent review, 
focusing particularly on substance abuse and 
dependence, synthesizes research findings of the past 
decade (Weinberg et al., 1998). The authors review 
epidemiology, course, etiology, treatment, and 
prevention and discuss comorbidity with other mental 
disorders in adolescents. All of these issues are 
important to public health, but none is more relevant to 
this report than the co-occurrence of alcohol and other 
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substance use disorders with other mental disorders in 
adolescents. 
According to the National Comorbidity Study, 41 
to 65 percent of individuals with a lifetime substance 
abuse disorder also have a lifetime history of at least 
one mental disorder, and about 5 1 percent of those with 
one or more lifetime mental disorders also have a 
lifetime history of at least one substance use disorder 
(Kessler et al., 1996). The rates are highest in the 15-to 
24-year-old age group (Kessler et al., 1994). The cross- 
sectional data on association do not permit any 
conclusion about causality or clinical prediction 
(Kessler et al., 1996), but an appealing theory suggests 
that a subgroup of the population abuses drugs in an 
effort to self-medicate for the co-occurring mental 
disorder. Little is actually known about the role of 
mental disorders in increasing the risk of children and 
adolescents for misuse of alcohol and other drugs. 
Stress appears to play a role in both the process of 
addiction and the development of many of the 
comorbid conditions. 
The review by Weinberg and colleagues (1998) 
provides more detail on epidemiology and assessment 
of alcohol and other drug use in adolescents and 
describes several effective treatment approaches for 
these problems. A meta-analysis and literature review 
(Stanton & Shadish, 1997) concluded that family- 
oriented therapies were superior to other treatment 
approaches and enhanced the effectiveness of other 
treatments. Multisystemic family therapy, discussed 
elsewhere in this chapter, is effective in reducing 
alcohol and other substance use and other severe 
behavioral problems among adolescents (Pickrel & 
Henggeler, 1996). 
Eating Disorders 
Eating disorders are serious, sometimes life- 
threatening, conditions that tend to be chronic (Herzog 
et al., 1999). They usually arise in adolescence and 
disproportionately affect females. About 3 percent of 
young women have one of the three main eating 
disorders: anorexia nervosa, bulimia nervosa, or binge- 
eating disorder (Becker et al., 1999). Binge-eating 
disorder is a newly recognized condition featuring 
Children and Mental Health 
episodic uncontrolled consumption, without 
compensatory activities, such as vomiting or laxative 
abuse, to avert weight gain (Devlin, 1996). Bulimia, in 
contrast, is marked by both binge eating and by 
compensatory activities. Anorexia nervosa is 
characterized by low body weight (< 85 percent of 
expected weight), intense fear of weight gain, and an 
inaccurate perception of body weight or shape 
(DSM-IV). Its mean age of onset is 17 years (DSM-IV). 
The causes of eating disorders are not known with 
precision but are thought to be a combination of 
genetic, neurochemical, psychodevelopmental, and 
sociocultural factors (Becker e; al., 1999; Kaye et al., 
1999). Comorbid mental disorders are exceedingly 
common, but interrelationships are poorly understood. 
Comorbid disorders include affective disorders 
(especially depression), anxiety disorders, substance 
abuse, and personality disorders (Herzog et al., 1996). 
Anorexia nervosa has the most severe consequence, 
with a mortality rate of 0.56 percent per year (or 5.6 
percent per decade) (Sullivan, 1995), a rate higher than 
that of almost all other mental disorders (Herzog et al., 
1996). Mortality is from starvation, suicide, or 
electrolyte imbalance (DSM-IV). The mortality rate 
from anorexia nervosa is 12 times higher than that for 
other young women in the population (Sullivan, 1995). 
Treatment of eating disorders entails psychotherapy 
and pharmacotherapy, either alone or in combination. 
Treatment of comorhid mental disorders also is 
important, as is treatment of medical complications. 
There are some controlled studies of the efficacy of 
specific treatments for u&.&s with bulimia and binge- 
eating disorder (Devlin, 1996), but fewer for anorexia 
nervosa (Kaye et al., 1999). Controlled studies in 
adolescents are rare for any eating disorder (Steiner and 
Lock, 1998). Pharmacological studies in young aduEt 
women found conflicting evidence of benefit from 
antidepressants for anorexia and some reduction in the 
frequency of binge eating and purging with tricychc 
antidepressants, monoamine oxidase inhibitors, and 
SSRIs (see Jimerson et al., 1993; Jacobi et al., 1997). 
Studies mostly of adult women find cognitive- 
behavioral therapy and interpersonal therapy to be 
effective for bulimia and binge-eating disorder 
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(Fairbum et al., 1993; Devlin, 1996; Becker et al., 
1999). Clearly, more research is warranted for the 
treatment of eating disorders, especially because a 
sizable proportion of those with eating disorders have 
limited response to treatment (Kaye et al., 1999). 
Services Interventions 
Treatment Interventions 
This section examines the effectiveness of such 
treatment interventions as outpatient, partial 
hospitalization/day, residential, inpatient treatments, 
and medication. Much of the research on their 
effectiveness deals with children’s outcomes largely 
independent of diagnosis. As noted earlier in this 
chapter (see Treatment Strategies), practitioners and 
researchers previously shied away from diagnosis 
because of the inherent difficulty of making a 
diagnosis, concerns about labeling children, and the 
limited usefulness of DSM classifications for children. 
Each intervention was developed to treat a host of 
mental health conditions in children and adolescents. 
Each also was delivered in a wide range of settings. 
Over time, the combination of interventions and 
settings, with the exception of medication, became 
conceptualized as “treatments,” which stimulated 
research on their effectiveness (Goldman, 1998). They 
are not, however, treatments in the conventional sense 
of the term because they are less specific than other 
treatments with respect to indications, intensity (i.e., 
“dose”), and elements of the intervention. There is little 
research describing treatment in actual clinical settings. 
Outpatient Treatment 
The term “outpatient treatment” covers a large variety 
of therapeutic approaches, with most falling into the 
broad theoretical categories of the psychodynamic, 
interpersonal, and behavioral psychotherapy. 
Outpatient psychotherapy is the most common form of 
treatment for children and adolescents, utilized 
annually by an estimated 5 to 10 percent of children 
and their families in the United States (Bums et al., 
1998). It is also the most extensively studied 
intervention and, with over 300 studies, has the 
strongest research base (Weisz et al., 1998). Outpatient 
therapy is offered to individuals, groups, or families, 
usually in a clinic or private office. The duration of 
treatment varies from 6 to 12 weekly sessions to a year 
or longer. Newer outpatient interventions (e.g., case 
management, home-based therapy) that were developed 
more recently for youth with severe disorders are 
provided with greater frequency (i.e., daily) in the 
home, school, or community. Those interventions are 
reviewed later in this chapter. 
The strongest support for the effectiveness of 
outpatient treatment comes from a series of meta- 
analyses. Meta-analyses are an important type of 
research methodology, described in Chapter 1, that 
enable one to combine research findings from separate 
studies. Nine meta-analyses, published between 1985 
and 1995, probed the effectiveness of research on 
individual, group, and family therapy for children and 
adolescents (Casey & Berman, 1985; Hazelrigg et al., 
1987; Weisz et al., 1987; Kazdin et al., 1990; Baer & 
Nietzel,. 1991; Grossman & Hughes 1992; Shadish et 
al., 1993; Weisz & Weiss, 1993; Weisz et al., 1995). 
Although these meta-analyses vary in time period, age 
groups, and meta-analytic approach, they were largely 
restricted to studies of treatment given in a research 
clinical setting, and their findings are relatively 
consistent. The major findings indicated that the 
improvements with outpatient therapy are greater than 
those achieved without treatment; the treatment is 
highly effective, as was found in meta-analyses of 
adults (Brown, 1987); and the effects of treatment are 
similar, whether applied to problems such as anxiety, 
depression, or withdrawal (internalizing problems) or 
to hyperactivity and aggression (externalizing 
problems) (Kazdin, 1996). 
Given strong evidence of efficacy for outpatient 
treatment, the question of applicability to real-world 
settings has been examined. A meta-analysis was 
performed on studies of the effectiveness of various 
types of outpatient treatment, regardless of whether 
their efficacy had been established through research 
(Weisz et al., 1995). The researchers were able to 
identify only nine studies of treated children in 
nonresearch clinical settings where therapy was a 
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regular service of the clinic and was carried out by 
practicing clinicians. Those nine studies demonstrated 
little or no effect. Clearly, real-world therapy was 
found to be less effective than that provided through a 
research protocol. A variety of factors may account for 
the gap, including less attention in real-world settings 
to careful matching of patients with treatments, less 
adherence to a treatment protocol, and less followup 
care. 
Partial Hospitalization/Day Treatment 
Partial hospitalization, also called day treatment and 
partial care, has been a growing treatment modality for 
youth with mental disorders. Research on partial 
hospitalization as an alternative to inpatient treatment 
generally finds benefit from a structured daily 
environment that allows youth to return home at night 
to be with their family and peers. 
Partial hospitalization is a specialized and intensive 
form of treatment that is less restrictive than inpatient 
care but is more intensive than the usual types of 
outpatient care (i.e., individual, family, or group 
treatment). The most frequently used type of partial 
hospitalization is an integrated curriculum combining 
education, counseling, and family interventions. The 
setting, be it a hospital, school, or clinic, may be tied to 
the theoretical orientation of the treatment, which 
ranges from psychoanalytic to behavioral. Partial 
hospitalization has also been used as a transitional 
service after either psychiatric hospitalization or 
residential treatment, at the point when the child no 
longer needs 24-hour care but is not ready to be 
integrated into the school system. It also is used to 
prevent institutional placement. 
Overall, the research literature points to positive 
gains from adolescent use of day treatment, but most of 
the studies are uncontrolled. Gains relate to academic 
and behavioral improvement; reduction in, or delay of, 
hospital and residential placement; and a return to 
regular school for about 75 percent of patients (Baenen 
et al., 1986; Gabel & Finn, 1986). Day treatment 
programs are not being used as frequently as they might 
be because third-party payers are reluctant to support 
this form of treatment. They claim that the modality is 
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ambiguous, that it induces demand among those who 
would not otherwise seek treatment, and that its length, 
treatment outcomes, and costs are unpredictable (Kiser 
et al., 1986). Research is needed to address these 
issues. 
To date, the only controlled study of partial 
hospitalization compared outcomes for young children 
(ages 5 to 12) with disruptive behavior disorders who 
received intensive day treatment with children who 
received traditional outpatient treatment services (in 
fact, a waiting list control) (Grizenko et al., 1993). The 
results at 6 months favored day treatment in reducing 
behavior problems, decreasing symptoms, and improv- 
ing family functioning. 
Findings from uncontrolled studies of partial 
hospitalization are informative, although not conclu- 
sive. Based on approximately 20 studies, multiple 
benefits have been reported even over the long term 
(see reviews by Kutash & Rivera, 1996; Grizenko, 
1997). In general, child behavior and family 
functioning improve following partial hospitalization. 
Findings for improved academic achievement are 
mixed and possibly suggest that implementation of 
school-based models should be considered. About 
three-fourths of youth are reintegrated into regular 
school, often with the help of special education or other 
school- or community-based services. Several 
uncontrolled studies found that day treatment could 
prevent youth from entering other costly placements 
(particularly inpatient and residential treatment 
centers), which suggests that partial hospitalization 
may reduce overall costs of treatment (Kutash & 
Rivera, 1996). Finally, family participation during and 
following day treatment is essential to obtaining and 
maintaining results (Kutash & Rivera, 1996). 
Residential Treatment Centers 
Residential treatment centers are the second most 
restrictive form of care (next to inpatient 
hospitalization) for children with severe mental 
disorders. Although used by a relatively small 
percentage (8 percent) of treated children, nearly one- 
fourth of the national outlay on child mental health is 
spent on care in these settings (Bums et al., 1998). 
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However, there is only weak evidence for their 
effectiveness. 
A residential treatment center (RTC) is a licensed 
24-hour facility (although not licensed as a hospital), 
which offers mental health treatment. The types of 
treatment vary widely; the major categories are 
psychoanalytic, psychoeducational, behavioral 
management, group therapies, medication management, 
and peer-cultural. Settings range from structured ones, 
resembling psychiatric hospitals, to those that are more 
like group homes or halfway houses. While formerly 
for long-term treatment (e.g., a year or more), RTCs 
under managed care are now serving more seriously 
disturbed youth for as briefly as 1 month for intensive 
evaluation and stabilization. 
Concerns about residential care primarily relate to 
criteria for admission; inconsistency of community- 
based treatment established in the 1980s; the costliness 
of such services (Friedman & Street, 1985); the risks of 
treatment, including failure to learn behavior needed in 
the community; the possibility of trauma associated 
with the separation from the family; difficulty 
reentering the family or even abandonment by the 
family; victimization by RTC staff; and learning of 
antisocial or bizarre behavior from intensive exposure 
to other disturbed children (Barker, 1998): These 
concerns are discussed below. 
In the past, admission to an RTC has been justified 
on the basis of community protection, child protection, 
and benefits of residential treatment per se (Barker, 
1982). However, none of these justifications have stood 
up to research scrutiny. In particular, youth who display 
seriously violent and aggressive behavior do not appear 
to improve in such settings, according to limited 
evidence (Joshi & Rosenberg, 1997). One possible 
reason is that association with delinquent or deviant 
peers is a major risk factor for later behavior problems 
(Loeber & Farrington, 1998). Moreover, community 
interventions that target change in peer associations 
have been found to be highly effective at breaking 
contact with violent peers and reducing aggressive 
behaviors (Henggeler et al., 1998). Although removal 
from the community for a time may be necessary for 
some, there is evidence that highly targeted behavioral 
interventions provided on an outpatient basis can 
ameliorate such behaviors (Brestan & Eyberg, 1998). 
For children in the second category (i.e., those needing 
protection from themselves because of suicide attempts, 
severe substance use, abuse, or persistent running 
away), it is possible that a brief hospitalization for an 
acute crisis or intensive community-based services may 
be more appropriate than an RTC. An intensive long- 
term program such as an RTC with a high staff to child 
ratio may be of benefit to some children, especially 
when sufficient supportive services are not available in 
their communities. In short, there is a compelling need 
to clarify criteria for admission to RTCs (Wells, 1991). 
Previous criteria have been replaced and strengthened 
(i.e., with an emphasis on resources needed after 
discharge) by the National Association of Psychiatric 
Treatment Centers for Children (1990). 
The evidence for outcomes of residential treatment 
comes from research published largely in the 1970s and 
1980s and, with three exceptions, consists of 
uncontrolled studies (see Curry, 1991). 
Of the three controlled studies of RTCs, the first 
evaluated a program called Project Re-Education (Re- 
Ed). Project Re-Ed, a model of residential treatment 
developed in the 196Os, focuses on training teacher- 
counselors, who are backed up by consultant mental 
health specialists. Project Re-Ed schools are located 
within communities, facilitating therapeutic work with 
the family and allowing the child to go home on 
weekends. Camping also is an important component of 
the program, inspired by the Outward Bound Schools 
in England. The first published study of Project Re-Ed 
compared outcomes for adolescent males in Project Re- 
Ed with untreated disturbed adolescents and with 
nondisturbed adolescents. Treated adolescents 
improved in self-esteem, control of impulsiveness, and 
internal control compared with untreated adolescents, 
according to ratings by Project Re-Ed staff and by 
families (Weinstein, 1974). A 1988 followup study of 
Project Re-Ed found that when adjustment outcomes 
were maintained at 6 months after discharge from 
Project Re-Ed, those outcomes were predicted more by 
community factors at admission (e.g., condition of the 
family and school, supportiveness of the local 
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community) than by client factors (e.g., diagnosis, 
school achievement, age, IQ). This suggested that 
interventions in the child’s community might be as 
effective as placement in the treatment setting (Lewis, 
1988). 
The only other controlled study compared an RTC 
with therapeutic foster care through the Parent 
Therapist Program. Both client groups shared 
comparable backgrounds and made similar progress in 
their respective treatment program. However, the 
residential treatment cost twice as much as therapeutic 
foster care (Rubenstein et al., 1978). 
Despite strong caveats about the quality, 
sophistication, and import of uncontrolled studies, 
several consistent findings have emerged. For most 
children (60 to 80 percent), gains are reported in areas 
such as clinical status, academic skills, and peer 
relationships. Whether gains are sustained following 
treatment appears to depend on the supportiveness of 
the child’s post-discharge environment (Wells, 1991). 
Several studies of single institutions report main- 
tenance of benefits from 1 to 5 years later (Blackman et 
al,, 1991; Joshi &Rosenberg, 1997). In contrast, a large 
longitudinal six-state study of children in publicly 
funded RTCs found at the ‘I-year followup that 75 
percent of youth treated at an RTC had been either 
readmitted to a mental health facility (about 45 percent) 
or incarcerated in a correctional setting (about 30 
percent) (Greenbaum et al., 1998). 
In summary, youth who are placed in RTCs clearly 
constitute a difficult population to treat effectively. The 
outcomes of not providing residential care are 
unknown. Transferring gains from a residential setting 
back into the community may be difficult without clear 
coordination between RTC staff and community 
services, particularly schools, medical care, or 
community clinics. Typically, this type of coordination 
or aftercare service is not available upon discharge. The 
research on RTCs is not very enlightening about the 
potential to substitute RTC care for other levels of care, 
as this requires comparisons with other interventions. 
Given the limitations of current research, it is 
premature to endorse the effectiveness of residential 
treatment for adolescents. Moreover, research is needed 
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Inpatient hospitalization is the most restrictive type of 
care in the continuum of mental health services for 
children and adolescents. Questions about excessive 
and inappropriate use of hospitals were raised in the 
early 1980s (Knitzer, 1982) and clearly documented 
thereafter in rising admission rates from the 1980s into 
the mid- 199Os, without evidence of increased social or 
clinical need for such treatment (Weller et al., 1995). 
Inpatient care consumes about half of child mental 
health resources, based on the latest estimate available 
(Bums, 199 l), but it is the clinical intervention with the 
weakest research support. Nevertheless, because some 
children with severe disorders do require a highly 
restrictive treatment environment, hospitals are 
expected to remain an integral component of mental 
health care (Sir@ et al., 1994). More concerted 
attention to the risks and benefits of hospital use is 
critical, however, along with development of 
community-based alternative services. 
Research on inpatient treatment mostly consists of 
uncontrolled studies (Curry, 1991). Factors that are 
likely to predict benefit have been identified from such 
studies. Beneficial factors were found to include higher 
child intelligence; the quality of family functioning and 
family involvement in treatment; specific 
characteristics of treatment (e.g., completion of 
treatment program and planned discharge); and the use 
of aftercare services. Neither age nor gender affected 
prognosis after hospitalization. The prognosis was poor 
for several clinical characteristics, including children 
with a psychotic diagnosis and antisocial features with 
conduct disorder (Kutash & Rivera, 1996). 
Only three controlled studies evaluated the 
effectiveness of inpatient treatment: one that random- 
ized antisocial children to specific interventions on an 
inpatient unit (Kazdin et al., 1987a, 1987b) and two 
older clinical trials (Flomenhaft, 1974; Winsberg et al., 
1980). All three studies demonstrated that community 
care was at least as effective as inpatient treatment. 
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to identify those groups of children and adolescents for 
whom the benefits of residential care outweigh the 
potential risks. 
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More recently there have been preliminary 
favorable findings from a randomized trial of inpatient 
treatment versus multisystemic therapy (MST), an 
intensive home-based intervention. For example, MST 
was more effective than psychiatric hospitalization in 
reducing antisocial behavior, improving family 
structure and cohesion, improving social relationships, 
and keeping children in school and out of institutions 
(after the initial period when the control group was in 
the hospital). Hospitalized youth reported improved 
self-esteem, and youth in both treatment conditions 
showed comparable decreases in emotional distress 
(Henggeler et al., 1998). A great deal more research is 
needed on inpatient hospitalization, as it is by far the 
costliest and most restrictive form of care. Recent 
changes in health care management have resulted in 
short lengths of stay for children and adolescents. 
Preliminary results from the study of MST indicate that 
intensive home-based services may be a viable 
alternative to hospitalization. However, even when 
such services are available, there may be a need for 
brief 24-hour stabilization units for handling crises (see 
Crisis Services). 
Newer Community-Based Interventions ’ 
Since the 1980s the field of children’s mental health 
has witnessed a shift from institutional to community- 
based interventions. The forces behind this 
transformation are presented in a subsequent section, 
Service Delivery. This section attempts to answer the 
question of whether community-based interventions are 
effective. It covers a range of comprehensive 
community-based interventions, including case 
management, home-based services, therapeutic foster 
care, therapeutic group homes, and crisis services. 
Although the evidence for the benefits of some of these 
services is uneven at best, even uncontrolled studies 
offer a starting point for studying the effectiveness and 
feasibility of their implementation. Many of the 
evaluations to date offer a first glimpse into the benefits 
of these services and the extent to which they may be 
valuable for further examination. Of these inter- 
ventions, the most convincing evidence of effectiveness 
is for home-based services and therapeutic foster care, 
as discussed below. 
There is a special emphasis throughout this section 
on “children with serious emotional disturbances,” as 
many of these community-based services are targeted 
to this population of the most serious severely affected 
children. The term serious emotional disturbance refers 
to a diagnosed mental health problem that substantially 
disrupts a child’s ability to function socially, 
academically, and emotionally. It is not a formal 
DSM-IV diagnosis but rather a term that has been used 
both within states and at the Federd level to identify a 
population of children with significant functional 
impairment due to mental, emotional, and behavioral 
problems who have a high need for services. The 
official definition of children with serious emotional 
disturbance adopted by the Substance Abuse and 
Mental Health Services Administration is “persons 
from birth up to age 18 who currently or at any time 
during the past year had a diagnosable mental, 
behavioral, or emotional disorder of sufficient duration 
to meet diagnostic criteria specified within the DSM- 
III-R, and that resulted in functional impairment which 
substantially interferes with or limits the child’s role or 
functioning in family, school, or community activities” 
(SAMHSA, 1993, p. 29425).15 The term is used in a 
variety of Federal statutes in reference to children 
fitting that description and does not signify any 
particular diagnosis per se; rather, it is a legal term that 
triggers a host of mandated services to meet the needs 
of these children (see Service Delivery section). 
Case Management 
Case management is an important and widespread 
component of mental health services, especially for 
children with serious emotional disturbances. The main 
purpose of case management is to coordinate the 
provision of services for individual children and their 
families who require services from multiple service 
providers. Case managers take on roles ranging from 
brokers of services to providers of clinical services. 
” This definition is also used with newer diagnostic systems, such 
as DSM-IV. 
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There is a considerable amount of variation in models 
of case management. In one important model, called 
“wraparound,” case managers involve families in a 
participatory process of developing an individualized 
plan focusing on individual and family strengths in 
multiple life domains. Research on wraparound is still 
in its early stages (Bums & Goldman, 1999). 
There have been controlled studies of three 
programs that used case managers who work 
individually rather than as part of an interdisciplinary 
team (discussed later). In one study of the Partner’s 
Project in Oregon, case management was compared 
with “usual services,” which did not include case 
management (Gratton et al., 1995). The authors found 
at 1 -year followup that children in the Partner’s Project 
scored significantly higher on measures of social 
competence and had received more individualized, 
comprehensive services, and a greater degree of service 
coordination. 
The second study compared the outcomes of 
intensive case management and regular case 
management for mentally ill homeless children in 
Seattle (Cauce et al., 1994). The case managers in the 
intensive condition had lower caseloads, were required 
to spend more hours supervising the youth,.had flexible 
funds (for clothing, transportation, etc.) at their 
disposal, spent more hours in consultation with 
psychologists, and were of higher educational status. 
After 1 year, the study found that both groups showed 
substantial yet similar improvement in mental health 
and social adjustment. 
A model known as Children and Youth Intensive 
Case Management (CYICM) was evaluated in two 
controlled studies. The program has been described as 
an Expanded Broker Model, which means that the case 
manager, in addition to brokering services, is 
responsible for assessment, planning, linking, and 
advocating on behalf of the youth and family. Case 
managers, with caseloads of 10 children, are given 
$2,000 of flexible funds per child each year to purchase 
treatment and ancillary services (e.g., transportation 
and educational aids). In the first study, the authors 
found that children in the program spent significantly 
more days in the community between episodes of 
psychiatric hospitalization and were hospitalized for 
fewer days than before enrollment (Evans et al., 1994). 
A subsequent study evaluated a random sample of 199 
children enrolled in CYICM (Evans et al., 1996b). 
Findings at 3-year followup indicated significant 
behavioral improvements and decreases in unmet 
medical, recreational, and educational needs compared 
with findings at enrollment. As in the previous study, 
children who had been in CYICM for 2 years had spent 
fewer days in psychiatric hospitals and more days in 
community settings during the intervals between 
hospitalizations. This study went further to compare 
their hospital utilization with that by children not 
enrolled in the program. Although CYICM clients spent 
more days in psychiatric hospitals before enrollment, 
they used inpatient services after enrollment 
significantly less than did non-enrollees. CYICM 
clients’ hospital admissions declined fivefold after 
enrollment whereas among non-enrollees the decline in 
admission rates was less than half that value. This 
difference translated into a savings of almost 
$8,000,000 for New York State, where the project took 
place. 
Some research has investigated the effects of 
extending case management on children with a dual 
diagnosis of a mental disorder and a substance abuse 
problem. Within the CYICM program, researchers 
looked at whether adolescents with mental disorders 
and substance abuse problems derived comparable 
benefits from the program as did those without 
substance abuse problems (Evans et al., 1992). No 
significant differences were found in the average 
number of inpatient admissions both before and after 
enrollment. There was also no significant difference 
between groups in the average decrease from pre- to 
postenrollment in the number of days spent in 
hospitals. These results indicate that case management 
can be as effective for youth presenting with substance 
abuse problems as for youth presenting with other 
psychiatric disorders. 
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Team Approaches to Case Management 
Several studies assessed the value of case management 
as part of a treatment team. In a randomized trial in 
North Carolina (Burns et al., 1996), youth served by an 
interdisciplinary treatment team led by a case manager 
were compared with a control group of youth served by 
a treatment team led by their primary clinician in the 
role of case manager (also called clinician case 
manager). At l-year followup, case managers in the 
experimental group reported spending significantly 
more time with their clients, as well as significantly 
more time on the core functions of case management 
(e.g., outreach; assessment of strengths, needs, and 
resources; service planning and monitoring; linking, 
referral, and advocacy; and crisis intervention). The 
experimental group also remained in the case-managed 
program longer, spent fewer days in psychiatric 
hospitals, and received more community-based services 
and a more comprehensive array of services. Although 
both groups showed similar clinical and functional 
improvements, parents of youth in the experimental 
group reported more satisfaction with the service 
system. The study concluded that traditional case 
managers, rather than clinician case managers, provide 
a more cost-effective method for attaining positive 
behavioral outcomes and access to mental health 
services. 
Another example of a team approach to case 
management is the Family Centered Intensive Case 
Management (FCICM) program. This was originally 
created as a variation of Child and Youth Intensive 
Case Management in New York, with the later addition 
of a wraparound approach. The wraparound approach 
is based on a belief that the child and family should be 
placed at the center of an array of coordinated health 
and mental health, educational, and other social welfare 
services and resources, which a case manager wraps 
around the patient and family. In a randomized trial, 
children were assigned to either FCICM or Family- 
Based Treatment (Evans et al., 1996a). Family-Based 
Treatment included training, support, and respite care 
for foster families but did not include case managers. 
The findings at 18 months (or at discharge) indicated 
that children in FCICM had significantly fewer 
behavioral symptoms and significantly greater 
improvements in overall functioning than those in 
Family-Based Treatment. In addition, the average 
annual cost of FCICM was less than half that of 
Family-Based Treatment. 
The Fostering Individualized Assistance Program 
(FLAP) is an example of case management provided 
through a wraparound approach. The effectiveness of 
this model, which used clinical case managers, was 
compared with standard foster care in a randomized 
trial involving 13 1 children and their families (Clark et 
al., 1998). The most important duty of the FIAP case 
managers was to arrange monthly team meetings for the 
monitoring of individualized service plans. Although 
both groups showed significant improvement in their 
behavioral adjustment over a 3%year period, children 
in the FIAP group were less likely to change 
placements, and boys in the group reported better social 
adjustment and fewer delinquencies. Older youth in the 
group were more likely to maintain placements in 
homes of relatives and less likely to run away. Youth in 
FIAP were also absent from school less often and spent 
fewer days suspended from school. Overall, youth in 
the FIAP group showed more improvement than did 
youth in standard foster care. Multiple uncontrolled 
studies of case management using a wraparound 
approach were summarized in a recent monograph 
focusing on the wraparound process (Bums & 
Goldman, 1999). Overall, the reviewed studies, 
although using uncontrolled methods, offer emerging 
evidence of the potential effectiveness of case 
management using a wraparound process. 
While evidence is limited and many of the positive 
outcomes focus on service use rather than clinical 
status, there is some indication that case management 
is an effective intervention for youth with serious 
emotional disturbances. Studies in this area are difficult 
to conduct because of resource limitations and of 
varying approaches to case management. Agreement on 
standards for specific case management models is 
174 
needed in order to proceed with efficient and reliable 
controlled research in this area. In addition, future 
research needs to address the issue of cost- 
effectiveness, as some evidence presented above has 
shown savings from less utilization of institutional care. 
Home-Based Services 
This section describes the strong record of 
effectiveness for home-based services, which provide 
very intensive services within the homes of children 
and youth with serious emotional disturbances. A major 
goal is to prevent an out-of-home placement (i.e., in 
foster care, residential, or inpatient treatment). Home- 
based services are usually provided through the child 
welfare, juvenile justice, and/or mental health systems. 
They are also referred to as in-home services, family 
preservation services, family-centered services, family- 
based services, or intensive family services. 
Stroul(l988) identified three major goals of home- 
based services: to preserve the family’s integrity and 
prevent unnecessary out-of-home placements; to put 
adolescents and their families in touch with community 
agencies and individuals, thus creating an outside 
support system; and to strengthen the family’s coping 
skills and capacity to function effectively in the 
community after crisis treatment is completed. The 
specific services provided most often include 
evaluation, assessment, counseling, skills training, and 
coordination of services. The historical evolution of 
home-based services is discussed further under Support 
and Assistance for Families in Service Delivery. 
The evidence for the benefits of home-based 
services was recently evaluated in a meta-analysis of 
controlled studies only (Fraser et al., 1997). The 
analysis referred to home-based services as “family 
preservation services”; these were sponsored either by 
the child welfare or juvenile justice systems. For 22 
studies the authors analyzed specific measures such as 
out-of-home placement, family reunification, arrest, 
incarceration, and hospitalization, with the control 
group defined as youth receiving “usual” or “routine” 
services. While a majority of the studies demonstrated 
marginal gains in effectiveness, other services appeared 
to be significantly more effective than usual services. 
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Within the child welfare system, particularly effective 
family reunification programs were the Homebuilders 
Program in Tacoma, Washington, which was designed 
to reunify abused and neglected children with their 
families by providing family-based services (Fraser et 
al., 1996), and the family reunification programs in 
Washington State and in UtzLh (Pecora et al., 1991). 
Studies suggested that 75 to 90 percent of the children 
and adolescents who participated in such programs 
subsequently did not require placement outside the 
home. The youths’ verbal and physical aggression 
decreased, and cost of services was reduced (Hinckley 
& Ellis, 1985). The success of these family 
preservation programs is based on the following: 
services are delivered in a home and community 
setting; family members are viewed as colleagues in 
defining a service plan; back-up services are available 
24 hours a day; skills are built according to the 
individual needs of family members; marital and family 
interventions are offered; community services are 
efficiently coordinated; and assistance with basic needs 
such as food, housing, and clothing is given (Fraser et 
al., 1997). 
Multisystemic Therapy 
Multisystemic therapy programs within the juvenile 
justice system have demonstrated effectiveness. MST 
is an intensive, short-term, home- and family-focused 
treatment approach for youth with severe emotional 
disturbances. MST was originally based on risk factors 
that were identified in the published literature and was 
designed for delinquents. MST intervenes directly in 
the youth’s family, peer group, school, and 
neighborhood by identifying and targeting factors that 
contribute to the youth’s problem behaviors. The main 
goal of MST is to develop skills in both parents and 
community organizations affecting the youth that will 
endure after brief (3 to 4 months) and intensive 
Children and Mental Health 
The findings are presented below according to their 
organizational sponsorship by either child welfare or 
juvenile justice system. 
Family Preservation Programs Under the Child 
Welfare System 
Mental Health: A Report of the Surgeon General 
treatment. MST was constructed around a set of 
principles that were put into practice and then 
expanded upon in a manual (Henggeler et al., 1998). 
Elaborate training, supervision, and monitoring for 
treatment adherence make this an exemplary approach. 
Furthermore, publication of an MST manual and the 
high level of clinical training in MST distinguish this 
model from other types of family preservation services. 
The efficacy of MST has been established in three 
randomized clinical trials for delinquents within the 
juvenile justice system. The first of these studies took 
place in Memphis, Tennessee, and revealed that MST 
was more effective than usual community services in 
decreasing adolescent behavioral problems and in 
improving family relations (Henggeler et al., 1986). 
The second was conducted in Simpsonville, South 
Carolina, and compared outcomes for 84 juvenile 
offenders randomly assigned to either MST or usual 
services. At 59 weeks after referral, youth who had 
received MST had fewer arrests and self-reported 
offenses and had spent an average of 10 fewer weeks 
incarcerated than did the youth in usual services. In 
addition, families served by MST reported increased 
family cohesion and decreased youth aggression in peer 
relations (Henggeler et al., 1992). In the third study, 
MST was compared with individual therapy in 
Columbia, Missouri, and was found to be more 
effective in ameliorating adjustment problems in 
individual family members. A 4-year followup of 
rearrest data indicated that MST was more effective 
than individual therapy in preventing future criminal 
behavior, including violent offenses (Borduin et al., 
1995). Studies found improved behavior, fewer arrests, 
and lower costs. These findings encouraged the 
investigators to test the effectiveness of MST in other 
organizational settings (e.g., child welfare and mental 
health), allowing them to target other clinical 
populations, including youthful sex offenders (Borduin 
et al., 1990), abused and neglected youth (Brunk et al., 
1987), and child psychiatric inpatients (see Inpatient 
Treatment section). Initial results are promising for 
youth receiving MST instead of psychiatric 
hospitalizations (Henggeler et al., 1998). As expected, 
some adjustments to MST are required to handle 
children who are dangerous to themselves and who do 
not respond as quickly to treatment as’the delinquent 
youth in previous studies. The efficacy of MST was 
demonstrated in real-world settings but only by one 
group of investigators; thus, the results need to be 
reproduced by others and future effectiveness research 
needs to determine whether the same benefits can be 
demonstrated with less support from experts. 
Therapeutic Foster Care 
Therapeutic foster care is considered the least 
restrictive form of out-of-home therapeutic placement 
for children with severe emotioni disorders. Care is 
delivered in private homes with specially trained foster 
parents. The combination of family-based care with 
specialized treatment interventions creates “a 
therapeutic environment in the context of a nurturant 
family home” (Stroul & Friedman, 1988). These 
programs, which are often funded jointly by child 
welfare and mental health agencies, are responsible for 
arranging for foster parent training and oversight. 
Although the research base is modest compared with 
‘other widely used interventions, some studies have 
reported positive outcomes, mostly related to 
behavioral improvements and movement to even less 
restrictive living environments, such as traditional 
foster care or in-home placement. 
While therapeutic foster care programs vary 
considerably, they have some features in common. 
Children are placed with foster parents who are trained 
to work with children with special needs. Usually, each 
foster home takes one child at a time, and caseloads of 
supervisors in agencies overseeing the program remain 
small. In addition, therapeutic foster parents are given 
a higher stipend than that given to traditional foster 
parents, and they receive extensive preservice training 
and in-service supervision and support. Frequent 
contact between case managers or care coordinators 
and the treatment family is expected, and additional 
resources and traditional mental health services may be 
provided as needed. 
Therapeutic foster care programs are inexpensive 
to start (few requirements for facilities or salaried staff) 
and have lower costs than more restrictive programs. In 
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Ontario, a study found that therapeutic foster care cost 
half that of residential treatment center placement for 
the same period of time (Rubenstein et al., 1978). 
There have been four efficacy studies, each with 
randomized, controlled designs. In the first study, 20 
youths who had been previously hospitalized were 
assigned to either therapeutic foster care or other out- 
of-hospital settings, such as residential treatment 
centers or homes of relatives. The youths in therapeutic 
foster care showed more improvements in behavior and 
lower rates of reinstitutionalization, and the costs were 
lower than those in other settings (Chamberlain & 
Reid, 1991). In another study, which concentrated on 
youths with histories of chronic delinquency, those in 
therapeutic foster care were incarcerated less frequently 
and for fewer days per episode than youths in other 
residential placements. Thus, at 2-year followup, 44 
percent fewer children in therapeutic foster care were 
incarcerated (Chamberlain & Weinrott, 1990). In a 
third study, outcomes for children in therapeutic foster 
care were compared with those of children in standard 
foster care. Children in therapeutic foster care were less 
likely during a 2-year study to run away or to be 
incarcerated and showed greater emotional and 
behavioral adjustment (Clark et al., 1994). In the most 
recent study, therapeutic foster care was compared with 
group care: children receiving the former showed 
significantly fewer criminal referrals, returned to live 
with relatives more often, ran away less often, and were 
confined to detention or training schools less often 
(Chamberlain & Reid, 1998). 
All four studies of treatment effectiveness showed 
that youths in therapeutic foster care made significant 
improvements in adjustment, self-esteem, sense of 
identity, and aggressive behavior. In addition, gains 
were sustained for some time after leaving the 
therapeutic foster home (Bogart, 1988; Hawkins et al., 
1989; Chamberlain & Reid, 1991). 
There are also promising indications from 
uncontrolled studies. Looking at 18 reports from 12 
therapeutic foster care programs across the country, 
Kutash and Rivera (1996) concluded that between 
about 60 and 90 percent of youth treated in therapeutic 
foster homes are discharged to less restrictive settings. 
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Three programs also reported followup data, indicating 
that about 70 percent of youth treated in therapeutic 
foster homes remained in less restrictive settings for a 
substantial amount of time after treatment. 
It is clear from these studies that therapeutic foster 
care produces better outcomes at lower costs than more 
restrictive types of placement. Furthermore, with the 
fairly recent development of standards for therapeutic 
foster care, as well as a standards review instrument 
(Foster Family-Based Treatment Association, 1995), 
services can be monitored for quality and fidelity to the 
therapeutic approach, making it easier to ascertain if 
the approach taken produces the favorable outcomes. 
Therapeutic Croup Homes 
For adolescents with serious emotional disturbances the 
therapeutic group home provides an environment 
conducive to learning social and psychological skills. 
This intervention is provided by specially trained staff 
in homes located in the community, where local 
schools can be attended. Each home typically serves 5 
to 10 clients and provides an array of therapeutic 
interventions. Although the types and combinations of 
treatment vary, individual psychotherapy, group 
therapy, and behavior modification are usually 
included. 
There are two major models of therapeutic group 
homes. The first is the teaching family model, 
developed at the University of Kansas, then moved to 
Boys Town in Omaha, Nebraska (Phillips et al., 1974). 
The second is the Charley model, developed at the 
Menninger Clinic. Both models use their staff as the 
key agents for change in the disturbed youth; selection 
and training of the staff are emphasized. Both models 
employ couples who live at the homes 24 hours a day. 
The teaching family model emphasizes structured 
behavioral interventions through teaching new skills 
and positively reinforcing improved behavior. Other 
group homes use individual psychotherapy and group 
interaction. 
There is a dearth of research on the effectiveness of 
therapeutic group home programs targeted toward 
emotionally disturbed adolescents. These homes have 
been developed primarily for children under the care of 
177 
Mental Health: A Report of the Surgeon General 
juvenile justice or social welfare. A dissertation 
(Roose, 1987) studied the outcomes of 20 adolescents 
treated in a group home. Adolescents with severe 
character pathology or major psychiatric disorders were 
not admitted. Twenty group home adolescents were 
compared with 20 untreated adolescents. At an 18- 
month followup, 90 percent of the treated group had 
fair or good functioning, defined by improved 
relationships with parents, peers, and fellow workers. 
Only 45 percent of the untreated group achieved similar 
functioning. The treated group experienced a 
significant decrease in psychopathology, while the 
untreated group did not. 
Therapeutic group homes were compared with 
therapeutic foster care in two studies. The first study 
found equivalent gains for youth in the two 
interventions, but group home placement was twice as 
costly as therapeutic foster care (Rubenstein et al., 
1978). A second study, a randomized clinical trial, 
compared the outcomes for 79 males with histories of 
juvenile delinquency placed in either group homes or 
therapeutic foster homes (Chamberlain & Reid, 1998). 
The boys treated in therapeutic foster homes had 
significantly fewer criminal referrals and returnedmore 
often to live with relatives, suggesting this to be a more 
effective intervention. The implication of these studies 
is that if therapeutic foster care is available, and if the 
foster parents are willing to take youth with serious 
behavioral problems, therapeutic foster care may be a 
better treatment choice for youth who previously would 
have been placed in group homes. 
Existing research suggests that therapeutic group 
home programs produce positive gains in adolescents 
while they are in the home, but the limited research 
available reveals that these changes are seldom 
maintained after discharge (Kirigin et al., 1982). The 
conclusion may be similar to that for residential 
treatment center placement: long-termoutcomes appear 
to be related to the extent of services and support after 
discharge. Adolescents who have been placed in 
therapeutic group homes because of mental disorders 
frequently have histories of multiple prior placements 
(particularly in foster homes), a situation that is 
associated with a poor prognosis. Thus, future 
programs would benefit from assessing alternative 
strategies for treatment after discharge from group 
homes. 
Crisis Services 
Crisis services are used in emergency situations either 
to furnish immediate and sufficient care or to serve as 
a transition to longer term care within the mental health 
system. These services are extremely important because 
many youth enter the mental health service system at a 
point of crisis. Crisis services include three basic 
components: (1) evaluation and assessment, (2) crisis 
intervention and stabilization, and (3) followup 
planning. The goals of crisis services include 
intervening immediately, providing brief and intensive 
treatment, involving families in treatment, linking 
clients and families with other community support 
services, and averting visits to the emergency 
department or hospitalization by stabilizing the crisis 
situation in the most normal setting for the adolescent. 
Crisis services include telephone hotlines, crisis group 
homes, walk-in crisis intervention services, runaway 
shelters, mobile crisis teams, and therapeutic foster 
homes when used for short-term crisis placements. 
Crisis programs are small in order to facilitate close 
relationships among the staff, child, and family. Crisis 
staff are required to have skills and experience in the 
areas of assessment, emergency treatment, and family 
support. Short-term services are provided, with the staff 
meeting more frequently with the client at the outset of 
the crisis. A typical treatment plan consists of 10 
sessions over a period of 4 to 6 weeks. Crisis services 
usually are available 24 hours a day, 7 days a week 
(Goldman, 1988). 
Research on crisis services consists exclusively of 
uncontrolled studies. Kutash and Rivera (1996) 
reviewed 12 studies with pre-postI designs. Positive 
behavioral and adjustment outcomes for youth 
presenting to crisis programs and emergency 
departments across the country were reported in all of 
I6 Pre-post design: a research design in which a measure is 
compared on the same individual research subjects before and after 
an intervention. 
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the studies. Most programs also demonstrated the 
capacity to prevent institutionalization. 
The most recent studies examine three different 
models: a mobile crisis team, short-term residential 
services, and intensive in-home service. The first study 
examined the Youth Emergency Services (YES) 
program in New York. This program included amobile 
crisis team that sent clinicians directly to the scene of 
the crisis. The data showed that YES prevented 
emergency department visits and out-of-home 
placements (Shulman & Athey, 1993). 
A second crisis program, in Suffolk County, New 
York, involved short-term residential services. In a 
study of 100 children served by the program over a 2- 
year period, more than 80 percent were discharged in 
less than 15 days. Most were diverted from inpatient 
hospitalization, and inpatient admissions to the state 
children’s psychiatric center for Suffolk County were 
reduced by 20 percent after the program was 
established (Schweitzer & Dubey, 1994). 
In the third study, records were analyzed from a 
large sample of youth (nearly 700) presenting to the 
Home Based Crisis Intervention (HBCI) program in 
New York over a 4-year period. Youth received short- 
term, intensive, in-home emergency services. After an 
average service episode of 36 days, 95 percent of the 
youth were referred to, or enrolled in, other services 
(Boothroyd et al., 1995). The HBCI program was 
established at eight locations across the State of New 
York. Overall, programs with more access to 
community resources reported shorter average lengths 
of services. 
Although crisis and emergency services represent 
a promising intervention, the research done so far only 
includes uncontrolled studies, limiting the conclusions 
that can be drawn. Kutash and Rivera (1996) 
recommend additional effectiveness research using 
controlled study designs and comparing differences 
between the various types of crisis services. Finally, 
there remains a need for investigation of cost- 
effectiveness as well as an exploration of the 
integration of crisis services into systems of care. 
Service Delivery 
The focus of this section is on service systems-their 
origins, nature, and financing and also their 
effectiveness, delivery, and utilization-rather than on 
individual interventions and treatments, which were 
covered in previous sections of this chapter. 
About 20 years ago it became clear that children 
and families were failing to receive adequate care from 
the public sector, whose services were fragmented, 
inadequate, and overreliant on institutional care. As a 
result, the emphasis of service delivery has shifted to 
systems of care that are designed to provide culturally 
competent, coordinated se&ices; community-based 
services; new financing arrangements in the private and 
public sectors; family participation in decisionmaking 
about care for their children; and individualized care 
drawing on treatment and social supports called 
wraparound services, described above. Thus, there has 
been progress in transforming the nature of service 
delivery and its financing, but the central question of 
the effectiveness of systems of care has not yet been 
resolved. 
At the outset, it is important to note that while 
systems of care are designed to provide the appropriate 
level of services for all children, it is children with 
serious emotional disturbances, particularly children 
who are involved in multiple service sectors, who are 
likely to benefit the most. There are approximately 6 
million to 9 million children and adolescents in the 
United States with serious emotional disturbances 
(Friedman et al., 1996a; Lavigne et al., 1996), 
accounting for 9 to 13 percent of all children (Friedman 
et al., 1996a; Friedman et al., 1998). 
The system for delivering mental health services to 
children and their families is complex, sometimes to the 
point of inscrutability-a patchwork of providers, 
interventions, and payers. Much of the complexity 
stems from the multiple pathways into treatment and 
the multiple funding streams for services. However, 
once care has begun, the interventions and settings 
themselves are generally the same as those covered in 
previous sections of this chapter. 
179 
Mental Health: A Report of the Surgeon General 
Service Utilization 
This section presents research findings about the 
utilization of mental health services by children and 
adolescents. The foremost finding is that most children 
in need of mental health services do not get them. 
Another finding refutes the common perception that 
children who do not need specialty mental health 
services are more likely to receive such services than 
those who really do need them. This section also 
discusses children’s high dropout rates from treatment 
and the significance of this problem for children of 
different cultural backgrounds. 
Utilization in Relation to Need 
The conclusion that a high proportion of young people 
with a diagnosable mental disorder do not receive any 
mental health services at all (Bums et al., 1995; Leaf et 
al., 1996) reinforces an earlier report by the U.S. Office 
of Technology Assessment ( 1986), which indicated that 
approximately 70 percent of children and adolescents 
in need of treatment do not receive mental health 
services. Only one in five children with a serious 
emotional disturbance used mental health specialty 
services, although twice as many such children 
received some form of mental health intervention 
(Bums et al., 1995). Thus, about 75 to 80 percent fail to 
receive specialty services, and the majority of these 
children fail to receive any services at all, as reported 
by their families. The most likely reasons for 
underutilization relate to the perceptions that treatments 
are not relevant or are too demanding or that stigma is 
associated with mental health services; the reluctance 
of parents and children to seek treatment; 
dissatisfaction with services; and the cost of treatment 
(Pavuluri et al., 1996; Kazdin et al., 1997). 
Studies do, however, demonstrate a clear and 
strong relationship between use of services and 
presence of a diagnosis and/or presence of impaired 
functioning. In the study by Leaf and colleagues 
(1996), young people with both a diagnosis and 
impaired functioning were 6.8 times more likely to see 
a specialist than were those with no diagnosis and a 
higher level of functioning. 
The study by Bums and colleagues also showed 
where children were receiving treatment. Of those who 
received services and had both a diagnosis and 
impaired functioning, about 40 percent received 
services in the specialty mental health sector, about 70 
percent received services from the schools, about 11 
percent from the health sector, about 16 percent from 
the child welfare sector, and about 4 percent from the 
juvenile justice sector. For nearly half the children with 
serious emotional disturbances who received services, 
the public school system was the sole provider (Bums 
et al., 1995). After reviewing thFse findings and the 
findings from other studies, Hoagwood and Erwin 
(1997) also concluded that schools were the primary 
providers of mental health services for children. 
Early Termination of Treatment 
Among children and adolescents who begin treatment, 
the dropout rate is high, although estimates vary 
considerably. According to Kazdin and colleagues 
(1997), 40 to 60 percent of families who begin 
treatment terminate it prematurely. Armbruster and 
Fallon (1994) found that the great majority of children 
who enter outpatient treatment attend for only one or 
two sessions. One of the explanations for the high 
dropout rate and for failure to keep the first 
appointment is that referrals are often made not by 
children and adolescents or their families, but by 
schools, courts, or other agencies. Most of the research 
on dropping out has focused exclusively on examining 
demographic or diagnostic correlates of dropping out, 
and few researchers have directly asked the children or 
their parents about their reasons for discontinuing 
treatment. 
There are a number of effective interventions to 
reduce dropout from treatment and to increase 
enrollment and retention (Szapocznik et al., 1988; 
McKay et al., 1996; Santisteban et al., 1996). Offering 
services in the schools improves treatment access 
(Catron & Weiss, 1994). A variety of case management 
approaches can also improve engagement of low- 
income families in the treatment of their children 
(Bums et al., 1996; Koroloff et al., 1996a; Lambert & 
Guthrie, 1996). 
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poverty status has been associated with both dropping 
out of services and shorter lengths of treatment 
(Hoberman, 1992). This relationship between 
underutilization of mental health services and poverty 
is especially significant for minority children and 
families. Youths receiving community mental health 
services supported by public agencies tend to be male, 
poor, and referred by social agencies (Canino et al., 
1986; Costello & Janiszewski, 1990). Furthermore, 
investigators have found this pattern particularly true 
for African Americans as compared with Caucasians. 
Hoberman (1992) has found that 90 percent of African 
American youths entering the mental health systemlive 
in poverty. 
Culture and Utilization 
Although it is clear that an insufficient number of 
children receive mental health services, it is not clear 
whether utilization of services varies by race or 
ethnicity. The majority of studies have found that 
African Americans tend to use some mental health 
services, particularly inpatient care, more than would 
be expected from their proportion in the population. 
However, research findings are conflicting, probably 
due to divergent methodological approaches (Attkisson 
et al., 1995; McCabe et al., 1998; Quinn & Epstein, 
1998). Furthermore, as Attkisson and colleagues (1995) 
point out, consistent with the study by McCabe and 
colleagues (1998), it is difficult to interpret these 
findings in the absence of epidemiologic data on the 
prevalence of a mental disorder in different racial and 
ethnic groups. Recent reviews of epidemiological 
findings concluded that present data are inadequate to 
determine the relationship between race or ethnicity 
and prevalence of a mental disorder (Friedman et al., 
1996b; Roberts et al., 1998). 
The task of understanding treatment patterns is 
made even more difficult because there are racial and 
ethnic differences in family preferences and family- 
initiated patterns of help-seeking (see also Culturally 
Appropriate Social Support Services). For example, 
parents from various cultural backgrounds have been 
found to differ in the degree to which they identify 
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child behavioral and emotional problems as disturbed 
(Weisz & Weiss, 1991). Differences also have been 
found across cultural groups in their beliefs about 
whether these child problems are likely to improve in 
the absence of professional support. Weisz and Weiss 
(1991) have also identified cultural differences in the 
power of various children’s behavioral and emotional 
problems to motivate a parent’s search for professional 
help. 
Differences also arise indirectly from the 
multiplicity of service systems with authority and 
responsibility for protecting the well-being of children. 
These systems have different ‘criteria for initiating 
treatment and different patterns of utilization. African 
American children and youth are considerably more 
likely than those of other ethnic groups to enter the 
child welfare system (National Research Council, 
1993). Their greater chances of having parents 
compelled to surrender them or of suffering abuse or 
neglect lead them in greater numbers to be referred to 
child welfare authorities, to be placed out-of-home, and 
to be involved with the child welfare system longer. 
Studies in one California county have found that 
African American youths are overrepresented in 
arrests, detention, and incarceration in the juvenile 
justice system, and in the schools they are 
overrepresented in educational classes for the severely 
emotionally disturbed. Hispanic/Latin0 children and 
youths are no more likely than whites to come under 
supervision of the child welfare system but, once 
involved, remain longer. They are also more likely than 
whites to be detained in juvenile justice facilities 
(McCabe et al., 1998). 
As a group, Hispanic/Latin0 and African American 
children more often leave mental health services 
prematurely than do Caucasian children (Sue et al., 
1991; Bui & Takeuchi, 1992; Takeuchi et al., 1993; 
Viale-Val et al., 1984). Many factors contribute to 
premature termination, such as insensitivity of mental 
health providers to the culture of children and families 
(Woodward et al., 1992). In general, even after 
demonstrated success with middle-class Caucasians, 
mental health treatments should not be applied without 
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culturally appropriate modification to people from 
other cultures and races (Rosado & Elias, 1993). 
Specialized programs and supports linked with the 
culture of the community being served have been found 
to be successful in promoting favorable patterns of 
service utilization for all ages (Snowden & Hu, 1997). 
It is becoming clear that the children and families 
served by mental health programs designed to be linked 
to community cultures are less ,likely to drop out of 
treatment compared with similar families in mainstream 
programs (Takeuchi et al., 1995). For example, Asian 
American children at an Asian community- or culture- 
focused program were found to use more services, drop 
out less often, and improve more than did Asian 
American children at mainstream programs (Yeh et al., 
1994). 
In summarizing the relationship between race and 
ethnicity, need for service, and use of service, Isaacs- 
Shockley and colleagues (1996) raised the concern that 
minority children are less likely to receive the care they 
need than nonminority children-a concern that should 
energize advocacy for the development of systems of 
care tailored to the needs of distinct cultures (Cross et 
al., 1989; Hemandez & Isaacs, 1998). 
Service Systems and Financing 
In the past, mental health services paid for by the 
private sector were viewed as separate entities from 
those funded by the public sector, particularly since the 
public sector only paid for services that it itself 
delivered. As this section explains below, the 
distinction between public and private sectors has been 
blurred by the advent of publicly supported payment 
systems such as Medicaid and grants of public funds to 
private organizations and providers. Now in the public 
sector, services are paid for with governmental 
resources but delivered either by public or private 
organizations in institutional or community-based 
settings. 
Private Sector 
The private sector uses a health insurance model that 
reimburses for acute medical problems. Under this 
traditional model, mental health coverage usually 
entails outpatient counseling, medication treatments, 
and short-term inpatient hospitalization. Under more 
generous insurance plans, including some managed 
care plans, intermediate services, such as crisis respite 
and day hospitalization (also called partial 
hospitalization or day treatment), are becoming more 
popular although more traditional insurance plans 
continue to restrict their use. The drive to reduce the 
cost of inpatient care is sparking an expansion in the 
range of services supported by the private sector. 
When children and adolescents have complex and 
long-term mental health problems, required services are 
not usually covered by private sector insurance plans. 
Families must either pay for the services themselves or 
obtain the services through the public sector. In many 
states, parents are forced to give up custody of their 
children to the state child welfare system in order to 
obtain needed residential services (Cohen et al., 1991). 
This unfortunate choice results from a limited supply of 
public sector services and special requirements for 
gaining access to them. 
Over the past decade, managed care has become a 
major payer for private health care. Managed care 
provision of mental health services emerged partially in 
response to the overutilization of costly inpatient 
hospitalization by adolescents in the 1980s (Lourie et 
al., 1996). The purpose of managed care has been to 
control spiraling mental health service costs, mostly by 
limiting hospital stays and rigorously managing 
outpatient service usage (Stroul et al., 1998). Managed 
care can offer advantages in terms of cost-effective 
services to meet the needs of children with flexible 
benefits. It may also lead to denial of needed treatment. 
While its potential negative effect on the efficacy of 
mental health care delivered under its aegis is a hotly 
debated issue, for the most part managed care furnishes 
the same traditional services available under fee-for- 
service insurance. The drive for efficiency, however, 
has led to the introduction of intermediate services 
designed to divert children from hospitalization. 
Managed care has shortened hospital stays and 
increased the use of short-term therapy models (Eisen 
et al., 1995; Merrick, 1998). Managed care also has 
lowered reimbursements for services provided by both 
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individual professionals and institutions. This has been 
accompanied by the construction of provider networks, 
under which professionals and institutions agree to 
accept lower than customary fees as a tradeoff for 
access to patients in the network. 
Public Sector 
Mental health services provided by the public sector are 
more wide-ranging than those supported by the private 
sector, and the types of payers are more diverse. Some 
public agencies, such as Medicaid and state and local 
departments of mental health, are mandated to support 
mental health services. Others provide mental health 
services to satisfy mandates in special education, 
juvenile justice, andchild welfare, among others. 
Medicaid is a major source of funding for mental 
health and related support services. For the most part, 
Medicaid has supported the traditional mix of 
outpatient and inpatient services. However, unlike 
private sector insurance, Medicaid also funds long-term 
services for those children who need more intensive or 
restrictive services, often through hospitalizations and 
residential treatments. Some states cover in-home 
services, school-based services, and case management 
through a variety of Medicaid options. Medicaid also 
supports the Early Periodic Screening, Diagnosis, and 
Treatment (EPSDT) program. 
without individualized wraparound provisions, early 
intervention programs, crisis stabilization, in-home 
therapy, and day programs. Since there has never been 
a mandate to states to provide mental health services to 
children and adolescents, the state or local support for 
such services has been variable; Thus, one might find 
a well-supported, innovative array of mental health 
services for children in one state or community, and 
almost no services in the next. The new State Child 
Health Insurance Program (CHIP) is an attempt by 
Congress to address the health care needs of low- 
income, uninsured children. States have great flexibility 
in their approach to coverage, and it remains to be seen 
how they will deal with mental health services. 
States and communities have sweeping mandates to 
serve children and adolescents in schools and under 
child welfare and juvenile service auspices. Many of 
these state and community programs, however, lack the 
expertise to recognize, refer, or treat mental health 
problems that trigger mandated services, When they do 
recognize problems, some of the needed mental health 
services are paid for by Medicaid, by the federal 
Maternal and Child Block Grant, or by a state or local 
mental health authority; often, however, they are not. 
Under these circumstances, the school, welfare, or 
juvenile justice agency ends up paying the bill for the 
mental health services. 
Trapped between the private and public sectors is 
a group of uninsured individuals and families who do 
not qualify for the public sector programs, cannot 
afford to pay for services themselves, and have no 
access to private health insurance. The American 
Academy of Pediatrics estimates that in 1999 there will 
be 11 million uninsured children, about 3 million of 
whom do not qualify for existing public programs 
(American Academy of Pediatrics website 
www.aap.org). State and local mental health authorities 
fund some mental health services for these children, 
often offered through the same community mental 
health centers that are funded by Medicaid. Mental 
health departments in some jurisdictions also fund a 
broader array of mental health services than the 
traditional acute service package. These “intermediate” 
services include intensive case management with and 
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Under the Federal special education law, the 
Individuals with Disabilities Education Act” (IDEA; 
see also New Roles for Families in Systems of Care), 
school systems are mandated to provide special 
education services to children and adolescents whose 
disabilities interfere with their education, When these 
disabilities take the form of serious emotional or 
behavioral disturbances, school systems are required to 
respond through assessment, counseling, behavior 
management, and special classes or schools. When 
school systems lack sufficient capacity to meet such 
needs directly, school funds are used to send children 
and youths to specialized private day schools or to 
long-term residential schools, even if such schools are 
out of the child’s state or community. In this way, 
” Public Law 94-142; Public Law 101-476; Public Law 10517. 
Mental Health: A Report of the Surgeon General 
school systems support an extensive array of mental 
health services in the public and private sectors. 
Preschool children with developmental and 
emotional disabilities are covered by some state and 
local legislation. Services for them also are mandated 
under IDEA. Whereas some states coordinate this 
education-based mandate through school systems, 
others administer the preschool programs through 
mental health or developmental disability agencies, an 
interagency coordinating body, or other state agency. 
Child welfare agencies in states and communities 
also have powerful mandates to protect children and to 
ensure that they receive the services they need; 
including mental health services. Child welfare 
agencies primarily serve poor children who are 
separated from their parents because they are orphaned, 
abandoned, abused, or neglected. Although many 
mental health services are provided either under 
Medicaid or through state and locally supported 
community mental health centers, many are not and are 
paid for directly by child welfare agencies. This 
happens most often when children and adolescents have 
severe, complicated conditions. As with education 
agencies, when funding is not available through 
Medicaid or other mental health funds, child’welfare 
agencies directly pay for group home care, therapeutic 
foster care, or residential treatment. 
The same is true for juvenile justice agencies, 
which have strong mandates to protect children and the 
public. Many children and adolescents in the juvenile 
justice system have serious mental health problems. 
Beyond the more traditional “training schools” and 
“detention centers,” run by state and local juvenile 
authorities, respectively, these agencies also purchase 
care from the same group home, therapeutic foster care, 
and residential providers as do child welfare agencies. 
Children Served by the Public Sector 
Children needing services are identified under the 
auspices of five distinct types of service sectors: 
schools, juvenile justice, child welfare, general health, 
and mental health agencies. These agencies are mostly 
publicly supported, each with different mandates to 
serve various groups and to provide somewhat varied 
levels of services. Many of these agencies arose 
historically for another purpose, only to recognize later 
that mental disorders cause, contribute to, or are effects 
of the problem being addressed. In the past, these 
sectors operated somewhat autonomously, with little 
ongoing interaction. Catalyzed by the NMHA’s 
Invisible Children’s Project (NMHA, 1987, 1993), the 
combined impetus of Federal policies and managed 
care more recently has begun to forge their integration. 
Two recent review articles examined the 
characteristics of children served in public systems. 
Based on an appraisal of six prior studies, it was 
concluded that, in addition to emotional and behavioral 
functioning, these young people have problems in life 
domains such as intellectual and educational 
performance and social and adaptive behavior 
(Friedman et al., 1996b). Frequently, such children and 
their families have contact not only with the mental 
health system, but also with special education, child 
welfare, and juvenile justice (Landrum et al., 1995; 
Duchnowski et al., 1998; Greenbaumet al., 1998; Quinn 
& Epstein, 1998). 
It is estimated that in a l-year period more than 
700,000 children nationwide are in out-of-home 
placements, mostly under the supervision of either the 
child welfare or to some extent the juvenile justice 
system (Glisson, 1996). Also, during the 1996-1997 
school year more than 400,000 emotionally disturbed 
children and youths between the ages of 6 and 2 1 were 
served in the public schools nationwide (U.S. 
Department of Education, 1997). This is just under 
1 percent of the school enrollment for ages 6 to 17, and 
8.5 percent of all children with disabilities receiving 
any kind of special education service (Oswald & 
Coutinho, 1995; U.S. Department of Education, 1997). 
These figures and percentages have remained relatively 
constant since national data were first collected about 
20 years ago, although there are great variations 
between states. For example, in 1992-1993,0.4 percent 
of school-enrolled children in Mississippi were 
identified as having a serious emotional disturbance 
compared with 2.08 percent in Connecticut (Coker et 
al., 1998). 
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In addition to children with a serious emotional 
disturbance served by the special education system, 
children served by child welfare and juvenile justice 
systems also have need for mental health services 
(Friedman & Kutash, 1986; Cohen et al., 1990; 
Greenbaumet al., 1991,1998; Otto et al., 1992; Glisson, 
1996; Claussen et al., 1998), because they are much 
more likely to have emotional and behavioral disorders 
than is the general population (Duchnowski et al., 
1998; Quinn & Epstein, 1998). Thus, the emphasis on 
interagency community-based systems of care is 
warranted and essential (see Integrated SystemModel). 
Managed Care in the Public Sector 
Since 1992, managed care has begun to penetrate the 
public sector (Essock & Goldman, 1995). The prime 
impetus for this has been an attempt to control the costs 
of Medicaid, in both the general health and mental 
health arenas. Since Medicaid appears, on the surface, 
to be similar to a private health insurance plan, 
administrators of state Medicaid programs have 
recently implemented managed care approaches and 
structures to reduce health care costs. However, 
Medicaid populations tend to have a higher prevalence 
of children with serious emotional disturbance than that 
seen in privately insured populations. Those children 
generally need longer-term care (Friedman et al., 
1996b; Broskowski & Harshbarger, 1998). Managed 
care strategies, which developed in the private sector, 
are geared toward a relatively low utilization of mental 
health services by a population whose mental health 
needs tend to be short term and acute in nature. As a 
result, the kinds of cost-cutting measures used by 
managed care organizations, such as reduction of 
hospital days and encouragement of short-term 
outpatient therapies, have not worked as well in the 
public sector with seriously emotionally disturbed 
children as they have in the private sector (Stroul et al., 
1998). 
Advocates express concern that the restrictions of 
public managed care on mental health services shift 
costs of diagnosis and treatment to other agencies, a 
process known as cost-shifting. Under public managed 
care, hospitalization for mental disorders is being 
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substantially cut, with youths being discharged from 
the hospital before adequate personal and/or 
community safety plans can be instituted. Child welfare 
and juvenile justice agencies have been compelled to 
create and pay for services to support those children 
who are no longer kept in hospitals. Thus, while 
Medicaid’s mental health costs may be decreasing in 
such cases, there may be a substantial cost increase to 
the other agencies involved, resulting in little if any 
overall cost saving (Stroul et al., 1998). 
Similarly, management of only the Medicaid 
portion of a complex funding system that includes 
Medicaid, mental health, special education, child 
welfare, and juvenile justice funds not only creates the 
cost-shifting described above, but also underestimates 
the need to manage the funds spent by all agencies. 
Demonstration programs of managed care strategies for 
children and adolescents with severe emotional 
disturbances have included the creation of an 
interagency funding pool, shared by all affected 
agencies, to meet the full range of needs of this 
population. Under the demonstration program, the 
funds in such a pool are capitated” to ensure that the 
most appropriate services are purchased, regardless of 
which agency’s mandate they come under. In this way, 
long-term, complex care can be offered in an efficient 
way that reduces costs for all of the involved child and 
youth agencies. 
An excellent example of an approach in a managed 
care setting is “Wraparound Milwaukee,” one of the 
Center for Mental Health Services’ Comprehensive 
Community Mental Health Services for Children and 
Their Families Programs (Stroul et al., 1998; Goldman 
& Faw, 1998). Wraparound Milwaukee, a coordinated 
system of community-based care and resources for 
families of children with severe emotional, behavioral, 
and mental health problems, is operated by the Children 
and Adolescent Services Branch of the Milwaukee 
County Mental Health Division. The features of this 
care management model are a provider network that 
furnishes an array of mental health and child welfare 
services; an individualized plan of care; a care 
” Capitation: a fixed sum per individual per month. 
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coordinator management system to ensure that services 
are coordinated, monitored, and evaluated; a Mobile 
Urgent Treatment Team to provide crisis intervention 
services; a managed care approach including 
preauthorization of services and service monitoring; 
and a reinvestment strategy in which dollars saved from 
decreased use of inpatient or residential care are 
invested in increased service capacity. 
Since its inception in 1994, one of the goals of the 
program has been to blend funding streams. 
Wraparound Milwaukee operates as a behavioral health 
care “carve-out”” that blends funds from a monthly 
capitation rate from Medicaid, a case rate from county 
child welfare and juvenile justice funds, and a Center 
for Mental Health Services child mental health services 
grant. The Wraparound Milwaukee capitated rate of 
approximately $4,300 covers all mental health and 
substance abuse services, including inpatient 
hospitalization. Additional funds from child welfare 
and/or juvenile justice are used for children with 
serious emotional disturbances in the child welfare and 
juvenile justice systems in Milwaukee County to cover 
residential treatment, foster care, group home and 
shelter care costs, and nontraditional mental health 
community services (e.g., mentors, job coaches, after- 
school programs). Wraparound Milwaukee is at “full 
risk” for all services costs, meaning it is responsible for 
charges in excess of the capitated rate. The average 
monthly costs, including administrative costs, are 
$3,400 per child. Medicaid-eligible children constituted 
80 percent of the population served by the program in 
1998. 
Culturally Appropriate Social Support 
Services 
One of the fundamental requirements of culturally 
appropriate services is for mental health providers to 
identify and then to work in concert with natural 
support systems within the diverse communities they 
serve (Greenbaum, 1998). (Background information on 
cultural diversity and culturally competent services is 
I9 Carve-out: separation of funding for mental health services and 
their management from those of general health. 
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provided in Chapter 2.) If they are culturally 
appropriate, services can transcend mental health’s 
focus on the “identified client” to embrace the 
community, cultural, and family context of a client 
(Szapocznik & Kurtines, 1993; Hemandez et al., 1998). 
According to Greenbaum (1998), considering a client’s 
context is important because people who live close to 
each other frequently have developed ways of coping 
with similar personal problems. Becoming aware of 
these natural systems and adapting formal services to 
be congruent with them are ways to make services more 
accessible and useful to diverse populations. 
Community- and neighborhood-based social net- 
works act as important resources for easing emotional 
stress and for facilitating the process of seeking 
professional help (Saunders, 1996). Often natural social 
supports ameliorate emotional distress and have been 
found to reduce the need for formal mental health 
treatment (Linn & McGranahan, 1980; Birkel & 
Reppucci, 1983; Cohen & Wills, 1985). According to 
Saunders (1996), obtaining social support is not a 
single event but rather an ongoing process. In general, 
people use their neighborhood and familial supports 
many times before they decide they have a problem and 
determine what type of help they will seek (Rew et al., 
1997). A key to the success of mental health programs 
is how well they use and are connected with 
established, accepted, credible community supports. 
The more this is the case, the less likely families view 
such help as threatening and as carrying stigma; this is 
particularly true for families who are members of racial 
and ethnic minority groups (Bentelspacher et al., 1994). 
Minority parents are more likely than nonminority 
parents to seek input regarding their children from 
family and community contacts (Briones et al., 1990; 
Hoberman, 1992). In a study by McMiller and Weisz 
(1996), two-thirds of the parents of minority children 
did not seek help from professionals and agencies as 
their first choice. For example, in Hispanic/Latin0 
families, important decisions related to health and 
mental health are often made by the entire family 
network rather than by individuals (Council of 
Scientific Affairs, 1991). According to Ruiz (1993), 
health care settings that are not modified to work with 
Hispanic/Latin0 family networks find that their clients 
do not comply with medical advice; as a result, their 
health status can be compromised. 
In sum. mental health programs attempting to serve 
diverse populations must incorporate an understanding 
of culture, traditions, beliefs, and culture-specific 
family interactions into their design (Dasen et al., 1988) 
and form working partnerships with communities in 
order to become successful (Kretzman & McKnight, 
1993). Ultimately, the solution offered by professionals 
and the process of problem resolution or treatment 
should be consistent with, or at least tolerable to, the 
natural supportive environments that reflect clients’ 
values and help-seeking behaviors (Lee, 1996). 
Such partnerships sometimes fail, however, 
because they concentrate on neighborhood and 
community problems. According to Kretzman and 
McKnight (1993), this approach often reinforces the 
negative stereotypes of violent, drug- and gang-ridden, 
and poverty-stricken communities. A more effective 
alternative approach to working with communities is to 
focus on community strengths (Kretzman & McKnight, 
1993). This approach works best when community 
residents themselves are interested in participating in 
the partnership. Mental health providers who approach 
minority communities in a paternalistic manner fail to 
engage residents and fail to recognize whether the 
community wants their assistance (Gutierrez-Mayka & 
Contreras-Neira, 1998). Service providers who attend 
to the wishes of community residents are more likely to 
be respectful in their delivery of services, a respect that 
is a prerequisite to cultural responsiveness and 
competence in service planning and delivery to diverse 
communities (Gutierrez-Mayka & Contreras-Neira, 
1998). 
Support and Assistance for Families 
Any parent or guardian of a child with an emotional or 
behavioral disorder can testify to the challenging, 
sometimes overwhelming, task of caring for and raising 
such a child. In the past, support from public agencies 
has been inadequate and disjointed. Compounding the 
problem was the view that parents were partly, if not 
completely, to blame for their child’s condition 
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(Friesen 8z Stephens, 1998). In 1982, a particularly 
incisive description of the problems faced by families 
raising children with emotional or behavioral disorders 
was published. It concluded that parents received little 
assistance in finding services for their children and 
.were either ignored or coerced by public agencies; 
respite and support services to relieve the stress on 
parents were unavailable; parents with children needing 
residential care were compelled to give up custody to 
get them placed; and few advocacy efforts were aimed 
at relieving their problems (Knitzer, 1982). 
Over the past two decad$s, however, recognition 
and response to the plight of families have become 
increasingly widespread. The role of families has been 
redefined as that of a partner in care. Furthermore, 
there was growing awareness of the difficulties families 
faced because services are provided by so many 
different public sources. In addition to problems with 
coordination, parents and caregivers encountered 
conflicting requirements, different atmospheres and 
expectations, and contradictory messages from system 
to system, office to office, and provider to provider 
(Knitzer, 1982). Although some agencies began to 
provide families with training, information, education, 
and financial assistance, there was often a gap between 
what families needed and what agencies provided. 
Also, service agencies themselves began to recognize 
that putting children into institutions may not have 
served the child, the family, or the state and that 
keeping a child with his or her family could reduce the 
ever-growing costs of institutionalization (Stroul, 
1993a, 1993b). Emerging awareness of these foregoing 
problems galvanized advocacy for a better way to care 
for children with emotional and behavioral disorders. 
Reforms were instituted in many Federal programs, as 
discussed later in this section. 
According to Knitzer andcolleagues (1993), family 
participation promotes four changes in the way children 
are served: increased focus on families; provision of 
services in natural settings; greater cultural sensitivity; 
and a community-based system of care. Research is 
accumulating that family participation improves the 
process of delivering services and their outcomes. For 
example, Koren and coworkers (1997) found that, for 
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children with serious mental health problems, the more 
the family participates in planning services, the better 
family members feel their children’s needs are being 
met; participation in service planning also helps service 
coordination. Curtis and Singh (1996) and Thompson 
and colleagues (1997) also found that family 
involvement in services was a determinant of the level 
of parental empowerment, that is, how much control 
parents felt they had over their children’s treatment. 
New Roles for Families in Systems of Care 
Over the past two decades, the Federal government 
established a series of initiatives to support families. 
Parents were given progressively greater roles as 
decisionmakers with the passage of the Education of 
the Handicapped Act in 1975 and its successor 
legislation, the Individuals with Disabilities Education 
Acts of 1991 and 1997. For simplicity, these pieces of 
legislation are collectively referred to hereinafter as the 
IDEA Act. This act requires parent involvement in 
decisions about educating children with disabilities. It 
guarantees that all children with disabilities receive 
free and appropriate public education. It also provides 
funding assistance to states for implementation. 
A novel approach taken by some community-level 
systems of care to encouraging involvement of.families 
is to train and hire family members into a wide range of 
well-paying, career-ladder jobs as outreach workers, 
service coordinators (sometimes called case managers), 
and direct support services providers. These positions 
are critical to achieving major program goals because 
they make it possible for children and families to 
remain together and to participate in the more clinical 
components of their service plan. Family members are 
also employed as supervisors of services, involved in 
hiring staff, providing them with orientation and on- 
the-job training (e.g., of case managers), overseeing 
their work, and evaluating their performance. They also 
participate in research. 
Beginning in 1989, the Child and Adolescent 
Service System Program, a component of the Center for 
Mental Health Services, began providing some support 
for statewide family organizations through a series of 
funding and technical assistance mechanisms (Koroloff 
et al., 1991; Briggs et al., 1994; also see Integrated 
System Model). Such organizations were funded to 
develop statewide networks of information and support 
for families, to coordinate with other organizations that 
shared common goals, and to promote needed changes. 
Currently, Federal funding for 22 statewide family 
organizations is provided through the Child and Family 
Branch, Center for Mental Health Services, Substance 
Abuse and Mental Health Services Administration. 
Support and technical assistance to community-level 
family organizations are also provided by the 
Federation of Families for Children’s Mental Health, 
the National Alliance for the M&tally Ill, and other 
family-run consumer organizations. 
Family Support 
Family support is defined here as the assistance given 
to families to cope with the extra stresses that 
accompany caring for a child with emotional 
disabilities. In addition to the stress of raising a child 
with an emotional disability, families often face other 
difficulties such as poverty, joblessness, substance 
abuse, and victimization. Family support often helps 
keep families together by assisting them with the 
practicalities of living and by attending to the needs of 
all family members (Will, 1998). The main goal of 
family support services is to strengthen adults in their 
roles as parents, nurturers, and providers (Weissbourd 
& Kagan, 1989). Too often, family support services are 
not available within local communities. 
Natural support systems are often diminished for 
families of children with serious emotional, behavioral, 
or physical disorders or handicaps because of the 
stigma of, or embarrassment about, their child’s 
problems, or because caregivers have insufficient 
energy to reach out to others. Not surprisingly, most 
parents report that limited social support decreases 
their quality of life (Crowley & Kazdin, 1998) and that 
they feel less competent, more depressed, worried, and 
tired and have more problems with spouses and other 
family relationships than other parents (Farmer et al., 
1997). although a few families do feel enriched by 
caring for these children (Yatchmenoff et al., 1998). 
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In a national survey of parents of children with an 
emotional or behavioral disorder, 72 percent of 
respondents indicated that emotional support 
(irrespective of its form) was the most helpful aspect of 
family support services (Friesen, 1990). Benefits 
included increased access to information, improved 
problem-solving skills, and more positive views about 
parenting and their children’s behavior (Friesen & 
Koroloff, 1990). 
Family support services occur in several forms: 
assistance with daily tasks and psychosocial support 
and counseling; informal or professional provision of 
services; and practical support such as housing 
assistance, food stamps, income support, or respite care 
(i.e., temporary relief for family members caring for 
individuals with disabilities). 
Efforts to stop blaming parents for children’s 
problems have resulted in parents becoming viewed 
less as patients than as partners, actively involved in 
every phase of the treatment process (e.g., home-based 
care, case management) and as a resource for their 
children, as discussed above. For the self-help and 
professionally led family support services described 
subsequently, parents may function either as partners or 
as providers. As “partners,” parents act as a resource, 
active contributor, or decisionmaker; as “providers,” 
they are viewed as contributing to the welfare and 
growth of other members of the family. 
Results of research on the effectiveness of family 
services are only beginning to appear, in the form of 
some controlled studies and evaluations of support 
services for families of children with emotional and 
behavioral disorders (although there is a larger 
literature on families whose children have other types 
of disability and illness). Although this database on 
family support programs is still limited, many positive 
effects have been reported. The following paragraphs 
cover family support groups as well as concrete 
services. For the latter, only two types of interventions, 
respite care and the family associate, are included. 
Family therapy is covered in this chapter under 
Outpatient Treatment. Furthermore, several forms of 
parent training were found to be effective for individual 
Children and Mental Health 
diagnoses, such as conduct disorder (see section on 
Selected Mental Disorders in Children). 
Family Support Croups 
The primary focus of family support groups is to 
provide information and emotional support to members 
&ho share a common problem or concern (e.g., 
disability, substance abuse, bereavement). Support 
groups for families of children with emotional or 
behavioral disorders are expanding. Although there is 
a wide variation in membership, format, and duration 
of these groups, most share some characteristics. 
Usually, from 4 to 20 parents meet regularly to discuss 
the problems and issues associated with parenting a 
child with emotional and behavioral disorders and to 
provide mutual encouragement and suggestions for 
dealing with problematic situations. Support services 
may be informal, organized, and parent led and are 
often associated with organizations such as the 
National Mental Health Association, Children and 
Adults with Attention Deficit Disorders, the National 
Alliance for the Mentally Ill, or the Federation of 
Families for Children’s Mental Health. Mental health 
professionals may also participate in support groups 
(Koroloff & Friesen, 1991). 
It was found that support groups for parents of 
children hospitalized with mental illness make parents 
feel more positive about themselves and increase their 
understanding of and communication with their 
children (Dreier & Lewis, 1991). Participation in a six- 
session education and support group for parents of 
adolescents with schizophrenia led to increased 
relaxation and concentration, less worry, changed 
attitudes toward discipline, and greater ease in 
discussing feelings. The support from parents in similar 
situations was highly valued (Sheridan & Moore, 
1991). 
Another approach to support for parents of children 
receiving mental health services is education: 
knowledge of the services; skills needed to interact 
with the system; and the caregivers’ confidence in their 
ability to collaborate with service providers (self- 
efficacy). A training curriculum for parents was tested 
in a randomized controlled trial involving more than 
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200 parents who either did or did not receive the 
training curriculum. Three-month and 1 -year followup 
results demonstrated significant improvement in 
parents’ knowledge and self-efficacy with the training 
curriculum, whereas there was no effect on the mental 
health status of their children, service use, or caregiver 
involvement in treatment (Heflinger & Bickman, 1996; 
Bickman et al., 1998). 
Practical Support 
Respite care is a type of concrete support that provides 
temporary relief to family caregivers. An investigation 
of the benefit of respite care is under way in New York 
in families with children at risk of hospital placement. 
When respite care was available, families preferred in- 
home to out-of-home care. The younger the children, 
the greater the child’s functional impairment, and the 
fewer the social supports (Boothroyd et al., 1998), the 
more respite care was used. Outcomes have not yet 
been reported. 
Another form of concrete support is exemplified by 
the Family Associate Intervention, which was 
developed in Oregon. It appears to be an inexpensive 
way to assist children in actually obtaining care after 
they have been identified as needing care. The goal is 
to use paraprofessionals (known as family associates), 
rather than professionals, to facilitate entry into an 
often intimidating service system. In a controlled study, 
family associates were found to be effective in helping 
families initiate mental health service use. Families 
receiving this support service were more likely to make 
and keep a first appointment at the mental health clinic. 
The effectiveness of the intervention was moderate but 
sufficient to encourage further development of such a 
low-cost intervention (Koroloff et al., 1996b; Elliot et 
al., 1998). 
Integrated System Model 
Within the public mental health system, the 1980s and 
1990s have seen an increased emphasis on developing 
interagency community-based systems of care (Stroul 
& Friedman, 1986). This focus is driven by awareness 
that a large number of children are served in systems 
other than mental health, as well as by children’s 
complex and interrelated needs, as indicated earlier 
(Friedman et al., 1996a, 1996b; Quinn & Epstein, 
1998). In 1984, the Child and Adolescent Service 
System Program (CASSP) was launched to respond to 
the fragmentation of public services (Stroul & 
Friedman, 1986). It was funded by the services 
component of the National Institute of Mental Health, 
which later became the Center for Mental Health 
Services under the Alcohol and Drug Abuse and 
Mental Health Administration Reorganization Act of 
1992 (Public Law 102-321). 
CASSP recognized the need for public sector 
programs to become more integrated in their attempts 
to meet more fully and efficiently the needs of children 
and adolescents with a serious emotional disturbance 
and their families. This Federal program pioneered the 
concept of a “system of care” for this population, as 
delineated by Stroul and Friedman (1986, 1996). A 
system of care, described further below, is a 
comprehensive approach to coordinating and delivering 
a far-reaching array of services from multiple agencies. 
All 50 states and numerous communities have received 
CASSP grants to improve the organization of their 
response to the mental health needs of the most 
severely affected children and adolescents. Although 
CASSP principles have become a standard for program 
design, many communities do not offer comprehensive 
services according to the CASSP model. 
CASSP provided the conceptual framework for the 
Robert Wood Johnson Foundation’s Mental Health 
Services Program for Youth and the Annie E. Casey 
Foundation’s Urban Mental Health Initiative. These 
foundation programs were devoted to the development 
of local interagency models (Cole, 1990). They were 
followed in 1992 by the authorization for what was to 
become the largest Federal program for child mental 
health, the Comprehensive Community Mental Health 
Services for Children and Their Families Program (also 
known as the Children’s Services Program), sponsored 
by the Center for Mental Health Services (Public Law 
102-321). 
The Children’s Services Program provides grants 
to states, communities, territories, and Indian tribes and 
tribal organizations to improve and expand systems of 
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cue to meet the needs of approximately 6.3 million 
children and adolescents with serious emotional 
disturbance and their families. The program now 
s~pp~rts 45 sites across the country. 
Built on the principles of CASSP, the Children’s 
Services Program promotes the development of service 
delivery systems through a “system of care” approach. 
The systemof care approach embraced by this initiative 
is defined as a comprehensive spectrum of mental 
health and other services and supports organized into a 
coordinated network to meet the diverse and changing 
needs of children and adolescents with serious 
emotional disturbance and their families (Stroul & 
Friedman, 1996). The system of care model is based on 
three main elements: (1) the mental health service 
system must be driven by the needs and the preferences 
of the child and family; (2) the locus and management 
of services must be within a muhiagency collaborative 
environment, grounded in a strong community base; 
and (3) the services offered, the agencies participating, 
and the programs generated must be responsive to 
children’s different cultural backgrounds. The 
Children’s Services Program requires a national cross- 
site evaluation, which has been continuously 
implemented since the spring of 1994. Preliminary 
evidence from the uncontrolled evaluation indicates 
some improvements in outcomes, such as fewer law 
enforcement contacts and better school grades, living 
arrangements, and mental health status. As part of the 
evaluation, comparisons are being made between 
system of care sites and comparable communities 
without systems of care (Holden et al., 1999). 
Effectiveness of Systems of Care 
The previous sections have highlighted the trans- 
formations that have taken place since the early 1980s 
to create comprehensive, interagency, community- 
based systems of care. This section reviews the 
findings of research into the effectiveness of such 
systems of care as compared with more traditional 
systems. 
Several studies on the effectiveness of systems of 
care have been conducted in recent years (Stroul, 
1993a, 1993b; Bruns et al., 1995; Rosenblatt, 1998). 
Children and Mental Health 
Although findings are encouraging, their effectiveness 
has not yet been demonstrated conclusively, largely 
because evaluation studies have not had a control 
group. Most evaluations indicate that systems of care 
reduce rates of reinstitutionalization after discharge 
from residential settings, -reduce out-of-state place- 
‘ments of children, and improve other individual 
outcomes such as number of behavior problems and 
satisfaction with services. After reviewing findings 
from the demonstration project of the Robert Wood 
Johnson Foundation, their own work in Vermont, 
research in California and. Alaska, and early findings 
from the Fort Bragg evaluatidn, Bruns, Burchard, and 
Yoe (1995) conclude that “initial findings are encourag- 
ing, especially with the history of disappointing results 
of outcome studies for child and adolescent services” 
(p. 325). Details are available in the individual studies 
(Attkisson et al., 1997; Illback et al., 1998; Santarcan- 
gelo et al., 1998). 
Reviews (Stroul, 1993a, 1993b; Rosenblatt, 1998) of 
uncontrolled studies of community-based systems of 
care showed that young people with serious emotional 
disturbances who were served under community-based 
systems of care consistently showed improvement 
across a range of outcomes. However, most of these 
studies used a so-called pre-post evaluation design that 
does not answer the question of whether the changes 
occurring over time (pre to post) are a consequence of 
the intervention or of the passage of time itself. Indeed, 
when comparison groups are studied, such as in the 
Fort Bragg demonstration project, results tend to be 
less favorable (see below). 
The Fort Bragg Study 
The Fort Bragg study, conducted by Bickman and his 
colleagues (Bickman et al., 1995; Bickman, 1996a; 
Hamner et al., 1997), merits detailed discussion 
because of the basic issues it raises and the controversy 
it engendered. The Fort Bragg study is an evaluation of 
a large-scale system change project initiated by the 
State of North Carolina and the Department of Defense 
in the early 1990s; it was designed to determine what 
systemic, clinical, and functional outcomes could be 
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achieved if a wide range of individualized and family- 
centered services were provided without any barriers to 
their availability. The project involved replacing the 
traditional CHAMPUS benefit for children who were 
military dependents in the Fort Bragg area with a 
continuum of care that included a broad range of 
services, a single point of entry, comprehensive 
assessments, and no copayment. or benefit limit. The 
provider agency at Fort Bragg was reimbursed for 
costs. The impact of this change on children was 
assessed by comparing outcomes at Fort Bragg with 
those at two other military installations in the Southeast 
where the traditional CHAMPUS benefit package 
remained in effect. The comparison sites restricted 
services to outpatient treatment, placement in a 
residential treatment center, or treatment in an inpatient 
hospital setting; regular copayment and benefit limits 
were in effect at the comparison sites. 
Over a 3-year period, the evaluators collected 
service use, cost, satisfaction, clinical, and functional 
data for 984 young people served either at Fort Bragg 
(574) or the comparison sites (410). Overall, there were 
a number of favorable findings for the demonstration 
site at Fort Bragg: access for children was increased; 
children referred for services were indeed in need.of 
help; parents and adolescents were more satisfied with 
the services they received than were parents and 
adolescents at the comparison sites; children received 
services sooner; care was provided in less restrictive 
environments; there was heavy use of intermediate- 
level services; fewer clients received only one session 
of outpatient treatment; overall, children stayed in 
treatment longer (although the length of stay in 
hospitals and residential treatment centers was shorter); 
and there were fewer disruptions in services (Bickman, 
1996a). Thus, the major findings were that the 
expanded continuum of care resulted in greater access, 
higher satisfaction with services by patients, and less 
use of inpatient hospitalization and residential 
treatment. Bickman also concluded, however, that 
despite the fact that the intervention was well 
implemented at Fort Bragg, there were no differences 
between sites in clinical outcomes (emotional- 
behavioral functioning), and the cost was considerably 
greater at Fort Bragg. 
The interpretation of the results by the project’s 
principal investigator has generated much discussion 
and controversy in the children’s mental health field, 
both in support of and questioning the study’s 
conclusions (Friedman & Bums, 1996; Behar, 1997; 
Feldman, 1997; Hoagwood, 1997; Laurie, 1997; Pires, 
1997; Saxe & Cross, 1997; Se&rest,& Walsh, 1997; 
Weisz et al., 1997). Most of the controversy surrounds 
study interpretation, implementation, methodology, and 
the interpretation of the cost data (Behar, 1997; 
Feldman, 1997; Heflinger & Northrup, 1997; 
Langmeyer, 1997). Furthermore, it has been pointed out 
that Fort Bragg was not a multiagency community- 
based system of care (Friedman & Burns, 1996), a 
point that has been acknowledged by the principal 
investigator of the study (Bickman, 1996b). Overall, 
despite the controversy surrounding it, the Fort Bragg 
evaluation has challenged the notion that changes at the 
system level have consequences at the practice level 
and, ultimately, improve outcomes for children and 
families. The results have stimulated an increased focus 
on practice-level issues. 
The Stark County Study 
The shift in focus to the practice level is being re- 
inforced by results from another study by Bickman and 
colleagues (1997, 1999) of children with emotional 
disturbances who were served in Stark County, Ohio. 
In this study, participating children were served within 
the public mental health system by a multiagency 
system of care; this was in contrast to the Fort Bragg 
sample of military dependents seen in a mental health- 
funded and -operated continuum of care. Children and 
families who consented to participate in the study were 
randomly assigned to one of two groups. The first 
group was immediately eligible to receive services 
within the existing community-based system of care in 
Stark County. Families in the second group were 
required to seek services on their own rather than to 
receive them within the system of care. The major 
differences in services provided were that significantly 
more children and families in the system of care group 
received case management and home visits than those 
in the comparison group. Findings indicate no 
differences in clinical or functional status 12 months 
after intake. These results are similar to those of the 
Fort Bragg study and suggest that attention should be 
paid to the effectiveness of services delivered within 
systems of care rather than only to the organization of 
these systems. 
Summary: Effectiveness of Systems of Care 
Collectively, the results of the evaluations of systems 
of care suggest that they are effective in achieving 
important system improvements, such as reducing use 
of residential placements, and out-of-state placements, 
and in achieving improvements in functional behavior. 
There also are indications that parents are more 
satisfied in systems of care than in more traditional 
service delivery systems. The effect of systems of care 
on cost is not yet clear, however. Nor has it yet been 
demonstrated that services delivered within a system of 
care will result in better clinical outcomes than services 
delivered within more traditional systems. There is 
clearly a need for more attention to be paid to the 
relationship between changes at the system level and 
changes at the practice level. 
Conclusions 
1. 
2. 
3. 
Childhood is characterized by periods of transition 
and reorganization, making it critical to assess the 
mental health of children and adolescents in the 
context of familial, social, and cultural 
expectations about age-appropriate thoughts, 
emotions, and behavior. 
The range of what is considered “normal” is wide; 
still, children and adolescents can and do develop 
mental disorders that are more severe than the “ups 
and downs” in the usual course of development. 
Approximately one in five children and adoles- 
cents experiences the signs and symptoms of a 
DSM-IV disorder during the course of a year, but 
only about 5 percent of all children experience 
what professionals term “extreme functional im- 
pairment.” 
4. 
5. 
6. 
7. 
8. 
9. 
Children and Mental Health 
Mental disorders and mental health problems 
appear in families of all social classes and of all 
backgrounds. No one is immune. Yet there are 
children who are at greatest risk by virtue of a 
broad array of factors. These include physical 
problems; intellectual disabilities (retardation); low 
birth weight; family history of mental and addictive 
disorders; multigenerational poverty; and caregiver 
separation or abuse and neglect. 
Preventive interventions have been shown to be 
effective in reducing the impact of risk factors for 
mental disorders and improving social and 
emotional development by providing, for example, 
educational programs for young children, parent- 
education programs, and nurse home visits. 
A range of efficacious psychosocial and 
pharmacologic treatments exists for many mental 
disorders in children, including attention- 
deficit/hyperactivity disorder, depression, and the 
disruptive disorders. 
Research is under way to demonstrate the 
.effectiveness of most treatments for children in 
actual practice settings (as opposed to evidence of 
“efficacy” in controlled research settings), and 
significant barriers exist to receipt of treatment. 
Primary care and the schools are major settings for 
the potential recognition of mental disorders in 
children and adolescents, yet trained staff are 
limited, as are options for referral to specialty care. 
The multiple problems associated with “serious 
emotional disturbance” in children and adolescents 
are best addressed with a “systems” approach in 
which multiple service sectors work in an 
organized, collaborative way. Research on the 
effectiveness of systems of care shows positive 
results for system outcomes and functional 
outcomes for children; however, the relationship 
between changes. at the system level and clinical 
outcomes is still unclear. 
10. Families have become essential partners in the 
delivery of mental health services for children and 
adolescents. 
11. Cultural differences exacerbate the general 
problems of access to appropriate mental health 
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services. Culturally appropriate services have been 
designed but are not widely available. 
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CHAPTER 4 
A dulthood is a time for achieving productive vocations and for sustaining close relationships at 
home and in the community. These aspirations are 
readily attainable for adults who are mentally healthy. 
And they are within reach for adults who have mental 
disorders, thanks to major strides in diagnosis, 
treatment, and service delivery. 
This chapter reviews the current state of knowledge 
about mental health in adults, along with selected 
mental disorders: anxiety disorders, mood disorders, 
and schizophrenia. These disorders are highlighted 
largely because of their prevalence in the population 
and the burden of illness associated with each. The 
chapter then turns to service delivery, describing the 
effective organization and range of services for adults 
with the most severe mental disorders. It also reviews 
an array of other services and supports designed to 
provide comprehensive care beyond ‘the formal 
therapeutic setting. 
Chapter Overview 
Mental health in adulthood is characterized by the 
successful performance of mental function, enabling 
individuals to cope with adversity and to flourish in 
their education, vocation, and personal relationships. 
These are the areas of functioning most widely 
recognized by the mental health field. Yet, from the 
perspective of different cultures, these measures may 
define the concept of mental health too narrowly. As 
noted in Chapter 2, many groups, particularly ethnic 
and racial minority group members, also emphasize 
community, spiritual, and religious ties as necessary for 
mental health. The mental health profession is 
becoming more aware of the importance of reaching 
out to other cultures; an innovation termed 
“linguistically and culturally competent services” is 
ADUTS AND MENTAL HEALTH 
pertinent both to the field’s conception of mental health 
and to the diagnosis and treatment of mental disorders. 
An assortment of traits or personal characteristics 
have been viewed as contributing to mental health, 
including self-esteem, optimism, and resilience (Alloy 
& Abramson, 1988; Seligman, 199 1; Institute of 
Medicine [IOM], 1994; Beardslee & Vaillant, 1997). 
These and related traits are seen as sources of personal 
resilience needed to weather the storms of stressful life 
events. 
Stressful life events in adulthood include the 
breakup of intimate romantic relationships, death of a 
family member or friend, economic hardship, role 
conflict, work overload, racism and discrimination, 
poor physical health, accidental injuries, and 
intentional assaults on physical safety (Holmes & Rahe, 
1967; Lazarus & Folkman, 1984; Kreiger et al., 1993). 
Stressful life events in adulthood also may reflect past 
events. Severe trauma in childhood, including sexual 
and physical abuse, may persist as a stressor into 
adulthood, or may make the individual more vulnerable 
to ongoing stresses (Browne & Finkelhor, 1986). 
Although some kinds of stressful life events are 
encountered almost universally, certain demographic 
groups have greater exposure and/or vulnerability to 
their cumulative impact. These groups include women, 
younger adults, unmarried adults, African Americans, 
and individuals of lower socioeconomic status (Ulbrich 
et al., 1989; McLeod & Kessler, 1990; Turner et al., 
1995; Miranda & Green, 1999). 
Anxiety disorders are the most prevalent mental 
disorders in adults (Regier et al., 1990). The anxiety 
disorders affect twice as many women as men. A broad 
category, anxiety disorders include panic disorder, 
phobias, obsessive-compulsive disorder, post-traumatic 
stress disorder, and generalized anxiety disorder, 
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among others. Underlying this heterogeneous group of 
disorders is a state of heightened arousal or fear in 
relation to stressful events or feelings. The biological 
manifestations of anxiety, which are grounded in the 
“fight-or-flight” response, are unmistakable: they 
include surge in heart rate, sweating, and tensing of 
muscles. But this is certainly not the whole picture. 
Although the full array of biological causes and 
correlates of anxiety are not yet in our grasp, numerous 
effective treatments for anxiety disorders exist now. 
Treatment draws on an assortment of psychosocial and 
pharmacological approaches, administered alone or in 
combination. 
Mood disorders take a monumental toll in human 
suffering, lost productivity, and suicide. Moreover, 
when unrecognized, they can result in unnecessary 
health care use. Mood disorders rank among the top 10 
causes of worldwide disability (Murray & Lopez, 
1996). Major depression and bipolar disorder are the 
most familiar mood disorders, but there are others 
including cyclothymia (alternating manic and 
depressive states that, while protracted, do not meet 
criteria for bipolar disorder) and dysthymia (a chronic, 
albeit symptomatically milder formof depression). The 
causes of mood disorders are not fully known. They 
may be triggered by stressful life events and enduring 
stressful social conditions (e.g., poverty and 
discrimination). With the exception of bipolar disorder, 
they too, like the anxiety disorders, are twice as 
common in women as men. One subtype of mood 
disorder, seasonal affective disorder, in which episodes 
of depression tend to occur in the late fall and winter, 
is seven times more common in women than in men 
(Blumenthal, 1988). Many psychosocial and genetic 
factors interact to dictate the appearance and persis- 
tence of mood disorders, according to the biopsycho- 
social model presented in Chapter 2. 
Mood disorders, like anxiety disorders, can be 
treated with a host of effective pharmacological and 
psychosocial treatments. Either type of treatment is 
effective for about 50 to 70 percent of patients in 
outpatient settings (Depression Guideline Panel, 1993). 
Severe depression seems to resolve more quickly with 
pharmacotherapy (Depression Guideline Panel, 1993) 
and may be helped further by multimodal therapy (the 
combination of pharmacotherapy and psychotherapy) 
(Thase et al., 1997b). Despite the efficacy of treatment, 
a surprising fraction of those with mood disorders go 
untreated (Katon et al., 1992; Narrow et al., 1993; 
Wells et al., 1994; Thase, 1996). The foremost barriers 
to treatment include cost, stigma, and problems in the 
organization of service systems that contribute to the 
underrecognition of these disorders. 
Schizophrenia affects about 1 percent of the 
population, yet its severity and petsistence reverberate 
throughout the mental health service system 
Schizophrenia is marked by profound alterations in 
cognition and emotion. Symptoms frequently include 
hearing internal voices or experiencing other sensations 
not connected to an obvious source (hallucinations) and 
assigning. unusual significance or meaning to normal 
events or holding false personal beliefs (delusions). 
The course of illness in schizophrenia is quite variable, 
with most people having periods of exacerbation and 
remission. Schizophrenia had once been thought to 
have a uniformly downhill course, but recent research 
dispels this view. Long-term followup studies show 
that many individuals with schizophrenia significantly 
improve and some recover (Ciompi, 1980; Harding et 
al., 1992). Although the causes of schizophrenia are not 
fully known, research points to the prominent role of 
genetic factors and to the impact of adverse 
environmental influences during early brain 
development (Tsuang et al., 1991; Weinberger & 
Lip&a, 1995; Andreasen, 1997b). New pharmaco- 
logical treatments are at least as effective as past 
pharmacological treatments with fewer troubling side 
effects. 
Effective treatment of schizophrenia extends well 
beyond pharmacological therapy: it also includes 
psychosocial interventions, family interventions, and 
vocational and psychosocial rehabilitation. For those 
patients who are high service users, treatment should be 
coordinated by an interdisciplinary team that provides 
high-intensity, community-based services (Lehman & 
Steinwachs, 1998a). The prototype for this intensive 
case-management approach, which is useful for persons 
with other severe and persistent mental disorders as 
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w,ell. is assertive community treatment, described more 
thoroughly later in this chapter. Among the services 
included in this approach is substance abuse treatment. 
Its inclusion stems from findings that about half of 
patients with serious mental disorders (including 
schizophrenia) develop alcohol or other drug abuse 
problems (Drake & Osher, 1997). Even though research 
generated a range of recommendations for effective 
treatment of schizophrenia’, it is alarming that less than 
50 percent of patients actually receive many of the 
recommended treatments and that the gap was more 
pronounced in African Americans (Lehman & 
Steinwachs, 1998b). 
The social consequences of serious mental 
disorders-family disruption, loss of employment and 
housingdan be calamitous. Comprehensive treatment, 
which includes services that exist outside the formal 
treatment system, is crucial to ameliorate symptoms, 
assist recovery, and, to the extent that these efforts are 
successful, redress stigma. Consumer self-help 
programs, family self-help, advocacy, and services for 
housing and vocational assistance complement and 
supplement the formal treatment system. Many of these 
services are operated by consumers, that is, people who 
use mental health services themselves.. The logic 
behind their leadership in delivery of these services is 
that consumers are thought to be capable of engaging 
others with mental disorders, serving as role models, 
and increasing the sensitivity of service systems to the 
needs of people with mental disorders (Mowbray et al., 
1996). 
Mental Health in Adulthood 
What constitutes mental health during the adult years? 
A widely used standard of mental health is the absence 
of a defined mental disorder. This standard has its 
limitations (discussed later), yet remains useful for 
epidemiological purposes. Epidemiology studies 
investigate the prevalence of mental disorders within 
several time frames: current, the past 12 months, and 
across a lifetime. Two well-designed national 
epidemiologic surveys estimate that about 80percent of 
the adult population of the United States do not have a 
mental disorder during a year and hence may be 
considered “mentally healthy” (i.e., absence of amental 
disorder) during any given year (Regier et al., 1993; 
Kessler et al., 1994). Thus, the popular notion that 
everyone is “dysfunctional” is far from the truth 
(Table 4-l). Yet, from time to time, many adults 
experience mental health problems. 
Defining mental health by the absence of mental 
disorder does not convey the full picture of mental 
health. Among its limitations, this definition excludes 
adults with mental disorders who function well 
between episodes of illness. These people often are 
considered by themselves, and by coworkers, friends, 
and families, to be “mentally healthy” in spite of a 
history of mental illness and the risk of recurrence. 
In addition to the mental health criteria cited 
earlier-that is, the successful performance of mental 
function, enabling individuals to cope with adversity 
and to flourish in their education, vocation, and 
personal relationships-a complementary approach 
defines the positive features of mental health in terms 
of attaining developmental milestones of adulthood, or 
in terms of displaying selected personality 
characteristics, traits, or attributes. Developmental 
theorist Erik Erikson viewed mental health in adulthood 
as achieving developmental tasks or milestones. 
According to Erikson’s formulation and his subsequent 
empirical research on adult men, adulthood was the 
time for overcoming what he termed “psychosocial 
crises,” the resolution of which led to satisfactory 
interpersonal and sexual relationships and to the pursuit 
of broader concerns for society and future generations 
(Erikson, 1963; Vaillant, 1977). However, these 
milestones, and the developmental theories that 
underpin them, have been criticized as reflecting the 
norms of European males rather than of women and 
other cultures. 
Personality Traifs 
Mental health and mental illness can be seen as the 
product of various personality traits, behavior patterns, 
and other characteristics which have roots in the 
individual’s prior life experiences or biology. 
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Table 4-1. Best estimate 1 -year prevalence based on ECA and NCS, ages 1 B-54 
r 
// 
1 
ECA Prevalence (%) NCS Prevalence (%) Best Estimate l * (%) 
2ny Anxiety Disorder 13.1 18.7 16.4 
Simple Phobia 8.3 8.6 8.3 
Social Phobia 2.0 7.4 2.0 
Agoraphobia ;:g 3.7 4.9 
GAD 3.4 3.4 
Panic Disorder 1.6 
OCD 
t:::,* 
g,* 
1.6 
2.4 
PTSD 3.6 3.6 
_. ._ ~ r. _:-c.. +- _.-a _ ,_, Isi-/.. ,: i”i*9’1 _*il ,_ ” : .,bAr’#e~uB&a-s. * *a_ ;&r~..s&.,,;’ iis% 
Any Mood Disorder 7.1 11.1 7.1 
MD Episode 6.5 10.1 6.5 
Unipolar MD 5.3 8.9 6.3 
Dysthymia 1.6 2.5 1.6 
Biopolar I 1.1 1.3 1.1 
Biopolar II 0.6 0.2 0.8 
Schizophrenia 1.3 - 
Nonaffective Psychosis - 0.2 
Somatization 0.2 - 
ASP 2.1 - 
Anorexia Nervosa 0.1 - 
Severe Cognitive Impairment 1.2 
i .~ /, . . I .” ^  - -9 %  ‘- _*‘_ j .-ah;- i--‘*z \ ‘:,.-.~I+ a i.iLJ&&iiC*+.J..~~~. ass ‘-d&i*~ .d.&m5K- , 1,w*~*~“~-pi~ ‘^ .; s- ,.. . I-i;.hr ,-a .:.a& _
Any Disorder 19.5 23.4 21 .o 
*Numbers in parentheses indicate the prevalence of the disorder without any comorbidity. These rates were calculated using the NCS 
data for GAD and PTSD, and the ECA data for OCD. The rates were not used in calculating the any anxiety disorder and any disorder 
totals for the ECA and NCS columns. The unduplicated GAD and PTSD rates were added to the best estimate total for any anxiety 
disorder (3.3%) and any disorder (1.5%). 
‘“In developing best-estimate 1 -year prevalence rates from the two studies, a conservative procedure was followed that had previously 
been used in an independent scientific analysis comparing these two data sets (Andrews, 1995). For any mood disorder and any anxiety 
disorder, the lower estimate of the two surveys was selected, which for these data was the ECA. The best estimate rates for the 
individual mood and anxiety disorders were then chosen from the ECA only, in order to maintain the relationships between the individual 
disorders. For other disorders that were not covered in both surveys, the available estimate was used. 
Key to abbreviations: ECA, Epidemiologic Catchment Area; NCS, National Comorbidity Study; GAD, generalized anxiety disorder; 
OCD, obsessive-compulsive disorder; PTSD, post-traumatic stress disorder; MD, major depression: ASP, antisocial personality 
disorder. 
Source: D. Regier, W. Narrow, & D. Rae, personal communication, 1999 
Personality traits are thought to confer either beneficial 
or detrimental effects on mental health during adult- 
hood. Here too, however, there may be insufficient 
attention to gender and culture. The culture-bound 
nature of much of behavior has limited widespread 
predictive validity of personality research (Mischel &  
Shoda, 1968). W ith this caveat in mind, a brief 
summary of healthy and maladaptive characteristics 
follows. 
Self-Esteem 
Self-esteem refers to an abiding set of beliefs about 
one’s own worth, competence, and abilities to relate to 
others (Vaughan & Oldham, 1997). Self-esteem also 
has been conceptualized as buffering the individual 
from adverse life events. Emotional well-being is often 
associated with a slightly positive, yet realistic, outlook 
(Alloy &  Abramson, 1988). The opposite outlook is 
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characterized by pessimism, demoralization, or minor 
5ymptoms of anxiety and depression. One seminal 
aspect of self-esteem has garnered much research 
attention: self-efficacy (Bandura, 1977). Self-efficacy 
is defined as confidence in one’s own abilities to cope 
\vith adversity, either independently or by obtaining 
appropriate assistance from others. Self-efficacy is a 
major component of the construct known as resilience 
t i.e.. the ability to withstand and overcome adversity). 
Other components of resilience include intelligence and 
problem solving, although resilience is also facilitated 
by having adequate social support (Beardslee & 
Vaillant. 1997). 
Neuroticism 
Neuroticism is a construct that refers to a broad pattern 
of psychological, emotional, and psychophysiologic 
reactivity (Eysenck & Eysenck,‘1975). The opposite of 
neuroticism is stability or equanimity, which are major 
components of mental health. A high level of 
neuroticism is associated with a predisposition toward 
recognizing the dangerous, harmful, or defeating. 
aspects of a situation and the tendency to respond with 
worry, anticipatory anxiety, emotionality, pessimism, 
and dissatisfaction. Neuroticism is associated with a 
greater risk of early-onset depressive and anxiety 
disorders (Clark et al., 1994). Neuroticism also may be 
linked to a particular cognitive attributional style in 
which life events are perceived to be large in impact 
and more difficult to change (Alloy et al., 1984). For 
example, this attributional style is embodied by 
pessimists who see every setback or failure as lasting 
forever, undermining everything, and being their fault 
(Seligman, 1991). Neuroticism also is associated with 
more rigid or distorted attitudes and beliefs about one’s 
competence (Beck, 1976). 
Avoidance 
Avoidance describes an exaggerated predisposition to 
withdraw from novel situations and to avoid personal 
challenges as threats. This is the behavioral state that 
often accompanies the distress of someone who has a 
high level of neuroticism and low self-efficacy 
(Vaughan & Oldham, 1997). Closely related to the 
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characteristics of behavioral inhibition or introversion, 
the trait of avoidance appears to be partly inherited and 
is associated with shyness, anxiety, and depressive 
disorders in both childhood and adult life, as well as the 
subsequent development of substance abuse disorders 
,(Vaughan & Oldham, 1997; Kagan et al., 1988). The 
people with low levels of harm avoidance are described 
as “healthy extroverts” and are characterized by 
confident, carefree, or outgoing behaviors. 
lmpulsivity 
Impulsivity is a trait that is associated with poor 
modulation of emotions, especially anger, difficulty 
delaying gratification, and novelty seeking. There is 
some developmental continuity between high levels of 
impulsivity in childhood and several adult mental 
disorders, including attention deficit hyperactivity 
disorder, bipolar disorder, and substance abuse 
disorders (Svrakic et al., 1993; Rothbart & Ahadi. 
1994). Impulsivity also is associated with physical 
abuse (both as victim and, subsequently, as perpetrator) 
and antisocial personality traits (Vaughan & Oldham. 
1997). 
Sociopathy 
This set of traits and behaviors refers to the 
predisposition to engage in dishonest, hurtful, 
unfaithful, and at times dangerous conduct to benefit 
one’s own ends. The opposite of sociopathy may be 
referred to as character or scrupulosity. In its full form, 
sociopathy is referred to as antisocial personality 
disorder (DSM-IV). Sociopathy is characterized by a 
tendency and ability to disregard laws and rules, 
difficulties reciprocating within empathic and intimate 
relationships, less internalization of moral standards 
(i.e., a weaker conscience or superego), and an 
insensitivity to the needs and rights of others. People 
scoring high in sociopathy often have problems with 
aggressivity and are overrepresented among criminal 
populations. Although not invariably associated with 
criminality, sociopathy is associated with problematic, 
unethical, and morally questionable conduct in the 
workplace and within social systems. Marked 
sociopathy is much more common among men than 
229 
Mental Health: A Report of the Surgeon General 
women, although several other disorders (borderline 
and histrionic personality disorders and somatization 
disorder) are overrepresented among women within the 
same families (Widiger & Costa, 1994). 
In summary, *the various traits and behavioral 
patterns that epitomize strong mental health do not, of 
course, exist in a vacuum: they develop in a social 
context, and they underpin people’s ability to handle 
psychological and social adversity and the exposure to 
stressful life events. Furthermore, as reviewed in 
Chapter 3, severe or repeated trauma during youth may 
have enduring effects on both neurobiological and 
psychological development, altering stress responsivity 
and adult behavior patterns. Perhaps the best 
documented evidence of such enduring effects has been 
shown in young adults who experienced severe sexual 
or physical abuse in childhood. These individuals 
experience a greatly increased risk bf mood, anxiety, 
and personality disorders throughout adult life. 
Stressful life Events 
The most common psychological and social stressors in 
adult life include the breakup of intimate romantic 
relationships, death of a family member or friend, 
economic hardships, racism and discrimination, poor 
physical health, and accidental and intentional assaults 
on physical safety (Holmes & Rahe, 1967; Lazarus & 
Folkman, 1984; Kreiger et al., 1993). Although some 
stressors are so powerful that they would evoke 
significant emotional distress in most otherwise 
mentally healthy people, the majority of stressful life 
events do not invariably trigger mental disorders. 
Rather, they are more likely to spawn mental disorders 
in people who are vulnerable biologically, socially, 
and/or psychologically (Lazarus & Folkman, 1984; 
Brown & Harris, 1989; Kendler et al., 1995). 
Understanding variability among individuals to a 
stressful life event is a major challenge to research. 
Groups at greater statistical risk include women, young 
and unmarried people, African Americans, and 
individuals with lower socioeconomic status 
Wlbrich et al., 1989; McLeod & Kessler, 1990; Turner 
et al., 1995; Miranda & Green, 1999). 
Divorce is a common example. Approximately one- 
half of all marriages now end in divorce, and about 30 
to 40 percent of those undergoing divorce report a 
significant increase in symptoms of depression and 
anxiety (Brown & Harris, 1989). Vulnerability to 
depression and anxiety is greater among those with a 
personal history of mental disorders earlier in life and 
is lessened by strong social support. For many, divorce 
conveys additional economic adversities and the stress 
of single parenting. Single mothers face twice the risk 
of depression as do married mothers (Brown & Moran, 
1997). 
The death of a child or spoise during early or 
midadult life is much less common than divorce but 
generally is of greater potency in provoking emotional 
distress (Kim & Jacobs, 1995). Rates of diagnosable 
mental disorders during periods of grief are attenuated 
by the convention not to diagnose depression during the 
first 2 months of bereavement (Clayton & Darvish, 
1979). In fact, people are generally unlikely to seek 
professional treatment during bereavement unless the 
severity of the emotional and behavioral disturbance is 
incapacitating. 
A majority of Americans never will confront the 
stress of surviving a severe, life-threatening accident or 
physical assault (e.g., mugging, robbery, rape); 
however, some segments of the population, particularly 
urban youths and young adults, have exposure rates as 
high as 25 to 30 percent (Helzer et al., 1987; Breslau et 
al., 199 1). Life-threatening trauma frequently provokes 
emotional and behavioral reactions that jeopardize 
mental health. In the most fully developed form, this 
syndrome is called post-traumatic stress disorder 
(DSM-N), which is described later in this chapter. 
Women are twice as likely as men to develop post- 
traumatic stress disorder following exposure to life- 
threatening trauma (Breslau et al., 1998.) 
More familiar to many Americans is the chronic 
strain that poor physical health and relationship 
problems place on day-to-day well-being. Relationship 
problems include unsatisfactory intimate relationships; 
conflicted relationships with parents, siblings, and 
children; and “falling-out” with coworkers, friends, and 
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neighbors. In mid-adult life, the stress of caretaking for 
elderly parents also becomes more common. 
Relationship problems at least double the risk of 
developing a mental disorder, although they are less 
immediately threatening or potentially cataclysmic than 
divorce or the death of a spouse or child (Brown 8z 
Harris, 1989). Finally,.cumulative adversity appears to 
be more potent than StreSSfUl events in isolation as a 
predictor of psychological distress and mental disorders 
(Turner & Lloyd, 1995). 
fast Trauma and Child Sexual Abuse 
Severe trauma in childhood may have enduring effects 
into adulthood (Browne & Finkelhor, 1986). Past 
trauma includes sexual and physical abuse, and parental 
death, divorce, psychopathology, and substance abuse 
(reviewed in Turner & Lloyd, 1995). 
Child sexual abuse is one of the most common 
stressors, with effects that persist into adulthood. It 
disproportionately affects females. Although 
definitions are still evolving, child sexual abuse is often 
defined as forcible touching of breasts or genitals or. 
forcible intercourse (including anal, oral, or vaginal 
sex) before the age of 16 or 18 (Goodman et al., 1997). 
Epidemiology studies of adults in varying segments of 
the community have found that 15 to 33 percent of 
females and 13 to 16 percent of males were sexually 
abused in childhood (Polusny & Follette, 1995). A 
recent, large epidemiological study of adults in the 
general community found a lower prevalence (12.8 
percent for females and 4.3 percent for males); 
however, the definition of sexual abuse was more 
restricted than in past studies (MacMillan et al., 1997). 
Sexual abuse in childhood has a mean age of onset 
estimated at 7 to 9 years of age (Polusny & Follette, 
1995). In over 25 percent of cases of child sexual 
abuse, the offense was committed by a parent or parent 
substitute (Sedlak & Broadhurst, 1996). 
The long-term consequences of past childhood 
sexual abuse are profound, yet vary in expression. They 
range from depression and anxiety to problems with 
social functioning and adult interpersonal relationships 
(Polusny & Follette, 1995). Post-traumatic stress 
disorder is a common sequela, found in 33 to 86 
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percent of adult survivors of child sexual abuse 
(Polusny & Follette, 1995). In a recent review, Weiss 
et al. (1999) found that sexual abuse was a specific risk 
factor for adult-onset depression and twice as many 
women as men reported a history of abuse. Other long- 
term effects include self-destructive behavior, social 
isolation, poor sexual adjustment, substance abuse, and 
increased risk of revictimization (Browne & Finkelhor, 
1986; Briere, 1992). 
Very few treatments specifically for adult survivors 
of childhood abuse have been studied in randomized 
controlled trials (IOM, 1998) Group therapy and 
Interpersonal Transaction group therapy were found to 
be more effective for female survivors than an 
experimental control condition that offered a less 
appropriate intervention (Alexander et al., 1989,199 1). 
In the practice setting, most psychosocial and 
pharmacological treatments are tailored to the primary 
diagnosis, which, as noted above, varies widely and 
may not attend to the special needs of those also 
reporting abuse history. 
Domestic Violence 
Domestic violence is a serious and startlingly common 
public health problem with mental health consequences 
for victims, who are overwhelmingly female, and for 
children who witness the violence. Domestic violence 
(also known as intimate partner violence) features a 
pattern of physical and sexual abuse, psychological 
abuse with verbal intimidation, and/or social isolation 
or deprivation. Estimates are that 8 to 17 percent of 
women are victimized annually in the United States 
(Wilt & Olsen, 1996). Pinpointing the prevalence is 
hindered by variations in the way domestic violence is 
defined and by problems in detection and 
underreporting. Women are often fearful that their 
reporting of domestic violence will precipitate 
retaliation by the batterer, a fear that is not unwarranted 
(Sisley et al., 1999). 
Victims of domestic violence are at increased risk 
for mental health problems and disorders as well as 
physical injury and death. Domestic violence is 
considered one of the foremost causes of serious injury 
to women ages 15 to 44, accounting for about 30 
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percent of all acute injuries to women seen in 
emergency departments (Wilt & Olsen, 1996). 
According to the U.S. Department of Justice, females 
were victims in about 75 percent of the almost 2,000 
homicides between intimates in 1996 (cited in Sisley et 
al., 1999). The mental healthconsequences of domestic 
violence include depression, anxiety disorders (e.g., 
post-traumatic stress disorder), suicide, eating 
disorders, and substance abuse (IOM, 1998; Eisenstat 
& Bancroft, 1999). Children who witness domestic 
violence may suffer acute and long-term emotional 
disturbances, including nightmares, depression, 
learning difficulties, and aggressive behavior. Children 
also become at risk for subsequent use of violence 
against their dating partners and wives (el-Bayoumi et 
al., 1998; NRC, 1998; Sisley et al., 1999). 
Mental health interventions for victims, children, 
and batterers are highly important. Individual 
counseling and peer support groups are the 
interventions most frequently used by battered women. 
However, there is a lack of carefully controlled, 
methodologically robust studies of interventions and 
their outcomes, according to a report by the Institute of 
Medicine and National Research Council (IOM, 1998). 
A research agenda for violence against women was 
developed (IOM, 1996) and has served as an impetus 
for an ongoing research program sponsored by the U.S. 
Departments of Justice and Health and Human 
Services. Clearly, there is an urgent need for 
development and rigorous evaluation of prevention 
programs to safeguard against intimate partner violence 
and its impact on children. 
Interventions for Stressful Life Events 
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Stressful life events, even for those at the peak of 
mental health, erode quality of life and place people at 
risk for symptoms and signs of mental disorders. There 
is an ever-expanding list of formal and informal 
interventions to aid individuals coping with adversity. 
Sources of informal interventions include family and 
friends, education, community services, self-help 
groups. social support networks, religious and spiritual 
endeavors, complementary healers, and physical 
activities. As valuable as these activities may be for 
promoting mental health, they have received less 
research attention than have interventions for mental 
disorders. Nevertheless, there are selected interventions 
to help people cope with stressors, such as bereavement 
programs and programs for caregivers (see Chapter 5) 
as well as couples therapy and physical activity. 
Couples therapy is the umbrella term applied to 
interventions that aid couples in distress. The best 
studied interventions are behavioral couples therapy, 
cognitive-behavioral couples therapy, and emotion- 
focused couples therapy. A recent review. article 
evaluated the body of evidence on the effectiveness of 
couples therapy and programs ;o. prevent marital 
discord (Christensen & Heavey, 1999). The review 
found that about 65 percent of couples in therapy did 
improve, whereas 35 percent of control couples also 
improved. Couples therapy ameliorates relationship 
distress and appears to alleviate depression. The gains 
from couples therapy generally last through 6 months, 
but there are few long-term assessments (Christensen & 
Heavey, 1999). Similarly, interventions to prevent 
marital discord yield short-term improvements in 
marital adjustment and stability, but there is 
insufficient study of long-term outcomes. The 
prevention programs receiving the most study are the 
Couple Communication Program, Relationship 
Enhancement, and the Prevention and Relationship 
Enhancement Program (Christensen & Heavey, 1999). 
Greater research is needed to overcome gaps in 
knowledge and to extend findings to a broader array of 
programs, to diverse populations of couples, and to a 
wider set of outcomes, including effects on children. 
Physical activities are a means to enhance somatic 
health as well as to deal with stress. A recent Surgeon 
General’s Report on Physical Activity and Health 
evaluated the evidence for physical activities serving to 
enhance mental health (U.S. Department of Health and 
Human Services [DHHS], 1996). Aerobic physical 
activities, such as brisk walking and running, were 
found to improve mental health for people who report 
symptoms of anxiety and depression and for those who 
are diagnosed with some forms of depression. The 
mental health benefits of physical activity for 
individuals in relatively good physical and mental 
health were not as evident, but the studies did not have 
sufficient rigor from which to draw unequivocal 
conclusions (DHHS, 1996). 
prevention of Mental Disorders 
A promising development in prevention of a specific 
mental disorder in adults occurred with the publication 
of results from the San Francisco Depression Research 
Project (Munoz et al., 1995). This study investigated 
150 primary care patients who did not meet diagnostic 
criteria for depression and who were being seen in a 
public clinic for other problems. They were randomized 
to either psychoeducation-an 8-week cognitive 
behavioral course to help them control and manage 
moods--or to a control condition, One year later, those 
who received psychoeducation were found to have 
developed significantly fewer depression symptoms 
than members of the control group. This trial is 
noteworthy in two major respects: it was a randomized 
controlled trial and its participants were low-income 
individuals, with high representation of all major 
minority groups. Low-income individuals are 
considered a high-risk population because of studies 
documenting their higher prevalence of mental 
disorders. This study demonstrated in a 
methodologically rigorous fashion that depression may 
be preventable in some cases. It serves as a model for 
extending the concept of prevention to many mental 
disorders. Prevention research is vitally important and 
needs to be enhanced. 
and without a history of panic disorder), generalized 
anxiety disorder, specific phobia, social phobia, 
obsessive-compulsive disorder, acute stress disorder, 
and post-traumatic stress disorder (DSM-IV). In 
addition, there are adjustment disorders with anxious 
features, anxiety disorders due to general medical 
conditions, substance-induced anxiety disorders, and 
the residual category of anxiety disorder not otherwise 
specified (DSM-IV). 
Anxiety Disorders 
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The anxiety disorders are the most common, or 
frequently occurring, mental disorders. They 
encompass a group of conditions that share extreme or 
pathological anxiety as the principal disturbance of 
mood or emotional tone. Anxiety, which may be 
understood as the pathological counterpart of normal 
fear, is manifest by disturbances of mood, as well as of 
thinking, behavior, and physiological activity. 
Types of Anxiety Disorders 
The anxiety disorders include panic disorder (with and 
without a history of agoraphobia), agoraphobia (with 
Adults and Mental Health 
Anxiety disorders not only are common in the 
United States, but they are ubiquitous across human 
cultures (Regier et al., 1993; Kessler et al., 1994; 
Weissman et al., 1997). In the United States, l-year 
prevalence for all anxiety disorders among adults ages 
18 to 54 exceeds 16 percent (Table 4-l), and there is 
significant overlap or comorbidity with mood and 
substance abuse disorders (Regier et al., 1990; 
Goldberg & Lecrubier, 1995; Magee et al., 1996). The 
longitudinal course of these disorders is characterized 
by relatively early ages of onset, chronicity, relapsing 
or recurrent episodes of illness, and periods of 
disability (Keller & Hanks, 1994; Gorman & Coplan, 
1996; Liebowitz, 1997; Marcus et al., 1997). Although 
few psychological autopsy studies of adult suicides 
have included a focus on comorbid conditions (Conwell 
& Brent, 1995), it is likely that the rate of comorbid 
anxiety in suicide is underestimated. Panic disorder and 
agoraphobia, particularly, are associated with increased 
risks of attempted suicide (Homig & McNally, 1995; 
American Psychiatric Association, 1998). 
Panic Attacks and Panic Disorder 
A panic attack is a discrete period of intense fear or 
discomfort that is associated with numerous somatic 
and cognitive symptoms (DSM-IV). These symptoms 
include palpitations, sweating, trembling, shortness of 
breath, sensations of choking or smothering, chest pain, 
nausea or gastrointestinal distress, dizziness or 
lightheadedness, tingling sensations, and chills or 
blushing and “hot flashes.” The attack typically has an 
abrupt onset, building to maximum intensity within 10 
to 15 minutes. Most people report a fear of dying, 
“going crazy,” or losing control of emotions or 
behavior. The experiences generally provoke a strong 
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urge to escape or flee the place where the attack begins 
and, when associated with chest pain or shortness of 
breath, frequently results in seeking aid from a hospital 
emergency room or other type of urgent assistance. Yet 
an attack rarely lasts longer than 30 minutes. Current 
diagnostic practice specifies that a panic attack must be 
characterized by at least four of the associated somatic 
and cognitive symptoms described above. The panic 
attack is distinguished from other forms of anxiety by 
its intensity and its sudden, episodic nature. Panic 
attacks may be further characterized by the relationship 
between the onset of the attack and the presence or 
absence of situational factors. For example, a panic 
attack may be described as unexpected, situationally 
bound, or situationally predisposed (usually, but not 
invariably occurring in a particular situation). There are 
also attenuated or “limited symptom” forms of panic 
attacks. 
Panic attacks are not always indicative of a mental 
disorder, and up to 10 percent of otherwise healthy 
people experience an isolated panic attack per year 
(Barlow, 1988; Klerman et al., 1991). Panic attacks 
also are not limited to panic disorder. They commonly 
occur in the course of social phobia, generalized 
anxiety disorder, and major depressive disorder 
(DSM-IV). 
Panic disorder is diagnosed when a person has 
experienced at least two unexpected panic attacks and 
develops persistent concern or worry about having 
further attacks or changes his or her behavior to avoid 
or minimize such attacks. Whereas the number and 
severity of the attacks varies widely, the concern and 
avoidance behavior are essential features. The 
diagnosis is inapplicable when the attacks are presumed 
to be caused by a drug or medication or a general 
medical disorder, such as hyperthyroidism. 
Lifetime rates of panic disorder of 2 to 4 percent 
and l-year rates of about 2 percent are documented 
consistently in epidemiological studies (Kessler et al., 
1994; Weissman et al., 1997) (Table 4-l). Panic 
disorder is frequently complicated by major depressive 
disorder (50 to 65 percent lifetime comorbidity rates) 
and alcoholism and substance abuse disorders (20 to 30 
‘percent comorbidity) (Keller&Hanks, 1994; Magee et 
al., 1996; Liebowitz, 1997). Panic disorder is also 
concomitantly diagnosed, or co-occurs, with other 
specific anxiety disorders, including social phobia (up 
to 30 percent), generalized anxiety disorder (up to 25 
percent), specific phobia (up to 20 percent), and 
obsessive-compulsive disorder (up to 10 percent) 
(DSM-IV). As discussed subsequently, approximately 
one-half of people with panic disorder at some point 
develop such severe avoidance as to warrant a separate 
description, panic disorder with agoraphobia. 
Panic disorder is about twice as common among 
women as men (American Psychiatric Association, 
1998). Age of onset is most common between late 
adolescence and midadult life, with onset relatively 
uncommon past age 50. There is developmental 
continuity between the anxiety syndromes of youth, 
such as separation anxiety disorder. Typically, an early 
age of onset of panic disorder carries greater risks of 
comorbidity, chronicity, and impairment. Panic 
disorder is a familial condition and can be 
distinguished from depressive disorders by family 
studies (Rush et al., 1998). 
Agoraphobia 
The ancient term agoraphobia is translated from Greek 
as fear of an open marketplace. Agoraphobia today 
describes severe and pervasive anxiety about being in 
situations from which escape might be difficult or 
avoidance of situations such as being alone outside of 
the home, traveling in a car, bus, or airplane, or being 
in a crowded area (DSM-TV). 
Most people who present to mental health 
specialists develop agoraphobia after the onset of panic 
disorder (American Psychiatric Association, 1998). 
Agoraphobia is best understood as an adverse 
behavioral outcome of repeated panic attacks and the 
subsequent worry, preoccupation, and avoidance 
(Barlow, 1988). Thus, the formal diagnosis of panic 
disorder with agoraphobia was established. However, 
for those people in communities or clinical settings 
who do not meet full criteria for panic disorder, the 
formal diagnosis of agoraphobia without history of 
panic disorder is used (DSM-IV). 
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The l-year prevalence of agoraphobia is about 5 
percent (Table 4-l). Agoraphobia occurs about two 
times more commonly among women than men (Magee 
et al., 1996). The gender difference may be attributable 
to social-cultural factors that encourage, or permit, the 
greater expression of avoidant coping strategies by 
women (DSM-IV), although other explanations are 
possible. 
Specific Phobias 
These common conditions are characterized by marked 
fear of specific objects or situations (DSM-IV). 
Exposure to the object of the phobia, either in real life 
or via imagination or video, invariably elicits intense 
anxiety, which may include a (situationally bound) 
panic attack. Adults generally recognize that this 
intense fear is irrational. Nevertheless, they typically 
avoid the phobic stimulus or endure exposure with 
great difficulty. The most common specific phobias 
include the following feared stimuli or situations: 
animals (especially snakes, rodents, birds, and dogsj; 
insects (especially spiders and bees or hornets); 
heights; elevators; flying; automobile driving; water; 
storms; and blood or injections. 
Approximately 8 percent of the adult population 
suffers from one or more specific phobias in 1 year 
(Table 4-l). Much higher rates would be recorded if 
less rigorous diagnostic requirements for avoidance or 
functional impairment were employed. Typically, the 
specific phobias begin in childhood, although there is 
a second “peak” of onset in the middle 20s of 
adulthood (DSM-IV). Most phobias persist for years or 
even decades, and relatively few remit spontaneously 
or without treatment. 
The specific phobias generally do not result from 
exposure to a single traumatic event (i.e., being bitten 
by a dog or nearly drowning) (Marks, 1969). Rather, 
there is evidence of phobia in other family members 
and social or vicarious learning of phobias (Cook & 
Mineka, 1989). Spontaneous, unexpected panic attacks 
also appear to play a role in the development of specific 
phobia, although the particular pattern of avoidance is 
much more focal and circumscribed. 
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Social Phobia 
Social phobia, also known as social anxiety disorder, 
describes people with marked and persistent anxiety in 
social situations, including performances and public 
speaking (Ballenger et al., 1998). The critical element 
of the fearfulness is the possibiIity of embarrassment or 
ridicule. Like specific phobias, the fear is recognized 
by adults as excessive or unreasonable, but the dreaded 
social situation is avoided or is tolerated with great 
discomfort. Many people with social phobia are 
preoccupied with concerns that others will see their 
anxiety symptoms (i.e., trembling, sweating, or 
blushing); or notice their halting or rapid speech; or 
judge them to be weak, stupid, or “crazy.” Fears of 
fainting, losing control of bowel or bladder function, or 
having one’s mind going blank are also not uncommon. 
Social phobias generally are associated with significant 
anticipatory anxiety for days or weeks before the 
dreaded event, which in turn may further handicap 
performance and heighten embarrassment. 
The l-year prevalence of social phobia ranges 
from 2 to 7 percent (Table 4-l), although the lower 
figure probably better captures the number of people 
who experience significant impairment and distress. 
Social phobia is more common in women (Wells et al., 
1994). Social phobia typically begins in childhood or 
adolescence and, for many, it is associated with the 
traits of shyness and social inhibition (Kagan et al., 
1988). A public humiliation, severe embarrassment, or 
other stressful experience may provoke an 
intensification of difficulties (Barlow, 1988). Once the 
disorder is established, complete remissions are 
uncommon without treatment. More commonly, the 
severity of symptoms and impairments tends to 
fluctuate in relation to vocational demands and the 
stability of social relationships. Preliminary data 
suggest social phobia to be familial (Rush et al., 1998). 
Generalized Anxiety Disorder 
Generalized anxiety disorder is defined by a protracted 
(16 months’ duration) period of anxiety and worry, 
accompanied by multiple associated symptoms (DSM- 
IV). These symptoms include muscle tension, easy 
fatiguability, poor concentration, insomnia, and 
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irritability. In youth, the condition is known as 
overanxious disorder of childhood. In DSM-IV, an 
essential feature of generalized anxiety disorder is that 
the anxiety and worry cannot be attributable to the 
more focal distress of panic disorder, social phobia, 
obsessive-compulsive disorder, or other conditions. 
Rather, as implied by the name, the excessive worries 
often pertain to many areas, including work, 
relationships, finances, the well-being of one’s family, 
potential misfortunes, and impending deadlines. 
Somatic anxiety symptoms are common, as are 
sporadic panic attacks. 
Generalized anxiety disorder occurs more often in 
women, with a sex ratio of about 2 women to 1 man 
(Brawman-Mintzer & Lydiard, 1996). The l-year 
population prevalence is about 3 percent (Table 4-l). 
Approximately 50 percent of cases begin in childhood 
or adolescence. The disorder typically runs a 
fluctuating course, with periods of increased symptoms 
usually associated with life stress or impending 
difficulties. There does not appear to be a specific 
familial association for general anxiety disorder, 
Rather, rates of other mood and anxiety disorders 
typically are greater among first-degree relatives of 
people with generalized anxiety disorder (Kendler et 
al., 1987). 
Obsessive-Compulsive Disorder 
Obsessions are recurrent, intrusive thoughts, impulses, 
or images that are perceived as inappropriate, 
grotesque, or forbidden (DSM-IV). The obsessions, 
which elicit anxiety and marked distress, are termed 
“ego-alien” or “ego-dystonic” because their content is 
quite unlike the thoughts that the person usually has. 
Obsessions are perceived as uncontrollable, and the 
sufferer often fears that he or she will lose control and 
act upon such thoughts or impulses. Common themes 
include contamination with germs or body fluids, 
doubts (i.e., the worry that something important has 
been overlooked or that the sufferer has unknowingly 
inflicted harm on someone), order or symmetry, or loss 
of control of violent or sexual impulses. 
Compulsions are repetitive behaviors or mental acts 
that reduce the anxiety that accompanies an obsession 
or “prevent” some dreaded event from happening 
(DSM-IV). Compulsions include both overt behaviors, 
such as hand washing or checking, and mental acts 
including counting or praying. Not uncommonly, 
compulsive rituals take up long periods of time, even 
hours, to complete. For example, repeated hand 
washing, intended to remedy anxiety about 
contamination, is a common cause of contact 
dermatitis. 
Although once thought to be rare, obsessive- 
compulsive disorder has now been documented to have 
a l-year prevalence of 2.4 percent (Table 4-l). 
Obsessive-compulsive disorder is equally common 
among men and women. 
Obsessive-compulsive disorder typically begins in 
adolescence to young adult life (males) or in young 
adult life (females) (Burke et al., 1990; DSM-IV). For 
most, the course is fluctuating and, like generalized 
anxiety. disorder, symptom exacerbations are usually 
associated with life stress. Common comorbidities 
include major depressive disorder and other anxiety 
disorders. Approximately 20 to 30 percent of people in 
clinical samples with obsessive-compulsive disorder 
report a past history of tics, and about one-quarter of 
these people meet the full criteria for Tourette’s 
disorder (DSM-IV). Conversely, up to 50 percent of 
people with Tourette’s disorder develop obsessive- 
compulsive disorder (Pitman et al., 1987). 
Obsessive-compulsive disorder has a clear familial 
pattern and somewhat greater familial specificity than 
most other anxiety disorders. Furthermore, there is an 
increased risk of obsessive-compulsive disorder among 
first-degree relatives with Tourette’s disorder. Other 
mental disorders that may fall within the spectrum of 
obsessive-compulsive disorder include trichotillomania 
(compulsive hair pulling), compulsive shoplifting, 
gambling, and sexual behavior disorders (Hollander, 
1996). The latter conditions are somewhat discrepant 
because the compulsive behaviors are less ritualistic 
and yield some outcomes that are pleasurable or 
236 
gratifying. Body dysmorphic disorder is a more 
circumscribed condition in which the compulsive and 
obsessive behavior centers around a preoccupation with 
one’s appearance (i.e., the syndrome of imagined 
ugliness) (Phillips, 199 1). 
Acute and Post-Traumatic Stress Disorders 
Acute stress disorder refers to the anxiety and 
behavioral disturbances that develop within the first 
month after exposure to an extreme trauma. Generally, 
the symptoms of an acute stress disorder begin during 
or shortly following the trauma. Such extreme 
traumatic events include rape or other severe physical 
assault, near-death experiences in accidents, witnessing 
a murder, and combat. The symptom of dissociation, 
which reflects a perceived detachment of the mind from 
the emotional state or even the body, is a critical 
feature. Dissociation also is characterized by a sense of 
the world as a dreamlike or unreal place and may be 
accompanied by poor memory of the specific events, 
which in severe form is known as dissociative amnesia. 
Other features of an acute stress disorder include 
symptoms of generalized anxiety and hyperarousal, 
avoidance of situations or stimuli that elicit memories 
of the trauma, and persistent, intrusive recollections of 
the event via flashbacks, dreams, or recurrent thoughts 
or visual images. 
If the symptoms and behavioral disturbances of the 
acute stress disorder persist for more than 1 month, and 
if these features are associated with functional 
impairment or significant distress to the sufferer, the 
diagnosis is changed to post-traumatic stress disorder. 
Post-traumatic stress disorder is further defined in 
DSM-IV as having three subforms: acute’ (< 3 months’ 
duration), chronic (2 3 months’ duration), and delayed 
onset (symptoms began at least 6 months after exposure 
to the trauma). 
By virtue of the more sustained nature of post- 
’ The acute subform of post-traumatic stress disorder is distinct 
from acute stress.disorder because the latter resolves by the end 
of the first month, whereas the former persists until 3 months. 
If the condition persists after 3 months duration, the diagnosis is 
again changed to the chronic post-traumatic stress disorder 
subform (DSM-IV). 
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traumatic stress disorder (relative to acute stress 
disorder), a number of changes, including decreased 
self-esteem, loss of sustained beliefs about people or 
society, hopelessness, a sense of being permanently 
damaged, and difficulties in. previously established 
relationships, are typically observed. Substance abuse 
often develops, especially involving alcohol, marijuana, 
and sedative-hypnotic drugs. 
About 50 percent of cases of post-traumatic stress 
disorder remit within 6 months. For the remainder, the 
disorder typically persists for years and can dominate 
the sufferer’s life. A longitu’dinal study of Vietnam 
veterans, for example, found 15 percent of veterans to 
be suffering from post-traumatic stress disorder 19 
years after combat exposure (cited in McFarlane & 
Yehuda, 1996). In the general population, the l-year 
prevalence is about 3.6 percent, with women having 
almost twice the prevalence of men (Kessler et al., 
1995) (Table 4- 1). The highest rates of post-traumatic 
stress disorder are found among women who are 
victims of crime, especially rape, as well as among 
torture and concentration camp survivors (Yehuda, 
1999). Overall, among those exposed to extreme 
trauma, about 9 percent develop post-traumatic stress 
disorder (Breslau et al., 1998). 
Etiology of Anxiety Disorders 
The etiology of most anxiety disorders, although not 
fully understood, has come into sharper focus in the last 
decade. In broad terms, the likelihood of developing 
anxiety involves a combination of life experiences, 
psychological traits, and/or genetic factors. The anxiety 
disorders are so heterogeneous that the relative roles of 
these factors are likely to differ. Some anxiety dis- 
orders, like panic disorder, appear to have a stronger 
genetic basis than others (National Institute of Mental 
Health [NIMH], 1998), although actual genes have not 
been identified. Other anxiety disorders are more 
rooted in stressful life events. 
It is not clear why females have higher rates than 
males of most anxiety disorders, although some 
theories have suggested a role for the gonadal steroids. 
Other research on women’s responses to stress also 
suggests that women experience a wider range of life 
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events (e.g., those happening to friends) as stressful as 
compared with men who react to a more limited range 
of stressful events, specifically those affecting 
themselves or close family members (Maciejewski et 
al., 1999). 
What the myriad of anxiety disorders have in 
common is a state of increased arousal or fear (Barbee, 
1998). Anxiety disorders often are conceptualized as an 
abnormal or exaggerated version of arousal. Much is 
known about arousal because of decades of study in 
animals” and humans of the so-called “fight-or-flight 
response,” which also is referred to as the acute stress 
response. The acute stress response is critical to 
understanding the normal response to stressors and has 
galvanized research, but its limitations for 
understanding anxiety have come to the forefront in 
recent years, as this section later explains. 
In common parlance, the term “stress” refers either 
to the external stressor, which can be physical or 
psychosocial in nature, as well as to the internal 
response to the stressor. Yet researchers distinguish the 
two, calling the stressor the stimulus and the body’s 
reaction the stress response. This is an important 
distinction because in many anxiety states there is no 
immediate external stressor. The following paragraphs 
describe the biology of the acute stress response, as 
well as its limitations, in understanding human anxiety. 
Emerging views about the neurobiology of anxiety 
attempt to integrate and understand psychosocial views 
of anxiety and behavior in relation to the structure and 
function of the central and peripheral nervous system. 
Acute Stress Response 
When a fearful or threatening event is perceived, 
humans react innately to survive: they either are ready 
for battle or run away (hence the term “fight-or-flight 
response”). The nature of the acute stress response is 
all too familiar. Its hallmarks are an almost 
instantaneous surge in heart rate, blood pressure, 
sweating, breathing, and metabolism, and a tensing of 
2 Anxiety is one of the few mental disorders for which animal 
models have beendeveloped. Researchers can reproduce some 
of the symptoms of human anxiety in animals by introducing 
‘different types of stressors, either physical or psychosocial. 
muscles. Enhanced cardiac output and accelerated 
metabolism are essential for mobilizing fast action. The 
host of physiological changes activated by a stressful 
event are unleashed in part by activation of a nucleus in 
the brain stem called the locus ceruleus. This nucleus 
is the origin of most norepinephrine pathways in the 
brain. Neurons using norepinephrine as their 
neurotransmitter project bilaterally from the locus 
ceruleus along distinct pathways to the cerebral cortex, 
limbic system, and the spinal cord, among other 
projections. 
Normally, when someone is i? a serene, unstim- 
ulated state, the “firing” of neurons in the locus 
ceruleus is minimal. A novel stimulus, once perceived, 
is relayed from the sensory cortex of the brain through 
the thalamus to the brain stem. That route of signaling 
increases the rate of noradrenergic activity in the locus 
ceruleus, and the person becomes alert and attentive to 
the environment. If the stimulus is perceived as a threat, 
a more intense and prolonged discharge of the locus 
ceruleus activates the sympathetic division of the 
autonomic nervous system (Thase & Howland, 1995). 
The activation of the sympathetic nervous system leads 
to the release of norepinephrine from nerve endings 
acting on the heart, blood vessels, respiratory centers, 
and other sites. The ensuing physiological changes 
constitute a major part of the acute stress response. The 
other major player in the acute stress response is the 
hypothalamic-pituitary-adrenal axis, which is discussed 
in the next section. 
In the 198Os, the prevailing view was that excess 
discharge of the locus ceruleus with the acute stress 
response was a major contributor to the etiology of 
anxiety (Coplan & Lydiard, 1998). Yet over the past 
decade, the limitations of the acute stress response as a 
model for understanding anxiety have become more 
apparent. The first and most obvious limitation is that 
the acute stress response relates to arousal rather than 
anxiety. Anxiety differs from arousal in several ways 
(Barlow, 1988; Nutt et al., 1998). First, with anxiety, 
the concern about the stressor is out of proportion to 
the realistic threat. Second, anxiety is often associated 
with elaborate mental and behavioral activities 
designed to avoid the unpleasant symptoms of a full- 
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blown anxiety or panic attack. Third, anxiety is usually 
longer lived than arousal. Fourth, anxiety can occur 
without exposure to an external stressor. 
Other limitations of this model became evident 
from a lack of support from clinical and basic research 
(Coplan 8~ Lydiard, 1998). Furthermore, with its 
emphasis on the neurotransmitter norepinephrlne, the 
model could not explain why medications that acted on 
the neurotransmitter serotonin (the selective serotonin 
reuptake inhibitors, or SSRIs) helped to alleviate 
anxiety symptoms. In fact, these medications are 
becoming the first-line treatment for anxiety disorders 
(Kent et al., 1998). To probe the etiology of anxiety, 
researchers began to devote their energies to the study 
of other brain circuits and the neurotransmitters on 
which they rely. The locus ceruleus still participates in 
anxiety but is understood to play a lesser role. 
New Views About the Anatomical and 
Biochemical Basis of Anxiety 
An exciting new line of research proposes that anxiety 
engages a wide range of neurocircuits. This line of 
research catapults to prominence two key regulatory 
centers found in the cerebral hemispheres of the 
brain-the hippocampus and the amygdala. These 
centers, in turn, are thought to activate the 
hypothalamic-pituitary-adrenocortical (HPA) axis3 
(Goddard & Chamey, 1997; Coplan & Lydiard, 1998; 
Sullivan et al., 1998). Researchers have long 
established the contribution of the HPA axis to anxiety 
but have been perplexed by how it is regulated. They 
are buoyed by new findings about the roles of the 
hippocampus and the amygdala. 
The hippocampus and the amygdala govern 
memory storage and emotions, respectively, among 
their other functions. The hippocampus is considered 
important in verbal memory, especially of time and 
place for events with strong emotional overtones 
(McEwen, 1998). The hippocampus and amygdala are 
major nuclei of the limbic system, a pathway known to 
3 Hypothalamus and the pituitary gland, and then the cortex, 
or outer layer, of the adrenal gland. Upon stimulation by the 
pituitary hormone ACTH, the adrenal cortex releases gluco- 
corticoids into the circulation. 
underlie emotions. There are anatomical projections 
between the hippocampus, amygdala, and hypothal- 
alamus (Jacobson & Sapolsky, 1991; Charney & 
Deutch, 1996; Coplan & Lydiard, 1998). 
Studies of emotional processing in rodents 
(LeDoux, 1996; Rogan & LeDoux, 1996; Davis, 1997) 
and in humans with brain lesions (Adolphs et al., 1998) 
have identified the amygdala as critical to fear 
responses. Sensory information enters the lateral 
amygdala, from which processed information is passed 
to the central nucleus, the major output nucleus of the 
amygdala. The central nucleus projects, in turn, to 
multiple brain systems involved in the physiologic and 
behavioral responses to fear. Projections to different 
regions of the hypothalamus activate the sympathetic 
nervous system and induce the release of stress 
hormones, such as CRH: The production of CRH in 
the paraventricular nucleus of the hypothalamus 
activates a cascade leading to release of glucocorticoids 
from the adrenal cortex. Projections from the central 
nucleus innervate different parts of the periaqueductal 
gray matter, which initiates descending analgesic 
responses (involving the body’s endogenous opioids) 
that can suppress pain in an emergency, and which also 
activates species-typical defensive responses (e.g., 
many animals freeze when fearful). 
Anxiety differs from fear in that the fear-producing 
stimulus is either not present or not immediately 
threatening, but in anticipation of danger, the same 
arousal, vigilance, physiologic preparedness, and 
negative affects and cognitions occur. Different types 
of internal or external factors or triggers act to produce 
the anxiety symptoms of panic disorder, agoraphobia, 
post-traumatic stress disorder, specific phobias, and 
generalized anxiety disorder, and the prominent anxiety 
that commonly occurs in major depression. It is 
currently a matter of research to determine whether 
dysregulation of these fear pathways leads to the 
symptoms of anxiety disorders. It has now been 
established, using noninvasive neuroimaging, that the 
human amygdala is also involved in fear responses. 
Fearful facial expressions have been shown to activate 
4 Also known as coriocotropin-releasing factor. 
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the amygdala in MRI studies of normal human subjects 
(Breiter et al., 1996). Functional imaging studies in 
anxiety disorders, such as PET studies of brain 
activation in phobias (Rauch et al., 1993, are also 
beginning to investigate the precise neural circuits 
involved in the anxiety disorders. 
What is especially exciting is that neuroimaging 
has furnished direct evidence in humans of the 
damaging effects of glucocorticoids. In people with 
post-traumatic stress disorder, neuroimaging studies 
have found a reduction in the size of the hippocampus. 
The reduced volume appears to reflect the atrophy of 
dendrites-the receptive portion of nerve cells-in a 
select region of the hippocampus. Similarly, animals 
exposed to chronic psychosocial stress display atrophy 
in the same hippocampal region (McEwen & 
Magarinos, 1997). Stress-induced increases in 
glucocorticoids are thought to be responsible for the 
atrophy (McEwen, 1998). If the hippocampus is 
impaired, the individual is thought to be less able to 
draw on memory to evaluate the nature of the stressor 
(McEwen, 1998). 
A/eurofransmitfer Alterations 
There are many neurotransmitter alterations in anxiety 
disorders. In keeping with the broader view of anxiety, 
at least five neurotransmitters are perturbed in anxiety: 
serotonin, norepinephrine, gamma-aminobutyric acid 
(GABA), corticotropin-releasing hormone (CRH),5 and 
cholecystokinin (Coplan & Lydiard 1998; Rush et al., 
1998). There is such careful orchestration between 
these neurotransmitters that changes in one 
neurotransmitter system invariably elicit changes in 
another, including extensive feedback mechanisms. 
Serotonin and GABA are inhibitory neurotransmitters 
that quiet the stress response (Rush et al., 1998). All of 
these neurotransmitters have become important targets 
for therapeutic agents either already marketed or in 
development (as discussed in the section on treatment 
of anxiety disorders). 
s CRH may act as a neuromodulator, a neurotransmitter, or a 
neurohormone. depending on the pathway. 
Psychological Views of Anxiety 
There are several major psychological theories of 
anxiety: psychoanalytic and psychodynamic theory, 
behavioral theories, and cognitive theories (Thorn et 
al., 1999). Psychodynamic theories have focused on 
symptoms as an expression of underlying conflicts 
(Rush et al., 1998; Thorn et al., 1999). Although there 
are no empirical studies to support these 
psychodynamic theories, they are amenable to scientific 
study (Kandel, 1999) and some therapists find them 
useful. For example, ritualistic compulsive behavior 
can be viewed as a result ,of a specific defense 
mechanism that serves to channel ‘psychic energy away 
from conflicted or forbidden impulses. Phobic 
behaviors similarly have been viewed as a result of the 
defense mechanism of displacement. From the 
psychodynamic perspective, anxiety usually reflects 
more basic, unresolved conflicts in intimate 
relationships or expression of anger. 
More recent behavioral theories have emphasized 
the importance of two types of learning: classical 
conditioning and vicarious or observational learning. 
These theories have some empirical evidence to support 
them. In classical conditioning, a neutral stimulus 
acquires the ability to elicit a fear response after 
repeated pairings with a frightening (unconditioned) 
stimulus. In vicarious learning, fearful behavior is 
acquired by observing others’ reactions to fear- 
inducing stimuli (Thorn et al., 1999). With general 
anxiety disorder, unpredictable positive and negative 
reinforcement is seen as leading to anxiety, especially 
because the person is unsure about whether avoidance 
behaviors are effective. 
Cognitive factors, especially the way people 
interpret or think about stressful events, play a critical 
role in the etiology of anxiety (Barlow et al., 1996; 
Thorn et al., 1999). A decisive factor is the individual’s 
perception, which can intensify or dampen the 
response. One of the most salient negative cognitions 
in anxiety is the sense of uncontrollability. It is typified 
by a state of helplessness due to a perceived inability to 
predict, control, or obtain desired results (Barlow et al., 
1996). Negative cognitions are frequently found in 
individuals with anxiety (Ingram et al., 1998). Many 
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,,,odem psychological models of anxiety incorporate 
the role of individual vulnerability, which includes both 
genetic (Smoller & Tsuang, 1998) and acquired 
, Coplan et al.. 1997) predispositions. There is evidence 
that vvomen may ruminate more about distressing life 
e\‘ents compared with men, suggesting that a cognitive 
ri>k factor may predispose them to higher rates of 
anxiety and depression (Nolen-Hoeksema et al., in 
press ). 
Treatment of Anxiety Disorders 
The anxiety disorders are treated with some form of 
counseling or psychotherapy or pharmacotherapy, 
either singly or in combination (Barlow & Lehman, 
1996: March et al., 1997; American Psychiatric 
Association, 1998; Kent et al., 1998). 
Counseling and Psychotherapy 
Anxiety disorders are responsive to counseling and to 
a wide variety of psychotherapies. More severe and 
persistent symptoms also may require pharmacotherapy 
(American Psychiatric Association, 1998). 
During the past several decades, there has been 
increasing enthusiasm for more focused, time-limited 
therapies that address ways of coping with anxiety 
symptoms more directly rather than . exploring 
unconscious conflicts or other personal vulnerabilities 
(Barlow & Lehman, 1996). These therapies typically 
emphasize cognitive and behavioral assessment and 
interventions. 
The hallmarks of cognitive-behavioral therapies are 
evaluating apparent cause and effect relationships 
between thoughts, feelings, and behaviors, as well as 
implementing relatively straightforward strategies to 
lessen symptoms and reduce avoidant behavior 
(Barlow, 1988). A critical element of therapy is to 
increase exposure to the stimuli or situations that 
provoke anxiety. Without such therapeutic assistance, 
the sufferer typically withdraws from anxiety-inducing 
situations, inadvertently reinforcing avoidant or escape 
behavior. 
The therapist provides reassurance that the feared 
situation is not deadly and introduces a plan to enhance 
mastery. This plan may include approaching the feared 
situation in a graduated or stepwise hierarchy or 
teaching the patient to use responses that dampen 
anxiety, such as deep muscle relaxation or coping. One 
fundamental principle is that prolonged exposure to a 
feared stimulus reliably decreases cognitive and 
physiologic symptoms of anxiety (Marks, 1969; 
Barlow, 1988). With such experience generally comes 
greater self-efficacy and a greater willingness to 
encounter other feared stimuli. For panic disorder, 
interoceptive training (a type of conditioning 
technique) and breathing exercises are often employed 
to help the sufferer become more capable of 
recognizing and coping with the social cues, 
antecedents, or early signs of a panic attack. Cognitive 
interventions are used to counteract the exaggerated or 
catastrophic thoughts that characterize anxiety. For 
treatment of obsessive-compulsive disorder, the 
strategy of response prevention must be added to 
exposure to ensure that compulsions are not performed 
(Barlow, 1988). 
There is now extensive evidence that cognitive- 
behavioral therapies are useful treatments for a 
majority of patients with anxiety disorders (Chambless 
et al., 1998). Poorer outcomes are observed, however, 
in more complicated patient groups. With obsessive- 
compulsive disorder, approximately 20 to 25 percent of 
patients are unwilling to participate in therapy (March 
et al., 1997). Another major limitation of cognitive- 
behavioral therapies is not their effectiveness but, 
rather, the limited availability of skilled practitioners 
(Ballenger et al., 1998). 
It is possible that more traditional forms of therapy 
based on psychodynamic or interpersonal theories of 
anxiety also may prove to be effective treatments 
(Shear, 1995). However, these therapies have not yet 
received extensive empirical support. As a result, more 
traditional therapies are generally deemphasized in 
evidence-based treatment guidelines for anxiety 
disorders. 
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Pharmacofherapy 
The medications typically used to treat patients with 
anxiety disorders are benzodiazepines, antidepressants, 
and the novel compound buspirone (Lydiard et al., 
1996). In light of increasing awareness of numerous 
neurochemical alterations in anxiety disorders, many 
new classes of drugs are. likely to be developed, 
expressly targeting CRH and other neuroactive agents 
(Nemeroff, 1998). 
Benzodiazepines 
The benzodiazepines are a large class of relatively safe 
and widely prescribed medications that have rapid and 
profound antianxiety and sedative-hypnotic effects. The 
benzodiazepines are thought to exert their therapeutic 
effects by enhancing the inhibitory neurotransmitter 
systems utilizing GABA. Benzodiazepines bind to a 
site on the GABA receptor and act as receptor agonists 
(Perry et al., 1997). Benzodiazepines differ in terms of 
potency, pharmacokinetics (i.e., elimination half-life), 
and lipid solubility. 
The four benzodiazepines currently widely pre- 
scribed for treatment of anxiety disorders are diazepam, 
lorazepam, clonazepam, and alprazolam. Each is now 
available in generic formulations (Davidson, l998). 
Among these agents, alprazolam and lorazepam have 
shorter elimination half-lives-that is, are removed 
from the body more quickly-while diazepam and 
clonazepam have a long period of action (i.e., up to 24 
hours). Diazepam also has multiple active metabolites, 
which increase the risk of “carryover” effects such as 
sedation and “hangover.” Benzodiazepines that undergo 
conjugation appear to have longer elimination time in 
women, and oral contraceptive can decrease clearance 
(Dawlans, 1995). Since Asians are more likely to 
metabolize diazepam more slowly, they may require 
lower doses to achieve the same blood concentrations 
as Caucasians (Lin et al., 1997). 
Benzodiazepines have the potential for producing 
drug dependence (i.e., physiological or behavioral 
symptoms after discontinuation of use). Shorter acting 
compounds have somewhat greater liability because of 
more rapid and abrupt onset of withdrawal symptoms. 
Because the benzodiazepines do not have strong 
antiobsessional effects, their use in obsessive- 
compulsive disorder and post-traumatic stress disorder 
is generally viewed as palliative (i.e., relieving, but not 
eliminating symptoms). Rather, obsessive-compulsive 
disorder and post-traumatic stress disorder are more 
effectively treated by antidepressants, especially the 
SSRIs (as discussed below). When effective, 
benzodiazepines should be tapered after several months 
of use, although there is a substantial risk of relapse. 
Many clinicians favor a combined treatment approach 
for panic disorder and generalized inxiety disorder, in 
which benzodiazepines are used acutely in tandem with 
an antidepressant. The benzodiazepines are 
subsequently tapered as the antidepressant’s therapeutic 
effects begin to emerge (American Psychiatric 
Association, 1998). 
Antidepressants 
Most antidepressant medications have substantial 
antianxiety and antipanic effects in addition to their 
antidepressant action (Kent et al., 1998). Moreover, a 
large number of antidepressants have antiobsessional 
effects (Perry et al., 1997). The observation that the 
tricyclic antidepressant imipramine had a different 
anxiolytic profile than diazepam helped to differentiate 
panic disorder from generalized anxiety disorder and, 
subsequently, social phobia. 
Clomipramine, a tricyclic antidepressant (TCA) 
with relatively potent reuptake inhibitory effects on 
serotonin (5HT) neurons, subsequently was found to 
be the only TCA to have specific antiobsessional 
effects (March et al., 1997). The importance of this 
effect on 5-HT was highlighted when the SSRIs 
became available. By the late 199Os, it became clear 
that all of the SSRIs have antiobsessional effects 
(Greist et al., 1995; Kent et al., 1998). 
Current practice guidelines rank the TCAs below 
the SSRIs for treatment of anxiety disorders because of 
the SSRIs’ more favorable tolerability and safety 
profiles (March et al., 1997; American Psychiatric 
Association, 1998; Ballenger et al., 1998;). 
Nevertheless, there are patients who respond to the 
TCAs after failing to respond to one or more of t.he 
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newer agents. Similarly, although relatively rarely used, 
the monoamine oxidate inhibitors (MAOIs) have 
significant antiobsessional, antipanic, and anxiolytic 
effects (Sheehan et al., 1980; American Psychiatric 
Association, 1998). In the United States, the MAOIs 
phenelzine. tranylcypromine, and isocarboxazid (which 
has not been consistently marketed this decade) are 
seldom used unless simpler medication strategies have 
failed (American Psychiatric Association, 1998). 
The five drugs within the SSRI class-fluoxetine, 
sertraline, paroxetine, fluvoxamine, and 
citalopram-have emerged as the preferred type of 
antidepressant for treatment of anxiety disorders 
(Westenberg, 1996; Kent et al., 1998). In addition to 
well-established efficacy in obsessive-compulsive 
disorder, there is convincing and growing evidence of 
antipanic and broader anxiolytic effects (American 
Psychiatric Association, 1998; Kent et al., 1998). 
Treatment of panic disorder often requires lower initial 
doses and slower upward titration. By contrast, 
treatment for obsessive-compulsive disorder ultimately 
may entail higher doses (for example, 60 or 80 mg/day 
of fluoxetine or 200 mg per day of sertraline) and 
longer durations to achieve desired outcomes (Marchet 
al., 1997). As all of the SSRIs are currently protected 
by patents, there are no generic forms yet available. 
This adds to the direct costs of treatment. Cost may be 
offset indirectly, however, by virtue of need for fewer 
treatment visits and fewer concomitant medications, 
and cost likely will abate when these agents begin to 
lose patent protection in a few years. 
Other newer antidepressants, including 
venlafaxine, nefazodone, and mirtazapine, also may 
have significant antianxiety effects, for which clinical 
trials are under way (March et al., 1997; American 
Psychiatric Association, 1998). Paroxetine has been 
approved by the Food and Drug Administration (FDA) 
for social phobia, and sertraline is being developed for 
post-traumatic stress disorder. Nefazodone, which also 
is being studied in post-traumatic stress disorder, and 
mh-tazapine may possess lower levels of sexual side 
effects, a problem that complicates longer term 
treatment with SSRIs, venlafaxine, TCAs, and MAOIs 
(Baldwin & Birtwistle, 1998). 
Adults and Mental Health 
When effective in treating anxiety, antidepressants 
should be maintained for at least 4 to 6 months, then 
tapered slowly to avoid discontinuation-emergent 
activation of anxiety symptoms (March et al., 1997; 
American Psychiatric Association, 1998; Ballenger et 
al., 1998). Although less extensively researched than 
depression, it is likely that many patients with anxiety 
disorders may warrant longer term, indefinite treatment 
to prevent relapse or chronicity. 
Buspirone 
This azopyrine compound is a relatively selective 5- 
HT,, partial agonist (Stahl, 1996). It was approved by 
the FDA in the mid-1980s as an anxiolytic. However, 
unlike the benzodiazepines, buspirone is not habit 
forming and has no abuse potential. Buspirone also has 
a safety profile comparable to the SSRIs, and it is 
significantly better tolerated than the TCAs. 
Buspirone does not block panic attacks, and it is 
not efficacious as a primary treatment of obsessive- 
compulsive disorder or post-traumatic stress disorder 
(Stahl, 1996). B uspirone is most useful for treatment of 
generalized anxiety disorder, and it is now frequently 
used as an adjunct to SSRIs (Lydiardet al., 1996). 
Buspirone takes 4 to 6 weeks to exert therapeutic 
effects, like antidepressants, and it has little value for 
patients when taken on an “as needed” basis. 
Combinations of Psychotherapy and Pharmaco- 
therapy 
Some patients with anxiety disorders may benefit from 
both psychotherapy and pharmacotherapy treatment 
modalities, either combined or used in sequence 
(March et al., 1997; American Psychiatric Association, 
1998). Drawing from the experiences of depression 
researchers, it seems likely that such combinations are 
not uniformly necessary and are probably more cost- 
effective when reserved for patients with more 
complex, complicated, severe, or comorbid disorders. 
The benefits of multimodal therapies for anxiety need 
further study. 
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Mood Disorders 
In 1 year, about 7 percent of Americans suffer from 
mood disorders, a cluster of mental disorders best 
recognized by depression or mania (Table 4-l). Mood 
disorders are outside the bounds of normal fluctuations 
from sadness to elation. They have potentially severe 
consequences for morbidity and mortality. 
This section covers four mood disorders. As the 
predominant mood disorder, major depressive disorder 
(also known as unipolar major depression), garners the 
greatest attention. It is twice more common in women 
than in men, a gender difference that is discussed later 
in this section. The other mood disorders covered 
below are bipolar disorder, dysthymia, and 
cyclothymia. 
Mood disorders rank among the top 10 causes of 
worldwide disability (Murray & Lopez, 1996). 
Unipolat major depression ranks first, and bipolar 
disorder ranks in the top 10. Moreover, disability and 
suffering are not limited to the patient. Spouses, 
children, parents, siblings, and friends experience 
frustration, guilt, anger, financial hardship, and, on 
occasion, physical abuse in their attempts to assuage or 
cope with the depressed person’s suffering. Women 
between the ages of 18 and 45 comprise the majority of 
those with major depression (Regier et al., 1993). 
Depression also has a deleterious impact on the 
economy, both in diminished productivity and in use of 
health care resources (Greenberg et al., 1993). In the 
workplace, depression is a leading cause of 
absenteeism and diminished productivity. Although 
only a minority seek professional help to relieve a 
mood disorder, depressed people are significantly more 
likely than others to visit a physician for some other 
reason. Depression-related visits to physicians thus 
account for a large portion of health care expenditures. 
Seeking another or a less stigmatized explanation for 
their difficulties, some depressed patients undergo 
extensive and expensive diagnostic procedures and then 
get treated for various other complaints while the mood 
disorder goes undiagnosed and untreated (Wells et al., 
1989). 
Complications and Comorbidities 
Suicide is the most dreaded complication of major 
depressive disorders. About 10 to 15 percent of patients 
formerly hospitalized with depression commit suicide 
(Angst et al., 1999). Major depressive disorders 
account for about 20 to 35 percent of all deaths by 
suicide (Angst et al., 1999). Completed suicide is more 
common among those with more severe and/or 
psychotic symptoms, with late onset, with co-existing 
mental and addictive disorders (Angst et al., 1999), as 
well as among those who have experienced stressful 
life events, who have medical ill&sses, and who have 
a family history of suicidal behavior (Blumenthal, 
1988). In the United States, men complete suicide four 
times as often as women; women attempt suicide four 
times as frequently as do men (Blumenthal, 1988). 
Recognizing the magnitude of this public health 
problem, the Surgeon General issued a Cull to Action 
on Suicide in 1999 (see Figure 4-l). Individuals with 
depression also face an increased risk of death from 
coronary artery disease (Glassman & Shapiro, 1998). 
Mood disorders often coexist, or are comorbid, 
with other mental and somatic disorders. Anxiety is 
commonly comorbid with major depression. About 
one-half of those with a primary diagnosis of major 
depression also have an anxiety disorder (Barbee, 1998; 
Regier et al., 1998). The comorbidity of anxiety and 
depression is so pronounced that it has led to theories 
of similar etiologies, which are discussed below. 
Substance use disorders are found in 24 to 40 percent 
of individuals with mood disorders in the United States 
(Merikangas et al., 1998). Without treatment, substance 
abuse worsens the course of mood disorders. Other 
common comorbidities include personality disorders 
(DSM-IV) and medical illness, especially chronic 
conditions such as hypertension and arthritis. People 
with depression have a high prevalence (65 to 71 
percent) of any of eight common chronic medical 
conditions (Wells et al., 1991). The mood disorders 
also may alter or “scar” personality development. 
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Figure 4-1. Surgeon General’s Call to Action to 
Prevent Suicide-1999 
. Suicide is a serious public health problem 
. 31,000 suicides in 1996 
l 500,000 people visit emergency rooms due to 
attempted suicide 
. Suicide rate declined from 12.1 per 100,000 in 
1976 to 10.8 per ‘100,000 in 1996 
l Rate in adolescents and young adults almost 
tripled since 1952 
l Rate is 50 percent higher than the homicide 
rate 
I National Strategy for Suicide Prevention: AIM 
l Awareness: promote public awareness of 
suicide as.a public health problem 
l Intervention: enhance services and programs 
l Methodology: advance the science of suicide 
prevention 
. Risk factors 
l Male gender 
l Mental disorders, particularly depression and 
substance abuse 
l Prior suicide attempts 
. Unwillingness to seek help because of stigma 
l Barriers to accessing mental health treatment 
l Stressful life event/loss 
l Easy access to lethal methods such as guns 
. Protective factors 
l Effective and appropriate clinical care for 
underlying disorders 
l Easy access to care 
l Support from family, community, and health and 
mental health care staff 
Clinical Depression Versus Normal Sadness 
People have been plagued by disorders of mood for at 
least as long as they have been able to record their 
experiences. One of the earliest terms for depression, 
“melancholy,” literally meaning “black bile,” dates 
back to Hippocrates. Since antiquity, dysphoric states 
outside the range of normal sadness or grief have been 
recognized, but only within the past 40 years or so have 
researchers had the means to study the changes in 
cognition and brain functioning that are associated with 
severe depressive states. 
Adults and Mental Health 
At some time or another, virtually all adult human 
beings will experience a tragic or unexpected loss, 
romantic heartbreak, or a serious setback and times of 
profound sadness, grief, or distress. Indeed, something 
is awry if the usual expressions of sadness do not 
accompany such situations so common to the human 
ConditionAeath of a loved one, severe illness, 
prolonged disability, loss of employment or social 
status, or a child’s difficulties, for example. 
What is now called major depressive disorder. 
however, differs both quantitatively and qualifativef~ 
from normal sadness dr grief. Normal states of 
dysphoria (a negative or aversive mood state) are 
typically less pervasive and generally run a more time- 
limited course. Moreover, some of the symptoms of 
severe depression, such as anhedonia (the inability to 
experience pleasure), hopelessness, and loss of mood 
reactivity (the ability to feel a mood uplift in response 
to something positive) only rarely accompany “normal” 
sadness. Suicidal thoughts and psychotic symptoms 
such as delusions or hallucinations virtually always 
signify a pathological state. 
Nevertheless, many other symptoms commonly 
associated with depression are experienced during 
times of stress or bereavement. Among them are sleep 
disturbances, changes in appetite, poor concentration, 
and ruminations on sad thoughts and feelings. When a 
person suffering such distress seeks help, the 
diagnostician’s task is to differentiate the normal from 
the pathologic and, when appropriate, to recommend 
treatment. 
Assessment: Diagnosis and Syndrome 
Severity 
The criteria for diagnosing major depressive episode, 
dysthymia, mania, and cyclothymia are presented in 
Tables 4-2 through 4-5. Mania is an essential feature of 
bipolar disorder, which is marked by episodes of mania 
or mixed episodes of mania and depression. The 
reliability of the diagnostic criteria for major depressive 
disorder and bipolar disorder is impressive, with greater 
than 90 percent agreement reached by independent 
evaluators (DSM-IV). 
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Major Depressive Disorder 
Major depressive disorder features one or more major 
depressive episodes (see Table 4-2), each of which lasts 
at least 2 weeks (DSM-IV). Since these episodes are 
also characteristic of bipolar disorder, the term “major6 
depression” refers to both major depressive disorder 
and the depression of bipolar disorder. 
The cardinal symptoms of major depressive 
disorder are depressed mood and loss of interest or 
pleasure. Other symptoms vary enormously. For 
example, insomnia and weight loss are considered to be 
classic signs, even though many depressed patients gain 
weight and sleep excessively. Such heterogeneity is 
partly dealt with by the use of diagnostic subtypes (or 
course modifiers) with differing presentations and 
prevalence. For example, a more severe depressive 
syndrome characterized by a constellation of classical 
signs and symptoms, called melancholia, is more 
common among older than among younger people, as 
are depressions characterized by psychotic features 
(i.e., delusions and hallucinations) (DSM-IV). In fact, 
the presentation of psychotic features without 
concomitant melancholia should always raise suspicion 
about the accuracy of the diagnosis (vis-8-vis 
schizophrenia or a related psychotic disorder). The so- 
called reversed vegetative symptoms (oversleeping, 
overeating, and weight gain) may be more prevalent in 
women than men (Nemeroff, 1992). Anxiety symptoms 
such as panic attacks, phobias, and obsessions also are 
not uncommon. 
When untreated, a major depressive episode may 
last, on average, about 9 months. Eighty to 90 percent 
of individuals will remit within 2 years of the first 
episode (Kapur & Mann, 1992). Thereafter, at least 50 
percent of depressions will recur, and after three or 
more episodes the odds of recurrence within 3 years 
increases to 70 to 80 percent if the patient has not had 
preventive treatment (Thase & Sullivan, 1995). Thus, 
for many, an initial episode of major depression will 
evolve over time into the more recurrent illness 
6 The adjective “major” before the word “depression” denotes 
the number of symptoins required for the diagnosis, as distinct, 
From a proposed new category of “minor depression,” which 
requires fewer symptoms (see Chapter 5). 
sometimes referred to as unipolar major depression 
(Thase & Sullivan, 1995). Each new episode also 
confers new risks of chronicity, disability, and suicide. 
Dysthymia 
Dysthymia is a chronic form of depression. Its early 
onset and unrelenting, “smoldering” course are among 
the features that distinguish it from major depressive 
disorder (DSM-IV). Dysthymia becomes so intertwined 
with a person’s self-concept or personality that the 
individual may be misidentified as “neurotic” (resulting 
from unresolved early conflicts expressed through 
unconscious personality defenses ,or characterologic 
disorders) (Akiskal, 1985). Indeed, the onset of 
dysthymia in childhood or adolescence undoubtedly 
affects personality development and coping styles, 
particularly prompting passive, avoidant, and 
dependent “traits.” To avoid the pejorative 
connotations associated with the terms “neurotic” and 
“characterologic,” the term “dysthymia” is used in 
DSM-IV as a descriptive, or atheoretical, diagnosis for 
a chronic form of depression (see Table 4-3) 
(DSM-IV). Affecting about 2 percent of the adult 
population in 1 year, dysthymia is defined by its 
subsyndromal nature (i.e., fewer than the five persistent 
symptoms required to diagnose a major depressive 
episode) and a protracted duration of at least 2 years for 
adults and 1 year for children. Like other early-onset 
disorders, dysthymic disorder is associated with higher 
rates of comorbid substance abuse. People with 
dysthymia also are susceptible to major depression. 
When this occurs, their illness is sometimes referred to 
as “double depression,” that is, the combination of 
dysthymia and major depression (Keller & Shapiro, 
1982). Unlike the superimposed major depressive 
episode, however, the underlying dysthymia seldom 
remits spontaneously. Women are twice as likely to be 
diagnosed with dysthymia as men (Robins & Regier, 
1991). 
Bipolar Disorder 
Bipolar disorder is a recurrent mood disorder featuring 
one or more episodes of mania or mixed episodes of 
mania and depression ( DSM-IV; Goodwin & Jamison, 
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Table 4-2. DSM-IV criteria for maior dewessive episode 
I 4. 
B. 
C. 
D. 
E. 
Five (or more) of the following symptoms have been present during the same 2.week period and represent a 
change from previous functioning; at least one of the symptoms is either (1) depressed mood or (2) loss of 
interest or pleasure. 
Note: Do not include symptoms that are clearly due to a general medical condition, or mood-incongruent 
delusions or hallucinations. 
(1) 
(2) 
(3) 
(4) 
(5) 
(6) 
(7) 
(8) 
(9) 
depressed mood most of the day, nearly every day, as indicated by either subjective report (e.g., feels 
sad’or empty) or observation made by others (e.g., appears tearful). Note: In children and adolescents, 
can be irritable mood. 
markedly diminished interest or pleasure in all, or almost all, activities most of the day, nearly every day 
(as indicated by either subjective account or observation made by others). 
significant weight loss when not dieting or weight gain (e.g., a change of more than 5% of body weight in 
a month), or decrease or increase in appetite nearly every day. Note: In children, consider failure to 
make expected weight gains. . 
insomnia or hypersomnia nearly every day. 
psychomotor agitation or retardation nearly every day (observable by others, not merely subjective 
feelings or restlessness or being slowed down). 
fatigue or loss of energy nearly every day. 
feelings of worthlessness or excessive or inappropriate guilt (which may be delusional) nearly every day 
(not merely self-reproach or guilt about being sick). 
diminished ability to think or concentrate, or indecisiveness, nearly every day (either subjective account 
or as observed by others). 
recurrent thoughts of death (not just fear of dying), recurrent suicidal ideation without a specific plan, or a 
suicide attempt or a specific plan for committing suicide. 
The symptoms do not meet criteria for a mixed episode. 
The symptoms cause clinically significant distress or impairment in social, occupational, or other important areas 
of functioning. 
The symptoms are not due to the direct physiological effects of a substance (e.g., a drug of abuse, a medication) 
or a general medical condition (e.g.‘, hypothyroidism). 
The symptoms are not better accounted for by bereavement, i.e., after the loss of a loved one; the symptoms 
persist for longer than 2 months or are characterized by marked functional impairment, morbid preoccupation with 
worthlessness, suicidal ideation, psychotic symptoms, or psychomotor retardation. 
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Ta 
E 
_ J. 
D. 
E. 
F. 
G. 
H. 
lble 4-3. DSM-IV diagnostic criteria for Dysthymic Disorder 
Depressed mood for most of the day, for more days than not, as indicated either by subjective account or observation 
by others, for at least 2 years. Note: In children and adolescents, mood can be irritable and duration must be at 
least 1 year. 
Presence, while depressed, of two (or more) of the following: 
(1) poor appetite or overeating 
(2) insomnia or hypersomnia 
(3) low energy or fatigue 
(4) low self-esteem 
(5) poor concentration or difficulty making decisions 
(6) feelings of hopelessness 
During the 2-year period (1 year for children or adolescents) of the disturbance, the person has never been without 
the symptoms in Criteria A and 6 for more than 2 months at a time. . 
No major depressive episode has been present during the first 2 years of the disturbance (1 year for children and 
adolescents); i.e.! the disturbance is not better accounted for by chronic major depressive disorder, or major 
depressive disorder, in partial remission. 
Note: There may have been a previous major depressive episode provided there was a full remission (no significant 
signs or symptoms for 2 months) before development of the dysthymic disorder. In addition, after the initial 2 years 
(1 year in children or adolescents) of dysthymic disorder, there may be superimposed episodes of major depressive 
disorder, in which case both diagnoses may be given when the criteria are met for a major depressive episode. 
There has never been a manic episode, a mixed episode, or a hypomanic episode, and criteria have never been met 
for cyclothymic disorder. 
The disturbance does not occur exclusively during the course of a chronic psychotic disorder, such as schizophrenia 
or delusional disorder. 
The symptoms are not due to the direct physiological effects of a substance (e.g., a drug of abuse, a medication) or a 
general medical condition (e.g., hypothyroidism). 
The symptoms cause clinically significant distress or impairment in social, occupational, or other important areas of 
functioning. 
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1990). Bipolar disorder’ is distinct from major 
depressive disorder by virtue of a history of manic or 
hypomanic (milder and not psychotic) episodes. Other 
differences concern the nature of depression in bipolar 
disorder. Its depressive episodes are typically 
associated with an earlier age at onset, a greater 
likelihood of reversed vegetative symptoms, more 
frequent episodes or recurrences, and a higher familial 
prevalence (DSM-IV; Goodwin & Jamison, 1990). 
Another noteworthy difference between bipolar and 
nonbipolar groups is the differential therapeutic effect 
of lithium salts, which are more helpful for bipolar 
disorder (Goodwin & Jamison, 1990). 
Mania is derived from a French word that literally 
means crazed or frenzied. The mood disturbance can 
range from pure euphoria or elation to irritability to a 
labile admixture that also includes dysphoria (Table 
4-4). Thought content is usually- grandiose but also can 
be paranoid. Grandiosity usually takes the form both of 
overvalued ideas (e.g., “My book is the best one ever 
written”) and of frank delusions (e.g., “I have radio 
transmitters implanted in my head and the Martians are 
monitoring my thoughts.“) Auditory and visual 
hallucinations complicate more severe episodes. Speed 
of thought increases, and ideas typically race through 
the manic person’s consciousness. Nevertheless, 
distractibility and poor concentration commonly impair 
implementation. Judgment also can be severely 
compromised; spending sprees, offensive or 
disinhibited behavior, and promiscuity or other 
objectively reckless behaviors are commonplace. 
Subjective energy, libido, and activity typically 
increase but a perceived reduced need for sleep can sap 
physical reserves. Sleep deprivation also can 
exacerbate cognitive difficulties and contribute to 
development of catatonia or a florid, confusional state 
known as delirious mania. If the manic patient is 
delirious, paranoid, or catatonic, the behavior is 
difficult to distinguish from that of a schizophrenic 
patient. Clinicians are prone to misdiagnose mania as 
schizophrenia in African Americans (Bell & Mehta, 
’ Bipolar disorder is also known as bipolar affective disorder and 
manic depression. 
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198 1). Most people with bipolar disorder have a history 
of remission and at least satisfactory functioning before 
onset of the index episode of illness. 
In DSM-IV, bipolar depressions are divided into 
type I (prior mania) and type II (prior hypomanic 
episodes only). About 1.1 .percent of the adult 
population suffers from the type I form, and 0.6 percent 
from the type II form (Goodwin & Jar&on, 1990: 
Kessler et al., 1994) (Table 4-5). Episodes of mania 
occur, on average, every 2 to 4 years, although 
accelerated mood cycles can occur annually or even 
more frequently. The type I form of bipolar disorder is 
about equally common in men and women, unlike 
major depressive disorder, which is more common in 
women. 
Hypomania, as suggested above, is the sub- 
syndromal counterpart of mania (DSM-IV; Goodwin & 
Jamison, 1990). By definition, an episode of 
hypomania is never psychotic nor are hypomanic 
episodes associated with marked impairments in 
judgment or performance. In fact, some people with 
bipolar disorder long for the productive energy and 
heightened creativity of the hypomanic phase. 
Hypomania can be a transitional state (i.e., early in 
an episode of mania), although at least 50 percent of 
those who have hypomanic episodes never become 
manic (Goodwin & Jamison, 1990). Whereas a 
majority have a history of major depressive episodes 
(bipolar type II disorder), others become hypomanic 
only during antidepressant treatment (Goodwin & 
Jamison, 1990). Despite the relatively mild nature of 
hypomania, the prognosis for patients with bipolar type 
II disorder is poorer than that for recurrent (unipolar) 
major depression, and there is some evidence that the 
risk of rapid cycling (four or more episodes each year) 
is greater than with bipolar type I (Coryell et al., 1992). 
Women are at higher risk for rapid cycling bipolar 
disorder than men (Cot-yell et al., 1992). Women with 
bipolar disorder are also at increased risk for an episode 
during pregnancy and the months following childbirth 
(Blehar et al., 1998). 
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Ta lble 4-4. DSM-IV criteria for manic episode 
4. A distinct period of abnormally and persistently elevated, expansive, or irritable mood, lasting at least 1 week (or any 
duration if hospitalization is necessary). 
3. During the period of mood disturbance, three (or more) of the following symptoms have persisted (four if the mood is 
only irritable) and have been present to a significant degree: 
(1) inflated self-esteem or grandiosity 
(2) decreased need for sleep (e.g., feels rested after only 3 hours of sleep) 
(3) more talkative than usual or pressure to keep talking 
(4) flight of ideas or subjective experience that thoughts are racing 
(5) distractibility (i.e., attention too easily drawn to unimpoitant or irrelevant external stimuli) 
(6) increase in goal-directed activity (either socially, at work or school, or sexually) or psyctiomotor agitation 
(7) excessive involvement in pleasurable activities that have a high potential for painful consequences (e.g., 
engaging in unrestrained buying sprees, sexual indiscretions, or foolish business investments) 
I C. The symptoms do not meet criteria for a mixed episode. 
D. The mood disturbance is sufficiently severe to cause marked impairment in occupational functioning or in USUal 
social activities or relationships with others, or to necessitate hospitalization to prevent harm to self or others, or there 
are psychotic features. 
E. The symptoms are not due to the direct physiological effects of a substance (e.g., a drug of abuse, a medication, or 
other treatment) or general medical condition (e.g., hyperthyroidism). 
Note: Manic-like episodes that are clearly caused by somatic antidepressant treatment (e.g., medication, 
electroconvulsive therapy, light therapy) should not count toward a diagnosis of bipolar I disorder. 
able 4-5. DSM-IV diagnostic criteria for Cyclothymic Disorder 
4. 
3. 
cl. 
D. 
E. 
F. 
For at least 2 years, the presence of numerous periods with hypomanic symptoms and numerous periods with 
depressive symptoms that do not meet criteria for a major depressive episode. Note: In children and adolescents, 
the duration must be at least 1 year. 
During the above 2-year period (1 year in children and adolescents), the person has not been without the symptoms 
in Criterion A for more than 2 months at a time. 
No major depressive episode, manic episode, or mixed episode has been present during the first 2 years of the 
disturbance. 
Note: After the initial 2 years (1 year in children and adolescents) of cyclothymic disorder, there may be 
superimposed manic or mixed episodes (in which case both bipolar I disorder and cyclothymic disorder may be 
diagnosed) or major depressive episodes (in which case both bipolar II disorder and cyclothymic disorder may be 
diagnosed). 
The symptoms in Criterion A are not better accounted for by schizoaffective disorder and are not superimposed on 
schizophrenia, schizophreniform disorder, delusional disorder, or psychotic disorder not otherwise specified. 
The symptoms are not due to the direct physiological effects of a substance (e.g., a drug of abuse, a medication) or a 
general medical condition (e.g., hyperthyroidism). 
The symptoms cause clinically significant distress or impairment in social, occupational, or other important areas of 
functioning. 
? 
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cydothymia 
Cyclothymia is marked by manic and depressive states, 
yet neither are of sufficient intensity nor duration to 
merit a diagnosis of bipolar disorder or major 
depressive disorder. The diagnosis of cyclothymia is 
appropriate if there is a history of hypomania, but no 
prior episodes of mania or major depression (Table 4- 
5). Longitudinal follo%up studies indicate that the risk 
of bipolar disorder developing in patients with 
cyclothymia is about 33 percent; although 33 times 
greater than that for the general population, this rate of 
risk still is too low to justify viewing cyclothymia as 
merely an early manifestation of bipolar type I disorder 
(Howland & Thase, 1993). 
Differential Diagnosis 
Mood disorders are sometimes caused by general 
medical conditions or medications. Classic examples 
include the depressive syndromes associated with 
dominant hemispheric strokes, hypothyroidism, 
Cushing’s disease, and pancreatic cancer (DSM-IV). 
Among medications associated with depression, 
antihypertensives and oral contraceptives are the most 
frequent examples. Transient depressive syndromes are 
also common during withdrawal from alcohol and 
various other drugs of abuse. Mania is not uncommon 
during high-dose systemic therapy with glucocorticoids 
and has been associated with intoxication by stimulant 
and sympathomimetic drugs and with central nervous 
system (CNS) lupus, CNS human immunodeficiency 
viral (HIV) infections, and nondominant hemispheric 
strokes or tumors. Together, mood disorders due to 
known physiological or medical causes may account 
for as many as 5 to 15 percent of all treated cases 
(Quitkin et al., 1993b). They often go unrecognized 
until after standard therapies have failed. 
A challenge to diagnosticians is to balance their 
search for relatively uncommon disorders with their 
sensitivity to aspects of the medical history or review 
of symptoms that might have etiologic significance. For 
example, the onset of a depressive episode a few weeks 
or months after the patient has begun taking a new 
blood-pressure medication should raise the physician’s 
index of suspicion. Ultimately, occult or covert medical 
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illnesses must always be considered when an 
apparently clear-cut case of a mood disorder is 
refractory to standard treatments (Depression Guideline 
Panel, 1993). Cultural influences on the manifestation 
and diagnosis of depression are also important for the 
diagnostician to identify (DSM-IV). As discussed in 
Chapter 2, somatization is especially prevalent in 
individuals from ethnic minority backgrounds (Lu et 
al., 1995). Somatization is the expression of mental 
distress in terms of physical suffering. 
Etiology of Mood Disorders 
The etiology of depression, the mood disorder most 
frequently studied, is far from ideally understood. 
Many cases of depression are triggered by stressful life 
events, yet not everyone becomes depressed under such 
circumstances. The intensity and duration of these 
events, as well as each individual’s genetic endowment, 
coping skills and reaction, and social support network 
contribute to the likelihood of depression. That is why 
depression and many other mental disorders are broadly 
described as the product of a complex interaction 
between biological and psychosocial factors (see 
Chapter 2). The relative importance of biological and 
psychosocial factors may vary across individuals and 
across different types of depression. 
This section of the chapter describes the biological, 
genetic, and psychosocial factors-such as cognition, 
personality, and gender-that correlate with, or 
predispose to, depression. The discussion of genetic 
factors also incorporates the latest findings about 
bipolar disorder. Genes are implicated even more 
strongly in bipolar disorder than they are in major 
depression, galvanizing a worldwide search to identify 
chromosomal regions where genes may be located and 
ultimately to pinpoint the genes themselves (NIMH, 
1998). 
Bio/ogic Factors in Depression 
Much of the scientific effort expended over the past 40 
years on the study of depression has been devoted to 
the search for biologic alterations in brain function. 
From the beginning, it has been recognized that the 
clinical heterogeneity of depression disorders may 
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preclude the possibility of finding a single defect. 
Researchers have detected abnormal concentrations of 
many neurotransmitters and their metabolites in urine, 
plasma, and cerebrospinal fluid in subgroups of patients 
(Thase & Howland, 1995); dysregulation of the HPA 
axis (Thase & Howland, 1995); elevated levels of 
corticotropin-releasing factor (Nemeroff, 1992, 1998; 
Mitchell, 1998); and, most recently, abnormalities in 
second messenger systems and neuroimaging (Drevets, 
1998; Rush et al., 1998, Steffens & Krishnan, 1998). 
Much current research focuses on how the biological 
abnormaliries interrelate, how they correlate with 
behavioral and emotional patterns that seem to 
distinguish one subcategory of major depression from 
another, and how they respond to diverse forms of 
therapy. 
In the search for biological changes with 
depression, it must be understood that a biological 
abnormality reliably associated with depression may 
not actually be a causal factor. For example, a biologic 
alteration could be a consequence of sleep deprivation 
or weight loss. Any biological abnomaEity found in 
conjunction with any mental disorder may be a cause, 
a correlate, or a consequence, as discussed in Chapter 
2. What drives research is the determination to find 
which of the biological abnormalities in depression are 
true causes, especially ones that might be detectable 
and treatable before the onset of clinical symptoms. 
Monoamine Hypothesis 
For many years the prevailing hypothesis was that 
depression was caused by an absolute or relative 
deficiency of monoamine* transmitters in the brain. 
This line of research was bolstered by the discovery 
many years ago that reserpine, a medication for 
hypertension, inadvertently caused depression. It did so 
by depleting the brain of both serotonin and the three 
principal catecholamines (dopamine, norepinephrine, 
and epinephrine). Such findings led to the 
“catecholamine hypothesis” and the “indoleamine (i.e., 
’ Monoamine neurotransmitters are a chemical class that 
includes catecholamines (norepinephrine, epinephrine, dopa- 
mine) and indoleamines (serotonin). 
serotonin) hypothesis,” which in due course led to an 
integrated “monoamine hypothesis” (Thase & 
Howland, 1995). 
After more than 30 years of research, however, the 
monoamine hypothesis has been found insufficient to 
explain the complex etiology of depression. One 
problem is that many other neurotransmitter systems 
are altered in depression, including GABA and 
acetylcholine (Rush et al., 1998). Another problem is 
that improvement of monoamine neurotransmission 
with medications and lifting of the clinical signs of 
depression do not prove that depression actually is 
caused by defective monoamine neurotransmission. For 
example, diuretic medications do not specifically 
correct the physiological defect underlying congestive 
heart failure, but they do treat its symptoms. Neither 
impairment of monoamine synthesis, nor excessive 
degradation of monoamines, is consistently present in 
association with depression; monoamine precursors do 
not have consistent antidepressant effects, and a 
definite temporal lag exists between the quickelevation 
in monoamine levels and the symptom relief that does 
not emerge until weeks later (Duman et al., 1997). To 
account for these discrepancies, one new model of 
depression proposes that depression results from 
reductions in neurotrophic factors that are necessary for 
the survival and function of particular neurons, 
especially those found in the hippocampus (Duman et 
al., 1997). 
Despite the problems with the hypothesis that 
monoamine depletion is the primary cause of 
depression, monoamine impairment is certainly one of 
the manifestations, or correlates, of depression. 
Therefore, the monoamine hypothesis remains 
important for treatment purposes. Many currently 
available pharmacotherapies that relieve depression or 
cause mania, or both, enhance monoamine activity. One 
of the foremost classes of drugs for depression, SSRIs, 
for example, boost the level of serotonin in the brain. 
Evolving Views of Depression 
An important shortcoming of the monoamine 
hypothesis was its inattention to the psychosocial risk 
factors that influence the onset and persistence of 
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depressive episodes. The nature and interpretation of, 
and the response to, stress clearly have important 
causal roles in depression. The following discussion 
illustrates ongoing work aimed at understanding the 
pathophysiology of depression. While incomplete, it 
offers a coherent integration of the biological, 
psychological, and social factors that have long been 
associated clinically with this disorder. 
Many decades ago, Hans Selye demonstrated the 
damaging effects of chronic stress on the HPA axis, the 
gastrointestinal tract, and the immune system of rats: 
adrenal hypertrophy, gastric ulceration, and involution 
of the thymus and lymph nodes (Selye, 1956). Since 
that time, researchers have provided ample evidence 
that brain function, and perhaps even anatomic 
structure, can be influenced by stress, interpretation of 
stress, and learning (Weiss, 1991; Sapolsky, 1996; 
McEwen, 1998). Much current research has been 
directed at stress, the HPA axis, and CRH in the 
genesis of depression. 
Depression can be the outcome of severe and 
prolonged stress (Brownet al., 1994; Franket al., 1994; 
Ingram et al., 1998). The acute stress response is 
characterized by heightened arousal-the fight-or-flight 
response -that entails mobilization of the sympathetic 
nervous system and the HPA axis (see Etiology of 
Anxiety). Many aspects of the acute stress response are 
exaggerated, persistent, or dysregulated in depression 
(Thase & Howland, 1995). Increased activity in the 
HPA axis in depression is viewed as the “most 
venerable finding in all of biological psychiatry” 
(Nemeroff, 1998). 
Increased activity of the HPA axis, however, may 
be secondary to more primary causes, as was the 
problem with the monoamine hypothesis of depression. 
For this reason, much attention has been focused on 
CRH, which is hypersecreted in depression (Nemeroff, 
1992, 1998). CRH is the neuropeptide that is released 
by the hypothalamus to activate the pituitary in the 
acute stress response. Yet there are many other sources 
of CRH in the brain. 
CRH injections into the brain of laboratory animals 
produce the signs and symptoms found in depressed 
Patients, including decreased appetite and weight loss, 
decreased sexual behavior and sleep, and other changes 
(Sullivan et al., 1998). Furthermore, CRH is found in 
higher concentrations in the cerebrospinal fluid of 
depressed patients (Nemeroff, 1998). In autopsy studies 
of depressed patients, CRH gene expression is elevated, 
and there are greater numbers of hypothalamic neurons 
that express CRH (Nemeroff, 1998). These findings 
have ignited research to uncover how CRH expression 
in the hypothalamus is regulated, especially by other 
brain centers such as the hippocampus (Mitchell, 
1998). The hippocampus exerts control over the HPA 
axis through feedbackinhibit,ion (Jacobson & Sapolsky, 
1991). Shedding light on the regulation of CRH is 
expected to hold dividends for understanding both 
anxiety and depression. 
Anxiev and Depression 
Anxiety and depression frequently coexist, so much so 
that patients with combinations of anxiety and 
depression are the rule rather than the exception 
(Barbee, 1998). And many of the medications used to 
treat either one are often used to treat the other. Why 
are anxiety and depression so interrelated? 
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Clues to answering this question are expected to 
come from similarities in antecedents, correlates, and 
consequences of each condition. Certainly, stressful 
events are frequent, although not universal, 
antecedents. Overlapping biochemical correlates are 
found, most notably, an elevation in CRH (Arborelius 
et al., 1999). Interestingly, one new line of research 
finds that long-term consequences of anxiety and 
depression are evident at the same anatomical site-the 
hippocampus. Human imaging studies of the 
hippocampus revealed it to have smaller volume in 
patients with post-traumatic stress disorder (McEwen, 
1998) and in patients with recurrent depression 
(Sheline, 1996). In the latter study, the degree of 
volume reduction was correlated with the duration of 
major depression. In both conditions, excess 
glucocorticoid exposure was thought to be the culprit 
in inducing the atrophy of hippocampal neurons. But 
the complete chain of events leading up to and 
following the hippocampal damage is not Yet known. 
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Psychosocial and Genetic Factors in Depression 
If stressful events are the proximate causes of most 
cases of depression, then why is it that not all people 
become depressed in the face of stressful events? The 
answer appears to be that social, psychological, and 
genetic factors act together to predispose to, or protect 
against, depression. This section first discusses 
stressful life events, followed by a discussion of the 
factors that shape our responses to them. 
Stressful Life Events 
Adult life can be rife with stressful events, as noted 
earlier, and although not all people with depression can 
point to some precipitating event, many episodes of 
depression are associated with some sort of acute or 
chronic adversity (Brown et al., 1994; Frank et al., 
1994; Ingram et al., 1998). 
The death of a loved one is viewed as one of the 
most powerful life stressors. The grief that ensues is a 
universal experience, Common symptoms associated 
with bereavement include crying spells, appetite and 
weight loss, and insomnia. Grief, in fact, has such 
emotional impact that the diagnosis of depressive 
disorder should not be made unless there are definite 
complications such as incapacity, psychosis, or suicidal 
thoughts. 
The compelling impact of past parental neglect, 
physical and sexual abuse, and other forms of 
maltreatment on both adult emotional well-being and 
brain function is now firmly established for depression. 
Early disruption of attachment bonds can lead to 
enduring problems in developing and maintaining 
interpersonal relationships and problems with 
depression and anxiety. Research in animals bears this 
out as well. In both rodents and primates, maternal 
deprivation stresses young animals, and a pattern of 
repeated, severe, early trauma from maternal 
deprivation may predispose an animal to a lifetime of 
overreactivity to stress (Plotsky et al., 1995). 
Conversely, early experience with mild, nontraumatic 
stressors (such as gentle handling) may help to protect 
or “immunize” animals against more pathologic 
responses to subsequent severe stress. 
Cognitive Factors 
According to cognitive theories of depression, how 
individuals view and interpret stressful events 
contributes to whether or not they become depressed. 
One prominent theory of depression stems from studies 
of learned helplessness in animals, The theory posits 
that depression arises from a cognitive state of 
helplessness and entrapment (Seligman, 1991). The 
theory was predicated on experiments in which animals 
were trained in an enclosure in which shocks were 
unavoidable and inescapable, regardless of avoidance 
measures that animals attempted. When they later were 
placed in enclosures in which evasive action could have 
succeeded, the animals were inactive, immobile, and 
unable to learn avoidance maneuvers. The earlier 
experience engendered a behavioral state of 
helplessness, one in which actions were seen as 
ineffectual. 
In humans there is now ample evidence that the 
impact of a stressor is moderated by the personal 
meaning of the event or situation. In other words, the 
critical factor is the person’s interpretation of the 
stressor’s potential impact. Thus, an event interpreted 
as a threat or danger elicits a nonspecific stress 
response, and an event interpreted as a loss (of either an 
attachment bond or a sense of competence) elicits more 
grieflike depressive responses. 
Heightened vulnerability to depression is linked to 
a constellation of cognitive patterns that predispose to 
distorted interpretations of a stressful event (Ingram et 
al., 1998). For example, a romantic breakup will trigger 
a much stronger emotional response if the affected 
person believes, “I am incomplete and empty without 
her love,” or “I will never find another who makes me 
feel the way he does.” The cognitive patterns 
associated with distorted interpretation of stress include 
relatively harsh or rigid beliefs or attitudes about the 
importance of romantic love or achievement (again, the 
centrality of love and work) as well as the tendency to 
attribute three specific qualities to adverse events: (1) 
global impact-“This event will have a big effect on 
me”; (2) internality-“1 should have done something to 
prevent this,” or “This is my fault”; and (3) 
irreversibility-“I’ll never be able to recover from this.” 
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According to a recent model of cognitive vulner- 
ability to depression, negative cognitions by themselves 
are not sufficient to engender depression. This model 
postulates, on the basis of previously gathered 
empirical evidence, that interactions between negative 
cog&ions and mildly depressed mood are important in 
the etiology and recurrences of depression. Patterns or 
styles of thinking stem from prior negative experiences. 
When they are activated by adverse life events and a 
mildly depressed mood, a downward spiral ensues, 
leading to depression (Ingram et al., 1998). 
Temperament and Personality 
Responses to life events also can be linked’ to 
personality (Hirschfeld & Shea, 1992). Personality may 
be understood in terms of one’s attitudes and beliefs as 
well as more enduring neurobehavioral predispositions 
referred to as temperaments. The study of personality 
and temperament is gaining momentum. Neuroticism (a 
temperament discussed earlier in this chapter) 
predisposes to anxiety and depression (Clark et al., 
1994). Having an easy-going temperament, on the other 
hand, protects against depression (IOM, 1994). Further, 
those with severe personality disorder are particularly 
likely to have a history of early adversity or 
maltreatment (Browne 8z Finkelhor, 1986). 
Temperaments are not destiny, however. Parental 
influences and individual life experiences may 
determine whether a shy child remains vulnerable or 
becomes a healthy, albeit somewhat reserved, adult. In 
adults, several constellations of personality traits are 
associated with mood disorders: avoidance, 
dependence, and traits such as reactivity and 
impulsivity (Hirschfeld & Shea, 1992). People who 
have such personality traits not only cope less 
effectively with stressors but also tend to provoke or 
elicit adversity. A personality disorder or 
temperamental disturbance may mediate the 
relationship between stress and depression. 
Gender 
Major depressive disorder and dysthymia are more 
prevalent among women than men, as noted earlier. 
This difference appears in different cultures throughout 
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Keys to understanding the sex-related difference in 
rates in the United States may be found in two types of 
epidemiologic findings: (1) there are no sex-related 
differences in rates of bipolar disorder (type I) (NJMH, 
1998) and, (2) within the agrarian culture of the Old 
Order Amish of Lancaster, Pennsylvania, the rate of 
major depressive disorder is b&h low (i.e., comparable 
to that of bipolar disorder)’ and equivalent for men and 
women (Egeland et al., 1983). Something about the 
environment thus appears to interact with a woman’s 
biology to cause a disproportionate incidence of 
depressive episodes among women (Blumenthal, 
1994a). 
Research conducted in working-class 
neighborhoods suggests that the combination of life 
stress and inadequate social support contributes to 
women’s greater susceptibility to depressive symptoms 
(Brown et al., 1994). Because women tend to use more 
ruminative ways of coping (e.g., thinking and talking 
about a problem, rather than seeking out a distracting 
activity) and, on average, have less economic power, 
they may be more likely to perceive their problems as 
less solvable. That perception increases the likelihood 
of feeling helpless or entrapped by one’s problem. 
Subtle sex-related differences in hemispheric 
processing of emotional material may further 
predispose women to experience emotional stressors 
more intensely (Baxter et al., 1987). Women are also 
more likely than men to have experienced past sexual 
abuse: as noted earlier in this chapter, physical and 
sexual abuse is strongly associated with the subsequent 
development of major depressive disorder. Women’s 
greater vulnerability to depression may be amplified by 
endocrine and reproductive cycling, as well as by a 
9 A small, albeit noteworthy, sex-related difference is Seen in 
the higher incidence of rapid-cycling bipolar disorder in women 
(cited in Blumenthal, 1994). 
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the world (Weissman et al., 1993). Understanding the 
gender-related difference is complex and likely related 
to the interaction of biological and psychosocial factors 
(Blumenthal, 1994a), including differences in stressful 
life events as well as to personality (Nolen-Hoeksema 
et al., in press). 
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greater susceptibility to hypothyroidism (Thase & 
Howland, 1995). Menopause, on the other hand, has 
little bearing on gender differences in depression. 
Contrary to popular beliefs, menopause does not appear 
to be associated with increased rates of depression in 
women (Pearlstein et al., 1997). Untreated mental 
health problems are likely to worsen at menopause, but 
menopause by itself is not a risk factor for depression 
(Pearce et al., 1995; Thacker, 1997). The increased risk 
for depression prenatally or after childbirth suggests a 
role for hormonal influences, although evidence also 
exists for the role of stressful life events. In short, 
psychosocial and environmental factors likely interact 
with biological factors to account for greater 
susceptibility to depression among women. 
Poor young women (white, black, and Hispanic) 
appear to be at the greatest risk for depression 
compared with all other population groups (Miranda & 
Green, 1999). They have disproportionately higher 
rates of past exposure to trauma, including rape, sexual 
abuse, crime victimization, and physical abuse; poorer 
support systems; and greater barriers to treatment, 
including financial hardship and lack of insurance 
(Miranda & Green, 1999). Many of the same problems 
apply to single mothers, whose risk of depression is 
double that of married mothers (Brown & Moran, 
1997). 
The interaction between stressful life events, 
individual experiences, and genetic factors also plays 
a role in the etiology of depression in women. Some 
research suggests that genetic factors, which are 
discussed below, may alter women’s sensitivity to the 
depression-inducing effect of stressful life events 
(Kendler et al., 1995). A recent report of depression in 
a sample of 2,662 twins found genetic factors in 
depression to be stronger for women than men, for 
whom depression was only weakly familial. For both 
genders, individual environmental experiences played 
a large role in depression (Bierut et al., 1999). 
Genetic Factors in Depression and Bipolar 
Disorder 
Depression, and especially bipolar disorder, clearly 
tend to “run in families,” and a definite association has 
been scientifically established (Tsuang & Faraone, 
1990). Numerous investigators have documented that 
susceptibility to a depressive disorder is twofold to 
fourfold greater among the first-degree relatives of 
patients with mood disorder than among other people 
(Tsuang & Faraone, 1990). The risk among first-degree 
relatives of people with bipolar disorder is about six to 
eight times greater. Some evidence indicates that first- 
degree relatives of people with mood disorders are also 
more susceptible than other people to anxiety and 
substance abuse disorders (Tsuang & Faraone, 1990). 
Remarkable as those statistics may be, they do not 
by themselves prove a genetic connection. Inasmuch as 
first-degree relatives typically live in the same 
environment, share similar values and beliefs, and are 
subject to similar stressors, the vulnerability to 
depression could be due to nurture rather than nature. 
One method to distinguish environmental from genetic 
factors is to compare concordance rates among same- 
sex twins. At least in terms of simple genetic theory, a 
solely hereditary trait that appears in one member of a 
set of identical (monozygotic) twins also should always 
appear in the other twin, whereas the trait should 
appear only 50 percent of the time in same-sex fraternal 
(dizygotic) twins. 
The results of studies comparing the prevalence of 
depression among twins vary, depending on the specific 
mood disorder, the age of the study population, and the 
way the depression is defined. In all instances, 
however, the reported concordance for mood disorders 
is greater among monozygotic than among dizygotic 
twins, and often the proportion is 2 to 1 (Tsuang & 
Faraone, 1990). In Denmark, Bertelsen and colleagues 
(1977) found that among 69 monozygotic twins with 
bipolar illness, 46 co-twins also had bipolar disorder 
and 14 other co-twins had psychoses, affective 
personality disorders, or had died by suicide. In studies 
of monozygotic twins reared separately (“adopted 
away”), the results also revealed an increased risk of 
depression and bipolar disorder compared with controls 
(Mendlewicz & Rainer 1977; Wender et al., 1986). 
Within the major depressive disorder grouping, greater 
heritable risk has been associated with more severe, 
recurrent, or psychotic forms of mood disorders 
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(Tsuang & Faraone, 1990). Those at greater heritable 
risk also appear more vulnerable to stressful life events 
(Kendler et al., 1995). 
The availability of modem molecular genetic 
methods now allows the translation of clinical 
associations into identification of specific genes 
(McInnis, 1993; Baron, 1997). Evidence collected to 
date strongly sugge’sts that vulnerability to mood 
disorders may be associated with several genes 
distributed among various chromosomes. For bipolar 
disorder, numerous distinct chromosomal regions 
(called loci) show promise, yet the complex nature of 
inheritance and methodological problems have 
encumbered investigators (Baron, 1997). Heritability in 
some cases may be sex linked or vary depending on 
whether the affected parent is the father or mother of 
the individual being studied. The genetic process of 
anticipation (which has been associated with an 
expansion of trinucleotide repeats) may further alter the 
expression of illness across generations (McGinnis, 
1993). Thus, the genetic complexities of the common 
depressive disorders ultimately may rival their clinical 
heterogeneity (Tsuang & Faraone, 1990). 
Based on a comprehensive review of the genetics 
literature, the National Institute of Mental Health 
Genetics Workgroup recently evaluated several mood 
disorders according to their readiness for large-scale 
genetics research initiatives. Bipolar disorder was rated 
in the highest category, meaning that the evidence was 
strong enough to justify large-scale molecular genetic 
studies. Depression, eating disorders, obsessive- 
compulsive disorder, and panic disorder were rated in 
the second highest category, which called for 
nonmolecular genetic and/or epidemiologic al studies to 
document further their estimated heritability (NIMH, 
1998). 
Treatment of Mood Disorders 
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So much is known about the assortment of 
pharmacological and psychosocial treatments for mood 
disorders that the most salient problem is not with 
treatment, but rather with getting people into treatment. 
Surveys consistently document that a majority of 
individuals with depression receive no specific form of 
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treatment (Katon et al., 199:. ?&row et al., 1993; 
Wells et al., 1994; Thase, 199~ _ Nearly 40 percent of 
people with bipolar disorder LY untreated in 1 year, 
according to the Epidemiologic Catchment Area survey 
(Regier et al., 1993). Undertrezz-Xnt of mood disorders 
stems from many factors, inL:ding societal stigma, 
financial barriers to treatmer.:. underrecognition by 
health care providers, and ;mderappreciation by 
consumers of the potential be~fits of treatment (e.g., 
Regier et al., 1988; Wells et ai.. i994; Hirschfeld et al., 
1997). The symptoms of depression. such as feelings of 
worthlessness, excessive gui!t. :md lack of motivation, 
also deter consumers from kyting treatment; and 
members of racial and ethnic minor@ groups often 
encounter special barriers, as ‘i&cussed in Chapter 2. 
Mood disorders have i-rufoundly deleterious 
consequences on we&being: thi’ir toll On quality Of life 
and economic productivity Inatches that of heart 
disease and is greater than that ~jipeptic ulcer, arthritis, 
hypertension, or diabetes (Wells et al., 1989). 
Stages of Therapy 
The treatment of mood disordcn is complex because it 
involves several stages: acute. continuation, and 
maintenance stages. The stages apply to 
pharmacotherapy and psychosoCial therapy alike. Most 
patients pass through these stages to restore full 
functioning. 
Acute Phase Therapy 
Acute phase treatment with cithttr psychotherapy or 
pharmacotherapy covers the tinle period leading up to 
an initial treatment response. r-\ treatment response is 
defined by a significant reduction (i.e., > 50 percent) in 
symptom severity, such that the patient no longer meets 
syndromal criteria for the disorder (Frank et al., 
1991b). The acute phase for medication typically 
requires 6 to 8 weeks (Depression Guideline Panel, 
1993), during which patients are seen wee&’ or 
biweekly for monitoring of symptoms, side effects, 
dosage adjustments, and support (FJwcettet al., 1987). 
Psychotherapies during the acute phase for depression 
typically consist of 6 to 20 w&l\’ visits. 
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Outpatient Treatment. In outpatient clinical trials, 
about 50 to 70 percent of depressed patients who 
complete treatment respond to either antidepressants or 
psychotherapies (Depression Guideline Panel, 1993). 
An acute treatment response includes the effects of 
placebo expectancy, spontaneous remission, and active 
treatment. The magnitude of the active treatment effect 
may be estimated from randomized clinical trials by 
subtracting the placebo response rate from that of 
active medication. Overall, the active treatment effect 
for major depression typically ranges from 20 to 40 
percent, after accounting for a placebo response rate of 
about 30 percent (Depression Guideline Panel, 1993). 
Although psychotherapy trials do not employ placebos 
in the form of an inert pil!, they do rely on comparisons 
of active treatment with psychological placebos (e.g., 
a form of therapy inappropriate for a given disorder), a 
comparison form of treatment, or wait list (i.e., no 
therapy). The figures cited above must be understood 
as rough averages. The efficacy of specific 
pharmacotherapies and psychotherapies is coveredlater 
in this section. 
Acute phase therapy is often compromised by 
patients leaving treatment. Attrition rates from clinical 
trials often are as high as 30 to 40 percent, and rates of 
nonadherence” are even higher (Depression Guideline 
Panel, 1993). Medication side effects are a factor, as 
are other factors such as inadequate psychoeducation 
(resulting in unrealistic expectations about treatment), 
ambivalence about seeing a therapist or taking 
medication, and practical roadblocks (e.g., the cost or 
accessibility of services). 
Another problem is clinician failure to monitor 
symptomatic response and to change treatments in a 
timely manner. Antidepressants should be changed if 
there is no clear effect within 4 to 6 weeks (Nierenberg 
et al., 1995; Quitkin et al., 1996). Similar data are not 
available for psychotherapies, but revisions to the 
treatment plan should be considered, including the 
addition of antidepressant medication, if there is no 
lo Nonadherence is defined as lack of adherence to prescribed 
activities such as keeping appointments, taking medication, and 
completing assignments. 
symptomatic improvement within 3 or 4 months 
(Depression Guideline Panel, 1993). 
Acute Inpatient Treatment. Hospitalization for acute 
treatment of depression is necessary for about 5 to 10 
percent of major depressive episodes and for up to 50 
percent of manic episodes. The principal reasons for 
hospitalization are overwhelming severity of symptoms 
and functional incapacity and suicidal or other life- 
threatening behavior. Hospital median lengths of stay 
now are about 5 to 7 days for depression and 9 to 14 
days for mania. Such abbreviated stays have reduced 
costs but necessitate greater trans&onal or aftercare 
services. Few severely depressed or manic people are 
in remission after only 1 to 2 weeks of treatment. 
Electroconvulsive Therapy. As described above, first- 
line treatment for most people with depression today 
consists of antidepressant medication, psychotherapy, 
or the combination (Potter et al., 1991; Depression 
Guideline Panel, 1993). In situations where these 
options are not effective or too slow (for example, in a 
person with delusional depression and intense, 
unremitting suicidality) electroconvulsive therapy 
(ECT) may be considered. ECT, sometimes referred to 
as electroshock or shock treatment, was developed in 
the 1930s based on the mistaken belief that epilepsy 
(seizure disorder) and schizophrenia could not exist at 
the same time in an individual. Accumulated clinical 
experience-later confirmed in controlled clinical 
trials, which included the use of simulated or “sham” 
ECT as a control (Janicak et al., 1985)--determined 
ECT to be highly effective against severe depression, 
some acute psychotic states, and mania (Small et al., 
1988). No controlled study has shown any other 
treatment to have superior efficacy to ECT in the 
treatment of depression (Janicak et al., 1985; Rudorfer 
et al., 1997). ECT has not been demonstrated to be 
effective in dysthymia, substance abuse, or anxiety or 
personality disorders. The foregoing conclusions, and 
many of those discussed below, are the products of 
review of extensive research conducted over several 
decades (Depression Guideline Panel, 1993; Rudorfer 
et al., 1997) as well as by an independent panel of 
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scientists, practitioners, and consumers (NIH & NIMH 
Consensus Conference, 1985). 
ECT consists of a series of brief generalized 
seizures induced by passing an electric current through 
the brain by means of two electrodes placed on the 
scalp. A typical course of ECT entails 6 to 12 
treatments, administered at a rate of three times per 
week, on either an inpatient or outpatient basis. The 
exact mechanisms by which ECT exerts its therapeutic 
effect are not yet known. The production of an 
adequate, generalized seizure using the proper amount 
of electrical stimulation at each treatment session is 
required for therapeutic efficacy (Sackheim et al., 
1993). 
With the development of effective medications for 
the treatment of major mental disorders a half-century 
ago, the need for ECT lessened but did not disappear. 
Prior to that time, ECT often had been administered for 
a variety of conditions for which it is not effective, and 
administered without anesthesia or neuromuscular 
blockade. The result was grand ma1 seizures that could 
produce injuries and even fractures. Despite the 
availability of a range of effective antidepressant 
medications and psychotherapies, as discussed above, 
ECT continues to be used (Rosenbach et al., 1997), 
occupying a narrower but important niche. It is 
generally reserved for the special circumstances where 
the usual first-line treatments are ineffective or cannot 
be taken, or where ECT is known to be particularly 
beneficial, such as depression or mania accompanied 
by psychosis or catatonia (NM & NIMH Consensus 
Conference, 1985; Depression Guideline Panel, 1993; 
Potter & Rudorfer, 1993). Examples of specific 
indications include depression unresponsive to multiple 
medication trials, or accompanied by a physical illness 
or pregnancy, which renders the use of a usually 
preferred antidepressant dangerous to the patient or to 
a developing fetus. Under such circumstances, carefully 
weighing risks and benefits, ECT may be the safest 
treatment option for severe depression. It should be 
administered under controlled conditions, with 
appropriate personnel (Rudorfer et al., 1997). 
Although the average 60 to 70 percent response 
rate seen with ECT is comparable to that obtained with 
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pharmacotherapy, there is evidence that the 
antidepressant effect of ECT occurs faster than that 
seen with medication, encouraging the use of ECT 
where depression is accompanied by potentially 
uncontrollable suicidal ideas and actions (Rudorfer et 
al., 1997). However, ECT does not exert a long-term 
protection against suicide. Indeed, it is now recognized 
that a single course of ECT should be regarded as a 
short-term treatment for an acute episode of illness. To 
sustain the response to ECT, continuation treatment, 
often in the form of antidepressant and/or mood 
stabilizer medication, must be instituted (Sackeim, 
1994). Individuals who repeatedly relapse following 
ECT despite continuation medication may be 
candidates for maintenance ECT, delivered on an 
outpatient basis at a rate of one treatment weekly to as 
infrequently as monthly (Sackeim, 1994; Rudorfer et 
al., 1997). 
The major risks of ECT are those of brief general 
anesthesia, which was introduced along with muscle 
relaxation and oxygenation to protect against injury and 
to reduce patient anxiety. There are virtually no 
absolute health contraindications precluding its use 
where warranted (Potter & Rudorfer, 1993; Rudorfer et 
al., 1997). 
The most common adverse effects of this treatment 
are confusion and memory loss for events surrounding 
the period of ECT treatment. The confusion and 
disorientation seen upon awakening afterECT typically 
clear within an hour. More persistent memory problems 
are variable. Most typical with standard, bilateral 
electrode placement (one electrode on each side of the 
head) has been a pattern of loss of memories for the 
time of the ECT series and extending back an average 
of 6 months, combined with impairment with learning 
new information, which continues for perhaps 2 months 
following ECT (NM & NIMH Consensus Conference, 
1985). Well-designed neuropsychological studies have 
consistently shown that by several months after 
completion of ECT, the ability to learn and remember 
are normal (Calev, 1994). Although most patients 
return to full functioning following successful ECT, the 
degree of post-treatment memory impairment and 
resulting impact on functioning are highly variable 
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across individuals (NM & NIMH Consensus 
Conference, 1985; CMHS, 1998). While clearly the 
exception rather than the rule, no reliable data on the 
incidence of severe post-ECT memory impairment are 
available. Fears that ECT causes gross structural brain 
pathology have not been supported by decades of 
methodologically sound research in both humans and 
animals (NM & NIMH Consensus Conference, 1985; 
Devanand et al., 1994; Weiner & Krystal, 1994; 
Greenberg, 1997; CMHS, 1998). The decision to use 
ECT must be evaluated for each individual, weighing 
the potential benefits and known risks of all available 
and appropriate treatments in the context of informed 
consent (NM & NIMH Consensus Conference, 1985). 
Advances in treatment technique over the past 
generation have enabled a reduction of adverse 
cognitive effects of ECT (NIH & NIMH Consensus 
Conference, 1985; Rudorfer et al., 1997). Nearly all 
ECT devices deliver a lower current, brief-pulse 
electrical stimulation, rather than the original sine wave 
output; with a brief pulse electrical wave, a therapeutic 
seizure may be induced with as little as one-third the 
electrical power as with the older method, thereby 
reducing the potential for confusion and memory 
disturbance (Andrade et al., 1998). Placement of both 
stimulus electrodes on one side of the head 
(“unilateral” ECT), over the nondominant (generally 
right) cerebral hemisphere, results in delivery of the 
initial electrical stimulation away from the primary 
learning and memory centers. According to several 
controlled trials, unilateral ECT is associated with 
virtually no detectable, persistent memory loss (Home 
et al., 1985; NIH Consensus Conference, 1985; 
Rudorfer et al., 1997). However, most clinicians find 
unilateral ECT less potent and more slowly acting an 
intervention than conventional bilateral ECT, 
particularly in the most severe cases of depression or in 
mania. One approach that is sometimes used is to begin 
a trial of ECT with unilateral electrode placement and 
switch to bilateral treatment after about six treatments 
if there has been no response. Research has 
demonstrated that the relationship of electrical dose to 
clinical response differs depending on electrode 
placement: for bilateral ECT, as long as an adequate 
seizure is obtained, any additional dosage will merely 
add to the cognitive toxicity, whereas for unilateral 
electrode placement, a therapeutic effect will not be 
achieved unless the electrical stimulus is more than 
mininially above the seizure threshold (Sackeim et al., 
1993). Even a moderately high electrical dosage in 
unilateral ECT still has fewer cognitive adverse effects 
than bilateral ECT. On the other hand, high-dose 
bilateral ECT may be unnecessarily risky and may be 
a preventable cause of severe memory impairment. 
Some types of medication, such as lithium, also add to 
confusion and cognitive impairment when given during 
a course of ECT and are best avoided. Medications that 
raise the seizure threshold and make it harder to obtain 
a therapeutic effect from ECT, including 
anticonvulsants and some minor tranquilizers, may also 
need to be tapered or discontinued. 
Informed consent is an integral part of the ECT 
process (NIH & NIMH Consensus Conference, 1985). 
The potential benefits and risks of this treatment, and 
of available alternative interventions, should be 
carefully reviewed and discussed with patients and, 
where appropriate, family or friends. Prospective 
candidates for ECT should be informed, for example, 
that its benefits are short-lived without active 
continuation treatment, and that there may be some risk 
of permanent severe memory loss after ECT. In most 
cases of depression, the benefit-to-risk ratio will favor 
the use of medication and/or psychotherapy as the 
preferred course of action (Depression Guideline Panel, 
1993). Where medication has not succeeded, or is 
fraught with unusual risk, or where the potential 
benefits of ECT are great, such as in delusional 
depression, the balance of potential benefits to risks 
may tilt in favor of ECT. Active discussion with the 
treatment team, supplemented by the growing amount 
of printed and videotaped information packages for 
consumers, is necessary in the decisionmaking process, 
both prior to and throughout a course of ECT. Consent 
may be revoked at any time during a series of ECT 
sessions. 
Although many people have fears related to stories 
of forced ECT in the past, the use of this modality on 
an involuntary basis today is uncommon. Involuntary 
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ECT may not be initiated by a physician or family 
member without a judicial proceeding. In every state, 
the administration of ECT on an involuntary basis 
requires such a judicial proceeding at which patients 
may be represented by legal counsel. As a rule, such 
petitions are granted only where the prompt institution 
of ECT is regarded as potentially lifesaving, as in the 
case of a person who is in grave danger because of lack 
of food or fluid intake caused by Catalonia. Recent 
epidemiological surveys show that the modem use of 
ECT is generally limited to evidence-based indications 
(Hermann et al., 1999). Indeed, concern has been raised 
that in some settings, particularly in the public sector 
and outside major metropolitan areas, ECT may be 
underutilized due ‘to the wide variability in the 
availability of this treatment across the country 
(Hermann et al., 1995). Consequently, minority patients 
tend to be under-represented among those receiving 
ECT (Rudorfer et al., 1997). 
On balance, the evidence supports the conclusion 
that modem ECT is among those treatments effective 
for the treatment of select severe mental disorders, 
when used in accord with current standards of care, 
including appropriate informed consent. 
Continuation Phase Therapy 
Successful acute phase antidepressant pharmacotherapy 
or ECT should almost always be followed by at least 6 
months of continued treatment (Prien & Kupfer, 1986; 
Depression Guideline Panel, 1993; Rudorfer et al., 
1997). During this phase, known as the continuation 
phase, most patients are seen biweekly or monthly. The 
primary goal of continuation pharmacotherapy is to 
prevent relapse (i.e., an exacerbation of symptoms 
sufficient to meet syndromal criteria). Continuation 
pharmacotherapy reduces the risk of relapse from40-60 
percent to lo-20 percent (Prien & Kupfer, 1986; Thase, 
1993). Relapse despite continuation phmacotherapy 
might suggest either nonadherence (Myers & 
Branthwaithe, 1992) or loss of a placebo response 
(Quitkin et al., 1993a). 
A second goal of continuation pharmacotherapy is 
consolidation of a response into a complete remission 
and subsequent recovery (i.e., 6 months of sustained 
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remission). A remission is defined as a complete 
resolution of affective symptoms to a level shnilar to 
healthy people (Frank et al., 1991a). As residual 
symptoms are associated with increased relapse risk 
(Keller et al., 1992; Thase et al., 1992), recovery 
should be achieved before withdrawing antidepressant 
phar-macotherapy. 
Many psychotherapists similarly taper a successful 
course of treatment by scheduling several sessions 
(every other week or monthly) prior to termination. 
There is some evidence, albeit weak, that relapse is less 
common following successful treatment with one type 
of psychotherapy-cognitive-behavioral therapy-than 
with antidepressants (Kovacs et al., 198 1; Blackbum et 
al., 1986; Simons et al., 1986; Evans et al., 1992). If 
confirmed, this advantage may offset the greater short- 
term costs of psychotherapy. 
Maintenance Phase Therapies 
Maintenance pharmacotherapy is intended to prevent 
future recurrences of mood disorders (Kupfer, 1991; 
Thase, 1993; Prien & Kocsis, 1995). A recurrence is 
viewed as a new episode of illness, in contrast to 
relapse, which represents reactivation of the index 
episode (Frank et al., 1991a). Maintenance 
pharmacotherapy is typically recommended for 
individuals with a history of three or more depressive 
episodes, chronic depression, or bipolar disorder 
(Kupfer, 1991; Thase, 1993; Prien & Kocsis, 1995). 
Maintenance pharmacotherapy, which may extend for 
years, typically requires monthly or quarterly visits. 
Longer term, preventive psychotherapy to prevent 
recurrences has not been studied extensively. However, 
in one study of patients with highly recurrent 
depression, monthly sessions of interpersonal 
psychotherapy were significantly more effective than 
placebo but less effective than pharmacotherapy (Frank 
et al., 1991a). 
Specific Treatments for Episodes of 
Depression and Mania 
This section describes specific types of pharmaco- 
therapies and psychosocial therapies for episodes of 
depression and mania. Treatment generally targets 
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symptom patterns rather than specific disorders. 
Differences in the treatment strategy for unipolar and 
bipolar depression are described where relevant. 
Treatment of Major Depressive Episodes 
Pharmacotherapies 
Antidepressant medications are effective across the 
full range of severity of major depressive episodes in 
major depressive disorder and bipolar disorder 
(American Psychiatric Association, 1993; Depression 
Guideline Panel, 1993; Frank et al., 1993). The degree 
of effectiveness, however, varies according to the 
intensity of the depressive episode. With mild 
depressive episodes, the overall response rate is about 
70 percent, including a placebo rate of about 60 percent 
(Thase & Howland, 1995). With severe depressive 
episodes, the overall response rate is much lower, as is 
the placebo rate. For example, with psychotic 
depression, the overall response rate to any one drug is 
only about 20 to 40 percent (Spiker, 1985), including a 
placebo response rate of less than 10 percent (Spiker & 
Kupfer, 1988; Schatzberg & Rothschild, 1992). 
Psychotic depression is treated with either an 
antidepressant/antipsychotic combination gr ECT 
(Spiker, 1985; Schatzberg & Rothschild, 1992). 
There are four major classes of antidepressant 
medications. The tricyclic and heterocyclic 
antidepressants (TCAs and HCAs) are named for their 
chemical structure. The MAOIs and SSRIs are 
classified by their initial neurochemical effects. In 
general, MAOIs and SSRIs increase the level of a target 
neurotransmitter by two distinct mechanisms. But, as 
discussed below, these classes of medications have 
many other effects. They also have some differential 
effects depending on the race or ethnicity of the patient. 
The mode of action of antidepressants is complex 
and only partly understood. Put simply, most 
antidepressants are designed to heighten the level of a 
target neurotransmitter at the neuronal synapse. This 
can be accomplished by one or more of the following 
therapeutic actions: boosting the nemotransmitter’s 
synthesis, blocking its degradation, preventing its 
reuptake from the synapse into the presynaptic neuron, 
or mimicking its binding to postsynaptic receptors. To 
make matters more complicated, many antidepressant 
drugs affect more than one neurotransmitter. 
Explaining how any one drug alleviates depression 
probably entails multiple therapeutic actions, direct and 
indirect, on more than one neurotransrnitter system 
(Feighner, 1999). 
Selection of a particular antidepressant for a 
particular patient depends upon the patient’s past 
treatment history, the likelihood of side effects, safety 
in overdose, and expense (Depression Guideline Panel, 
1993). A vast majority of U.S. psychiatrists favor the 
SSRIs as “first-line” medications (Olfson & Klerman, 
1993). These agents are viewed more favorably than 
the TCAs because of their ease of use, more 
manageable side effects, and safety in overdose (Kapur 
et al., 1992; Preskom & Burke, 1992). Perhaps the 
major drawback of the SSRIs is their expense: they are 
only available as name brands (until 2002 when they 
begin to come off patent). At minimum, SSRI therapy 
costs about $80 per month (Burke et al., 1994), and 
patients taking higher doses face proportionally greater 
costs. 
Four SSRIs have been approved by the FDA for 
treatment of depression: fluoxetine, sertraline, 
paroxetine, and citalopram. A fifth SSRI, fluvoxamine, 
is approved for treatment of obsessive-compulsive 
disorder, yet is used off-label for depression.” There 
are few compelling reasons to pick one SSRI over 
another for treatment of uncomplicated major 
depression, because they are more similar than different 
(Aguglia et al., 1993; Schone & Ludwig, 1993; Tignol, 
1993; Preskom, 1995). There are, however, several 
distinguishing pharmacokinetic differences between 
SSRIs, including elimination half-life (the time it takes 
for the plasma level of the drug to decrease 50 percent 
from steady-state), propensity for drug-drug 
interactions (e.g., via inhibition of hepatic enzymes), 
and antidepressant activity of metabolite(s) (DeVane, 
1992). In general, SSRIs are more likely to be 
’ ’ Technically, FDA approves drugs for a selected indication 
(a disorder in a certain population). However, once the drug 
is marketed, doctors are. at liberty to prescribe it for unapproved 
(off-label) indications. 
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metabolized more slowly by African Americans and 
Asians, resulting in higher blood levels (Lin et al., 
1997). 
The SSRIs as a class of drugs have their own class- 
specific side effects, including nausea, diarrhea, 
headache, tremor, daytime sedation, failure to achieve 
orgasm, nervousness, .and insomnia. Attrition from 
acute phase therapy because of side effects is typically 
10 to 20 percent (Preskorn & Burke, 1992). The 
incidence of treatment-related suicidal thoughts for the 
SSRIs is low and comparable to the rate observed for 
other antidepressants (Beasley et al., 1991; Fava 8z 
Rosenbaum, 1991), despite reports to the contrary 
(Breggin & Breggin, 1994). 
Some concern persists that the SSRIs are less 
effective than the TCAs for treatment of severe 
depressions, including melancholic and psychotic 
subtypes (Potter et al., 1991; Nelson, 1994). Yet there 
is no definitive answer (Danish University Anti- 
depressant Group, 1986, 1990; Pande & Sayler, 1993; 
Roose et al., 1994; Stuppaeck et al., 1994). 
Side effects and potential lethality in overdose are 
the major drawbacks of the TCAs. An overdose of as 
little as 7-day supply of a TCA can result in potentially 
fatal cardiac arrhythmias (Kapur et al., 1992). TCA 
treatment is typically initiated at lower dosages and 
titrated upward with careful attention to response and 
side effects. Doses for African Americans and Asians 
should be monitored more closely, because their slower 
metabolism of TCAs can lead to higher blood 
concentrations (Lin et al., 1997). Similarly, studies also 
suggest that there may be gender differences in drug 
metabolism and that plasma levels may change over the 
course of the menstrual cycle (Blumenthal, 1994b). 
In addition to the four major classes of anti- 
depressants are bupropion, which is discussed below, 
and three newer FDA-approved antidepressants that 
have mixed or compound synaptic effects. Venlafaxine, 
the first of these newer antidepressants, inhibits 
reuptake of both serotonin and, at higher doses, 
norepinephrine. In contrast to the TCAs, venlafaxine 
has somewhat milder side effects (Bolden-Watson & 
Richelson, 1993), which are like those of the SSRIs. 
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Nefazodone, the second newer antidepressant, is 
unique in terms of both .struc&re and neurochemical 
effects (Taylor et al., 1995). In contrast to the SSRIs, 
nefazodone improves sleep efficiency (An&age et al., 
1994). Its side effect profile is comparable to the other 
newer antidepressants, but it has the advantage of a 
lower rate of sexual side effects (Preskom, 1995). The 
more recently FDA-approved antidepressant, mirta- 
zapine, blocks two types of serotonin receptors, the 5- 
HT, and 5-HT, receptors (Feighner, 1999). Mirtazapine 
is also a potent antihistamine and tends to be more 
sedating than most other newer antidepressants. Weight 
gain can be another troublesome side effect. 
Figure 4-2 presents summary findings on newer 
pharmacotherapies from a recent review of the 
treatment of depression by the Agency for Health Care 
Policy and Research (AHCPR, 1999). There have been 
few studies of gender differences in clinical response to 
treatments for depression. A recent report (Komstein et 
al., in press) found women with chronic depression to 
respond better to a SSRI than a tricyclic, yet the oppo- 
site for men. This effect was primarily in premeno- 
pausal women. The AHCPR report (1999) also noted 
that there were almost no data to address the efficacy of 
pharmacotherapies in post partum or pregnant women. 
Alternate Pharmacotherapies 
Regardless of the initial choice of pharmacotherapy, 
about 30 to 50 percent of patients do not respond to the 
initial medication. It has not been established fidy 
whether patients who respond poorly to one class of 
antidepressants hould be switched automatically to an 
alternate class (Thase & Rush, 1997). Several studies 
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Venlafaxine also has a low risk of cardiotoxicity and, 
although experience is limited, it appears to be less 
toxic than the others in overdose. Venlafaxine has 
shown promise in treatment of severe (Guelfi et al., 
1995) or refractory (Nierenberg et al., 1994) depres- 
sive states and is superior to fluoxetine in one inpatient 
study (Clerc et al., 1994). Venlafaxine also 
occasionally causes increased blood pressure, and this 
can be a particular concern at higher doses (Thase, 
1998). 
Mental Health: A Report of the Surgeon General 
have examined the efficacy of the TCAs and SSRIs 
when used in sequence (Peselow et al., 1989; Beasley 
et al., 1990). Approximately 30 to 50 percent of those 
not responsive to one class will respond to the other 
(Thase & Rush, 1997). 
Among other types of antidepressants, the MAOIs 
and bupropion are important alternatives for SSRI and 
TCA nonresponders (Thase & Rush, 1995). These 
agents also may be relatively more effective than TCAs 
or SSRIs for treatment of depressions characterized by 
atypical or reversed vegetative symptoms (Goodnick & 
Extein, 1989; Quitkin et al., 1993b; Thase et al., 1995). 
Bupropion and the MAOIs also are good choices to 
treat bipolar depression (Himmelhoch et al., 1991; 
Thase et al., 1992; Sachs et al., 1994). Bupropion also 
has the advantage of a low rate of sexual side effects 
(Gardner & Johnston, 1985; Walker et al., 1993). 
Bupropion’s efficacy and overall side effect profile 
might justify its first-line use for all types of depression 
(e.g., Kiev et al., 1994). Furthermore, bupropion has a 
novel neurochemical profile in terms of effects on 
dopamine and norepinephrine (Ascher et al., 1995). 
However, worries about an increased risk of seizures 
delayed bupropion’s introduction to the U.S. market by 
more than 5 years (Davidson, 1989). Although clearly 
effective for a broad range of depressions, use of the 
MAOIs has been limited for decades by concerns that 
when taken with certain foods containing the chemical 
tyramine (for example, some aged cheeses and red 
wines); these medications may cause a potentially 
lethal hypertensive reaction (Thase et al., 1995). There 
has been continued interest in development of safer, 
selective and reversible MAOIs. 
Hypericum (St. John’s Wart). The widespread publicity 
and use of the botanical product from the yellow- 
flowering Hypericum perforutum plant with or without 
medical supervision is well ahead of the science 
database supporting the effectiveness of this putative 
antidepressant. Controlled trials, mainly in Germany, 
have been positive in mild-to-moderate depression, 
with only mild gastrointestinal side effects reported 
(Linde et al., 1996). However, most of those studies 
were methodologically flawed, in areas including 
Figure 4-2. Treatment of depression-newer 
pharmacotherapies: Summary findings 
n Newer antidepressant drugs* are effective 
treatments for major depression and dysthymia. 
l They are efficacious in primary care and specialty 
mental health care settings: 
- Major depression: 
50 percent response to active agent 
32 percent response to placebo 
- Dysthymia (fluoxetine, ser$aline, and 
amisulpride): 
59 percent response to active agent 
37 percent response to placebo 
n Both older and newer antidepressants demonstrate 
similar efficacy. 
n Drop-out rates due to all causes combined are 
similar for newer and older agents: 
l Drop-out rates due to adverse effects are slightly 
higher for older agents. 
. Newer agents are often easier to use because of 
single daily dosing and less titration. 
l SSRls and all other antidepressants marketed 
subsequently. 
Source: AHCPR, 1999. 
diagnosis (more similar to adjustment disorder with 
depressed mood than major depression), length of trial 
(often an inadequate 4 weeks), and either lack of 
placebo control or unusually low or high placebo 
response rates (S&man, 1998). 
Post-marketing surveillance in Germany, which 
found few adverse effects of Hypericum, depended 
upon spontaneous reporting of side effects by patients, 
an approach that would not be considered acceptable in 
this country (Deltito & Beyer, 1998). In clinical use, 
the most commonly encountered adverse effect noted 
appears to be sensitivity to sunlight. 
Basic questions about mechanism of action and 
even the optimal formulation of a pharmaceutical 
product from the plant remain; dosage in the 
randomized German trials varied by sixfold (Linde et 
al., 1996). Several pharmacologically active 
components of St. John’s wort, including hypericin, 
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have been identified (Nathan, 1999); although their 
long half-lives in theory should permit once daily 
dosing, in practice a schedule of 300 mg three times a 
time is most commonly used. While initial speculation 
about significant MAO-inhibiting properties of 
hypericum have been largely discounted, possible 
serotonergic mechanisms suggest that combining this 
agent with an SSRI or other serotonergic antidepressant 
should be approached with caution. However, data 
regarding safety of hypericum in preclinical models or 
clinical samples are few (Nathan, 1999). At least two 
placebo-controlled trials in the United States are under 
way to compare the efficacy of Hypericum with that of 
an SSRI. 
Augmentation Strategies 
The transition from one antidepressant to another is 
time consuming, and patients sometimes feel worse in 
the process (Thase & Rush, 1997). Many clinicians 
bypass these problems by using a second medication to 
augment an ineffective antidepressant. The best studied 
strategies of this type are lithium augmentation, thyroid 
augmentation, and TCA-SSRI combinations 
(Nierenberg & White, 1990; Thase & Rush, 1997; 
Crismon et al., 1999). 
Increasingly, clinicians are adding a noradrenergic 
TCA to an ineffective SSRI or vice versa. In an earlier 
era, such polypharmacy (the prescription of multiple 
drugs at the same time) was frowned upon. Thus far, 
the evidence supporting TCA-SSRI combinations is not 
conclusive (Thase & Rush, 1995). Caution is needed 
when using these agents in combination because SSRIs 
inhibit metabolism of several TCAs, resulting in a 
substantial increase in blood levels and toxicity or other 
adverse side effects from TCAs (Preskorn & Burke, 
1992). 
Psychotherapy and Counseling 
Many people prefer psychotherapy or counseling over 
medication for treatment of depression (Roper, 1986; 
Seligman1995). Research conducted in the past two 
decades has helped to establish at least several newer 
forms of time-limited psychotherapy as being as 
effective as antidepressant pharmacotherapy in mild-to- 
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moderate depressions (DiMascio et al., 1979; Elkin et 
al., 1989; Hollon et al., 1992; Depression Guideline 
Panel, 1993; Thase, 1995; Persons et al., 1996). The 
newer depression-specific therapies include cognitive- 
behavioral therapy (Becket al., 1979) and interpersonal 
psychotherapy (Klerman et al., 1984). These 
approaches use a time-limited approach, a present tense 
(‘here-and-now”) focus, and emphasize patient 
education and active collaboration. Interpersonal 
psychotherapy centers around four common problem 
areas: role disputes, role transitions, unresolved grief, 
and social deficits. Cognitivebehavioral therapy takes 
a more structured approach by emphasizing the 
interactive nature of thoughts, emotions, and behavior. 
It also helps the depressed patient to learn how to 
improve coping and lessen symptom distress. 
There is no evidence that cognitive-behavioral 
therapy and interpersonal psychotherapy are 
differentially effective (Elkin et al., 1989; Thase, 
1995). As reported earlier, both therapies appear to 
have some relapse prevention effects, although they are 
much less studied than the pharmacotherapies. Other 
more traditional forms of counseling and psycho- 
therapy have not been extensively studied using a 
randomized clinical trial design (Depression Guideline 
Panel, 1993). It is important to determine if these more 
traditional treatments, as commonly practiced, are as 
effective as interpersonal psychotherapy or cognitive- 
behavioral therapy. 
The brevity of this section reflects the succinctness 
of the findings on the effectiveness of these 
interventions as well as the lack of differential 
responses and “side effects.” It does not reflect a 
preference or superiority of medication except in 
conditions such as psychotic depression where 
psychotherapies are not effective. 
Bipolar Depression 
Treatment of bipolar depression’2 has received 
surprisingly little study (Zornberg &Pope, 1993). Most 
psychiatrists prescribe the same antidepressants for 
l2 Bipolar depression refers to episodes with symptoms 
of depression in patients diagnosed with bipolar disorder. 
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treatment of bipolar depression as for major depressive 
disorder, although evidence is lacking to support this 
practice. It also is not certain that the same strategies 
should be used for treatment of depression in bipolar II 
(i.e., major depression plus a history of hypomania) and 
bipolar I (i.e., major depression with a history of at 
least one prior manic episode) (DSM-IV). 
Pharmacotherapy of ‘bipolar depression typically 
begins with lithium or an alternate mood stabilizer 
(DSM-IV; Frances et al., 1996). Mood stabilizers 
reduce the risk of cycling and have modest 
antidepressant effects; response rates of 30 to 50 
percent are typical (DSM-IV; Zomberg & Pope, 1993). 
For bipolar depressions refractory to mood stabilizers, 
an antidepressant is typically added. Bipolar depression 
may be more responsive to nonsedating 
antidepressants, including the MAOIs, SSRIs, and 
bupropion (Cohn et al., 1989; Haykal & Akiskal, 1990; 
Himmelhoch et al., 1991; Peet, 1994; Sachs et al., 
1994).The optimal length of continuation phase 
pharmacotherapy of bipolar depression has not been 
established empirically (DSM-IV). During the 
continuation phase, the risk of depressive relapse must 
be counterbalanced against the risk of inducing mania 
or rapid cycling (Kukopulos et al., 1980; Wehr & 
Goodwin, 1987; Solomon et al., 1995). Although not 
all studies are in agreement, antidepressants may 
increase mood cycling in a vulnerable subgroup, such 
as women with bipolar II disorder (Coryell et al., 1992; 
Bauer et al., 1994). Lithium is associated with 
increased risk of congenital anomalies when taken 
during the first trimester of pregnancy, and the 
anticonvulsants are contraindicated (see Cohen et al., 
1994, for a review). This is problematic in view of the 
high risk of recurrence in pregnant bipolar women 
(Viguera & Cohen 1998). 
Pharmacotherapy, Psychosocial Therapy, and 
Multimodal Therapy 
The relative efficacy of pharmacotherapy and the newer 
forms of psychosocial treatment, such as interpersonal 
psychotherapy and the cognitive-behavioral therapies, 
is a controversial topic (Meterissian & Bradwejn, 1989; 
Klein &Ross, 1993; Munoz et al., 1994; Persons et al., 
1996). For major depressive episodes of mild to 
moderate severity, meta-analyses of randomized 
clinical trials document the relative equivalence of 
these treatments (Dobson, 1989; Depression Guideline 
Panel, 1993). Yet for patients with bipolar and 
psychotic depression, who were excluded from these 
studies, pharmacotherapy is required: there is no 
evidence that these types of depressive episodes can be 
effectively treated with psychotherapy alone 
(Depression Guideline Panel, 1993; Thase, 1995). 
Current standards of practice suggest that therapists 
who withhold somatic treatments (i.e., 
pharmacotherapy or ECT) from such patients risk 
malpractice (DSM-IV; Klerman, 1990; American 
Psychiatric Association, 1993; Depression Guideline 
Panel, 1993). 
For .patients hospitalized with depression, somatic 
therapies also are considered the standard of care 
(American Psychiatric Association, 1993). Again, there 
is little evidence for the efficacy of psychosocial 
treatments alone when used instead of 
pharmacotherapy, although several studies suggest hat 
carefully selected inpatients may respond to intensive 
cognitive-behavioral therapy (DeJong et al., 1986; 
Thase et al., 1991). However, in an era in which 
inpatient stays are measured in days, rather than in 
weeks, this option is seldom feasible. Combined 
therapies emphasizing both pharmacologic and 
intensive psychosocial treatments hold greater promise 
to improve the outcome of hospitalized patients, 
particularly if inpatient care is followed by ambulatory 
treatment (Miller et al., 1990; Scott, 1992). 
Combined therapies-also called multimodal 
treatments-are especially valuable for outpatients with 
severe forms of depression. According to a recent meta- 
analysis of six studies, combined therapy (cognitive or 
interpersonal psychotherapy plus pharmacotherapy) 
was significantly more effective than psychotherapy 
alone for more severe recurrent depression. In milder 
depressions, psychotherapy alone was nearly as 
effective as combined therapy (Thase et al., 1997b). 
This meta-analysis was unable to compare combined 
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therapy with pharmacotherapy alone or placebo due to 
an insufficient number of patients. 
In summary, the DSM-IV definition of major 
depressive disorder spans a heterogenous group of 
conditions that benefit from psychosocial and/or 
pharmacological therapies. People with mild to 
moderate depression respond to psychotherapy or 
pharmacotherapy alone. People with severe depression 
require pharmacotherapy or ECT and they may also 
benefit from the addition of psychosocial therapy. 
Preventing Relapse of Major Depressive Episodes 
Recurrent Depression. Maintenance pharmacotherapy 
is the best-studied means to reduce the risk of recurrent 
depression (Prien & Kocsis, 1995; Thase & Sullivan, 
1995). The magnitude of effectiveness in prevention of 
recurrent depressive episodes depends on the dose of 
the active agent used, the inherent risk of the 
population (i.e., chronicity, age, and number of prior 
episodes), the length of time being considered, and the 
patient’s adherence to the treatment regimen (Thase, 
1993). Early studies, which tended to use lower 
dosages of medications, generally documented a 
twofold advantage relative to placebo (e.g., 60 vs. 30 
percent) (Prien & Kocsis, 1995). In a more recent study 
of recurrent unipolar depression, the drug-placebo 
difference was nearly fivefold (Frank et al., 1990; 
Kupfer et al., 1992). This trial, in contrast to earlier 
randomized clinical trials, used a much higher dosage 
of imipramine, suggesting that full-dose maintenance 
pharmacotherapy may improve prophylaxis. Indeed, 
this was subsequently confirmed in a randomized 
clinical trial comparing full- and half-dose maintenance 
strategies (Frank et al., 1993). 
There are few published studies on the prophylactic 
benefits of long-term pharmacotherapy with SSRIs, 
bupropion, nefazodone, or venlafaxine. However, 
available studies uniformly document 1 year efficacy 
rates of 80 to 90 percent in preventing recurrence of 
depression (Montgomery et al., 1988; Doogan & 
Caillard, 1992; Claghom & Feighner, 1993; Duboff, 
1993; Shrivastava et al., 1994; Franchini et al., 1997; 
Stewart et al., 1998). Thus, maintenance therapy with 
the newer agents is likely to yield outcomes comparable 
to the TCAs (Thase & Sullivan, 1995). 
How does maintenance pharmacotherapy compare 
with psychotherapy? In one study of recurrent depres- 
sion, monthly sessions of maintenance interpersonal 
psychotherapy had a 3-year success rate of about 35 
percent (i.e., a rate falling between those for active and 
placebo pharmacotherapy) (Frank et al., 1990). 
Subsequent studies found maintenance interpersonal 
psychotherapy to be either a powerful or ineffective 
prophylactic therapy, depending on the 
patient/treatment match (Kupfer et al., 1990; Frank et 
al., 1991a; Spanier et al., 1966). 
Bipolar Depression. No recent randomized clinical 
trials have examined prophylaxis against recurrent 
depression in bipolar disorder. In one older, well- 
controlled study, recurrence rates of more than 60 
percent were observed despite maintenance treatment 
with lithium, either alone or in combination with 
imipramine (Shapiro et al., 1989). 
267 
Acute Phase Efficacy 
Success rates of 80 to 90 percent were once expected 
with lithium for the acute phase treatment of mania 
(e.g., Schou, 1989); however, lithium response rates of 
only 40 to 50 percent are now commonplace (Frances 
et al., 1996). Most recent studies thus underscore the 
limitations of lithium in mania (e.g., Gelenberg et al., 
1989; Small et al., 1991; Freeman et al., 1992; Bowden 
et al., 1994). The apparent decline in lithium 
responsiveness may be partly due to sampling bias (i.e., 
university hospitals treat more refractory patients), but 
could also be attributable to factors such as younger 
age of onset, increased drug abuse comorbidity, or 
shorter therapeutic trials necessitated by briefer 
hospital stay (Solomon et al., 1995). The effectiveness 
of acute phase lithium treatment also is partially 
dependent on the clinical characteristics of the manic 
episode: dysphoric/mixed, psychotic, and rapid cycling 
episodes are less responsive to lithium alone (DSM-IV; 
Solomon et al., 1995). 
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A number of other medications initially developed 
for other indications are increasingly used for lithium- 
refractory or lithium-intolerant mania. The efficacy of 
two medications, the anticonvulsants carbamazepine 
and divalproex sodium, has been documented in 
randomized clinical trials (e.g., Small et al., 1991; 
Freeman et al., 1992; Bowden et al., 1994; Keller et al., 
1992). Divalproex sodium has received FDA approval 
for the treatment of mania. The specific mechanisms of 
action for these agents have not been established, 
although they may stabilize neuronal membrane 
systems, including the cyclic adenosine monophosphate 
second messenger system (Post, 1990). The 
anticonvulsant medications under investigation for their 
effectiveness in mania include lamotrigine and 
gabapentin. 
Another newer treatment, verapamil, is a calcium 
channel blocker initially approved by the FDA for 
treatment of cardiac arrhythmias and hypertension. 
Since the mid- 198Os, clinical reports and evidence from 
small randomized clinical trials suggest that the 
calcium channel blockers may have antimanic effects 
(Dubovsky et al., 1986; Garza-Trevino et al., 1992; 
Janicak et al., 1992, 1998). Like lithium and the 
anticonvulsants, the mechanism of action of verapamil 
has not been established. There is evidence of 
abnormalities of intracellular calcium levels in bipolar 
disorder (Dubovsky et al., 1992), and calcium’s role in 
modulating second messenger systems (Wachtel, 1990) 
has spurred continued interest in this class of 
medication. If effective, verapamil does have the 
additional advantage of having a lower potential for 
causing birth defects than does lithium, divalproex, or 
carbamazepine. 
Adjunctive neuroleptics and high-potency benzo- 
diazepines are used often in combination with mood 
stabilizers to treat mania. The very real risk of tardive 
dyskinesia has led to a shift in favor of adjunctive use 
of benzodiazepines instead of neuroleptics for acute 
stabilization of mania (Chouinard, 1988; Lenox et al., 
1992). The novel antipsychotic clozapine has shown 
promise in otherwise refractory manic states (Suppes et 
al., 1992), although such treatment requires careful 
monitoring to help protect against development of 
agranulocytosis, a potentially lethal bone marrow 
toxicity. Other newer antipsychotic medications, 
including risperidone and olanzapine, have safer side 
effect profiles than clozapine and are now being studied 
in mania. For manic patients who are not responsive to 
or tolerant of pharmacotherapy, ECT is a viable 
alternative (Black et al., 1987; Mukherjee et al., 1994). 
Further discussion of antipsychotic drugs and their side 
effects is found in the section on schizophrenia. 
Maintenance Treatment to Prevent Recurrences of 
Mania 
The efficacy of lithium for prevention of mania also 
appears to be significantly lower now than in previous 
decades; recurrence rates of 40 to 60 percent are now 
typical despite ongoing lithium therapy (Prien et al., 
1984; Gelenberg et al., 1989; Winokur et al., 1993). 
Still, more than 20 studies document the effectiveness 
of lithium in preventing suicide (Goodwin &Jan&on, 
1990). Medication noncompliance almost certainly 
plays a role in the failure of longer term lithium 
maintenance therapy (Aagaard et al., 1988). Indeed, 
abrupt discontinuation of lithium has been shown to 
accelerate the risk of relapse (Suppes et al., 1993). 
Medication “holidays” may similarly induce a lithium- 
refractory state (Post, 1992), although data are 
conflicting (Coryell et al., 1998). As noted earlier, 
antidepressant cotherapy also may accelerate cycle 
frequency or induce lithium-resistant rapid cycling 
(Kukopulos et al., 1980; Wehr & Goodwin, 1987). 
With increasing recognition of the limitations of 
lithium prophylaxis, the anticonvulsants are used 
increasingly for maintenance therapy of bipolar 
disorder. Several randomized clinical trials have 
demonstrated the prophylactic efficacy of 
carbamazepine (Placidi et al., 1986; Lerer et al., 1987; 
Coxhead et al., 1992), whereas the value of divalproex 
preventive therapy is only supported by uncontrolled 
studies (Calabrese & Delucchi, 1990; McElroy et al., 
1992; Post, 1990). Because of increased teratogenic 
risk associated with these agents, there is a need to 
obtain and evaluate information on alternative 
interventions for women with bipolar disorder of 
childbearing age. 
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Service Delivery for Mood Disorders 
The mood disorders are associated with significant 
suffering and high social costs, as explained above 
(Broadhead et al., 1990; Greenberg et al., 1993; Wells 
et al., 1989; Wells et al., 1996). Many treatments are 
efficacious, yet in the case of depression, significant 
numbers of individuals either receive no care or 
inappropriate care (Katon et al., 1992; Narrow et al., 
1993; Wells et al., 1994; Thase, 1996). Limitations in 
insurance benefits or in the management strategies 
employed in managed care arrangements may make it 
impossible to deliver recommended treatments. In 
addition, treatment outcome in real-world practice is 
not as effective as that demonstrated in clinical trials, 
a problem known. as the gap between efficacy and 
effectiveness (see Chapter 2). The gap is greatest in the 
primary care setting, although it also is observed in 
specialty mental health practice. There is a need to 
develop case identification approaches for women in 
obstetrics/gynecology settings due to the high risk of 
recurrence in childbearing women with bipolar 
disorder. Little attention also has been paid to screening 
and mental health services for women in 
obstetrics/gynecology settings despite their high risk of 
depression (Miranda et al., 1998). 
Primary care practice has been studied’extensively, 
revealing low rates of both recognition and appropriate 
treatment of depression. Approximately one-third to 
one-half of patients with major depression go 
unrecognized in primary care settings (Gerber et al., 
1989; Simon & Von Korff, 1995). Poor recognition 
leads to unnecessary and expensive diagnostic 
procedures, particularly in response to patients’ vague 
somatic complaints (Callahan et al., 1996). Fewer than 
one-half receive antidepressant medication according 
to Agency for Health Care Policy Research 
recommendations for dosage and duration (Simon et 
al., 1993; Rost et al., 1994; Katon 1995, 1996; 
Schulberg et al., 1995; Simon & Von Korff, 1995). 
About 40 percent discontinue their medication on their 
own during the first 4 to 6 weeks of treatment, and 
fewer still continue their medication for the 
recommended period of 6 months (Simon et al., 1993). 
Although drug treatment is the most common strategy 
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for treating depression in primary care practice (Glfson 
& Klerman, 1992; Williams et al., 1999), about one- 
half of primary care physicians express a preference to 
include counseling or therapy as a component of 
treatment (Meredith et al., 1994, 1996). Few primary 
care practitioners, however, have formal training in 
psychotherapy, nor do they have the time (Meredith et 
al., 1994, 1996). A variety of strategies have been 
developed to improve the management of depression in 
primary care settings (cited in Katon et al., 1997). 
These are discussed in more detail in Chapter 5 because 
of the special problem of gecognizing and treating 
depression among older adults. 
Another major service delivery issue focuses on the 
substantial number of individuals with mood disorders 
who go on to develop a chronic and disabling course. 
Their needs for a wide array of services are similar to 
those of individuals with schizophrenia. Many of the 
service delivery issues relevant to individuals with 
severe and persistent mood disorders are presented in 
the final sections of this chapter. 
Schizophrenia 
Overview 
Our understanding of schizophrenia has evolved since 
its symptoms were first catalogued by German 
psychiatrist Emil Kraepelin in the late 19th century 
(Andreasen, 1997a). Even though the cause of this 
disorder remains elusive, its frightening symptoms and 
biological correlates have come to be quite well 
defined. Yet misconceptions abound about symptoms: 
schizophrenia is neither “split personality” not 
“multiple personality.” Furthermore, people with 
schizophrenia are not perpetually incoherent or 
psychotic (DSM-IV; Mason et al., 1997) (Table 4-6). 
Schizophrenia is characterized by profound 
disruption in cognition and emotion, affecting the most 
fundamental human attributes: language, thought, 
perception, affect, and sense of self. The array of 
symptoms, while wide ranging, frequently includes 
psychotic manifestations, such as hearing internal 
voices or experiencing other sensations not connected 
to an obvious source (hallucinations) and assigning 
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Table 4-6. DSM-IV diagnostic criteria for schizophrenia 
4. 
B. 
C. 
D. 
E. 
F. 
Characteristic symptoms: Two (or more) of the following, each present for a significant portion of time during a l- 
month period (or less if successfully treated): 
(1) delusions 
(2) hallucinations 
(3) disorganized speech (e.g., frequent derailment or incoherence) 
(4) grossly disorganized or catatonic behavior 
(5) negative symptoms, i.e., affective flattening, alogia, or avolition 
Note: Only one Criterion A symptom is required if delusions are bizarre or hallucinations consist of a voice keeping up 
a running commentary on the person’s behavior or thoughts, or two or more voices conversing with each other. 
Social/occupational dysfunction: For a significant portion of the time since the onset of the disturbance, one or more 
major areas of functioning such as work, interpersonal relations, or self-care are markedly below the level achieved 
prior to the onset (or when the onset is in childhood or adolescence, failure to achieve expected level of interpersonal, 
academic, or occupational achievement). 
Duration: Continuous signs of the disturbance persist for at least 6 months. This 6-month period must include at least 
1 month of symptoms (or less if successfully treated) that meet Criterion A (i.e., active-phase symptoms) and may 
include periods of prodromal or residual symptoms. During these prodromal or residual periods, the signs of the 
disturbance may be manifested by only negative symptoms or two or more symptoms listed in Criterion A present in 
an attenuated form (e.g., odd beliefs, unusual perceptual experiences). 
Schizoaffective and mood disorder exclusion: Schizoaffective disorder and mood disorder with psychotic features 
have been ruled out because either (1) no major depressive, manic, or mixed episodes have occurred concurrently 
with the active-phase symptoms: or (2) if mood episodes have occurred during active-phase symptoms, their total 
duration has been brief relative to the duratipn of the active and residual periods. 
Substance/general medical condition exclusion: The disturbance is not due to the direct physiological effects of a 
substance (e.g., a drug of abuse, a medication) or a general medical condition. 
Relationship to a pervasive developmental disorder; If there is a history of autistic disorder or another pervasive 
developmental disorder, the additional diagnosis of schizophrenia is made only if prominent delusions or 
hallucinations are also present for at least a month (or less if successfully treated). 
unusual significance or meaning to normal events or 
holding fixed false personal beliefs (delusions). No 
single symptom is definitive for diagnosis; rather, 
the diagnosis encompasses a pattern of signs and 
symptoms, in conjunction with impaired occupational 
or social functioning (DSM-IV). 
Symptoms are typically divided into positive and 
negative symptoms (see Table 4-7) because of their 
impact on diagnosis and treatment (Crow, 1985; 
Andreasen, 1995; Eaton et al., 1995; Klosterkotter et 
al., 1995; Maziade et al., 1996). Positive symptoms are 
those that appear to reflect an excess or distortion of 
normal functions (Peralta & Cuesta, 1998). The 
diagnosis of schizophrenia, according to DSM-IV, 
requires at least l-month duration of two or more 
positive symptoms, unless hallucinations or delusions 
are especially bizarre, in which case one alone suffices 
for diagnosis. Negative symptoms are those that appear 
to reflect a diminution or loss of normal functions (Roy 
& DeVriendt, 1994; Crow, 1995; Blanchard et al., 
1998). These often persist in the lives of people 
with schizophrenia during periods of low (or absent) 
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Table 4-7. Positive and negative symptoms of schizophrenia 
~~ 
Posltive Symptoms of Schizophrenia 
I 
Delusions are firmly held erroneous beliefs due to distortions or exaggerations of reasoning and/or misinterpretations of j 
perceptions or experiences. Delusions of being followed or watched are common, as are beliefs that comments, radio or 
TV programs, etc., are directing special messages directly to him/her. 
, 
Hallucinations are distortions or exaggerations of perception in any of the senses, although auditory hallucinations 
(“hearing voices” within, distinct from one’s own thoughts) are the most common, followed by visual hallucinations. 
Disorganized speech/thinking, also described as “thought disorder” or “loosening of associations,” is a key aspect of 
! schizophrenia. Disorganized thinking is usually assessed primarily based on the person’s speech. Therefore, tangential, 
j 
; 
I I oosely associated, or incoherent speech severe enough to substantially impair effective communication is used as an 
ndicator of thought disorder by the DSM-IV. 
I 
/ I 
Gross/y disorganized behavior includes difficulty in goal-directed behavior (leading to difficulties iii activities in daily 
living), unpredictable agitation or silliness, social disinhibition, or behaviors that are bizarre to onlookers. Their 
purposelessness distinguishes them from unusual behavior prompted by delusional beliefs. 
L 
Catatonic behaviors are characterized by a marked decrease in reaction to the immediate surrounding environment, 
sometimes taking the form of motionless and apparent unawareness, rigid or bizarre postures, or aimless excess motor 
activity. 
Other symptoms sometimes present in schizophrenia but not often enough to be definitional alone include affect 
inappropriate to the situation or stimuli, unusual motor behavior (pacing, rocking), depersonalization, derealization, and 
somatic preoccupations. 
Negative Symptoms of Schizophrenia 
Affective Mtenhg is the reduction in the range and intensity of emotional expression, including facial expression, voice 
tone, eye contact, and body language. 
Alogla, or poverty of speech, is the lessening of speech fluency and productivity, thought to reflect slowing or blocked ’ 
thoughts, and often manifested as laconic, einpty replies to questions. 1 
Avolition is the reduction, difficulty, or inability to initiate and persist in goal-directed behavior; it is often mistaken for 
apparent disinterest. 
j 
I 
positive symptoms. Negative symptoms are difficult to 
evaluate because they are not as grossly abnormal as 
positives ones and may be caused by a variety of other 
factors as well (e.g., as an adaptation to a persecutory 
delusion). However, advancements in diagnostic 
assessment ools are being made, 
Diagnosis is complicated by early treatment of 
schizophrenia’s positive symptoms. Antipsychotic 
medications, particularly the traditional ones, often 
produce side effects that closely resemble the negative 
symptoms of affective flattening and avolition. In 
addition, other negative symptoms are sometimes 
present in schizophrenia but not often enough to satisfy 
diagnostic criteria (DSM-IV): loss of usual interests or 
pleasures (anhedonia); disturbances of sleep and 
eating; dysphoric mood (depressed, anxious, irritable, 
or angry mood); and difficulty concentrating or 
focusing attention. 
Currently, discussion is ongoing within the field 
regarding the need for a third category of symptoms for 
diagnosis: disorganized symptoms (Brekke et al., 1995; 
Cuesta & Peralta, 1995). Disorganized symptoms 
include thought disorder, confusion, disorientation, and 
memory problems. While they are listed by DSM-IV as 
common in schizophrenia-especially during 
exacerbations of positive or negative symptoms 
(DSM-IV)-they do not yet constitute a formal new 
category of symptoms. Some researchers think that a 
new category is not warranted because disorganized 
symptoms may instead reflect an underlying 
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dysfunction common to several psychotic disorders, 
rather than being unique to schizophrenia (Toomey et 
al., 1998). 
Cognitive Dysfunction 
Recently there has also been more clinical and research 
attention on cognitive difficulties that many people 
with schizophrenia experience (Levin et al., 1989; 
Harvey et al., 1996). Cognitive problems include 
information processing (Cadenhead et al., 1997), 
abstract categorization (Keri et al., 1998), planning and 
regulating goal-directed behavior (“executive 
functions”), cognitive flexibility, attention, memory, 
and visual processing (Cornblatt & Keilp, 1994; 
Mahurin et al., 1998). These cognitive problems are 
especially associated with negative and disorganized 
symptoms but seem to be distinct (-Basso et al., 1998; 
Brekke et al., 1995; Cuesta & Peralta, 1995; Voruganti 
et al., 1997), although others disagree (Roy & 
DeVriendt, 1994). 
These cognitive problems vary from person to 
person and can change over time. In some situations it 
is unclear whether such deficits are due to the illness or 
to the side effects of certain neuroleptic medications 
(Zalewski et al., 1998). As research oh brain 
functioning grows more sophisticated, some models 
posit dysfunction of fundamental cognitive processes at 
the center of schizophrenia, rather than as one of 
numerous symptoms (Andreasen, 1997a, 1997b; 
Andreasen et al., 1996). On the basis of neuro- 
psychological and neuroanatomical data, for example, 
some researchers posit that schizophrenia is a disorder 
of the prefrontal cortex and its ability to perform the 
essential cognitive function of working memory 
(Goldman-Rakic & Selemon, 1997). Problems in such 
fundamental areas as paying selective attention, 
problem-solving, and remembering can cause serious 
difficulties in learning new skills (social interaction, 
treatment and rehabilitation) and performing daily tasks 
(Medalia et al., 1998); treatment of such deficits is 
discussed in later sections of the chapter. 
Functiona/ impairment 
The criteria for a diagnosis of schizophrenia include 
functional impairment in addition to the constellation 
of symptoms outlined above. For formal diagnosis, a 
person must be experiencing significant dysfunction in 
one or more major areas of life activities such as 
interpersonal relations, work or education, family life, 
communication, or self-care (Docherty et al., 1996; 
Patterson et al., 1997, 1998). These problems result 
from the complex of symptoms and their sequelae, but 
have been linked more to negative than to positive 
symptoms (Ho et al., 1998). *They have serious 
economic, social, and psychological effects: 
unemployment, disrupted education, limited social 
relationships, isolation, legal involvement, family 
stress, and substance abuse. Such sequelae form the 
most distressing aspects of the illness for many people 
and contribute to the increased risk of suicide among 
people diagnosed with schizophrenia. 
Cultural Variation 
On first consideration, symptoms like hallucinations, 
delusions, and bizarre behavior seemeasily defined and 
clearly pathological. However, increased attention to 
cultural variation has made it very clear that what is 
considered delusional in one culture may be accepted 
as normal in another (Lu et al., 1995). For example, 
among members of some cultural groups, “visions” or 
“voices” of religious figures are part of normal 
religious experience. In many communities, “seeing” or 
being “visited” by a recently deceased person are not 
unusual among family members. Therefore, labeling an 
experience as pathological or a psychiatric symptom 
can be a subtle process for the clinician with a different 
cultural or ethnic background from the patient; indeed, 
cultural variations and nuances may occur within the 
diverse subpopulations of a single racial, ethnic, or 
cultural group. Often, however, clinicians’ training, 
skills, and views tend to reflect their own social and 
cultural influences. 
Clinicians can misinterpret and misdiagnose 
patients whose cognitive style, norms of emotional 
expression, and social behavior are from a different 
culture, unless clinicians become culturally competent 
272 
(see Chapter 2 and Center for Mental Health Services 
[CMHS], 1997). For example, clinicians may 
misinterpret a client’s deferential avoidance of direct 
eye contact as a sign of withdrawal or paranoia, or a 
normal emotional reserve as flattened affect if they are 
unaware of the norms of cultural groups other than 
their own. There is some empirical evidence that such 
misinterpretations happen widely. One finding is that 
African-American patients are more likely than white 
patients to be diagnosed with severe psychotic 
disorders in clinical settings (Snowden & Cheung, 
1990; Hu et al., 1991; Lawson et al., 1994, Strakowski 
et al., 1995). The overdiagnosis of psychotic disorders 
among African Americans is interpreted by some as 
evidence of clinician bias. 
People with differing cultural backgrounds also 
may experience and exhibit true schizophrenia 
symptoms differently (Brekke &Barrio, 1997; Thakker 
& Ward, 1998). Culture shapes the content and form of 
positive and negative symptoms (Maslowski et al., 
1998). For example, people in non-Western countries 
report catatonic behavior among psychiatric patients 
much more commonly than in the United States. How 
culture, societal conditions, and diagnosing tendencies 
among clinicians in various countries interact to create 
these differences is being studied but is not yet well 
understood. 
Nodescription of symptoms can adequately convey 
a person’s experience of schizophrenia or other serious 
mental illness. Two individuals with very different 
internal experiences and outward presentations may be 
diagnosed with schizophrenia, if both meet the 
diagnostic criteria (Brazo & Dollfus, 1997; Kirkpatrick 
et al., 1998). Additionally, their symptoms and 
presentation may vary considerably over time (Ribeyre 
& Dollfus, 1996). This considerable variation (Basso et 
al., 1997; Sperling et al., 1997) has led to the naming of 
several subtypes of schizophrenia, depending on what 
symptoms are most prominent. Currently these are seen 
as variations within a single disorder. Similarly, the 
diagnosis is often difficult because other mental 
disorders share some common features. Diagnosis 
depends on the details of how people behave and what 
they report during an evaluation, the diagnostician, and 
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variations in the illness over time. Therefore, many 
people receive more than one diagnostic label over the 
course of their involvement with mental health 
services. Refining the definition of schizophrenia and 
other serious mental illnesses to account for these 
‘individual and cultural variations remains a challenge 
to researchers and clinicians. 
Prevalence 
Studies of schizophrenia’s prevalence in the general 
population vary depending on the way diagnostic 
criteria are applied and the population, setting, and 
method of study (Hafner & ar’der Heiden, 1997). In 
general, l-year prevalence in adults ages 18 to 54 is 
estimated to be 1.3 percent (Table 4-l). Onset generally 
occurs during young adulthood (mid-20s for men, late- 
20s for women), although earlier and later onset do 
occur. It may be abrupt or gradual, but most people 
experience some early signs, such as increasing social 
withdrawal, loss of interests, unusual behavior, or 
decreases in functioning prior to the beginning of active 
positive symptoms. These are often the first behaviors 
to worry family members and friends. 
Prevalence of Comorbid Medical illness 
The mortality rate in persons with schizophrenia is 
significantly higher than that of the general population. 
While elevated suicide accounts for some of the excess 
mortality-and is a serious problem in its own 
right-comorbid somatic illnesses also contribute to 
excess mortality. Until recently, there was little 
information on the prevalence of comorbid medical 
illnesses in people with schizophrenia (Jeste et al., 
1996). A recent study was among the first to document 
systematically that people with schizophrenia are beset 
by vision and dental problems, as well as by high blood 
pressure, diabetes, and sexually transmitted diseases. 
Their self-reported lifetime rates of high blood pressure 
(34.1 percent), diabetes (14.9 percent), and sexually 
transmitted diseases (10.0 percent) are higher than 
those for people of similar age in the general 
population (Dixon et al., 1999; Dixon et al., in press-a). 
The reasons for excess medical comorbidity are 
unclear, yet medical comorbidity is independently 
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associated with lower perceived physical health status, 
more severe psychosis and depression, and greater 
likelihood of a history of a suicide attempt (Dixon et 
al., 1999). These findings have important implications 
for improving patient management (Dixon et al., in 
press-b). 
Course and Recovery 
It is difficult to study the course of schizophrenia 
and other serious mental illnesses because of the 
changing nature of diagnosis, treatment, and social 
norms (Schultz et al., 1997). Overall, research indicates 
that schizophrenia’s course over time varies 
considerably from person to person (DSM-IV; Wiersma 
et al., 1998) and varies for any one person (Moller & 
von Zerssen, 1995). The variability may emanate from 
the underlying heterogeneity of the disease process 
itself, as well as from biological and genetic 
vulnerability, neurocognitive impairments, socio- 
cultural stressors, and personal and social factors that 
confer protection against stress and vulnerability 
(Liberman et al., 1980; Nuechterlein et al., 1994). Most 
individuals experience periods of symptom 
exacerbation and remission, while others maintain a 
steady level of symptoms and disability which can 
range from moderate to severe (Wiersma et al:, 1998). 
Most people experience at least one, often more, 
relapse after their first actively psychotic episode (Herz 
& Melville, 1980; Falloon, 1984; Gaebel et al., 1993; 
Wiersma et al., 1998). Often these are periods of more 
intense positive symptoms, yet the person continues to 
struggle with negative symptoms in between episodes 
(Gupta et al., 1997; Schultz et al., 1997). However, 
whether such exacerbations have the same degree of 
disabling and distressing effects each time depends 
greatly on the person’s coping skills and support 
system. Over time, many people learn successful ways 
of managing even severe symptoms to moderate their 
disruptiveness to daily life (e.g., Hamera et al., 1992). 
Therefore, earlier years with the illness are often more 
difficult than later ones. Additionally, gradual onset 
and delays in obtaining treatment seem to raise the risk 
of longer episodes of acute illness over time (Wiersma 
et al., 1998). Early treatment with antipsychotic 
medications has been found to predict better long-term 
outcomes for people experiencing their first psychotic 
episode, as compared with a variety of control groups, 
including those in more advanced stages (Lieberman et 
al., 1996; Wyatt et al., 1997, 1998; Wyatt & Henter, 
1998). 
The course of schizophrenia is also influenced by 
personal orientation and motivation, and by supports in 
the form of skill-building assistance and rehabilitation 
(Lieberman et al., 1996; Awad et al., 1997; Hafner & 
an der Heiden, 1997). These, in turn, are heavily 
influenced by regional, cultural,~ and socioeconomic 
factors in addition to individual factors (Dassori et al., 
1995). 
Family factors also are related to the course of 
illness. Following hospitalization, patients who return 
home are more likely to relapse if their family is 
identified as critical, hostile, or emotionally 
overinvolved than if their family is not so identified 
(Jenkins & Kamo, 1992; Bebbington & Kuipers, 1994). 
This is a controversial finding because it appears to 
blame family members (Hatfield et al., 1987). 
However, recent studies suggest an interaction between 
families and the patient (Goldstein, 1995b), suggesting 
that the negative emotions of some family members 
may be a reaction to, more than a cause of relapse in, 
the family member. Blaming either the family or the 
patient overlooks important ways both parties interact 
and how such interactions are associated with the 
course of schizophrenia. In addition, there is a need to 
examine what part the role of families’ prosocial 
functioning (family warmth and family support) plays 
in the course of schizophrenia to identify how family 
factors can serve as protective factors (Lopez et al., in 
press). 
Despite the variability, some generalizations about 
the long-term course of schizophrenia are possible 
largely on the basis of longitudinal research. A small 
percentage (10 percent. or so) of patients seem to 
remain severely ill over long periods of time (Jablensky 
et al., 1992; Gerbaldo et al., 1995). Most do not return 
to their prior state of mental function. Yet several long- 
term studies reveal that about one-half to two-thirds of 
people with schizophrenia significantly improve or 
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recover, some completely (for a review see Harding et 
al., 1992). These studies were important because they 
began to dispel the traditional view, dating back to the 
19th century, that schizophrenia had a uniformly 
downhill course (Harding et al., 1992). Several other 
longitudinal studies, however, found less favorable 
patient outcomes with other cohorts of patients 
(Harrow et al., 1997). The differences in outcomes 
between the studies are thought to be explained on the 
basis of differences in patient age, length of followup, 
expectations about prognosis, and types of services 
received (Harrow et al., 1997). 
The importance of a rehabilitation focus in shaping 
patient outcome was supported by one of the only 
direct comparisons between patient cohorts. The 
Vermont cohort consisted of the most severely affected 
patients from the “back wards!’ of the state hospital 
(Harding et al., 1987). As part of a statewide program 
of deinstitutionalization, the cohort was released in the 
1950s to a hospital-based rehabilitation program and 
then to what was at the time an innovative, broad-based 
community rehabilitation program, which incorporated 
social, residential, and vocational components.‘3 
Patients’ degree of recovery at followup after three 
decades was measured by global * functional 
improvement and other functional measures..One-half 
to two-thirds of the Vermont cohort significantly 
improved or recovered (Harding et al., 1987). The 
receipt of community-based rehabilitation was 
considered key to their recovery on the basis of a study 
comparing their progress with that of a matched cohort 
of deinstitutionalized patients from Maine. The Maine 
cohort did not function as well after receiving more 
traditional aftercare services without a rehabilitation 
emphasis (Desist0 et al., 1995a, 1995b). Although the 
findings from the Vermont cohort, as well as those 
from a cohort in Switzerland (Ciompi, 1980), are 
widely cited by consumers as evidence of recovery 
from mental illness, a topic discussed in detail in 
Chapter 2, it bears noting that patients in the Vermont 
cohort represented a less rigorously defined 
I3 These are the vital components of most contemporary rehabil- 
itation programs (see section on szrvice delivery). 
In summary, schizophrenia does not follow a single 
pathway. Rather, like other mental and somatic 
disorders, course and recovery are determined by a 
constellation of biological, psychological, and 
sociocultural factors. That different degrees of recovery 
are attainable has offered hope to consumers and 
families. 
Gender and Age at Onset 
There appear to be gender differences in the course and 
prognosis of schizophrenia. Women are more likely 
than men to experience later onset, more pronounced 
mood symptoms, and better prognosis (DSM-IV), 
although the prognosis difference recently has come 
under question. 
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Current research (e.g., Hafner & an der Heiden, 
1997; Hafner et al., 1998) suggests that some of the 
apparent gender differences in course and outcome 
occur because for some women schizophrenia does not 
develop until after menopause. This delay is thought to 
be related to the protective effects of estrogen, the 
levels of which diminish at menopause. According to 
this line of reasoning, men have no such delay because 
they lack the protective estrogen levels. Therefore, a 
higher proportion of men develop schizophrenia earlier. 
Generally, early onset (younger than age 25 in most 
studies) is associated with more gradual development 
of symptoms, more prominent negative symptoms 
across the course (DSM-IV), and more neuro- 
psychological problems (Basso et al., 1997; Symonds 
et al., 1997), regardless of gender. Early onset also 
usually involves more disruption of adult milestones, 
such as education, employment achievements, and 
long-term social relationships (Nowotny et al., 1996). 
People with later onset often have reached these 
milestones, cushioning them from disruptive sequelae 
and enabling better coping with symptoms (Hafner et 
al., 1998). Therefore, early onset (more men than 
women) often yields a more difficult first several years, 
although not necessarily a worse long-term outcome. 
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conceptualization of schizophrenia than is common 
today, which may account, in part, for the more 
favorable outcomes. 
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However, it must be emphasized that group 
probabilities do not necessarily speak to individual 
cases. 
Etiology of Schizophrenia 
The cause of schizophrenia has not yet been 
determined, although research points to the interaction 
of genetic endowment and major environmental 
upheaval during development of the brain. This section 
first discusses genetic studies and then turns to the 
evidence for neurodevelopmental disruption. These 
lines of research are beginning to converge: 
neurodevelopmental disruption may be the result of 
genetic and/or environmental stressors early in 
development, leading to subtle alterations in the brain. 
Furthermore, environmental factors later in 
development can either exacerbate or ameliorate 
expression of genetic or neurodevelopmental defects. 
The overarching message is that the onset and course of 
schizophrenia are most likely the result of an 
interaction between genetic and environmental 
influences. 
Current research proposes that schizophrenia is 
caused by a genetic vulnerability coupled with 
environmental and psychosocial stressors, the so-called 
diathesis-stress model (Zubin & Spring, 1977; Russo et 
al., 1995; Portin & Alanen, 1997). Family studies 
suggest that people have varying levels of inherited 
genetic vulnerability, from very low to very high, to 
schizophrenia. Whether or not the person develops 
schizophrenia is partly determined by this vulnerability. 
At the same time, the development of schizophrenia 
also depends on the amount and types of stresses the 
person experiences over time. An a@ogy can be drawn 
to diabetes by virtue of both genetic factors (e.g., 
family history) and behavioral factors (e.g., diet, 
exercise, stress) that interact to determine whether or 
not a given person develops diabetes. How the 
interaction works in schizophrenia is unknown, yet the 
subject of ongoing research (Murray et al., 1992; 
Spaulding, 1997; Jones & Cannon, 1998; van OS & 
Marcelis, 1998). 
Family, twin, and adoption studies support the role 
of genetic influences in schizophrenia (Kendler & 
Diehl, 1993; McGuffin et al., 1995; Portin & Alanen, 
1997). Immediate biological relatives of people with 
schizophrenia have about 10 times greater risk than that 
of the general population. Given prevalence estimates, 
this translates into a 5 to 10 percent lifetime risk for 
first-degree relatives (including children and siblings) 
and suggests a substantial genetic component to 
schizophrenia (e.g., Kety, 1987; Tsuang et al., 1991; 
Cannon et al., 1998). What also bolsters a genetic role 
are findings that the identical twin of a person with 
schizophrenia is at greater risk than a sibling or 
fraternal twin, and that adoptive relatives do not share 
the increased risk of biological relatives (see Figure 
4-3). However, in about 40 percent of identical twins 
in which one is diagnosed with schizophrenia, the other 
never meets the diagnostic criteria. The discordance 
among identical twins clearly indicates that environ- 
mental factors likely also play a role (DSM-IV). 
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Despite the evidence for genetic vulnerability to 
schizophrenia, scientists have not yet identified the 
genes responsible (Kendler & Diehl, 1993; Levinson et 
al., 1998). The current consensus is that multiple genes 
are responsible (Kendler et al., 1996; Kunugi et al., 
1996, 1997; Portin & Alanen, 1997; Straub et al., 
1998). 
Numerous brain abnormalities have been found in 
schizophrenia. For example, patients often have 
enlarged cranial ventricles (cavities in the brain that 
transport cerebrospinal fluid), especially the third 
ventricle (Weinberger, 1987; Schwarzkopf et al., 199 1; 
Woods & Yurgelun-Todd, 1991; Dykes et al., 1992; 
Lieberman et al., 1993; DeQuardo et al., 1996), and 
decreased cerebral size (Schwarzkopf et al., 1991; 
Ward et al., 1996) compared with control groups. 
Several studies suggest this may be more common 
among men (Nopoulos et al., 1997) whose families do 
not have a history of schizophrenia (Schwarzkopf et al., 
1991; Vita et al., 1994). There is also some evidence 
that at least some people with schizophrenia have 
unusual cortical laterality, with dysfunction localizing 
: 
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to the left hemisphere (Braun et al., 1995). To explain This is perhaps related to unusual neuronal density 
laterality, some have proposed a prenatal injury or (Selemon et al., 1998) and may be more prevalent 
insult at the time of left hemisphere development, among patients whose families have a history of 
which normally lags behind that of the right schizophrenia than those whose do not (Sautter et al., 
hemisphere (Bracha, 1991). 1995). However, mapping patients’ symptoms with 
The anatomical abnormalities found in different brain regions is complex and variable. Researchers 
parts of the brain tend to correlate with schizophrenia’s believe that the dysfunctions are present in brain 
positive symptoms (Barta et al., 1990; Shenton et al., circuitry rather than in one or two localized areas of the 
1992, Bogerts et al., 1993; Wible et al., 1995) and brain (Andreasenet al., 1997,1998; Wiser et al., 1998). 
negative symptoms (Buchanan et al., 1993). Positive Excessive levels of the neurotransmitter dopamine 
symptoms are often linked to temporal lobe have long been implicated in schizophrenia, although 
dysfunction, as shown by imaging studies that utilize it is unclear whether the excess is a primary cause of 
blood flow and glucose metabolism. Such dysfunction schizophrenia or a result of a more fundamental 
possibly is related to abnormal phospholipid dysfunction. More recent evidence implicates much 
metabolism (Fukuzako et al., 1996). Disorganized greater complexity in the dysregulation of dopamine 
speech (taken to reflect disorganized thinking) has been and other neurotransmitter systems (Grace, 1991,1992; 
associated with abnormalities in brain regions Olie & Bayle, 1997). Some of this research ties 
associated with speech regulation (McGuire et al., schizophrenia to certain variations in dopafine 
1998). Negative and cognitive symptoms, especially receptors (Nakamura et al., 1995; Serretti et al., 1998), 
those related to volition and planning, are commonly while other research focuses on the serotonin system 
associated with prefrontal lobe dysfunction (Capleton, (Inayama et al., 1996). However, it must be emphasized 
1996; Abbruzzese et al., 1997; Mattson et al., 1997). that in many cases it is possible that perturbations in 
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neurotransmitter systems may result from 
complications of schizophrenia, or its treatment, rather 
than from its causes (Csemansky & Grace, 1998). 
The “stressors” investigated in schizophrenia 
research include a wide range of biological, 
environmental, psychological, and social factors. There 
is consistent evidence that prenatal stressors are 
associated with increased risk of the child developing 
schizophrenia in adulthood, although the mechanisms 
for these associations are unexplained. Some 
interesting preliminary research suggests risk factors 
include maternal prenatal poverty (Cohen, 1993), poor 
nutrition (Susser & Lin, 1992; Susser et al., 1996, 
1998), and depression (Jones et al., 1998). Other 
stressors are exposure to influenza outbreaks (Mednick 
et al., 1988; Adams et al., 1993; Rantakallio et al., 
1997), war zone exposure (van OS &Selten, 1998), and 
Rh-factor incompatibility (Hollister, 1996). Their 
variety suggests other stressors might also be risk 
factors, under the general rubric of “maternal stress.” 
As a result of such stresses, newborns of low birth 
weight and short gestation have been linked to 
increased risk of later developing schizophrenia (Jones 
et al., 1998), as have delivery complications (Hultrnan 
et al., 1997; Jones & Cannon, 1998) and other early 
developmental problems (Brixey et al., 1993; 
Ellenbroek & Cools, 1998; Portin & Alanen, 1998; 
Preti et al., 1998). Among children, especially infants, 
viral central nervous system infections may be 
associated with greater risk (Rantakallio et al., 1997; 
Iwahashi et al., 1998), thereby explaining links between 
schizophrenia and being born or raised in crowded 
conditions (Torrey & Yolken, 1998) or during the flu- 
prone winter and spring months (Castrogiovanni et al., 
1998). However, support for these hypotheses is 
inconsistent and incomplete (Yolken & Torrey, 1995). 
In fact, it is possible that prenatal and obstetric 
complications associated with schizophrenia could 
reflect already disrupted fetal development, rather than 
being causal themselves (Lipska& Weinberger, 1997). 
More generally, across the life span, the chronic 
stresses of poverty (Cohen, 1993; Saraceno & Barbui, 
,1997) and some facets of minority social status appear 
to alter the course of schizophrenia. 
Presently, it is unclear whether and how these risks 
contribute to the diathesis-stress interaction for any one 
person because specific causes may differ (Onstad et 
al., 1991; Cardno & Farmer, 1995; Tsuang & Faraone, 
1995; Miller, 1996). Although genetic vulnerability is 
difficult to control, certain other important factors can 
be addressed with current knowledge. An awareness of 
stressors that increase the likelihood of genetic 
vulnerability being actualized supports preventive 
strategies, such as good prenatal health care and 
nutrition. Furthermore, since life stresses can 
exacerbate the course of the ill&s, access to good 
quality services and social supports, as well as attention 
to relapse prevention interventions, can have beneficial 
effects on longer term outcome (Wiersma et al., 1998). 
At the same time, researchers and clinicians are 
striving to integrate findings concerning both diathesis 
and stress into models of how schizophrenia develops 
(Andreasen, 1997b). Not only does brain biology 
influence behavior and experience, but behavior and 
experience mold brain biology as well. One promising 
integrative model is the neurodevelopmental theory of 
schizophrenia developed by Weinberger and others 
(Murray & Lewis, 1987; Weinberger, 1987, 1995; 
Bloom, 1993; Weinberger & Lipska, 1995; Lipska & 
Weinberger, 1997). It posits that schizophrenia 
develops from “a subtle defect in cerebral development 
that disrupts late-maturing, highly evolved neocortical 
functions, and fully manifests itself years later in adult 
life” (Lip&a & Weinberger, 1997; see also Susser et 
al., 1998). 
The nature of the defect, which has not been 
identified, may be a product of a pre- or neonatal insult 
to the brain. Further support for the neuro- 
developmental theory comes from abnormalities in 
brain structure that have long been found in people 
with schizophrenia. Such findings have been 
interpreted to reflect abnormal neuronal migration in 
early development (Jakob & Beckmann, 1986; Arnold 
et al., 1991; Akbarian et al., 1993; Falkai et al., 1995). 
Researchers have developed animal models of early 
neurodevelopmental dysfunctions that manifest in later 
behavioral and functional deficits (Geyer et al., 1993; 
Lipska & Weinberger, 1993; Wilkinson et al., 1994; 
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Table 4-8. Selected treatment recommendations, Schizophrenia Patient Outcomes Research Team 
t 
bcommendation 1. Antipsychotic medications, other than clozapine, should be used as the first-line treatment to reduce 
)sychotic symptoms for persons experiencing an acute symptom episode of schizophrenia. 
3ecommendation 2. The dosage of antipsychotic medication for an acute symptom episode should be in the range of 
300-l ,000 chlorpromazine (CPZ) equivalents per day for a minimum of 6 weeks. Reasons for dosages outside this range 
should be justified. The minimum effective dose should be used. 
?ecommendation 8.‘ Persons who experience acute symptom relief with an antipsychotic medication should continue to 
,eceive this medication for at least 1 year subsequent to symptom stabilization to reduce the risk of relapse or worsening 
)f positive symptoms. 
3ecommendation 9. The maintenance dosage of antipsychotic medication should be in the range of 300-600 CPZ 
equivalents (oral or depot) per day. 
Recommendation 12. Depot antipsychotic maintenance therapy should be strongly considered for persons who have 
difficulty complying with oral medication or who prefer the depot regimen. 
Recommendation 23. Individual and group therapies employing well-specified combinations of support, education, and 
Dehavioral and cognitive skills training approaches designed to address the specific deficits of persons with schizophrenia 
should be offered over time to improve functioning and enhance other target problems, such as medication 
noncompliance. 
Recommendation 24. Patients who have ongoing contact with their families should be offered a family psychosocial 
intervention that spans at least 9 months and that provides a combination of education about the illness, family support, 
crisis intervention, and problem-solving skills training. Such interventions should also be offered to nonfamily members. 
Recommendation 27. Selected persons with schizophrenia should be offered vocational services.* 
Recommendation 29. Systems of care serving persons with schizophrenia who are high users should include ACT and 
ACM programs. 
l Edited 
Source: Lehman & Steinwachs, 1998a, 1998b. 
Lipskaet al., 1995) and are influenced by genetics (de 
Kloet et al., 1996; Zaharia et al., 1996). As promising 
as these theories are, the causes and mechanisms of 
schizophrenia remain unknown. Nonetheless, research 
has uncovered several types of treatment for 
schizophrenia that are effective in reducing symptoms 
and functional impairments. 
Interventions 
The treatment of schizophrenia has advanced 
considerably in recent years. A battery of treatments 
has become available to ameliorate symptoms, to 
improve quality of life, and to restore productive lives. 
Treatment and other service interventions often are 
linked to the clinical phases of schizophrenia: acute 
phase, stabilizing phase, stable (or maintenance) phase, 
and recovery phase. Where possible, this report ties 
available data to these treatment phases. 
Optimal treatment across all phases of treatment 
includes some form of pharmacotherapy with 
antipsychotic medication, usually combined with a 
variety of psychosocial interventions. Psychosocial 
interventions include supportive psychotherapy, and 
family psychoeducational interventions, as well as 
psychosocial and vocational rehabilitation. The 
treatment of individuals with schizophrenia who are 
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high service users should be orchestrated by an 
interdisciplinary treatment team to ensure continuity of 
services (i.e., assertive community treatment, which is 
discussed below). Others may benefit from less 
intensive forms of case management and various self- 
help and consumer-operated services, described later. 
It is also important to assist individuals with schizo- 
phrenia in meeting their many related needs, such as for 
supported housing, transportation, and general medical 
care. These are among the 30 pivotal treatment 
recommendations of the Agency for Health Care Policy 
and Research- and NIMH-sponsored Schizophrenia 
Patient Outcomes Research Team (PORT), which 
developed its recommendations on the basis of a 
comprehensive review of the treatment outcomes 
literature (Lehman & Steinwachs, 1998a). Table 4-8 
contains a distillation of key recommendations. 
Although the Schizophrenia PORT study 
recommendations are grounded in research such as that 
reviewed in the following paragraphs, it is noteworthy 
that treatment practices fail to adhere to these 
recommendations, with conformance generally falling 
below 50 percent (Lehman & Steinwachs, 1998b). The 
disturbing gap between knowledge and practice is 
discussed later in this chapter. Many barriers. exist in 
the transfer of information about treatment. and 
evidence-based practice to clinicians, family members, 
and service users. 
fbarmacotherapy 
Pharmacotherapies are the most extensively evaluated 
intervention for schizophrenia. The conventional or 
older antipsychotic medications (e.g., chlorpromazine, 
haloperidol, fluphenazine, molindone) and the more 
recently developed medications (e.g., clozapine, 
risperidone, olanzapine, quetiapine, sertindole) are used 
to reduce the positive symptoms of schizophrenia. The 
newer medications, often called atypical because they 
have a different mechanism action than their 
predecessors, also appear in preliminary studies to be 
more effective against negative symptoms, display 
fewer side effects, and show promise for treating 
people for whom older medications are ineffective 
(Ballus, 1997). Their introduction has created more 
treatment options for people with schizophrenia and 
other serious mental illnesses. Although the newer, 
more broadly effective medications have increased 
hopes for recovery, they also have resulted in greater 
treatment complexity for patients and providers alike 
(Fenton & Kane, 1997). 
Conventional antipsychotics have been shown to be 
highly effective both in treating acute symptom 
episodes and in long-term maintenance and prevention 
of relapse (Cole & Davis, 1969; Davis et al., 1989; 
Kane, 1992). Across many studies, positive symptoms 
improved in about 70 percent of patients, compared 
with only 25 percent improvement in placebo groups 
(Kane, 1989; Kane & Marder, 1993). Their common 
mechanism of action is by blocking dopamine D, 
receptors, and their therapeutic effects are presumably 
due to D, blockade in the mesolimbic system (Dixon et 
al., 1995). 
For acute symptom episodes, treatment recom- 
mendations call for dosages of antipsychotic 
medication in the range of 300 to 1,000 
“chlor@omazine equivalents”14 per day (Lehman & 
Steinwachs, 1998b). Among patients discharged from 
inpatient units whose dosage fell outside of this range, 
minority patients often are much more likely than 
Caucasian patients to be on a higher dose (> 1,000 
chlorpromazine equivalents) (Lehman & Steinwachs, 
1998b). Such dosing patterns run counter to evidence 
that a higher proportion of minority patients, because of 
lower rates of drug metabolism, may require lower 
doses of antipsychotics. 
Dosage studies have found that moderate levels 
(300 to 750 chlorpromazine equivalents daily for acute 
episodes, 300 to 600 for maintenance, although many 
people require less than 300) are more effective for 
positive symptom reduction over the long run than very 
high (“loading”), intermittent, or very low doses 
(Donlon et al., 1978, 1980; Neborsky et al., 1981; 
Baldessarini et al., 1990; Levinson et al., 1990; Van 
Putten et al., 1990,1992; Rifkin et al., 1991). Very low 
I4 A chlorpromazine equivalent is a measure in milligrams 
of antipsychotic medication doses indexed to the potency of 
a standard dosage of chlorpromazine, one of the earliest, most 
widely used antipsychotic medications. 
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and intermittent dosing substantially increases the risk 
of relapse, while rapid loading and very high doses 
greatly increase adverse effects (Davis et al., 1989), 
although medication programs must be tailored to 
individual needs. On conventional neuroleptics, 
patients experience symptom reduction over the first 5 
to 10 weeks of treatment, with more gradual 
improvement sometimes continuing for more than 
double that time (Baldessarini et al., 1990). The older 
medications are occasionally found to reduce some 
negative symptoms as well, although it is impossible to 
tell from existing research if this is a primary or 
secondary effect of reduced positive symptoms (Davis 
et al., 1989; Cassens et al., 1990). 
Apart from their minimal effects on negative 
symptoms, the greatest problem with conventional 
neuroleptic medications is their pervasive, 
uncomfortable, and sometimes disabling and dangerous 
side effects. The spectrum of side effects is broad 
(Davis et al., 1989; Casey, 1997), yet the most common 
and troubling are extrapyramidal effects such as acute 
dystonia, parkinsonism, and tardive dyskinesia (Chakos 
et al., 1996; Yuen et al., 1996; Trugman, 1998) 
andakathisia (Kane, 1985).15 Side effects are evident in 
an estimated 40 percent of patients, but .pinpointing 
their prevalence is complicated by the vagaries of 
diagnosis, length of prescription and observation, and 
variability across individuals and medications. Rare 
side effects (seizures, paradoxical exacerbation of 
psychotic symptoms, neuroleptic malignant syndrome) 
also can be devastating. 
Acute dystonia, parkinsonism, dyskinesias, and 
akathisia are usually treated by lowering the doses of 
neuroleptics and/or using adjunctive anticholinergic, 
antiparkinsonian medications (e.g., benztropine). 
Because these side effects can be mistaken for core 
psychotic symptoms, the neuroleptic dose is often 
increased, rather than decreased, exacerbating the side 
I5 Acute dystonia is involuntary muscle spasms resulting in 
abnormal and usually painful body positions. Parkinsonism 
is defined by tremors, muscle rigidity, and stuporous appearance. 
Dyskinesias are involuntary repetitive movements, often of the 
mouth, face, or hands, and akathisia is painful muscular restless- 
ness requiring the person to move constantly. 
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effects. Many other side effects such as attention and 
vigilance problems, sleepiness, blurry vision, dry 
mouth, and constipation are worse in the initial weeks 
of treatment and usually taper off as a person adjusts to 
the medication. However, the discomfort and disability 
of the initial weeks are intolerably disruptive to some 
individuals. Dosages can be individualized to minimize 
side effects while maximizing benefit. 
Efficacy data on the newer antipsychotics indicate 
that they are as efficacious as the older agents at 
reducing positive symptoms and carry fewer side 
effects. They also offer important additional advantages 
for some who have had treatment-resistant 
schizophrenia (Kane, 1996, 1997; Vanelle, 1997; van 
OS et al., 1997; Andersson et al., 1998). 
The prototype of the newer medications, 
clozapine, has been found effective for about 30 to 50 
percent of treatment-resistant patients (Kane & Marder, 
1993; Lieberman et al., 1994; Buchanan, 1995; Kane & 
McGlashan, 1995; Kane, 1996), as well as for patients 
who have responded to previous medications. 
Clozapine also seems to help secondary depression and 
anxiety, and perhaps the negative symptoms of 
schizophrenia (Buchanan, 1995). Clozapine not only 
has a very low incidence of tardive dyskinesia (Barnes 
& McPhillips, 1998) but may also show some promise 
as its treatment (Walters et al., 1997). However, the use 
of clozapine was constrained for many years in the 
United States because of findings that in about 1 
percent of patients it causes a potentially fatal blood 
condition: agranulocytosis, a loss of white blood cells 
that fight infection. Because agranulocytosis is 
reversible if detected early, frequent (weekly) blood 
monitoring is critical (Lamarque, 1996; Meltzer, 1997). 
Although effective safeguards exist, use of clozapine 
tends to be limited to those who are unresponsive to, or 
cannot tolerate, other antipsychotics. The Veterans’ 
Administration sponsored the largest cost-effectiveness 
study to date of clozapine, comparing it to haloperidol. 
Studies by Rosenheck and his collaborators (1997, 
1998b, 1999) replicated previous findings that 
clozapine was more effective than haloperidol in 
treating positive and negative symptoms and had fewer 
extrapyramidal side effects. In addition to its direct 
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pharmacologic effect, the investigators found that 
clozapine enhances participation in psychosocial 
treatments, which augments its overall clinical 
effectiveness (Rosenheck et al., 1998b). Savings 
associated with use of clozapine were particularly 
significant among study participants who had averaged 
2 15 inpatient hospital days in the year prior to the study 
(Rosenheck et al., 19981;). 
Increasing numbers of patients with schizophrenia 
receive newer agents like risperidone (Smith et al., 
1996a; Foster & Goa, 1998), olanzapine (Bymaster et 
al., 1997), and quetiapine (Wetzel et al., 1995; 
Gunasekara & Spencer, 1998). They have replaced the 
older antipsychotics in many cases because they cause 
fewer side effects at therapeutic levels (Umbricht & 
Kane, 1995) and do not require clozapine’s close 
monitoring. Their effects on negative schizophrenia 
symptoms are currently being evahtated and hold some 
promise, as do their effects on some cognitive 
dysfunctions (Gallhofer et al., 1996; Green et al., 1997; 
Kern et al., 1998). Furthermore, current cost analyses 
find these newer medications at least cost-neutral and 
sometimes more cost-effective in the long run than 
older agents, despite being more expensive per pill 
(Loebel et al., 1998). 
Thus, as a whole, there is evidence that the newer 
antipsychotics are more clinically advantageous than 
the older ones due to the combination of their effective 
treatment of positive (and perhaps negative) symptoms, 
their treatment of ancillary symptoms such as anxiety 
and depression, and their more favorable side effect 
profile (Liebetman, 1993, 1996; Fleischhacker & 
Hummer, 1997; Shore, 1998). Having fewer side 
effects generally results in better compliance with the 
medication, although atypical side effects can include 
sedation, weight gain, sexual dysfunction, and other 
dose-related discomforts (Casey, 1997; Hasan & 
Buckley, 1998). Although the newer agents have less 
adverse impact on fecundity, so that more women with 
schizophrenia can conceive, there are very little data to 
address the impact of treatment on pregnancy and 
lactation. While it is not clear whether the newer 
medications directly lessen the functional disabilities 
that usually accompany schizophrenia, they may 
Growing awareness that ethnicity and culture influence 
patients’ response to medications has catapulted to 
prominence the field of ethnopharmacology. In the past 
decade, studies have demonstrated that psychiatric 
medications interact with patient ethnicity in multiple 
ways, with response to the same medication and dose 
varying by patient ethnicity (Frackiewicz et al., 1997). 
For example, due to racial and ethnic variation in 
pharmacokinetics, Asians and Hispanics with 
schizophrenia may require lower doses of 
antipsychotics than Caucasians to achieve the same 
blood levels (Collazo et al., 1996; Ramirez, 1996; Ruiz 
et al., 1996). Pharmacokinetics and pharrnacodynamics 
also vary across other ethnic group~.‘~ Racial and 
ethnic variation likely stem from a combination of 
genetic and psychosocial factors, such as diet and 
health behaviors (Lin et al., 1995). 
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At the same time, it is possible that the documented 
medication differences are the result of underlying 
biological mechanisms of mental illness related to 
ethnicity, culture, and gender variations. Additionally, 
the effects of psychotropic medications may be 
interpreted differently by culture (Lewis et al., 1980). 
Although knowledge in these areas is incomplete, it is 
important to consider cultural patterns in dosing 
decisions and medication management, as well as risks 
of side effects and tardive dyskinesia. Furthermore, 
studies suggest that medication differences among 
African American people diagnosed with schizophrenia 
may reflect clinician biases in diagnosis and 
prescription practices more than differences in 
I6 For Caucasian, Hispanic, Asian, Africian-Americans varia- 
tions, see Frackiewicz et al., 1997; Chinese-Jam et al., 1992; 
black, white, Chinese, Mexican American-Lam et al., 1995; 
Lin et al., 1995). 
improve a person’s quality of life (Lehman, 1996) and 
responsiveness to psychosocial, rehabilitation, and 
therapeutic interventions (Buckley, 1997). 
Effectiveness in real-world settings may be 
substantially lower than efficacy in clinical trials, 
possibly due to patient heterogeneity, prescribing 
practices, and noncompliance (Dixon et al., 1995). 
f ttmopsychopharmaco/ogy 
medication metabolism or health behaviors alone 
(Frackiewicz et al., 1997). 
psychosocial Treatments 
Psychosocial treatments are vital complements to 
medication for individuals with schizophrenia. They 
help patients maximize functioning and recovery. The 
PORT treatment recommendations, as noted earlier, 
stipulate that patients should receive pharmacotherapy 
in conjunction with supportive psychotherapy, family 
treatment, psychosocial rehabilitation and skill 
development, and vocational rehabilitation (Lehman & 
Steinwachs, 1998a). In the active phase of illness, 
medication enables patients to be more receptive to 
psychosocial treatments. During periods of remission, 
when maintenance medication is still recommended, 
psychosocial treatments continue to help patients to 
improve quality of life. Psychosocial treatments assume 
even greater importance for patients who do not 
respond to, cannot tolerate, or refuse to take 
medications. Several decades ago, psychosocial 
programs were developed that used little or no 
medication (Mosher, 1999). For a highly selected group 
of patients at the beginning of their first acute episode 
of schizophrenia, these programs were reported 
effective (Mosher & Menn, 1978). Most patients, 
however, do not meet the selection criteria employed in 
this study. Few such programs are currently operating 
(Mosher, 1999), and treatment with antipsychotic 
medication is recommended in conjunction with 
psychosocial treatments (Lehman & Steinwachs, 
1998a). 
Psychotherapy 
Outcomes of individual and group therapies have been 
studied for people with schizophrenia, although not 
extensively and not in relation to current managed care 
practices. Overall, it is clear that individual and group 
therapies that focus on practical life problems 
associated with schizophrenia (e.g., life skills training) 
are superior to psychodynamically oriented therapies 
(Scott & Dixon, 1995a). Psychodynamically oriented 
therapies are considered to be potentially harmful; 
therefore, their use is not recommended (Lehman, 
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1997). Individual, group, or famiiy therapies that 
combine support, education, and behavioral and 
cognitive skills, and that address specific challenges, 
can help clients cope with their illness and improve 
their functioning, quality of life, and degree of social 
integration. However, the optimum length of therapy 
seems to be longer than that afforded by “brief therapy” 
(Gunderson et al., 1984; Stanton et al., 1984; Hogarty 
et al., 1997). Additionally, certain targeted therapeutic 
interventions may be useful in addressing specific 
symptoms (Drury et al., 1996; Jensen & Kane, 1996). 
Certain subgroups of clients- appear to find different 
types of therapy more or less useful than others (Scott 
& Dixon, 1995a). 
Family Interventions 
Several professionally operated family intervention 
programs have been developed to help the family 
member with severe mental illness (e.g., Hogarty et al., 
1987; Cazzullo et al., 1989; Mari & Streiner, 1994; 
McFarlane, 1997). Randomized trials have been 
conducted for interventions that educate families about 
schizophrenia, provide support and crisis intervention, 
and offer training in effective problem solving and 
communication. These interventions have strongly and 
consistently demonstrated their value in preventing or 
delaying symptom relapse and appear to improve the 
patient’s overall functioning and family well-being 
(Goldstein et al., 1978; Falloon et al., 1985; Strachan, 
1986; Lam, 1991; Tarrier et al., 1994; Goldstein 1995a; 
Penn & Mueser, 1996). Research has suggested that 
groups of multiple families are more effective and less 
expensive than individual family interventions 
(McFarlane et al., 1995). Incorporating family religious 
and ethnic background may prove useful in family 
interventions (Guamaccia et al., 1992). Family self- 
help groups are discussed subsequently in this chapter. 
Psychosocial Rehabilitation and Skills Development 
Psychosocial skills training strives to teach clients 
verbal and nonverbal interpersonal skills and 
competencies to live successfully in community 
settings. Skills or tasks are divided into small, simple 
behavioral elements that the client then learns, 
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practices, and puts together. Currently, there is a 
growing addition of cognitive skill remediation to 
rehabilitation programs that have focused on social 
skills training (Bellack et al., 1989; Bellack & Mueser, 
1993; Scott & Dixon, 1995a). As one example of the 
scope of such programs, the program examined by 
Liberman and co-workers (1998) focused on four skill 
areas: medication management, symptommanagement, 
recreation for leisure, and basic conversation skills. 
Each area was addressed through concrete topics, with 
the basic conversation skills module, for example, 
consisting of active listening skills, initiating 
conversations, maintaining conversations, terminating 
conversations, and putting it all together. 
The evolution of psychosocial skills training is 
important yet incomplete. A review in the mid-1990s 
concluded that its overall impact on social, cognitive, 
or vocational functioning is modest, and it remains 
unclear whether these gains are maintained after the 
training is over and can be used in real-life situations 
(Scott & Dixon, 1995a). However, a more recent study 
found greater independent living skills among clients 
who had received skills training during a 2-year 
followup of everyday community functioning 
(Liberman et al., 1998). Several others agree that skills 
training is effective for specific behavioral outcomes 
(Marder et al., 1996; Penn & Mueser, 1996). Specific 
symptom profiles may also influence how effective 
skills training is for a given person (Kopelowicz et al., 
1997). Furthermore, Medalia and coworkers (1998) 
report recent success adapting cognitive rehabilitation 
techniques, originally developed for survivors of 
serious head injuries, for people with schizophrenia, 
but long-term effects and generalizability have not been 
determined. This exemplifies both the progress and the 
need for further refinement of this intervention (Smith 
et al., 1996b). 
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In a recent review article, a team of researchers 
concluded that the most potent rehabilitation programs 
(1) establish direct, behavioral goals; (2) are oriented to 
specific effects on related outcomes; (3) focus on long- 
term interventions; (4) occur within or close to clients’ 
naturally preferred settings; and (5) combine skills 
training with an array of social and environmental 
supports. They also note that most programs do not 
contain all of these elements, but most are much 
improved over previous eras (Mueser et al., 1997b). 
There are a host of multi-component psychosocial 
rehabilitation services that combine pharmacologic 
treatment, independent living and social skills training, 
psychological support to clients and their families, 
housing, vocational rehabilitation, social support and 
network enhancement, and access to leisure activities 
(World Health Organization [WHO], 1997). These are 
discussed in the later section on service delivery. 
Coping and Self-Monitoring 
An important goal of recovery and the consumer 
movement is to enable patients themselves to 
participate more actively in their own treatment. While 
complete remission of all symptoms is unlikely for the 
majority, most can and do learn skills and techniques 
over time that they can use to manage distressing 
symptoms and the effects of the illness. Often, better 
skills in coping and monitoring one’s own health status 
occurs simply through experience. However, the 
growth of self-help and the development of recovery 
models for serious mental illnesses has spawned 
interventions that purposefully teach and encourage 
active coping on the part of clients and their families. 
Controlled research is sparse (Penn & Mueser, 1996), 
except in the area of relapse prevention. 
For example, some people find it very useful to pay 
attention to their own warning signs of relapse or 
symptom exacerbation, so that additional coping 
practices, supports, or interventions can be put into 
place. Norman and Malla (1995) conclude that there is 
not a standardized set of signs that predict relapse, but 
that some individuals have and get to know their own 
reasonably consistent patterns. Herz and Lamberti 
(1995) agree that many people experience predictable 
signs, although whether a relapse occnrs depends on 
many factors besides the signs themselves. Therefore, 
the risk and magnitude of relapse can be reduced by 
monitoring early symptoms and intervening when they 
emerge (Herz & Larnberti, 1995). Watching for such 
signs is recommended for consumers, family members, 
and clinicians (Jorgensen, 1998). Specific training 
programs for teaching individuals with schizophrenia 
to identify the warning signs of relapse and to develop 
relapse prevention plans have been shown to be 
effective (Liberman et al., 1998). 
Vocational Rehabilitation 
Unemployment is pervasive among people with serious 
and persistent mental illness. Employment is valued 
highly by the general public and by people with 
schizophrenia alike because it generates financial 
independence, social status, contact with other people, 
structured time and goals, and opportunities for 
personal achievement and community contribution 
(Mowbray et al., 1997). These attributes of 
employment, combined with the self-esteem and 
personal purpose that it engenders, make vocational 
rehabilitation a prominent facet of treatment for serious 
mental illnesses. Vocational rehabilitation is especially 
important because early adult onset often disrupts 
education and employment history. 
Controlled studies of vocational rehabilitation 
interventions have shown mixed results (Lehman, 1995, 
1998; Cook & Jonikas, 1996). Although such programs 
do seem to increase work-related activities while 
people are engaged in them, the gains do not seem to be 
translated into more independent employment once 
services cease. This has led to the conclusion that 
ongoing support is needed for many individuals with 
schizophrenia who wish to work in competitive 
employment (Wehman, 1988). Recent controlled 
studies have shown the effectiveness of this newer type 
of so-called supported employment models, which 
emphasize rapid placement in a real job setting and 
strong support from a job coach to learn, adapt, and 
maintain the position (Drake et al., 1994, 1996; Bond 
et al., 1997). These models, which are growing in use, 
strike a dynamic balance between being supportive yet 
challenging in order to avoid clients’ dependency and 
maximize their growth (Mowbray et al., 1997). 
As vocational rehabilitation has moved away from 
sheltered workshops and toward supported employment 
models, the Americans With Disabilities Act of 1990 
has helped to open jobs and educate employers about 
reasonable accommodations for people with psychiatric 
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disabilities (Mechanic, 1998; Scheid, 1998). 
Additionally, innovations like client-run and client- 
owned vocational programs and independent businesses 
have begun to be developed on a larger scale (Rowland 
et al., 1993; Miller & Miller, 1997). These innovations 
are part of a larger movement of consumer involvement 
in the provision of services for people with mental 
illness (see Chapter 2). 
Service Delivery 
The organization of services for adults with severe 
mental disorders is the linchpi#n of effective treatment. 
Since many mental disorders are best treated by a 
constellation of medical and psychosocial services, it is 
not just the services in isolation, but the delivery 
system as a whole, that dictates the outcome of 
treatment (Goldman, 1998b). Access to a delivery 
system is critical for individuals with severe mental 
illness not only for treatment of symptoms but also to 
achieve a measure of community participation. 
Among the fundamental elements of effective 
service delivery are integrated community-based 
services, continuity of providers and treatments, and 
culturally sensitive and high-quality, empowering 
services (Mowbray et al., 1997; Lehman & Steinwachs, 
1998a). Effective service delivery also requires support 
from the social welfare system in the form of housing, 
job opportunities, welfare, and transportation 
(Goldman, 1998a), issues that are discussed in the final 
section of this chapter. 
What models of service delivery are most 
effective? This section strives to answer this question 
by focusing on models of service delivery for 
individuals with severe and persistent mental disorders, 
including severe depression and bipolar disorder, as 
well as schizophrenia. Although adults with mental 
illness in midlife confront many service delivery 
issues-for example, the problem of proper 
identification and treatment of depression in primary 
care settings-those who are most disabled by mental 
disorders encounter special service delivery problems. 
The focus on the most disabled is warranted for three 
reasons: (1) Society has a special obligation to those 
who are most impaired and consequently are the “least 
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well off’ (Callahan, 1999; Goldman, 1999; Rosenheck, 
1999); (2) the body of research on mental health 
services delivery for this population is extensive; and 
(3) existing service systems are seriously deficient. 
The deficiency of existing service systems is best 
documented for individuals with schizophrenia. The 
majority of people with schizophrenia do not receive 
the treatment and support they need, according to a 
groundbreaking finding of PORT (Lehman & 
Steinwachs, 1998a). PORT, as noted earlier, developed 
a series of basic treatment recommendations after 
reviewing hundreds of outcome studies. It proceeded to 
determine whether these recommendations were being 
met by examining current patterns of care in two states 
in the United States. 
Among those with severe mental disorders, any 
number of special populations might have been the 
focus for this section. These special populations have 
severe mental disorders and HIV/AIDS (Coumos & 
McKinnon, 1997); are involved in the criminal justice 
system(Abram& Teplin, 1991; CMHS, 1995;Lamb & 
Weinberger, 1998); or have somatic health problems 
(Berren et al., 1994; Felker et al., 1996; Brown, 1997). 
Although some of what follows may be relevant to the 
unique needs of each of these groups, the evidence base 
is less well developed. 
The remainder of this section focuses on case 
management, assertive community treatment, 
psychosocial rehabilitation services, inpatient 
hospitalization and community alternatives for crisis 
care, and combined treatment for people with the dual 
diagnosis of substance abuse and severe mental illness. 
Case Management 
The purpose of case management is to coordinate 
service delivery and to ensure continuity and 
integration of services. Case managers engage in a 
variety of activities, ranging from simple roles in 
locating services to more intensive roles in 
rehabilitation and clinical care. The less intensive 
models of case management seem to increase clients’ 
links to, and use of, other mental health services at 
relatively modest cost. More intensive models also 
appear to help clients to increase daily-task functioning, 
residential stability, and independence, and to reduce 
their hospitalizations (Borland et al., 1989; Mueser et 
al., 1998a). Overall, models that focus on specific 
outcomes are more effective than those with global, 
vaguely defined goals (Attkisson et al., 1992). 
More programs are beginning to employ mental 
health consumers as case managers in their 
multidisciplinary staff. Results have been positive, but 
the programs are challenging to implement and require 
ongoing supervision as do all case management 
programs (Mowbray et al., 1996). In a controlled study, 
clients served by case management’teams, along with 
consumers as peer-specialists, displayed greater gains 
in several areas of quality of life and greater reductions 
in major life problems, as compared with two 
comparison groups of clients served by case 
management teams without peer-specialists (Felton et 
al., 1995). One randomized clinical trial compared case 
management teams wholly staffed by consumers versus 
case management teams staffed by nonconsumers. The 
study (at 1 -year and 2-year followup) found that clients 
improved equally well with consumer and 
nonconsumer case managers (Solomon & Draine, 
1995). In this series of studies, the case management 
teams were part of an intensive program of services 
known as assertive community treatment. 
Assertive Community Treatment 
Assertive community treatment is an intensive 
approach to the treatment of people with serious mental 
illnesses that relies on provision of a comprehensive 
array of services in the community. The model 
originated in the late 1970s with the Program of 
Assertive Community Treatment in Madison, 
Wisconsin (Stein & Test, 1980). Fueled by 
deinstitutionalization and the vital need for cornmunity- 
based services, a multidisciplinary team serving 
psychiatric inpatients adapted its role to patients in the 
community. For this reason, assertive community 
treatment often is likened to a “hospital without walls.” 
The hallmark of assertive community treatment is 
an interdisciplinary team of usually 10 to 12 
professionals, including case managers, a psychiatrist, 
several nurses and social workers, vocational 
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specialists, and more recently includes substance abuse 
treatment specialists and peer specialists. Assertive 
community treatment also possesses these features: 
coverage 24 hours, 7 days per week; comprehensive 
treatment planning; ongoing responsibility; staff 
continuity; and small caseloads, most commonly with 
1 staff member for every 10 clients (Scott & Dixon, 
1995b). Because of the intensity of services, assertive 
community treatment is most cost-effective when 
targeted to individuals with the greatest service need, 
particularly those with a history of multiple 
hospitalizations (Scott & Dixon, 1995b; Lehman & 
Steinwachs et al., 1998a). 
Randomized controlled trials have demonstrated 
that assertive comtintnity treatment and similar models 
of intensive case management substantially reduce 
inpatient service use, promote continuity of outpatient 
care, and increase community tenure and residence 
stability for people with serious mental illnesses (Stein 
& Test, 1980; Bond et al., 1995; Lehman, 1998; 
Mueser et al., 1998a). Among the beneficiaries are 
homeless individuals and those with substance abuse 
problems and mental disorders. Evidence of 
effectiveness is weaker for other outcomes (e.g., social 
integration, employment) and for amelioration of 
substance abuse problems associated with 
schizophrenia, particularly when combined treatment is 
not offered (Mueser et al., 1998b). Assertive 
community treatment models are generally popular 
with clients (Stein & Test, 1980) and family members 
(Flynn, 1998). There also are some preliminary results 
suggesting that employing peer (i.e., consumer) or 
family outreach workers on the multidisciplinary 
assertive community treatment teams increases positive 
outcomes (Dixon et a1.,1997, 1998) and creates more 
positive attitudes among team members toward people 
with mental illnesses. 
Psychosocial Rehabilitation Services 
As noted above, there are a range of multicomponent 
programs called psychosocial rehabilitation services 
that are distinct from the single component skills 
training interventions described in the section on 
interventions for schizophrenia. These psychosocial 
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rehabilitation programs combine pharmacologic 
treatment, independent living and social skills training, 
psychological support to clients and their families, 
housing, vocational rehabilitation, social support and 
network enhancement, and access to leisure activities 
(WHO, 1997). Randomized clinical trials have shown 
that psychosocial rehabilitation recipients experience 
fewer and shorter hospitalizations than comparison 
groups in traditional outpatient treatment (Dincin & 
Witheridge, 1982; Bell & Ryan, 1984). In addition, 
recipients are more likely to be employed (Bond & 
Dincin, 1986). Cook & Jon&as (1996) review the 
outcomes of a wide range of psychosocial rehabilitation 
programs, including Fairweather lodges (Fairweather et 
al., 1969) and psychosocial clubhouses (Dincin, 1975), 
some of which were demonstrated as effective 20 and 
30 years ago but have not been widely implemented. 
Inpatient Hospitalization and Community 
Alternatives for Crisis Care 
The role of psychiatric hospitalization has changed 
greatly over recent decades, stemming from the 
recognition of poor and occasionally abusive 
conditions, excessive patient dependency, and patients’ 
loss of connection to the community (Wing, 1962; 
Gruenberg, 1974). More recent evolution in 
hospitalization traces to changes in the financing of 
care and the introduction of new medications (Appleby 
et al., 1993; Bezold et al., 1996). Community-based 
alternatives for crisis care services began to flourish in 
lieu of hospitalization (Fenton et al., 1998; Mosher, 
1999). 
The new priorities of psychiatric hospitalization 
focus on ameliorating the risk of danger to self or 
others in those circumstances in which dangerous 
behavior is associated with mental disorder, and the 
rapid return of patients to the community (Sederer & 
Dickey, 1995). Inpatient units are seen as short-term 
intensive settings to contain and resolve crises that 
cannot be resolved in the community. For this reason, 
inpatients are commonly suicidal, homicidal, or 
decompensating (experiencing the rapid return of 
severe symptoms) to the degree that they cannot care 
for themselves or respond to community-based 
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services. Inpatient services therefore emphasize safety 
measures, crisis intervention, acute medication and re- 
evaluation of ongoing medications, and (re)establishing 
the client’s links to other supports and services 
(Sederer & Dickey, 1997). 
Mobile crisis services have developed in many 
urban areas to prevent hospitalization (Zealberg, 1997), 
as have day hospital programs. With crisis services, a 
multidisciplinary team comes directly to the aid of the 
client in the community to provide immediate 
evaluation and services. This new conceptualization of 
inpatient care and crisis intervention services 
minimizes the use of hospital resources; however, welI- 
coordinated teams, sufficient community programs, and 
ready linkages are not widely available, particularly in 
rural and frontier areas. 
African Americans and Native Americans are 
overrepresented in psychiatric inpatient units in relation 
to their representation in the population (Snowden & 
Cheung, 1990; Snowden, in press). Overrepresentation 
is found in hospitals of all types except private 
psychiatric hospitals. The reasons for this disparity, 
while not completely understood, may reflect a mix of 
limited access to outpatient services and differences in 
cultural patterns of help-seeking behavior and overt 
discriminatory practices. Cost, disinclination to seek 
help, and lack of community support may contribute to 
patients’ delay in seeking treatment until symptoms are 
severe enough to warrant inpatient care. Clinician bias 
may also be at work. Cultural differences in treatment 
seeking and treatment utilization are discussed in 
greater detail in Chapter 2. 
Services for Substance Abuse and Severe 
Mental Illness 
As many as hal’of people with serious mental illnesses 
develop alcohol or other drug abuse problems at some 
point in their lives (Mueser et al., 1990; Regier et al., 
1993, Drake & Osher, 1997). Theories to explain 
comorbidity (also known as dual diagnosis) range from 
genetic to psychosocial, but empirical support for any 
one theory is inconclusive (Kosten & Ziedonis, 1997; 
Mueser et al., 1998b). In short, the cause of such 
widespread comorbidity is unknown. 
Comorbidity worsens clinical course and outcomes 
for individuals with mental disorders. It is associated 
with symptom exacerbation, treatment noncompliance, 
more frequent hospitalization, greater depression and 
likelihood of suicide, incarceration, family friction, and 
high services, use, and cost (Bartels et al., 1995; 
Mueser et al., 1997a; Bellack& Gearon, 1998; Havassy 
& Ams, 1998). Furthermore, patients may be 
jeopardized by the consequences of substance abuse, 
namely, increased risk of violence, HIV infection, and 
alcohol-related disorders (IOM,,1995). 
In light of the extent of mental disorder and 
substance abuse comorbidity, substance abuse 
treatment is a critical element of treatment for people 
with mental disorders. Likewise, treatment of 
symptoms and signs of mental disorders is a critical 
element of recovery from substance abuse. Yet decades 
of treating comorbidity through separate mental health 
and substance abuse service systems proved ineffective 
(Ridgely et al., 1990; Mueser et al., 1997a). 
Research amassed over the past 10 years supports 
a shift to treatment that combines interventions directed 
simultaneously to both conditions-that is, severe 
mental illness and substance abuse-by the same group 
of providers (Kosten & Ziedonis, 1997; for an 
example, see Mowbray et al. 1995), but access to such 
treatment remains limited. Most successful models of 
combined treatment include case management, group 
interventions (such as persuasion groups and social 
skills training), and assertive outreach to bring people 
into treatment (Mueser et al., 1997a). They typically 
take into account the cognitive and motivational 
deficits that characterize serious mental illnesses 
(Bellack & Gearon, 1998), although many providers 
still need to be educated (Kirchner et al., 1998). 
Combined treatment is effective at engaging people 
with both diagnoses in outpatient services, maintaining 
continuity and consistency of care, reducing 
hospitalization, and decreasing substance abuse, while 
at the same time improving social functioning (Miner 
et al., 1997; Mueser et al., 1997a). 
Although there is little evidence for any particular 
approach to combining treatments for comorbidity (Ley 
et al., 1999), recent research suggests that services 
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incorporating behavioral (motivational) approaches to 
substance abuse treatment are superior to traditional 
1Zstep approaches (e.g., Alcoholics Anonymous) with 
this population of clients (Drake et al., 1998). This may 
be because the more structured behavioral methods 
better accommodate the cognitive difficulties that 
accompany schizophrenia. Others, however, find self- 
help interventions tailored to dual-diagnosis clients 
quite useful (Vogel et al., 1998). Current research also 
is seeking to tailor combined treatment to the needs and 
preferences of specific patient subgroups, such as men, 
women (Alexander, 1996), people with addiction to 
multiple substances (as opposed to alcohol addiction 
alone), and people with histories of physical and 
psychological trauma (Mueser et al., 1997a). 
Other Services And Stipports 
Comprehensive care for adults with severe and 
persistent mental disorders also includes ancillary 
services to deal with such social consequences as 
family disruption and loss of employment and housing. 
Ancillary services are those above and beyond 
symptom management and rehabilitation. They include 
consumer self-help and advocacy, consumer-operated 
programs, family self-help and advocacy, and human 
services. The chapter concludes with a brief review of 
. evidence about integrating the mental health service 
system and the human services system of which it is 
Pm* 
A driving force for many of these services is to 
redress the stigma associated with severe and persistent 
mental illness. Stereotypes and ignorance are 
omnipresent (Robert Wood Johnson Foundation, 1990; 
Wahl et al., 1995). They lead many people to avoid 
living, socializing, or working with, renting to, or 
employing people with severe mental disorders (Levey 
et al., 1995). Stigma reduces consumers’ access to 
resources and opportunities (e.g., housing, jobs), fuels 
isolation and hopelessness, and leads to outright 
discrimination and abuse. Thus, overcoming stigma 
represents yet another challenge of coping with severe 
and persistent mental illness and of working toward 
recovery (Wahl & Harman, 1989; Reidy, 1993). 
Adults and Mental Health 
Consumer Self-Help 
Self-help groups are geared for mutual support, 
information, and growth. Self-help is based on the 
premise that people with a shared condition who come 
together can help themselves and each other to cope, 
with the two-way interaction of giving and receiving 
help considered advantageous. Self-help groups are 
peer led rather than professionally led. 
Organized self-help has a long history, with an 
estimated 2 to 3 percent of the general population 
involved in some self-help,group at any one time 
(Borkman, 199 1,1997). Over the past several decades, 
people with serious mental illnesses have formed 
mutual assistance organizations to aid each other and to 
combat stigma. These range from small groups held in 
a member’s home to freestanding nonprofit 
organizations with paid staff and a range of programs. 
In general, however, the self-help empowerment trend 
does not appear to have reached the African-American, 
Native American, HispaniclLatino, and Asian- 
American populations. 
As the number and variety of self-help groups has 
grown, so too has social science research on their 
benefits (Borkman, 1991). In general, participation in 
self-help groups has been found to lessen feelings of 
isolation, increase practical knowledge, and sustain 
coping efforts (Powell, 1994; Kurtz, 1997). Similarly, 
for people with schizophrenia or other mental 
illnesses, participation in self-help groups increases 
knowledge and enhances coping (Borkman, 1997; 
Trainor et al., 1997). Various orientations include 
replacing self-defeating thoughts and actions with 
wellness-promoting activities (Murray, 1996), 
improved vocational involvement (Kaufmann, 1995), 
social support and shared problem solving (Mowbray 
& Tan, 1993), and crisis respite (Mead, 1997). Such 
orientations are thought to contribute greatly to 
increased coping, empowerment, and realistic hope for 
the future. Additionally, some groups are tailored to 
meet the needs of consumers who are members of 
sexual minority groups, men, or those who have also 
have substance disorders (Noordsy et al., 1996; Vogel 
et al., 1998). 
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A number of controlled studies have demonstrated 
benefits for consumers participating in self-help. One 
study of the self-help group Recovery, Inc., found that 
leaders and members who were surveyed 
retrospectively reported fewer symptoms and fewer 
hospitalizations after joining the group than before. It 
also found the leaders’ reports of their psychological 
well-being to have been comparable to community 
controls (Galanter, 1988). In another study of 115 
former mental patients, Luke (1989) found that those 
who continued to attend self-help meetings at least 
once per month over a period of 10 months were more 
likely to show improvement on psychological, 
interpersonal, or community adjustment measures than 
those who attended less frequently. Through a case 
study, which included focus groups and interviews, 
Lieberman and colleagues (1991) found a consumer- 
run support group to improve members’ self-confidence 
and self-esteem and to lead to fewer hospitalizations. 
In a survey of mental health self-help group leaders 
in New York State, respondents identified three 
positive outcomes that were directly related to their 
self-help group membership: greater self-esteem, more 
hopefulness about the future, and a greater sense of 
well-being. According to survey respondents,’ all of 
these positive changes led to fewer hospitalizations 
(Carpinello & Knight, 1993). A study of six self-help 
programs in several parts of the United States also 
reported on consumers’ perceptions of self-help 
programs (Chamberlin & Rogers, 1990). Although not 
nationally representative, consumers in this study 
expressed satisfaction with their self-help program, at 
which they spent an average of 15 hours per week. 
They reported that their participation helped them to 
solve problems and feel more in control of their lives. 
Consumer-Operated Programs 
Propelled by the growing consumer movement, 
consumer self-help extends beyond self-help groups. It 
also encompasses consumer-operated programs, such as 
drop-in centers, case management programs, outreach 
programs, businesses, employment and housing 
programs, and crisis services, among others (Long & 
Van Tosh, 1988; National Resource Center on 
Homelessness and Mental Illness, 1989; Van Tosh & 
de1 Vecchio, in press). Drop-in centers are places for 
obtaining social support and assistance with problems, 
without professionals in attendance. The rationale for 
cons,umer roles in service delivery is that consumer 
staff, clients, and the mental health system can benefit. 
Consumer staff are thought to gain meaningful work, to 
serve as role models for clients, and to enhance the 
sensitivity of the service system to the needs of people 
with mental disorders. Clients are thought to gain from 
being served by staff who are more,empathic and more 
capable of engaging them in mental health services 
(Mowbray et al., 1996). 
An appreciation for the potential value of peer 
support stimulated the Community Support Program of 
the National Institute of Mental Health to fund local 
consumer-operated Services Demonstration Projects 
from 1988 to 1991. These demonstration projects also 
resulted in the increasing involvement of mental health 
consumers in the development and provision of peer 
support, involvement in traditional service roles, 
evaluation of services, and advocacy. A variety of 
consumer-operated programs were developed, staffed, 
and evaluated as states began to fund locally based 
initiatives (Nikkel et al., 1992; Kaufmann et al., 1993; 
Mowbray & Tan, 1993). Most evaluations of drop-in 
centers were in the form of process evaluations that 
generally found consumers to be satisfied or that 
programs met their objectives (Kaufmann et al., 1993; 
Mowbray & Tan, 1993). In 1998, the Federal Center 
for Mental Health Services initiated a multisite 
evaluation study of consumer-operated services across 
the United States (see http://www.cstprogrum.edu). 
In addition to ongoing evaluations, there are several 
published studies of client outcomes withconsumer-run 
programs, although the research base is modest. Several 
studies, noted earlier, found improved outcomes with 
consumer self-help programs. Another study evaluated 
a consumer-run case management program. It compared 
the effectiveness of a case management program staffed 
by consumers with a similar program staffed by 
nonconsumers. Case managers in both programs, which 
were part of assertive community treatment, performed 
brokering, assistance, and support functions, rather than 
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clinical management and treatment, The randomized 
trial found that clients assigned to either case 
management program fared equally well in clinical, 
social, and quality of life outcomes (Solomon & 
Draine, 1995). Recently, peer specialists were added to 
the recommended staffing for assertive community 
treatment teams; peer specialists provide expertise and 
consultation to the entire treatment team (Allness & 
Knoedler, 1999). 
Consumers also may be employed as staff in more 
traditional mental health services operated by 
nonconsumer professionals. Consumer positions most 
commonly include peer counselors, peer job coaches, 
case managers, staff for drop-in centers, outreach 
workers, and housing assistants. In a survey of 400 
agencies offering supported housing to people with 
severe mental illness, 38 percent employed mental 
health consumers as paid staff (Besio & Mahler, 1993). 
As noted previously, consumers in the role of peer- 
specialists integrated into case management eams led 
to improved patient outcomes (Felton et al., 1995). 
Consumer Advocacy 
The mental health field has witnessed great changes in 
policy development, with consumers playing 
increasingly visible roles in advocacy. Consumer 
contribution to policy was initially encouraged by 
Federal laws mandating consumer participation in 
planning, oversight, and advocacy activities at the state 
level (Chamberlin & Rogers, 1990; Van Tosh & de1 
Vecchio, in press). With the establishment of state 
mental health planning councils and local mental health 
advisory boards and committees, consumers 
increasingly have become equal partners in a process 
often reserved for seasoned policymakers. In addition, 
consumers have become active participants in the 
process to reform health and mental health care 
financing. For example, the Managed Care Consortium 
was formed in 1995 to create educational opportunities 
for a host of advocacy organizations across the United 
States. With funding support from the federal Center 
for Mental Health Services, this consortium encouraged 
teams to form in each state to influence the design of 
managed care programs. Consumers also have entered 
the halls of many public sector bureaucracies, serving 
in leadership roles in Offices of Consumer Affairs and 
interfacing withother government departments. In what 
was once believed to be the last bastion for consumer 
integration, consumers are now seen as critical 
stakeholders and valued resources in the policy process. 
Consumers also have become advocates in the 
communities where they live and work. Advocacy 
enables consumer groups to shape policy at the local 
level, where a direct impact can be felt. At the local 
level, advocacy strives to improve access to, or quality 
of, needed services and to saunter employment and 
housing discrimination. It can also be helpful in 
mobilizing resources to build and sustain programs. 
The National Mental Health Association (NMHA. 
available at http://www.nmha.org), comprising more 
than 340 affiliates nationwide, works with and supports 
the efforts of consumers to achieve advocacy goals. 
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Family Self-Help 
Family members of people with severe mental illnesses 
also encounter ignorance and stigma. Stigma translates 
into avoiding or blaming family members (Phelan et al., 
1998; Wahl & Harman, 1989). Families also are under 
a great deal of stress associated with care giving and 
obtaining resources for their mentally ill members. 
Families--especially parents, siblings, adult 
children, and spouses--often provide housing, food, 
transportation, encouragement, and practical assistance. 
At the same time, schizophrenia and other mental 
disorders strain family ties. Symptoms of mental 
disorders may be disruptive and troubling, especially 
when they flare up. Even when there are no problems, 
living together can be stressful-interpersonally, 
socially, and economically. Parents and their adult 
children often perceive mental disorders and treatment 
differently, sometimes disagreeing about the best 
course of action. 
Consequently, families too have created support 
organizations. Some of these are professionally based 
and facilitated, often as part of a clinic or other 
treatment program. Others are peer run in the self-help 
model. Similar to self-help among people with mental 
illnesses, family self-help can range from small 
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supportive groups to large organizations. The National 
Alliance for the Mentally Ill (NAMI) is the largest such 
organization. Founded in 1979 in Wisconsin, NAM1 
now has 208,000 members nationally. It has more than 
1,200 local self-help groups (affiliates) across all 50 
states (see http://www.nami.org). While still growing, 
its members include only a small percentage of the 
family members of people with mental illnesses in the 
country (Monking, 1994; Heller et al., 1997a). 
Family members primarily attend self-help and 
support groups to receive emotional support and 
accurate information about mental illness and mental 
health services (Heller et al., 1997a, 1997b). 
Participation often leads to better quality of life for the 
attending family members and also indirectly benefits 
the member diagnosed as mentally ill (Wahl & Harman, 
1989; Monking, 1994). Family self-help groups can 
result in better communication and interaction among 
family members (Heller et al., 1997b). 
Family Advocacy 
In addition to providing each other with mutual 
support, families often devote time, energy, and 
resources for advocacy to improve services and 
opportunities for their family members with mental 
disorders. Similar to consumer advocacy,’ family 
advocacy on a local level might include organizing to 
improve local mental health services, or to redress 
grievances with service providers. On the national 
level, consumer groups work to influence legislation 
and to support research and education initiatives (Wahl 
& Harman, 1989). Through their advocacy, families 
have been quite effective in raising their concerns and 
perspectives to service providers, legislators, and the 
public. 
Human Services 
The clinical symptoms of schizophrenia and other 
mental disorders are often disruptive and distressing. 
Their consequences are no less severe-truncated 
education, unemployment, social isolation, and 
exclusion from community participation. Facing 
multiple life stressors, all severe, with a minimum of 
.resources, people with severe mental illnesses often 
need a variety of supportive services. Paramount among 
these are housing, employment and income assistance, 
and health benefits. Consumers have reported their 
major needs to include adequate income, meaningful 
employment, decent and affordable housing, quality 
health care, and education to increase skills (Ball & 
Havassy, 1984; Rosnow & Rucker, 1985; Lynch & 
Kruzich, 1986). 
Housing 
Housing ranks as a priority concern of individuals with 
serious mental illness. Locating affordable, decent, safe 
housing is often difficult, and out of financial reach. 
Stigma and discrimination also restrict consumer access 
to housing. Despite legislation such as the Fair Housing 
Act, allegations of housing discrimination based on 
psychiatric disabilities are highly prevalent (U.S. 
Department of Education, 1998). Landlords and public 
housing programs are often unwilling to accept tenants 
with severe mental disorders. In a survey of parents of 
mentally ill adults, the dearth of decent and affordable 
housing was a direct barrier to the person moving out 
of the family home, even when all parties wanted it 
(Hatfield, 1992). 
The actual proportion of people with severe mental 
illnesses who lack affordable and decent housing has 
not been assessed directly. Yet indirect assessments 
point to a serious problem, In 1994, the U.S. 
Department of Housing and Urban Development 
(HUD) reported that almost half of all very low-income 
disabled residents-including persons with serious 
mental illness-have “worst case” needs for housing 
assistance. Furthermore, it was reported that the 
majority of these persons often live in the most severely 
inadequate housing (U.S. Department of Housing and 
Urban Development, 1994; U.S. Department of 
Education, 1998). It is estimated that up to one in three 
individuals who experience homelessness has a mental 
illness (Federal Interagency Task Force on 
Homelessness and Mental Illness, 1992). 
The housing preferences of people with 
schizophrenia and other serious mental disorders are 
clear: these individuals strongly desire their own decent 
living quarters where they have control over who lives 
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with them and how decisions are made (Owen et al., 
1996; Schutt & Goldfinger, 1996; Sohng, 1996). In an 
analysis of 26 consumer preference surveys, Tanzman 
( 1993) found that at least 59 percent of those surveyed 
wanted independent living in a house or apartment. 
They also preferred to live alone (or with a spouse or 
partner), yet not with other people with mental 
disorders. Most also preferred access to mental health 
and rehabilitation services to support them where they 
were living. 
When deinstitutionalization led to the need for 
more community housing, the residential programs that 
were developed replicated institutional programs 
(Carling, 1989). Although residential programs varied 
in the degree of oversight and services, they generally 
proved to be ineffective in meeting consumers’ needs. 
Moreover, living in such programs added to stigma. 
Because of these shortfalls, greater emphasis has been 
placed on conventional housing supplemented by 
appropriate assistance tailored to individual need 
(Srebnik et al., 1995). This new concept, called 
supported housing, moves away from “placing” clients, 
grouping clients by disability, staff monopolizing 
decisionmaking, and use of transitional settings and 
standardized levels of service (Carling, 1989; Lehman 
& Newman, 1996). Instead, supported housing focuses 
on consumers having a permanent home that is 
integrated socially, is self-chosen, and encourages 
empowerment and skills development. The services and 
supports offered are individualized, flexible, and 
responsive to changing consumer needs. Thus, instead 
of fitting a person into a housing program “slot,” 
consumers choose their housing, where they receive 
support services. The level of support is expected to 
fluctuate over time. With residents living in 
conventional housing, some of the stigma attached to 
group homes and residential treatment programs is 
avoided. 
Although there are no randomized clinical trials to 
support the effectiveness of the supported housing 
approach, consumer advocacy and changes in clinical 
practice affirm the shift to supported housing. In a 
quasi-experimental study, an evaluation of the Robert 
Wood Johnson Foundation Program on Chronic Mental 
Illness demonstrated the feasibility and modest benefits 
of the supported housing approach using rental 
subsidies from HUD (Newman et al., 1994). 
Consumers experienced better mental health and more 
self-determination when they lived in adequate housing 
(Nelson et al., 1998). For example, one study found that 
personal empowerment and functioning were enhanced, 
and hospitalization reduced, after 5 months in a 
supported housing program (McCarthy & Nelson, 
1991). Also, resident control over decisions was 
directly related to satisfaction and empowerment 
(Seilheimer & Doyal, 19967. Similarly, another study 
found that having greater choice in housing was 
associated with greater happiness and life satisfaction 
(Srebnik et al., 1995). 
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Despite these findings, serious housing problems 
persist for people with schizophrenia and other mental 
disorders. Most such individuals are poor and thereby 
face very limited housing options. 
Income, Education, and Employment 
People with severe mental illnesses tend to be poor 
(Polak & Warner, 1996). Although the reasons are not 
understood, poverty is a risk factor for some mental 
disorders, as well as a predictor of poor long-term 
outcome among people already diagnosed (Cohen, 
1993; Rabins et al., 1996; Saraceno & Barbui, 1997). 
People with serious mental illnesses often become 
dependent on public assistance shortly after their initial 
hospitalization (Ho et al., 1997). They rely on 
government disability-income programs, rent subsidies 
(Loyd & Tsuang, 1985; Polak & Warner, 1996; Ho et 
al., 1997), and informal sources of economic support 
(e.g., living with parents). The unemployment rate 
among adults with serious and persistent mental 
disorders hovers at 90 percent (National Institute on 
Disability and Rehabilitation Research, 1992). 
Conversely, adequate standards of living and 
employment are associated with better clinical 
outcomes and quality of life (Cohen, 1993; Bell & 
Lysaker, 1997). In a randomized trial of consumers 
assigned to paid versus unpaid work, paid employment 
was found to reduce symptoms of schizophrenia (Bell 
et al., 1996). Moreover, employer accommodations for 
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those with psychiatric disabilities appear to be 
inexpensive. The most frequently requested 
accommodations focus on orientation and training of 
supervisors, provision of onsite support, and adaptive 
work schedules. Such accommodations rarely result in 
significant cost to the employer (Mancuso, 1990; 
Fabian et al., 1993). 
While newer vocational rehabilitation and 
employment initiatives strive to remedy persistently 
high levels of unemployment, most consumers find 
themselves unable to work consistently or at all. This is 
due not only to active symptoms but also to profound 
interruptions of education and employment caused by 
symptom onset and exacerbations, stigma and 
discrimination, lack of higher education programs for 
this population, and low-paying menial jobs. 
When the onset of mental health-problems begins 
during school-age years, educational systems are often 
ill prepared. Several studies have identified educational 
deficits in their clientele, who function in reading and 
math at a level far below their achieved grades in 
school (Cook et al., 1987; Cook & Solomon, 1993). 
Supported education models can provide assistance to 
consumers with their education (Cook & Solomon, 
1993; Hoffman & Mastrianni, 1993; Ryglewicz & 
Glynn, 1993). One example is Consumers and 
Alliances United for Supported Education, aconsumer- 
operated program in Quincy, Massachusetts, that 
provides a wide range of services to encourage 
individuals with psychiatric disabilities to enter or 
reenter college or technical school programs. Services 
include academic and career counseling, assistance 
with finding financial aid, study skills, stress control, 
tutoring/coaching, and assistance with crisis while 
hospitalized (CMHS, 1996). 
Consumers lack control over their financial affairs 
when benefit checks are given directly to care providers 
for the person’s housing and other expenses, or to a 
legally appointed representative payee (if the person 
has been deemed unable to manage his/her own 
finances) (Conrad et al., 1998). Those consumers who 
manage their own finances usually face such modest 
monthly budgets that there is no room for error. Funds 
frequently are depleted before the end of the month. 
Furthermore, disability payments are sometimes 
reduced or discontinued when a recipient is working. 
Since employment is rarely consistent, they need to 
resume disability benefits. Yet, once they are canceled, 
government disability benefits can be cumbersome to 
restart. The Social Security Administration has 
developed new measures to facilitate reactivation of 
benefits for individuals who return to work, but they 
are not yet widely disseminated. In some ways the 
requirements of Social Security disability benefits and 
other such programs often act as disincentives to the 
pursuit of employment (Polak & W+uner, 1996; Priebe 
et al., 1998). 
Some people with serious mental illnesses have 
adequate income or fmancial assistance (Ware & 
Goldfinger, 1997). Some have affluent families who 
can subsidize their expenses. Others collect pensions 
because they were not disabled by their illness until 
after they had a substantial work history. Finally, some 
have found well-paying positions through a formal 
rehabilitation program, a community-based educational 
or vocational training program, or a supportive 
employer. 
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Health Coverage 
Health coverage goes hand in hand with housing and 
income in determining standards of living for people 
with serious psychiatric disabilities. Due to their low 
incomes and the high cost of psychiatric and other 
health services, most people with schizophrenia and 
other forms of severe and persistent mental disorders 
rely on Medicare, Medicaid, and other government 
programs to cover their therapeutic services, 
medications, and other health care. When reductions or 
loss of these benefits curtail access to needed 
medication or services, clients’ health suffers and their 
use of more expensive emergency services increases 
(Soumerai et al., 1994). Even when they have access to 
health insurance coverage, individuals with a mental 
disorder encounter barriers to procuring that insurance 
and in receiving general medical care (Druss & 
Rosenheck 1998). 
Integrating Service Systems 
Integrating the range of services needed by individuals 
with severe and persistent mental disorders has been a 
vexing problem for decades. The General Accounting 
Office (1977) criticized the Federal community mental 
health centers for their failure to meet the multiple 
needs of individuals with chronic mental illness. The 
Federal response was to establish a Community 
Support Program to provide resources and technical 
assistance to communities to help them in formulating 
community support systems to integrate the various 
services provided by fragmented human services 
agencies (Turner & TenHoor, 1978; Tessler & 
Goldman, 1982). The limitations of a community 
support program in dealing with severe and persistent 
mental illness in major cities, particularly those with 
high rates of homelessness, prompted the Robert Wood 
Johnson Foundation to partner with HUD to create the 
Programon Chronic Mental Illness (Aiken et al., 1986). 
This program promoted the concept of local mental 
health authorities as the agencies responsible for 
integrating all services for individuals with chronic 
mental illness, including housing opportunities (Shore 
& Cohen, 1990, 1994). The Robert Wood Johnson 
Foundation Program on Chronic Mental Illness was 
initiated in late 1986 and evaluated over a 6-year period 
(Goldman et al., 1990a, 199Ob, 1994a, 1994b). 
The evaluation determined that local mental health 
authorities were established or strengthened in almost 
all of the nine cities, resulting in measurable increases 
in organizational centralization and reduced 
fragmentation of services (Morrissey et al., 1994). Case 
management services also were expanded, producing 
greater continuity of care and reductions in family 
burden (Lehman et al., 1994; Shem et al., 1994; Tessler 
et al., 1994). Client outcomes, including social 
functioning and quality of life measures, improved 
during the demonstration (Lehman et al., 1994; Shem 
et al., 1994). Yet the time course of most clients’ 
improvement did not coincide with improvements in 
system integration. This suggested that their 
improvement could not be attributed to system 
integration. For a subset of clients, improved client 
outcomes were due to the benefits of special combined 
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housing and support services. Yet, even for this subset, 
improvements were related, but not directly 
attributable, to systems integration (Newman et al., 
1994). 
Evaluators concluded that system integration and 
traditional case management alone probably were not 
sufficient to produce optimal social and clinical 
outcomes (Goldman et al., 1994b; Lehman et al., 1994). 
They speculated that the availability of rental subsidies 
and supports or more intensive and higher quality case 
management services-such as those offered in 
assertive community treatment-were essential 
(Ridgely et al., 1996). This set of findings, coincident 
with the release of the report of the Federal Interagency 
Task Force on Homelessness and Mental Illness 
(1992), Ourcasts on Main Street, prompted the 
development of another demonstration program. 
Access to Community Care and Effective Services 
and Supports was launched by the Federal Center for 
Mental Health Services in 1993 (Randolph et al., 
1997). Still in the midst of its evaluation, preliminary 
findings sustain the benefits of providing assertive 
community treatment to obtain good clinical and social 
outcomes. They support the association of better 
system integration with higher rates of moving 
individuals with severe mental illness from 
homelessness into independent housing (Rosenheck et 
al., 1998a). It remains to be seen, however, whether the 
improvements in system integration observed over time 
are associated with improvements in consumers’ 
clinical and social outcomes. 
Integrating service systems remains a challenge to 
mental health and related human service agencies. Its 
benefits for accountability and centralization of 
authority have been established. Its impact on 
individuals with severe and persistent mental illness 
may be limited by the lack of available high-quality 
services and mainstream welfare resources, reflecting 
the gap between what can be done and what is available 
(Goldman, 1998a). 
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Conclusions 
1. As individuals move into adulthood, developmental 
goals focus on productivity and intimacy including 
pursuit of education, work, leisure, creativity, and 
personal relationships. Good mental health enables 
individuals to cope with adversity while pursuing 
these goals. 
2. Untreated, mental disorders can lead to lost 
productivity, unsuccessful relationships, and 
significant distress and dysfunction. Mental illness 
in adults can have a significant and continuing 
effect on children in their care. 
3. Stressful life events or the manifestation of mental 
illness can disrupt the balance adults seek in life 
and result in distress and dysfunction. Severe or 
life-threatening trauma experienced either in 
childhood or adulthood can further provoke 
emotional and behavioral reactions that jeopardize 
mental health. 
4. 
5. 
6. 
7. 
Research has improved our understanding of 
mental disorders in the adult stage of the life cycle. 
Anxiety, depression, and schizophrenia, 
particularly, present special problems in this age 
group. Anxiety and depression contribute to the 
high rates of suicide in this population. 
Schizophrenia is the most persistently disabling 
condition, especially for young adults, in spite of 
recovery of function by some individuals in mid to 
late life. 
Research has contributed to our ability to 
recognize, diagnose, and treat each of these 
conditions effectively in terms of symptom control 
and behavior management. Medication and other 
therapies can be independent, combined, or 
sequenced depending on the individual’s diagnosis 
and personal preference. 
A new recovery perspective is supported by 
evidence on rehabilitation and treatment as well as 
by the personal experiences of consumers. 
Certain common events of midlife (e.g., divorce or 
other stressful life events) create mental health 
problems (not necessarily disorders) that may be 
addressed through a range of interventions. 
8. Care and treatment in the real world of practice do 
not conform to what research determines as best. 
For many reasons, at times care is inadequate but 
there are models for improving treatment. 
9. Substance abuse is a major co-occurring problem 
for adults with mental disorders, Evidence supports 
combined treatment, although there are substantial 
gaps between what research recommends and what 
typically is available in communities. 
10. Several special problems in care and treatment of 
adults have been recognizec, beyond traditional 
mainstream mental health concerns, including 
racial and ethnic differences, lack of consumer 
involvement, and the consequences of disability 
and poverty. 
11. Barriers of access exist in the organization and 
financing of services for adults. There are specific 
problems with Medicare, Medicaid, income 
supports, housing, and managed care. 
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CHAPTER 5 
OLDER ADULTS AND MENTAL HEALTH 
T he past century has witnessed a remarkable lengthening of the average life span in the United 
States, from 47 years in 1900 to more than 75 years in 
the mid-1990s (National Center for Health Statistics 
[NCHS], 1993). Equally noteworthy has been the 
increase in the number of persons ages 85 and older 
(Figure 5-l). These trends will continue well into the 
next century and be magnified as the numbers of older 
Americans increase with the aging of the post-World 
War II baby boom generation. 
Millions of older Americans-indeed, the major- 
ity-cope constructively with the physical limitations, 
cognitive changes, and various losses, such as 
bereavement, that frequently are associated with late 
life. Research has contributed immensely to our 
understanding of developmental processes that 
continue to unfold as we age. Drawing on new 
scientific information and acting on clinical common 
sense, mental health and general health care providers 
are increasingly able to suggest mental health strategies 
and skills that older adults can hone to make this stage 
of the life span satisfying and rewarding. 
The capacity for sound mental health among older 
adults notwithstanding, a substantial proportion of the 
population 55 and older-almost 20 percent of this age 
group-experience specific mental disorders that are 
not part of “normal” aging (see Table 5-l). Research 
that has helped differentiate mental disorders from 
“normal” aging has been one of the more important 
achievements of recent decades in the field of geriatric 
health. Unrecognized or untreated, however. 
depression, Alzheimer’s disease, alcohol and drug 
misuse and abuse, anxiety, late-life schizophrenia, and 
other conditions can be severely impairing, even fatal; 
Figure 5-1. Increases in the percent of the US. population over age 65 years and over age 65 years (Malmgren, 1994). 
6.8% 
1 .3% 
1940 
132 million 
1960 
180 million 
I 980 
227 million 
Total U.S. Population 
1990 
249 million 
2010 
298 million 
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Table 5-1. Best Estimate l-Year Prevalence Rates 
Based on Epidemiologic Catchment Area, 
Age 55+ 
Prevalence 
(“W 
Any Anxiety Disorder 11.4 I _. i _1 “_L. __. . .al.-.d. .;.a- Le.+* ._, .-.- *_ i 
Simple Phobia 7.3 
_. 
Social Phobia 1.0 ,,_ _,,. _ :-.. . . . ^“I __.,-.,- I. >dLL r.bd.-..i..r /._. I-& ,,..._..-. 
Agoraphobia 4.1 
‘, _. 
:;;; P&ic’Disorder :‘. - + a.“,, 0.5 .( . . 
Obsessive-Compulsive Disorder 1.5 
_(..“. _.ji,.. “.,.. _ 
Any Mood Disorder 4.4 . ~. t 1 ../ 
Major Depressive Episode 3.8 
-_ .x ^* ‘” _ -“,. 
-.: __ i k+ipolar Major Depression ’ -‘- 3.7 . %““.e. .I ._ . .” 
Dysthymia 1.6 
*’ Bipolar I 0.2 
Bipolar II 0.1 
. .y.‘....~ fl I,l(rl, _. _I_._ .- , .“._ _ . .*. . .- . . . . .‘ 
Schizophrenia 0.6 rurL.i: . “. ‘_..._ I . . ( .., . . . . i ~. _., 
Somatization 0.3 
),. is-, ) .- x , ;. . . .*:. *< -. -_ 
Antibcial Personality Disorder ’ 0.0 “.*a.” . ,. , . . . ^ . . . ..,.. ,_ . _ . ..., . * __ : 
Anorexia Nervosa 010 
“.,” I . . I. 
Seve’re Cognitive Impairment 6.6 rX_“_leI” _ - . . .._ _ /- ._c ., 
Any Disorder 19.8 i 
Source: D. Regier & W. Narrow, personal communication, 
1999. 
in the United States, the rate of suicide, which is 
frequently a consequence of depression, is highest 
among older adults relative to all other age groups 
(Hoyert et al., 1999). The clinical challenges such 
conditions present may be exacerbated, moreover, by 
the manner in which they both affect and are affected 
by general medical conditions or by changes in 
cognitive capacities. Another complicating factor is 
that many older people, disabled by or at risk for 
mental disorders, find it difficult to afford and obtain 
needed medical and related health care services. Late- 
life mental disorders also can pose difficulties for the 
burgeoning numbers of family members who assist in 
caretaking tasks for their loved ones (Light & 
Lebowitz, 1991). 
Chapter Overview 
Fortunately, the past 15 to 20 years have been marked 
by rapid growth in the number of clinical, research, and 
training centers dedicated to the mental illness- and 
mental health-related needs of older people. As evident 
in this chapter, much has been learned. The chapter 
reviews, first, normal developmental milestones of 
aging, highlighting the adaptivecapacities that enable 
many older people to change, cope with loss, and 
pursue productive and fulfilling activities. The chapter 
then considers mental disorders in older people-their 
diagnosis and treatment, and the various risk factors 
that may complicate the course or outcome of 
treatment. Risk factors include co-occurring, or 
comorbid, general medical conditions, the high 
numbers of medications many older individuals take, 
and psychosocial stressors such as bereavement or 
isolation. These are cause for concern, but, as the 
chapter notes, they also point the way to possible new 
preventive interventions. The goal of such prevention 
strategies may be to limit disability or to postpone or 
even eliminate the need to institutionalize an ill person 
(Lebowitz & Pearson, in press). The chapter reviews 
gains that have been realized in making appropriate 
mental health services available to older people and the 
challenges associated with the delivery of services to 
this population. The advantages of a decisive shift 
away from mental hospitals and nursing homes to 
treatment in community-based settings today are in 
jeopardy of being undermined by fragmentation and 
insufficient availability of such services (Gatz & 
Smyer, 1992; Cohen & Cairl, 1996). The chapter 
examines obstacles and opportunities in the service 
delivery sphere, in part through the lens of public and 
private sector financing policies and managed care. 
Finally, the chapter reviews the supports for older 
persons that extend beyond traditional, formal 
treatment settings. Through support networks, self-help 
groups, and other means, consumers, families, and 
communities are assuming an increasingly important 
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role in treating and preventing mental health problems 
and disorders among older persons. 
Normal Life-Cycle Tasks 
With improved diet, physical fitness, public health, and 
health care, more adults are reaching age 65 in better 
physical and mental -health than in the past. Trends 
show that the prevalence of chronic disability among 
older people is declining: from 1982 to 1994, the 
prevalence of chronic disability diminished 
significantly, from 24.9 to 21.3 percent of the older 
population (Manton et al., 1997). While some disability 
is the result of more general losses of physiological 
functions with aging (i.e., normal aging). extreme 
disability in older persons, including that which stems 
from mental disorders, is not an inevitable part of aging 
(Cohen, 1988; Rowe & Kahn, 1997). 
Normal aging is a gradual process that ushers in 
some physical decline, such as decreased sensory 
abilities (e.g., vision and hearing) and decreased 
pulmonary and immune function (Miller, 1996; 
Carman, 1997). With aging come certain changes in 
mental functioning, but very few of these changes 
match commonly held negative stereotypes about aging 
(Cohen, 1988; Rowe & Kahn, 1997). In normal aging, 
important aspects of mental health include stable 
intellectual functioning, capacity for change, and 
productive engagement with life. 
Cognitive Capacity With Aging 
Cognition subsumes intelligence, language, learning, 
and memory. With advancing years, cognitive capacity 
with aging undergoes some loss, yet important 
functions are spared. Moreover, there is much 
variability between individuals, variability that is 
dependent upon lifestyle and psychosocial factors 
(Gottlieb, 1995). Most important. accumulating 
evidence from human and animal research finds that 
lifestyle modifies genetic risk in influencing the 
outcomes of aging (Finch & Tanzi, 1997). This line of 
research is beginning to dispel the pejorative 
stereotypes of older people as rigidly shaped by 
heredity and incapable of broadening their pursuits and 
acquiring new skills. 
Older Adults and Mental Health 
A large body of research, including both cross- 
sectional studies and longitudinal studies. has 
investigated changes in cognitive function with aging. 
Studies have found that working memory declines with 
aging, as does long-term memory (Siegler et al., 1996), 
with decrements more apparent in recall than in 
recognition capacities. Slowing or some loss of other 
cognitive functions takes place, most notably in 
information processing, selective attention, and 
problem-solving ability, yet findings are variable 
(Siegler et al., 1996). These cognitive changes translate 
into a slower pace of learnmg and greater need for 
repetition of new information. Vocabulary increases 
slightly until the mid-70s, after which it declines 
(Carman, 1997). In older people whose IQ declines, 
somatic illness is implicated in some cases (Cohen, 
1988). Fluid intelligence, aformof intelligence defined 
as the ability to solve novel problems, declines over 
time, yet research finds that fluid intelligence can be 
enhanced through training in cognitive skills and 
problem-solving strategies (Baltes et al., 1989). 
Memory complaints are exceedingly common in 
older people, with 50 to 80 percent reporting subjective 
memory complaints (cited in Levy-Cushman & Abeles, 
in press). However, subjective memory complaints do 
not correspond with actual performance. In fact, some 
who complain about memory display performance 
superior to those who do not complain (Collins & 
Abeles, 1996). Memory complaints in older people, 
according to several studies, are thought to be more a 
product of depression than of decline in memory 
performance (cited in Levy-Cushman & Abeles, in 
press). (The importance of proper diagnosis and 
treatment of depression is emphasized in subsequent 
sections of this chapter.) Studies attempting to treat 
memory complaints associated with normal 
aging-using either pharmacological or psychosocial 
means-have been, with few exceptions, unsuccessful 
(Crook, 1993). In one of these exceptions, a recent 
study demonstrated a significant reduction in memory 
complaints with training workshops for healthy older 
people. The workshops stressed not only memory 
promotion strategies, but also ways of dealing with 
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expectations and perceptions about memory loss (Levy- 
Cushman & Abeles, in press). 
One large, ongoing longitudinal study found high 
cognitive performance to be dependent on four factors, 
ranked here in decreasing order of importance: 
education, strenuous activity in the home, peak 
pulmonary flow rate, and “self-efficacy,” which is a 
personality measure defined by the ability to organize 
and execute actions required to deal with situations 
likely to happen in the future (Albert et al., 1995). 
Education, as assessed by years of schooling, is the 
strongest predictor of high cognitive functioning. This 
finding suggests that education not only has salutary 
effects on brain function earlier in life, but also 
foreshadows sustained productive behavior in later life, 
such as reading and performing crossword puzzles 
(Rowe & Kahn. 1997). 
The coexistence of mental and somatic disorders 
(i.e., comorbidity) is common (Kramer et al., 1992). 
Some disorders with primarily somatic symptoms can 
cause cognitive. emotional, and behavioral symptoms 
as well, some of which rise to the level of mental 
disorders. At that point, the mental disorder may result 
from an effect of the underlying disorder on the central 
nervous system (e.g., dementia due to a medical 
condition such as hypothyroidism) or an effect of 
treatment (e.g., delirium due to a prescribed 
medication). Likewise, mental problems or disorders 
can lead to or exacerbate other physical conditions by 
decreasing the ability of older adults to care for 
themselves, by impairing their capacity to rally social 
support, or by impairing physiological functions. For 
example, stress increases the risk of coronary heart 
disease and can suppress cellular immunity (McEwen, 
1998). Depression can lead to increased mortality from 
heart disease and possibly cancer (Frasure-Smith et al., 
1993, 1995; Penninx et al., 1998). 
A new model postulates that successful aging is 
contingent upon three elements: avoiding disease and 
disability, sustaining high cognitive and physical 
function, and engaging with life (Rowe & Kahn, 1997). 
The latter encompasses the maintenance of 
interpersonal relationships and productive activities, as 
defined by paid or unpaid activities that generate goods 
or services of economic value. The three major 
elements are considered to act in concert, for none is 
deemed sufficient by itself for successful aging. This 
new model broadens the reach of health promotion in 
aging to entail more than just disease prevention. 
Change, Human Potential, and Creativity 
Descriptive research reveals evidence of the capacity 
for constructive change in later life (Cohen, 1988). The 
capacity to change can occur even in the face of mental 
illness, adversity, and chronic mental health problems. 
Older persons display flexibility in behavior and 
attitudes and the ability to grow intellectually and 
emotionally. Time plays a key role. Externally imposed 
demands upon one’s time may diminish, and the 
amount of time left at this stage in life can be 
significant. In the United States in the late 20th century, 
late-life expectancy approaches another 20 years at the 
age of 65. In other words, average longevity from age 
65 today approaches what had been the average 
longevity from birth some 2,000 years ago. This leaves 
plenty of time to embark upon new social, 
psychological, educational, and recreational pathways, 
as long as the individual retains good health and 
material resources. 
In his classic developmental model, Erik Erikson 
characterized the final stage of human development as 
a tension between “ego integrity and despair” (Erikson, 
1950). Erikson saw the period beginning at age 65 
years as highly variable. Ideally, individuals at this 
stage witness the flowering of seeds planted earlier in 
the prior seven stages of development. When they 
achieve a sense of integrity in life, they garner pride 
from their children, students and proteges, and past 
accomplishments. With contentment comes a greater 
tolerance and acceptance of the decline that naturally 
accompanies the aging process. Failure to achieve a 
satisfying degree of ego integrity can be accompanied 
by despair. 
Cohen (in press) has proposed that with increased 
longevity and health, particularly for people with 
adequate resources, aging is characterized by two 
human potential phases. These phases, which 
emphasize the positive aspects of the final stages of the 
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life cycle. are termed Retirement/Liberation and 
Slrmming Up/Swan Song. 
Retirement often is viewed as the most important 
life event prior to death. Retirement frequently is 
associated with negative myths and stereotypes 
(Sheldon et al., 1975; Bass, 1995). Cohen points out, 
however, that most people fare well in retirement. They 
have the opportunity to explore new interests, 
acrivities, and relationships due to retirement’s 
liberating qualities. In the Retirement/Liberation phase, 
new feelings of freedom, courage, and confidence are 
experienced. Those at risk for faring poorly are 
individuals who typically do not want to retire, who are 
compelled to retire because of poor health, or who 
experience a significant decline in their standard of 
living (Cohen, 1988). In short, the liberating experience 
of having more time and an increased sense of freedom 
can be the springboard for creativity in later life. 
Creative achievement by older people can change the 
course of an individual, family, community, or culture. 
In the late-life Summing Up/Swan Song phase, 
there is a tendency to appraise one’s life work, ideas, 
and discoveries and to share them with family or 
society. The desire to sum up late in life is driven by 
varied feelings, such as the desire to complete one’s life 
work, the desire to give back after receiving much in 
life, or the fear of time evaporating. Important 
opportunities for creative sharing and expression ensue. 
There is a natural tendency with aging to reminisce and 
elaborate stories that has propelled the development of 
reminiscence therapy for health promotion and disease 
prevention. The swan song, the final part of this phase, 
connotes the last act or final creative work of a person 
before retirement or death. 
There is much misunderstanding about thoughts of 
death in later life. Depression, serious loss, and 
terminal illness trigger the sense of mortality, 
regardless of age. Contrary to popular stereotypes, 
studies on aging reveal that most older people generally 
do not have a fear or dread of death in the absence of 
being depressed, encountering serious loss, or having 
been recently diagnosed with a terminal illness 
(Kastenbaum, 1985). Periodic thoughts of death-not 
in the form of dread or angst-do occur. But these are 
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usually associated with the death of a friend or family 
member. When actual dread of death does occur, it 
should not be dismissed as accompanying aging, but 
rather as a signal of underlying distress (e.g., 
depression). This is particularly important in light of 
the high risk of suicide among depressed older adults, 
which is discussed later in this chapter. 
Coping With Loss and Bereavement 
Many older adults experience loss with aging-loss of 
social status and self-esteem, loss of physical 
capacities, and death of friends and loved ones. But in 
the face of loss, many older people have the capacity to 
develop new adaptive strategies, even creative 
expression (Cohen, 1988, 1990). Those experiencing 
loss may be able to move in a positive direction, either 
on their own, with the benefit of informal support from 
family and friends, or with formal support from mental 
health professionals. 
The life and work of William Carlos Williams are 
illustrative. Williams was a great poet as well as a 
respected physician. In his 60s he suffered a stroke that 
prevented him from practicing medicine. The stroke did 
not affect his intellectual abilities, but he became so 
severely depressed that he needed psychiatric 
hospitalization. Nonetheless, Williams, with the help of 
treatment for a year, surmounted the depression and for 
the next 10 years wrote luminous poetry, including the 
Pulitzer Prize-winning Pictures From Bruegel, which 
was published when he was 79. In his later life, 
Williams wrote about “old age that adds as it takes 
away.” What Williams and his poetry epitomize is that 
age can be the catalyst for tapping into creative 
potential (Cohen, 1998a). 
Loss of a spouse is common in late life. About 
800,000 older Americans are widowed each year. 
Bereavement is a natural response to death of a loved 
one. Its features, almost universally recognized, include 
crying and sorrow, anxiety and agitation, insomnia. and 
loss of appetite (Institute of Medicine [IOMI, 1984). 
This constellation of symptoms, while overlaPpi% 
somewhat with major depression, does not bY itself 
constitute a mental disorder. Only when symptoms 
persist for 2 months and longer after the loss does the 
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DSM-IV permit a diagnosis of either adjustment 
disorder or major depressive disorder. Even though 
bereavement of less than 2 months’ duration is not 
considered a mental disorder, it still warrants clinical 
attention (DSM-IV). The justification for clinical 
attention is that bereavement, as a highly stressful 
event, increases the probability of, and may cause or 
exacerbate, mental and somatic disorders. 
Bereavement is an important and well-established 
risk factor for depression. At least 10 to 20 percent of 
widows and widowers develop clinically significant 
depression during the first year of bereavement. 
Without treatment, such depressions tend to persist, 
become chronic, and lead to further disability and 
impairments in general health, including alterations in 
endocrine and immune function (Zisook & Shuchter, 
1993; Zisook et al., 1994). Several preventive 
interventions, including participation in self-help 
groups, have been shown to prevent depression among 
widows and widowers, although one study suggested 
that self-help groups can exacerbate depressive 
symptoms in certain individuals [Levy et al., 1993). 
These are described later in this chapter. 
Bereavement-associated depression often coexists 
with another type of emotional distress, which has been 
termed traumatic grief (Prigerson et al., in press). The 
symptoms of traumatic grief, although not formalized 
as a mental disorder in DSM-IV, appear to be a mixture 
of symptoms of both pathological grief and post- 
traumatic stress disorder (Frank et al., 1997a). Such 
symptoms are extremely disabling, associated with 
functional and health impairment and with persistent 
suicidal thoughts, and may well respond to pharmaco- 
therapy (Zygmont et al., 1998). Increased illness and 
mortality from suicide are the most serious 
consequences of late-life depression. 
The dynamics around loss in later life need greater 
clarification. One pivotal question is why some, in 
confronting loss with aging, succumb to depression and 
suicide-which, as noted earlier, has its highest 
frequency after age 65--while others respond with new 
adaptive strategies. Research on health promotion also 
needs to identify ways to prevent adverse reactions and 
to promote positive responses to loss in later life. 1 
Meanwhile, despite cultural attitudes that older persons 
can handle bereavement by themselves or with support 
from family and friends, it is imperative that those who 
are unable to cope be encouraged to access mental 
health services. Bereavement is not a mental disorder 
but, if unattended to, has serious mental health and 
other health consequences. 
Overview of Mental Disorders in 
Older Adults 
Older adults are encumbered bg many of the same 
mental disorders as are other adults; however, the 
prevalence, nature, and course of each disorder may be 
very different. This section provides a general overview 
of assessment, diagnosis, and treatment of mental 
disorders in older people. Its purpose is to describe 
issues common to many mental disorders. Subsequent 
sections of this chapter provide more detailed reviews 
of late-life depression and Alzheimer’s disease. Also, 
to shed light on the range and frequency of disorders 
that impair the mental well-being of older Americans, 
the chapter reviews the impact on older adults of 
anxiety, schizophrenia, and alcohol and substance 
abuse. 
Assessment and Diagnosis 
Assessment and diagnosis of late-life mental disorders 
are especially challenging by virtue of several 
distinctive characteristics of older adults. First, the 
clinical presentation of older adults with mental 
disorders may be different from that of other adults, 
making detection of treatable illness more difficult. For 
example, many older individuals present with somatic 
complaints and experience symptoms of depression and 
anxiety that do not meet the full criteria for depressive 
or anxiety disorders. The consequences of these 
subsyndromal conditions may be just as deleterious as 
the syndromes themselves. Failure to detect individuals 
who truly have treatable mental disorders represents a 
serious public health problem (National Institutes of 
Health [NIH] Consensus Development Panel on 
Depression in Late Life, 1992). 
Detection of mental disorders in older adults is 
complicated further by high comorbidity with other 
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medical disorders. The symptoms of somatic disorders 
n,ay mimic or mask psychopathology, making 
diagnosis more taxing. In addition, older individuals are 
more likely to report somatic symptoms than 
psychological ones, leading to further under- 
identification of mental disorders (Blazer, 1996b). 
Primary care providers carry much of the burden 
for diagnosis of mental disorders in older adults, and, 
unfortunately, the rates at which they recognize and 
properly identify disorders often are low. With respect 
to depression, for example, a significant number of 
depressed older adults are neither diagnosed nor treated 
in primary care (NIH Consensus Development Panel on 
Depression in Late Life, 1992; Unutzer et al., 1997b). 
In one study of primary care physicians, only 5.5 
percent of internists felt confident in diagnosing 
depression, and even fewer (35 percent of the total) felt 
confident in prescribing antidepressants to older 
persons (Callahan et al., 1992). Physicians were least 
likely to report that they felt “very confident” in 
evaluating depression in other late-life conditions 
(Gal10 et al., in press). Researchers estimate that an 
~rnet need for mental health services may be 
experienced by up to 63 percent of adults aged 65 years 
and older with a mental disorder, based on prevalence 
estimates from the Epidemiologic Catchment Area 
(ECA) study (Rabins, 1996). 
The large unmet need for treatment of mental 
disorders reflects patient barriers (e.g., preference for 
primary care, tendency to emphasize somatic problems, 
reluctance to disclose psychological symptoms), 
provider barriers (e.g., lack of awareness of the 
manifestations of mental disorders, complexity of 
treatment, and reluctance to inform patients of a 
diagnosis), and mental health delivery system barriers 
(e.g., time pressures, reimbursement policies), 
Stereotypes about normal aging also can make 
diagnosis and assessment of mental disorders in late 
life challenging. For example, many people believe that 
“senility” is normal and therefore may delay seeking 
care for relatives with dementing illnesses. Similarly, 
Patients and their families may believe that depression 
and hopelessness are natural conditions of older age, 
especially with prolonged bereavement. 
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Cognitive decline. both normal and pathological. 
can be a barrier to effective identification and 
assessment of mental illness in late life. Obtaining an 
accurate history, which may need to be taken from 
family members, is important for diagnosis of most 
disorders and especially for distinguishing betlveen 
somatic and mental disorders. Normal decline in 
short-term memory, and especially the severe 
impairments in memory seen in dementing illnesses 
hamper attempts to obtain good patient histories. 
Similarly, cognitive deficits are prominent features of 
many disorders of late life that make diagnosis of 
psychiatric disorders more difficult. 
Overview of Prevention 
Prevention in mental health has been seen until recently 
as an area limited to childhood and adolescence. Now 
there is mounting a\vareness of the value of prevention 
in the older population. While the body of published 
literature is not as extensive as that for diagnosis or 
treatment, investigators are beginning to shape new 
approaches to pre\,ention. Yet because prevention 
research is driven. in part, by refined understanding of 
disease etiology-and etiology research itself continues 
to be rife with uncertainty-prevention advances are 
expected to lag behind those in etiology. 
There are man! ways in which prevention models 
can be applied to older individuals, provided a broad 
view of prevention is used (Lebowitz & Pearson. in 
press). Such a broad view entails interventions for 
reducing the risk of developing, exacerbating, or 
experiencing the consequences of a mental disorder. 
Consequently, this section covers primary prevention 
(including the pre\.ention of depression and suicide), 
treatment-related prevention, prevention of excess 
disability, and prevention of premature institutionaliza- 
tion. However, many of the research advances noted in 
this section have yet to be translated into practice. 
Given the frequency of memory complaints and 
depression, the tnne may soon arrive for older adu ts ~0 
be encouraged to have “mood and memory cneckups” 
in the same manner that they are now encouraged to 
have physical checkups (N. Abeles, personal 
communication. 1998). 
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Primary Prevention 
Primary prevention, the prevention of disease before it 
occurs, can be applied to late-onset disorders. Progress 
in our understanding of etiology, risk factors, 
pathogenesis, and the course of mental disorders- 
discussed later in this chapter for depression, 
Alzheimer’s disease, and other conditions-stimulates 
and channels the development of prevention 
interventions. 
The largest body of primary prevention research 
focuses on late-life depression, where some progress 
has been documented. With other disorders, primary 
prevention research is in its infancy. Prevention in 
Alzheimer’s disease might target individuals at 
increased genetic risk with prophylactic nutritional 
(e.g., vitamin E), cholinergic, or amyloid-targeting 
interventions. Prevention research on late-onset 
schizophrenia might explore potential protective 
factors, such as estrogen. 
Prevention of Depression and Suicide 
Depression is strikingly prevalent among older people. 
As noted below, 8 to 20 percent of older adults in the 
community and up to 37 percent in primary care 
settings experience symptoms of depression. 
One approach to preventing depression is through 
grief counseling for widows and widowers. For 
example, participation in self-help groups appears to 
ameliorate depression, improve social adjustment, and 
reduce the use of alcohol and other drugs of abuse in 
widows (Constantino, 1988; Lieberman & 
Videka-Sherman, 1986). The efficacy of self-help 
groups approximates that of brief psychodynamic 
psychotherapy in older bereaved individuals without 
significant prior psychopathology (Mat-mar et al., 
1988). The battery of psychosocial and 
pharmacological treatments to prevent recurrences of 
depression (i.e., secondary prevention) is discussed 
later in this chapter under the section on depression. 
Depression is a foremost risk factor for suicide in 
older adults (Conwell, 1996; Conwell et al., 1996). 
Older people have the highest rates of suicide in the 
U.S. population: suicide rates increase with age, with 
older white men having a rate of suicide up to six times 
that of the general population (Kachur et al., 1995; 
Hoyert et al., 1999). Despite the prevalence of 
depression and the risk it confers for suicide, 
depression is neither well recognized nor treated in 
primary care settings, where most older adults seek and 
receive health care (Unutzer et al., 1997a). Studies 
described in the depression section of this chapter have 
found that undiagnosed and untreated depression in the 
primary care setting plays a significant role in suicide 
(Caine et al., 1996). This awareness has prompted the 
development of suicide prevention strategies expressly 
for primary care. One of the first published suicide 
prevention studies, an uncomrolled experiment 
conducted in Sweden, suggested that a depression 
training program for general practitioners reduces 
suicide (Rihmer et al., 1995). Suicide interventions, 
especially in the primary care setting, have become a 
priority of the U.S. Public Health Service, with lead 
responsibility assumed by the Office of the Surgeon 
General and the National Institute of Mental Health. 
Depression and suicide prevention strategies also 
are important for nursing home residents. About half of 
patients newly relocated to nursing homes are at 
heightened risk for depression (Parmelee et al., 1989). 
Treatment-Related Prevention 
Prevention of relapse or recurrence of the underlying 
mental disorder is important for improving the mental 
health of older patients with mental disorders. For 
example, treatments that are applied with adequate 
intensities for depression (Schneider, 1996) and for 
depression in Alzheimer’s disease (Small et al., 1997) 
may prevent relapse or recurrence. Substantial residual 
disability in chronically mentally ill individuals 
(Lebowitz et al., 1997) suggests that treatment must be 
approached from a longer term perspective (Reynolds 
et al., 1996). 
Prevention of medication side effects and adverse 
reactions also is an important goal of treatment-related 
prevention efforts in older adults. Comorbidity and the 
associated polyphatmacy for multiple conditions are 
characteristic of older patients. New information on the 
genetic basis of drug metabolism and on the action of 
drug-metabolizing enzymes can lead to a better 
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understanding of complex drug interactions (Nemeroff 
St 31.. 1996). For example, many of the selective 
zerotonin reuptake inhibitors compete for the same 
metabolic pathway used by beta-blockers, type 1C anti- 
;uThythmics, and benzodiazepines (Nemeroff et al., 
1996). This knowledge can assist the clinician in 
choosing medications that can prevent the likelihood of 
side effects. In addition, many older patients require 
antipsychotic treatment for management of behavioral 
symptoms in Alzheimer’s disease, schizophrenia, and 
depression. Although doses tend to be quite low, age 
and length of treatment represent major risk factors for 
movement disorders (Saltz et al., 1991; Jeste et al., 
1995a). Recent research on older people suggests that 
the newer antipsychotics present a much lower risk of 
movement disorders, highlighting their importance for 
prevention (Jeste et al., in press). Finally, body sway 
and postural stability are affected by many drugs, 
although there is wide variability within classes of 
drugs (Laghrissi-Thode et al., 1995). Minimizing the 
risk of falling, therefore, is another target for 
prevention research. Falls represent a leading cause of 
injury deaths among older persons (IOM, 1999). 
Prevention of Excess Disabilify 
Prevention efforts in older mentally ill populations also 
target avoidance of excessive disability. The concept of 
excess disability refers to the observation that many 
older patients, particularly those with Alzheimer’s 
disease and other severe and persistent mental 
disorders, are more functionally impaired than would 
be expected according to the stage or severity of their 
disorder. Medical, psychosocial, and environmental 
factors all contribute to excess disability. For example, 
depression contributes to excess disability by hastening 
functional impairment in patients with Alzheimer’s 
disease (Ritchie et al., 1998). The fast pace of modem 
life. with its emphasis on independence, also 
contributes to excess disability by making it more 
difficult for older adults with impairments to function 
autonomously. Attention to depression, anxiety, and 
other mental disorders may reduce the functional 
limitations associated with concomitant mental and 
somatic impairments. Many studies have demonstrated 
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that attention to these factors and aggressive 
intervention, where appropriate, maximize function 
(Lebowitz & Pearson, in press). 
Prevention of Premature institutionalization 
Another important goal of prevention efforts in older 
adults is prevention of premature institutionalization. 
While institutional care is needed for many older 
patients who suffer from severe and persistent mental 
disorders, delay of institutional placement until 
absolutely necessary generally is what patients and 
family caregivers prefer. It also has significant public 
health impact in terms of reducing costs. A randomized 
study of counseling and support versus usual care for 
family caregivers of patients with Alzheimer’s disease 
found the intervention to have delayed patients’ nursing 
home admission by over 300 days (Mittelman et al., 
1996). The intervention also resulted in a significant 
reduction in depressive symptoms in the caregivers. 
The intervention consisted of three elements: 
individual and family counseling sessions, support 
group participation, and availability of counselors to 
assist with patient crises. 
The growing importance of avoiding premature 
institutionalization is illustrated by its use as one 
measure of the effectiveness of pharmacotherapy in 
older individuals. For example, clinical trials of drugs 
for Alzheimer’s disease have begun using delay of 
institutionalization as a primary outcome (San0 et al., 
1997) or as a longer-term outcome in a followup study 
after the double-blind portion of the clinical trial ended 
(Knopman et al., 1996). 
Overview of Treatment 
Treatment of mental disorders in older adults 
encompasses pharmacological interventions, electro- 
convulsive therapy, and psychosocial interventions. 
While the pharmacological and psychosocial 
interventions used to treat mental health problems and 
specific disorders may be identical for older and 
younger adults, characteristics unique to older adults 
may be important considerations in treatment selection. 
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Pharmacological Treatment 
The special considerations in selecting appropriate 
medications for older people include physiological 
changes due to aging; increased vulnerability to side 
effects, such as tardive dyskinesia; the impact of 
polypharmacy; interactions with other comorbid 
disorders; and barriers to compliance. All are discussed 
below. 
The aging process leads to numerous changes in 
physiology, resulting in altered blood levels of certain 
medications, prolonged pharmacological effects, and 
greater risk for many side effects (Kendell et al., 1981). 
Changes may occur in the absorption, distribution, 
metabolism, and excretion of psychotropic medications 
(Pollock & Mulsant, 1995). 
As people age. there is a gradual decrease in 
gastrointestinal motility, gastric blood flow, and gastric 
acid production (Greenblatt et al., 1982). This slows the 
rate of absorption, but the overall extent of gastric 
absorption is probably comparable to that in other 
adults. The aging process is also associated with a 
decrease in total body water, a decrease in muscle 
mass, and an increase in adipose tissue (Borkan et al., 
1983). Drugs that are highly lipophilic, such as neuro- 
leptics, are therefore more likely to be accumulated in 
fatty tissues in older patients than they are in’younger 
patients. 
The liver undergoes changes in blood flow and 
volume with age. Phase I metabolism (oxidation, 
reduction, hydrolysis) may diminish or remain 
unchanged, while phase II metabolism (conjugation 
with an endogenous substrate) does not change with 
aging. Renal blood flow, glomerular surface area, 
tubular function, and reabsorption mechanisms all have 
been shown to diminish with age. Diminished renal 
excretion may lead to a prolonged half-life and the 
necessity for a lower dose or longer dosing intervals. 
Pharmacodynamics, which refers to the drug’s 
effect on its target organ, also can be altered in older 
individuals. An example of aging-associated pharmaco- 
dynamic change is diminished central cholinergic 
function contributing to increased sensitivity to the 
anticholinergic effects of many neuroleptics and 
antidepressants in older adults (Molchan et al., 1992). 
Because of the pharmacokinetic and pharmaco- 
dynamic concerns presented above, it is often 
recommended that clinicians “start low and go slow” 
when prescribing new psychoactive medications for 
older adults. In other words, efficacy is greatest and 
side effects are minimized when initial doses are small 
and the rate of increase is slow. Nevertheless, the 
medication should generally be titrated to the regular 
adult dose in order to obtain the full benefit. The 
potential pitfall is that, because of slower titration and 
the concomitant need for more frequent medical visits, 
there is less likelihood of oldec adults receiving an 
adequate dose and course of medication. 
Increased Risk of Side Effects 
Older people encounter an increased risk of side 
effects, most likely the result of taking multiple drugs 
or having higher blood levels of a given drug. The 
increased risk of side effects is especially true for 
neuroleptic agents, which are widely prescribed as 
treatment for psychotic symptoms, agitation, and 
behavioral symptoms. Neuroleptic side effects include 
sedation, anticholinergic toxicity (which can result in 
urinary retention, constipation, dry mouth, glaucoma, 
and confusion), extrapyramidal symptoms (e.g., parkin- 
sonism, akathisia, and dystonia), and tar-dive 
dyskinesia. Chapter 4 contains more detailed 
information about the side effects of neuroleptics. 
Tardive dyskinesia is a frequent and persistent side 
effect that occurs months to years after initiation of 
neuroleptics. In older adults, tardive dyskinesia 
typically entails abnormal movements of the tongue. 
lips, and face. In a recent study of older outpatients 
treated with conventional neuroleptics the incidence of 
tardive dyskinesia after 12 months of neuroleptic 
treatment was 29 percent of the patients. At 24 and 36 
months, the mean cumulative incidence was 50.1 
percent and 63.1 percent, respectively (Jeste et al., 
1995a). This study demonstrates the high risk of tardive 
dyskinesia in older patients even with low doses of 
conventional neuroleptics. Studies of younger adult 
patients reveal an annual cumulative incidence of 
tardive dyskinesia at 4 to 5 percent (Kane et al., 1993). 
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Unlike conventional neuroleptics, the newer 
atypical ones, such as clozapine, risperidone, 
olanzapine, and quetiapine, apparently confer several 
advantages with respect to both efficacy and safety. 
These drugs are associated with a lower incidence of 
extrapyramidal symptoms than conventional neuro- 
leptics are. For clozapine. the low risk of tardive 
dyskinesia is well established (Kane et al., 1993). The 
incidence of tar-dive dyskinesia with other atypical 
antipsychotics is also likely to be lower than that with 
conventional neuroleptics because extrapyramidal 
symptoms have been found to be a risk factor for 
tardive dyskinesia in older adults (Saltz et al., 1991; 
Jeste et al., 1995a). The determination of exact risk of 
tardive dyskinesia with these newer drugs needs 
long-term studies. ’ 
Polypharmacy 
In addition to the effects of aging on pharmacokinetics 
and pharmacodynamics and the increased risk of side 
effects, older individuals with mental disorders also are 
more likely than other adults to be medicated with 
multiple compounds, both prescription and 
nonprescription (i.e., polypharmacy). Older adults (over 
the age of 65) fill an average of 13 prescriptions a year 
(for original or refill prescriptions), which is 
approximately three times the number filled by younger 
individuals (Chrischilles et al., 1992). Polypharmacy 
greatly complicates effective treatment of mental 
disorders in older adults. Specifically, drug-drug 
interactions are of concern, both in terms of increasing 
side effects and decreasing efficacy of one or both 
compounds. 
Treatment Compliance 
Compliance with the treatment regimen also is a special 
concern in older adults, especially in those with 
moderate or severe cognitive deficits. Physical 
problems, such as impaired vision, make it likely that 
instructions may be misread or that one medicine may 
be mistaken for another. Cognitive impairment may 
also make it difficult for patients to remember whether 
or not they have taken their medication. Although in 
general. older patients are more compliant about taking 
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psychoactive medications than other types of drugs 
(Cooper et al., 1982), when noncompliance does occur, 
it may be less easily detected, more serious, less easily 
resolved, mistaken for symptoms of a new disease, or 
even falsely labeled as “old-age” symptomatology. 
Accordingly, greater emphasis must be placed on strict 
compliance by patients in this age group (Lamy et al., 
1992). Medication noncompliance takes different forms 
in older adults, that is, overuse and abuse, forgetting, 
and alteration of schedules and doses. The most 
common type of deliberate noncompliance among older 
adults may be the underuse of the prescribed drug. 
mainly because of side effects and cost considerations. 
Factors that contribute to medication noncompliance in 
older patients include inadequate information given to 
them regarding the necessity for drug treatment, 
unclear prescribing directions, suboptimal 
doctor-patient relationship, the large number of times 
per day drugs must be taken, and the large number of 
drugs that are taken at the same time (Lamy et al., 
1992). Better compliance may be achieved by giving 
simple instructions and by asking specific questions to 
make sure that the patient understands directions. 
Psychosocial Interventions 
Several types of psychosocial interventions have 
proven effective in older patients with mental disorders, 
but the research is more limited than that on 
pharmacological interventions (see Klausner & 
Alexopoulos, in press). Both types are frequently used 
in combination. Most of the research has been 
restricted to psychosocial treatments for depression, 
although, as discussed below, there is mounting interest 
in dementia. For other mental disorders, psychosocial 
interventions found successful for younger adults are 
often tailored to older people in the practice setting 
without the benefit of efficacy research. 
Despite the relative paucity of research, psycho- 
social interventions may be preferred for some older 
patients, especially those who are unable to tolerate, or 
prefer not to take, medication or who are confronting 
stressful situations or low degrees of social support 
(Lebowitz et al., 1997). The benefits of psychosocial 
interventions are likely to assume greater prominence 
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as a result of population demographics: as the number 
of older people grows, progressively more older people 
in need of mental health treatment-especially the very 
old-are expected to be suffering from greater levels of 
comorbidity or dealing with the stresses associated with 
disability. Psychosocial interventions not only can help 
relieve the symptoms of a variety of mental disorders 
and related problems but also can play more diverse 
roles: they can help strengthen coping mechanisms, 
encourage (and monitor) patients’ compliance with 
medications, and promote healthy behavior (Klausner 
& Alexopoulos, in press). 
New approaches to service delivery are being 
designed to realize the benefits of established psycho- 
social interventions. Many older people are not 
comfortable with traditional mental health settings, 
partially as a result of stigma (Waters, 1995). In fact, 
many older people prefer to receive treatment for 
mental disorders by their primary care physicians, and 
most older people do receive such care in the primary 
care setting (Brody et al., 1997; Unutzer et al., 1997a). 
Since older people show willingness to accept 
psychosocial interventions in the primary care setting, 
new models are striving to integrate into the primary 
care setting the delivery of specialty mental health 
services. The section of this chapter on service delivery 
discusses new models in greater detail. 
Gap Between Efficacy and Effectiveness 
A problem common to both pharmacological and 
psychosocial interventions is the disparity between 
treatment efficacy, as demonstrated in randomized 
controlled clinical trials, and effectiveness in real-world 
settings. While this problem is certainly not unique to 
older people (see Chapter 2 for a broader discussion of 
the problem), this problem is especially significant for 
older people with mental disorders. Older people are 
often undertreated for their mental disorders in primary 
care settings (Unutzer et al., 1997a). When they do 
receive appropriate treatment, older people are more 
likely than other people to have comorbid disorders and 
social problems that reduce treatment effectiveness 
(Unutzer et al.. 1997a). An additional overlay of 
barriers, including financing and systems of care, is 
discussed later in this chapter. 
Depression in Older Adults 
Depression in older adults not only causes distress and 
suffering but also leads to impairments in physical, 
mental, and social functioning. Despite being 
associated with excess morbidity and mortality, 
depression often goes undiagnosed and untreated. The 
startling reality is that a substantial proportion of older 
patients receive no treatment or inadequate treatment 
for their depression in primary care settings, according 
to expert consensus (NM Consensus Development 
Panel on Depression in Late Life, 1992; Lebowitz et 
al., 1997). Part of the problem is that depression in 
older people is hard to disentangle from the many other 
disorders that affect older people, and its symptom 
profile is somewhat different from that in other adults. 
Depressive symptoms are far more common than full- 
fledged major depression. However, several depressive 
symptoms together represent a condition-explained 
below as “minor depression”-that can be as disabling 
as major depression (Unutzer et al., 1997a). Minor 
depression, despite the implications of the term, is 
major in its prevalence and impact. Eight to 20 percent 
of older adults in the community and up to 37 percent 
in primary care settings suffer from depressive 
symptoms. Treatment is successful, with response rates 
between 60 and 80 percent, but the response generally 
takes longer than that for other adults. In addition to 
reviewing information on prevalence and treatment, 
this section also discusses depression’s course, barriers 
to diagnosis, interactions with physical disease, 
consequences, cost, and etiology. 
Diagnosis of Major and “Minor” Depression 
The term “major depression” refers to conditions with 
a major depressive episode, such as major depressive 
disorder, bipolar disorder, and related conditions. 
Major depressive disorder, the most common type of 
major depression in adults, is characterized by one or 
more episodes that include the following symptoms: 
depressed mood, loss of interest or pleasure in 
activities, significant weight loss or gain, sleep 
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disturbance, psychomotor agitation or retardation, 
fatigue, feelings of worthlessness, loss of 
concentration, and recurrent thoughts of death or 
suicide. (For further discussion of the diagnosis of 
major depressive disorder, see Chapter 4.) Major 
depressive disorder cannot be diagnosed if symptoms 
last for less than 2 months after bereavement, among 
other exclusionary factors (DSM-IV). 
Most older patients with symptoms of depression 
do not meet the full criteria for major depression. The 
new diagnostic entity of minor depression has been 
proposed to characterize some of these patients. “Minor 
depression,” a subsyndromal form of depression, is not 
yet recognized as an official disorder, and DSM-IV 
proposes further research on it. 
Minor depression is more frequent than major 
depression, with 8 to 20 percent of older community 
residents displaying symptoms (Alexopoulos, 1997; 
Gallo & Lebowitz, 1999). The diagnosis of minor 
depression is not yet standardized; the research criteria 
proposed in DSM-IV are the same as those for major 
depression, but a diagnosis would require fewer 
symptoms and less impairment. Minor depression, in 
fact, is not thought to be a single syndrome, but rather 
a heterogeneous group of syndromes that may signify 
either an early or residual form of major depression, a 
chronic, though mild, form of depression that does not 
present with a full array of symptoms at any one time, 
called dysthymia. or a response to an identifiable 
stressor (Judd et al., 1994; Pincus & Wakefield-Davis, 
1997). Since depression is more difficult to assess and 
detect in older adults, research is needed on what 
clinical features might help identify older adults at 
increased risk for sustained depressive symptoms and 
suicide. 
Both major and minor depression are associated 
with significant disability in physical, social, and role 
functioning (Wells et al., 1989). The degree of 
disability may not be as great with minor depression, 
but because of its higher prevalence, minor depression 
is associated with 5 1 percent more days lost from work 
than is major depression (Broadhead et al., 1990). 
Major and minor depression are associated with high 
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health care utilization and poor quality of life (see 
Unutzer et al.. 1997a, for a review). 
Late-Onset Depression 
Major or minor depression diagnosed with first onset 
later than age 60 has been termed late-onset 
depression. Late-onset depression is not a diagnosis; 
rather, it refers to a subset of patients with major or 
minor depression whose later age at first onset imparts 
slightly different clinical characteristics, suggesting the 
possibility of distinct etiology. Late-onset depression 
shares many clinical characteristics with early-onset 
depression, yet some distinguishing features exist. 
Patients with late-onset depression display greater 
apathy (Krishnan et al., 1995) and less lifetime 
personality dysfunction (Abrams et al., 1994). 
Cognitive deficits may be more prominent, with more 
impaired executive and memory functioning (Salloway 
et al., 1996) and greater medial temporal lobe 
abnormalities on magnetic resonance imaging, similar 
to those seen in dementia (Greenwald et al., 1997). 
Other studies, however, have shown no differences in 
cognition between patients with late- and early-onset 
depression (Holroyd & Duryee. 1997). The risk of 
recurrence of depression is relatively high among 
patients with onset of depression after the age of 60 
(Reynolds, 1998). 
Risk factors for late-onset depression, based on 
results of prospective studies, include widowhood 
(Bruce et al., 1990; Zisook & Shuchter, 1991; Harlow 
et al., 1991; Mendes de Leon et al., 1994), physical 
illness (Cadoret & Widmer, 1988; Harlow et al., 1991: 
Bachman et al., 1992), educational attainment less than 
high school (Wallace & O’Hara. 1992; Gallo et al.. 
1993),impaired functional status (Bruce &Hoff, 1994) 
and heavy alcohol consumption (Saunders et al., 199 1). 
Prevalence and Incidence 
Estimates of the prevalence of major depression vary 
widely, depending on the definition and the procedure 
used for counting persons with depression (Gallo & 
Lebowitz, 1999). Researchers applying DSM criteria 
for major depression have found 1-yearU.S. prevalence 
rates of about 5 percent or less in older people (Gurland 
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et al., 1996). The prevalence of major depression 
declines with age, while depressive symptoms increase 
(symptoms that now might warrant classification as 
minor depression). Romanoski and colleagues, on the 
basis of psychiatric interviews of adults in the 
Baltimore Epidemiologic Catchment Area, showed that 
major depression declined with advancing age 
(Romanoski et al., 1992). Prevalence estimates derived 
from symptom scales are consistent with the clinical 
impression that prevalence of depressive symptoms 
increases with advancing age. Depressive symptoms 
and syndromes have been identified in 8 to 20 percent 
of older community residents (Alexopoulos, 1997; 
Gallo & Lebowitz, 1999) and 17 to 35 percent of older 
primary care patients (Gurland et al., 1996). 
Several incidence studies based on DSM criteria 
reflect a similar pattern of decline in rates of major 
depression with advancing age (Eaton et al., 1989; 
Eaton et al., 1997). The 13-year followup of the 
participants of the Baltimore Epidemiologic Catchment 
Area (ECA) sample revealed, however, that the 
distribution of the incidence of DSM-based major 
depression across the life span was bimodal, with a 
primary peak in the fourth decade and a secondary peak 
in the sixth decade (Eaton et al., 1997). In contrast to 
studies based on DSM criteria, several incidence 
studies report increased rates of depressive symptoms 
with age. A Swedish study reported that rates of 
depressive symptoms were highest in the older age 
groups and that rates of depression had increased in the 
interval from 1947-1957 to 1957-1972 (Hagnell et al., 
1982). Incidence studies reveal an increased risk of 
depression among women as they age, consistent with 
findings based on prevalence surveys (Hagnell et al., 
1982; Eaton et al., 1989; Gallo et al., 1993). 
Thus, both prevalence and incidence studies that 
rely on DSM-based diagnosis of major depression 
suggest a decline with age, whereas symptom-based 
assessment studies show increased rates of depression 
among older adults, especially women. Evidence that 
older adults are less likely than younger persons to 
report feelings of dysphoria (i.e., sadness. unhappiness, 
or irritability) suggests that the standard criteria for 
depression may be more difficult to apply to older 
adults (Gallo et al., 1994) or that older adults are 
disinclined to report such feelings. 
Other mood disorders, such as dysthymia, bipolar 
disorder, and hypomania,’ also are present in older 
individuals. Little difference has been found in the 
prevalence of affective disorders between African 
Americans and whites over the age of 65 (Weissman et 
al., 199 1). The prevalence of bipolar disorder among 
people aged 65 and over is reportedly less than 1 
percent (Robins & Regier, 1991). Approximately 5 to 
10 percent of older patients presenting with mood 
disorders are manic or hypomanic (Yassa et al., 1988). 
However, these mood disorders will not be the focus of 
this section of the report, as they are much less 
common in older adults than depression. 
Barriers to Diagnosis and Treatment 
The underdiagnosis and undertreatment of depression 
in primary care represent a serious public health 
problem (NIH Consensus Development Panel on 
Depression in Late Life, 1992). One study found that 
only about 11 percent of depressed patients in primary 
care received adequate antidepressant treatment (in 
terms of dose and duration of pharmacotherapy), while 
34 percent received inadequate treatment and 55 
percent received no treatment (Katon et al., 1992). 
There are many barriers to the diagnosis of 
depression in late life. Some of these barriers reflect the 
nature of the disorder: depression occurs in a complex 
medical and psychosocial context. In the elderly, the 
signs and symptoms of major depression are frequently 
attributed to “normal aging,” atherosclerosis, 
Alzheimer’s disease, or any of a host of other age- 
associated afflictions. Psychosocial antecedents such as 
loss, combined with decrements in physical health and 
sensory impairment, can also divert attention from 
clinical depression. 
Another reason for the underdiagnosis is that older 
patients are less likely to report symptoms of dysphoria 
and worthlessness, which are often considered 
hallmarks of the diagnosis of depression. The 
’ Hypomania is marked by abnormally elevated mood, but the 
symptoms are not severe enough for mania (see Chapter 4). 
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consequences of underdiagnosis of this subset of 
patients can be severe. On the basis of a followup of 
older adults in the Baltimore Epidemiologic Catchment 
Area sample, persons with depressive symptoms (e.g., 
sleep and appetite disturbance) without sadness (e.g., 
hopelessness, worthlessness, thoughts of death, wanting 
to die, or suicide) were at increased risk for subsequent 
functional impairment, cognitive impairment, 
psychological distress, and death over the course of the 
13-year interval (Gallo et al., 1997). 
Other barriers to diagnosis are patient related. 
Depression can and frequently does amplify physical 
symptoms, distracting patients’ and providers’ attention 
from the underlying depression; and many older 
patients may deny psychological symptoms of 
depression or refuse to accept the diagnosis because of 
stigma. This appears to be particularly the case with 
older men, who also have the highest rates of suicide in 
later life (Hoyert et al., 1999). 
Provider-related factors also appear to play a role 
in underdetection of depression and suicide risk. 
Providers may be reluctant to inform older patients of 
a diagnosis of depression, owing to uncertainty about 
diagnosis, reluctance to stigmatize, uncertainty about 
optimal treatment, concern about medication 
interactions or lack of access to psychiatric care, and 
continuing concern about the effectiveness and cost- 
effectiveness of treatment intervention (NIH Consensus 
Development Panel on Depression in Late Life, 1992; 
Unutzer et al., 1997a). 
Societal stereotypes about aging also can hamper 
efforts to identify and diagnose depression in late life. 
Many people believe that depression in response to the 
loss of a loved one, increased physical limitations, or 
changing societal role is an inevitable part of aging. 
Even physicians appear to hold such stereotyped views. 
Three-quarters of physicians in one study thought that 
depression “was understandable” in older persons 
(Gallo et al., in press), consistent with other studies 
(Bartels et al., 1997). Suicidal thoughts are sometimes 
considered a normal facet of old age. These mistaken 
beliefs can lead to underreporting of symptoms by 
patients and lack of effort on the part of family 
members to seek care for patients. 
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Finally, the health care system itself is increasingly 
restricting the time spent in patient care, forcing mental 
health concerns to compete with comorbid general 
medical conditions. Primary care physicians often 
report feeling too pressured for time to investigate 
depression in older people (Glasser & Gravdal, 1997). 
Given the inseparability of mental and general health in 
later life particularly, this trend is worrisome. 
Course 
Across the life span, the course of depression is marked 
by recurrent episodes of depression followed by 
periods of remission. In late life, the course of 
depression tends to be more chronic than that in 
younger adults (Alexopoulos & Chester, 1992; 
Callahan et al., 1994; Cole & Bellavance, 1997). This 
means that recurrences extend for longer duration, 
while intervals of remission are shorter. It also means 
that cycles of recurrence and remission persist over a 
longer period of time. Patients’ response to treatment is 
highly variable, and the determinants of treatment 
response and its temporal profile are the subjects of 
intense research (Reynolds & Kupfer, 1999). A slower, 
less consistent response, which suggests a higher 
probability of relapse, is related to older age, presence 
of acute and chronic stressors, lower levels of 
perceived social support, higher levels of pretreatment 
anxiety, and greater biologic dysregulation as reflected 
in higher levels of rapid eye movement sleep (Dew et 
al., 1997). The temporal profile of the initial treatment 
response also may provide important clues about which 
patients are likely to fare well on maintenance 
treatment and which ones are likely to have a brittle 
treatment response and stormy long-term course. 
A recent update of the NIH Consensus Develop- 
pment Conference on the Diagnosis and Treatment of 
Late-Life Depression emphasized the need for more 
data to guide long-term treatment planning, especially 
in patients 70 years and older with major depression 
(Lebowitz et al., 1997). Little is currently known about 
differences, if any, in speed and rate of remission, 
relapse, recovery, and recurrence in patients aged 60 to 
69 and those aged 70 and above. In a study at the 
University of Pittsburgh, two groups of patients (ages 
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60 to 69 and 70+) showed comparable times to 
remission and recovery, as well as similar absolute 
rates of remission during acute therapy, relapse during 
continuation therapy, and recovery. However, patients 
aged 70 and older experienced a significantly higher 
rate of recurrence during the first year of maintenance 
therapy (Reynolds. 1998). Thus, the course of 
depression and its interaction with treatment are 
influenced by age. This highlights the importance of 
research targeted at older age groups instead of reliance 
on extrapolations from younger patients. 
Interactions With Somatic Ihess 
Late-life mental disorders are often detected in 
association with somatic illness (Reynolds & Kupfer, 
1999). The prevalence of clinically significant 
depression in later life is estimated to be highest- 
approximately 25 percent-among those with chronic 
illness. especially with ischemic heart disease, stroke, 
cancer, chronic lung disease, arthritis, Alzheimer’s 
disease, and Parkinson’s disease (Borson et al., 1986; 
Blazer, 1989; Oxman et al., 1990; Callahan et al., 1994; 
Beekman et al., 1995; Borson, 1995). 
The relationship between somatic illness and 
mental disorders is likely to be reciprocal, but the 
mechanisms are far from understood. Biological and 
psychological factors are thought to play a role 
(Unutzer et al., 1997a). The nature and course of 
late-life depression can be greatly affected by the 
coexistence of one or more other medical conditions. 
Insomnia and sleep disturbance play a large role in 
the clinical presentation of older depressed patients. 
Sleep complaints over time in community-residing 
older people have been found to vary with the intensity 
of depressive symptoms (Rodin et al., 1988). Sleep 
disturbances in older men and women have also been 
recently linked to poor health, depression, angina. 
limitations in activities of daily living, and chronic use 
of benzodiazepines (Newman et al., 1997). 
Furthermore, persistent or residual sleep disturbance in 
older patients with prior depressive episodes predicts a 
less successful maintenance response to 
pharmacotherapy (Buysse et al., 1996). The prevalence 
of chronic. primary insomnia in older adults is 
estimated at 5 to 10 percent (Ohayon et al., 1996). 
Relatively little is known about the etiology or 
pathophysiology of chronic primary insomnia and why 
it constitutes a risk factor for depression in older adults. 
An important issue for further research is whether 
effective treatment for chronic insomnia could prevent 
the subsequent development of clinical depression in 
midlife and later. 
Consequences of Depression 
The most serious consequence of depression in later 
life-especially untreated or inadequately treated 
depression-is increased mortality from either suicide 
or somatic illness. Older persons (65 years and above) 
have the highest suicide rates of any age group. The 
suicide rate for individuals age 85 and older is the 
highest, at about 21 suicides per 100,000, a rate almost 
twice the overall national rate of 10.6 per 100,000 
(CDC, 1999). The high suicide rate among older people 
is largely accounted for by white men, whose suicide 
rate at age 85 and above is about 65 per 100,000 (CDC, 
1999). Trends from 1980 to 1992 reveal that suicide 
rates are increasing among more recent cohorts of older 
persons (Kachur et al., 1995). Since national statistics 
are unlikely to include more veiled forms of suicide, 
such as nursing home residents who stop eating, 
estimates are probably conservative. 
Suicide in older adults is most associated with late- 
onset depression: among patients 75 years of age and 
older, 60 to 75 percent of suicides have diagnosable 
depression (Conwell, 1996). Using a “psychological 
autopsy,” Conwell and coworkers investigated all 
suicides within a geographical region and found that 
with increasing age, depression was more likely to be 
unaccompanied by other conditions such as substance 
abuse (Conwell et al., 1996). While thoughts of death 
may be developmentally expected in older adults, 
suicidal thoughts are not. From a stratified sample of 
primary care patients over age 60, Callahan and 
colleagues estimated the prevalence of specific suicidal 
thoughts at 0.7 to 1.2 percent (Callahan et al., 1996b). 
Unfortunately, no demographic or clinical variables 
distinguished depressed suicidal patients from 
depressed nonsuicidal patients (Callahan et al., 1996b). 
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Swedish researchers found much higher rates of 
suicidal ideation after interviewing adults aged 85 years 
and older. They found a l-month prevalence of any 
suicidal feelings in 9.6 percent of men and 18.7 percent 
of women (Skoog et al., 1996). Suicidal feelings were 
strongly associated with depression. For example, 6.2 
percent of the participants who did not meet criteria for 
depression or anxiety reported suicidal thoughts, while 
almost 50 percent of those meeting criteria for 
depression reported such thoughts. The higher 
prevalence of suicidal feelings in this study, compared 
with that cited earlier, is likely due to the older age of 
subjects and to methodological differences. 
Studies of older persons who have committed 
suicide have revealed that older adults had seen their 
physician within a short interval of completing suicide, 
yet few were receiving mental health treatment. Caine 
and coworkers studied the records of 97 adults aged 50 
years and older who completed suicide (Caine et al., 
1996). Of this group, 51 had seen their primary care 
physician within 1 month of the suicide. Forty-five had 
psychiatric symptoms. Yet in only 29 of the 45 
individuals were symptoms recognized, in only 19 was 
treatment offered, and in only 2 of these 19 cases was 
the treatment rendered considered adequate. Treatment 
was deemed inadequate if an incorrect medicine (such 
as a benzodiazepine for severe major depression) or 
inadequate dose was prescribed. This line of research 
highlights important opportunities for suicide 
prevention. 
Depression also can lead to increased mortality 
from other diseases, such as heart disease and possibly 
cancer. How depression exerts these effects is not yet 
understood. In nursing home patients, major depression 
increases the likelihood of mortality by 59 percent, 
independent of physical health measures (Rovner, 
1993). In the case of myocardial infarction, depression 
elevates mortality risk fivefold (Frasure-Smith et al., 
1993. 1995). Depression also has been linked to the 
onset of cancer, but results have been inconsistent. Yet 
a new epidemiological study, considered the most 
compelling to date, finds that chronic depression 
(lasting an average of about 4 years) raises the risk of 
cancer by 88 percent in older people (Penninx et al., 
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1998). Thus, increased understanding of depression in 
older people may be, literally, a matter of life and 
death. 
cost 
The high prevalence of depressive syndromes and 
symptoms in older adults exacts a large economic toll. 
Depression as a whole for all age groups is one of the 
most costly disorders in the United States (Hirschfeld 
et al., 1997). The direct and indirect costs of depression 
have been estimated at $43 billion each year, not 
including pain and suffering and diminished quality of 
life (Finkelstein et al., 1996). Late-life depression is 
particularly costly because of the excess disability that 
it causes and its deleterious interaction with physical 
health. Older primary care patients with depression 
visit the doctor and emergency room more often, use 
more medication, incur higher outpatient charges. and 
stay longer at the hospital (Callahan et al., 1994: 
Cooper-Patrick et al., 1994; Callahan & Wolinsky, 
1995; Unutzer et al., 1997b). 
Etiology of Late-Onset Depression 
Despite major advances. the etiology of depression 
occurring at any age is not fully understood, although 
biological and psychosocial factors clearly play an 
important and interactive role. 
With respect to late-onset depression, several risk 
factors have been identified. Persistent insomnia, 
occurring in 5 to 10 percent of older adults, is a known 
risk factor for the subsequent onset of new cases of 
major depression both in middle-aged and older 
persons (Ford & Kamerow, 1989). Grief following the 
death of a loved one also is an important risk factor for 
both major and minor depression. At least 10 to 20 
percent of widows and widowers develop clinically 
significant depression during the first year of 
bereavement. Without treatment, such depressions tend 
to persist, becoming chronic and leading to further 
disability and impairments in general health (Zisook & 
Shuchter, 1993). A final pathway to late-onset 
depression, suggested by computed tomography and 
magnetic resonance imaging studies, may involve 
structural, neuroanatomic factors. Enlarged lateral 
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ventricles, cortical atrophy, increased white matter 
hyperintensities, decreased caudate size, and vascular 
lesions in the caudate nucleus appear to be especially 
prominent in late-onset depression associated with 
vascular risk factors (Ohayon et al., 1996; Baldwin & 
Tomenson, 1995). These findings have generated the 
vascular hypothesis of late-onset depression; namely, 
that even in the absence of a clear stroke, disorders that 
cause vascular damage, such as hypertension, coronary 
artery disease, and diabetes mellitus, may induce 
cerebral pathology that constitutes a vulnerability for 
depression (Alexopoulos et al., 1997; Steffens & 
Krishnan, 1998). 
Treatment of Depression in Older Adults 
A broad array of effective treatments, both 
pharmacological and psychosocial, exists for 
depression. Despite the pervasiveness of depression 
and the existence of effective treatments, a substantial 
fraction of patients receive either no treatment or 
inadequate treatment, as described earlier. Some of the 
barriers relate to underdiagnosis, while others relate to 
treatment where there are patient, provider, and clinical 
barriers (for more details, see Unutzer et al., 1996). 
Pharmacological Treatment 
There is consistent evidence that older patients, even 
the very old, respond to antidepressant medication 
(Reynolds & Kupfer, 1999). About 60 to 80 percent of 
older patients respond to treatment, while the placebo 
response rate is about 30 to 40 percent (Schneider, 
1996). These rates are comparable to those in other 
adults (see Chapter 4). Treatment response is typically 
defined by a significant reduction-usually 50 percent 
or greater-in symptom severity. Yet because patients 
75 years old and older typically have higher prevalence 
of medical comorbidity, both they and their physicians 
are often reluctant to add another medication to an 
already complex regimen in a frail individual. 
However, newer antidepressants are less frequently 
associated with factors contraindicating their use. 
Moreover, because the very old are also at high risk for 
adverse medical outcomes of depression and for 
suicide, treatment may be favored. Despite the 
availability of effective treatments, a minority of 
patients properly diagnosed with depression receive 
adequate dosage and duration of pharmacotherapy, as 
noted earlier. 
In general, pharmacological treatment of 
depression in older people is similar to that in other 
adults, but the selection of medications is more 
complex because of side effects and interactions with 
other medications for concomitant somatic disorders. 
Treatment of minor depression is generally the same as 
treatment for major depression, but there is not a large 
body of evidence to support this practice. Studies are 
under way to identify effectivE pharmacological 
treatments for minor depression (Lebowitz et al., 1997). 
The following paragraphs describe the major 
classes of medications for treatment of depression in 
older adults. They focus on side effects and other 
concerns that distinguish the treatment of depression in 
older adults from that in younger ones. 
Tricyclic Antidepressants 
Tricyclic antidepressants (TCAs) have been widely 
used to treat depressed patients of all ages. 
Alexopoulos and Salzman (1998) reviewed studies of 
TCAs in older depressed patients and concluded that 
these compounds are similar in efficacy across the age 
spectrum, but the side effect profiles differ 
considerably. Widespread use of the TCAs in older 
adults is limited by adverse reactions. While 
anticholinergic effects such as dry mouth, urinary 
retention, and constipation can be annoying in younger 
adults, they can lead to severe problems in older adults. 
For example, constipation can lead to impaction, and 
dry mouth can prevent the wearing of dentures. The 
anticholinergic effects of the TCAs may also cause 
tachycardia or arrhythmias and can further compromise 
preexisting cardiac disease (Roose et al., 1987; 
Glassman et al., 1993). Central anticholinergic effects 
may result in acute confusional states or memory 
problems in the depressed older adult (Branconnier et 
al., 1982). Orthostatic hypotension, which may lead to 
falls and hip fractures, is also a concern when the TCAs 
are administered. Nevertheless, TCAs are still frequent- 
ly used in older adults. 
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Selective Serotonin Reuptake Inhibitors and Other 
Newer Antidepressants 
Selective serotonin reuptake inhibitors (SSRIs) such as 
fluoxetine, paroxetine, and sertraline, whose use is 
increasing across age groups. may be especially useful 
in the treatment of late-life depression, because these 
agents are reported to have fewer anticholinergic and 
cardiovascular side effects than the TCAs. The more 
commonly observed side effects with SSRIs include 
sexual dysfunction and gastrointestinal effects such as 
nausea, vomiting, and loose stools. Treatment with the 
SSRIs may also produce insomnia, anxiety, and 
restlessness. The few studies that have examined the 
efficacy of these compounds in older adults have 
shown efficacy similar to the TCAs and fewer side 
effects (see Small & Saliman, 1998, for a review). 
While the relative efficacy of SSRIs and TCAs is still 
debated, SSRIs are easier to prescribe because of 
simpler dosing patterns and more manageable side 
effects. 
One concern when prescribing the SSRIs in older 
adults is the potential for drug-drug interactions. This 
is of clinical importance since older adults commonly 
receive a large number of medications. The SSRIs vary 
in their inhibition of the cytochrome ~450 family of 
isoenzymes. Knowledge of these patterns of inhibition 
in the SSRIs and other medications commonly used in 
older adults (such as other psychoactive compounds, 
calcium channel blockers, or warfarin) can help to 
avoid or minimize interactions. Other newer non-SSRI 
antidepressants (venlafaxine, bupropion, trazodone, and 
nefazodone) are often suggested for treating later life 
depression because their side effects are better tolerated 
by older adults. 
Some compounds that are useful in other 
individuals may be less useful for treatment of older 
patients. For example, despite evidence of the efficacy 
of monamine oxidase inhibitors (see Alexopoulos & 
Salzman. 1998, for a review), clinical use is often 
restricted to patients who are refractory to other 
antidepressant drugs. This is due to potentially 
life-threatening pharmacodynamic interactions with 
sympathomimetic drugs or tyramine-containing foods 
and beverages. The sympathomimetic amines (e.g., 
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phenylpropanolamine and pseudoephedrine) may be 
present in over-the-counter decongestant products that 
older patients are prone to self-administer. An 
additional concern is the risk of orthostatic 
hypotension, which occurs even at therapeutic doses 
(Alexopoulos & Salzman, 1998). In addition, 
bupropion has been shown in older patients to be as 
effective as TCAs (Branconnier et al., 1983; Kane et 
al., 1983). Although generally well tolerated, its use 
requires added caution because of an increased risk of 
seizures and thus should be avoided in patients with 
seizure disorder or focal central nervous system 
disease. Its advantages include a relatively low 
incidence of cardiovascular complications and a lack of 
confusion. 
Multimodal Therapy 
Combining pharmacotherapy with psychosocial 
interventions also appears to be effective in older 
depressed patients. A high response rate of about 80 
percent was found for acute and continuation treatment 
with combined nortriptyline and interpersonal 
psychotherapy. The response rate was similar between 
so-called “young old” patients (primarily in their 60s 
and early 70s) and patients in their 30s and 40s 
(Reynolds et al., 1996). Yet older patients showed a 
somewhat longer time to remission than did other 
patients (about 2 weeks longer) and twice the rate of 
relapse during continuation treatment (about 15 percent 
versus 7 percent). However, because the trial was not 
controlled, it is not known whether multimodal 
treatment was more effective than either 
pharmacological or psychosocial treatment alone. 
Treatment resistance-defined by the lack of recovery 
in spite of combined treatment with nortriptyline and 
interpersonal psychotherapy-was seen in about 18 
percent of older patients with recurrent major 
depression (nonpsychotic unipolar depression) (Little 
et al., 1998). Nortriptyline and interpersonal 
psychotherapy (IPT) have been shown to be effective 
maintenance treatments for late-life depression. After 
3 years of comparing various treatments, the percentage 
of older adults who did not experience recurrence were 
57 percent of older adults receiving nortriptyline, 36 
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percent receiving IPT, and 80 percent of those 
receiving nortriptyiine plus IPT. Those receiving a 
placebo and routine clinical visits had a 90 percent 
recurrence rate (Reynolds et al., 1999). 
Course of Treatment 
Although 60 to 80 percent of older patients with 
moderate to severe unipolar depression’ can be 
expected to respond well to antidepressant treatment 
(especially combined treatment with medication and 
psychotherapy), the clinical response to antidepressant 
treatment in later life follows a variable course, with a 
median time to remission of 12 weeks (J. L. Cummings 
& D. J. Kupfer, personal communication, 1999). Thus, 
treatment response takes 1 month or more longer than * 
that for other adults, for whom treatment response takes 
an average of 6 to 8 weeks (see Chapter 4). In addition 
to highly variable trajectories to recovery, reliable 
prediction of response status (recovery/nonrecovery) is 
generally not possible in older adults before 4 to 5 
weeks of treatment. The delayed onset of 
antidepressant activity in older adults leads to unique 
problems. Suffering and disability are prolonged, which 
often reduces compliance and may increase risk for 
suicide. The development of strategies to accelerate 
treatment response and to improve the early 
identification of nonresponders would be an important 
advance (Reynolds & Kupfer, 1999). 
Data from naturalistic studies have identified 
several predictors of relapse and recurrence in late-life 
depression, including a history of frequent episodes, 
first episode after age 60, concurrent somatic illness, 
especially a history of myocardial infarction or vascular 
disease. high pretreatment severity of depression and 
anxiety, and cognitive impairment, especially frontal 
lobe dysfunction. These factors appear to interact with 
low treatment intensity -that is, at dosage and duration 
below recommended levels-in determining more 
severe courses of illness. Despite the evidence that high 
treatment intensity is effective in preventing relapse 
and recurrence (Reynolds et al., 1995), naturalistic 
’ Unipolar depression refers to the depression in patients with 
major depressive disorders but not to the depression in patients 
with bipolar disorders. 
studies have shown that intensity of treatment 
prescribed by psychiatrists begins to decline within 16 
weeks of entry and approximately 10 weeks prior to 
recovery (Alexopoulos et al., 1996). Residual 
symptoms of excessive anxiety and worrying predict 
early recurrence after tapering continuation treatment 
in older depressed patients (Meyers, 1996). 
Although progress has been made in identifying 
effective pharmacological and combined treatments for 
late-life depression, there is a need for more outcome 
studies with newer antidepressants. In addition, studies 
examining effectiveness in real-world settings-rather 
than in clinical trials conducted in academic clinical 
sites-are particularly crucial in the older population 
because of medical comorbidity and provision of care 
in primary, rather than specialty, care. 
Electroconvulsive Therapy 
Electroconvulsive therapy (ECT) is regarded as an 
effective intervention for some forms of treatment- 
resistant depression across the life cycle (NIH & NIMH 
Consensus Conference, 1985; Depression Guideline 
Panel, 1993). It may offer a particularly attractive 
benefit:risk ratio in older persons with depression (NIH 
Consensus Development Panel on Depression in Late 
Life, 1992; Sackeim, 1994). Chapter4 reviews research 
on ECT and considers risk-benefit issues and 
controversy surrounding them. As described there, ECT 
entails the electrical induction of seizures in the brain, 
administered during a series of 6 to 12 treatment 
sessions on an inpatient or outpatient basis. Practice 
guidelines recommend that ECT should be reserved for 
severe cases of depression, particularly with active 
suicidal risk or psychosis; patients unresponsive to 
medications; and those who cannot tolerate medications 
(NIH & NIMH Consensus Conference, 1985; Depres- 
sion Guideline Panel, 1993). For those patients, the 
response rate to ECT is on the order of 50 to 70 
percent, and there is no evidence that ECT is any less 
effective in older individuals than younger ones 
(Sackeim, 1994; Weiner & Krystal, 1994). ECT is 
advantageous for older people with depression because 
of the special problems they encounter with 
medications, including sensitivity to anticholinergic 
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toxicity, cardiac conduction slowing, and hypotension 
(see above). Although the newer antidepressants offer 
a more favorable side-effect profile than do the older 
tricyclics, their efficacy in melancholic depression, for 
which ECT is particularly helpful (Rudorfer et al., 
1997), is not yet firmly established. Moreover, as noted 
earlier, older adults respond more slowly than younger 
ones to antidepressant medications, rendering the faster 
onset of action of ECT another advantage in the older 
patient (Markowitz et al., 1987). Immobility and 
reduced food and fluid intake in the older person with 
depression may pose a greater imminent physical health 
risk than would typically be the case in a younger 
patient, again strengthening the case for considering 
ECT early in the treatment hierarchy (Sackeim, 1994). 
Although the clinical+effectiveness of ECT is 
documented and acknowledged, the treatment often is 
associated with troubling side effects, principally a 
brief period of confusion following administration and 
a temporary period of memory disruption (Rudorfer et 
al., 1997). As described in Chapter 4, there may also be 
longer term memory losses for the time period 
surrounding the use of ECT. Although the exception 
rather than the rule; persistent memory loss following 
ECT is reported. Its actual incidence is unknown. There 
are no absolute medical contraindications’ to ECT. 
However, a recent history of myocardial infarct, 
irregular cardiac rhythm, or other heart conditions 
suggests the need for caution due to the risks of general 
anesthesia and the brief rise in heart rate, blood 
pressure, and load on the heart that accompany ECT 
administration. On the other hand, the safety of ECT is 
enhanced by the time-limited nature of treatment 
sessions, which enables this intervention to be 
administered under controlled conditions, for example, 
with a cardiologist or other specialist in attendance. 
Following completion of a course of ECT, maintenance 
treatment. typically with antidepressant or mood- 
stabilizing medication or less frequent maintenance 
ECT, in most cases is required to prevent relapse 
(Rudorfer et al., 1997). 
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Psychosocial Treatment of Depression 
Most research to date on psychosocial treatment of 
mental disorders has concentrated on depression. These 
studies suggest that several forms of psychotherapy are 
effective for the treatment of late-life depression. 
including cognitive-behavioral therapy, interpersonal 
psychotherapy, problem-solving therapy, brief psycho- 
dynamic psychotherapy, and reminiscence therapy, an 
intervention developed specifically for older adults on 
the premise that reflection upon positive and negative 
past life experiences enables the individual to 
overcome feelings of depression and despair (Butler. 
1974; Butler et al., 1991). Group and individual 
formats have been used successfully. 
A meta-analysis of 17 studies of cognitive. 
behavioral, brief psychodynamic. interpersonal, remini- 
scence, and eclectic therapies for late-life depression 
found treatment to be more effective than no treatment 
or placebo (Scogin & McElreath. 1994). The following 
paragraphs spotlight some of the key studies 
incorporated into this meta-analysis and provide 
evidence from newer studies. 
Cognitive-behavioral therapy is designed to modify 
thought patterns, improve skills, and alter the emotional 
states that contribute to the onset, or perpetuation, of 
mental disorders. In a 2-year followup study of 
cognitive-behavioral therapy, 70 percent of all patients 
studied no longer met criteria for major depression and 
maintained treatment gains (Gallagher-Thompson et al.. 
1990). In another trial, group cognitive therapy was 
found to be effective. Older patients with major 
depression partially randomized to receive group 
cognitive therapy with alprazolam (a benzodiazepine) 
or group cognitive therapy with placebo had more 
improvement in depressed mood and sleep efficiency 
than patients who received alprazolam alone or placebo 
alone (Beutler et al., 1987). Cognitive-behavioral 
therapy also has been demonstrated to be effective in 
other late-life disorders. including anxiety disorders 
(Stanley et al., 1996; Beck & Stanley, 1997). 
Cognitive-behavioral therapy’s effectiveness for mood 
symptoms in Alzheimer’s disease is discussed in the 
section on psychosocial treatments of Alzheimer’s 
disease. 
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Problem-solving therapy postulates that 
deficiencies in social problem-solving skills enhance 
the risk for depression and other psychiatric symptoms. 
Through improving problem-solving skills, older 
patients are given the tools to enable them to cope with 
stressors and thereby experience fewer symptoms of 
psychopathology (Hawton & Kirk, 1989). Problem- 
solving therapy has been found effective in the 
treatment of depression of older patients. For example, 
problem-solving therapy was found to significantly 
reduce symptoms of major depression, leading to the 
greatest improvement in a randomized controlled study 
comparing problem-solving therapy, reminiscence 
therapy, and placement on a waiting list for treatment 
(Arean et al., 1993). In a ,randomized study of 
depressed younger primary care patients, six sessions 
of problem-solving therapy were as effective as 
amitriptyline, with about 50 to 60 percent of patients in 
each group recovering (Mynors-Wallis et al., 1995). 
Interpersonal psychotherapy was initially designed 
as a time-limited treatment for midlife depression. It 
focuses on grief, role disputes, role transitions, and 
interpersonal deficits (Klerman et al., 1984). This form 
of treatment may be especially meaningful for older 
patients given the multiple losses, role changessocial 
isolation, and helplessness associated with late-life 
depression. Controlled trials suggest that interpersonal 
psychotherapy alone, or in combination with pharmaco- 
therapy, is effective in all phases of treatment for late- 
life major depression. Interpersonal psychotherapy was 
as effective as the antidepressant nortriptyline in 
depressed older outpatients, and both were superior to 
placebo (Sloane et al., 1985; Reynolds et al., 1992; 
Schneider, 1995). In an open trial, a treatment protocol 
combining interpersonal psychotherapy with 
nortriptyline and psychoeducational support groups led 
to minimal attrition and high remission rates 
(approximately 80 percent) in older patients with 
recurrent major depression (Reynolds et al., 1992, 
1994). Finally, interpersonal psychotherapy also is 
effective in the treatment of depression following 
bereavement (Pastemak et al., 1997). 
Brief psychodynamic therapy, typically of 3 to 4 
months’ duration. also is successful in older depressed 
patients. Brief psychodynamic therapy is distinguished 
from traditional psychodynamic therapy primarily by 
duration of treatment. The goals of brief psycho- 
dynamic therapy vary according to patients’ medical 
health and function. In disabled older people, the 
purpose of psychodynamic psychotherapy is to 
facilitate mourning of lost capacities, promote 
acceptance of physical limitations, address fears of 
dependency, and promote resolution of interpersonal 
difficulties with family members (Lazarus & Sadavoy, 
1996). In older patients who are not disabled, 
psychodynamic psychotherapy deal; with the resolution 
of interpersonal conflicts, adaptation to loss and stress, 
and the reconciliation of personal accomplishments and 
disappointments (Pollock, 1987). Brief psychodynamic 
therapy has been found to be as effective as cognitive- 
behavioral therapy in reducing symptoms of late-life 
major depression. An early study found brief 
psychodynamic therapy to yield higher relapse and 
recurrence rates than did cognitive and behavioral 
therapy (Gallagher&Thompson, 1982). However, with 
a greater number of patients, brief psychodynamic 
therapy was determined to be as effective as cognitive 
and behavioral therapy (and superior to being on a 
waiting list) in preventing recurrences of major 
depression up to 2 years after treatment 
(Gallagher-Thompson et al., 1990). 
Alzheimer’s Disease 
Alzheimer’s disease, a disorder of pivotal importance 
to older adults, strikes 8 to 15 percent of people over 
the age of 65 (Ritchie & Kildea, 1995). Alzheimer’s 
disease is one of the most feared mental disorders 
because of its gradual, yet relentless, attack on memory. 
Memory loss, however, is not the only impairment. 
Symptoms extend to other cognitive deficits in 
language, object recognition, and executive 
functioning.3 Behavioral symptoms-such as 
psychosis, agitation, depression, and wandering-are 
common and impose tremendous strain on caregivers. 
Diagnosis is challenging because of the lack of 
3 Executive functioning refers to the ability to plan, organize, 
sequence, and abstract. 
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biological markers, insidious onset, and need to 
exclude other causes of dementia. 
This section covers assessment and diagnosis, 
behavioral symptoms, course, prevalence and 
incidence, cost, etiology, and treatment. It features 
Alzheimer’s disease because it is the most prevalent 
form of dementia. However, many of the issues raised 
also pertain to other forms of dementia, such as multi- 
infarct dementia, dementia of Parkinson’s disease, 
dementia of Huntington’s disease, dementia of Pick’s 
disease, frontal lobe dementia, and others. 
Assessment and Diagnosis of Alzheimer’s 
Disease 
Mild Cognitive Impairm&t 
Declines in cognitive functioning have been identified 
both as part of the normal process of aging and as an 
indicator of Alzheimer’s disease. DSM-IV first 
designated this as “age-related cognitive decline” and, 
more recently, as “mild cognitive impairment” (MCI). 
MCI characterizes those individuals who have a 
memory prcblem but do not meet the generally 
accepted criteria for Alzheimer’s disease such as those 
issued by the National Institute of Neurological and 
Communicative Disorders and Stroke-Alzheimer’s 
Disease and Related Disorders Association or DSM-IV. 
MCI is important because it is known that a certain 
percentage of patients will convert to Alzheimer’s 
disease over a period of time (probably in the range of 
15 to 20 percent per year). Thus, if such individuals 
could be identified reliably, treatments could be given 
that would delay or prevent the progression to 
diagnosed Alzheimer’s disease. This is the rationale for 
the Alzheimer’s Disease Cooperative Study trial of 
vitamin E or donepezil for MCI, which began in 1999, 
and it is also the basis for the use of neuroimaging in 
early diagnosis. The evaluation of MCI spans the 
boundary between normal aging and Alzheimer’s 
disease, and this topic is being evaluated in a number of 
research groups. 
The diagnosis of Alzheimer’s disease depends on 
the identification of the characteristic clinical features 
and on the exclusion of other common causes of 
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dementia. There are currently no biological markers for 
Alzheimer’s disease except for pathological 
verification by biopsy or at autopsy (or through rare 
autosomal dominant mutations), With the reliance on 
clinical criteria and the need for exclusion of other 
causes of dementia, the current approach to 
Alzheimer’s disease diagnosis is time- and 
labor-intensive, costly, and largely dependent on the 
expertise of the examiner. Although genetic risk 
factors, such as APO-E status (see etiology section), 
give some indication of the relative risk for 
Alzheimer’ s disease, they are as yet rarely useful on an 
individual basis. 
The diagnosis of Alzheimer‘s disease not only 
requires the presence of memory impairment but also 
another cognitive deficit, such as language disturbance 
or disturbance in executive functioning. The diagnosis 
also calls for impairments in social and occupational 
functioning that represent a significant functional 
decline (DSM-IV). The other causes of dementia that 
must be ruled out include cerebrovascular disease, 
Parkinson’s disease, Huntington’s disease. subdural 
hematoma, normal-pressure hydrocephalus, brain 
tumor, systemic conditions (e.g., hypothyroidism. 
vitamin B ,* or folic acid deficiency, niacin deficiency, 
hypercalcemia, neurosyphilis, HIV infection), and 
substance-induced conditions. 
Some diagnostic schemes distinguish between 
possible, probable, and definite Alzheimer’s disease 
(McKhann et al., 1984). With these criteria, probable 
Alzheimer’s disease is confirmed to be Alzheimer’s 
disease at autopsy with 85 to 90 percent accuracy 
(Galasko et al., 1994). Definite Alzheimer’s disease can 
only be diagnosed pathologically through biopsy or at 
autopsy. The pathological hallmarks of Alzheimer’s 
disease are neurofibrillary tangles (intracellular 
aggregates of a cytoskeletal protein called tau found in 
degenerating or dead brain cells) and neuritic plaques 
(extracellular deposits largely made up of a protein 
called amyloid P-peptide) (Cummings, 1998b). (See 
Figure 5-2.) 
The diagnosis of dementia can be complicated by 
the possibility of other disorders that coexist with, or 
share features of, Alzheimer’s disease. For example, 
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Figure 5-2. Neuritic plaques and many neurofibrillary tangles 
in the hippocampus of an Alzheimer’s disease patient (Photo 
courtesy of Peter Davies, Ph.D., Department of Pathology, 
Albert Einstein College of Medicine.) 
. 
delirium is a common condition in older patients and 
can be confused with dementia in its acute stages. 
Other types of dementia, such as vascular dementia, 
share cognitive and behavioral symptoms with 
Alzheimer’s disease, and thus may be difficult to 
distinguish from Alzheimer’s disease. The cognitive 
symptoms of early Alzheimer’s disease and those 
associated with normal age-related decline also may be 
similar. Finally, cognitive deficits are prominent in 
both late-life depression and schizophrenia. While the 
severity of deficits is less in these disorders than that in 
later stages of dementia, distinctions may be difficult if 
the dementia is early in its course. 
A further challenge in the identification of 
Alzheimer’s disease is the widespread societal view of 
“senility” as a natural developmental stage. Early 
symptoms of cognitive decline may be excused away or 
ignored by family members and the patient, making 
early detection and treatment difficult. The clinical 
diagnosis of Alzheimer’s disease relies on an accurate 
history of the patient’s symptoms and rate of decline. 
Such information is often impossible to obtain from the 
patient due to the prominence of memory dysfunction. 
Family members or other informants are usually 
helpful, but their ability to provide useful information 
sometimes is hampered by denial or lack of knowledge 
about signs and symptoms of the disorder. 
With diagnosis so challenging, Alzheimer’s disease 
and other dementias are currently under-recognized, 
especially in primary care settings, where most older 
patients seek care. In a study in the United Kingdom, 
O’Connor and colleagues found that general 
practitioners recognized only 58 percent of patients 
identified by research psychiatrists using a structured 
diagnostic interview (O’Connoret al., 1988). Similarly, 
in a study conducted in the United States, Callahan and 
colleagues found that only 3.2 percent of patients with 
mild cognitive impairment were recognized by general 
practitioners as having intellectual compromise, and 
only 23.5 percent of those with moderate to severe 
dementia were identified as having a dementia 
syndrome (Callahan et al., 1995). The reasons for 
primary care provider difficulty with diagnosis are 
speculated to include lack of knowledge or skills, 
misdiagnosis of depression as dementia, lack of time, 
and lack of adequate referrals to specialty mental health 
care. 
The urgency of addressing obstacles to recognition 
and accurate diagnosis is underscored by promising 
studies that point to the pronounced clinical advantages 
of early detection. Therapies that slow the progression 
of Alzheimer’s disease or improve existing symptoms 
are likely to be most effective if given early in the 
clinical course. Recognition of early Alzheimer’s 
disease, in addition to facilitating pharmacotherapy, has 
a variety of other benefits that improve the plight of 
patients and their families. Direct benefits to patients 
include improved diagnosis of other potentially 
reversible causes of dementia, such as hypothyroidism, 
and identification of sources of Alzheimer’s disease’s 
excess disability such as depression and anxiety that 
can be targeted with nonpharmacological interventions. 
Family members benefit from early detection by having 
more time to adjust and plan for the future and by 
having the opportunity for greater patient input into 
decisions regarding advanced directives while the 
patient is still at a mild stage of the illness (Cummings 
& Jeste, 1999). 
Diagnosis of Alzheimer’s disease would be greatly 
improved by the discovery of a biological marker that 
correlates strongly with neuropathological signs of 
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Alzheimer’s disease, reflects the severity of 
pathological changes in Alzheimer’s disease, and 
precedes the appearance of clinical symptomatology. 
Ideally, such a marker also would be used to monitor 
the effectiveness of treatment on the clinical 
manifestations of Alzheimer’s disease, would show 
specificity for Alzheimer’s disease with few false 
positives (i.e., a diagnosis of Alzheimer’s disease in 
someone who does not have the disease), and would be 
convenient and inexpensive enough to justify wide use, 
including screening (Cummings & Jeste, 1999). 
Discovery of such a marker is clearly a research 
priority. 
t?ehavioral Symptoms 
Alzheimer’s disease is asociated with a range of 
symptoms evident in cognition and other behaviors; 
these include, most notably, psychosis, depression, 
agitation, and wandering. Other behavioral symptoms 
of Alzheimer’ s disease include insomnia; incontinence; 
catastrophic verbal, emotional, or physical outbursts; 
sexual disorders; and weight loss. Behavioral 
symptoms, however, are not required for diagnosis. 
While behavioral symptoms have received less 
attention than cognitive symptoms, they have serious 
ramifications: patient and caregiver distress, premature 
institutionalization, and significant compromise of the 
quality of life of patients and their families (Rabins et 
al., 1982; Ferris et al., 1987; Finkel et al., 1996; Kaufer 
et al., 1998). Alzheimer’s disease, especially behavioral 
symptoms, appears to place patients at risk for abuse by 
caregivers (Coyne et al., 1993). 
Behavioral symptoms occur at some point during 
the disease with high frequencies: 30 to 50 percent of 
individuals with Alzheimer’s disease experience 
delusions, 10 to 25 percent have hallucinations, and 40 
to 50 percent have symptoms of depression (Mega et 
al., 1996: Cummings et al., 1998b). Patients with 
psychotic disorders have greater cognitive impairment, 
more rapidly progressive dementia, and greater frontal 
and temporal dysfunction on functional brain imaging 
(Jeste et al., 1992; Sultzer et al., 1995). Patients with 
psychotic illness also exhibit more agitation, 
depression, wandering, anger, personality change, 
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family or marital problems, and lack of self-care 
(Rockwell et al., 1994). Depression in patients with 
Alzheimer’s disease accelerates loss of functioning in 
everyday activities (Ritchie et al., 1998). Even modest 
reduction in behavioral symptoms can produce 
substantial improvements in functioning and quality of 
life. 
Course 
Patients with Alzheimer’s disease experience a gradual 
decline in functioning throughout the course of their 
illness. Typically, a loss of 4 points per year on the 
Mini Mental Status Exam is detected, but there is a 
great deal of heterogeneity in the rate of decline 
(Olichney et al., 1998). Memory dysfunction is not only 
the most prominent deficit in dementia but also is the 
most likely presenting symptom. Deficits in language 
and executive functioning, while common in the 
disorder, tend to manifest later in its course (Locascio 
et al.. 1995). Depression is prevalent in the early stages 
of dementia and appears to recede with functional 
decline (Locascio et al., 1995). Although this may 
reflect decreasing awareness of depression by the 
patient, it also could reflect inadequate detection of 
depression by health professionals. Behavioral 
symptoms, such as agitation, seem to be more prevalent 
in the later stages of Alzheimer’s disease (Patterson & 
Bolger, 1994); however, psychosis has been observed 
in patients with varying levels of severity (Borson & 
Raskind, 1997). The duration of illness, from onset of 
symptoms to death, averages 8 to 10 years (DSM-IV). 
Prevalence and hcidence 
Alzheimer’s disease is a prominent disorder of old age: 
8 to 15 percent of people over age 65 have Alzheimer’ s 
disease (Ritchie 8z Kildea, 1995). The prevalence of 
dementia (most of which is accounted for by 
Alzheimer’s disease) nearly doubles with every 5 years 
of age after age 60 (Jorm et al., 1987). Although more 
women than men have Alzheimer’s disease (that is, the 
prevalence of the disease appears to be higher among 
women), this may reflect women’s longer life spans, 
because studies do not show marked gender differences 
in incidence rates (Lebowitz et al., 1998). Incidence 
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studies also reveal age-related increases in Alzheimer’s 
disease (Breteler et al., 1992; Paykel et al., 1994; 
Hebert et al., 1995; Johansson & Zarit, 1995; 
Aevarsson & Skoog, 1996). One percent of those age 
60 to 64 are affected with dementia; 2 percent of those 
age 65 to 69; 4 percent of those age 70 to 74; 8 percent 
of those 75 to 79; 16 percent of those age 80 to 84; and 
30 to 45 percent of those age 85 and older (Jorm et al., 
1987; Evans et al., 1989). 
The “graying of America” is likely to result in an 
increase in the number of individuals with Alzheimer’s 
disease, yet shifts in the composition of the affected 
population also are anticipated. Increased education is 
correlated with a lower frequency of Alzheimer’s 
disease (Hill et al., 1993; Katzman, 1993; Stem et al., 
1994), and future cohorts are expected to have attained 
greater levels of education. Fdr example, the portion of 
those currently 75 years of age and older-those most 
vulnerable to Alzheimer’s disease-with at least a high 
school education is 58.7 percent. Of those currently age 
60 to 64 who will enter the period of maximum 
vulnerability by the year 2010, 75.5 percent have at 
least a high school education. A higher educational 
level among the at-risk cohort may delay the onset of 
Alzheimer’s disease and thereby decrease the overall 
frequency of Alzheimer’s disease (by decreasing the 
number of individuals who live long enough to enter 
the period of maximum vulnerability). However, this 
trend may be counterbalanced or overtaken by greater 
longevity and longer survival of affected individuals. 
Specifically, improvements in general health and health 
care may lengthen the survival of dementia patients, 
increasing the number of severely affected patients and 
raising their level of medical comorbidity. Similarly, 
through dissemination of information to patients and 
clinicians, better detection, especially of early-stage 
patients, is expected. Increased use of putative 
protective agents, such as vitamin E, also may increase 
the number of patients in the middle phases of the 
illness (Cummings & Jeste, 1999). 
cost 
The growing number of patients with Alzheimer’s 
disease is likely to have serious public health and 
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economic consequences. Direct and indirect costs for 
medical and long-term care, home care, and loss of 
productivity for caregivers are estimated at nearly $100 
billion each year (Ernst & Hay, 1994; National Institute 
on Aging, 1996). This economic burden is borne mostly 
by families of patients with Alzheimer’s disease, 
although a significant portion of the direct costs is 
covered by Medicare, Medicaid, and private insurance 
companies. Costs are especially high among patients 
with behavioral symptoms, who often require earlier or 
more frequent institutionalization (Ferris et al., 1987). 
Etiology of Alzheimer’s Dise’ase 
Siological Factors 
The etiology of Alzheimer’s disease is still 
incompletely understood yet is thought to entail a 
complex combination of genetic and environmental 
factors. Genetic factors appear to play a significant role 
in the pathogenesis of Alzheimer’s disease. In the 
familial form, Alzheimer’s disease is caused by 
mutations in chromosomes 21, 14, and 1 and is 
transmitted in an autosomal dominant mode. Each of 
these mutations appears to result in overproduction of 
the protein found in neuritic plaques, /3-amyloid. Onset 
of the familial form is usually early, but the course and 
nature of the disorder appear to be influenced by 
environmental factors (Cummings et al., 1998b). 
However, the familial form accounts for only a small 
proportion of cases of Alzheimer’s disease (less than 5 
percent) (Cummings et al., 1998b). 
Approximately 50 percent of individuals with a 
family history of Alzheimer’s disease, if followed into 
their 80s and 90s develop the disorder (Mohs et al., 
1987). Certain genotypes (the pattern of genetic 
inheritance in an individual) appear to confer risk for 
the more common late-onset form of Alzheimer’s 
disease. For example, the ApoE-e4 allele4 on 
chromosome 19, which increases the deposition of 
j3-amyloid, has been shown to increase risk for 
developing Alzheimer’s disease (Corder et al., 1993). 
4 An allele is a variant form of a gene. 
Other possible candidate genes are under study (Kang 
et al., 1997). 
Other biological risk factors for the development of 
Alzheimer’s disease include aging and cognitive 
capacities (Cummings et al., 1998b). The mechanisms 
by which these traits confer increased risk have not yet 
been fully determined; however, several neurobiologic 
changes related to normal aging of the brain may play 
a role in the increased risk for Alzheimer’s disease with 
increasing age. These include neuron and synaptic loss, 
decreased dendritic span, decreased size and density of 
neurons in the nucleus basalis of Meynert, and lower 
cortical acetylcholine levels (Cummings et al., 1998b). 
These findings, as well as extrapolations from the 
prevalence and incidence a curves for Alzheimer’s 
disease, have led some to suggest that most individuals 
would eventually develop Alzheimer’s disease if the 
human life span was extended (for example, to age 
120). 
Protective Factors 
Several protective factors that delay the onset of 
Alzheimer’s disease have been identified. Genetic 
endowment with the ApoE-e2 allele decreases the risk 
for Alzheimer’s disease (Duara et al., 1996); although 
the mechanism of action is not yet fully understood. 
Higher educational level also is related to delayed onset 
of Alzheimer’s disease (Stem et al., 1994; Callahan et 
al., 1996a). The use of certain medications, such as 
nonsteroidal anti-inflammatory drugs (Andersen et al., 
1995; McGeer et al., 1996) and estrogen replacement 
therapy (Paganini-Hill & Henderson, 1994), may delay 
onset of the disorder. Vitamin E and the drug selegiline 
(also known as deprenyl) appear to delay the 
occurrence of important milestones in the course of 
Alzheimer’s disease, including nursing home 
placement, severe functional impairments even as the 
disease progresses, and death (Sano et al.. 1997). 
The mechanism of action of these protective agents 
is not fully understood but is thought to counter the 
deleterious action of oxidative stress (via antioxidants 
such as vitamin E or estrogen) (Behl et al., 1995) or the 
action of inflammatory mediators associated with 
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plaque formation (via anti-inflammatories) (Mrak et al.. 
1995). 
Histopathology 
The pathophysiology of Alzheimer’s disease appears to 
be linked to the histopathologic changes in Alzheimer’s 
disease, which include neuritic plaques, neurofibrillary 
tangles, synaptic loss, hippocampal granulovacuolar 
degeneration, and amyloid angiopathy. Most of the 
genetic and epigenetic risk factors have been related in 
some way to P-amyloid. Thus, the generation of 
P-amyloid peptide is increasingly regarded as the 
central pathological event in Alzheimer’s disease 
(Cummings et al., 1998b; Hardy & Higgins, 1992). 
Effective intervention for Alzheimer’s disease may 
involve interfering with the multiple steps within the 
putative Alzheimer’s disease pathogenetic cascade. 
Targets of intervention include reducing P-amyloid 
generation from the amyloid precursor protein, 
decreasing P-amyloid aggregation and formation of 
beta-pleated sheets, and interfering with 
amyloid-related neurotoxicity. In addition, therapies 
could involve interruption of neuronal cell death, 
inhibition of the inflammatory response occurring in 
neuritic plaques, use of growth factors and hormonal 
therapies, and replenishment of deficient neurotrans- 
mitters. Because complete blockade of steps within the 
P-amyloid cascade may interfere with normal cerebral 
metabolic processes, efficacious interventions could 
involve partial interruptions (Cummings & Jeste, 
1999). 
Researchers in the molecular neuroscience of 
Alzheimer’s disease are exploring a number of 
important aspects of pathophysiology and etiology. As 
understanding of mechanisms of cell death and 
neuronal degeneration increases, new opportunities for 
the development of therapeutics are expected to emerge 
(National Institute on Aging, 1996). 
Role of Acetylcholine 
Loss of the neurotransmitter acetylcholine also is 
thought to play an instrumental role in the pathogenesis 
of Alzheimer’s disease. Postmortem studies of 
Alzheimer’s disease consistently have demonstrated the 
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loss of basal forebrain and cortical cholinergic neurons 
and the depletion of choline acetyltransferase, the 
enzyme responsible for acetylcholine synthesis 
(Mesulam, 1996). The degree of this central cholinergic 
deficit is correlated with the severity of dementia, 
which has led to the “cholinergic hypothesis” of 
cognitive deficits in Alzheimer’s disease. This 
hypothesis has led, in iurn, to promising clinical 
interventions discussed below. It should be 
emphasized, however, that acetylcholine is not 
necessarily the only neurotransmitter involved in 
Alzheimer’s disease; research has not ruled out the 
contributions of other substances in pathogenesis of the 
disease. 
Pharmacological Treatment of Alzheimer’s 
Disease 
Pharmacological treatment of Alzheimer’s disease is a 
promising new focus for interventions. A delay in onset 
of Alzheimer’s disease for 5 years might reduce the 
prevalence of Alzheimer’s disease by as much as 
one-half (Breitner, 1991). In other words, to influence 
the prevalence of Alzheimer’s disease, it may be 
necessary only to delay the onset of the disease to the 
point where mortality from other sources supersedes 
the incidence of Alzheimer’s disease. Thus, a central 
goal in Alzheimer’s disease treatment research is the 
identification of agents that prevent the occurrence, 
defer the onset, slow the progression, or improve the 
symptoms of Alzheimer’s disease. Progress has been 
made in this research arena, with several agents 
showing beneficial effects in Alzheimer’s disease. 
Acetylcholines terase inhibitors 
Recent attempts to treat Alzheimer’s disease have 
focused on enhancing acetylcholine function, using 
either cholinergic receptor agonists (e.g., nicotine) or, 
most commonly, using acetylcholinesterase (AChE) 
inhibitors (e.g., physostigmine, velnacrine, tacrine, 
donepezil, or metrifonate) to increase the availability of 
acelylcholine in the synaptic cleft. Such treatments 
have generally been beneficial in ameliorating global 
cognitive dysfunction and, more specifically, are most 
effective in improving attention (Norberg, 1996; 
Lawrence & Sahakian, 1998). Amelioration of learning 
and memory impairments, the most prominent 
cognitive deficits in Alzheimer’s disease, have been 
found less consistently (Lawrence & Sahakian, 1998), 
although some studies have shown improvements 
(Thal, 1996). It has been argued that failure of AChE 
inhibitors and nicotine to improve learning and memory 
may be due to high levels of neurodegeneration in the 
medial temporal lobe (Lawrence & Sahakian, 1998). 
Neuronal degeneration in this region of the brain leaves 
neurons impervious to the benefits of some types of 
replacement therapy. Detailed. neuropsychological 
studies of the effects of the newer cognitive enhancers, 
donepezil and metrifonate (an experimental drug), have 
not yet been published, but global cognitive functioning 
appears to be improved with both compounds 
(Cummings et al., 1998a; Rogers et al., 1998). 
Treatment with these AChE inhibitors also appears to 
benefit noncognitive symptoms in Alzheimer’s disease, 
such as delusions (Raskind et al., 1997) and behavioral 
symptoms (Kaufer et al., 1996; Morris et al., 1998). 
Treatment of Behavioral Symptoms 
The behavioral symptoms of Alzheimer’s disease have 
received less therapeutic attention than cognitive 
symptoms. Few double-blind, placebo-controlled 
studies of medications for behavioral symptoms of 
Alzheimer’s disease have been performed. For the most 
part, behavioral symptoms have been treated with 
medications developed for primary psychiatric 
symptoms. The emergence of new antipsychotic and 
antidepressant medications requires that these agents be 
studied specifically for Alzheimer’s disease. The 
observation that cholinergic agents used to enhance 
cognition in Alzheimer’s disease may have beneficial 
behavioral effects also needs further exploration 
(Kaufer et al., 1996; Bodick et al., 1997; Raskind et al., 
1997). 
One area that has been studied is the treatment of 
depression in Alzheimer’s disease. Treatment with the 
antidepressants paroxetine and imipramine has been 
shown to be effective in depressed Alzheimer’s disease 
patients (Reifler et al., 1989; Katona et al., 1998). 
Treatment may not only be effective for relieving 
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depressive symptoms but also for its potential to 
improve functional ability (Pearson et al., 1989; Ritchie 
et al., 1998). 
Several challenges are encountered with the 
pharmacological treatment of Alzheimer’s disease. 
First, because of the cognitive deficits that are the 
hallmarkof dementia, caregiver assistance is crucial for 
compliance with pharmacotherapy regimens. Second. 
although the current pharmacotherapies are likely to be 
most useful if administered early in the course of the 
disorder, early detection of Alzheimer’s disease is 
encumbered by the lack of a verified biological or 
biobehavioral marker. Third, little is currently known 
about the optimal duration of treatment with pharmaco- 
therapies. * 
Psychosocial Treatment of Alzheimer’s 
Disease Patients and Caregivers 
Psychosocial interventions are extremely important in 
Alzheimer’s disease. Although there has been some 
research on preserving cognition, most research has 
focused on treating patients’ behavioral symptoms and 
relieving caregiver burden. Support for caregivers is 
crucial because caregivers of older patients are at risk 
for depression, anxiety, and somatic problems (Light & 
Lebowitz, 1991). Psychosocial interventions targeted 
either at patients or family caregivers can improve 
outcomes for patients and caregivers alike. 
Psychosocial techniques developed for use in 
patients with cognitive impairment may be helpful in 
Alzheimer’s disease. Strengthening ways to deal with 
cognitive losses may reduce functional limitations for 
patients with the early stages of Alzheimer’s disease, 
before multiple brain systems become compromised. 
For example, training in the use of memory aids, such 
as mnemonics, computerized recall devices, or copious 
use of notetaking, may assist patients with mild 
dementia. While initial research on the use of cognitive 
rehabilitation in dementia is promising, further studies 
are needed (Pliskin et al., 1996). 
Of the behavioral symptoms experienced by 
patients with Alzheimer’s disease. depression and 
anxiety occur most frequently during the early stages of 
dementing disorders, whereas psychotic symptoms and 
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aggressive behavior occur during later stages 
(Alexopoulos & Abrams, 1991; Devanand et al., 1997). 
Early evidence suggested that cognitive and behavioral 
therapies are beneficial in treating depressed older 
patients with dementia (Teri & Gallagher-Thompson. 
1991; Teri & Uomoto, 1991). Cognitive therapy, seen 
as more promising for the early stages of dementia. 
strives to help patients cope with depression by 
reducing cognitive distortions and by fostering more 
adaptive perceptions. Behavioral therapy, seen as more 
promising for more moderately or severely affected 
adults with dementia, targets family caregivers 
directly-and patients indirectly-by helping care- 
givers identify, plan, and increase pleasant activities for 
the patient, such as taking a walk, designed to improve 
their mood (Teri & Gallagher-Thompson, 199 1). 
Further affirmation for behavioral therapy for 
depression of patients with Alzheimer’s disease 
recently was provided by a controlled clinical trial. The 
trial compared two types of behavioral therapy with a 
typical care condition and a waiting list control. One of 
the behavioral therapies targeted family caregivers to 
help them increase pleasant events for the patients, 
while the other gave caregivers more latitude in 
choosing which behavioral problem-solving strategies 
to deal with patients’ depression. Both behavioral 
therapies led to significant improvement in patients’ 
depressive symptoms. Moreover, the caregivers also 
showed significant improvement in their own 
depressive symptoms (Teri et al., 1997). 
For alleviating caregiver and family distress, a 
broad array of psychosocial interventions was assessed 
in a meta-analysis of 18 studies (Knight et al., 1993). 
The interventions included psychoeducation, support, 
cognitive-behavioral techniques. self-help, and respite 
care. Individual and respite programs were found 
moderately effective at reducing caregiver burden and 
dysphoria, but group interventions were only 
marginally effective. Subsequent research buttressed 
the utility of adult day care in reducing caregivers’ 
stress and depression and in enhancing their well-being 
(Zarit et al., 1998). Beyond direct benefits to 
caregivers, support interventions also have benefited 
patients and have saved resources. For example, a 
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psychosocial intervention-individual and family 
counseling plus support group participation-aimed at 
caregiving spouses was shown to delay institutionaliza- 
tion of patients with dementia by almost a year in a 
randomized trial (Mittelman et al., 1993, 1996). 
Targeted behavioral techniques also improved the 
quality of caregivers’ sleep (McCurry et al., 1996), 
whereas psychoeducation and family support appeared 
to promote better patient management (Zarit et al., 
1985). 
The virtues of psychosocial interventions also 
extend to patients with Alzheimer’s disease in nursing 
homes. Until the late 1980s nursing homes employed 
restraints and sedatives and other medications to 
control behavioral symptoms in patients with dementia. 
But the untoward consequences, in terms of injuries 
from physical restraints * and increased patient 
disorientation, led to nursing home reform practices 
required by the Federal Nursing Home Reform Act of 
the Omnibus Budget Reconciliation Act of 1987 
(Cohen & Cairl, 1996). In the past few years, a range of 
behavioral interventions for nursing home staff has 
been shown to be effective in improving behavioral 
symptoms of Alzheimer’s disease, such as incontinence 
(Burgio et al., 1990; Schnelle et al., 1995), dressing 
problems (Beck et al., 1997), and verbal agitation 
(Burgio et al., 1996; Cohen-Mansfield & Werner, 
1997). A major problem is that interventions are not 
maintained or implemented correctly by nursing home 
staff (Schnelle et al., 1998). New approaches seek to 
teach and maintain behavior management skills of 
nursing home assistants through a formal staff 
management system (Barinaga, 1998; Stevens et al., 
1998). 
Other Mental Disorders in Older 
Adults 
Anxiety Disorders 
Prevalence of Anxiety 
Anxiety symptoms and syndromes are important but 
understudied conditions in older adults. Overall, 
community-based prevalence estimates indicate that 
about 11.4 percent of adults aged 55 years and older 
meet criteria for an anxiety disorder in 1 year (Flint, 
1994; Table 5-l). Phobic anxiety disorders are among 
the most common mental disturbances in late life 
according to the ECA study (Table 5-l). Prevalence 
studies of panic disorder (0.5 percent) and 
obsessive-compulsive disorder ( 1.5 percent) in older 
samples reveal low rates (Table 5-l) (Copeland et al., 
1987a; Copeland et al., 1987b; Bland et al., 1988; 
Lindesay et al., 1989). Although the National 
Comorbidity Survey did not cover this age range, and 
the ECA did not include this disorder, other studies 
showed a prevalence of generalized anxiety disorder in 
older adults ranging from 1.1 percent to 17.3 percent 
higher than that reported for panic disorder or 
obsessive-compulsive disorder (Copeland et al., 1987a; 
Skoog, 1993). Worry or “nervous tension,” rather than 
specific anxiety syndromes may be more important in 
older people. Anxiety symptoms that do not fulfill the 
criteria for specific syndromes are reported in up to 17 
percent of older men and 21 percent of older women 
(Himmelfarb & Murrell, 1984). 
In addition, some disorders that have received less 
study in older adults may become more important in the 
near future. For example, post-traumatic stress disorder 
(PTSD) is expected to assume increasing importance as 
Vietnam veterans age. At 19 years after combat 
exposure, this cohort of veterans has been found to 
have a PTSD prevalence of 15 percent (cited in 
McFarlane & Yehuda, 1996). As affected patients age, 
there is a continuing need for services. In addition, 
research has shown that PTSD can manifest for the first 
time long after the traumatic event (Aarts & Op den 
Velde, 1996), raising the specter that even more 
patients will be identified in the future. 
Treatment of Anxiety 
The effectiveness of benzodiazepines in reducing acute 
anxiety has been demonstrated in younger and older 
patients, and no differences in the effectiveness have 
been documented among the various benzodiazepines. 
Some research suggests that benzodiazepines are 
marginally effective at best in treating chronic anxiety 
in older patients (Smith et al., 1995). 
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The half-life of certain benzodiazepines and their 
metabolites may be significantly extended in older 
patients (particularly for the compounds with long 
half-life). If taken over extended periods, even 
short-acting benzodiazepines tend to accumulate in 
older individuals. Thus, it is generally recommended 
that any use of benzodiazepines be limited to discrete 
periods (less than 6 months) and that long-acting 
compounds be avoided in this population. On the other 
hand, use of short-acting compounds may predispose 
older patients to withdrawal symptoms (Salzman, 
1991). 
Side effects of benzodiazepines may include 
drowsiness, fatigue, psychomotor impairment, memory 
or other cognitive impairment, confusion, paradoxical 
reactions, depression, res$ratory problems, abuse or 
dependence problems, and withdrawal reactions. 
Benzodiazepine toxicity in older patients includes 
sedation, cerebellar impairment (manifested by ataxia, 
dysarthria, incoordination, or unsteadiness), cognitive 
impairment, and psychomotor impairment (Salzman, 
199 1). Psychomotor impairment from benzodiazepines 
can have severe consequences, leading to impaired 
driver skills and motor vehicle crashes (Bat-bone et al., 
1998) and falls (Caramel et al., 1998). . 
Buspirone is an anxiolytic (antianxiety) agent that 
is chemically and pharmacologically distinct from 
benzodiazepines. Controlled studies with younger 
patients suggest that the efficacy of buspirone is 
comparable to that of the benzodiazepines. It also has 
proven effective in studies of older patients 
(Napoliello, 1986; Robinson et al., 1988; Bohm et al., 
1990). On the other hand, buspirone may require up to 
4 weeks to take effect, so initial augmentation with 
another antianxiety medication may be necessary for 
some acutely anxious patients (Sheikh, 1994). 
Significant adverse reactions to buspirone are found in 
20 to 30 percent of anxious older patients (Napoliello, 
1986; Robinson et al., 1988). The most frequent side 
effects include gastrointestinal symptoms, dizziness, 
headache, sleep disturbance, nausea/vomiting, 
uneasiness, fatigue, and diarrhea. Still, buspirone may 
be less sedating than benzodiazepines (Salzman, 1991; 
Seidel et al., 1995). 
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Although the efficacy of antidepressants for the 
treatment of anxiety disorders in late life has not been 
studied, current patterns of practice are informed by the 
efficacy literature in adults in midlife (see Chapter 4). 
Schizophrenia in Late Life 
Although schizophrenia is commonly thought of as an 
illness of young adulthood, it can both extend into and 
first appear in later life. Diagnostic criteria for 
schizophrenia are the same across the life span, and 
DSM-IV places no restrictions on age of onset for a 
diagnosis to be made. Symptoms include delusions, 
hallucinations, disorganized speech, disorganized or 
catatonic behavior (the so-called “positive” symptoms), 
as well as affective flattening, alogia, or avolition’ (the 
so-called “negative” symptoms). Symptoms must cause 
significant social or occupational dysfunction, must not 
be accompanied by prominent mood symptoms, and 
must not be uniquely associated with substance use. 
Prevalence and Cost 
One-year prevalence of schizophrenia among those 65 
years or older is reportedly only around 0.6 percent, 
about one-half the 1 -year prevalence of the 1.3 percent 
that is estimated for the population aged 18 to 54 
(Tables 5-l and 4-l). 
The economic burden of late-life schizophrenia is 
high. A study using records from a large California 
county found the mean cost of mental health service for 
schizophrenia to be significantly higher than that for 
other mental disorders (Cuffel et al., 1996); the mean 
expenditure among the oldest patients with 
schizophrenia (> 74 years old) was comparable to that 
among the youngest patients (age 18 to 29). While 
long-term studies have shown that use of nursing 
homes, state hospitals, and general hospital care by 
patients with all mental disorder diagnoses has declined 
in recent decades, the rate of decline is lower for older 
patients with schizophrenia (Kramer et al., 1973; 
Redick et al., 1977). The high cost of these settings 
’ Alogia refers to poverty of speech, and avolition refers to lack of 
goal-directed behavior. 
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contributes to the greater economic burden associated 
with late-life schizophrenia. 
Late-Onset Schizophrenia 
Studies have compared patients with late onset (age at 
onset 45 years or older) and similarly aged patients 
with earlier onset of schizophrenia (Jeste et al., 1997); 
both were very similar in terms of genetic risk, clinical 
presentation, treatment response. and course. 
Among key differences between the groups. 
patients with late-onset schizophrenia were more likely 
to be women in whom paranoia was a predominant 
feature of the illness. Patients with late-onset 
schizophrenia had less impairment in the specific 
neurocognitive areas of learning and abstraction/ 
cognitive flexibility and required lower doses of 
neuroleptic medications for management of their 
psychotic symptoms. These and other differences 
between patients with early- and late-onset illness 
suggest that there might be neurobiologic differences 
mediating the onset of symptoms (DeLisi, 1992; Jeste 
et al., in press). 
Course and Recovery 
The original conception of “dementia praecoxl” the 
early term for schizophrenia, emphasized progressive 
decline (Kraepelin, 197 1); however, it now appears that 
Kraepelin’s picture captures the outcome for a small 
percentage of patients, while one-half to two-thirds 
significantly improve or recover with treatment and 
psychosocial rehabilitation (Chapter 4). Although the 
rates of full remission remain unclear, some patients 
with schizophrenia demonstrate remarkable recovery 
after many years of chronic dysfunction (Nasar, 1998). 
Research suggests that a factor in better long-term 
outcome is early intervention with antipsychotic 
medications during a patient’s first psychotic episode 
(See Chapter 4). 
A recent cross-sectional study that compared 
middle-aged with older patients, all of whom lived in 
community settings, found some similarities and 
differences (Eyler-Zonilla et al., 1999). The older 
patients experienced less severe symptoms overall and 
were on lower daily doses of neuroleptics than middle- 
aged patients who were similar in demographic, 
clinical, functional, and broad cognitive measures. In 
addition, positive symptoms were less prominent (or 
equivalent) in the older group, depending on the 
measure used. Negative symptoms were more 
prominent (or equivalent) in the older group, and older 
patients scored more poorly on severity of dyskinesia. 
Older patients were impaired relative to middle-aged 
ones on two measures of global cognitive function. 
This finding, however, appeared to reflect a normal 
degree of decline from an impaired baseline, as the 
degree of change in cognitive function with age in the 
patient group was equivalent to that seen in the 
comparison group. 
A recent study used the Direct Assessment of 
Functional Status scale (DAFS) (Loewenstein et al., 
1989) to compare the everyday living skills of 
middle-aged and older adults with schizophrenia with 
those of people without schizophrenia of similar ages 
(Klapow et al., 1997). The patients exhibited 
significantly more functional limitations than the 
controls did across most DAFS subscales. In another 
recent study that used a measure of overall disease 
impact, the Quality of Well-Being Scale, older 
outpatients with schizophrenia manifested significantly 
lower quality of well-being than did comparison 
subjects, and their scores were slightly worse than 
those of ambulatory AIDS patients (Patterson et al.. 
1996). 
Thus. while schizophrenia may be less universally 
deteriorating than previously has been assumed, older 
patients with the disorder continue nonetheless to 
exhibit functional deficits that warrant research and 
clinical attention. 
Etiology of Late-Onset Schizophrenia 
Recent studies support a neurodevelopmental view of 
late-onset schizophrenia (Jeste et al., 1997). Equivalent 
degrees of childhood maladjustment have been found 
in patients with late-onset schizophrenia and early- 
onset schizophrenia, for example, suggesting that some 
liability for the disorder exists early in life. Equivalent 
degrees of minor physical anomalies in patients with 
late-onset schizophrenia and early-onset schizophrenia 
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suggest the presence of developmental defects in both 
groups (Lohr et al., 1997). The presence of a genetic 
contribution to late-onset and early-onset schizophrenia 
is evident in increased rates of schizophrenia among 
first-degree relatives (Rokhlina, 1975; Castle & 
Howard, 1992; Castle et al., 1997). 
If late-onset schizophrenia is neurodevelopmental 
in origin, an explanation for the delayed onset may be 
that late-onset schizophrenia is a less severe form of the 
disorder and, as such, is less likely to manifest early in 
life. Recent research suggests that in several arenas- 
for example. neuropsychological impairments in 
learning, retrieval, abstraction, and semantic memory as 
well as electroencephalogram abnormalities-the 
deficits of patients with late-onset schizophrenia are 
less severe (Heaton et al, 1994; Jeste et al., 1995b; 
Olichneyet al., 1995, 1996; Paulsen et al., 1995, 1996). 
Also, negative symptoms are less pronounced and 
neuroleptic doses are lower in patients with late-onset 
schizophrenia (Jeste et al., 1995b). The etiology and 
onset of schizophrenia in younger adults often are 
explained by a diathesis-stress model in which there is 
a genetic vulnerability in combination with an 
environmental insult (such as obstetric complications), 
with onset triggered by maturational changes or life 
events that stress a developmentally damaged brain 
(Feinberg, 1983; Weinberger, 1987; Wyatt. 1996). 
Under this multiple insult model, patients with late- 
onset schizophrenia may have had fewer insults and 
thus have a delayed onset. An alternative or 
complementary explanation for the delayed onset in 
late-onset schizophrenia is the possibility that these 
patients possess protective features that cushion the 
blow of any additional insults. The preponderance of 
women among patients with late-onset schizophrenia 
has fueled hypotheses that estrogen plays a protective 
role. 
The view of late-onset schizophrenia as a less 
severe form of schizophrenia. in which the delayed 
onset results from fewer detrimental insults or the 
presence of protective factors, suggests a continuous 
relationship between age at onset and severity of 
liability. An alternative view is that late-onset 
schizophrenia is a distinct neurobiological subtype of 
schizophrenia. The preponderance of women and of 
paranoid subtype patients seen in late-onset 
schizophrenia supports this view. These two etiologic 
theories of late-onset schizophrenia call for further 
research. 
Treatment of Schizophrenia in Late Life 
Pharmacological treatment of schizophrenia in late life 
presents some unique challenges. Conventional 
neuroleptic agents, such as haloperidol. have proven 
effective in managing the “positive symptoms” (such as 
delusions and hallucinations) of many older patients, 
but these medications have a high risk of potentially 
disabling and persistent side effects, such as tardive 
dyskinesia (Jeste et al., in press). The cumulative 
annual incidence of tardive dyskinesia among older 
outpatients (29 percent) treated with relatively low 
daily doses of conventional antipsychotic medications 
is higher than that reported in younger adults (Jeste et 
al., in press). 
Recent years have witnessed promising advances in 
the management of schizophrenia. Studies with mostly 
younger schizophrenia patients suggest that the newer 
“atypical” antipsychotics, such as clozapine, 
risperidone, olanzapine, and quetiapine, may be 
effective in treating those patients previously 
unresponsive to traditional neuroleptics. They also are 
associated with a lower risk of extrapyramidal 
symptoms and tardive dyskinesia (Jeste et al., in press). 
Moreover, the newer medications may be more 
effective in treating negative symptoms and may even 
yield partial improvement in certain neurocognitive 
deficits associated with this disorder (Green et al.. 
1997). 
The foremost barriers to the widespread use of 
atypical antipsychotic medications in older adults are 
(1) the lack of large-scale studies to demonstrate the 
effectiveness and safety of these medications in older 
patients with multiple medical conditions, and (2) the 
higher cost of these medications relative to traditional 
neuroleptics (Thomas & Lewis, 1998). 
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Alcohol and Substance Use Disorders in 
Older Adults 
Older people are not immune to the problems 
associated with improper use of alcohol and drugs, but 
as a rule, misuse of alcohol and prescription 
medications appears to be a more common problem 
among older adults than abuse of illicit drugs. Still, 
because few studies of the, incidence and prevalence of 
substance abuse have focused on older adults-and 
because those few were beset by methodological 
problems-the popular perception may be misleading. 
A persistent research problem has been that 
diagnostic criteria for substance abuse were developed 
and validated on young and middle-aged adults. For 
example, DSM-IV criteria include increased tolerance 
to the effects of the substance, which results in 
increased consumption ove’r time; yet, changes in 
pharmacokinetics and physiology may alter drug 
tolerance in older adults. Decreased tolerance to 
alcohol among older individuals may lead to decreased 
consumption of alcohol with no apparent reduction in 
intoxication. Criteria that relate to the impact of drug 
use on typical tasks of young and middle adulthood, 
such as school and work performance or child rearing, 
may be largely irrelevant to older adults, who often live 
alone and are retired. Thus, abuse and dependence 
among older adults may be underestimated (Ellor & 
Kurz, 1982; Miller et al., 1991; King et al., 1994). 
Epidemiology 
Alcohol Abuse and Dependence 
The prevalence of heavy drinking (12 to 2 1 drinks per 
week) in older adults is estimated at 3 to 9 percent 
(Liberto et al., 1992). One-month prevalence estimates 
of alcohol abuse and dependence in this group are 
much lower, ranging from 0.9 percent (Regier et al., 
1988) to 2.2 percent (Bailey et al., 1965). Alcohol 
abuse and dependence are approximately four times 
more common among men than women (1.2 percent vs. 
0.3 percent) ages 65 and older (Grant et al., 1994). 
Although lifetime prevalence rates for alcoholism are 
higher for white men and women between ages 18 and 
29, African American men and women have higher 
rates among those 65 years and older. For Hispanics, 
men had rates between those of whites and African 
Americans. Hispanic females had a much lower rate 
than that for whites and African Americans (Helzer et 
al., 1991). Longitudinal studies suggest variousiy that 
alcohol consumption decreases with age (Temple & 
Leino, 1989; Adams et al., 1990), remains stable 
(Ekerdt et al., 1989) or increases (Gordon & Kannel, 
1983), but it is anticipated that alcohol abuse or 
dependence will increase as the baby boomers age, 
since that cohort has a greater history of alcohol 
consumption than current cohorts of older adults (Reid 
& Anderson, 1997). 
Misuse of Prescription and Over-the-Counter 
Medications 
Older persons use prescription drugs approximately 
three times as frequently as the general population 
(Special Committee on Aging, 1987), and the use of 
over-the-counter medications by this group is even 
more extensive (Kofoed, 1984). Annual estimated 
expenditures on prescription drugs by older adults in 
the United States are $15 billion annually, a fourfold 
greater per capita expenditure on medications 
compared with that of younger individuals (Anderson 
et al., 1993; Jeste & Palmer, 1998). Not surprisingly, 
substance abuse problems in older adults frequently 
may result from the misuse-that is, underuse, overuse, 
or erratic use-of such medications; such patterns of 
use may be due partly to difficulties older individuals 
have with following and reading prescriptions (Devor 
et al., 1994). In its extreme form, such misuse of drugs 
may become drug abuse (Ellor & Kurz, 1982; 
DSM-IV). 
Research studies that have relied on medical 
records review show consistently that alcohol abuse 
and dependence are significantly more common than 
other forms of substance abuse and dependence 
(Finlayson & Davis, 1994; Moos et al., 1994). Yet 
prescription drug dependence is not uncommon and, as 
Finlayson and Davis (1994) found, the greatest risk 
factor for abuse of prescription medication was being 
female. This finding is supported by other studies 
showing that older women are more likely than men to 
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visit physicians and to be prescribed psychoactive 
drugs (Cafferata et al., 1983; Baum et al., 1984; Mos- 
sey & Shapiro, 1985; Adams et al., 1990). In contrast, 
an analysis of data from the National Household 
Survey on Drug Abuse concluded that older men were 
more likely than women to report use of sedatives, 
tranquilizers, and stimulants (Robins & Clayton, 1989). 
Older adults of both sexes are at risk for analgesic 
abuse, which can culminate in various nephropathies 
(Elseviers & De Broe, 1998). 
Benzodiazepine use represents an area of particular 
concern for older adults given the frequency with 
which these medications are prescribed at 
inappropriately high doses (Shorr et al., 1990) and for 
excessive periods of time. A national survey of 
approximately 3,000 community-dwelling persons 
found that older persons were overrepresented among 
the 1.6 percent who had taken benzodiazepines daily 
for 1 year or longer (7 1 percent > 50 years; 33 percent 
> 65 years of age) (Mellinger et al., 1984). 
Benzodiazepine users were more likely to be older, 
white, female, less educated, separated/divorced, to 
have experienced increased stressful life events, and to 
have a psychiatric diagnosis (Swartz et al., 1991). 
Illicit Drug Abuse and Dependence 
In contrast to alcohol and licit medications, older adults 
infrequently use illicit drugs. Less than 0.1 percent of 
older individuals in the Epidemiologic Catchment Area 
study met DSM-III (American Psychiatric Association, 
1980) criteria for drug abuse/dependence during the 
previous month (Regier et al., 1988). This compared 
with a l-month prevalence rate of 3.5 percent among 
18-to 24-year-olds. ECA data further suggest a lifetime 
prevalence of illegal drug use of 1.6 percent for persons 
older than 65 years (Anthony & Helzer, 1991). 
The development of addiction to illict drugs after 
young adulthood is rare, while mortality is high 
(Atkinson et al., 1992). For example, over 27 percent of 
heroin addicts died during a 24-year period (Hser et al., 
1993), and 5.6 percent of deaths associated with heroin 
or morphine use were among persons older than 55 
(National Institute on Drug Abuse, 1992). 
Older Adults and Mental Health 
As is projected to occur with trends in alcohol 
consumption, the low prevalence of older adults’ drug 
use and abuse in the late 1990s may change as the baby 
boomers age. Annual “snapshot” data extrapolated 
from the National Household Survey on Drug Abuse. 
which has been conducted since 197 1, afford a glimpse 
of trends. Patterson and Jeste ( 1999) recently compared 
prevalence estimates of those born during the baby 
boom with an older (> 35 years) non-baby-boomer 
cohort. The difference between baby boomers and the 
previous cohort translated in 1996 into an excess of 
approximately 1.1 million individuals using drugs. 
Their excess drug use, combined with their sheer 
numbers, means that more drug use is expected as this 
cohort ages, placing greater pressures on treatment 
programs and other resources. 
Projections also suggest that the costs of alcohol 
and substance abuse are likely to rise in the near future. 
Across age ranges, drug abuse and alcohol abuse have 
been estimated to cost over $109.8 billion and $166.5 
billion, respectively (Harwood et al., 1998). Although 
no studies have estimated the annual costs of alcohol 
and substance abuse among older adults, there is 
evidence that the presence of drug abuse and 
dependence greatly increases health care expenditures 
among individuals with comorbid medical disorders. 
For example, in a study of over 3 million Medicare 
patients who were hospitalized and discharged with a 
diagnosis of cardiovascular disease, average annual 
hospital charges were $17,979 for older patients with a 
concomitant diagnosis of drug dependence and $14,253 
for those with a concomitant diagnosis of drug abuse. 
compared with only $11,387 for older patients with no 
concomitant drug disorder (Ingster & Cartwright. 
1995). In addition, increased expenditures due to the 
presence of a drug disorder were greatest among older 
patients who also had a mental disorder. 
Course 
A longstanding assumption holds that substance 
abuse declines as people age. Winick (1962) proposed 
one of the most popular theories to explain apparent 
decreases in substance abuse, particularly narcotics, 
with aging. His “maturing out” theory posits that 
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factors associated with aging processes and length of 
abuse contribute to a decline in the number of older 
narcotic addicts. These factors include changes in 
developmental stages and morbidity and mortality 
associated with use of substances. Consistent with 
these hypotheses. substance abusers have higher 
mortality rates compared with age-matched nonabusers 
(Finney & Moos, 1991; Moos et al., 1994). However, 
some research contradicts the “maturing out” theory. 
For example, some studies show that persons who have 
been addicted for more than 5 years do not become 
abstinent as they age (Haastrup & Jepsen, 1988; Hser 
et al.. 1993). Also, addicts approaching 50 years of age 
who were followed for more than 20 years remained 
involved in criminal activitiegHser et al., 1993). These 
findings emphasize the need to focus more attention on 
substance abuse in late life, especially in light of 
demographic trends. 
Treatment of Substance Abuse and Dependence 
The treatment of substance abuse and dependence in 
older adults is similar to that for other adults. 
Treatment involves a combination of pharmacological 
and psychosocial interventions, supplemented by 
family support and participation in self-help groups 
(Blazer, 1996a). 
Pharmacotherapy for substance abuse and 
dependence in older adults has been targeted mostly at 
the acute management of withdrawal. When there is 
significant physical dependence. withdrawal from 
alcohol can become a life-threatening medical 
emergency in older adults. The detoxification of older 
adult patients ideally should be done in the inpatient 
setting because of the potential medical complications 
and because withdrawal symptoms in older adults can 
be prolonged. Benzodiazepines are often used for 
treatment of withdrawal symptoms. In older adults, the 
doses required to treat the signs and symptoms of 
withdrawal are usually one-half to one-third of those 
required for a younger adult. Short- or intermediate- 
acting forms usually are preferred. 
Pharmacological agents for treatment of substance 
dependence rarely have been studied in older adults. 
Disulfiram use in older adults to promote abstinence is 
not recommended because of the potential for serious 
cardiovascular complications. Compounds recently 
proposed for use in treatment of addiction, such as 
flagyl, deserve further study. A rare controlled clinical 
trial of substance abuse treatment in older patients 
recently revealed naltrexone to be effective at 
preventing relapse with alcohol dependence (Oslin et 
al., 1997). 
Service Delivery 
Overview of Services 
New perspectives are evolving on the nature of mental 
health services for older adults and the settings in 
which they are delivered. Far greater emphasis is being 
placed on community-based care, which entails care 
provided in homes, in outpatient settings, and through 
community organizations. The emphasis on 
community-based care has been triggered by a 
convergence of demographic, consumer, and public 
policy imperatives. In terms of demographics. 
approximately 95 percent of older persons at a given 
point in time live in the community rather than in 
institutions, such as nursing homes (U.S. Department of 
Health and Human Services, Administration on Aging, 
and American Association of Retired Persons 
[U.S.DHHS, AoA & AARP], 1995). Of those living in 
the community, approximately 30 percent, mostly 
women, live alone (U.S. DHHS, AoA & AARP, 1995). 
Most older persons prefer to remain in the community 
and to maintain their independence. Yet living alone 
makes them even more reliant on community-based 
services if they have a mental disorder. 
Service delivery also is being shaped by public 
policy and the emergence of managed care. The 
escalating costs of institutional care, combined with the 
recognition of past abuses. stimulated policies to limit 
nursing home admissions and to shift treatment to the 
community (Maddox et al., 1996). Mental disorders are 
leading risk factors for institutionalization (Katz & 
Parmelee, 1997). Therefore, to keep older people in the 
community, where they prefer to be, more energies are 
being marshaled to promote mental health and to 
prevent or treat mental disorders in the community. In 
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other words, treating mental disorders is seen as a 
means to stave off costly institutionalization-resulting 
either from a mental disorder or a comorbid somatic 
disorder. An untreated mental disorder, for example, 
can turn a minor medical problem into a life- 
threatening and costly condition. Problems with 
forgetting to take medication (e.g., with dementia), 
developing delusions about medication (e.g., with 
schizophrenia), or lowering motivation to refill 
prescriptions (e.g., with depression) can increase the 
likelihood of having more severe illnesses that demand 
more intensive and expensive institutional care. 
Therefore, promotion of mental health and treatment of 
mental disorders are crucial elements of service 
delivery. 
The delivery of community-based mental health 
services for older adults faces an enormous challenge. 
Services for older adults are insufficient and 
fragmented, often divided between systems of health, 
mental health, and social services (Gatz & Smyer, 
1992; Cohen & Cairl, 1996). Under these three 
systems, services include medical and psychosocial 
care, rehabilitation, recreation, housing, education, and 
other supports. Yet although every community has an 
Administration on Aging to assist with services for 
older adults generally, there is no administrative body 
responsible for integrating the daunting array of 
services needed specifically for individuals with severe 
mental illnesses. Similar problems are encountered 
with coordinating services for children, as discussed in 
Chapter 3. Local mental health authorities and systems 
of care have been effective in coordinating care for 
some groups of adults, but no special administrative 
mental health entities exist for older adults. The 
fragmentation of service systems for older people in the 
United States stands in contrast to the United Kingdom 
and Ireland, where governmental authorities coordinate 
their care (Reifler, 1997). Older adults eventually may 
benefit from the local mental health authorities 
developing in the United States, but thus far these 
authorities have been focused on services for other 
adults. Because of ethnic diversity in the United States, 
systems of care must also deal with the special needs of 
Older Adults and Mental Health 
older Americans who have limited English proficiency 
and different cultural backgrounds. 
The following section describes the nature and 
settings in which older people receive mental health 
services. It concentrates on primary care, adult day 
centers and other community care settings, and nursing 
homes. A recurrent theme across these settings is the 
failure to address mental health needs of older people. 
Selected issues in financing of services for older adults 
are discussed briefly at the end of this section, but most 
of the issues related to financing policy (e.g., Medicare, 
Medicaid) and managed care are discussed in 
Chapter 6. 
Service Settings and the New Landscape for 
Aging 
Demographic, consumer, and public policy imperatives 
have propelled tremendous growth in the diversity of 
settings in which older persons simultaneously reside 
and receive care (Table 5-2). Care is no longer the strict 
province of home or nursing home. The diversity of 
home settings in suburban and urban communities 
extends from naturally occurring retirement 
communities to continuing care retirement communities 
to newer types of alternative living arrangements. 
These settings include congregate or senior housing, 
senior hotels, foster care, group homes, day centers 
(where people reside during the day), and others. The 
diversity of institutional settings includes nursing 
homes, general hospitals (with and without psychiatric 
units), psychiatric hospitals, and state mental hospitals. 
among others. In fact, the range of settings, and the 
nature of the services provided within each, has blurred 
the distinction between home and nursing home (Kane, 
1995). 
Across the range of settings, the duration of care 
can be short term or long term, depending on patients’ 
needs. The phrase, “long-term care,” has come to refer 
to a range of services for people with chronic or 
degenerative illness or disabilities who require support 
over a prolonged period of time. In the past, long-term 
care was synonymous with nursing home care or other 
forms of institutional care, but the term has come to 
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Table 5-2. Settings for mental health services for older 
adults’ 
I 
Communities 
Homes 
Group homes 
Retirement communities 
Primary care and general 
medical sector 
Institutions 
Nursing homes 
General hospitals with 
psychiatric units 
General hospitals without 
psychiatric units 
State mental hospitals 
Outpatient therapy 
I / Veterans Affairs hospitals 
Community mental health 
centers -1 
*Two other settings (not included in this table) are board and 
care homes and assisted living facilities. These are 
residential facilities that serve as a bridge between 
community and institutional settings and have elements of 
each. 
apply to a full complement of institutional or 
community-based settings. 
Within the continuum of services,’ one new 
perspective-conceived as the landscape for aging- 
strives to tailor the environment to the needs of the 
person through a combined focus on health and 
residential requirements (Cohen, 1994). Whether at 
home, in a retirement community, or in a nursing home. 
this health and home perspective is deemed to be 
crucial to achieving high quality of life for older adults. 
Over the past 30 years, improvements in the health side 
of this perspective have occurred, but the home part has 
lagged. The challenge is to stimulate an 
interdisciplinary collaboration between systems of care 
and consumers. 
One important area for an interdisciplinary 
approach is the extent to which a given setting fosters 
independent functioning versus dependent functioning, 
an issue influencing mental health and quality of life. 
Though certainly not a goal, some settings 
inadvertently foster dependency rather than 
independence. Nursing homes and hospitals, for 
example, are understandably more focused on what 
individuals cannot do, as opposed to what they can do. 
Yet their major focus on incapacity (the nursing and 
health focus) runs the risk of overshadowing function 
and independence (the home and humanities focus). In 
other settings, the balance between dependence and 
independence shifts in the other direction, with the risk 
of nursing and health needs being inadequately 
addressed. In recent years, the emphasis has been on 
“aging in place, ” either at home or in the community, 
rather than in alternate settin&. 
The landscape for aging is a construct within 
which to examine the depth and breadth of human 
experience in later life (Cohen, 1998b). A health and 
humanities focus across this landscape offers a design 
for dealing with mental health problems as well as with 
health promotion to harness human potential. The 
landscape for aging, with its health and humanities 
orientation, is a construct designed to stir new thinking 
in research, practice, and policy. It also defines a clear 
need for new mental health services’ development and 
delivery, training, research, and policies to address the 
range of sites, each with its own unique characteristics 
and growing populations. The service systems, 
however, have yet to embrace a broader view. 
Primary Care 
Primary care6 represents a pivotal setting for the 
identification and treatment of mental disorders in older 
people. Many older people prefer to receive mental 
health treatment in primary care (Unutzer et al., 1997a), 
a preference bolstered by public financing policies that 
encourage their increasing reliance on primary, rather 
than specialty, mental health care (Mechanic, 1998). 
Primary care offers the potential advantages of 
proximity, affordability, convenience, and coordination 
of care for mental and somatic disorders, given that 
comorbidity is typical. 
’ Primary care includes services provided by general practitioners, 
family physicians, general internists, certain specialists designated 
as primary care physicians (such as pediatricians and obstetrician- 
gynecologists), nurse practitioners, physician assistants, and other 
health care professionals. General medical settings include all 
primary care settings plus all non-mental health specialty care. 
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The potential advantages of primary care, however, 
have yet to be realized. Diagnosis and treatment of 
older people’s mental disorders in the primary care 
setting are inadequate. The efficacious treatments 
described in the depression section of this chapter are 
not being practiced, particularly not in primary care and 
other general medical settings. As documented earlier, 
a significant percentage of older patients with 
depression are underdiagnosed and undertreated. The 
concern about inadequate treatment of late-life 
depression in primary care is magnified by growing 
enrollment in managed care. 
Primary care is generally not well equipped to treat 
chronic mental disorders such as depression or 
dementia. It has limited capacity to identify patients 
with common mental disorders and to provide the 
proactive followup that is required to retain patients in 
treatment. To ensure better treatment of late-life 
depression in primary care, there is heightening 
awareness of the need for new models for mental health 
service delivery (Unutzeret al., 1997a). New models of 
service delivery in primary care include mental health 
teams, consultation-liaison models,’ and integration of 
mental health professionals into primary care (Katon & 
Gonzales, 1994; Schulberg et al., 1995; Katon et al., 
1996. 1997; Stolee et al., 1996; Gasket al.,‘1997). For 
example, the intervention developed by Katon and 
colleagues introduced a structured depression treatment 
program into the primary care setting. The program 
included behavioral treatment to inculcate more 
adaptive coping strategies and counseling to enhance 
compliance with antidepressant medications. Patients 
were randomized in a controlled trial comparing this 
structured depression program with usual care by 
primary care physicians. The investigators found 
patients participating in the program to have displayed 
better medication adherence, better satisfaction with 
care, and a greater decrease in severity of major 
depression (Katon et al., 1996). 
’ Consultation-liaison models provide a bridge between psychiatry 
and the rest of medicine. In most models, a mental health specialist 
is called in as a consultant at the request of a primary care provider 
or works as a regular member of a team of health care providers. 
Older Adults and Mental Health 
Models that integrate mental health treatment into 
primary care, while thus far designed largely for 
depression, also may have utility for other mental 
disorders seen in primary care. Nevertheless, primary 
care is not appropriate for all patients with mental 
disorders. Primary care providers can be guided by a 
set of recommendations for appropriate referrals to 
specialty mental health care (American Association for 
Geriatric Psychiatry, 1997). 
Adult Day Centers and Other Community Care 
Settings 
Over the past few decades, adult day centers have 
developed as an important service delivery approach to 
providing community-based long-term care. Adult day 
centers, although heterogeneous in orientation. provide 
a range of services (usually during standard “9 to 5” 
business hours), including assessment, social, and 
recreation services, for adults with chronic and serious 
disabilities. They represent a form of respite care 
designed to give caregivers a break from the 
responsibility of providing care and to enable them to 
pursue employment. Over the past 30 years, adult day 
centers have grown in number from fewer than 100 to 
over 4,000, under the sponsorship of community 
organizations or residential facilities. A large national 
demonstration program on adult day centers showed 
that they can care for a wide spectrum of patients with 
Alzheimer’s disease and related dementias and can 
achieve financial viability (Reifler et al., 1997; Reifler 
et al., in press). There also is evidence that adult day 
centers are cost-effective in terms of delaying 
institutionalization, and participants show improvement 
in some measures of functioning and mood (Wimo et 
al., 1993, 1994). 
There are several approaches to delivering services 
in adult day centers. There is no research evidence that 
any one model of service delivery is superior to 
another. For example, a social model has been 
developed by Little Havana Activities & Nutrition 
Centers of Dade County (Florida). The Little Havana 
Senior Center provides mental health, health, social, 
nutritional, transportation, and recreational services, 
emphasizing both remedial and preventive services. 
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The center focuses on the predominantly Cuban 
population of South Florida. Yet much more research 
is needed to demonstrate the relative effectiveness of 
different models of adult day services (Reifler et al., 
1997). 
Beyond adult day centers, other innovative models 
of community-based long-term care strive to 
incorporate mental health services. Few have been 
evaluated and none implemented on a wide scale. 
These models include the social/health maintenance 
organization (,S/HMO) (Greenberg et al., 1988), On 
Lok Senior Services Program, and life care 
communities or continuing care retirement 
communities (Robinson, 1990b). These new features of 
the landscape of aging show promise, but there is 
insufficient evidence of cost-effectiveness and 
generalizability of these models, particularly the mental 
health component. Perhaps the lack of a research base 
and limited market account for the slow pace of their 
proliferation in the United States. 
Nursing Homes 
Most older adults live in the community and only a 
minority of them live in nursing homes; of the latter, 
about fwo-rhirds have some kind of mental disorder 
(Bums, 1991). The majority have some type of 
dementia, while others have disabling depression or 
schizophrenia (Bums, 1991). Despite the high 
prevalence of people with mental disorders in nursing 
homes, these settings generally are ill equipped to meet 
their needs (Lombardo, 1994). 
Deinstitutionalization of state mental hospitals 
beginning in the 1960s encouraged the expanded use of 
nursing homes for older adults with mental disorders. 
This trend was enhanced by Medicaid incentives to use 
nursing homes instead of mental hospitals. But the shift 
to nursing homes was not accompanied by alterations 
in care. In 1986, the Institute of Medicine issued a 
landmark report documenting inappropriate and 
inadequate care in nursing homes, including the 
excessive use of physical and chemical restraints (IOM, 
1986). This subsequent visibility of problems prompted 
the passage in 1987 of the Nursing Home Reform Act 
(also known as the Omnibus Budget Reconciliation Act 
of 1987). This legislation restricted the inappropriate 
use of restraints and required preadmission screening 
for all persons suspected of having serious mental 
illness. The purpose of the screening was to exclude 
from nursing homes people with mental disorders who 
needed either more appropriate acute treatment in 
hospitals or long-term treatment in community-based 
settings. Preadmission screening also was designed to 
improve the quality of psychosocial assessments and 
care for nursing home residents with mental disorders. 
Nursing home placement is appropriate for patients 
with mental disorders if the disorders have produced 
such significant dysfunction that patients are unable to 
perform activities of daily living. 
To meet the legislation’s requirements, nursing 
homes must have the capacity to deliver mental health 
care. Such capacity depends on trained mental health 
professionals to deliver appropriate care and treatment. 
Unfortunately, prior to and even after passage of the 
Omnibus Budget Reconciliation Act of 1987, Medicaid 
policies discouraged nursing homes from providing 
specialized mental health services, and Medicaid 
reimbursements for nursing home patients have been 
too low to provide a strong incentive for participation 
by highly trained mental health providers (Taube et al., 
1990). The emphasis on community-based care, 
combined with inadequate nursing home 
reimbursement policies, has limited the development of 
innovative mental health services in nursing homes. 
Major barriers persist in the delivery of appropriate 
care to mentally ill residents of nursing homes. 
Services for Persons With Severe and Persistent 
Men tat Disorders 
Older adults with severe and persistent mental 
disorders (SPMD) are the most frequent users of long- 
term care either in community or institutional settings. 
SPMD in older adults includes lifelong and late-onset 
schizophrenia, delusional disorder, bipolar disorder. 
and recurrent major depression. It also includes 
Alzheimer’s disease and other dementias (and related 
behavioral symptoms, including psychosis), severe 
treatment-refractory depression, or severe behavioral 
problems requiring intensive and prolonged psychiatric 
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intervention. Although these groups of disorders have 
different courses of illness and outcomes, they have 
many overlapping clinical features, share the cotnmon 
need for mental health long-term care services, and are 
frequently treated together in long-term care settings 
(Bums, 1991; Gottesman et al., 1991; American 
Psychiatric Association, 1993). It is estimated that 0.8 
percent of persons older than 55 years in the United 
States have SPMD (Kessler et al., 1996). 
As a result of the dramatic downsizing and closure 
of state hospitals in past decades, 89 percent of 
institutionalized older persons with SPMD now live in 
nursing homes (Bums, 199 1). However, institutions are 
expected to play a substantially smaller role than 
community-based settings in future systems of mental 
health long-term care (Bart’els et al., in press). First, the 
majority of older adults with SPMD presently live in 
the community (Meeks & Murrell, 1997; Meeks et al., 
1997) and prefer to remain there. Second, experience 
with the Preadmission Screening and Resident Review 
mandated by the Omnibus Budget Reconciliation Act 
of 1987 has been mixed. It may have slowed 
inappropriate admissions to nursing homes, restricted 
inappropriate use of restraints, and reduced overuse of 
psychotropic medications, but it did not .otherwise 
improve the quality of mental health services 
(Lombardo, 1994). Furthermore, states’ opposition to 
what they perceived to be Federal government 
interference in local health care policy and a general 
trend toward deregulation subsequently curtailed 
Federal nursing home reform. Finally, the growing 
costs of nursing home care are stimulating dramatic 
reforms in reimbursement and policy, including state 
mandates to limit Medicaid expenditures by decreasing 
nursing home beds and Federal reform by Medicare to 
implement prospective payment for nursing home 
services (Bartels & Levine, 1998). To accommodate the 
mounting number of individuals who have disorders 
requiring chronic care, future projections suggest the 
greatest growth in services will be in home and 
community-based settings (Institute for Health and 
Aging, 1996), increasingly financed through capitated 
and managed care arrangements. 
Older Adults and Mental Health 
Older adults with SPMD are high users of services 
(Cuffel et al., 1996; Semke & Jensen, 1997) and require 
mental health long-term care that is comprehensive. 
integrated, and multidisciplinary (Moak, 1996; Small et 
al., 1997; Bartels & Colenda, 1998). The mental health 
care needs of this population include specialized 
geropsychiatric services (Moak, 1996); integrated 
medical care (Moak & Fisher, 1991; Small et al.. 
1997); dementia care (Small et al., 1997; Bartels & 
Colenda, 1998); home and community-based long-term 
care; and residential and family support services, 
intensive case management, and psychosocial 
rehabilitation services (Aiken, 1990: Robinson, 1990a; 
Schaftt & Randolph, 1994; Lipsman, 1996). With 
adequate supports, older persons with SPMD can be 
maintained in the community, sometimes at lower cost. 
and with equal or improved quality of life in 
comparison with institutions (Bernstein & Hensley, 
1988; Mosher-Ashley, 1989; Leff, 1993; Trieman et al., 
1996). 
However, current mental health policies have left 
many older persons with SPMD with decreased access 
to mental health care in both community and 
institutional settings (Knight et al., 1998). Community- 
based mental health services for older people are 
largely provided through the general medical sector, 
partly due to poor responsiveness to the needs of older 
people by community mental health organizations 
(Light et al., 1986). Yet reliance on the general medical 
sector also has not met their needs because of its focus 
on acute care (George, 1992). In addition, most home 
health agencies provide only limited short-term mental 
health care. The long-term care programs that exist 
primarily aid older adults with chronic physical 
disabilities or cognitive impairment but fail to address 
impairments in mood and behavior (Robinson, 1990a). 
An additional barrier is that the majority of 
community-residing older adults do not seek mental 
health services, except for medication (Meeks & 
Murrell, 1997), despite continued need (Meeks et al., 
1997). Those without family support generally live in 
nursing homes, assisted living facilities, and board and 
care homes. These three are forms of residential care 
that offer some combination of housing, supportive 
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services, and, in some cases, medical care. In short, 
more resources must be devoted to programs that 
integrate mental health rehabilitative services into 
long-term care in both community and institutional 
settings. 
Financing Services for Older Adults 
Financing policies furnish incentives that favor 
utilization of some services over others (e.g., nursing 
homes rather than state mental hospitals) or preclude 
the provision of needed services (e.g., mental health 
services in nursing homes). Details on financing and 
organizing mental health services, with a special focus 
on access, are presented in Chapter 6. Selected issues 
germane to older adults are addressed here. 
Historically, Federal financing policy has imposed 
special limits on reimbursement for mental health 
services. Medicaid precluded payment for care in so- 
called “institutions for mental diseases,” Medicaid’s 
term for mental hospitals and the small percentage of 
nursing homes with specialized mental health services. 
This Medicaid policy provided a disincentive for the 
majority of nursing homes to specialize in delivering 
mental health services for fear of losing Medicaid 
payments (Taube et al., 1990). Under Medicare, the 
most salient limits were higher copayments for 
outpatient mental health services and a limited number 
of days for hospital care. Medicare’s special limits on 
outpatient mental health services were changed over the 
past decade, resulting in significantly increased access 
to and utilization of such services (Goldman et al., 
1985; Rosenbach & Ammering, 1997). The concern, 
however, is that the gains made as a result of policy 
changes easily could be eroded by the shift to managed 
care (Rosenbach & Ammering, 1997). 
Increased Role of Managed Care 
Projections are that 35 percent of all Medicare 
beneficiaries will be in managed care plans by the year 
2007, amounting to approximately 15.3 million people 
(Komisar et al., 1997). Although the managed care 
industry has the potential to provide a range of 
integrated services for people with long-term care 
needs, managed care’s awareness of and response to 
chronic care are rudimentary (Institute for Health and 
Aging, 1996). Despite the potential of systems of 
managed health care, such as HMOs, to provide 
comprehensive preventive, acute, and chronic care 
services, their current specialized geriatric programs 
and clinical case management for older persons tend to 
be inadequate or poorly implemented (Friedman & 
Kane, 1993; Pacala et al., 1995; Kane et al., 1997). In 
addition, older patients are likely to be poorly served in 
primary care settings (including primary care HMOs) 
because of minimal use of specialty providers and 
suboptimal pharmacological management (Bartels et 
al., 1997). Further, current systems lack the array of 
community support, residential, and rehabilitative 
services necessary to meet the needs of older persons 
with more severe mental disorders (Knight et al., 1995). 
These shortcomings are unlikely to be remedied until 
more research becomes available demonstrating cost- 
effective models for treating older people with mental 
illness. 
Carved-In Mental Health Services for Older 
Adults 
The types of mental health services available within 
managed care organizations vary greatly with respect to 
how services are provided. In some organizations, 
mental health care is directly integrated into the 
package of general health care services (“carved-in” 
mental health services), while it is provided in others 
through a contract with a separate specialty mental 
health organization that provides only these services 
and accepts the financial risk (“carved-out” mental 
health services). 
Proponents of carved-in mental health services 
argue that this model better integrates physical and 
mental health care, decreases barriers to mental health 
care due to stigma, and is more likely to produce 
cost-offsets and overall savings in general health care 
expenditures. These features are particularly relevant to 
older persons, as they commonly have comorbid 
somatic disorders for which they take multiple 
medications that may affect mental disorders, often 
avoid specialty mental health settings. and incur 
significant health care expenses related to psychiatric 
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symptoms (George, 1992: Paveza & Cohen, 1996; 
soak. 1996; Riley et al., 1997). Unfortunately, mental 
health specialty services for older persons tend to be a 
low priority in managed health care organizations, by 
comparison with medical or surgical specialty services 
(Bartels et al., 1997). More importantly, carved-in 
mental health care may have superior potential for 
individuals with diagnoses such as minor depression 
and anxiety disorders but tends to shortchange older 
patients with SPMD who require intensive and long- 
term mental health care (Mechanic, 1998). The range of 
outreach, rehabilitative, residential, and intensive 
services needed for patients with SPMD is likely to 
exceed the capacity, expertise, and investment of most 
general health care providers. 
Economic factors also hay limit the usefulness of 
mental health carve-ins in serving the needs of older 
individuals with SPMD. First, evidence from private 
sector health plans suggests that without mandated 
parity, insurers offer inferior coverage of mental health 
care (Frank et al., 1997b, 1997~). Furthermore, if 
providers or payers compete for enrollees, there is 
strong incentive to avoid enrollees expected to have 
higher costs from mental health problems (e.g., older 
persons with SPMD). To avoid such discrimination, 
equal coverage of mental health care would have to be 
mandated through legislation on mental health parity or 
through specialized contract requirements with 
managed care organizations. 
Carved-Out Mental Health Services for Older 
Adults 
Proponents of mental health service carve-outs for 
older persons argue that separate systems of financing 
and services are likely to be superior for individuals 
needing specialty mental health services, especially 
those with SPMD. In particular, advocates suggest that 
carved-out mental health organizations have superior 
technical knowledge, specialized skills, a broader array 
of services, greater numbers and varieties of mental 
health providers with experience treating severe mental 
disorders, and a willingness and commitment to service 
high-risk populations (Riley et al., 1997). From an 
economic perspective, since competition is largely over 
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the carve-out contract with the payer (generally a 
public organization or an employer), there is less 
incentive to compete on risk selection, and risk 
adjustment becomes unnecessary. In addition, mental 
health carve-out organizations may be better equipped 
to provide rehabilitative and community support mental 
health services necessary to care for older persons with 
SPMD. Finally, growth of innovative outpatient 
alternatives could be stimulated by reinvestment of 
savings by the payer from any decrease in inpatient 
service use. 
Unfortunately, research is la’cking on outcomes and 
costs for older persons with SPMD in mental health 
carve-outs. A carve-out arrangement could lead to 
adverse clinical outcomes in older patients due to 
fragmentation of medical and mental health care 
services in a population with high risk of complications 
of comorbidity and polypharmacy. Also, from a 
financial perspective, the combination of physical and 
mental comorbidities seen in older adults, especially 
those with SPMD, may reduce the economic 
advantages of carved-out services (Bazemore, 1996; 
Felker et al., 1996; Tsuang & Woolson, 1997). If the 
provider cannot appropriately manage services and 
costs associated with the combination of somatic and 
mental health disorders, anticipated savings may not 
materialize. Furthermore, fragmentation of 
reimbursement streams would likely complicate the 
assessment of cost-effectiveness or cost-offsets. For 
example, apparent savings of mental health carve-outs 
under Medicare actually may be due to shifting costs 
when an individual is also covered under Medicaid. In 
this situation, Medicaid may cover prescription drugs, 
long-term care, and other services that are not paid for 
by Medicare. In order to offer true efficiencies, 
Medicare mental health carve-outs need to find a way 
to bridge the fragmentation of financing care for older 
persons. 
Outcomes Under Managed Care 
There do not appear to be any studies of mental health 
outcomes for older adults under managed care. In 
general, the available research on mental health 
outcomes for other adults consistently finds that 
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managed care is successful at reducing mental health 
care costs (Busch, 1997; Sturm, 1997), yet clinical 
outcomes (especially for the most severely and 
chronically ill) are mixed and difficult to interpret due 
to differences in plans and populations served. Several 
studies suggest that outcomes under managed care for 
younger adults are as favorable as, or better than, those 
under fee-for-service (Lurie et al., 1992; Cole et al., 
1994). In contrast, others report that the greater use of 
nonspecialty services for mental health care under 
managed care is associated with less cost-effective care 
(Sturm & Wells, 1995), and that older and poor 
chronically ill patients may have worse health 
outcomes or outcomes that vary substantially by site 
and patient characteristics (Ware et al., 1996). A recent 
review of health outcomes for both older and younger 
adults in the managed care literature (Miller & Luft, 
1997) concluded that there were no consistent patterns 
that suggested worse outcomes. However, negative 
outcomes were more common in patients with chronic 
conditions, those with diseases requiring more 
intensive services, low-income enrollees in worse 
health, impaired or frail elderly, or home health patients 
with chronic conditions and diseases. These risk factors 
apply to older adults with SPMD, suggesting that this 
group is at high risk for poor outcomes under managed 
care programs that lack specialized long-term mental 
health and support services. To definitively address the 
question of mental health outcomes for older persons 
under managed care, appropriate outcome measures for 
older adults with mental illness will need to be 
developed and implemented in the evolving health care 
delivery systems (Bartels et al., in press). 
Other Services and Supports 
Older adults and their families depend on a multiplicity 
of supports that extend beyond the health and mental 
health care systems. Patients and caregivers need 
access to education, support networks, support and self- 
help groups. respite care, and human services, among 
other supports (Scott-Lennox & George, 1996). These 
services assume heightened importance for older 
people who are living alone, who are uncomfortable 
with formal mental health services, or who are 
inadequately treated in primary care. Services and 
supports appear to be instrumental not only for the 
patient but also for the family caregiver, as this section 
explains, but research on their efficacy is sparse. The 
strongest evidence surrounds the efficacy of services 
for family caregivers. Support for family caregivers is 
crucial for their own health and mental health, as well 
as for controlling the high costs of institutionalization 
of the family member in their care. The longer the 
patient remains home, the lower the total cost of 
institutional care for those who eventually need it. 
Support and Self-Help Groups 
Support groups, which are an adjunct to formal 
treatment, are designed to provide mutual support, 
information, and a broader social network. They can be 
professionally led by counselors or psychologists, but 
when they are run by consumers* or family members, 
they are known as self-help groups. The distinction is 
somewhat clouded by the fact that mental health 
professionals and community organizations often aid 
self-help groups with logistical support, start-up 
assistance, consultation, referrals, and education 
(Waters, 1995). For example, self-help support groups 
sponsored by the Alzheimer’s Association use 
professionals to provide consultation to groups 
orchestrated by lay leaders. 
Support groups for people with mental disorders 
and their families have been found helpful for adults 
(see Chapter 4). Participation in support groups, 
including self-help groups, reduces feelings of 
isolation, increases knowledge, and promotes coping 
efforts. What little research has been conducted on 
older people is generally positive but has been limited 
mostly to caregivers (see later section) and widows (see 
below), rather than to older people with mental 
disorders. 
Despite the scant body of research, there is reason 
to believe that support and self-help group participation 
is as beneficial, if not more beneficial, for older people 
with mental disorders. Older people tend to live alone 
’ Consumers are people engaged in and served by mental health 
services. 
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and to be more socially isolated than are other people. 
They also are less comfortable with formal mental 
health services. Therefore, social networks established 
through support and self-help groups are thought to be 
especially vital in preventing isolation and promoting 
health. Support programs also can help reduce the 
stigma associated with, mental illness, to foster early 
detection of illnesses, and to improve compliance with 
formal interventions. 
Earlier sections of this chapter documented the 
untoward consequences of prolonged bereavement: 
severe emotional distress, adjustment disorders, 
depression, and suicide. Outcomes have been studied 
for two programs of self-help for bereavement. One 
program, They Help Each Other Spiritually (THEOS), 
had robust effects on those’who were more active in the 
program. Those widows and widowers displayed the 
improvements on health measures such as depression, 
anxiety, somatic symptoms, and self-esteem 
(Lieberman & Videka-Sherman, 1986). The other 
program, Widow to Widow: A Mutual Health Program 
for the Widowed, was developed by Silverman (1988). 
The evaluation in a controlled study found program 
participants experienced fewer depressive symptoms 
and recovered their activities and developed new 
relationships more quickly (Vachon, 1979; Vachon et 
al., 1980, 1982). 
Education and Health Promotion 
There is a need for improved consumer-oriented public 
information to educate older persons about health 
promotion and the nature of mental health problems in 
aging. Understanding that mental health problems are 
not inevitable and immutable concomitants of the aging 
process, but problems that can be diagnosed, treated, 
and prevented, empowers older persons to seek 
treatment and contributes to more rapid diagnosis and 
better treatment outcomes. 
With respect to health promotion, older persons 
also need information about strategies that they can 
follow to maintain their mental health. Avoiding 
disease and disability, sustaining high cognitive and 
physical function, and engaging with life appear to be 
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important ways to promote mental and physical health 
(Rowe & Kahn, 1997). The two are interdependent. 
Established programs for health promotion in older 
people include wellness programs, life review, 
retirement, and bereavement groups (see review by 
Waters, 1995). Although controlled evaluations of 
these programs are infrequent, bereavement and life 
review appear to be the best studied. Bereavement 
groups produce beneficial results, as noted above, and 
life review has been found to produce positive 
outcomes in terms of stronger life satisfaction, 
psychological well-being, self-esteem, and less 
depression (Haight et al., 1998). Life review also was 
investigated through individualized home visits to 
homebound older people in the community who were 
not depressed but suffered chronic health conditions. 
Life review for these older people was found to 
improve life satisfaction and psychological well-being 
(Haight et al., 1998). 
Another approach to promoting mental health is to 
develop a “social portfolio,” a program of sound 
activities and interpersonal relationships that usher 
individuals into old age (Cohen, 1995b). While people 
in the modem work force are advised to plan for future 
economic security-to strive for a balanced financial 
portfolio-too little attention is paid to developing a 
balanced social portfolio to help to plan for the future. 
Ideally, such a program will balance individual with 
group activities and high mobilir;v/energy activities 
requiring significant physical exertion with lo+v 
mobiZio/energy ones. The social portfolio is a mental 
health promotion strategy for helping people develop 
new strengths and satisfactions. 
Families and Caregivers 
Among the many myths about aging is that American 
families do not care for their older members. Such 
myths are based on isolated anecdotes as opposed to 
aggregate data. Approximately 13 million caregivers, 
most of whom are women, provide unpaid care to older 
relatives (Biegel et al., 1991). Families are committed 
to their older members and provide a spectrum of 
assistance, from hands-on to monetary help (Bengston 
et al., 1985; Sussman, 1985; Gatz et al., 199% Cohen, 
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1995a). Problems occur with older individuals who 
have no children or spouse, thereby reducing the 
opportunity to receive family aid. Problems also occur 
with the “old-old,” those over 85 whose children are 
themselves old and, therefore, unable to provide the 
same intensity of hands-on help that younger adult 
children can provide. These special circumstances 
highlight the need for careful attention to planning for 
mental health service delivery to older individuals with 
less access to family or informal support systems. 
Conversely, a large and growing number of older 
family members care for chronically mentally ill and 
mentally retarded younger adults (Bengston et al., 
1985; Gatz et al., 1990; Eggebeen & Wilhelm, 1995). 
Too little is known about ways to help the afflicted 
younger individuals and their caregiving parents. 
Families are eager to help themselves, and society 
needs to find ways to better enable them to do so. 
There is a great need to better educate families 
about what they can do to help promote mental health 
and to prevent and treat mental health problems in their 
older family members. Families fall prey to negative 
stereotypes that little can be done for late-life mental 
health problems. They need to know that mental health 
problems in later life, like physical health problems, 
can be treated. They need to understand how to better 
recognize symptoms or signals of impending mental 
health problems among older adults so that they can 
help their loved ones receive early interventions. They 
need to know what services are available, where they 
can be found, and how to help their older relatives 
access such help when necessary. 
The plight of family caregivers is pivotal. As noted 
earlier, the burden of caring for an older family 
member places caregivers at risk for mental and 
physical disorders. Virtually all studies find elevated 
levels of depressive symptomatology among caregivers, 
and those using diagnostic interviews report high rates 
of clinical depression and anxiety (Schultz et al., 1995). 
Ensuring their mental and physical health is not only 
vital for their well-being but also is vital for the older 
people in their care. Support groups and services aimed 
at caregivers can improve their health and quality of 
life, can improve management of patients in their care, 
and can delay their institutionalization. 
Communities and Social Services 
Family support is often supplemented by enduring 
long-term relationships between older people and their 
neighbors and community, including religious, civic, 
and public organizations (Scott-Lennox & George, 
1996). Linkages to these organizations instill a sense of 
belonging and companionship. Such linkages also 
provide a safety net, enabling some older people to live 
independently in spite of functional decline. 
While the vast majority of frail and homebound 
older people receive quality care at home, abuse does 
occur. Estimates vary, but most studies find rates of 
abuse by caregivers (either family or nonfamily 
members) to range up to 5 percent (Coyne et al., 1993; 
Scott-Lennox & George, 1996). Abuse is generally 
defined in terms of being either physical, 
psychological, legal, or financial. The abuse is most 
likely to occur when the patient has dementia or late- 
life depression, conditions that impart relatively high 
psychological and physical burdens on caregivers 
(Coyne et al., 1993). A recent report by the Institute of 
Medicine describes the range of interventions for 
protection against abuse of older people, including 
caregiver participation in support groups and training 
programs for behavioral management (especially for 
Alzheimer’s disease) and social services programs 
(e.g.. adult protective services, casework, advocacy 
services, and out-of-home placements). While there are 
very few controlled evaluations of these services (IOM, 
1998), communities need to ensure that there are 
programs in place to prevent abuse of older people. 
Programs can incorporate any of a number of effective 
psychosocial and support interventions for patients 
with Alzheimer’s disease and their caregivers- 
interventions that were presented earlier in this section 
and the section on Alzheimer’s disease. 
Communities need to ensure the availability of 
adult day care and other forms of respite services to aid 
caregivers striving to care for family members at home. 
They also can provide assistance to self-help and other 
support programs for patients and caregivers. In the 
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process of facilitating or providing services, 
communities need to consider the diversity of their 
older residents-racial and ethnic diversity, socio- 
economic diversity, diversity in settings where they 
live, and diversity in levels of general functioning. 
Such diversity demands comprehensive program 
planning, information and referral services (including 
directories of what is available in the community), 
strong outreach initiatives, and concerted ways to 
promote accessibility. Moreover, each component of 
the community-based delivery system targeting older 
adults should incorporate a clear focus on mental 
health. Too often, attention to mental health services 
for older people and their caregivers is negligible or 
absent, despite the fact, as noted earlier, that mental 
health problems and care$ver distress are among the 
leading reasons for institutionalization (Lombardo, 
1994). Important life tasks remain for individuals as 
they age. Older individuals continue to learn and 
contribute to society, in spite of physiologic changes 
due to aging and increasing health problems. 
Conclusions 
1. 
2. 
3. 
4. 
5. 
Important life tasks remain for individuals as they 
age. Older individuals continue to ,learn and 
contribute to the society, in spite of physiologic 
changes due to aging and increasing health 
problems. 
Continued intellectual, social. and physical activity 
throughout the life cycle are important for the 
maintenance of mental health in late life. 
Stressful life events, such as declining health 
and/or the loss of mates, family members, or 
friends often increase with age. However, 
persistent bereavement or serious depression is not 
“normal” and should be treated. 
Normal aging is not characterized by mental or 
cognitive disorders. Mental or substance use 
disorders that present alone or co-occur should be 
recognized and treated as illnesses, 
Disability due to mental illness in individuals over 
65 years old will become a major public health 
problem in the near future because of demographic 
changes. In particular, dementia, depression, and 
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schizophrenia, among other conditions, will all 
present special problems in this age group: 
a. Dementia produces significant dependency and 
is a leading contributor to the need for costly 
long-term care in the last years of life; 
b. Depression contributes to the high rates of 
suicide among males in this population; and 
c. Schizophrenia continues to be disabling in 
spite of recovery of function by some 
individuals in mid to late life. 
6. There are effective interventions for most mental 
disorders experienced by older persons (for 
example, depression and anxiety), and many 
mental health problems, such as bereavement. 
7. Older individuals can benefit from the advances in 
psychotherapy, medication, and other treatment 
interventions for mental disorders enjoyed by 
younger adults, when these interventions are 
modified for age and health status. 
8. Treating older adults with mental disorders accrues 
other benefits to overall health by improving the 
interest and ability of individuals to care for 
themselves and follow their primary care 
provider’s directions and advice, particularly about 
taking medications. 
9. Primary care practitioners are a critical link in 
identifying and addressing mental disorders in 
older adults. Opportunities are missed to improve 
mental health and general medical outcomes when 
mental illness is underrecognized and undertreated 
in primary care settings. 
10. Barriers to access exist in the organization and 
financing of services for aging citizens. There are 
specific problems with Medicare, Medicaid, 
nursing homes, and managed care. 
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CHAPTER 6 
T his chapter examines what recent research has revealed about the organization and financing of 
mental health services as well as the cost and quality of 
those services. The discussion places emphasis on the 
tremendous growth of managed care and the attempts 
to gain parity in insurance. Understanding these issues 
can inform the decisions made by people with mental 
health problems and disorders, as well as their family 
members and advocates, and health care administrators 
and policymakers. Earlier chapters reviewed data on 
the occurrence of mental disorders in the population at 
large and described the treatment system. In each stage 
of the life cycle, issues related to mental health services 
have been discussed, including, for example, the 
breadth of mental health and human services involved 
in caring for children with mental health problems and 
disorders; deinstitutionalization and its role in shaping 
contemporary mental health services for children and 
adults; the problems associated with discontinuity of 
care in a fragmented service system; and the impor 
tance of primary care medical providers in meeting the 
mental health needs of older persons. Special mental 
health services concerns such as homelessness, crim- 
inalization of persons with mental illness, and dis- 
parities in access to and utilization of mental health 
services due to racial, cultural, and ethnic identities as 
well as other demographic characteristics have been 
discussed throughout the report. 
There are four main sections in this chapter. The 
first section provides an overview of the current system 
of mental health services. It describes where people get 
care and how they use services. The next section 
presents information on the costs of care and trends in 
spending. The third section discusses the dynamics of 
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insurance financing and managed care. It also addresses 
both positive and adverse effects of managed care on 
access and quality and describes efforts to guard 
against untoward consequences of aggressive cost- 
containment policies. The final section documents 
some of the inequities between general medical and 
mental health care and describes efforts to correct them 
through legislation, regulation, and financing changes. 
Overview of the Current Service 
System 
The Structure of the U.S. Mental Health 
Service System 
A broad array of services and treatments exists to help 
people with mental illnesses-as well as those at 
particular risk of developing them-to suffer less 
emotional pain and disability and live healthier, longer, 
and more productive lives. Mental disorders and mental 
health problems are treated by a variety of caregivers 
who work in diverse, relatively independent, and 
loosely coordinated facilities and services-both public 
and private-that researchers refer to, collectively, as 
the de facto mental health service system (Regier et al., 
1978; Regier et al., 1993). 
About 15 percent of all adults and 21 percent of 
U.S. children and adolescents use services in the de k_ 
fact6:ystemeach year. The system is usually described 
as having four major components or sectors: 
l The specialty mental health sector consists 
mental health professionals such as psychiatrists, 
psychologists, psychiatric nurses, and psychiatric 
social workers who are trained specifically to treat 
405 
Mental Health: A Report of the Surgeon General 
people with mental disorders. The great bulkof 
specialty treatment is now provided in 
outpatient settings such as private office-based 
practices or in private or public clinics. Most 
acute hospital care is now provided in special 
psychiatric units ,of general hospitals or beds 
scattered throughout general hospitals. Private 
psychiatric hospitals and residential treatment 
centers for children and adolescents provide 
additional intensive care in the private sector. 
Public sector facilities include state/county 
mental hospitals and multiservice mental 
health facilities, which often coordinate a wide 
range of outpatient, intensive case manage- 
ment, partial hospl”talization, and inpatient 
services. Altogether, slightly less than 6 
percent of the adult population and about 8 
percent of children and adolescents (ages 9 to 
17) use specialty mental health services in a 
year. 
l The general medical/primary care sector consists 
of health care professionals such as general 
internists, pediatricians, and nurse practitioners in 
office-based practice, clinics, acute medicaY 
surgical hospitals, and nursing homes, More than 6 
percent of the adult U.S. population use the general 
medical sector for mental health care, with an 
average of about 4 visits per year-far lower than 
the average of 14 visits per year found in the 
specialty mental health sector.’ The general medi- 
cal sector has long been identified as the initial 
point of contact for many adults with mental 
disorders; for some, these providers may be their 
only source of mental health services. However, 
only about 3 percent of children and adolescents 
contact general medical physicians for mental 
’ The National Comorbidity Survey, using a single interview 
requiring a 12-month recall period, determined that 4 percent of 
adults sought mental or addictive treatment services from primary 
care physicians. With a more intensive examination of primary 
health care use involving three interviews about service use during 
a 1 -year period in the Epidemiologic Catchment Area study, more 
than 6 percent of adults indicated that they specifically spoke with 
their general medical physicians about their “emotions, nerves, 
drugs or alcohol.” 
health services; the human services sector (see 
below) plays a much larger role in their care. 
l The human services sector consists of social 
services, school-based counseling services, 
residential rehabilitation services, vocational 
rehabilitation, criminal justice/prison-based ser- 
vices, and religious professional counselors. In the 
early 198Os, about 3 percent of U.S. adults used 
mental health services from this sector. But by the 
early 199Os, the National Comorbidity Survey 
(NCS) revealed that 5 percent of adults used such 
services. For children, school mental health ser- 
vices are a major source of care (used by 16 
percent), as are services in the child welfare and 
juvenile justice systems, which serve about 3 per- 
cent. 
l The voluntary support network sector, which 
consists of self-help groups, such as 12-step 
programs and peer counselors, is a rapidly growing 
component of the mental and addictive disorder 
treatment system. The Epidemiologic Catchment 
Area (ECA) study demonstrated that about 1 per- 
cent of the adult population used self-help groups 
in the early 1980s; the NCS showed a rise to about 
3 percent in the early 1990s. 
Table 6-l summarizes the percentage of U.S. adults 
who use different sectors of the de facto mental health 
treatment system. (There is overlap across these sectors 
because some people use services in multiple sectors.) 
Table 6-2 summarizes the percentage of U.S. children 
and adolescents using various sectors of this system. 
Table 6-l. Proportion of adult population using mental/ 
addictive disorder services in one year 
I 
Total Health Sector ll%* 
Specialty Mental Health 6% / 
General Medical 6% 
Human Services Professionals 5% 
Voluntary Support Network 3% I 
Any of Above Services 15% 
L 
*Subtotals do not add to total due to overlap. 
Source: Regier et al., 1993; Kessler et al., 1996 
Table 6-2. Proportion of child/adolescent populations 
(ages 9-l 7) using mental/addictive disorder 
services in one year 
Total Health Sector 9%’ 
Specialty Mental Health 8% 
General Medical 3% 
Human Services Professionals 17%’ 
School Services 16% 
Other Human Services 3% 
Any of Above Services 21% 
‘Subtotals do not add to total due to overlap. 
Source: Shaffer et al., 1996 
The Public and Privite Sectors 
The de facto mental health service system is divided 
into public and private sectors. The term “public 
sector” refers both to services directly operated by 
government agencies (e.g., state and county mental 
hospitals) and to services financed with government 
resources (e.g., Medicaid, a Federal-state program for 
financing health care services for people who are poor 
and disabled, and Medicare, a Federal health insurance 
program primarily for older Americans and people who 
retire early due to disability). Publicly financed 
services may be provided by private organizations. The 
term “private sector” refers both to services directly 
operated by private agencies and to services financed 
with private resources (e.g., employer-provided 
insurance). Funding for the de facto mental health 
service system is discussed later in the report. 
State and local government has been the major 
payer for public mental health services historically and 
remains so today. Since the mid-1960s however, the 
role of the Federal government has increased. In 
addition to Medicare and Medicaid, the Federal 
government funds special programs for adults with 
serious mental illness and children with serious 
emotional disability. Although small in relation to state 
and local funding, these Federal programs provide 
additional resources. They include the Community 
Mental Health Block Grant, Community Support 
Organizing and Financing Mental Health Set-vices 
programs, the PATH program for people with mental 
illness who are homeless, the Knowledge Development 
and Application Program, and the Comprehensive 
Community Mental Health Services for Children and 
Their Families Program. 
The fact that 16 percent of the U.S. adult 
population-largely the working poor-have no health 
insurance at all is the focus of considerable policy 
activity. Many others are inadequately insured. Ini- 
tiatives designed to increase enrollment for selected 
populations include the newly created Child Health 
Insurance Program, which provides block grants to r 
states for coverage of children not eligible for 
Medicaid. 
These federally funded public sector programs 
buttress the traditional responsibility of state and local 
mental health systems and serve as the mental health 
service “safety net” and “catastrophic insurer” for those 
citizens with the most severe problems and the fewest 
resources in the United States. The public sector serves 
particularly those individuals with no health insurance, 
those who have insurance but no mental health 
coverage, and those who exhaust limited mental health 
benefits in their health insurance. 
Each sector of the de facto mental health service 
system has different patterns and types of care and 
different patterns of funding. W ithin the specialty 
mental health sector, state- and county-funded mental 
health services have long served as a safety net for 
people unable to obtain or retain access to privately 
funded mental health services. The general medical 
sector receives a relatively greater proportion of 
Federal Medicaid funds, while the voluntary support 
network sector, staffed principally by people with 
mental illness and their families, is largely funded by 
private donations of time and money to emotionally 
supportive and educational groups. The relative quality 
of care in these various sectors is a matter of intense 
interest and discussion, although there is little 
definitive research to date. 
Effective functioning of the mental health service 
system requires connections and coordination among 
many sectors (public-private, specialty-general health. 
health-social welfare, housing, criminal justice, and 
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education). Without coordination, it can readily become 
organizationally fragmented, creating barriers to access, 
Adding to the system’s complexity is its dependence on 
many streams of funding, with their sometimes 
competing incentives. For example, if as part of a 
Medicaid program reform, financial incentives lead to 
a reduction in admissions to psychiatric inpatient units 
in general hospitals and patients are sent to state mental 
hospitals instead, this cost containment policy con- 
ceivably could conflict with a policy directive to reduce 
the census of state mental hospitals. 
The public and private parts of the de facto mental 
health system treat distinct populations with some 
overlap. As shown in Table 6-1, 11 percent of the U.S. 
population use specialty or general medical mental 
health services each year. Nearly 10 percent of the 
population-almost all users-received some care in 
private facilities, while 2 percent of the population 
received care in public facilities. About 1 percent of the 
population used inpatient care; of these, one-third 
received care in the public sector, suggesting that those 
requiring more intensive services rely more heavily on 
the public safety net (Regier et al., 1993; Kessler et al., 
1994). Nonetheless, many people with severe and 
persistent illness now receive at least some of their care 
in the private sector. This makes it important to ensure 
that the private sector can meet the full treatment needs 
of this population. 
Patterns of Use 
Adults 
Americans use the mental health service system in 
complex ways, or patterns. A total of about 15 percent 
of the U.S. adult population use mental health services 
in any given year. These data come from two 
epidemiologic surveys: the Epidemiologic Catchment 
Area (ECA) study of the early 1980s and the National 
Comorbidity Survey (NCS) of the early 1990s. Those 
surveys defined mental illness according to the 
prevailing editions of the Diagnosric and Statistical 
Manual of Mental Disorders (i.e., DSM-III and DSM- 
IILR) and defined mental health services in accordance 
with the “de facto” system described above. Figure 6- 1 
presents a hierarchy of sectors in the treatment system 
(i.e., specialty mental health, general medical, and other 
human services).’ About 6 percent of the adult 
population use specialty mental health care; 5 percent 
of the population receive their mental health services 
from general medical and/or human services providers, 
and 3 to 4 percent of the population receive their 
mental health services from other human service 
professionals or self-help groups. (The overlap across 
these latter two sectors accounts for these figures 
totaling more than 15 percent) (Figure 6-l). 
Also, slight19 more than half of the 15 percent of 
the population that use mental health services have a 
specific mental or addictive disorder (8 percent), while 
the remaining portion has a mental health problem or a 
disorder not included in the ECA or NCS (7 percent). 
The surveys estimate that during a 1-year period, about 
one in five American adults-or 44 million people- 
have diagnosable mental disorders, according to 
reliable, established criteri; To be more specific, 19 
percent of thq’bdult U.S. population have a mental 
disorder alone.&r 1 year); 3 percent have both mental 
and addictive disorders; and 6 percent have addictive 
disorders alone.‘Consequently, about 28 percent of the 
population have either a r&ental or addictive disorder 
(Regier et al., 1993; Kessler et al., 1994). 
Given that 28 percenz; of the population have a 
diagnosable mental or substance abuse disorder and 
only 8 percent of adults both have a diagnosable dis- 
order and use mental health services, one can conclude 
that less than one-third of adults with a diagnosable 
mental disorder receives treatment in one year. In short, 
a substantial majority of those with specific mental 
disorders do not receive treatment. Figure 6-l depicts 
the 28 percent of the U.S. adult population who meet 
full criteria for a mental or addictive disorder, and 
illustrates that 8 percent receive mental health services 
while 20 percent do not receive such services in a given 
year. 
Among the service users with specific disorders, 
between 30 and 40 per&& perceived some need for 
2 For those who use more than one sector of the service system, 
preferential assignment is to the most specialized level of mental 
care. However, most of those with disorders who did 
not seek care believed their problems would go away 
by themselves or that they could handle them on their 
own (Kessler et al., 1997). In a recent 1998 Robert 
Wood Johnson national household telephone survey, 11 
percent of the population perceived a need for mental 
or addictive services, with about 25 percent of these 
reporting difficulties in obtaining needed care (Sturm 
& Sherboume, 1999). Worry about costs was listed as 
the highest reason for not receiving care, with 83 
percent of the uninsured and 55 percent of the privately 
insured listing this reason. The inability to obtain an 
appointment soon enough because of an insufficient 
supply of services was listed by 59 percent of those 
with Medicaid but by far fewer of those with private 
insurance. . 
Children and Adolescents 
Comparable data on service use by children and 
adolescents with diagnoses of mental disorder and at 
least minimal impairment only recently have been 
obtained from a National Institute of Mental Health 
(NIMH) multisite survey of children and adolescents 
ages 9 to 17 years (Shaffer et al., 1996). Results from 
this survey are summarized in Table 6-2 and in 
Figure 6-2. 
Although 9 percent of the entire child/adolescent 
sample received some mental health services in the 
health sector (that is, the general medical sector and 
specialty mental health sector), the largest provider of 
mental health services to this population was the school 
system. As shown in Figure 6-2, nearly 11 percent of 
the child/adolescent sample received their mental 
health services exclusively from the schools or the 
human services sector (with no services from the health 
sector); another 5 percent (not shown in Figure 6-2) 
received school services in addition to health sector 
services. Many children served by schools do not have 
diagnosable mental health conditions covered in 
available surveys-some may have other diagnoses 
such as adjustment reactions or acute stress reactions. 
In addition, I percent of children and adolescents 
received their mental health services from human 
service professionals, such as those in child welfare and 
Organizing and Financing Mental Health Services 
juvenile justice. The latter is a setting under increasing 
scrutiny as the result of pending Federal legislation. At 
present, child data are unavailable that would exactly 
match the adult data on service use (analyzed by 
diagnostic severity and by public versus private 
sectors). 
Almost 21 percent of children and adolescents 
(ages 9 to 17) had some evidence of distress or 
impairment associated with a specific diagnosis and 
also had at least a minimal level of impairment on a 
global assessment measure. Almost half of this group 
(almost 10 percent of the child/adolescent population) 
had some treatment in one or more sectors of the de 
facto mental health service system, and the remainder 
(more than 11 percent of the population) received no 
treatment in any sector of the health care system. This 
translates to a majority with mental disorders not 
receiving any care. Of the 21 percent of the young 
population receiving any mental health services, 
slightly less than half (about 10 percent) met full 
criteria for a mental disorder diagnosis; the remainder 
(more than I1 percent of the population) received 
diagnostic or treatment services for mental health 
problems, conditions that do not fully meet diagnostic 
criteria (Shaffer et al., 1996). 
In summary, the mental health treatment system is 
a dynamic array of services accessed by patients with 
different levels of disorder and severity, as well as 
different social and medical service needs and levels 
and types of insurance financing. Disparities in access 
due to sociocultural factors have been described in 
earlier sections of this report. In a system in which 
substantial numbers of those with even the most severe 
mental illness do not receive any mental health care in 
a year, the match between service use and service need 
is clearly far from perfect. Neither the number nor the 
proportion of people with mental health problems who 
need or want treatment is yet established, and many 
factors influence perceived need for treatment. 
including severity of symptoms and functional 
disability as well as cultural factors. But obviously not 
everyone with a diagnosable mental disorder perceives 
a need for treatment, and not all who desire treatment 
have acurrently diagnosable disorder. Providing access 
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Figure 6-l. Annual prevalence of mental/addictive disorders and services for adults 
Percent of Population (28%) With 
MentaUAddictive Disorders 
(in one year) 
Percent of Population (15%) Receiving 
Mental Health Services’ 
(in one year) 
_______---_--_---------- 
Percent of Population Receiving 
Specialty Care (6%) 
_____-_-----_------- 
No Treatment 
Percent of Population Receiving 
General Medical Care (5%) 
________-_---------- 
Percent of Population Receiving 
Other Human Services and 
Voluntary Support (4%) 
_______-_--_--_---------- 
* Due to roundin;, it appears that 9 percent of the population has a diagnosis and receives treatment. The actual 
figure is closer to 8 percent, as stated in the text. It also appears that 6 percent of the population receives 
services but has no diagnosis, due to rounding. The actual total is 7 percent, as stated in the text. 
** For those who use more than one sector of the service system, preferential assignment is to the most 
specialized level of mental health treatment in the system. 
Sources: Regier et al., 1993; Kessler et al., 1996 
Figure 6-2. Annual prevalence of mentavaddictive disorders and services for children 
Percent of Population (21%) With 
MentaUAddlctive Disorders 
(in one year) 
Percent of Populatlon (21%) Recelvfng 
Mental Health Servlces 
(in one year) 
Diagnosis and 
No Treatment 
(11%) 
Percent of Population Receiving 
Specialty Care (6%) 
-----_--_--_----. 
Percent of Population Receiving 
General Medical Care (1%) -------_-------- 
Percent of Population 
Receiving School 
Services (11%) 
------- -_,-__- :--- 
Percent of Populatton Receiving 
Other Human Services and 
Voluntary Support (1%) __-_--_--_--_-------- 
** For those who use more than one sector of the service system, preferential assignment IS to the mOSt 
specialized level of mental health treatment in the system. 
Source: Shaffer et al., 1996 
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to appropriate mental health services is a fundamental 
concern for mental health policymakers in both the 
public and private arenas. 
The Costs of Mental Illness 
As many of the preceding chapters have indicated, 
mental disorders impose an enormous emotional and 
financial burden on ill individuals and their families. 
They are also costly for our Nation in reduced or lost 
productivity (indirect costs) and in medical resources 
used for care, treatment, and rehabilitation (direct 
costs). 
Indirect Costs 
The indirect costs of all mental illness imposed a nearly 
$79 billion loss on the U.S. economy in 1990 (the most 
recent year for which estimates are available) (Rice & 
Miller, 1996). Most of that amount ($63 billion) 
reflects morbidity costs-the loss of productivity in 
usual activities because of illness. But indirect costs 
also include almost $12 billion in mortality costs (lost 
productivity due to premature death), and almost $4 
billion in productivity losses for incarcerated indi- 
viduals and for the time of individuals providing family 
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care. For schizophrenia alone, the total indirect cost 
was almost $15 billion in 1990. These indirect cost 
estimates are conservative because they do not capture 
some measure of the pain, suffering, disruption, and 
reduced productivity that are not reflected in earnings. 
The fact that morbidity costs comprise about 80 
percent of the indirect costs of all mental illness 
indicates an important characteristic of mental dis- 
orders: Mortality is relatively low, onset is often at 
younger age, and most of the indirect costs are derived 
from lost or reduced productivity at the workplace, 
school, and home (Rupp et al.; 1998). 
The Global Burden of Disease, a recent publication 
of the World Bank and the World Health Organization, 
reported on a study of the indirect costs of mental 
disorders associated with years lived with a disability, 
with and without years of life lost due to premature 
death. Disability Adjusted Life Years (DALYs) are 
now being used as a common metric for describing the 
burden of disability and premature death resulting from 
the full range of mental and physical disorders 
throughout the world (Figure 6-3). A striking finding 
from the study has been that mental disorders account 
for more than 15 percent of the burden of disease 
Figure 6-3. Global burden of disease*--DALYs’* worldwide-1990 
Disorders 
I 
Conditions 
l Global Burden of Disease (Murray & Lopez, 1996) 
l * DALYs - Disability Adjusted Life Years 
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established market economies; unipolar major 
depression, bipolar disorder, schizophrenia, and 
obsessive-compulsive disorder are identified as among 
the top 10 leading causes of disability worldwide 
(Murray & Lopez. 1996). 
Direct Costs 
Mental health expenditures for treatment and rehabil- 
itation are an important part of overall health care 
spending but differ in important ways from other types 
of health care spending. Many mental health services 
are provided by separate specialty providers-such as 
psychiatrists, psychologists, social workers, and nurses 
in office practice-or by facilities such as hospitals, . 
multiservice mental health organizations, or residential 
mental health services is typically less generous than 
that for general health, and government plays a larger 
role in financing mental health services compared to 
overall health care. 
In 1996, the United States spent more than $99 
billion for the direct treatment of mental disorders, as 
well as substance abuse, and Alzheimer’s disease and 
other dementias (Figure 6-4). 
More than two-thirds of this amount ($69 billion or 
more than 7 percent of total health spending) was for 
mental health services. Spending fo? direct treatment of 
substance abuse was almost $13 billion (more than 1 
percent of total health spending), and that for 
Alzheimer’s disease and other dementias was almost 
$18 billion (almost 2 percent of total health spending) 
treatment centers for children. Insurance coverage of (Figure 6-4).3 
Figure 6-4. 1996 National health accounts, $943 billion total-$99 billion* mental, addictive, 
and dementia disorders 
Other Physical Disorde 
90% = $8430 
Mental Disorders 
Alzheimer’s/Dementias 
Addictive Disorders 
* Figures add to more than $99 billion due to rounding. 
Source: Mark et al., 1998, and additional analyses performed by Mark et al. for this report. 
3 Figure 6-4 comes from the spending estimates project conducted by the Center for Mental Health Services and the Center for Substance 
Abuse Treatment. Substance Abuse and Mental Health Services Administration. It is limited to spending for formal treatment of disorders 
and excludes spending for most services not ordinarily classified as health care. Some of these data come directly from the most recent 
report published by this project (Mark et al., 1998), while others are based on unpublished data. Further, minor modifications in estimation 
methodology have been made since the Mark et al, (1998) report to meet the special requirements of the Surgeon General’s report. The 
estimates presented here differ from those published previously by Rice and her colleagues (Rice et al., 1990) in several important respects. 
First. they are limited to a definition of mental illness that more closely reflects what most payers regard as mental disorders. Diagnostic 
codes such as mental retardation and non-mental health comorbid conditions, which were included in the Rice study, have not been used. 
Second. they are based on data sources that were not available at the time of the Rice study. Finally, they result from a different approach 
to estimation. which emphasizes linkage to the National Health Accounts published by the Health Care Financing Administration. 
Although Alzheimer’s disease and other dementias are not discussed further in this chapter, the reader should note that the definition of 
serious mental illness promulgated by the Center for Mental Health Services includes these disorders. Further. care of these patients is a 
Despite the historical precedent for linking all these 
disorder groups together for diagnostic and cost 
accounting purposes, they are handled differently by 
payers and providers. A majority of private health 
insurance plans have a benefit that combines coverage 
of mental illness and substance abuse. However. most 
of the treatment services for mental illness and for 
substance abuse are separate (and use different types of 
providers), as are virtually all of the public funds for 
these services. This separation causes problems for 
treating the substantial proportion of individuals with 
comorbid mental illness and substance abuse disorders, 
who benefit from treating both disorders together 
(Drake et al., 1998). 
Alzheimer’s disease and other dementias historical- 
ly have been considered as both mental and somatic 
disorders. However, recent efforts to destigmatize 
dementias and improve care have removed some 
insurance coverage limitations. Once mostly the 
province of the public sector, Alzheimer’s disease now 
enjoys more comprehensive coverage, and care is better 
integrated into the private health care system. Inequities 
in coverage are diminishing (U.S. Department of 
Health and Human Services Task Force on Alzheimer’s 
Disease, 1984; Goldman et al., 1985). 
As indicated, coverage differs for treatment of 
substance abuse and Alzheimer’s disease. With respect 
to financing policy, both conditions are outside the 
scope of this report (although some services aspects of 
Alzheimer’s disease are discussed in Chapter 5); thus, 
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they will not be included in the spending estimates that 
follow. 
Mental Health Spending 
Of the $69 billion spent in 1996 for diagnosis and 
treatment of mental illness (see Figure 6-5), more than 
70 percent was for the services of specialty providers. 
with most of the remainder for general medical services 
providers.” The distribution for all types of providers 
shown in the figure. 
I 
Spending by the Public and Private Sectors 
Funding for the mental health service system comes 
from both public and private sources [Table 6-3 and 
Figure 6-6 (percent distribution) and Table 6-4 (dollar 
distribution and per capita mental health costs)]. 
1996, approximately 53 percent ($37 billion) of the 
funding for mental health treatment came from public 
payers. Of the 47 percent ($32 billion) of expenditures 
from private sources, more than half ($18 billion) were 
from private insurance. Most of the remainder was out- 
of-pocket payments. These out-of-pocket payments 
include copayments from individuals with private in- 
surance, copayments and prescription costs not covered 
by Medicare or Medigap (i.e., supplementary) 
insurance, and payment for direct treatment from the 
uninsured or insured who choose not to use their insur- 
ance coverage for mental health care. 
’ In estimating mental health expenditures, spending can be categorized by provider type, which includes both general medical service 
providers and specialty mental health providers. Since spending for mental health services in the human services sector is not covered by 
health insurance or included in the national health accounts, neither total costs nor total spending estimates for mental health services are 
covered under these direct cost figures, Indirect costs generally include estimates of lost productivity as well as disability insurance and the 
costs of treating those with mental illness in the criminal justice system. Hence, it is not possible to provide completely parallel analyses 
the prevalence of mental disorders in the population, the prevalence of treatment in different service sectors, and expenditures in the 
treatment system. However, the estimate given here is the best approximation of that intent. 
For purpose of these analyses, general medical service providers include community hospitals, nursing homes, non-psychiatrist physicians. 
and home health agencies. An intermediate funding category is that of prescription medications, which are prescribed in both general 
medical and specialty mental health settings, Other than prescription medications, 18 percent of total mental health funds are allocated in 
this analysis to the general medical sector. which provides some mental health services to slightly more than half of all persons (about 6 
Percent of the population) using any services in the health system during 1 year. 
Specialty providers include psychiatric hospitals. psvchiatrists. office-practice psychologists and counselors (including social workers and 
psychiatric nurses), residential treatment centers for-children. and multiservice mental health organizations. These mental health specialists 
provided some mental health services to nearly 6 percent of the population-also about half of all people requesting such services from 
health and mental health services in the health system. 
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Figure 6-5. 1996 National health accounts, $69 billion total mental health 
expenditures by provider type 
Multi-Sv 
18% 
Psychiatrists GM Physicians 
T;y/chiatry Hospitals 
OO 
Source: Mark et al., 1998 (Revised) 
Figure 6-6. Mental health expenditures by payer-1996 (total = $69 billion) 
ULI ler maera 
2% As 
Medicaid (PUN Private: 473 
Private Insurance 
27% 
Medic> 
14% Other Private 3% 
I Source: Mark et al., 1998 (Revised) 
Table 6-3. Distribution of 1996 U.S. population and 
mental disorder direct costs by insurance 
status 
Insurance Status Population Direct Costs 
Private 63%’ 47% 
Public *a)* 53% 
Medicare 13%” 14% 
Medicaid 12%” 19% 
Uninsured 
State/Local 
Other 
Federal 
tt. - 
16% 18% 
*t* 2% 
Total 100% 100% 
* About 70 percent of the population has some private 
insurance-reflecting the fact that 7 percent of the 
population has both Medicare and Medigap or other 
dual private insurance coverage. Although 61 percent of 
the population has employment-based private 
insurance, this percentage also includes some military 
insurance coverage. 
l * Since 2 percent of the population has both Medicare 
and Medicaid insurance coverage, adding this 
duplicated count to each insurance category results in 
the first column adding to a duplicated total of 104 
percent. 
*** Although some state/local/and other Federal 
government support goes to those who are. 
underinsured in the private and public insured groups, 
these funds are primarily allocated to the uninsured 
population. 
Source: Mark et al., 1998 (Revised) J 
Trends in Spending 
Between 1986 and 1996, mental health expenditures 
grew at an average annual growth rate of more than 7 
percent (Table 6-5). Because of changes in population, 
reimbursement policies, and legislative and regulatory 
requirements during this decade, the share of mental 
health funding from public sources grew from 49 
percent to 53 percent. Overall, the rate of growth in the 
public sector was slightly more than 8 percent per year 
(Medicare and Medicaid, both about 9 percent; 
state/local government, nearly 8 percent). 
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Table 6-4. Population, spending, and per capita mental 
he&h costs by insurancestatus (1996) 
isurance Status 
‘rivate 
Insurance 
Payment 
Out-of-Pocket 
Payment 
Other Private 
Medicare 
Medicaid 
Xher and 
Jninsured 
SPMI* 
Other 
‘otal 
Number Spending 
(millions) ($ billions) 
167.5 32.3 
18.4 
11.7 
2.2 
30.6 9.8 
27.0 13.0 
41.7 13.9 
5.1 12.4 
36.6 1.5 
266.8 69.0 
Severe and persistent mental illness 
‘er Capita 
6 per year) 
193 
320 
481 
333 
2,431 
41 
259 
source: Mark et al., 1998, and calculations by D. Regier, 
personal communication, 1999 
In the private sector, out-of-pocket costs increased 
only 3 percent, which, together with the private 
insurance increases of almost 9 percent, resulted in 
net private cost increase of little more than 6 percent- 
significantly lower than the increase found in the public 
sector. 
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Table 6-5. Mental health expenditures in relation to 
national health expenditures, by source of 
payer, annual growth rate (1986-1996) 
Average Annual 
Growth Rate 
(1986-l 996) 
Mental All Health 
Health Care Care 
srivate 
Out-of-Pocket Payment 3% 5% 
Private Insurance 9% 9% 
Other Private 7% 7% 
rotal Private 6% 7% 
Public 
Medicare 
Medicaid 
Other Federal Government 
State/Local Government 
Total Public 
- 
9% 10% 
9% 13% 
4% 6% 
8% 10% 
8% 10% 
Total Expenditures 7% 8% 
Source: Mark et al., 1998 (Revised) 
Among the fastest-rising expenses for mental 
health services were outpatient prescription drugs, 
which account for about 9 percent of total mental 
health direct costs (Figure 6-5). Although these 
medications are prescribed in both specialty and 
general medical sectors, they are increasingly being 
covered under general medical rather than mental 
health private insurance benefits. 
The higher than average growth rate (almost 10 
percent) of spending for prescription drugs reflects, in 
part, the increasing availability and application of 
medications of demonstrable efficacy in treating mental 
disorders. Estimates from the National Ambulatory 
Medical Care Survey show that the number of visits 
during which such medication was prescribed increased 
from almost 33 million in 1985 to almost 46 million in 
1994. Only one-third of psychotropic medications are 
now prescribed by psychiatrists, with two-thirds 
prescribed by primary care physicians and other 
medical specialists (Pincus et al., 1998). Although 
Medicaid covers 21 percent of drug costs (and 
state/local/other Federal government covers 4 percent), 
Medicare does not cover prescription drugs. Although 
many older adults have supplemental insurance that 
does cover prescription drugs, the failure to cover any 
prescription drugs under Medicare is a barrier to 
effective treatment among the elderly who cannot 
afford supplemental insurance. 
Mental Health Compared With Total Health 
Mental health spending figures acquire more meaning 
when they are compared with thqse for all health care. 
Annually, the Health Care Financing Administration 
produces estimates of this spending. These estimates 
include nearly all of the expenditures presented for 
mental health services. However, some specialty pro- 
viders who work in social service industries are ex- 
cluded from the national health care spending 
estimates. Accordingly, mental health estimates require 
adjustment to allow direct comparison with these 
national figures, reducing the total from $69 billion 
cited earlier to $66 billion (Table 6-6). 
Table 6-6. Mental health expenditures in relation to 
national health expenditures, by source of 
ili 
~ 
Care Care Percentage / 
“ci, Out-of-Pocket $11 $171 6% 
Private Insurance $17 $292 6% 
Other Private $2 $32 5% 
/Total Private $30 $495 6% 
~ Public 
Medicare $10 $198 5% 
Medicaid $13 $140 9% 
Other Federal Government $1 $41 3% 
State/Local Government $12 $69 18% 
iTotal Public $36 $447 8% / 
I 
iTotal Expenditures $66 $943 7% 
/Source: Mark et al., 1998 (Revised) 
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Estimated total health care expenditures were $943 
billion in 1996. Of this amount, 7 percent was for 
mental health services. Table 6-6 describes expen- 
ditures on mental health services as a percentage of 
national health spending by source of payment. The 
significance of mental health spending for various 
payers varies from a low of only 3 percent of “other” 
Federal government spending to a high of 18 percent of 
health care expenditures by state and local govem- 
ments. 
Between 1986 and 1996, spending for mental 
health treatment grew more slowly than health care 
spending in general, increasing by more than 7 percent 
annually, compared with health care’s overall rate of 
more than 8 percent (see Table 6-5). This difference 
may stem from the greater reliance of mental health 
services on managed care cost-containment methods 
during this period. Increased efficiency could account 
for a slower rate of growth in mental health care 
expenditures. Slowing of the growth rate in the public 
sector may also be due to other Federal and state 
government policies, such as limitations in states’ 
ability to use certain Medicaid funds to support state 
mental hospitals and states’ greater emphasis on 
community-based outpatient care as opposed to 
inpatient care. Finally, it may also reflect the greater 
contribution of institutional care, particularly in nursing 
homes, to total health care figures. Changes in these 
components affect overall growth rates more in general 
health care than in mental health care. 
For most provider categories, the rise in mental 
health spending was not much different than spending 
growth rates for personal health care, with the 
exception of home health (higher) and nursing home 
(lower) expenditures. For various types of payers, 
spending growth in mental health care has been about 
the same or less than that in general health care. Mental 
health spending in Medicare, Medicaid, and other 
Federal programs has grown more slowly than overall 
program spending. For private sources, the growth rate 
of mental health out-of-pocket expenditures has been 
below that of total out-of-pocket spending (see 
Table 6-5). 
During the past two decades there have been 
important shifts in what parties have final responsibility 
for paying for mental health care. The role of direct 
state funding of mental health care has been reduced. 
whereas Medicaid funding of mental health care has 
grown in relative importance. This is in part due to 
substantial funding offered to the states by the Federal 
government. One consequence of this shift is that 
Medicaid program design has become very influential 
in shaping the delivery of mental health care. State 
mental health authorities, however, continue to be an 
important force in making public mental health services 
policy, working together with state Medicaid programs. 
Considerable administrative responsibility for mental 
health services has devolved to local mental health 
authorities in recent years (Shore & Cohen, 1994). 
Private insurance coverage has played a somewhat 
more limited role in mental health financing in the past 
decade. Various cost containment efforts have been 
pursued aggressively in the private sector through the 
introduction of managed care. There is also some 
emerging evidence on the imposition of new benefit 
limits on coverage for mental health services 
(HayGroup, 1998). At the same time private insurance 
coverage for prescription drugs has expanded 
dramatically over the past 15 years. In this area, 
insurance coverage for mental health treatments is on 
par with coverage for other illnesses. Accompanying 
this pattern of private insurance coverage are the 
availability of innovative new prescription drugs aimed 
at treating major mental illnesses and a shift in mental 
health spending in private insurance toward 
pharmaceutical agents. 
In summary, spending for mental health care has 
declined as a percentage of overall health spending 
over the past decade. Further, public payers have 
increased their share of total mental health spending. 
Some of the decline in resources for mental health 
relative to total health care may be due to reductions 
inappropriate and wasteful hospitalizations and other 
improvements in efficiency. However. it also may 
reflect increasing reliance on other (non-mental health) 
public human services and increased barriers to service 
access. 
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Financing and Managing Mental 
Health Care 
History of Financing and the Roots of 
Inequality 
Private health insurance is generally more restrictive in 
coverage of mental illness than in coverage for somatic 
illness. This was motivated by several concerns. 
Insurers feared that coverage of mental health services 
would result in high costs associated with long-term 
and intensive psychotherapy and extended hospital 
stays. They also were reluctant to pay for long-term, 
often custodial, hospital stays that were guaranteed by 
the public mental health system, the provider of 
“catastrophic care.” These factors encouraged private 
insurers to limit coverage for mental health services 
(Frank et al., 1996). 
Some private insurers refused to cover mental 
illness treatment; others simply limited payment to 
acute care services. Those who did offer coverage 
chose to impose various financial restrictions, such as 
separate and lower annual and lifetime limits on care 
(per person and per episode of care), as well as separate 
(and higher) deductibles and copayments. As a result, 
individuals paid out-of-pocket for a higher proportion 
of mental health services than general health services 
and faced catastrophic financial losses (and/or transfer 
to the public sector) when the costs of their care 
exceeded the limits. 
Federal public financing mechanisms, such as 
Medicare and Medicaid, also imposed limitations on 
coverage, particularly for long-term care, of “nervous 
and mental disease” to avoid a complete shift in 
financial responsibility from state and local 
governments to the Federal government. Existence of 
the public sector as a guarantor of “catastrophic care” 
for the uninsured and underinsured allowed the private 
sector to avoid financial risk and focus on acute care of 
less impaired individuals, most of whom received 
health insurance benefits through their employer 
(Goldman et al., 1994). 
Goals for Mental Health Insurance Coverage 
The purpose of health insurance is to protect 
individuals from catastrophic financial loss. While the 
majority of individuals who use mental health services 
incur comparatively small expenses, some who have 
severe illness face financial ruin without the protection 
afforded by insurance. For people with health 
insurance. the range of covered benefits and the limits 
imposed on them ultimately determine where they will 
get service, which, in turn, affects their ability to access 
necessary and effective treatment’services. Adequate 
mental health treatment resources for large population 
groups require a wide range of services in a variety of 
settings, with sufficient flexibility to permit movement 
to the appropriate level of care. A 1996 review of the 
evidence for the efficacy of well-documented 
treatments (Frank et al., 1996) suggested that covered 
services should include the following: 
. Hospital and other 24-hour services (e.g., crisis 
residential services); 
. Intensive community services (e.g., partial 
hospitalization); 
. Ambulatory or outpatient services (e.g., focused 
forms of psychotherapy); 
l Medical management (e.g., monitoring 
psychotropic medications); 
l Case management: 
l Intensive psychosocial rehabilitation services; and 
l Other intensive outreach approaches to the care of 
individuals with severe disorders. 
Since resources to provide such services are finite, 
insurance plans are responsible for allocating resources 
to support treatment. Each type of insurance plan has a 
different model for matching treatment need with 
insurance support for receiving services. 
Patterns of Insurance Coverage for Mental 
Health Care 
Health insurance, whether funded through private or 
public sources, is one of the most important factors 
influencing access to health and mental health services. 
In 1996, approximately 63 percent of the U.S. 
population had private insurance, 13 percent had 
Medicare as a primary insurer (with about 7 percent 
also having supplemental private insurance), 12 percent 
had Medicaid (2 percent had dual Medicaid/Medicare), 
and 16 percent were uninsured (Bureau of the Census, 
1996) (Table 6-3.) 
Most Americans (84 percent) have some sort of 
insurance coverage-primarily private insurance 
obtained through the workplace. However, its adequacy 
for mental health care is extremely variable across 
types of plans and sponsors. Of the more than $32 
billion spent for mental health services for people with 
private insurance, more than $18 billion came from that 
insurance, almost $12 billion came from client out-of- 
pocket payments, and more than $2 billion came from 
other private sources. For these more than 167 million 
people, the per capita expenditure was $193 per person 
per year (Table 6-4). . 
Slightly more than 13 percent of the U.S. 
population are entitled to Medicare, which includes 
mental health coverage. The nearly $10 billion spent 
for mental health coverage under Medicare for nearly 
31 million people reflects an average per capita 
expenditure of $320 per year. 
Nearly 12 percent of U.S. adults (27 million low- 
income individuals on public support) receive Medicaid 
coverage (with more than 2 percent having dual 
Medicare/Medicaid coverage). With’ per capita 
expenditures of $48 1 a year for mental health services, 
the average cost of this coverage is 2.5 times higher 
than that in the private sector. An explanation for this 
higher average cost is the severity of illness of this 
population and greater intensity of services needed to 
meet their needs. 
Finally, more than $12 billion (other than Medicaid 
funds) from state/local government and more than $1 
billion from other Federal government block grant and 
Veterans Affairs funds contribute a total of almost $14 
billion to cover mental health services for the unin- 
sured. Most (75 percent) of the uninsured are members 
of employed families who cannot afford to purchase 
insurance coverage. Individuals with severe and 
persistent mental illness who are uninsured have the 
highest annual costs, leaving few resources for 
treatment for those with less severe disorders (see 
Table 6-4). By applying the technique of Frank and 
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colleagues (1994) to 1996 funding patterns. it 
estimated that public sector costs for seriously mentally 
ill patients receiving care in the public sector (about j. 
million people or 1.9 percent of the population) are 
about $2,430 per year. As a result, although it is only 
rough estimate, only about $40 per year per capita 
available for those uninsured with less severe mental 
illness. 
State mental health policymakers have begun 
blend funding streams from Medicaid and the state 
public mental health expenditures under Medicaid 
“waivers,” which offer the potential of purchasing . 
private insurance for certain public beneficiaries who 
have not been eligible for Medicaid. This new option 
has recently been raised as a means of concentrating 
public mental health services on forensic and other 
long-term intensive care programs not covered by 
private insurance (Hogan, 1998). Given the extremely 
low level of funding for the uninsured with less severe 
mental illness, the recently implemented Federal 
legislation to fund a State Child Health Insurance 
Program (CHIP) could result in considerably increased 
coverage for previously uninsured children. It 
noteworthy that CHIP benefits vary from state-to-state 
particularly for mental health coverage. 
Traditional Insurance and the Dynamics of 
Cost Containment 
From the time they were introduced in 1929 until the 
199Os, fee-for-service (indemnity) plans, such as Blue 
Cross/Blue Shield, were the most common form 
health insurance. Insurance plans would identify the 
range of services they considered effective for the 
treatment of all health conditions and then reimburse 
physicians, hospitals, and other health care providers 
for the usual and customary fees charged 
independent practitioners. To prevent the overuse 
services, insurance companies would often require 
patients to pay for some portion of the costs out-of- 
pocket (i.e., co-insurance) and would use annual 
deductibles, much as auto insurance companies do. 
minimize the administrative costs of processing small 
claims. 
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For most health insurance plans covering somatic 
illness, to protect the insured. costs above a certain 
“catastrophic limit” would be borne entirely by the 
insurance company. To protect the insurer against 
potentially unlimited claims. however. “annual” or 
“lifetime limits”-often as high as $1 million-would 
be imposed for most medical or surgical conditions. It 
was expected that any expenses beyond that limit 
would become the responsibility of the patient’s family. 
In contrast, in the case of coverage for mental 
health services, insurance companies often set lower 
annual or lifetime limits, for reasons discussed in the 
following paragraphs, to protect themselves against 
costly claims, leaving patients and their families 
exposed to much greater personal financial risks. The 
legacy of the public mental health system safety net as 
the provider of catastrophic coverage encouraged such 
practices. Further, when federal financing mechanisms 
such as Medicare and Medicaid were introduced, they 
also limited coverage of long-term care of “nervous and 
mental disease” to avoid shifting financial respon- 
sibility from state and local government to the Federal 
government. 
Economists have observed that for potential 
insurers of mental health care or general health care, 
two financial concerns are key: moral hazard and ad- 
verse selection. The terms are technical. but the 
concepts are basic. Moral hazard reflects a concern that 
if people with insurance no longer have to pay the full 
costs of their own care, they will use more services- 
services that they do not value at their full cost. To 
control moral hazard. insurers incorporate cost-sharing 
and care management into their policies. Adverse 
selection reflects a concern that. in a market with 
voluntary insurance or multiple insurers, plans that 
provide the most generous coverage will attract 
individuals with the greatest need for care, leading to 
elevated service use and costs for those insurers 
independent of their efficiency in services provision. 
To control adverse selection, insurers try to restrict 
mental health coverage to avoid enrolling people with 
higher mental health service needs. 
Both forces are at work in the insurance market. 
and they tend to be stronger for coverage of some 
mental health services than for some general health 
services. There is evidence of moral hazard, for 
example, from the RAND Health Insurance Experi- 
ment. which showed that increased use of insured 
services in response to decreased out-of-pocket costs 
for consumers (known as “demand response”) is twice 
as great for outpatient mental health services (mostly 
psychotherapy) as for all ambulatory health services 
taken together (Manning et al., 1989). The RAND 
study did not include a sufficient number of individuals 
who used inpatient care or who were severely disabled 
to make a determination of the effect of changes in 
price on hospital care or on outpatient use by 
individuals with severe mental disorders. 
While these economic forces are important, insurer 
responses to them may have been exaggerated. In the 
fee-for-service insurance system, for example, some 
insurers have addressed their concerns about moral 
hazard by assigning higher cost-sharing to mental 
health services. Coverage limitations, imposed to 
control costs, have been applied unevenly, however, 
and without full consideration of their consequences. In 
particular, higher cost-sharing, such as placing a 50 
percent copayment on outpatient psychotherapy, may 
reduce moral hazard and inappropriate use, but it may 
also reduce appropriate use. Limits on coverage may 
reduce adverse selection but leave people to bear 
catastrophic costs themselves. 
In addition, such measures do not address the issue 
of fairness in coverage policy. In particular, although 
similar levels of price response and presumed moral 
hazard occur in other areas of health care, mental health 
coverage is singled out for special cost-sharing 
arrangements. There may be a rationale for some level 
of differential cost-sharing, but such policies are fair 
only if the benefit design policies are applied to all 
services in which demand is highly responsive to price. 
Managed Care 
Managed care represents a confluence of several forces 
shaping the organization and financing of health care. 
These include the drive to deliver more highly 
individualized, cost-effective care; a more health- 
promoting and preventive orientation (often found in 
health maintenance organizations, or HMOs); and a 
concern with cost containment to address the problem 
of moral hazard. Managed care implies a range of 
financing and payment strategies that depart in 
important ways from traditional fee-for-service 
indemnity insurance. Managed care strategies have 
resulted in dramatic savings in a wide range of settings 
over the past decade .(Bloom et al., 1998; Callahan et 
al., 1995; Christianson et al., 1995: Coulam & Smith, 
1990; Goldman et al., 1998; Ma & McGuire, 1998). 
Major Types of Managed Care Plans 
Health mainfenance orgnnkzrions were the first form 
of managed care. Originally developed by the Kaiser 
Foundation to provide health services to company 
employees, these large group practices initiated con- 
tracts to provide all medical services on a prepaid, per 
capita basis. Medical staff members were originally 
salaried and not paid on a fee-for-service basis, as is the 
case in most other financing arrangements. However, in 
recent years, some HMOs have developed networks of 
physicians-so-called Independent Practice Associa- 
tions, or IPAs-who are paid on a fee-for-service basis 
and function under common management guidelines. 
Health maintenance organizations initially treated 
only those mental disorders that were responsive to 
short-term treatment. but they reduced copayments and 
deductibles for any brief therapy. There was an implicit 
reliance on the public mental health system for 
treatment of any chronic or severe mental disorder- 
especially those for whom catastrophic coverage was 
needed. 
Preferred Provider Organizations (PPOs) are 
managed care plans that contract with networks of 
providers to supply services. Providers are typically 
paid on a discounted fee-for-service basis. Enrollees are 
offered lower cost-sharing to use providers on the 
“preferred” list but can use non-network providers at a 
higher out-of-pocket cost. 
Point-of-Service (POS) plans are managed care 
plans that combine features of prepaid (or capitatedj 
and fee-for-service insurance. Enrollees can choose to 
use a network provider at the time of service. A 
significant copayment typically accompanies use of 
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non-network providers. Although few plans are purely 
of one type, an important difference between a PPO 
and a POS is that in a PPO plan, the patient may select 
any type of covered care from any in-network provider. 
while in a POS, use of in-network services must 
approved by a primary care physician. 
In Carve-out Managed Behavioral Health Care, 
segments of insurance risk-defined by service 
disease-are isolated from overall insurance risk and 
covered in a separate contract between the payer 
(insurer or employer) and the carve-out vendor. Even 
with highly restrictive admission criteria, many HMOs 
have recently found it cost effective to carve out mental 
health care for administration by a managed behavioral 
health company, rather than relying on in-house staff. 
This arrangement permits a larger range of services 
than can be provided by existing staff without 
increasing salaried staff and management overhead 
costs. Carve-outs generally have separate budgets, 
provider networks, and financial incentive arrange- 
ments. Covered services, utilization management tech- 
niques, financial risk, and other features vary 
pending on the particular carve-out contract. The 
employee as a plan member may be unaware of any 
such arrangement. These separate contracts delegate 
management of mental health care to specialized 
vendors known as managed behavioral health care 
orgnnizarions (MBHOs). 
There are two general forms of carve-outs: payer 
carve-outs and health plan subcontracts. In payer 
carve-outs, an enrollee chooses a health plan 
coverage of health care with the exception of mental 
health and must enroll with a separate carve-out vendor 
for mental health care. Examples of payer carve-outs 
include the state employee health plans of Ohio and 
Massachusetts. In health plan subcontracts. adminis- 
trators of the general medical plan arrange to have 
mental health care managed by a carve-out vendor 
MBHO; the plan member does not have to take steps 
select mental health coverage. Examples of payer 
carve-outs include health plans associated with 
Prudential and Humana. 
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The Ascent of Managed Care 
Over the past decade, the pace of change in U.S. health 
insurance has been striking. In 1988, insurance based 
on fee-for-service was the predominant method of fin- 
ancing health care. But in the ensuing decade, various 
management echniques were added such that insurance 
that used “unmanaged fee-for-service” as its payment 
mechanism plummeted from 71 percent to 15 percent 
(HayGroup, 1998). Managedcare arrangements (HMO, 
PPO, or POS plans), which fundamentally alter the way 
in which health care resources are allocated, now cover 
the majority (56 percent) of Americans (Levit & 
Lundy, 1998). During the 1988-1998 decade, PPO 
plans rose from being 13 percent to 34 percent of 
primary medical plans, with a similar rapid rise in 
HMO plans from 9 percent tb 24 percent. Point-of- 
service (POS) plans rose more slowly as the principal 
medical plan. from 12 percent in 1990 to 20 percent in 
1998 (HayGroup, 1998). 
Managed care has also made significant inroads 
into publicly funded health care. Between 1988 and 
1997, Medicaid enrollees in managed care rose from 9 
percent to 48 percent, while Medicare enrollees in 
managed care increased from 5 percent to 14 percent. 
Most Medicaid and Medicare managed care growth has 
occurred since 1994. In Medicaid, growth is primarily 
focused on the population receiving Temporary Aid to 
Needy Families support (as opposed to the population 
with severe and chronic mental illness, eligible for 
Medicaid because of Supplemental Security Income- 
eligible disability) (HayGroup, 1998). 
In 1999, almost 177 million Americans with health 
insurance (72 percent) were enrolled in managed 
behavioral health organizations. This represents a 9 
percent increase over enrollment in 1998 (OPEN 
MINDS, 1999). This administrative mechanism has 
changed the incentive structure for mental health 
professionals, with “supply-side” controls (e.g., 
provider incentives) replacing “demand-side” controls 
(e.g., benefit limits) on service use and cost. In 
addition, the privatization of service delivery is 
increasing in the public sector. As a result of these 
changes, access to specific types of mental health 
services is increasingly under the purview of managed 
behavioral care companies and employers. 
It is difficult to know precisely how many people 
are enrolled in various forms of carve-out plans. Recent 
reports estimate that 35 percent of employers with more 
than 5,000 employees have created payer carve-outs, 
while only 5 percent of firms with fewer than 500 
employees have adopted them(Mercer/Foster-Higgins, 
1997). A survey of 50 large HMOs revealed that 
roughly half of HMO enrollees were enrolled in carve- 
out plans (OPEN MINDS, 1999). The carve-out 
concept has also been adopted by’a number of state 
Medicaid programs. At most recent count, 15 states are 
using payer carve-out arrangements to manage mental 
health care (Substance Abuse and Mental Health 
Services Administration [SAMHSA], 1998). More than 
20 states use carve-out arrangements to manage non- 
Medicaid public sector services. 
As the states have adopted Medicaid managed care 
for mental health, at least two distinct models have 
emerged. States that entered managed care early have 
tended to issue contracts to private sector organizations 
to perform both administrative (payments, network 
development) and management (utilization review) 
functions. States that entered managed care more 
recently have tended to contract administrative 
functions with Administrative Services Organizations 
(ASOs), while retaining control of management func- 
tions. Under any of these arrangements, financial risk 
for the provision of care to a particular population can 
be distributed in a variety of ways (Essock & Goldman, 
1995). 
As the foregoing discussion indicates, mental 
health services associated with private insurance, 
public insurance, and public direct-service programs 
often have managed mental health care arrangements 
that are organized differently than are overall health 
services. These arrangements have emerged mostly 
within the past decade. The next section describes how 
the ascent of managed care has shifted patterns of 
resource allocation toward financial incentives aimed 
at providers, organizational structure, and adminis- 
trative mechanisms and away from the use of benefit 
design (e.g., using copayments and annual deductibles) 
meant to encourage consumer cost-sharing. As a result, 
cost control and care management are accomplished 
through a more complicated set of policies than at any 
time in the recent past, and benefit design is no longer 
the only factor in determining service allocation or 
predicting costs to a health insurer. 
Dynamics of Cost Controls in Managed Care 
In a managed care system, the moral hazard of 
unnecessary utilization need not be addressed through 
benefit design. Utilization typically is controlled at the 
level of the provider of care, through a series of 
financial incentives and through direct management of 
the care. For example, managed care reduces cost in 
part by shifting treatmenl from inpatient to outpatient 
settings, negotiating discounted hospital and 
professional fees, and using utilization management 
techniques to limit unnecessary services. In this 
fashion, at least theoretically, unnecessary utilization, 
the moral hazard, is eliminated at the source, on a case- 
by-case basis. 
Adverse selection may be addressed through 
regulations, such as mandates in coverage that require 
all insurers in a market to offer the same level of 
services. In this way, no one insurer runs ‘the risk that 
offering superior coverage will necessarily attract 
people who are higher utilizers of care. Efforts to 
regulate adverse selection may not produce the 
intended effect, however, when insurers who offer the 
same services use management techniques to control 
costs by restricting care to those who use services most 
intensely-effectively denying care to those who most 
need it. In such instances, patients with the greatest 
needs might become concentrated in plans with the 
most generous management of care. This may lead to 
financial losses for such plans or encourage them to cut 
back on services for those who need care most or to 
divert resources from other beneficiaries. 
As managed care grows, the structure of the 
industry changes, with companies merging and 
disappearing. Managed behavioral health care 
organizations now cover approximately 177 million 
Americans. with only three companies controlling 57 
percent of all insured persons (or 91 million covered 
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lives) (OPEN MINDS, 1999). However, the range 
management controls currently applied to enrollees 
covered plans extends from simple utilization review 
hospitalizations on an administrative services only 
(ASO) contract to prepaid, at-risk contracts with exten- 
sive employee assistance plan (EAP) screening and 
networks of eligible mental health specialists and 
hospitals providing services for discounted fees. If and 
when mental health service benefits expand, it 
possible for managed behavioral health plans to tighten 
the level of supply-side controls to maintain costs at . 
desired level. 
Some consumers and consumer advocates have 
expressed concern that the management measures used 
to cut the costs of health care may also lower its quality 
and/or accessibility. Although this issue was addressed 
by the President’s Advisory Commission on Consumer 
Protection and Quality in the Health Care Industry and 
by current Patient Bill of Rights legislation, more 
research is needed to understand the effects of industry 
competition on costs, access, and quality. (See Appen- 
dix 6-A for Patient Bill of Rights.) 
Managed Care Effects on Mental Health 
Services Access and Quality 
Managed care demonstrably reduces the cost of mental 
health services (Ma & McGuire, 1998; Goldman et al.. 
1998; Callahan et al., 1995; Bloom et al., 1998: 
Christianson et al., 1995; Coulam & Smith, 1990). That 
was one of its goals-to remove the excesses 
overutilization, such as unnecessary hospitalization. 
and to increase the number of individuals treated 
using more cost-effective care. This was to 
accomplished through case-by-case “management” 
care. The risk of cost-containment, however, is that 
can lead to undertreatment. Research is just beginning 
on how managed care cost-reduction techniques affect 
access and quality. Excessively restrictive cost- 
containment strategies and financial incentives 
providers and facilities to reduce specialty referrals. 
hospital admissions, or length or amount of treatment 
may ultimately contribute to lowered access and quality 
of care. These restrictions pose particular risk to People 
on either end of the severity spectrum: individuals with 
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mental health problems may be denied services 
entirely, while the most severely and persistently ill 
patients may be undertreated. These risks must be seen, 
however, in the context of similar problems inherent in 
fee-for-service practice. Access and quality problems 
and the failure to treat those most in need predate 
managed care. 
Impact on Access to Services 
Despite considerable concern that managed care cost 
reductions may inappropriately restrict access to mental 
health services, the actual impact of these reductions 
has received relatively little systematic study. In 
addition, there are currently no benchmark standards 
for access to specialty merital health services.5 A 
system to measure access and track it over time is 
clearly needed. Establishing targets for treated 
prevalence6 is also problematic because the appropriate 
level and type of service utilization for specific 
population groups is only beginning to be documented 
(McFarland et al., 1998). 
The term “access to mental health services” refers 
generally to the ability to obtain treatment with 
appropriate professionals for mental disorders.‘Having 
health insurance-and the nature of its coverage and 
administration-are critical determinants of such 
access. But so are factors such as the person’s clinical 
status and personal and sociocultural factors affecting 
’ Between the early 1980s and 1990s-prior to the dominance of 
managed care-about 5.8 percent of U.S. adults used some type of 
specialty mental health outpatient services in any year. This rate 
now can be used as one reference point for assessing subsequent 
changes in access to mental health services, although there is no 
evidence on the appropriateness of this care. 
6 Researchers and administrators often report access in terms of 
treated prevalence or penetration rates. These rates reflect the 
proportion of individuals in a given population (e.g., members of a 
particular managed behavioral health care plan) that use specialty 
mental health and/or substance abuse services in 1 year. 
’ This phrase has many additional dimensions and meanings to 
consumers. health care providers. and health services researchers. 
These include (a) waiting time for emergency, urgent, and routine 
initial and followup appointments; (b) telephone access, including 
call pick-up times and call abandonment rates; (c) access to a 
continuum of services, including treatment in the least restrictive 
setting: (d) access to providers from a full range of mental health 
disciplines: (e) choice of individual provider; (f) geographic access; 
and (g) access to culturally competent treatment. 
desire for care; knowledge about mental health services 
and the effectiveness of current treatments: the level of 
insurance copayments, deductibles, and limits; ability 
to obtain adequate time off from work and other 
responsibilities to obtain treatment; and the availability 
of providers in close proximity, as well as the 
availability of transportation and child care. In addition, 
because the stigma associated with mental disorders is 
still a barrier to seeking care. the availability of 
services organized in ways that reduce stigma-such as 
employee assistance programs-can provide important 
gateways to further treatment when necessary. 
A small number of studies provide a limited 
picture of access to managed behavioral health care. It 
has been found that the proportion of individuals 
receiving mental health treatment varies considerably 
across managed behavioral health plans (National 
Advisory Mental Health Council, 1998). Some long- 
term case studies of managed care’s impact on access 
find that the probability of using mental health care- 
especially outpatient care-increases after managed 
behavioral health care is implemented in private 
insurance plans (Goldman et al., 1998). 
Impact on Quality of Care 
The quality of care within health systems has been 
assessed traditionally on three dimensions: (1) the 
strilcture of the health care organization or system; (2) 
the process of the delivery of health services; and (3) 
the outcomes of service for consumers (Donabedian, 
1966). Many of these dimensions are being tapped in 
current efforts to assess-and, it is hoped, ultimately 
improve-the overall quality of mental health care in 
the United States. These include the use of 
accreditation practices, clinical- and systems-level 
practice guidelines, outcome measures and “report 
cards,” and systems-level performance indicators. For 
example, to maximize the potential mental health 
benefit of patients’ contact with the primary health care 
sector, which 70 to 80 percent of all Americans visit at 
least once a year, guidelines and treatment algorithms 
have been developed. The Agency for Health Care 
Policy and Research has developed comprehensive 
guidelines for the treatment of depression in primary 
care settings (1993) as well as recommendations for the 
treatment of schizophrenia (Patient Outcome Research 
Team, Lehman & Steinwachs. 1998). Also funded by 
the Agency is the Depression PORT that will soon 
release findings on the quality and cost of the treatment 
of depression in managed, primary care practice (Wells 
et al., in press). In addition, multiple studies are now 
under way to develop better coordination between 
primary care physicians and mental health specialists 
for management of both chronic and acute mental 
disorders (Katon et al., 1997; Wells, 1999). These 
studies are described in more detail in Chapters 4 
and 5. 
Current incentives both within and outside 
managed care generally do not encourage an emphasis 
on quality of care, Nonetheless, some managed mental 
health systems recognize the potential uses of quality 
assessment of their services. These include monitoring 
and assuring quality of care to public and private 
oversight organizations; developing programs to 
improve services or outcomes from systematic 
empirical evaluation; and permitting reward on the 
basis of quality and performance, not simply cost (Kane 
et al., 1994, 1995; Institute of Medicine, 1997; 
President’s Advisory Commission on’ Consumer 
Protection and Quality in the Health Care Industry. 
1997). In the public sector, the Center for Mental 
Health Services (CMHS), in conjunction with the 
Mental Health Statistics Improvement Program, has 
developed a Consumer-Oriented Report Card. Designed 
to obtain a consumer perspective on access, 
appropriateness, prevention, and outcome, it is being 
tested in 40 states under CMHS grant support. 
Efforts are ongoing within managed behavioral 
health systems to develop quality-reporting systems 
based on existing administrative claims data, which 
measure aspects of the process of care as well as some 
clinical outcome data (American Managed Behavioral 
Healthcare Association, 1995; American College of 
Mental Health Administrators, 1997; National 
Committee for Quality Assurance, 1997). 
The first comparative study of quality indicators 
within the managed behavioral health care industry 
(Frank & Shore, 1996) has revealed very diverse 
Organizing and Financing Mental Health Services 
practices. For example, across the responding 
companies, expected outpatient followup visits within 
30 days after hospital discharge for depression occurred 
among 92 percent of patients in one plan. but only 39 
percent in another. One indicator of inadequate hospital 
treatment or discharge planning is rapid hospital 
readmission after discharge-an event that occurred 
2 percent to 4 1 percent of discharges. Another indicator 
of quality is the proportion of patients with 
schizophrenia who received a minimum of four 
medication visits per year; this figure ranged from 15 
percent to 97 percent. Meas’ures of access (treated 
prevalence rates) also varied widely. Although 
methodological problems probably contribute to the 
variation among companies, these data raise concerns 
about real differences in quality among managed 
behavioral health care companies. They also 
underscore the need to improve quality measurement. 
In a more positive vein, investigators recently 
found that rates of readmission after hospital discharge 
were not adversely affected by the 1993 transition to 
managed behavioral health carve-out for Massachusetts 
state employees. In fact, the proportion of cases 
receiving outpatient followup (within 15 or 30 days) 
actually increased for patients with major depressive 
disorder, despite substantial reductions in inpatient 
utilization and costs. However, because the study was 
based on the plan’s administrative claims data, only 
limited conclusions could be made about the quality 
care provided (Merrick, 1997). 
Clinical outcome data systems, although more 
expensive and complicated than administrative data 
systems, have much greater potential for evaluating 
how programs and practices actually affect patient 
outcomes. Several managed care companies are 
currently testing the feasibility of implementing 
systemwide collection of clinical outcome data, to 
managed through newly developed comprehensive 
clinical quality information systems (Goldman. 1997: 
Goldman et al., 1998). 
Another way to measure quality takes into account 
outcomes outside the mental health specialty sector. 
Two recent studies suggest that when management and 
financial incentives limit access to mental health care 
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or encourage a shift to general health care services for 
mental health care, disability may increase and work 
performance decline (Rosenheck et al., 1999; Salkever, 
1998). These losses to employers may well offset 
management-based savings in mental health specialty 
costs. Findings such as these raise concern about the 
use of shortsighted cost-cutting measures that may 
contribute to less appropriate and less effective 
treatment, reduced work function, and no net economic 
benefits. 
Many of the administrative techniques used in 
managed care (such as case management, utilization 
review, and implementation of standardized criteria) 
have the potential to improve the quality of care by 
enhancing adherence to p?ofessional consensus 
treatment guidelines (Bemdt et al.. 1998) and possibly 
improving patient outcomes (Katon et al., 1997). 
However, little is known about what happens when 
management is introduced into service systems in 
combination with high cost-sharing (often the case with 
non-parity mental health benefits) (Bumam & Escarce, 
1999). These combined limitations on services may 
seriously inhibit the provision of full and necessary 
treatment and lower the quality of care. The differential 
impact on service use on the basis of gender or other 
sociocultural factors is unknown. 
In summary, managed behavioral health plans 
differ considerably in their access and other aspects of 
quality in mental health care. Current practices often 
provide little incentive to improve quality. There is, 
however, some evidence that access and quality can be 
maintained or improved after managed care is 
introduced (Merrick, 1997). This is particularly 
important because some evidence suggests that 
limitations in mental health access affect people’s well- 
being and result in decreases in work performance. 
increased absenteeism, and increased use of medical 
services (Rosenheck et al., 1999). Outcome 
assessments which focus on functional improvements 
are particularly important in the mental health area 
because of the ease with which management practices 
have been able to reduce treatment intensity and cost of 
mental health services. 
Toward Parity in Coverage of Mental 
Health Care 
“Parity” refers to the effort to treat mental health 
financing on the same basis as financing for general 
health services. In recent years advocates have 
repeatedly tried to expand mental health coverage-in 
the face of cost-containment policies that have been 
widespread since the 1980s. Parity legislation is an 
effort to address at once both the adverse selection 
problem and the fairness problem associated with moral 
hazard. The fundamental motivahon behind parity 
legislation is the desire to cover mental illness on the 
same basis as somatic illness, that is, to cover mental 
illness fairly. A parity mandate requires all insurers in 
a market to offer the same coverage, equivalent to the 
coverage for all other disorders. The potential ability of 
managed care to control costs (through utilization 
management of moral hazard) without limiting benefits 
makes a parity mandate more affordable than under a 
fee-for-service system. 
Managed care coupled with parity laws offers 
opportunities for focused cost control by eliminating 
moral hazard without unfairly restricting coverage 
through arbitrary limits or cost-sharing and by 
controlling adverse selection. However, continued use 
of unnecessary limits or overly aggressive management 
may lead to undertreatment or to restricted access to 
services and plans. 
Benefit Restrictions and Parity 
As noted above, mental health benefits are often 
restricted through greater limits on their use or by 
imposing greater cost-sharing than for other health 
services. Despite both the cost-controlling impact of 
managed care and advocacy to expand benefits, 
inequitable limits continue to be applied to mental 
health services. Parity legislation in the states and 
Federal government has attempted to redress this 
inequity. 
In 1997, the most common insurance restriction 
was an annual limit on inpatient days; annual or 
lifetime limits were used somewhat less. Higher cost- 
sharing was used by the smallest percentage, with the 
use of separate deductibles almost nonexistent on 
326 
inpatient mental health benefits. For outpatient mental 
health services, a quarter of the most prevalent plans 
had no special limitations (Buck et al., 1999). Unlike 
the situation for inpatient services, there was no marked 
preference for the use of any particular type of 
limitation for outpatient services. 
Mental health benefits are significantly restricted 
when special limitations are employed. Maximum 
lifetime limits for both inpatient and outpatient services 
were typically only $25,000. In some extreme cases, 
annual limits were only $5,000 for inpatient care and 
$2,000 for outpatient care. Day limits remained at the 
traditional limit of 30 inpatient days. However, the 
median limit on outpatient visits, traditionally 20, 
reached 25 in 1997 (Buck et al., 1999) 
Studies show that the gap in insurance coverage 
between mental health and other health services has 
been getting wider. One study found that the proportion 
of employees with coverage for mental health care 
increased from 1991 to 1994 (Jensen et al., 1998). 
However, more have multiple limits on their benefits, 
partly due to the increased use of managed care. 
Another study found that while health care costs per 
employee grew from 1989 to 1995, behavioral health 
care costs decreased, both absolutely and as a share of 
employers’ total medical plan costs (Buck & Umland, 
1997). 
A report by the HayGroup (1998) on changes in the 
health plans of medium and large employers provides 
more recent evidence for these trends. Between 1988 
and 1997, the proportion of such plans with day limits 
on inpatient psychiatric care increased from 38 percent 
to 57 percent, whereas the proportion of plans with 
outpatient visit limits rose from 26 percent to 48 
percent. On the basis of this and other information, the 
HayGroup estimated that the value of behavioral health 
care benefits within the surveyed plans decreased from 
6.1 percent to 3.1 percent from 1988 to 1997 as a 
proportion of the value of the total health benefit 
(HayGroup, 1998). 
Extensive limits on mental health benefits can 
create major financial burdens for patients and their 
families. One economic study modeled the out-of- 
pocket burden that families face under existing mental 
Organizing and Financing Mental Health Services 
health coverage using different mental health expense 
scenarios (Zuvekas et al., 1998). For a family with 
mental health treatment expenses of $35,000 a year, the 
average out-of-pocket burden is $12,000; for those with 
$60,000 in mental health expenses a year, the burden 
averages $27,000. This is in stark contrast to the out-of- 
pocket expense of only $1,500 and $1,800, respect- 
ively, that a family would pay for medical/surgical 
treatment. 
legislative Trends Affecting Parity in Mental 
Health Insurance Coverage 
Federal legislative efforts to achieve parity in mental 
health insurance coverage date from the 1970s and 
have continued through to present times. However, a 
major parity initiative was included in the failed 1994 
Health Security Act (the Clinton Administration’s 
health care reform proposal). Although national health 
care reform stalled, the drive for mental health parity 
continued, culminating in passage of the Mental Health 
Parity Act in 1996. Implemented in 1998, this 
legislation focused on only one aspect of the inequities 
in mental health insurance coverage: “catastrophic” 
benefits. It prohibited the use of lifetime and annual 
limits on coverage that were different for mental and 
somatic illnesses. As Federal legislation, it included 
within its mandate some of the Nation’s largest 
companies that are self-insured and otherwise 
exempted from state parity laws because of the 
Employment Retirement Income Security Act. 
Although it was seen as an important first substantive 
step and rhetorical victory for mental health advocacy, 
the Parity Act was limited in a number of important 
ways. Companies with fewer than 50 employees or 
which offered no mental health benefit were exempt 
from provisions of the law, The parity provisions did 
not apply to other forms of benefit limits, such as per 
episode limits on length of stay or visit limits, or 
copayments or deductibles, and they did not include 
substance abuse treatment. In addition, insurers who 
experienced more than a 1 percent rise in premium as 
a result of implementing parity could apply for an 
exemption. Despite these limitations, Federal parity 
legislation put mental health coverage concerns “on the 
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map” for policymakers and demonstrated an 
unprecedented concern to redress inequities in coverage 
(Goldman, 1997). 
State efforts at parity legislation paralleled those at 
the Federal level. During the past decade, a growing 
number of states have implemented parity (Hennessy & 
Stephens, 1997; National Advisory Mental Health 
Council, 1998; SAMHSA, 1999). Some (e.g., Texas) 
target their parity legislation narrowly to include only 
people with severe mental disorders: others use a 
broader definition of mental illness for parity coverage 
(e.g., Maryland) and include, in some cases, substance 
abuse. Some states (e.g., Maryland) focus on a broad 
range of insured populations; others focus only on a 
single population (e.g., Texas state employees) 
(National Alliance for the Mentally Ill, 1999). 
Until recently, efforts to achieve parity in insurance 
coverage for the treatment of mental disorders were 
hampered by limited information on the effects of such 
mandates. This led to wide variations in estimates of 
the costs of implementing such laws. For example, past 
estimates of the increase in premium costs of full parity 
in proposed federal legislation have ranged from 3 
percent to more than 10 percent (Sing et al., 1998). 
Recent analyses of the experience with state and 
Federal parity laws have begun to provide a firmer 
basis for such estimates. These studies indicate that 
implementing parity laws is not as expensive as some 
have suggested. 
Case studies of five states that had a parity law for 
at least a year revealed a small effect on premiums-at 
most a change of a few percent, plus or minus. Further, 
employers did not attempt to avoid the laws by 
becoming self-insured or by passing on costs to 
employees (Sing et al., 1998). Separate studies of laws 
in Texas, Maryland, and North Carolina have shown 
that costs actually declined after parity was introduced 
where legislation coincided with the introduction of 
managed care. In general, the number of users 
increased, with lower average expenditures per user. 
There is no evidence on the appropriateness of 
treatment delivered following the introduction of parity 
laws (National Advisory Mental Health Council. 1998). 
Similar findings come from case studies of private 
insurance plans that have provided generous mental 
health benefits (Goldman et al., 1998) and of plans that 
have switched to carve-out managed care (Ma & 
McGuire, 1998; Sturm et al., 1999). 
Some evidence also exists of the effects of the 
Federal Mental Health Parity Act, which went into 
effect in 1998. Under that law, group health plans 
providing mental health benefits may not impose a 
lower lifetime or annual dollar limit on mental health 
benefits than exists for medical/surgical benefits. A 
national survey of employers conducted after the Act 
went into effect found that while -mid- to large-size 
companies made some reductions in benefits and added 
cost-sharing, small companies (the majority of 
companies in the country) did not make compensatory 
changes to their benefits. This was because they judged 
that the projected costs were minimal or nonexistent 
(SAMHSA, 1999). Additional evidence that the law has 
resulted in minimal added expense comes from 
exemptions that may be granted if a plan experiences a 
cost increase of at least 1 percent because of the law. In 
the first year of the law’s implementation, only a few 
plans nationwide had requested such an exemption 
(SAMHSA, 1999). 
In summary, evidence of the effects of parity laws 
shows that their costs are minimal. Introducing or 
increasing the level of managed care can significantly 
limit or even reduce the costs of implementing such 
laws. Within carve-out forms of managed care, research 
generally shows that parity results in less than a 1 
percent increase in total health care costs. In plans that 
have not previously used managed care, introducing 
parity simultaneously with managed care can result in 
an actual reduction in such costs. 
Conclusions 
In the United States in the late 20th century, research- 
based capabilities to identify, treat, and, in some 
instances, prevent mental disorders are outpacing the 
capacities of the service system the Nation has in place 
to deliver mental health care to all who would benefit 
from it. Approximately 10 percent of children and 
adults receive mental health services from mental 
health specialists or general medical providers in a 
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given year. Approximately one in six adults, and one in 
five children, obtain mental health services either from 
health care providers, the clergy, social service 
agencies, or schools in a given year. 
Chapter 6 discusses the organization and financing 
of mental health services. The chapter provides an 
overview of the current system of mental health 
services, describing where people get care and how 
they use services. The chapter then presents 
information on the costs of care and trends in spending. 
Only within recent decades, in the face of concerns 
about discriminatory policies in mental health 
financing, have the dynamics of insurance financing 
become a significant issue in the mental health field. In 
particular, policies that have emphasized cost 
containment have ushered in managed care. Intensive 
research currently is addressing both positive and 
adverse effects of managed care on access and quality, 
generating information that will guard against untoward 
consequences of aggressive cost-containment policies. 
Inequities in insurance coverage for mental health and 
general medical care-the product of decades of stigma 
and discrimination-have prompted efforts to correct 
them through legislation designed to produce financing 
changes and create parity. Parity calls, for equality 
between mental health and other health coverage. 
1. Epidemiologic surveys indicate that one in five 
Americans has a mental disorder in any one year. 
2. Fifteen percent of the adult population use some 
form of mental health service during the year. 
Eight percent have a mental disorder; 7 percent 
have a mental health problem. 
3. Twenty-one percent of children ages 9 to 17 
receive mental health services in a year. 
4. The U.S. mental health service system is complex 
and connects many sectors (public-private, 
specialty-general health, health-social welfare, 
housing, criminal justice, and education). As a 
result, care may become organizationally 
fragmented, creating barriers to access. The 
system is also financed from many funding 
streams, adding to the complexity, given 
sometimes competing incentives between funding 
sources. 
5. 
6. 
7. 
8. 
9. 
10. 
11. 
In 1996, the direct treatment of mental disorders. 
substance abuse, and Alzheimer’s disease cost the 
Nation $99 billion; direct costs for mental 
disorders alone totaled $69 billion. In 1990. 
indirect costs for mental disorders alone totaled 
$79 billion. 
Historically, financial barriers to mental health 
services have been attributable to a variety of 
economic forces and concerns (e.g., market 
failure, adverse selection, moral hazard, and 
public provision). This has accounted for 
differential resource allocation rules for financing 
mental health services. 
a. “Parity” legislation has been a partial 
solution to this set of problems. 
b. Implementing parity has resulted in 
negligible cost increases where the care has 
been managed. 
In recent years, managed care has begun to 
introduce dramatic changes into the organization 
and financing of health and mental health 
services. 
Trends indicate that in some segments of the 
private sector per capita mental health 
expenditures have declined much faster than they 
have for other conditions. 
There is little direct evidence of problems with 
quality in well-implemented managed care 
programs. The risk for more impaired populations 
and children remains a serious concern. 
An array of quality monitoring and quality 
improvement mechanisms has been developed, 
although incentives for their full implementation 
have yet to emerge. In addition, competition on 
the basis of quality is only beginning in the 
managed care industry. 
There is increasing concern about consumer 
satisfaction and consumers’ rights. A Consumers 
Bill of Bights has been developed and 
implemented in Federal Employee Health Benefit 
Plans, with broader legislation currently pending 
in the Congress. 
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Appendix 6-A: Quality and 
Consumers’ Rights 
The Federal government’s concern with quality in the 
Nation’s health care system was expressed in President 
Clinton’s charge to the Advisory Commission on 
Consumer Protection and Quality in the Health Care 
Industry (March 26, 1997) “to recommend such 
measures as may be necessary to promote and assure 
health care quality and value and protect consumers 
and workers in the health care system.” In November 
1997 the Commission recommended a Consumer Bill 
of Rights and Responsibilities (President’s Advisory 
Commission on Consumer Protection and Quality in 
the Health Care Industry, 1997). 
The Consumer Bill of Rights and Responsibilities 
(Bill of Rights) is intended to meet three major goals: 
. Strengthen consumer confidence by assuring that 
the health care system is fair and responsive to 
consumers’ needs; it gives consumers credible and 
effective mechanisms for addressing their 
concerns and encourages them to take an active 
role in improving and assuring their health. 
. Reaffirm the importance of a strong relationship 
between consumers and their health care 
professionals. 
. Underscore the critical role of consumers in 
safeguarding their own health by establishing both 
rights and responsibilities for all participants in 
improving health status. 
The Bill of Rights addresses a number of issues that are 
particularly relevant to mental health care: 
. Information disclosure of comparable measures of 
quality and consumer satisfaction from health 
plans, professionals, and facilities; 
. Direct access to specialists of choice for 
consumers with complex or serious medical 
conditions who require frequent specialty care; 
. Authorization, when required, for an adequate 
number of visits under an approved treatment 
p!an; 
. Vulnerable groups, including individuals with 
mental disabilities, require special attention by 
decisionmakers to protect their health coverage 
and quality of care; 
Confidentiality protections for sensitive services, 
such as mental health and substance abuse 
services, provided by health plans, providers, 
employers, and purchasers to safeguard against 
improper use or release of individually 
identifiable information. 
To move the mental health care system from a 
focus on providers to a focus on consumers, future 
care systems and quality tools will need to reflect 
person-centered values. This nascent trend is 
driven both by the consvmer movement in 
American society and by a strong focus on 
consumer rights in a managed care environment. 
First steps include the voluntary adoption of the 
principles of the Consumer Bill of Rights by 
Federal agencies and passage of legislation 
requiring their national implementation. 
References 
Agency for Health Care Policy and Research. (1993). 
Depression in primary care. Vol. 2: Treatment of 
major depression (Clinical Practice Guideline NO. 5; 
AHCPR Publication No. 93-055 1). Washington, DC: 
Author. 
American College of Mental Health Administrators. (1997). 
Final report of Santa Fe Summit ‘97. Preserving 
quality and value in the managed care equation. 
Pittsburgh, PA: Author. 
American Managed Behavioral Healthcare Association. 
(1995). Performance measures for managed 
behavioral healthcare programs (PERMS I). 
Washington, DC: AMBHA Quality Improvement and 
Clinical Services Committee. 
American Psychiatric Association. (1994). Diagnostic and 
statistical manual of mental disorders (4th ed.). 
Washington, DC: Author 
Bemdt, G. B., Busch, S. H., & Frank, R. G. (1998). Price 
indexes for acute phase treatment of depression 
(NBER Working Paper No. W6799) [On-line]. 
Cambridge, MA: National Bureau of Economic 
Research. Available: http://www.nber.org 
Bloom, J., Hu, T., Wallace, N., Cuffel, B., Hausman, J., & 
Schaffer, R. (1998). Mental health costs and outcomes 
under alternative capitation in systems in Colorado: 
Early results. Journal of Mental Health Policy and 
Economics, 1, 3- 13. 
430 
Organizing and Financing Mental Health Services 
Buck, J. A., Teich, J. L., Umland, B., & Stein, M. (1999). 
Behavioral health benefits in employer-sponsored 
health plans, 1997. Health Affairs (Millwood), 18, 
67-78. 
Buck, J. A., & Umland, B. (1997). Covering mental health 
and substance abuse. Health Aflairs (Millwood), 16, 
120-126. 
Bureau of the Census. (1996). Health insurance coverage: 
1996. Table A: Health insurance coverage status and 
type of coverage: 1996 [Online]. Washington, DC: 
Author. Available: http://www.census.org/hhrs/hlthins/ 
cover96//c96taba.html 
Bumam, M. A., & Escarce, J. J. (1999). Equity in managed 
care for mental disorders. Health AfSairs (Millwood), 
18,22-31 
Callahan, J. J., Shepard, D. S., Beinecke, R. H., Larson, M. 
J., & Cavanaugh, D..( 1995). Mental health/substance 
abuse treatment in managed care: The Massachusetts 
Medicaid experience. Health Affairs (Millwood), 14, 
173-184. 
Christianson, J. B., Manning, W., Lurie, N., Stoner, T. J., 
Gray, D. Z., Popkin, M., & Marriott, S. (1995). Utah’s 
prepaid mental health plan: The first year. Health 
Aflairs (Millwood), 14, 160-172. 
Coulam, G., & Smith, J. (1990). Evaluation of the CPA- 
Nogolk Demonsrration: Final Report. Cambridge, 
MA: ABT Associates. 
Donabedian, A. (1966). Evaluating the quality of managed 
care. Milbank Memorial Fund Quarterly, S(Suppl.), 
166-206. 
Drake, R. E., Mercer-McFaddin, C., Mueser, K. T., 
McHugo, G. J.. & Bond. G. R. (1998). Review of 
integrated mental health and substance abuse treatment 
for patients with dual disorders. Schizophrenia 
Bulletin, 24,589-608. 
DSM-IV. See American Psychiatric Association. (1994). 
Essock, S. M., & Goldman, H. H. (1995). States’ embrace of 
managed mental health care. Health Affairs (Millwood), 
14,34-44. 
Frank, R. G., McGuire, T. G., & Goldman, H. (1996). 
Buying in the public interest. Washington, DC: 
Bazelon Center. 
Frank, R. G., McGuire, T. G., Regier, D. A., Manderscheid, 
R., & Woodward, A. (1994). Paying for mental health 
and substance abuse care. Health Affairs (Millwood), 
13,337-342. 
Frank, R. G., & Shore, M. F. (1996). Peeormance measures 
for managed behavioral healthcare programs: PERMS 
1.0. Washington, DC: American Behavioral Healthcare 
Association. 
Goldman, H. H., Cohen, G., & Davis, M. (1985). Expanded 
Medicare outpatient coverage for Alzheimer’s disease 
and related disorders. Hospital and Communin 
Psychiatry, 36, 939-942. 
Goldman, H., Frank, R., & McGuire, T. (1994). Mental 
health care. In E. Ginzberg (Ed.), Critical issues in U.S. 
health reform (pp. 73-92). Boulder, CO: Westview. 
Goldman, W. (1997). Goalfocused treatment planning and 
outcomes. Minneapolis, MN: United Behavioral . 
Health. 
Goldman, W., McCulloch, J., & Sturm, R. (1998). Costs and 
use of mental health services before and after managed 
care. Health Affairs (Millwood), 17,40-52. 
HayGroup. (1998). Health care plan design and cost 
trends-l 988 through 1997. Arlington, VA: Author. 
Hennessy, K. D., & Stephens, S. (1997). Mental health 
parity: Clarifying our objectives. Psychiatric Services, 
48, 161-164. 
Hogan, M. (1998). The public sector and mental health 
parity: Time for inclusion. Journal of Mental Health 
Policy and Economics, 1, 189-198. 
Institute of Medicine. (1997). Managing managed care: 
Quality improvement in behavioral health (Vols. 1 and 
2). Washington, DC: National Academy Press. 
Jensen, G. A., Rost, K., Burton, R. P., & Bulycheva, M. 
(1998). Mental health insurance trends in the 1990s: 
Are employers offering less to more? Health Afsairs 
(Millwood), 17,201-208. 
Kane, R., Bartlett, J., & Potthoff, S. (1994). Integrating an 
outcomes information system into managed care for 
substance abuse. Behavioral Healthcare Tomorrow, 
May/June, 57-6 1. 
Kane, R., Bartlett, J., Kz Potthoff, S. (1995). Building an 
empirically based outcomes information system for 
managed mental health care. Psychiatric Services, 46, 
45946 1. 
Katon, W., VonKorff, M., Lin, E., Unutzer, J., Simon, G.. 
Walker, E., Ludman, E., & Bush, T. (1997). 
Population-based care of depression: Effective disease 
management strategies to decrease prevalence. General 
Hospital Psychiatry, 19, 169-178. 
431 
Mental Health: A Report of the Surgeon General 
Kessler, R. C., Frank, R. G., Edlund, M., Katz, S. J., Lin, E., 
& Leaf, P. (1997). Differences in the use of psychiatric 
outpatient services between the United States and 
Ontario. New England Journal of Medicine, 336, 
551-557. 
Kessler, R. C., McGonagle, K. A., Zhao, S., Nelson, C. B., 
Hughes, M., Eshleman, S., Wittchen, H. U., & Kendler, 
K. S. (1994). Lifetime and 12month prevalence of 
DSM-III-R psychiatric disorders in the United States. 
Results from the National Comorbidity Survey. 
Archives of General Psychiatry, 51, 8-19. 
Kessler, R. C., Berglund, P. A., Zhao, S., Leaf, P. J., Kouzis, 
A. C., Bruce, M. L., Friedman, R. M., Grosser, R. C., 
Kennedy, C., Narrow, W. E., Kuehnel, T. G., Laska, E. 
M., Manderscheid, R. W., Rosenheck, R. A., Santoni, 
T. W., & Schneier, M. (1996). The 12-month 
prevalence and correlates of serious mental illness 
(SMI). In R. W. Manderscheid & M.A. Sonnenschein 
(Eds.), Center for Mental Health Services, Mental 
health United States, 1996, (DHHS Pub. No. SMA 
96-3098) (pp. 59-70). Washington, DC: 
Superintendent of Documents, U.S. Government 
Printing Office. 
Lehman, A. F., Steinwachs, D. M., &Co-Investigators of the 
PORT Project. (1998). Translating research into 
practice: The Schizophrenia Patient Outcomes 
Research Team (PORT) treatment recommendations. 
Schizophrenia Bulletin, 24, l-10. 
Levit, L., & Lundy, J. (1998). Trends and indicators in the 
changing health care marketplace: Chartbook. Menlo 
Park, CA: The Henry J. Kaiser Family Foundation. 
McFarland, B. H., George, R. A., Goldman. W., Pollack, D. 
A., McCullough, J., Penner, S., Angell, R. H. (1998). 
Population-based guidelines for performance 
measurement: A preliminary report. Harvard Review of 
Psychiatry, 6( 1). 23-27. 
Ma, C. A., & McGuire, T. G. (1998). Costs and incentives in 
a behavioral health carve-out. Health Affairs 
(Millwood), 17,53-69. 
Manning, W. G., Wells, K. B., Buchanan, J. L., Keeler, E. 
B., Valdez, E. B., & Newhouse, J. P. (1989). Efsects of 
mental health insurance: Evidence from the Health 
Insurance Experiment. Santa Monica, CA: The RAND 
Corporation. 
Mark, T., McKusick, D., King, E., Harwood, H., & 
Genuardi, J. (1998). National expenditures for mental 
health, alcohol, and other drug abuse treatment, 1996. 
Rockville, MD: Substance Abuse and Mental Health 
Services Administration. 
Mercer/Foster Higgins. (1997). National Survey of 
Employer-Sponsored Health Plans. New York: Mercer. 
Merrick, E. (1997). Impact of a behavioral health carve-out 
on treatment of major depression. Unpublished 
doctoral dissertation, Brandeis University, New York. 
Murray, C. J., & Lopez, A. D. (Eds.). (1996). The global 
burden of disease: A comprehensive assessment of 
mortality and disabilir): from di;eases, injuries, and 
riskfactors in 1990 andprojected to 2020. Cambridge, 
MA: Harvard University Press. 
National Advisory Mental Health Council. (1998). Parity in 
financing mental health services: Managedcare eflects 
on cost, access and quality: An interim report to 
Congress by the National Advisory Mental Health 
Council. Bethesda, MD: Department of Health and 
Human Services, National Institutes of Health, 
National Institute of Mental Health. 
National Alliance for the Mentally Ill. (1999). State mental 
illness par@ laws. Arlington, VA: Author. 
National Committee for Quality Assurance. (1997). Health 
Plan Employer Data and Information Set 3.0 (HEDIS 
3.0). Washington, DC: Author. 
OPEN MINDS. (1999). Over 72% of insured Americans are 
enrolled in MBHOs: Magellan Behavioral Health 
continues to dominate the market. OPEN MINDS 
Behavioral Health and Social Service Zndustry Analyst, 
11,9. 
Pincus, H. A., Tanelian, T. L., Marcus, S. C.. Olfson, M., 
Zarin, D. A., Thompson, J., & Zito, J. M. (1998). 
Prescribing trends in psychotropic medications: 
Primary care, psychiatry, and other medical specialties. 
Journal of the American Medical Association, 279, 
526-531. 
President’s Advisory Commission on Consumer Protection 
and Quality in the Health Care Industry. (1997). Final 
report to the President: Qualiofirst: Better health care 
for all Americans. Washington, DC: Author. 
Regier, D., Goldberg, I., & Taube, C. (1978). The de facto 
U.S. mental health services system: A public health 
perspective. Archives of General Psychiatry, 35, 
685-693. 
432 
Organizing and Financing Mental Health Services 
Regier, D. A., Narrow, W., Rae, D. S., Manderscheid, R. W., 
Locke, B. Z., & Goodwin, F. K. (1993). The de facto 
US mental and addictive disorders service system. 
Epidemiologic Catchment Area prospective 1 -year 
prevalence rates of disorders and services. Archives of 
General Psychiatry, 50, 85-94. 
Rice, D. P.. Kelman, S., Miller, L. S., & Dunmeyer, S. 
(1990). The economic costs of alcohol and drug abuse 
and mental illness; 1985. San Francisco: Institute for 
Health and Aging. 
Rice, D. P., & Miller, L. S. (1996). The economic burden of 
schizophrenia: Conceptual and methodological issues, 
and cost estimates. In M. Moscarelli, A. Rupp, & N. 
Sartorious (Eds.), Handbook of mental health 
economics and health policy. Vol. I: Schizophrenia 
(pp. 321-324). New York: John Wiley and Sons. 
Rosenheck, R. A., Druss, B., Stolar, M., Leslie, D., & 
Sledge, W. (1999). Effect of declining mental health 
service use on employees of a large private corporation. 
Health Affairs (Millwood), 18, 193-203. 
Rupp, A., Gause, E., & Regier, D. A. (1998). Research 
policy implications of cost-of-illness studies for mental 
disorders. British Journal of Psychiatry. 
Supplement,173(36), 19-25. 
Salkever, D. (1998). Psychiatric disability in the workplace. 
Insight, 5. 
Shaffer, D., Fisher, P., Dulcan, M. K.. Davies, M., 
Piacentini, J., Schwab-Stone, M. E., Lahey, B. B., 
Bourdon, K., Jensen, P. S., Bird, H. R., Canino, G., & 
Regier, D. A. (1996). The NIMH Diagnostic Interview 
Schedule for Children, version 2.3 (DISC 2.3): 
Description, acceptability, prevalence rates and 
performance in the MECA study. Methods for the 
Epidemiology of Child and Adolescent Mental 
Disorders Study. Journal of the American Academy of 
Child and Adolescent Psychiatq, 35, 865-871. 
Shore, M., & Cohen, M. (1994). Introduction. Milbank 
Quarterly, 72, 3 l-35. 
Sing, M., Hill, S., Smolkin, S., & Heiser, N. (1998). The 
costs and effects of par& for mental health and 
substance abuse insurance benefits (DHHS Publication 
NO. (SMA) 98-3205). Rockville. MD: Substance 
Abuse and Mental Health Services Administration. 
Sturm, R., McCulloch, J., & Goldman, W. (1999). Mental 
health and substance abuse parity: A case study of 
Ohio’s state employee program (Working Paper No. 
128). Los Angeles: UCLA/RAND Center on Managed 
Care for Psychiatric Disorders. 
Sturm, R., & Sherboume, C. D. (1999). Are barriers to 
mental health and substance abuse care still rising? 
Manuscript submitted for publication. 
Substance Abuse and Mental Health Services 
Administration. (199%). State profiles on public sector 
managed behavioral health care and other reforms. 
Rockville, MD: Author. 
Substance Abuse and Mental Health Services 
Administration. (1999). Background report: Effects of 
the mental health parity act of 1996. Rockville, MD: 
Author. 
U.S. Department of Health and Human Services Task Force 
on Alzheimer’s Disease. (1984). Report of the 
SecretaT’s Task Force onAlzheimer’.s Disease (DHHS 
Publication No. (ADM) 84-1323). Washington, DC: 
Government Printing Office. 
Wells, K. B. (1999). The design of partners in care: 
Evaluating the cost-effectiveness of improving care for 
depression in primary care. Social Psychiatry and 
Psychiatric Epidemiology, 34, 20-29. 
Wells, K. B., Sherboume, C., Schoenbaum, M., Duan, N.. 
Meredith, L., Unutzer, J., Miranda. J., Camey, M., & 
Rubenstein, L. (in press). Can managed, primary care 
practices improve quality and outcomes of care and 
employment status of depressed patients? Results from 
a randomized trial. Journal of the American Medical 
Association. 
Zuvekas, S. H.. Banthin, J. S., & Selden, T. M. (1998). 
Mental health parity: What are the gaps in coverage? 
Journal of Mental Health Policy and Economics, I. 
135-146. 
433 
CHAPTER 7 
CONFIDENTIALITY OF MENTAL 
HEALTH INFORMATION: ETHICAL, LEGAL, 
AND POLICY ISSUES 
Contents 
ChapterOverview . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 438 
Ethical Issues About Confidentiality . . . . , . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 438 
Values Underlying Confidentiality ................................................. 439 
Reducing Stigma.. .......................................................... 439 
FosteringTrust ............................................................. 439 
Protecting Privacy.. ......................................................... 439 
Research on Confidentiality and Mental Health Treatment . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 440 
Current State of Confidentiality Law ............................................... 441 
Overview of State Confidentiality Laws ......................................... 44 1 
Exceptions to Confidentiality .................................................. 442 
Consent by the Person in Treatment ......................................... 442 
Disclosure to the Client ................................................... 443 
Disclosure to Other Providers .............................................. 443 
DisclosuretoPayers ...................................................... 443 
Disclosure of Information to Families ........................................ 444 
Oversight and Public Health Reporting ....................................... 444 
Research ............................................................... 444 
Disclosure to Law Enforcement Agencies ..................................... 445 
Disclosure to Protect Third Parties .......................................... 445 
Contents, continued 
Federal Confidentiality Laws ...................................................... 446 
Potential Problems With the Current Legal Framework ................................. 447 
summary ..................................................................... 448 
Conclusions ................................................................... 449 
References .................................................................... 449 
CHAPTER 7 
CONFIDENTIALITY OF MENTAL 
HEALTH INFORMATION: ETHICAL, LEGAL, 
AND POLICY ISSUES 
Effective psychotherapy. . . depends upon an atmosphere of confidence and trust in which the patient is 
willing to make a frank and complete disclosure of facts, emotions, memories, and fears. Because of the 
sensitive nature of the problems for which individuals consult psychotherapists, disclosure of confidential 
communications made during counseling sessions may cause embarrassment or disgrace. For this reason, 
the mere possibility of disclosure may impede development of the confidential relationship necessary for 
successful treatment. 
T his ringing endorsement of the importance of confidentiality in the provision of mental health 
treatment comes from the U.S. Supreme Court (JafSee 
v. Redmond, 1996). The Court’s language, in a decision 
creating a psychotherapist privilege in Federal court, 
appears to leave little doubt that there is’broad legal 
protection for the principle of confidentiality. Public 
opinion polls also show widespread support for the 
privacy of health care information: 8.5 percent of those 
responding to one survey characterized protecting the 
privacy of medical records as essential or very 
important (Peck, 1994). 
Yet the reality is much more complex. State and 
Federal laws do protect the confidentiality of health 
care information, including information created in 
providing mental health and substance abuse treatment. 
However, these laws have numerous exceptions, are 
inconsistent from state to state, and, in the opinion of 
many experts, provide less protection of confidentiality 
than is warranted. 
In addition, changes in the health care industry, and 
advances in technology, have created new concerns 
regarding the privacy of health care information. Health 
care increasingly is delivered and paid for by for-profit 
corporations with business in many states. This shift 
has several relevant consequences. First, individual 
health care information may be held and disseminated 
far beyond the office of the practitioner providing care. 
Second, cost containment concerns have resulted in the 
emergence of a variety of techniques that depend on 
third-party review of a practitioner’s judgment that an 
individual should receive care, reviews that have 
resulted in increased demands for patient-specific 
information before care is approved. In addition. 
private health care information may be distributed for 
the purpose of marketing commercial products, such as 
pharmaceuticals, a growing business that many believe 
constitutes an improper use of such information 
(Jeffords, 1997; O’Harrow, 1998). Finally, private 
health information is used to create much larger 
databases, for various purposes including treatment and 
research, thereby increasing the number of people with 
access to such information. 
Technology also has emerged as a major issue in 
privacy debates. The ultimate impact of technology is 
not yet clear. One leading expert on the privacy of 
health care information asked whether technology 
would help or hinder the protection of health care 
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privacy, responded that the answer was yes and no 
(Gellman. in press). On the one hand, new technologies 
can support, and in some cases make possible, the 
changes that have transformed the health care industry. 
The “health information technology industry” in 1997 
sold approximately $15 billion of products to health 
care organizations, including medical business 
decision-support software;data warehousing, clinical 
expert systems, and electronic medical record systems 
designed to support large health care enterprises 
(Kleinke, 1998). There also have been ongoing efforts 
to create computer-based patient records for several 
years (Dick & Stean, 1991). Such records in many ways 
can be more secure than paper records through various 
mechanisms, for example, by restricting access to 
designated users. Yet much of the same technology 
raises concerns about privacy, because of its capacity 
to store and disseminate rapidly to multiple users 
personal information that many individuals would 
prefer remain private. If the myriad needs of the health 
care system could be met by using only data stripped of 
patient-specific information, many concerns about 
privacy might be ameliorated. However, data that 
identify the individual are still considered necessary for 
many purposes, including the administration of 
payment systems and fraud investigations. This’has led 
some to conclude that the ultimate question when 
patient-specific data are transported and used outside of 
the clinical context is security of the data (Moran, 
1998). 
Congress, in an effort to respond to growing public 
concern over health care information privacy, has 
committed the Federal government to the creation of a 
national confidentiality standard by 2000. Congress 
also has directed the Secretary of Health and Human 
Services to produce recommendations for simplifying 
and standardizing requirements for the electronic 
transmission of health information (Health Insurance 
Portability and Accountability Act, 1996). The purpose 
is to improve the effectiveness and efficiency of the 
health care system (Gellman, 2000). It is not yet clear, 
given the complexities of the issues, that the deadline 
for a national privacy standard will be met. However, 
it is clear that the confidentiality of health care 
information has emerged as a core issue in recent years, 
as concerns regarding the accessibility of health care 
information and its uses have risen. 
Chapter Overview 
This section of the report discusses the values 
underlying confidentiality, its importance in individual 
decisions to seek mental health treatment, the legal 
framework governing confidentiality and potential 
problems with that framework, and policy issues that 
must be addressed by those concerned with the 
confidentiality of mental health apd substance abuse 
information. Although the current debate regarding 
Federal standards is not presented in great detail, it is 
referred to when appropriate to provide context for the 
broader discussion. 
Ethical Issues About Confidentiality 
Each profession that provides mental health treatment 
embraces confidentiality as a core ethical principle. For 
example, the Code of Ethics of the American Medical 
Association (AMA) states that “a physician . . . shall 
safeguard a patient’s confidences within the restraints 
of the law” (American Medical Association [AMA], 
1996). The AMA more recently has observed that 
“patients have a basic right to privacy of their medical 
information and records. . .patients’ privacy should be 
honored unless waived by the patient in a meaningful 
way, or in rare instances of strongly countervailing 
public interest” (AMA, 1998). The Ethical Principles 
of Psychologists state that “psychologists have a 
primary obligation and take reasonable precautions to 
respect . . . confidentiality rights” (American 
Psychological Association, 1992). (See also, American 
Managed Behavioral Healthcare Association, 1998; 
American Psychiatric Association, 1998; National 
Alliance for the Mentally Ill, 1998). 
While the importance of confidentiality as an 
ethical principle is evident from these statements, it is 
also clear that confidentiality is not an absolute value. 
The AMA’s 1996 statement qualifies the principle of 
confidentiality by observing that it is to be protected 
“within the restraints of the law.” The American 
Psychological Association provides exceptions as well, 
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noting for example that disclosure of otherwise 
confidential information is permissible “where 
permitted by law for a valid purpose, such as. . .(3) to 
protect the patient or client from harm” (Ethical 
Principles of Psychologists and Code of Conduct, 
5.05). As the discussion below suggests, the law creates 
many circumstances .in which confidentiality may or 
must be breached. At the same time, legal principles 
reflect broader values, and so there is often significant 
disagreement about the exceptions to confidentiality 
that the law permits or requires. 
It is also important to note at the outset that the 
right to confidentiality belongs to the person receiving 
services (Campbell, 2000). The ethical codes of the 
various professions, and most confidentiality laws, 
obligate professionals‘ to take steps to protect 
confidentiality. However, in general, the right to 
confidentiality belongs to the client; the right to waive 
confidentiality also is the client’s, although there are 
situations in which the provider of treatment has no 
choice under the law but to disclose. 
Values Underlying Confidentiality 
The principle of confidentiality is designed to advance 
certain values. These include reducing the stigma and 
discrimination associated with seeking and receiving 
mental health treatment, fostering trust in the treatment 
relationship, ensuring individuals privacy in their 
health care decisions, and furthering individual 
autonomy in health care decisionmaking. 
Reducing Stigma 
There are certain illnesses that often evoke public 
unease and on occasion overt discrimination. For 
example, in the past, cancer was often not discussed; in 
fact. physicians often chose not to tell patients that they 
had diagnosed cancer. In recent years, individuals with 
AIDS have often faced discrimination. Mental illness 
has often fallen into this category as well. For years. the 
stigma and discrimination associated with mental 
illness were reinforced by laws that stripped people of 
their legal rights upon admission to a psychiatric 
hospital, and by social attitudes that often equated 
mental illness with potential violence. While many of 
Confidentiality of Mental Health Information 
the legal rules that reinforced discrimination have been 
removed, public attitudes regarding mental illness 
continue to vary. In an effort to reduce the risk of 
stigma and the discrimination that often results. 
confidentiality laws seek to protect both the fact that an 
individual has sought mental health treatment as well as 
the disclosures that are made during treatment. 
Fostering Trust 
Confidentiality generally is considered to be a 
cornerstone of a doctor-patient relationship (Dierks, 
1993). Many psychotherapists assume that mental 
health treatment is most likely to be successful only if 
the client has a trusting relationship with the clinician 
(Sharkin, 1995). The Supreme Court language quoted 
at the beginning of this section reflects the same 
assumption. While the research findings on this subject 
are somewhat mixed (see discussion below), it is 
beyond dispute that many individuals in seeking 
treatment for mental illness reveal much of their private 
selves. It seems reasonable to assume that for many 
people, trust that their privacy will not be intruded 
upon beyond the confines of the clinical relationship is 
an important element in permitting unguarded 
exchanges during treatment. Concerns regarding 
confidentiality may cause individuals to take steps to 
protect themselves from unwanted disclosures in other 
ways that carry their own costs. For example, an 
individual may decide to pay for his or her own care, 
withhold certain types of sensitive information during 
treatment, or avoid seeking care. 
Protecting Privacy 
The law has given considerable attention in the last 3 
decades to the idea that people have a right to privacy 
in making decisions regarding their health care. While 
the legal right to privacy has been discussed and 
applied most often in the context of decisions involvin,o 
procreation and decisions at the end of life, the general 
principle that the value of privacy is important to 
mental health treatment is not disputed. 
Competent individuals, or in the case of minor 
children, their parents or legal guardians, have a right 
to self-determination in deciding to seek or forego 
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health care, including mental health or substance abuse 
treatment. There are exceptions, for example, the use of 
involuntary civil commitment or court-ordered 
treatment. However, the general trend has been to 
expand autonomy in health care decisionmaking. Two 
ethical and legal principles are important anchors to the 
principle of autonomy. The first, informed consent, 
assumes that the better informed an individual is, the 
better equipped he or she is to make health care 
decisions. The second, confidentiality, is considered to 
be particularly important in the context of mental health 
treatment. This is because of the assumption that an 
absence of confidentiality may make a person less 
likely to seek treatment. 
Research on Confidkntiality and 
Mental Health Treatment 
The values that underlie confidentiality in large part 
assume that people will be less likely to seek needed 
help (Corcoran & Winsalde, 1994) and, once in 
treatment, less likely to disclose sensitive information 
about themselves if they believe that the information 
may be disseminated outside the treatment relationship. 
Available research supports these assumptions. For 
example, in one study, individuals receiving 
psychotherapy placed a high value on the importance of 
confidentiality to the therapeutic relationship, as did a 
matched group of hospital employees (McGuire et al., 
1985). Parents of children in psychotherapy reported 
that confidentiality was an important issue that needed 
to be discussed in the context of informed consent 
processes (Jensen et al., 1991). Another study suggests 
that concerns regarding stigma and confidentiality were 
factors in decisions by people with dual diagnoses 
(psychiatric illness and substance abuse disorder) to 
seek treatment from the community mental health 
system (Howland, 1995). Yet another study reports that 
the decision of therapists to seek or not seek treatment 
was influenced, among other things, by concerns 
regarding confidentiality (Norman & Rosvall, 1994). In 
the context of drug testing, the degree to which 
confidentiality was protected influenced the attitudes of 
those who had been ordered into drug testing regarding 
the seeking of employment (Sujak et al.. 1995). 
Subjects who were told that confidentiality was 
absolute reported that they were more willing to 
disclose information about themselves than individuals 
who were told that confidentiality was limited (Nowell 
& Spruill, 1993). Confidentiality, of course, is not 
absolute, and so the impact on individuals in treatment 
of various limits on confidentiality is an important 
question. This was explored in one of the few 
confidentiality studies to use as research subjects 
people actually in treatment (rather than students 
simulating the role of patient). Taube and Elwork 
(1990) found that patient self-disclosure was influenced 
in large measure by how informed the patient was 
about confidentiality law and by how consequential to 
the patient the legal limits on confidentiality were in his 
or her particular circumstances. Roback and Shelton 
(1995), noting that some studies suggested that 
perceived limitations on confidentiality did not deter 
patients from self-disclosing, also noted that as persons 
perceived themselves at risk for serious sociolegal 
consequences, being informed that certain disclosures 
would result in mandatory reporting did limit 
self-disclosing. 
Finally, one of the most recent studies of this 
subject, which used clients and college students as 
subjects for the research, concluded that subjects were 
less candid with a therapist if they understood that 
information regarding their treatment was to be 
disclosed to a third party for case utilization review 
(Kremer & Gesten, 1998). As a result, another observer 
concluded that “psychiatric treatment is often paid for 
by patients out-of-pocket, precisely to avoid creating a 
record over which a patient has little or no control” 
(Alpert, 1998, p. 89). 
Surveys of the general public also indicate that 
privacy of health care information is a major concern. 
For example, 27 percent of the respondents to a 1993 
Harris survey believed that health care information 
about them had been improperly disclosed, 11 percent 
previously had decided to not file an insurance claim 
because of privacy concerns, and 7 percent had decided 
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to forego care because of concern that information that 
would be generated in care might harm their 
employment possibilities or other opportunities (Louis 
Harris & Associates, 1993). 
These findings suggest a dilemma for individuals 
who may wish to pursue treatment for mental illness 
and for treatment providers. All available data indicate 
that confidentiality of health care information is a 
significant concern for individuals. The evidence also 
indicates that people may become less willing to make 
disclosures during treatment if they know that 
information will be disseminated beyond the treatment 
relationship. At the same time, the caregiver is ethically 
obligated to disclose to the client the limits on 
confidentiality: A failure to reveal the limits of . 
confidentiality seriously threatens the therapeutic 
relationship and the provider’s credibility. As a result, 
treatment may be compromised, and the patient may 
terminate treatment prematurely (Kremer & Gesten, 
1998). 
In short, available research supports the conclusion 
that strong confidentiality laws are critical in creating 
assurances for individuals seeking mental health 
treatment and thereby increasing willingness to 
participate in treatment to the degree necessary to 
achieve successful outcomes. However, the present 
legal framework does not provide strong, consistent 
protection of confidentiality in many instances. 
It is important to note that additional factors may 
contribute to concern that confidentiality may be 
breached and, in turn, an unwillingness on the part of 
consumers to disclose or share information. In many 
instances, these factors cannot be addressed through 
stronger legal protections alone. In given clinical 
settings, for example, concern may stem from the 
existence of crowded or open facilities, frequent 
changes in clinical staff, language differences, cultural 
considerations, and other constraints that would limit 
establishing a trusting therapeutic relationship. In 
addition, individuals may not wish to disclose 
information regarding “pre-existing conditions” for fear 
it may result in a loss of insurance coverage as well as 
privacy. 
Confidentiality of Mental Health Information 
Current State of Confidentiality Law 
One expert has described the current law goveming the 
confidentiality of health care information as a “crazy 
quilt of Federal and state constitutional, statutory, 
regulatory and case law” that “erodes personal privacy 
and forms a serious barrier to administrative 
simplification” (Waller, 1995, p. 44). This aptly 
describes the current legal framework for the 
confidentiality of mental health and substance abuse 
information as well. 
There is at present no national standard for the 
confidentiality of health care mformation in general or 
mental health information in particular. Rather, each 
state has laws that establish confidentiality rules and 
exceptions. In response to a serious public policy 
concern that the criminal justice ramifications of use of 
illegal substances would significantly deter individuals 
from seeking substance abuse treatment, a national 
standard governing the confidentiality of substance 
abuse treatment information was codified. However. 
there often are significant differences among states and 
between the state and Federal requirements, which can 
create problems for the administrators of health care 
plans and for those providing treatment for people with 
co-occurring mental illness and substance abuse 
disorders. 
Overview of State Confidentiality Laws 
As noted, nearly all states have discrete statutes 
addressing the confidentiality of mental health records 
and information. In a handful of states, a general law 
applicable to all health care information applies. In 
some states, the mental health confidentiality statute 
applies only to information gathered when a state 
facility provides treatment; in others, it applies to 
mental health treatment regardless of the auspice of 
care. 
One common criticism of health care information 
laws generally is that they apply primarily to 
information gathered in the course of treatment and in 
the possession of the caregiver. This means that 
different standards apply to the distribution of 
information held by others not party to the treatment 
relationship. This observation fairly characterizes most 
441 
Mental Health: A Report of the Surgeon General 
state mental health laws as well. The focus of the laws 
tends to be upon the clinical relationship, and often 
what happens to information once it is disseminated 
beyond the clinical relationship is unaddressed. Many 
of the reform proposals advanced in recent years would 
apply confidentiality rules to other parties that come 
into possession of protected information, although the 
proposals vary regarding application of a national 
standard to employers, schools, correctional facilities, 
and other settings in which a significant volume of 
health care is provided. In addition, the proposals vary 
regarding the question of whether the individual has a 
legal right to consent to disclosures beyond the clinical 
relationship: How this question is resolved will 
determine in large measure whether individuals in the 
role of patient believe that confidentiality protections 
are strong enough to warrant seeking treatment. 
While the various reform proposals differ in detail, 
few dispute the need to extend the obligation to protect 
confidentiality to other parties. In the early 1980s one 
expert found that between 25 and 100 people had 
access to an individual inpatient record (Siegler, 1982), 
a number that has grown in recent years. In addition, as 
health care delivery and payment have . become 
increasingly complex and as provider networks rather 
than individual practitioners increasingly provide care, 
the number of people who may come into possession of 
health care information continues to expand. One 
observer describes three “zones” of users of personal 
health care information. “Zone one” users are involved 
in direct patient care, while “zone two” users are 
involved in support and administrative activities like 
payment and quality of care reviews. “Zone three” 
users include public health agencies, social welfare 
agencies, researchers, and direct marketing firms 
(Westin, 1993). Some of these parties traditionally have 
had ready access to health care information; others, for 
example, utilization review managers and direct 
marketing firms, are comparatively new to health care. 
Whether a party that has access to information should 
have access to that information is a separate question 
that lies at the heart of much of the debate about 
confidentiality. 
Exceptions to Confidentiality 
Each state law creates exceptions to confidentiality. 
While state laws vary regarding the number and type of 
exceptions permitted, the most common exceptions to 
confidentiality are discussed briefly below. As a 
prefatory note, many experts assume that client consent 
presumptively should be required prior to most if not 
all disclosures, and that any waiver of confidentiality 
by the client must be truly informed (Campbell, 2000). 
However, as the discussion below suggests, many state 
laws permit a variety of disclosures without client 
consent, raising questions regarding the adequacy of 
these laws in protecting client confidentiality in the 
current environment. 
Consent by the Person in Treatment 
The most common exception to confidentiality is when 
the person who is or has been in treatment consents to 
the waiver of confidentiality. (For minor children, this 
right rests with the parents or legal guardians.) For 
example, the practitioner may ask that the person sign 
a consent form authorizing the release to the 
practitioner of other health care records. This reflects 
the fact that the right to confidentiality is designed 
primarily to protect the patient, not other parties, from 
unwanted disclosures, and that the right to waive 
confidentiality presumptively rests with the patient. In 
some instances, where confidentiality is waived, the 
patient nonetheless may wish to avoid release of certain 
information in any circumstances and direct that the 
provider not include in the file sensitive personal 
information-for example, sexual orientation or marital 
infidelities. 
Although each state provides for waiver of 
confidentiality by the person in treatment, few states 
spell out in statute the elements of a valid consent. This 
is in contrast to the Federal laws on substance and 
alcohol treatment information, discussed below, which 
provide explicit details regarding the content of a valid 
consent. 
In addition, the various reform proposals that have 
been introduced in Congress and elsewhere each 
contain criteria for consent. These typically include 
requirements that consent be in writing, name the 
individual or entity to which disclosure of information 
is to be made, identify the purpose or need for 
disclosure and the type of information to be disclosed, 
and state the period for which the consent is effective. 
However, it should be noted that the proposals differ on 
the question of the degree to which a person’s consent 
to disclosure would be truly voluntary. Many of the 
proposals suggest that a person’s treatment, or 
reimbursement for treatment, may depend on whether 
the person consents to have his or her records 
disclosed. This may raise questions about how 
*‘voluntary” such consent is, in fact, given that access 
to the services sought may be contingent upon agreeing 
to the release of information divulged during treatment. 
Disclosure to the Client 
Many, though not all, state laws provide that 
individuals have a right of access to health care records 
containing information about them. Some provide that 
a clinician may restrict access to the record, if in the 
clinician’s judgment, access would cause harm to the 
client. Some statutes also provide that a clinician may 
restrict access to particular parts of the record if access 
might harm the client or if third parties provided 
information with the expectation that it would be held 
in confidence. Some experts have suggested that limiting 
client access undercuts the principle that information 
contained in the record belongs first to the client 
(Campbell, 2000). Each reform proposal articulated to 
date provides for access by an individual to health care 
information. These proposals assume that access is 
necessary both so that the individual is fully informed 
regarding his or her health care and so that the individual 
can correct information that might be erroneous. 
Generally, for minor children, parents have the right of 
access. Some experts have suggested that in the case of 
children, even in instances in which the parents or 
guardians control the information, there should be a right 
for the child to establish a “zone of privacy” for certain 
“intimate” information. Such information could not be 
accessed by responsible adults except when the clinician 
determines that it indicates imminent danger of harm to 
self or others (Melton, 2000). 
Confidentiality of Mental Health Information 
Disclosure to Other Providers 
An important question in an era in which networks of 
providers provide increasing amounts of care is whether 
and how confidentiality laws permit disclosure to other 
caregivers. The majority of states that address this issue 
typically provide for disclosure to others involved in 
providing care. Some states require consent before 
information can be disclosed, although the majority of 
state laws that address the issue do not. Few states 
address the question of information exchange within a 
network of providers. 
Some proposals before Congress would permit 
disclosure of information to other care providers without 
requiring consent. Others would require consent prior to 
any disclosure. At least one presumptively would permit 
disclosure, but give the individual the opportunity to 
“opt out” of a particular disclosure. As noted earlier, 
conditioning access to treatment (or to reimbursement) 
on a waiver of confidentiality calls into question the 
voluntariness of the waiver. 
Disclosure to Payers 
Many states have provisions in their mental health 
confidentiality laws that permit disclosure of otherwise 
confidential information as necessary to obtain 
reimbursement or other financial assistance for the 
person in treatment. Most of these statutes were written 
before the emergence of managed care and third-party 
utilization review. Therefore, most state laws that create 
this exception to confidentiality impose few if any 
limitations on the type or amount of information that can 
be disclosed to obtain reimbursement, and most do not 
explicitly require consent prior to disclosure. There are 
exceptions that might prove useful models to other 
jurisdictions. For example, New Jersey restricts 
disclosure of information from licensed psychologists to 
third-party payers. The statute permits disclosure only if 
the client consents, and if disclosure is limited to: ( 1) 
administrative information; (2) diagnostic information: 
(3) the legal status of the patient; (4) the reason for 
continuing psychological services; (5) assessment of the 
client’s current level of functioning and level of distress: 
and (6) a prognosis, limited to the minimal time 
treatment might continue (New Jersey Statutes). The 
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Commonwealth of Massachusetts also limits disclosures 
to third-party payers of mental health information 
(Massachusetts Annotated Laws). 
As noted, the proposals that have been made to date 
to create a national standard for the confidentiality of 
health care information differ in how they treat 
disclosures to other providers and payers. Some 
proposals would require patient consent prior to any 
disclosure. Others would presume consent. Still others 
would permit the individual to “opt out” of specific 
disclosures. The last would require that individuals be 
given the names of providers and payers that might be 
provided access to information; the individual could then 
decline permission to provide information to specific 
payers or providers. 
The question of how much information should be 
made available to third-party reviewers is a contentious 
one. As the research described earlier suggests, the 
willingness to self-disclose, or to participate in 
treatment, appears to be contingent at least in part on the 
strength of confidentiality provisions. As the amount and 
sensitivity of information made available to third- party 
reviewers increases, a corresponding decrease on the 
part of some individuals to seek treatment is likely. 
Disclosure of Information to Families 
An issue of some controversy in mental health is wheth- 
er families should be provided information regarding 
their adult child in certain circumstances. As a general 
rule, access to information in circumstances involving 
minor children is provided to parents or the legal 
guardian of the child, until the child attains the age of 
majority or an age at which the child is permitted under 
state law to make his or her own treatment decisions. 
Some states provide that parents acting in the role of 
caregiver may be given information, usually limited to 
diagnosis, prognosis, and information regarding 
treatment, specifically medications. Of those states with 
these or similar provisions, some permit the disclosure of 
this information without the consent of the individual, 
while others require consent, with some providing for 
administrative review if consent is not given. All of the 
reform proposals that have been introduced before 
Congress provide for the disclosure of limited 
information regarding an individual’s current health 
status to family or next of km. Consent generally is not 
required, although most provide the patient with the 
opportunity to request that information not be provided 
in such circumstances. It should be noted that in the 
context of mental health treatment, there is disagreement 
regarding this issue, particularly on the issue of prior 
consent. Family advocates often take the position that a 
family in a caregiving role should have access to some 
types of information whether or not the individual 
specifically has consented to the disclosure, because it is 
necessary to play a caregiving- role (Lefly, 2000). 
Advocates for consumer-recipients often argue that 
consent should be required, because the right to 
confidentiality belongs to the recipient of services, and 
because there may be intrafamily conflicts that could be 
exacerbated by the release of information to family 
members. 
Oversight and Public Health Reporting 
All states have provisions that allow entities with 
oversight responsibilities to have access to medical 
records without client consent. Similarly, states mandate 
that certain types of information be made available to 
public health officials for various public health purposes, 
for example, the reporting of infectious diseases or the 
prescription of particular types of medication. The 
various reform proposals would do little to change this 
type of reporting, although at least one would create a 
preference for the use of records in which personal 
identifying information has been deleted. 
Research 
The confidentiality of individually identifiable 
information gathered in the course of conducting 
research can be protected from compelled disclosure by 
obtaining federally issued “certificates of confiden- 
tiality.” These certificates are issued through the Depart- 
ment of Health and Human Services upon application by 
the researcher for research which involves the collection 
of specific types of sensitive information judged 
necessary to achieve the research objectives. The 
importance of the protection against disclosure afforded 
by Federal “certificates of confidentiality” increases as 
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research expands its traditional boundaries to include 
genetic information of uncertain/evolving clinical 
relevance. An individual may voluntarily consent to the 
disclosure of information obtained in the course of 
protected research. In addition, the researcher may 
identify certain specific information which may be 
voluntarily disclosed in participants’ consent forms. 
States that address access to confidential information 
for research purposes generally provide for access 
without consent if it is impracticable to obtain individual 
consent and the research has been approved by the 
agency with approval authority under the state law. It 
should be noted that regardless of the aforementioned 
protections, information obtained in protected research 
studies, which finds its way into the participant’s regular 
medical chart, is not covered. 
Disclosure to Law Enforcement Agencies 
Many state laws limit access to information regarding 
people with mental illness by law enforcement officials 
to situations in which an individual who has been 
hospitalized has left the hospital and not returned, or to 
situations in which a crime has been committed on the 
grounds of a treatment facility. A handful of state laws 
provides access for the purpose of investigating health 
care fraud. In contrast, most of the reform proposals 
designed to create a national standard provide 
comparatively broad access by law enforcement 
officials. Others would limit discovery to situations in 
which law enforcement could demonstrate, usually by 
clear and convincing evidence, that disclosure is 
necessary. 
This is a controversial issue. Some professional and 
advocacy groups believe that broad access by law 
enforcement officials will lead to unwarranted invasions 
of privacy and encourage “fishing expeditions” in which 
material revealed during treatment becomes the basis of 
criminal prosecution. On the other hand, some have 
argued that broad access is necessary, particularly to 
investigate health care fraud in which the conduct of the 
provider rather than the client is at issue. The current 
Federal substance abuse laws provide for a stricter 
standard for access to information by law enforcement 
officials than is provided for in many of the proposals 
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before Congress. This strict standard is based on the 
assumption that broader access would have a negative 
effect on the willingness of people to seek substance 
abuse treatment, if seeking treatment might lead to 
criminal prosecution. While these provisions seem to 
have met their intended goal of encouraging individuals 
to seek treatment, there is no evidence that stricter 
Federal standards for access to substance abuse 
information have impeded law enforcement efforts. 
Disclosure to Protect Third Parties 
In 1976, the California Supreme Court ruled that a 
mental health professional has an obligation to take steps 
to protect identified third parties whom the professional 
reasonably believes might be endangered by a client 
(Tarasoff v. Regents, 1976). This decision was criticized 
by a number of groups, including the American 
Psychiatric Association and the American Psychological 
Association, on the grounds that it required mental 
health professionals to perform a task for which they 
were ill-suited (that is, assess future risk) and that it 
would compromise confidentiality. Since the court’s 
decision, many states, either through statute or judicial 
decision, have addressed this topic. 
The majority of states that have done so through 
statute provide that a mental health professional who 
concludes that his or her client represents an imminent 
danger to an identified third party may take steps, 
including notifying the individual or law enforcement 
officials, to protect the third party without becoming 
liable for a breach of confidentiality. These states also 
typically provide that the clinician will not be liable if he 
or she decides not to act-rather, the statutes give the 
clinician discretion in deciding how to proceed. 
In addition, all states permit or mandate disclosure 
in other situations where a third party might be at risk 
for harm. Child abuse and elder abuse reporting laws are 
examples. Most of the proposals to create a national 
standard permit disclosures necessary to protect an 
identifiable third party when the caregiver concludes that 
there is a risk of serious injury or death, or when 
disclosure is necessary to protect the patient from serious 
harm. 
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Federal Confidentiality Laws 
An individual who seeks treatment for mental illness 
runs the risk of discrimination and invasion of privacy if 
information disclosed during treatment becomes known 
to third parties. An individual who seeks treatment for a 
substance use problem may reveal information that if 
disclosed could become the basis for criminal 
prosecution. The prospect of prosecution as a price of 
entering treatment quite clearly may create disincentives 
to seek treatment. 
In an effort to create incentives for people with 
substance use and alcohol problems to seek treatment, 
Congress enacted perhaps the strictest confidentiality 
law extant. As a result, Federal law governs the 
confidentiality of information, obtained by federally 
assisted, specialized substance abuse treatment pro- 
grams, which would identify a patient as receiving treat- 
ment services (42 USC. 290dd-2; 42 C.F.R. 2.1, et 
seq.). 
Disclosure of patient identifying information by 
federally assisted programs is permitted only in 
explicitly delineated circumstances. The person 
receiving services can waive confidentiality, but consent 
must be written; name the client, the program making the 
disclosure, and the intended recipient of the information; 
state the purpose of the disclosure and the information to 
be disclosed; be signed by the client or representative of 
the patient where appropriate; and state the duration of 
the consent and conditions under which it expires. In the 
absence of consent, disclosures may be made only in the 
circumstances permitted by the regulations. For example, 
information may be exchanged within the program 
providing services, but only to the extent necessary to 
provide services. In other words, information is to be 
exchanged even within the treatment program on a “need 
to know” basis. Disclosures may be made without 
consent to other service providers if providers have 
entered into a “qualified service agreement” with the 
treating program. This is to permit the treating program 
to obtain collateral services, for example, blood work, 
that are not performed by the program itself. Disclosures 
to other providers not part of a qualified service 
agreement can only occur with consent. 
Disclosure also is permitted to law enforcement 
officials when there was a crime commuted on the 
premises or against the personnel of the treatment 
program. Even in this case, information provided is to be 
limited initially to the name, address, and last known 
whereabouts of the individual who committed or 
threatened to commit a crime. Other circumstances in 
which disclosures are permitted without consent include 
medical emergencies as defined in the regulations; child 
abuse reports; court orders, when the court has followed 
procedures established in the regulations; and incriminal 
investigations of “extremely se&us crimes” as defined 
in the regulations (Center for Substance Abuse 
Treatment, 1994). The statute and regulations do not 
address, and therefore do not permit, disclosures to 
families of clients or to payers without consent of the 
client. 
The Federal law is generally much more detailed 
than any state mental health law in delineating the 
conditions that must be met before disclosures can 
occur. In addition, as this brief summary suggests, state 
mental health laws and the Federal alcohol and 
substance abuse laws differ substantively in many 
respects. This may create difficulties for providers caring 
for people with co-occurring mental illness and 
substance use disorders, because the provider may be 
operating under two quite different legal standards in 
considering requests for information regarding the same 
individual. This issue is discussed in more detail below. 
Other Federal statutes have limited applicability to 
the confidentiality of health care information. The 
Privacy Act of 1974 prohibits disclosure of an 
individual’s record without prior written consent and 
provides access to review, copy, and correct records. 
However, the Act applies only to federally operated 
hospitals and to research or health care institutions 
operated pursuant to Federal contracts, so it does not 
cover the vast majority of organizations and entities 
collecting health care information (Gostin, 1995). In 
addition, disclosure of personally identifiable 
information is permitted if necessary for the “routine 
use” of the receiving facility, a very broad exception. 
Finally, the Americans With Disabilities Act (ADA) 
of 1990 requires employers to maintain medical 
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information in separate files and on discrete forms. As 
the ADA is enforced, it may lead to increased protection 
of the privacy of medical records at the workplace. In 
relevant part, however, the ADA applies only to people 
with a disability as defined by the statute, and to actions 
taken by employers based on an individual’s disability. 
Therefore, the ADA provides only limited confidential- 
ity protection; it does not create a general right to 
medical privacy within the workplace. 
Potential Problems With the Current 
Legal Framework 
There is general consensus that the current legal 
framework for protecting the confidentiality of health 
care information is inadequate. There are significant 
differences among the states in addressing 
confidentiality issues. While a state-by-state approach 
may have been good policy before recent trends in the 
organization and financing of health care, the increasing 
dominance of the health care industry by providers and 
payers doing business on a national scale has caused 
many to advocate for a national confidentiality standard. 
This lack of uniformity may be exacerbated in the 
context of mental health care. There are differences in 
standards not only among the states, but between the 
states and the Federal government. Separate state 
standards for mental health information and Federal 
standards for alcohol and substance use information may 
be problematic in an era in which it has become evident 
that many people with mental illnesses also have 
substance abuse or alcohol problems. In addition, there 
are often within the same state a number of statutory 
provisions that address the confidentiality of mental 
health information. These may include the state mental 
health law (which may apply to all mental health 
information or only information held by state-operated 
providers), judicial privilege statutes, laws applicable to 
licensed professionals, and various state oversight laws. 
This may make it difficult even within a particular state 
to articulate the state law on the confidentiality of mental 
health information. 
Many state mental health laws also lack provisions 
that most reform proposals contain. For example. many 
states do not articulate standards for client consent to 
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disclosure. In contrast, most reform proposals require 
that consent be in writing, be of definite rather than 
indefinite duration, and specify recipients of information 
rather than provide open-ended consent to disclose. 
Many state laws providing for disclosure of mental 
health information to payers without client consent were 
written before the increased demands for information 
common today. Access by other providers is variable as 
well. Many states provide for comparatively mild 
penalties for the breach of confidentiality. In contrast. 
most reform proposals would considerably strengthen 
penalties for violating confidentiality protections. 
As the debate regarding a national standard 
proceeds, there are two additional issues of consequence 
for those considering the confidentiality of mental health 
information. The first is the question of preemption. 
Most reform proposals considered by Congress in recent 
years would establish a national standard that would 
become the minimum standard for health care 
information. The standard would preempt (or supercede) 
any state laws that provided less protection than that in 
the national standard. The Secretary of the Department 
of Health and Human Services recommended such an 
approach in a recent report to Congress entitled, 
ConJidentiality of Individually Identifiable Health 
Information. Should a national standard be enacted, 
determining whether a state’s mental health law provides 
more or less protection than a national standard may be 
difficult in at least some cases. For example, in one state, 
the law permits disclosures without consent to some but 
not all types of providers. One of the proposals to 
establish a national standard would permit disclosures to 
be made to other providers without the consent of the 
individual, but would give the individual the opportunity 
to “opt out” of disclosures to specified providers. In this 
example, it is difficult to determine whether the state law 
in question is more or less protective than the proposed 
national standard. On the one hand, the state law in this 
example is more restrictive than the reform proposal 
because it limits the types of providers that can receive 
information without consent. On the other hand, it is 
weaker than the reform proposal because it does not 
provide the individual with an opportunity to decline 
permission to disclose to those providers. The problem 
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is not insurmountable: in this example, one solution 
might be to apply the opt-out provision of the national 
standard to that part of the state law that permits some 
types of disclosures without consent. At the same time, 
the current condition of many state mental health laws 
may make application of the preemption principle 
difficult. 
A second important question is whether there should 
continue to be separate legal standards for mental health 
confidentiality and for substance use and alcohol use 
confidentiality. The reform proposals advanced to date 
generally would leave the Federal substance use law 
intact. This would have the practical effect of locking in 
the disparate standards that currently exist for mental 
health information (governed by state laws) and 
substance and alcohol use information (governed by the 
Federal law). Some experts disagree with the notion of 
having discrete, disease-based standards, on the ground 
that there are other diseases that raise legitimate 
concerns regarding privacy that do not receive special 
protection (Gostin, 1995). Others would retain the strict 
protections currently available to substance and alcohol 
use data, while extending the same protections to mental 
health information. This report does not endorse either 
perspective. However, it would be useful to examine 
more closely whether disparate standards have an effect 
on clinical practice and on the privacy expectations of 
individuals in treatment, particularly those with both a 
mental illness and a substance abuse diagnosis. 
Summary 
There are many reasons why an individual with a mental 
illness might decide not to seek treatment. For example, 
some people might forego treatment for financial 
reasons. Others might decide that the risk of stigma and 
discrimination that people with mental illness still 
encounter is too high a price to bear. In the latter 
situation, being able to provide assurances that the 
principle of confidentiality receives strong protection 
may make the difference in the decision to enter and 
participate fully in treatment. 
Confidentiality is a matter of both ethical and legal 
concern. As noted earlier, each of the health care 
Professions endorses confidentiality as a core matter. 
However, it is the law that establishes the basic rules that 
govern confidentiality in practice. The law can expand 
confidentiality, as the U.S. Supreme Court did when it 
ruled that a psychotherapeutic privilege would apply in 
Federal court. The law also can decide that the principle 
of confidentiality must yield to other values, as the 
California Supreme Court did when it decided that 
mental health professionals had an obligation to protect 
third parties whom the professional reasonably 
concluded could be endangered by a client in treatment. 
It is clear that confidentiality is not absolute. There 
are other competing values that require its breach in 
certain circumstances. However, it also seems clear that 
there are significant gaps in the current legal framework 
that protects the confidentiality of mental health 
information. Consideration of an appropriate level of 
legal protection for mental health information should 
acknowledge that mental illness continues to be a 
category of illness that may subject a person receiving a 
diagnosis to discrimination and other disadvantages. 
In the absence of strong confidentiality protections, 
some individuals with mental illness may decide that the 
benefit of treatment is outweighed by the risk of public 
disclosure. This would be harmful not only to the 
individual, but to a public that has a stake in the mental 
health of its members. The U.S. Supreme Court 
summarized this public interest succinctly in the decision 
quoted at the beginning of this section: 
The psychotherapist privilege serves the public 
interest by facilitating the provision of 
appropriate treatment for individuals suffering 
the effects of a mental or emotional problem. 
The mental health of our citizenry, no less than 
its physical health, is a public good of 
transcendent importance. (Jaffee v. Redmond, 
1996) 
It is to be hoped that this public good, as well as the 
private good represented by successful treatment for 
mental illness, governs the continuing debate regarding 
the protection of confidentiality. 
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Conclusions 
In an era in which the confidentiality of all health care 
information, its accessibility, and its uses are of concern 
to all Americans, privacy issues are particularly keenly 
felt in the mental health field. An assurance of 
confidentiality is understandably critical in individual 
decisions to seek mental health treatment. Although an 
extensive legal framework governs confidentiality of 
consumer-provider interactions, potential problems exist 
and loom ever larger. 
1. 
2. 
3. 
4. 
5. 
6. 
7. 
People’s willingness to seek help is contingent on 
their confidence that personal revelations of mental 
distress will not be disclosed without their consent. 
The U.S. Supreme Court recently has upheld the 
right to the privacy of these records and the 
therapist-client relationship. 
Although confidentiality issues are common to 
health care in general, there are special concerns for 
mental health care and mental health care records 
because of the extremely personal nature of the 
material shared in treatment. 
State and Federal laws protect the confidentiality of 
health care information but are often incomplete 
because of numerous exceptions which often vary 
from state to state. Several states have, implemented 
or proposed models for protecting privacy that may 
serve as a guide to others. 
States, consumers, and family advocates take 
differing positions on disclosure of mental health 
information without consent to family caregivers. In 
states that allow such disclosure, information 
provided is usually limited to diagnosis, prognosis, 
and information regarding treatment, specifically 
medication. 
When conducting mental health research, it is in the 
interest of both the researcher and the individual 
participant to address informed consent and to 
obtain certificates of confidentiality before 
proceeding. Federal regulations require informed 
consent for research being conducted with Federal 
funds. 
New approaches to managing care and information 
technology threaten to further erode the 
confidentiality and trust deemed so essential 
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between the direct provider of mental health services 
and the individual receiving those services. It is 
important to monitor advances so that confidentiality 
of records is enhanced, instead of impinged upon, by 
technology. 
8. Until the stigma associated with mental illnesses is 
addressed, confidentiality of mental health 
information will continue to be a critical point of 
concern for payers, providers, and consumers. 
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CHAPTER 8 
A VISION FOR THE FUTURE 
M ental health is fundamental to health and human functioning. Yet much more is known about 
mental illness than about mental health. Mental ill- 
nesses are real health conditions that are characterized 
by alterations in thinking, mood, or behavior-all 
mental, behavioral, and psychological symptoms 
mediated by the brain. Mental illnesses exact a stagger- 
ing toll on millions of individuals, as well as on their 
families and communities and our Nation as a whole. 
Appropriate treatment can alleviate, if not cure, the 
symptoms and associated disability of mental illness. 
With proper treatment, the majority of people with 
mental illness can return to productive and engaging 
lives. There is no “one size fits all” treatment; rather, 
people can choose the type of treatment that best suits 
them from the diverse forms of treatment that exist. 
The main findings of the report, gleaned from an 
exhaustive review of research, are that the efficacy of 
mental health treatments is well documented and a 
range of treatments exists for most mental disorders. 
On the strength of these findings, the single, explicit 
recommendation of the report is to seek help if you 
have a mental health problem or think you have symp- 
toms of a mental disorder. 
Today, the majority of those who need mental 
health treatment do not seek it. The reluctance of 
Americans to seek and obtain care for mental illness is 
all too understandable, given the many barriers that 
stand in their way. If the information contained in this 
Surgeon General’s report is to be translated into its 
recommended action--to seek help for mental ill- 
ness-our society must resolve to dismantle barriers to 
seeking help that are sizable and significant, but not 
insurmountable. 
This vision for the future proposes to the American 
people broad courses of action meant to hasten progress 
toward the major recommendation of this report. These 
calls to action constitute necessary first steps toward 
overcoming the gaps in what.is known and removing 
the barriers that keep people from seeking and obtain- 
ing mental health treatment. Although these are not 
formal policy recommendations, they offer a focused 
vision that may inform future policy. They are intended 
for policymakers, service and treatment providers, 
professional and advocacy organizations, researchers, 
and, most importantly, the American people. The health 
of the American people demands that we act with 
resolve and a sense of urgency to place mental health as 
a cornerstone of health and address through research 
and education both the impact and the stigma attached 
to mental illness. 
Continue To Build the Science Base 
The Nation has realized immense dividends from 5 
decades of investment in research focused on mental 
illness and mental health. Yet to realize further ad- 
vances in treatment and, ultimately, prevention, the 
Nation must continue to invest in research at all levels. 
This Surgeon General’s report is issued at a time of 
unprecedented scientific opportunity. Today, integra- 
tive neuroscience and molecular genetics present some 
of the most exciting basic research opportunities in 
medical science. Molecular and genetic tools are being 
used to identify genes and proteins that might be 
involved in the origins of mental illness and that clearly 
are altered by drug treatment and by the environment. 
Genes and gene products promise to provide novel 
targets for new medications and psychosocial interven- 
tions. The opportunities available underscore the need 
for the Federal mental health research community to 
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strengthen partnerships with both the biotechnology 
and the pharmaceutical industries. Gaining new knowl- 
edge about mental illness and health is everybody’s 
business. A plethora of new pharmacologic agents and 
psychotherapies for mental disorders affords new 
treatment opportunities but also challenges the scien- 
tific community to develop new approaches to clinical 
and health services interventions research. Responding 
to the calls of managed mental and behavioral health 
care systems for evidence-based interventions will have 
a much needed and discernible impact on practice. 
Also, as this Surgeon General’s report emphasizes. 
high-quality research is a potent weapon against stigma, 
one that forces skeptics to let go of misconceptions and 
stereotypes concerning mental illness and the burdens 
experienced by persons who have these disorders. 
Special effort is required to address pronounced 
gaps in the mental health knowledge base. Key among 
these are the urgent need for research evidence that 
supports strategies for mental health promotion and 
illness prevention. Each chapter in this report has 
identified additional, specific gaps that must be ad- 
dressed. 
The vitality of clinical research hinges on the 
willing participation of clinical research volunteers. By 
law, subjects in federally sponsored research are 
required to give informed consent-that is, to agree to 
participate voluntarily after being informed about the 
purpose, benefits, and risks of the research, among 
other requirements (45 CFR 46). The law affords 
special protections for children and for persons with 
impaired decisionmaking capacity. Policies must be 
promulgated to ensure that vulnerable individuals are 
protected while they participate in research needed for 
the development of new treatments. 
Overcome Stigma 
The stigma that envelops mental illness deters people 
from seeking treatment. Stigma assumes many forms, 
both subtle and overt. It appears as prejudice and 
discrimination, fear, distrust, and stereotyping. It 
prompts many people to avoid working, socializing, 
and living with people who have a mental disorder. 
Stigma impedes people from seeking help for fear that 
the confidentiality of their diagnosis or treatment will 
be breached. It gives insurers-in the public sector as 
well as the private-tacit permission to restrict cover- 
age for mental health services in ways that would not 
be tolerated for other illnesses. Chapter 1 reviewed the 
influence of stigma historically in separating mental 
health from the mainstream of health and its role in 
thwarting access to appropriate treatment. Powerful and 
pervasive. stigma prevents people from acknowledging 
their own mental health problems, much less disclosing 
them to others. 
For our Nation to reduce the burden of mental I 
illness, to improve access to care, and to achieve 
urgently needed knowledge about the brain, mind, and 
behavior, stigma must no longer be tolerated. The 
issuance of this Surgeon General’s Report on Mental 
Health seeks to help reduce stigma by dispelling myths 
about mental illness and by providing accurate knowl- 
edge to ensure more informed consumers. Organiza- 
tions and individuals are encouraged to draw freely 
upon the report in their own efforts to combat the 
insidious effects of stigma. 
Improve Public Awareness of Effective 
Treatment 
The Surgeon General’s report itself is expected to 
stimulate the demand for effective treatment for needed 
mental health care. Americans are often unaware of the 
choices they have for effective mental health treat- 
ments. In fact. as the preceding chapters demonstrate, 
there exists a constellation of treatments for most 
mental disorders. Treatments fall mainly under several 
broad categories-counseling, psychotherapy, medica- 
tion therapy, rehabilitation-yet within each category 
are many more choices. 
Individuals should be encouraged to seek help from 
any source in which they have confidence. If they do 
not improve with the help obtained initially, they 
should be encouraged to keep trying to obtain assis- 
tance. If the path of help-seeking leads to only limited 
improvement, an array of options still exists: the 
intensity of treatment may be changed. new treatments 
may be introduced. or another provider may be sought. 
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Family members, clergy, and friends often can help by 
encouraging a distressed person to seek help. 
All human services professionals, not just health 
professionals, have an obligation to be better informed 
about mental health treatment resources in their com- 
munities. Managed care companies and other health 
insurers need to publish clear information about their 
mental health benefits (usually called “behavioral 
health benefits”). At present, many beneficiaries appear 
not to know ifthey have mental health coverage, much 
less where to seek help for problems. 
Ensure the Supply of Mental Health 
Services and Providers 
The service system as a whole. as opposed to treatment 
services considered in isolation, dictates the outcome of 
treatment (Goldman, 1998). The fundamental compo- 
nents of effective service delivery include integrated 
community-based services, continuity of providers and 
treatments, family support services (including 
psychoeducation), and culturally sensitive services. 
Effective service delivery for individuals with the most 
severe conditions also requires supported housing and 
supported employment. For adults and children with 
less severe conditions, primary health care, the schools, 
and other human services must be prepared to assess 
and, at times, to treat individuals who come seeking 
help. All services for those with a mental disorder 
should be consumer oriented and focused on promoting 
recovery. That is, the goal of services must not be 
limited to symptom reduction but should strive for 
restoration of a meaningful and productive life. 
Across the Nation, certain mental health services 
are in consistently short supply. These include the 
following: 
l Wraparound services for children with serious 
emotional problems and multisystemic treatment. 
Both treatment strategies should actively involve 
the participation of the multiple health, social 
service, educational, and other community re- 
sources that play a role in ensuring the health and 
well-being of children and their families; 
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l Assertive community treatment, an intensive 
approach to treating people with serious mental 
illnesses; 
l Combined services for people with co-occurring 
severe mental disorders and substance abuse 
disorders; 
. A range of prevention and early case identification 
programs; and 
l Disease management programs for conditions such 
as late-life depression in primary care settings. 
All too frequently, these effeitive programs are simply 
unavailable in communities. It is essential to expand the 
supply of effective, evidence-based services throughout 
the Nation. 
The supply of well-trained mental health profes- 
sionals also is inadequate in many areas of the country, 
especially in rural areas (Peterson et al., 1998). Particu- 
larly keen shortages are found in the numbers of mental 
health professionals serving children and adolescents 
with serious mental disorders and older people (Peter- 
son et al., 1998). More mental health professionals also 
need to be trained in cognitive-behavioral therapy and 
interpersonal therapy, two forms of psychotherapy 
shown by rigorous research to be effective for many 
types of mental disorders. 
Ensure Delivery of State-of-the-Art 
Treatments 
State-of-the-art treatments, carefully refined through 
years of research, are not being translated into commu- 
nity settings. As noted throughout this report, a wide 
variety of community-based services are of proven 
value for even the most severe mental illnesses. Excit- 
ing new research-based advances are emerging that will 
enhance the delivery of treatments and services in areas 
crucial to consumers and families-employment. 
housing, and diversion of people with mental disorders 
out of the criminal justice systems. Yet a gap persists in 
the broad introduction and application of these 
advances in services delivery to local communities. and 
many people with mental illness are being denied the 
most up-to-date and advanced forms of treatment. 
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Multiple and complex explanations exist for the 
gap between what is known through research and what 
is actually practiced in customary care. Foremost 
among these are practitioners’ lack of knowledge of 
research results; the lag time between the reporting of 
research results and the translation of new knowledge 
into practice; and the cost of introducing innovations in 
health systems. In addition, significant differences that 
exist between academic research settings and actual 
practice settings help account for the gap between what 
is known and what is practiced. The patients in actual 
practice are more heterogeneous in terms of their 
overall health and cultural backgrounds, and both 
patients and providers are subject to cost pressures. 
New strategies must be devised to bridge the gap 
between research and practice (National Advisory 
Mental Health Council, 1998). 
Tailor Treatment to Age, Gender, 
Race, and Culture 
This report presents clear evidence that mental health 
and mental illness are shaped by age, gender, race, and 
culture as well as additional facets of diversity that can 
be found within all of these population groups-for 
example, physical disability or a person’s sexual 
orientation. The consequences of not understanding 
these influences can be profoundly deleterious. 
To be effective, the diagnosis and treatment of 
mental illness must be tailored to individual circum- 
stances, while taking into account, age, gender, race, 
and culture and other characteristics that shape a 
person’s image and identity. Services that take these 
demographic factors into consideration have the 
greatest chance of engaging people in treatment, 
keeping them in treatment, and helping them to recover 
thereafter. The successful experiences of individual 
patients will positively influence attitudes toward 
mental health services and service providers, thus 
encouraging others who may share similar concerns or 
interests to seek help. 
While women and men experience mental disorders 
at almost equal rates. some mental disorders such as 
depression. panic disorder. and eating disorders affect 
women disproportionately. The mental health service 
system should be tailored to focus on women’s unique 
needs (Blumenthal, 1994). 
Members of racial and ethnic minority groups 
account for an increasing proportion of the Nation’s 
population. Mental illness is at least as prevalent 
among racial and ethnic minorities as in the majority 
white population (Regier et al.. 1993). Yet many racial 
and ethnic minority group members find the organized 
mental health system to be uninformed about cultural 
context and. thus, unresponsive and/or irrelevant. It is 
partly for this reason that minority group members 
overall are less inclined than whites to seek treatment 
(Sussman et al., 1987; Gallo et al., 1995), and to use 
outpatient treatment services to a much lesser extent 
than do non-Hispanic whites. Yet it is important to 
acknowledge and appreciate that there exist wide 
variations within and among racial and ethnic minority 
groups with respect to use of mental health services. 
The use of inpatient treatment services by African 
Americans, for example, is much higher than use of 
these services by whites, a difference that cannot be 
accounted for by differences in prevalence alone 
(Chapter 2). The reasons for these disparities in utiliza- 
tion of services must be further understood through 
research. In the interim, culturally competent ser- 
vices-that is, services that incorporate understanding 
of racial and ethnic groups, their histories, traditions, 
beliefs, and value systems-are needed to enhance the 
appropriate use of services and effectiveness of treat- 
ments for ethnic and racial minority consumers. With 
appropriate training and a fundamental respect for 
clients, any mental health professional can provide 
culturally competent services that reflect sensitivity to 
individual differences and, at the same time, assign 
validity to an individual’s group identity. Still, many 
members of ethnic and racial minority groups may 
prefer to be treated by mental health professionals of 
similar background. There is an insufficient number of 
mental health professionals from racial and ethnic 
minority groups (Peterson et al., 1998), a problem that 
needs to be corrected. 
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Facilitate Entry Into Treatment 
The mental health service system is highly fragmented. 
Many who seek treatment are bewildered by the maze 
of paths into treatment; others in need of care are 
stymied by a lack of information about where to seek 
effective and affordable services. In recent years, some 
progress has been made in coordinating services for 
those with severe mental illness, but more can be 
accomplished. Public and private agencies have an 
obligation to facilitate entry into treatment. There are 
multiple “portals of entry” to mental health care and 
treatment, including a range of community and faith- 
based organizations. Primary health care could be an 
important portal of entry for children and adults of all 
ages with mental disorders. The schools and child 
welfare system are the initial points of contact for most 
children and adolescents, and can be useful sources of 
first-line assessment and referral, provided that exper- 
tise is available. The juvenile justice system represents 
another pathway, although many overburdened facili- 
ties tend to lack the staff required to-deal with the 
magnitude of the mental health problems encountered. 
Of equal concern are the adult criminal justice and 
corrections systems, which encounter substantial 
numbers of detainees with mental illness (Ditton, 
1999). Individuals with mental disorders often are 
neglected or victimized in these institutions. 
It is essential for first-line contacts in the commu- 
nity to recognize mental illness and mental health 
problems, to respond sensitively, to know what re- 
sources exist, and to make proper referrals and/or to 
address problems effectively themselves. For the 
general public, primary care represents a prime oppor- 
tunity to obtain mental health treatment or an appropri- 
ate referral. Yet primary health care providers vary in 
their capacity to recognize and manage mental health 
problems. Many highly committed primary care provid- 
ers do not know referral sources or do not have the time 
to help their patients find services. 
Some people do not seek treatment because they 
are fearful of being forced to accept treatments not of 
their choice or of being treated involuntarily for pro- 
longed periods (Sussman et al., 1987; Monahan et al., 
1999). For most, these fears are unwarranted: coercion, 
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or involuntary treatment, is restricted by law only to 
those who pose a direct threat of danger to themselves 
or others or, in some instances, who demonstrate a 
grave disability. Coercion takes the form of involuntary 
commitment to a hospital; in about 40 states and 
territories, it includes certain outpatient treatment 
requirements. Advocates for people with mental illness 
hold divergent views regarding coercion. Some advo- 
cates crusade for more stringent controls and treatment 
mandates, whereas others adamantly oppose coercion 
on any grounds. One point is clear: the need for 
coercion should be reduced- significantly when ade- 
quate services are readily accessible to individuals with 
severe mental disorders who pose a threat of danger to 
themselves or others (Policy Research Associates, 
1998). As the debate continues, more study is needed 
concerning the effectiveness of different strategies to 
enhance compliance with treatment. Almost all agree 
that coercion should not be a substitute for effective 
care that is sought voluntarily. 
Reduce Financial Barriers to Treatment 
Financial obstacles discourage people from seeking 
treatment and from staying in treatment. Repeated 
surveys have shown that concerns about the cost of care 
are among the foremost reasons why people do not seek 
care (Sussman et al., 1987; Sturm & Sherboume. 
1999). As documented in Chapter 6 of this report, there 
is an enormous disparity in insurance coverage for 
mental disorders in contrast to other illnesses. Mental 
health coverage often is arbitrarily restricted. Individu- 
als and families consequently are forced to draw on 
relatively-and substantially-more of their own 
resources to pay for mental health treatment than they 
pay for other types of health care. This inequity is a 
deterrent to treatment and needs to be redressed. 
Recent legislative efforts to mandate equitable 
insurance coverage for mental health services have 
been heralded as steps in the right direction for reduc- 
ing financial barriers to treatment. Still, for the more 
than 44 million Americans who lack any health insur- 
ance, equity of mental health and other health benefits 
is moot. For many who do have health insurance. 
coverage restrictions for mental health treatment 
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persist. Data reveal that access to and use of services 
have increased following enhancements of mental 
health benefits in private insurance, Medicare, 
Medicaid, and the Federal Employees Health Benefit 
Program. Chapter 6 of this report makes it clear that 
equality between mental health coverage and other 
health coverage-a concept known as “parity’‘-is an 
affordable and effective objective. In states in which 
legislation requires parity of mental health and general 
coverage, cost increases are nearly imperceptible as 
long as the care is managed. A recent paper suggests 
that the value of mental health treatment has increased 
in recent years-that is, effectiveness has 
increased-while expenditures have fallen (Franket al., 
1999). In light of cost-containment strategies of man- 
aged care, concerns about under-treatment still are 
warranted for individuals with the most severe mental 
disorders, but high-quality managed care has the 
potential to effectively match services to patient needs. 
Conclusion 
This Surgeon General’s Report on Mental Health 
celebrates the scientific advances in a field once 
shrouded in mystery. These advances have. yielded 
unparalleled understanding of mental illness and the 
services needed for prevention, treatment, and rehabili- 
tation. This final chapter is not an endpoint but a point 
of departure. The journey ahead must firmly establish 
mental health as a cornerstone of health: place mental 
illness treatment in the mainstream of health care 
services; and ensure consumers of mental health 
services access to respectful, evidenced-based, and 
reimbursable care. 
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APPENDIX 
DIRECTORY OF RESOURCES 
Lead Agencies 
Office of the U.S. Surgeon General 
5600 Fishers Lane 
Rockville, MD 20857 
Tel: 30 l-443-4000 
Fax: 301-443-3574 
Web site: www.surgeongeneral.gov 
Center for Mental Health Services 
Knowledge Exchange Network 
P.O. Box 42490 
Washington, DC 200 15 
Tel: 800-789-CMHS (2647) 
Fax: 301-984-8796 
Email: ken@mentalhealth.org 
Website: www.mentalhealth.org 
National Institute of Mental Health 
Office of Communications and Public Liaison 
600 1 Executive Boulevard 
Room 8 184, MSC 9663 
Bethesda, MD 20892-9663 
Tel: 301-443-4513 
TTY: 301-443-843 1 
Fax: 30 l-443-4279 
Email: nimhinfo@nih.gov 
Website: www.nimh.nih.gov 
Substance Abuse and Mental Health Services 
Administration 
Room 12-105 Parklawn Building 
5600 Fishers Lane 
Rockville, MD 20857 
Website: www.samhsa.gov 
Center for Substance Abuse Treatment 
Website: www.samhsa.gov/csat 
Center for Substance Abuse Prevention 
Website: www.samhsa.gov/csap 
Department of Health and Human 
Services Agencies 
Office of the Secretary 
200 Independence Avenue, S.W. 
Washington, DC 20201 
Tel: 202-690-7000 
Website: www.hhs.gov/progorg/ospage.html 
Administration for Children and Families 
370 L’Enfant Promenade, S.W. 
Washington, DC 20447 
Website: www.acf.dhhs.gov 
Administration on Aging 
National Aging Information Center 
330 Independence Avenue, SW 
Washington, DC 20201 
Tel: 202-6 19-750 1 
Tel: 800-677- 1116 (Eldercare Locator) 
Email: AoAInfo@aoa.gov 
Website: www.aoa.dhhs.gov 
Agency for Health Care Policy and Research 
Publications Clearinghouse 
P.O. Box 8547 
Silver Spring, MD 20907 
Tel: 800-358-9295 
Website: www.ahcpr.gov 
Agency for Toxic Substances and Disease 
Registry 
Tel: 888-42-ATSDR or 888-422-8737 
Email: ATSDRIC@cdc.gov 
Website: www.atsdr.cdc.gov 
Centers for Disease Control and Prevention 
1600 Clifton Road 
Atlanta, GA 30333 
Tel: 800-3 1 l-3435 or 404-639-3534 
Website: www.cdc.gov 
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Food and Drug Administration 
Center for Drugs, Evaluation and Safety 
5600 Fishers Lane, RM 12B-3 1 
Rockville, MD 20857 
Tel: 888-INFO-FDA (888-463-6332) 
Web-site: www.fda.gov 
Health Care Financing Administration 
500 Security Boulevard 
Baltimore, MD 21244 
Tel: 410-786-3000 
Website: www.hcfa.gov 
Health Resources and Services Administration 
Clearinghouse on Maternal and Child Health 
2070 Chain Bridge Road, # 450 
Vienna, VA 22182 
Tel: 88%434-4MCH 
Website: www.nmchc.org 
Indian Health Service 
Headquarters East 
Parklawn Building 
5600 Fishers Lane 
Rockville, MD 20857 
Website: www.ihs.gov 
National Institutes of Health 
Bethesda, MD 20892 
Email: NIHInfo@od.nih.gov 
Website: www.nih.gov 
Program Support Center 
5600 Fishers Lane 
Rockville, MD 20857 
Website: www.psc.gov 
Substance Abuse and Mental Health Services 
Administration 
Room 12-105 Parklawn Building 
5600 Fishers Lane 
Rockville, MD 20857 
Website: www.samhsa.gov 
General Federal Government Websites 
Consumer Information Center 
Website: www.pueblo.gsa.gov 
Health Finder 
Website: www.healthfinder.gov 
Mental Health: The Cornerstone of Health 
Website: www.mentalhealth.org . 
comerstone/index.cfm 
National Library of Medicine 
Website: www.nlm.nih.gov 
National Women’s Health Information Center 
Website: www.4woman.gov 
U.S. Consumer Gateway-Health 
Website: www.consumer.gov/health 
Additional Federal Resources 
Department of Education 
400 Maryland Avenue, SW 
Washington, DC 20202-0498 
Tel: 800-USA-LEARN 
Website: www.ed.gov 
Department of Housing and Urban Development 
45 1 Seventh Street, SW 
Washington, DC 20410 
Tel: 202-401-0388 
TTY: 202-708-1455 
Website: www.hud.gov 
Department of Housing and Urban Development 
Office of Community Planning and Development 
45 1 Seventh Street, SW, Room 7262 
Washington, DC 204 10 
Tel: 202-708-4300 
Fax: 202-708-3617 
Website: www.hud.gov/cpd/cpdhome.html 
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Department of Justice 
Housing and Civil Enforcement Section 
Civil Rights Division 
P.O. Box 65998 
Washington, DC 200355998 
Tel: 202-5 14-47 13 
Fax : 202-514-l 116 
Website: www.usdoj.gov/crt/activity.html#hce 
Department of Justice 
Office of Americans with Disabilities Act 
Civil Rights Division 
PO Box 66118 
Washington, DC 20035 
Tel: 800-5 14-0301 
Fax: 202-307-l 198 
TDD: 800-5 14-0383 
Website: www.usdoj.gov/crt/ada/adahoml.htm 
Equal Employment Opportunity Commission 
1801 L Street, N.W. 
Washington, DC 20507 
Tel: 202-663-4900 
TDD: 202-663-4494 
Website: www.eeoc.gov 
National Clearinghouse for Alcohol and Drug 
Information (NCADI) 
P.O. Box 2345 
Rockville, MD 20847-2345 
Tel: 800-729-6686 or 301-468-2600 
Fax: 301-468-6433 
TDD: 800-487-4889 
Email: info@health.org 
Website: www.health.org 
National Clearinghouse on Child Abuse and 
Neglect Information (NCCAN) 
P.O. Box 1182 
Washington, DC 200 13- 1182 
Tel: 800-FYI-3366 or 703-385-7565 
Fax: 703-385-3206 
National Criminal Justice Reference Service 
(NCJRS) 
P.O. Box 6000 
Rockville, MD 20849-6000 
Tel: 800-851-3420 or 301-519-5500 
TTY: 877-7 12-9279 
Website: www.ncjrs.org 
National Information Center for Children and 
Youth with Disabilities (NICHY) 
P.O. Box 1492 
Washington, DC 200 13 
Tel: 800-695-0285 
Fax: 202-884-8441 
E-mail: nichcy@aed.org 
Website: www.nichcy.org 
National Institute on Aging/NIH 
Alzheimer’s Disease Education and Referral 
Center (ADEAR) 
P.O. Box 8250 
Silver Spring, MD 20898-8057 
Tel: 800-43704380 
Website: www.alzheimers.org 
National Institute of Justice 
8 10 Seventh Street, NW 
Washington, DC 2053 1 
Website: www.ojp.usdoj.gov/nij 
National Institute on Alcohol Abuse and 
Alcoholism/NIH 
Office of Scientific Communication 
6000 Executive Boulevard 
Suite 409 
Bethesda, MD 20892-7003 
Tel: 30 l-443-3860 
Website: www.niaaa.nih.gov 
National Institute on Child 
Health and Human Development/NIH 
NICHD Clearinghouse 
P.O. Box 3006 
Rockville, MD 20847 
Tel: 800-370-2943 
Website: www.nichd.nih.gov 
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National Institute on Drug Abuse/ NIH 
6001 Executive Boulevard, Room 5213 
Bethesda, MD 20892-9561 
Tel: 301- 443-l 124 
Email: information@list.nida.nih.gov 
Website: www.drugabuse.gov 
National Institute on Neurological Disorders and 
Stroke/NM 
Office of Communications and Public Liaison 
P.O. Box 5801 
Bethesda, MD 20824 
Tel: 301-496-575 1 
Website: www.ninds.nih.gov 
Social Security Administration 
Office of Public Inquiries 
640 1 Security Boulevard, Room 4-C-5 Annex 
Baltimore, MD 21235-6401 
Tel: 800-772-1213 
TTY: 800-325-0778 
Fax: 410- 965-0696 
Website: www.ssa.gov 
Veterans Health Administration 
1120 Vermont Avenue. NW 
Washington, DC 20421 
Tel : 800-827-1000. 
Website: www.va.gov/health/index.htm 
Rehabilitation Services Administration 
U.S. Department of Education 
330 C Street. S.W., Room 3211 
Washington, DC 
Tel: 202-205-5474 
Website: www.ed.govlofficeslOSERS/RSA 
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